{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "cb10af52-465f-4933-8799-f05aeab26dac",
   "metadata": {},
   "source": [
    "# Natural language processing - getting the sentiment score for positive, negative and unceratinty. Using Loughran and McDonalds' method\n",
    "\n",
    "We are now going to move on to extracting the sentiment positive, negative and uncertainty scores for the transcripts.\n",
    "We are going to use the dictionary developed by Loughran and McDonald, compared to other methods, this is developed within our field of academia.\n",
    "A lot of other methods use dictionaries created from other data sources than financial texts, like social media. This will not be as suitable for our usecase.\n",
    "\n",
    "This is because words otherwise seen as negative are not always in finance.\n",
    "\"We find that almost three-fourths of negative word counts in 10-K filings based on the Harvard dictionary are typically not negative in a financial context. Common words like depreciation, liability, foreign, and board are not tona when occurring in a 10-K.\" - Loughran, Tim, and Bill McDonald. \"When is a liability not a liability? Textual analysis, dictionaries, and 10‚ÄêKs.\", The Journal of Finance 66, no. 1 (2011): 35-65."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "id": "8267d3bc-4330-44c3-86b3-9e31fd5d2928",
   "metadata": {},
   "outputs": [],
   "source": [
    "# If you run into a spacy problem, run this command again by removing the # before the next row\n",
    "#!python -m spacy download en_core_web_md "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "ded6704d-8b4a-41e2-ac35-4ddd8ec324bd",
   "metadata": {
    "scrolled": true,
    "tags": []
   },
   "outputs": [],
   "source": [
    "# Spacy is a NLP library that can be used for a lot of things, \n",
    "# we are going to be using it to remove stopwords, punctuations and so on. \n",
    "import spacy\n",
    "nlp=spacy.load('en_core_web_md')"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0465ab99-8190-4527-8dc8-efca90f0f2c2",
   "metadata": {},
   "source": [
    "## Lets import the transcripts again, and prepare one for analysis"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "id": "26a54f83-f774-484d-93d6-71fbfb098c9a",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pickle\n",
    "transcripts = pickle.load( open( str(\"transcripts/ABBV.p\"), \"rb\" ) )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "id": "5d7a2f50-3813-434e-a3f2-c06336cb7db2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "48"
      ]
     },
     "execution_count": 34,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(transcripts)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "89f6b2d9-761d-484d-8295-6dcdc4f06768",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "dict_keys(['audio', 'id', 'participant', 'quarter', 'symbol', 'time', 'title', 'transcript', 'year'])"
      ]
     },
     "execution_count": 35,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "transcripts[1].keys()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "id": "97495b06-5771-4324-bcf0-684122fcb375",
   "metadata": {
    "scrolled": true,
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "This transcript is from:  2021-02-04 00:59:09\n",
      "This transcript is from:  2020-10-30 20:18:17\n",
      "This transcript is from:  2020-07-31 19:59:11\n",
      "This transcript is from:  2020-05-01 19:27:53\n",
      "This transcript is from:  2020-02-07 18:36:46\n",
      "This transcript is from:  2020-01-15 19:22:17\n",
      "This transcript is from:  2019-11-01 19:45:10\n",
      "This transcript is from:  2019-09-10 20:22:25\n",
      "This transcript is from:  2019-07-26 17:56:58\n",
      "This transcript is from:  2019-06-25 19:29:10\n",
      "This transcript is from:  2019-06-12 21:21:57\n",
      "This transcript is from:  2019-04-25 22:11:10\n",
      "This transcript is from:  2019-03-13 19:19:09\n",
      "This transcript is from:  2019-03-12 16:14:08\n",
      "This transcript is from:  2019-01-25 18:52:18\n",
      "This transcript is from:  2019-01-09 21:27:30\n",
      "This transcript is from:  2018-11-27 20:25:24\n",
      "This transcript is from:  2018-11-02 16:23:27\n",
      "This transcript is from:  2018-09-12 19:19:10\n",
      "This transcript is from:  2018-07-27 21:46:59\n",
      "This transcript is from:  2018-04-26 18:04:21\n",
      "This transcript is from:  2018-01-26 21:18:06\n",
      "This transcript is from:  2017-10-27 18:12:06\n",
      "This transcript is from:  2017-07-28 22:38:23\n",
      "This transcript is from:  2017-04-27 19:34:39\n",
      "This transcript is from:  2017-01-27 19:31:15\n",
      "This transcript is from:  2016-10-28 18:47:11\n",
      "This transcript is from:  2016-07-29 20:04:23\n",
      "This transcript is from:  2016-04-29 05:36:22\n",
      "This transcript is from:  2016-01-29 18:50:13\n",
      "This transcript is from:  2015-10-30 23:38:12\n",
      "This transcript is from:  2015-07-24 18:17:10\n",
      "This transcript is from:  2015-04-23 21:30:10\n",
      "This transcript is from:  2015-03-13 06:15:11\n",
      "This transcript is from:  2015-03-05 21:41:17\n",
      "This transcript is from:  2015-01-30 20:44:14\n",
      "This transcript is from:  2014-10-31 19:29:15\n",
      "This transcript is from:  2014-07-25 15:58:12\n",
      "This transcript is from:  2014-04-25 18:44:09\n",
      "This transcript is from:  2014-03-05 18:57:07\n",
      "This transcript is from:  2014-01-31 16:51:14\n",
      "This transcript is from:  2013-10-25 16:30:05\n",
      "This transcript is from:  2013-09-10 22:25:10\n",
      "This transcript is from:  2013-07-26 17:10:06\n",
      "This transcript is from:  2013-06-13 23:59:05\n",
      "This transcript is from:  2013-05-15 03:26:07\n",
      "This transcript is from:  2013-04-26 16:01:16\n",
      "This transcript is from:  2013-03-13 23:56:19\n"
     ]
    }
   ],
   "source": [
    "for t in transcripts:\n",
    "    print('This transcript is from: ', t['time'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "id": "1e8f2a6f-0fff-4a67-867a-a4845e2b16d9",
   "metadata": {
    "scrolled": true,
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "\" Good morning and thank you for standing by. Welcome to the AbbVie Fourth Quarter 2020 Earnings conference call. All participants will be able to listen only until the question-and-answer portion of this call. [Operator Instructions] I would now like to introduce Ms. Liz Shea, Vice President of Investor Relations. Good morning and thanks for joining us. Also on the call with me today are Rick Gonzalez, Chairman of the Board and Chief Executive Officer; Michael Severino, Vice Chairman and President; and Rob Michael, Executive Vice President and Chief Financial Officer. Joining us for the Q&A portion of the call is Jeff Stewart, Executive Vice President, Commercial Operations. Before we get started, I remind you that some statements we make today may be considered forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. AbbVie cautions that these forward-looking statements are subject to risks and uncertainties, including the impact of the COVID-19 pandemic on AbbVie's operations and financial results that may cause actual results to differ materially from those indicated in the forward-looking statements. Additional information about these risks and uncertainties is included in our 2019 Annual Report on Form 10-K and in our other SEC filings. AbbVie undertakes no obligation to update these forward-looking statements except as required by law. On today's conference call, as in the past, non-GAAP financial measures will be used to help investors understand AbbVie's ongoing business performance. These non-GAAP financial measures are reconciled with comparable GAAP financial measures in our earnings release and regulatory filings from today, which can be found on our website. Unless otherwise noted, our commentary on sales growth is on a comparable basis, which includes full year -- full current year and historical results for Allergan. For this comparison of underlying performance, all historically reported Allergan revenues have been recast to conform to AbbVie's revenue recognition accounting policies and exclude the divestitures of Zenpep and Viokace. References to operational growth further excludes the impact of exchange. Following our prepared remarks, we'll take your questions. So with that, I'll now turn the call over to Rick. Thank you, Liz. Good morning, everyone and thank you for joining us today. I'll discuss our fourth quarter and full year 2020 performance as well as our expectations for 2021. Mike will then provide an update on recent advancements across our pipeline, and Rob will discuss the quarter and our 2021 guidance in more detail. Following our remarks, we'll take your questions. We delivered another strong quarter with adjusted earnings per share of $2.92, exceeding the midpoint of our guidance by $0.08. Fourth quarter total net revenues were up nearly 7% on a comparable operational basis. This performance was driven by robust double-digit sales growth from our immunology, hem/onc and neuroscience franchises, as well as 9% comparable operational sales growth of Botox Cosmetic, which is demonstrating a rapid recovery. Our fourth quarter performance topped off another excellent and truly transformational year for AbbVie, which included the successful acquisition and integration of Allergan, creating a stronger and much more diverse AbbVie with leadership across numerous attractive high growth markets. Significant contributions from our two new best in category immunology medicines, Rinvoq and Skyrizi, which combined for more than $2.3 billion in 2020 sales, their first full year on the market. We expect to combine contribution from Rinvoq and Skyrizi to nearly double in 2021 to approximately $4.6 billion based on their continued strong uptake in RA and psoriasis as well as Rinvoq's anticipated approvals in PSA, ankylosing spondylitis and atopic dermatitis later this year. We delivered continued robust growth from our leading hem/onc portfolio with Imbruvica and Venclexta contributing more than $6.6 billion in combined 2020 sales. We expect our hem/onc franchise to grow double-digits again in 2021. We also added two compelling oncology pipeline assets, Epcoritamab, a potential best-in-class CD3xCD20 bispecific antibody in development for B-cell malignancies and lemzoparlimab, an anti-CD47 monoclonal antibody being studied in multiple cancers. These two assets will further support the growth of our hem/onc franchise across our long-range plan. The acquisition of Allergan brought us a substantial neuroscience portfolio with compelling therapies for migraine and psychiatric conditions augmenting our already existing neuro franchise. The newly combined neuroscience franchise delivered nearly $4.9 billion in comparable 2020 revenue and is expected to grow double-digits in 2021. We also added the leading global Aesthetics franchise, a largely cash pay portfolio with roughly $3.5 billion in comparable 2020 revenues. As I previously noted, this portfolio has demonstrated a rapid V-shape recovery and we view Aesthetics as an extremely attractive long-term growth opportunity. And importantly, we made excellent progress in 2020 with our pipeline. We expect our R&D pipeline advancements to lead the FDA [ph] approval of more than a dozen new products or indications over the next two years, including a total of six additional indications for Rinvoq and Skyrizi, which will cover all of Humira's major indications plus new significant disease areas, including atopic dermatitis, expanded indications for Venclexta and Vraylar and several new product approvals including Atogepant for episodic migraine, Navitoclax for myelofibrosis and ABBV-951, a potentially transformative next-generation therapy for advanced Parkinson's disease. These new opportunities will collectively add meaningful revenue growth in advance of the US Humira LOE. We've entered 2021 in a strong position, which is reflected in our revenue and earnings per share guidance. Based on the recent outperformance of our business, we expect full-year 2021 comparable operational sales growth of approximately 9.4% with total AbbVie sales expected to be approximately $1.7 billion above current consensus, and we anticipate 2021 adjusted earnings per share of $12.32 to $12.52, representing growth of 17.6% at the midpoint. This level of guidance represents impressive performance with nearly all aspects of our business expected to perform at or above current consensus for 2021. The Allergan integration continues to go very well. The transition has been seamless despite the size of the transaction and the timing of the COVID pandemic. While we're making excellent progress against our expense synergies, which Rob will cover in more detail here momentarily, it remains increasingly clear to us that there are significant opportunities for long-term revenue contributions across numerous Allergan growth platforms. As we recently disclosed, we believe Ubrelvy, the first-to-market in leading oral CGRP for acute migraine represents a $1 billion plus peak sales opportunity. Atogepant, a potential once-daily, oral treatment for the prevention of episodic and chronic migraine also represents a $1 billion plus peak sales opportunity. We expect Vraylar's peak sales to approach $4 billion within its currently approved indications of schizophrenia, bipolar I disorder and bipolar depression with major depressive disorder or MDD representing a potentially significant incremental growth opportunity. Aesthetics, which is poised to regain its growth trajectory this year is expected to generate high single-digit revenue growth over the next decade. We continue to closely monitor the COVID dynamics, which will have an impact on our business again in 2021, predominantly in the first half of the year, but significantly moderated from the 2020 impact. And despite the recent COVID resurgence within select geographies, we feel the global healthcare system is much better equipped with COVID treatment protocols in PPE to safely see and treat patients throughout the current year. That said, some therapeutic areas continue to be more impacted than others, like CLL, HCV, certain hospital-based procedures among others, which we have contemplated in our 2021 guidance. Overall, we've been pleased with the rate of recovery across our business, a testament to our differentiated product profiles and our commercial execution. So in summary, we've assembled an impressive set of growth assets and the outlook for AbbVie's business remains strong. With Rinvoq and Skyrizi expected to contribute more than $15 billion in risk-adjusted sales by 2025 and our expectations for continued robust growth across hem/onc, neuroscience, and aesthetics, we have a high degree of confidence that we will be able to successfully absorb the Humira LOE impact in 2023, support an immediate return to total sales growth in 2024 and produce compelling high single-digit compounded annual total sales growth in 2025 through the remainder of the decade with the diversified portfolio and pipeline that we have today. With that, I'll turn the call over to Mike for additional comments on our R&D programs. Mike? Thank you, Rick. We've clearly made significant progress with our pipeline over the past few years, particularly our late-stage programs in hematologic oncology with Imbruvica and Venclexta, and in immunology with Rinvoq and Skyrizi. Since inception, our R&D organization has delivered an impressive set of new products, which collectively contributed approximately $11 billion in revenue in 2020. We also continue to see significant evolution of our early and mid-stage clinical programs with many assets expected to transition to late-stage registrational studies over the next several years. We will continue to replenish our late-stage pipeline with innovative assets that have the potential to drive additional growth for AbbVie in the second half of the decade. At our recent immunology investor event in December, we provided a detailed overview of our immunology programs, highlighting the robust data generated to-date for Rinvoq and Skyrizi across approved and pipeline indications. Included in this event, we presented positive topline data from two new Phase 3 studies for Rinvoq. Results from the first induction study in ulcerative colitis and results from the head-to-head study versus dupilumab in atopic dermatitis. We expect to see results from the second Phase 3 UC induction study later this quarter, and from the UC maintenance study in the middle of this year with regulatory submissions anticipated in the second half of 2021. Our regulatory applications for Rinvoq in atopic dermatitis are currently under review and we expect an approval decision in the US in the second quarter based on priority review and in Europe in the second half of the year. We recently received European Commission approval for Rinvoq in psoriatic arthritis and ankylosing spondylitis and expect approval decisions for those indications in the US in the first half of this year. I want to take a moment to address the topic of safety, specifically MACE and malignancies following the results from tofacitinib's post-marketing safety study. At present, there are no data to suggest the safety outcomes from their study applied to a specific JAK1 inhibitor such as Rinvoq. We are not aware of any signal for an elevated risk of MACE or malignancies with the Rinvoq or any JAK inhibitor other than Xeljanz. We conducted a pooled database analysis across our clinical trials for DVT, MACE and malignancies at the time of Rinvoq's regulatory submission and have updated it periodically including up to the present. Rates with Rinvoq have not been elevated relative to competitors or to expected baseline rates. Importantly, there has been no increase or meaningful change in those rates over time. Additionally, we adjudicate events for MACE and DVT, which is considered the highest standard of evidence. If we look across our long-term database in RA, a population that is at increased risk for MACE events, our rates remain low. At the approved dose in RA, we have followed more than 3,700 treated patients totaling more than 9,000 patient-years' experience. Our rate of MACE events is 0.4 per 100 patient-years, which compares favorably to the expected rate of 1.0 to 1.7 events for 100 patient-years. In addition, there is no evidence of a dose-response between the 15 and 30-milligram doses. Similarly, the rate of malignancy, excluding non-melanoma skin cancer with similar follow-up is 0.8 events per100 patient-years. This rate is also consistent with the expected range of rates of 0.86 to 0.94 per 100 patient-years. And again, we see no evidence of a dose-response between 15 and 30-milligrams. Moving now to Skyrizi; we also recently reported top-line results from the Phase 3 programs for Skyrizi in Crohn's disease and psoriatic arthritis. In the two Crohn's induction studies, Skyrizi demonstrated significant improvements in clinical remission and endoscopic endpoints compared to placebo with symptom improvement seen as early as week four. Based on the data generated to date, we believe Skyrizi has the potential to become an important new treatment option for patients with moderate to severe Crohn's disease. We expect to see results from the maintenance study in Crohn's disease later this year with regulatory submissions anticipated in the second half of 2021. We're also very pleased with Skyrizi's results in the Phase 3 studies in psoriatic arthritis, where we saw significant improvements in disease activity across both skin and joint endpoints compared to placebo. We believe that the activity we have seen on joint disease and the impressive skin clearance that is a hallmark of the Skyrizi program make it a compelling offering for patients with mixed joint and skin involvement. We plan to submit our regulatory applications for Skyrizi in psoriatic arthritis in the first half of this year. We're making good progress with our early and mid-stage immunology programs as well where we expect several data readouts and phase transitions in 2021. We expect to begin three new studies for ABBV-154, our TNF steroid conjugate including a Phase 2b dose-ranging study in RA as well as Phase 2 studies in Crohn's disease and polymyalgia rheumatica. And we'll see proof-of-concept data in the second quarter for ravagalimab, our CD40 antagonist in Phase 2 for ulcerative colitis, and for ABBV-157, our oral ROR-gamma T inhibitor in Phase 1 for psoriasis. Both of these programs experienced slight COVID-related delays with results now expected for both in the second quarter of this year. In oncology, we continue to make significant progress advancing our pipeline with numerous data readouts and regulatory milestones last year. As well as the addition of several new assets brought in through our in-licensing efforts, including Genmab's CD3xCD20 epcoritamab and I-Mab's anti-CD47 lemzoparlimab. We showcased new data from several programs at the recent ASH meeting where we presented nearly 40 abstracts from eight different assets. Notable presentations included data from the Phase 2 CAPTIVATE trial evaluating Imbruvica plus Venclexta in frontline CLL, which showed patients who achieved undetectable MRD following this combination maintain their deep remission at the one-year mark after stopping therapy with a 95% rate of disease free survival. We also presented new five-year data from Venclexta's Murano trial demonstrating the benefits of fixed duration Venclexta combinations and helping patients achieve sustained progression-free survival. The latest results from Murano in the relapsed refractory CLL setting showed a median progression-free survival of 54 months in the Venclexta and rituximab group, compared to 17 months in the bendamustine-rituximab group, three or more years after stopping treatment. Updated dose-escalation data from a Phase 1 study evaluating epcoritamab in B-cell malignancies were also presented at ASH. Epcoritamab is a subcutaneously delivered bispecific CD3xCD20 antibody being developed in collaboration with Genmab. In the Phase 1 study, epcoritamab demonstrated encouraging single agent anti-tumor activity in heavily pretreated patients with a consistent and favorable safety profile showing no Grade 3 or higher CRS events as well as limited neurotoxicity. We believe epcoritamab has the potential to become a best-in-class therapy across a number of B-cell malignancies including diffuse large B-cell lymphoma and follicular lymphoma. The Phase 3 trial in relapsed-refractory DLBCL recently began and we will provide updates on epcoritamab as its development program progresses. Initial results were also presented from a Phase 1 study evaluating TNB-383B in relapsed-refractory multiple myeloma. TNB-383B is a novel bispecific T-cell engaging immunotherapy targeting BCMA and CD3 being developed in collaboration with TeneoBio. These Phase 1 results demonstrated that the BCMA/CD3 bispecific provided overall response rates of 80% with a large number of patients achieving a very good partial response or better despite having received multiple prior lines of therapy. TNB-383B was well tolerated at all doses tested with a few off-target toxicities and no Grade 3 or higher CRS observed. With its safety profile efficacy and the convenience of once every three-week dosing, this agent has the potential to become a promising treatment option for myeloma patients. And our partner I-Mab published an abstract with initial results from a Phase 1 study evaluating lemzoparlimab in AML and MDS. These results demonstrated encouraging activity in relapsed-refractory AML patients and lemzoparlimab was well tolerated with no serious hematological adverse events reported today. Based on these promising initial results, we plan to begin new studies this year for lemzoparlimab in AML, MDS and in multiple myeloma. We also recently saw data from an interim analysis of a Phase 2 study evaluating Teliso-V in heavily pretreated non-squamous, non-small cell lung cancer patients. The encouraging results from Stage 1 of this study met the criteria for advancing the program. With Teliso-V demonstrating a 54% objective response rate in patients with wild-type EGFR with highly expressed c-MET. In EGFR wild-type patients with over-expressed c-MET, which includes both high and intermediate expression, the objective response rate was 35%. Based on these results, we believe that there is an important role for Teliso-V in this target population, which represents roughly 25% of the non-squamous, non-small cell lung cancer population. We will be opening the second stage of the study and are planning discussions with regulators regarding the potential of this study to support an accelerated filing. We expect 2021 to be another important year for our oncology pipeline with several regulatory submissions as well as data readouts across all stages of development. This year, we expect to see data for Imbruvica in the Phase 3 SHINE study in frontline MCL with regulatory submissions expected in the second half of the year. Data for Imbruvica in combination with Venclexta in [ph] second line or greater MCL and frontline CLL with regulatory submission for frontline CLL expected in the second half of the year. We also expect to see data from registration enabling studies for Venclexta in high-risk MDS and navitoclax in relapsed-refractory myelofibrosis. And we expect to see data from numerous programs in our early-stage oncology pipeline. In addition, the programs under collaboration with Calico are also progressing well. Our partnered effort is comprised of a strong pipeline of novel targets, which includes more than 20 active programs in discovery or preclinical development. Importantly, we currently have programs, which have advanced into clinical development in two areas immuno-oncology and neurodegeneration. The lead Calico program in oncology is focused on PTPN2 inhibitors, which act at multiple steps in the cancer immunity cycle and have potential applicability in a broad variety of tumor types. The discovery of novel orally bio-available PTPN2 inhibitors represents a significant breakthrough and a target class that has historically been considered un-druggable. We currently have two assets in Phase 1 development ABBV-CLS-579 and 484. We've seen evidence of immune activation in the clinic with this pathway and we expect to see proof-of-concept data from this program in 2022. The lead Calico program in neuroscience is an eIF2B activator, which targets a key regulator of the highly conserved integrated stress response pathway. Inhibition of this pathway has the potential to prevent pathology and restore function in a number of neurodegenerative diseases such as ALS and Parkinson's disease as well as in traumatic brain injury. Our lead eIF2B activator ABBV-CLS-7262 is currently progressing through Phase 1 and we plan to begin a study later this year in patients with ALS. In other neuroscience updates, last year, we completed our registrational program for atogepant in episodic migraine prevention and we recently submitted our regulatory application to the FDA. We expect an approval decision by the end of the third quarter. The data generated in our Phase 3 programs support a strong benefit-risk profile and we believe that atogepant has the potential to offer meaningful benefits to patients as a safe, effective, oral treatment option for the prevention of episodic migraine. In 2021, we expect to see data from several late-stage neuroscience assets, including results from two Phase 3 studies for Vraylar in major depressive disorder and results from the pivotal program for ABBV-951 in advanced Parkinson's disease with regulatory submissions for 951 expected in the second half of the year. We also expect to see proof-of-concept data for Elezanumab in a Phase 2 study in multiple sclerosis and ABBV-8E12, our lead anti-tau antibody in a Phase 2 study in Alzheimer's disease. In addition to 8E12, we have a number of promising approaches in Alzheimer's, including our neuroinflammation programs aimed at TREM2 and CD33, currently in clinical development, as well as other tau approaches in preclinical development. These include tau antibodies with different epitope specificity as well as approaches to clear intracellular tau. In Aesthetics, we continue to make excellent progress with our portfolio of facial toxins and dermal fillers with several regulatory submissions, data readouts and pivotal study starts expected this year. Our programs include new indications for Botox as well as innovative toxins such as new liquid formulations and both the long and short-acting toxins. We also have programs to develop new indications for the Juvederm Collection as well as novel dermal fillers such as HArmonyCa, which will be entering registration enabling studies in the U.S. And in eye care, based on the positive results from the Phase 3 studies evaluating our topical eye drop AGN-190584 for the treatment of symptoms associated with presbyopia. We plan to submit our regulatory application later this month and expect an approval decision in the fourth quarter of this year. So in summary, our R&D productivity remained high last year despite multiple COVID-related challenges and we were able to maintain steady continuity and minimize delays. We're entering 2021 well-positioned for continued success and we expect significant program advancement across all stages of our pipeline, again this year. This includes five new asset or major indication approvals, half a dozen regulatory submissions, more than 10 pivotal study readouts, and more than 15 data readouts from early and mid-stage programs. With that, I'll turn the call over to Rob for additional comments on our fourth quarter performance and our 2021 guidance. Rob? Thank you, Mike. Starting with fourth quarter results, we once again delivered strong top and bottom-line performance. We reported adjusted earnings per share of $2.92 above our guidance midpoint by $0.08. Total net revenues were approximately $13.9 billion, up 6.8% on a comparable operational basis and ahead of our expectations. Immunology global sales were approximately $6 billion, up 14.8% on an operational basis. Within immunology, Humira sales were approximately $5.2 billion, up 4.4% on an operational basis with continued high single-digit growth in the US offset by biosimilar competition across international markets. Skyrizi sales were $525 million and Rinvoq sales were $281 million with both products demonstrating strong sequential growth above expectations. Hematologic Oncology delivered another strong quarter with revenue of approximately $1.8 billion, up 15.5% on an operational basis with solid growth from Imbruvica and Venclexta. Aesthetic sales were more than $1.1 billion with Botox Cosmetic and Juvederm both experiencing a rapid recovery from the COVID pandemic. Neuroscience revenues were nearly $1.4 billion, up 14.9% on a comparable operational basis, led by Vraylar and our migraine portfolio. We also saw a significant contribution from eye care, which had sales of more than $900 million. Turning now to the P&L profile for the fourth quarter. Adjusted gross margin was 81.8% of sales, adjusted R&D investment was 12.6% of sales, and adjusted SG&A expense was 22.3% of sales. The adjusted operating margin ratio was 46.9% of sales, an improvement of 230 basis points versus the prior year. Net interest expense was $618 million and the adjusted tax rate was 11.6%. As we look ahead to 2021, our full year adjusted earnings per share guidance is between $12.32 and $12.52, reflecting growth of 17.6% at the midpoint. Excluded from this guidance is $5.63 of known intangible amortization and specified items. We expect adjusted net revenue of approximately $55.7 billion. At current rates, we expect foreign exchange to have a 1% favorable impact on full year comparable sales growth. This forecast comprehends the following assumptions for our key products and therapeutic areas. We expect immunology global sales of approximately $25 billion, including US Humira growth of approximately 8%, internationally Humira revenue of approximately $3 billion at current exchange rates, Skyrizi global sales of approximately $2.9 billion, and Rinvoq global sales of approximately $1.7 billion. We expect hematologic oncology to grow double-digits with Imbruvica global revenue of approximately $5.7 billion and Venclexta global sales of approximately $1.8 billion. For Aesthetics, we expect global sales of approximately $4.5 billion, including approximately $1.8 billion from Botox Cosmetic and approximately $1.3 billion from Juvederm. For neuroscience, we expect global revenue of approximately $5.7 billion, including Botox Therapeutic sales of approximately $2.3 billion, Vraylar sales of approximately $1.8 billion, and Ubrelvy sales of approximately $400 million. For eye care, we expect global sales of approximately $2.9 billion, including approximately $550 million from RESTASIS, which assumes no generic competition in the first half of 2021. For women's health, we expect global revenue of approximately $1.1 billion. For remaining larger products, we expect global sales of approximately $2 billion from Mavyret, $1.2 billion from Creon, $1 billion from Linzess, $800 million from Synthroid, and $750 million from Lupron. Looking at the P&L for 2021, we are forecasting full year adjusted gross margin of approximately 83% of sales, adjusted R&D investment of approximately $6.6 billion and adjusted SG&A expense of approximately $11.8 billion. This guidance includes approximately $1.7 billion in expense synergies from the Allergan acquisition. We are forecasting an adjusted operating margin ratio of approximately 50% of sales, which represents an improvement of roughly 200 basis points versus 2020. We expect adjusted net interest expense of approximately $2.4 billion. Our non-GAAP tax rate to be approximately 12.5% and our share count to be roughly flat to Q4 2020. As we look ahead to the first quarter, we anticipate net revenue approaching $12.7 billion. At current rates, we expect foreign exchange to have a 1% favorable impact on comparable sales growth. We are forecasting an adjusted operating margin ratio of approximately 50% of sales. And we model a non-GAAP tax rate of 12.3%. We expect adjusted earnings per share between $2.79 and $2.83, excluding approximately $1.32 of known intangible amortization and specified items. Finally, AbbVie's strong business performance and outlook continues to support our capital allocation priorities. Our cash balance at the end of December was $8.4 billion and we expect to generate free cash flow of approximately $21 billion in 2021. This fully supports a strong and growing dividend, which we have more than tripled since inception, as well as rapid debt repayment where we expect to pay down $17 billion of combined company debt by the end of 2021, including the $8.6 billion that was repaid in 2020. We expect to achieve a net debt to EBITDA ratio just below 2.5 times by the end of 2021 with further deleveraging through 2023. We anticipate that our net leverage ratio will be approximately 2 times by the end of 2022. Our strong cash flow also allows for continued business development with approximately $2 billion allocated annually to augment our pipeline with the most promising external technologies and innovative mid to late-stage assets. In closing, we are very pleased with AbbVie's strong performance in 2020. We've driven top tier growth while also advancing our strategic priorities and we expect to deliver robust performance in 2021 and over the long term. With that, I'll turn the call back over to Liz. Thanks, Rob. We will now open the call for questions. In the interest of hearing from as many analysts as possible over the remainder of the call, we ask that you please limit your questions to one or two. Operator, first question, please. [Operator Instructions] And our first question today is from Geoffrey Porges from SVB Leerink. Thank you very much. And as usual, appreciate all the detail in the guidance, and congratulations on the results. A quick question on Skyrizi and one on Rinvoq. First, one of your competitors had a negative result of a post-marketing study recently. I'm just wondering if you've had any discussions with regulators about conducting any other studies for Rinvoq or updating the label for Rinvoq as a result of that negative signal? And then, secondly on Skyrizi, a commercial question. Your current price for the 150-milligram dose is about $85,000 and you're using 4x of the dose for ulcerative colitis. Could you just tell us how you can manage that? And is it feasible to have sort of different prices despite the big difference in dosing? Thanks. Okay, this is Mike. I will take your second question first and then we can cover the Skyrizi question. With respect to Rinvoq, I assume you're talking about the tofacitinib safety study with [ph] top-line results fairly recently in the last several days and showed in that program that they were unable to exclude a risk of MACE or malignancy based on the criteria that were used to analyze that data sets. As I said in my prepared remarks, we've kept a very, very close eye on our data both at the time of the NDA and in an ongoing manner since that time and we've not seen a signal, our rates have not been elevated with respect to comparator or baseline rates and the rates overall remain low. With respect to your specific question about whether we've had discussions with regulators, regulators have not asked us to do long-term safety study in the way that Pfizer was asked. So that has not been discussed with regulators and we have not had any contact with regulators around labeling updates up to the present time. Great. And with respect to Skyrizi... Yes, hi. It's Jeff. It's Jeff Stewart on the commercial question. We have anticipated the different markets and how we will approach the pricing. Now, it's important that we're just starting to see the Skyrizi data. We saw the induction data, we'll [ph] see the maintenance data. I think it's important that as we look at our strategy that we're honing is for Skyrizi, you're going to -- for Crohn's, you're going to have an induction dose, which is an IV at a different dose and we know that based on the form and sometimes we can believe we can price that to market and also we are coming with a unique approach for the maintenance as well depending on where that dosing falls out and we would be using at that point, which is known as on-body injector. So the combination of the forms as well as basically the ways that we will deliver the medication when we get there, we believe that we can price effectively to the market and manage it across the indications. This is Rick. So I think the bottom line, as we've contemplated that it's a good question, Geoff, but I think we have a strategy that will allow us to deal with that and impact the market in an appropriate way. Thanks, Geoff. Operator, next question, please. And our next question is from Vamil Divan from Mizuho Securities. Hi, great. Thanks so much for taking the questions. And maybe two if I could. So I want to appreciate the long-term guidance you've given recently on the topline. I'm just wondering how we should maybe think about the margin progression as we think about the Humira LOE in a couple of years, and then because we could get past that and your sales touch ramp up again, if you could maybe give us some sense of where you think your margins could sort of come back to? And then, the other one I have is just on Vraylar. Again, appreciate the guidance you've given there. I think one of the big events for you guys this year will be the Phase 3 data in MDD, just curious kind of what gives you confidence that maybe you can just talk about whether it's around the drug or the study design, sort of, what gives you confidence or why should we be confident going into that data readout? Thanks. Vamil, this is, Rob, I'll take your question on margin progression. I think when you consider the greater than $2 billion expense synergies from Allergan by next year and the P&L leverage that will come from the sales growth, we also expect for next year, you should expect that our operating margin will continue to expand through '22. Upon the entry of US biosimilars in '23 and given Humira's profitability, it is reasonable to expect operating margin pull back, we've indicated before the 45% range based on our current LLP, I think it'll be a little bit higher than that, but then we've returned to growth immediately in '24, we'll return to revenue growth but very strong revenue growth starting in '25, you can expect then operating margins once again expand. We've had a long history of expanding operating margin by leveraging the P&L. And I would expect that to continue as we start to see very strong revenue growth starting in '25 and beyond. Yes, Vamil. This is Rick. Mike and I'll cover the second question on Vraylar. It's important to recognize that what we've communicated in long-term guidance on Vraylar is based on the three currently approved indications. So it doesn't count on the fact that MDD would be successful. Now having said that, I think we do have -- I'd say, we're cautiously optimistic about the MDD indication and I'll let Mike kind of walk through how we look at it and what gives us that level of confidence. But in the event, it weren't to play out, that doesn't impact the guidance that we gave. So, this is Mike. I'll pick up from here. I think that our optimism and I think that's the right way to express it in a disease like MDD, which is a challenging disease to work and is based on a couple of features. One is based on the basic pharmacology of Vraylar, which has a unique mix of D3, D2 specificity, and other features that lead clinically to what's been described as a brightening effect, which seems to be beneficial in a number of settings. It's also driven by the results that we have from the MDD study that is positive that we already have in hand. So with one positive study, we would need only one -- at least one or of course, both of the next two studies to read out positive either of those outcomes would support a filing. We've done a deep dive into the study design and the patient population. We think it's a well-designed study. And we think the patient characteristics with respect to baseline factors and other elements are all very appropriate for this sort of study and we can assess that in a blinded aggregate way in a way that's completely consistent with the study rules for the conduct of the study. And so all of those things make us feel optimistic that it's a molecule with a good chance to work, well-designed study, well-conducted study, and we look forward to seeing the results. But as I mentioned, MDD is a challenging area. And for that reason, we didn't build into our deal [ph] model and we didn't factor it into our guidance as Rick said, so we view this as upside. Thanks, Vamil. Operator, next question, please. Thank you. And our next question is from Randall Stanicky from RBC Capital Markets. Great. Back to Rinvoq in atopic derm, how quickly do you guys expect that launch to ramp? And maybe just help us with expectations given coinciding JAK competition from upadacitinib, the timing to payer ramp in the coverage, and then what we sense of a lot of patient warehousing, maybe if you could help quantify your thinking around that opportunity within the $1.7 billion outlook for the year, that would be helpful. And then a quick follow-up, Rick, you don't get asked about eye care a lot. It's a $3 billion global franchise. You have some pipeline behind it. It could be a good growth business but it's declining. Any appetite to strategically add to that business or reposition it or should we view it more as a mature cash flow generator? Thanks. Yes, hi. It's Jeff Stewart. I'll start off with the atopic derm commercial question. We're very encouraged with the market that we're about to enter and I'll give you some context there. So when we look at the population, we see that just on the moderate to severe atopic derm patients that the market size or the potential is at least 2 times and probably closer to 3 times the size of the psoriasis market. And so this is very, very encouraging in terms of our ability to enter. It's also significantly under-penetrated. I mean if you look at the psoriasis market, you're talking about far greater than 10% or 12% penetration and in the single-digit, the low-single digits, where we are right now with the one biologic dupilumab. So it's very, very attractive. The other thing that I would say is that we see from our go-to-market approach that we know the HCPs very intimately. So about 85% of the market is driven by the derms, we know the derms very well and there is a 90% -- roughly 90% overlap with the big prescribers of dupilumab and drugs like Skyrizi and our Humira. So we are very, very encouraged at the ability for this segment to rapidly expand, despite the fact there will be multiple new entrants coming in. To get to your specific question about the access ramp, we have a very strong position, as you know with Rinvoq right now in the existing indication of RA. We had greater than 95% commercial access, that's the dominant channel for atopic derm and our anticipation is we will have very strong access that we'll build to that level over the course of '21. Obviously, it's going to take some time, once we get the approval to go through the final approvals on the big commercial plans and so we see it's starting off slow, but then building into the middle of the year and certainly getting to a significant level at the end of the year. So the combination of the market, the asset itself, which looks very, very strong, as you've seen from the data and the way that we will play in our derm segment as well as the allergy segment give us a lot of confidence for a strong ramp in '21 and beyond. The only thing I would add to Jeff's comments, I mean if you look at Rinvoq did $731 million last year. Obviously, if you look at the running rate out of the fourth quarter had [ph] strong running rate coming out of the fourth quarter but that's a $1 billion worth of growth from '20 to '21. The majority of that growth is going to come from continued performance in RA. I think where you will see the most significant impact from atopic dermatitis will be as we flow into '22, much like as you saw what happened in the RA market, it takes time for physicians to start to get adapted. Once they do, their momentum picks up. So, I don't remember the specific number. I'm not sure we gave that guidance anyway, but I would be thinking about it more than its continued penetration and growth in RA which drive in the bulk of that growth. Rob, anything you want to add? Yes, I just -- on your question regarding warehouse patients who have a very modest amount of warehouse patients assumed [ph] in the forecast. So we're not count -- the $1.7 billion doesn't really count on that. And keep in mind that Rinvoq was of the product that was lesser impacted by COVID and so there's not really significant how warehousing in that forecast. And then, Randall, on your second question; I would say we absolutely agree with your point of view. I think eye care is a very attractive market. The kinds of markets that I think we look for and that we are the very best at is where there are specialized physicians who really drive the use of medications based on the clinical data and being able to restate markets and improve standard-of-care in those markets, and certainly, eye-care, I think it fits that description. And so we would have a strong appetite to look for opportunities and we are looking for opportunities now that we could add to that eye care business to be able to drive growth. Obviously, RESTASIS, as Rob indicated in his formal remarks, we've built in a half a year that's still an unknown of when that product will go generic or if it will go generic. But I think even aside from that regardless of what happens with RESTASIS longer-term, this is an area that we would have interest in and if we could find the right kind of assets to add to it, we would enthusiastically do that. Thanks, Randall. Operator, next question, please. And our next question is from Chris Schott from JPMorgan. Great. Thanks so much for the questions. Can you just elaborate a little bit more on Aesthetics and maybe some of the learnings you've had in that franchise since you've acquired it? Have there been changes in the way you think about approaching the business commercially in your levels of investment? I'm just trying to get my hands around that high single-digit growth over time does seem healthier than the street have been anticipating. I'm just trying to get a little bit more color of what you're seeing in the market that gives you confidence in that. And then, my second question was just on Imbruvica, the growth has slowed here a bit. Can you just elaborate a bit more and how much of this is -- is there any COVID related dynamics playing out here? How much of this is competitive? I'm just trying to [ph] sense of just how you're seeing that the health of that franchise over time? Thanks so much. Yes, Chris, this is Rick. So I'll cover the Aesthetics question for you. I'd say as we've studied the Aesthetics market and had an opportunity to be able to operate the business now for some time, I think we're even more enthusiastic about the long-term ability to be able to grow this market. I would say some of the areas that were a bit of a surprise to us is the responsiveness of this market to patient activation, and I would say that the strategy that we've put in place is one where we are funding the business on a very -- on a continuous basis at a high level to achieve the level of activation that we're looking for and we think that will, certainly, you can see, the response I guess an example in Botox already, we are seeing a very aggressive response in being able to grow the market, you saw the Botox grew -- Botox Cosmetic grew in the fourth quarter to 9%. I would expect that we can continue to drive that level of growth. And as part of legacy Allergan, I think it was much more episodic in the way this was funded quarter-to-quarter where we basically built a funding plan that will allow them to continue to drive activation over a longer term [ph]. I'd say the second thing that's it's of interest to us is, I think this is a market where you can drive significant innovation. If you fund that innovation in a way, again on a more continuous basis and advance those programs more aggressively, and have a well thought out strategic roadmap as to where you're trying to drive some of these markets. As Mike mentioned in his comments, our goal is to basically try to advance the level of performance of the toxin market significantly over time. And the same with the filler market. There are certainly things that we can do to expand the areas that you could use fillers, both within the US and globally and that's a significant opportunity. But long term, we think there is an opportunity to take some of the biologic expertise that we have here at AbbVie and create more biologically active fillers, and not only do physical filling but also improve collagen, improve elastin, and other kinds of characteristics that will improve skin quality. And we think that will be -- if we're successful, we think that will be a significant opportunity to drive long-term growth. And then, the last thing I'd say is the geographic footprint that AbbVie has. We obviously have a very broad geographic footprint and the structure that we've set up is this totally integrated global unit that we're operating the Aesthetics business really gives them the freedom to go out and expand or more aggressively fund areas around the globe that they think there is a significant opportunity. A good case in point is I believe it was in the fourth quarter, we funded a significant expansion in China to be able to increase the sales force there to be able to drive it more deeply into a broader set of the cities in China to the next level down and we are already seeing the benefits of that, China is already back to growing much like it did pre-COVID. So I think there's a lot of attractive attributes about that. On Imbruvica maybe Jeff and I will tag team on that one. What we're clearly seeing is the COVID is having an impact on patient starts in CLL. We're not only seeing it Imbruvica, but we're seeing in Venclexta as well. And then somewhat logical when you think about these oncology practices of trying to reduce density and CLL is a disease where you can, in many patients' cases, you can delay therapy for some period of time. I would say that's the vast majority of it. When we look at -- when I look at the overall share. And the reason why I'm talking about the overall share is Venclexta is now gaining a significant level of momentum in this market as well. When I look at our overall shares in first line, second line or third line, we continue to have the dominant share position. And I'd say probably, partially due to your question, if I look at Calico [ph] I'd say it's performing at the expectation we have. I think the first line share is about 12%, slightly higher in second line maybe 14%, and I don't recall the third line share... Very similar, yes. So I'd say that's within the range or we saw with MCL, it's within the range of what we had modeled. So it's not really a competitive issue that we're dealing with. It's more a function of getting those patients starts back up to the level they were before. Anything, you want to add, Jeff? No, I think Rick, that's exactly right. The only thing I would say in terms of our forecast, we think that in the first part of the year, the early part of the year, we continue to see some suppression in the new patient starts. But as we hit the second and third quarter, we anticipate that the market will recover. Thanks, Chris. Operator, next question, please. And our next question is from Tim Anderson from Wolfe Research. Hi. Can you hear me? This is Nicole Maher on for Tim Anderson. What does your long-term guidance assume for potential austerity measures in the ex-U.S. countries in 2021 and beyond, similar to what we saw in the post-2008 time period except this time around, it would be the fall from the COVID impact? Hey, Nicole. This is Rick. I think this is something we've got experience with, if you think about the economic crisis, I thought we saw a similar kind of uptick in price erosion outside the United States and in particular, I'd say in the European Union, we have factored in a reasonable assumption into our guidance for 2021, I feel good about that. I think it is reflective of what we're likely to see. So I think we're covered from that perspective. Anything you want to add Rob? No, that covered it. Thanks, Nicole. Operator, next question, please. And our next question is from Steve Scala from Cowen. Thank you. Two questions. AbbVie delivered one of the first completely clean and compelling quarters in pharma this cycle, and I have to believe, has something in reserve for upside as the year unfolds. I'm sure you monitor the competition, so beyond the AbbVie management team itself, what about your business do you think is allowing you to execute in this way? Would you attribute it to -- mainly to the products themselves, the payer strategies, geographic mix, or is there something else? And the second question is the ongoing Vraylar Phase 3 trials utilize doses up to 3-milligrams while the successful prior trials were up to 4.5-milligrams, so why were the doses lowered in the first place? And what placebo response mitigation methods are included in the ongoing trials? Thank you. Okay. Steve, this is Rick, I'll cover the first one, and Mike can cover the second one. I would say, first and foremost, we are a very disciplined organization in how we approach execution in the marketplace. We tend to probably, in [ph] some extent, obsessively plan and then go out and try to execute against that plan and I think in times of difficulties that kind of discipline tends to demonstrate itself and that's when you see the biggest differences. So that's not say [ph] other people don't do it like that. I'm not that familiar with how others operate, but I know how we operate and I know how we contingency plan and we look at. Okay, if that doesn't work, what are we going to do and we do that ahead of time, if that doesn't work, what are we going to do. And I think that kind of contingency planning and focus on execution is helpful. I'd say the second thing is, if I look at our business, we put a strategy in place and I feel very good about how the business is performing overall. I mean I would say the business is firing on all cylinders. And you can look at our fourth quarter performance, to your point, and I think it demonstrates that and you can look at our guidance and it demonstrates that almost every single product area is performing at or above, most of them above what consensus was and then I think it's another indicator for you and we have a much more diverse business now. We have four major growth platforms that are helping us drive that level of growth. Our new product launches are doing extremely well. Obviously, Skyrizi and Rinvoq are, but I'd also say Ubrelvy and Vraylar are performing extremely well and the pipeline, I would say one of the things gives me the most confidence is when I look at the pipeline behind that. It's designed to be able to drive our long-term growth because one of the things that we focus on is how we're going to make sure that we continue to drive this business to perform at the level its performing over the long term. And so if I look at the Skyrizi and Rinvoq R&D execution around the follow-on indications, it's been nothing less than spectacular both from a timing standpoint and the kind of data that we have been able to produce. When I look at our hem/onc strategy, we've had a very disciplined strategy there ensuring that we have enough assets to continue to grow. What has become a very large franchise for us. Our franchise is $6.6 billion as we said, we're going to grow in double digits. Over the long term, what's going to allow us to do that? Well obviously Imbruvica is going to continue to drive share, Venclexta is going to continue to drive share in CLL but Venclexta has indication expansions in the area of potential, in the areas of T1114 and a broader AML population and several other areas. Then I look at Navitoclax. We should get that product approved and give us an opportunity in myelofibrosis and then you look at Genmab and you look at our CD47, those will all allow us to ensure that we can sustain that growth profile over the long term. In neuroscience, same thing, atogepant will allow us to expand into the broader migraine population. So I feel very good about what we put in place and our ability to execute against that. So I think there is not one silver bullet that I can point to. I think it's all of those things, certainly, our ability in market access has helped a lot in the US. I think we're very good at that, but you have to have the right kinds of assets in order to execute that. You have to have assets that are differentiative like Skyrizi and Rinvoq. So it's the combination of all of that gives you this performance and gives you the long-term sustainable ability to deliver that kind of performance and I feel awfully good about where we are. So, this is Mike. I'll take the Vraylar question. I believe you're talking about the ongoing MDD studies and what I would say there is that the dose selection was based on everything we know about dose-response, not only from the prior MDD studies but across the program and we've done a deep dive into that and we're confident that we're at a dose that ought to have optimal effect in these indications -- in this indication. With respect to your question about placebo response rate, managing or controlling the placebo response is extremely important in all studies, but particularly in depression studies and other studies in psychiatry. And I would say that there are many different approaches that are taken that are complementary to each other. The first and most important is appropriate site selection, one has to select sites with an appropriate patient population with experienced investigators who are also experienced evaluators in a clinical trial setting and that's one of the most important things to getting high-quality data to determine whether a drug works. The next element has to do with investigator training, investigator manuals, protocol design and also with respect to inclusion and exclusion criteria to make sure that you have a patient population that is representative of the population that you would expect to treat post-registration if the study is successful. And we've taken a look at all of these things, we've taken a look at the blinded aggregate data and we feel good that the measures that we have in place will effectively control the placebo response and give us a quality readout. Thank you. Thanks, Steve. Operator, next question, please. Thank you. Our next question is from Gary Nachman from BMO Capital Markets. Hi, good morning. Could you talk about how much more you plan on investing behind the neuroscience franchise to accelerate growth there to get to the long-term targets you talked about like the $4 billion in Vraylar even with that MDD, and how you see the long-term potential in Botox Therapeutic? And then how are you thinking about the launch for atogepant later this year? And how will you leverage the work that you've done so far with Ubrelvy? And how do you think that product will take off in the migraine market? Thank you. Well, I'd say, on the neuroscience investment, I mean we obviously have a very broad neuroscience investment. I mean we have a significant investment from an R&D standpoint. And in disease-modifying approaches for a number of different neurological diseases that Mike has talked about and mentioned in his comments earlier. So I'd say we have a significant R&D investment. We obviously are investing in Vraylar to continue to expand that asset. Again, our goal will be to invest in these areas where you can get maximum capture -- market share capture. I think if you look at Vraylar and you look at the projections that we made over time, if you look at the sequential year-over-year dollar growth of that business, that's how you get to that number. And basically, we're going to be able to sustain that, we expect to continue to sustain it as relatively low market share, but that's not unusual. And in this market, because there's a lot of generic products that psychiatrists, cycle patients through and sometimes in combination with patients. So we're going to invest in the business to be able to drive the maximum level of profitable share as we do in any other segment that we're in. Same thing on Botox Therapeutics, obviously, we have R&D programs in there to continue to expand the opportunities in therapeutics. Anything you want to add from an investment standpoint, Rob? I think if you look at the overall portfolio, we've detailed out what we expect for Vraylar and that's without the additional indication. We think we can get to approaching $4 billion. When you look at the migraine portfolio, peak sales are greater than $1 billion for both the Ubrelvy and Atogepant. We have 951 in the pipeline that we think can be a significant contributor, obviously, Botox Therapeutic will continue to grow. So we feel pretty good about the portfolio we have and that double-digit growth outlook is supported by a number of very promising assets. Yes, hi. And it's Jeff, I'll take the second question on atogepant. I think first, the asset itself is very, very attractive. And when you look at the response on the migraine free days at the 10 to 60-milligram, it's really impressive data, very impressive data as this very strong oral. And so we think that we can come at this in a couple of different ways. Obviously, you highlighted the leveraging Ubrelvy. We've got a dedicated sales force that calls on the specialty organization, the neurologists as well as the headache specialists will actually carry both Ubrelvy and atogepant in their call plan to really leverage the knowledge of a very established sales force and as well as focus on the big primary care writers that see a lot of migraine sufferers. So this is -- this is an important dynamic that will, we'll be able to leverage when we get into the market towards the end of the year. Also, we are looking at the ability to see how you look on the back end of the migraine journey so patients are on Botox Therapeutics, for example, which is very substantial. It's the leading in play share for chronic migraine. But many of those patients don't get full efficacy results. So ultimately the combination of Botox plus atogepant as a way to get really migraine freedom in the toughest patients is another area over the long term that we think can leverage these assets across the board, whether it's you Ubrelvy on the front end with acute atogepant in the middle, oral for episodic and chronic or Botox on the back end. We think it's a nice portfolio that we can commercially manage over time to hit our ambitions that Rob described. Thanks, Gary. Operator, next question, please. Thank you. And our next question is from Naveen Jacob from UBS. Hi Naveen from UBS. Thanks for taking the question. So first on the ADC steroid you see for inflammatory conditions. Just wanted to get an update there, it's been, I believe you said delayed for COVID-19 do you still believe that this approach can lead to success for refractory RA or other inflammatory conditions. Just wondering about your confidence in this technology understanding, it's still early in development. And then secondly, as it relates to your current state of affairs with Rinvoq and Skyrizi, could you remind us of what the current in-play market share for our Rinvoq is in RA and Skyrizi in psoriasis. Thank you so much. Okay. This is Mike, I'll take your first question on ABBV 154 our TNF steroid conjugate has not been delayed because of COVID. There were some delays in other early immunology programs. Our CD 40 and our ROR gamma-T program experienced modest delays but 154 did not. As we said at the time of the COVID peak over the course of last summer, there were a small number of studies that we delayed initiation and delayed enrollment, is the programs that I'm talking about TD 40 and ROR gamma T were impacted modestly in that time period but 154 was not so that remains on-track. We remain confident in it. We have selected 154 as the agent to go forward. Remember that we had two 3373 and 154 and we selected 154 because of advantages it had in linker technology, we're planning to initiate a large Phase 2 B study in the first half of this year and then today, we're now saying that we will also be studying Phase 2 Crohn's disease, as well as polymyalgia rheumatica, and that's an important set of indication that covers a wide range of opportunities, RA and Crohn's disease areas where we are very active, PMR polymyalgia rheumatica is a new area where there is not a lot of therapeutics, unfortunately, it is a well-established area in medicine but there is very little in terms of treatment for these patients, they have considerable pain and suffering from their condition and it's -- and it's particularly steroid responsive. So we think it is a very attractive target for our steroid ADC approach. The 154 remains on track and we continue to have confidence. Thanks, Mike. It's Jeff, I'll take the in-play [ph] share. So if we look at the psoriasis market and Skyrizi we have on our latest data point 33% of in-play share, which is of course is new patients coming in or newly switch patients. If you look at the total AbbVie share, it's approximately 45%, so very remarkable when you add Humira plus Skyrizi in the dermatology space. If you look at the RA space, our latest data points are between 15% and 16% in terms of in-play share for Rinvoq in RA and that's basically neck and neck with Humira, so for a total AbbVie share of roughly a third of the RA market. This is, Rick. The only thing I'd add on that is when you look at that Skyrizi 33% in-play share, it's almost double what the next closest competitor is, I mean it's impressive. The gap between Skyrizi and the number two player and the other thing is, as these brands get more experience in the market, we'll also start to talk about the total TRx share and I think Skyrizi is at that point now. I think it's total TRx share now is 14% [indiscernible] or something like that. That's right. And that's pretty impressive for this short period of time and it is close to number two in the market in TRx share. So they are both doing very, very well. Thanks, Naveen. Operator, next question, please. And the next question is from Chris Raymond from Piper Sandler. Hi, thanks. Just a couple of questions. First, on the relationship with BI and Skyrizi. We had a few inbound questions on the treatment of the royalty and I know you've answered this question a little bit in the past, but also just noticing the big non-cash GAAP charge you took this quarter, you back out a non-GAAP earnings. So I know you have described accounting for this as a business combination. But can you maybe give a little bit more color on the rationale and the accounting behind that non-cash charge and then is there also some threshold number or other event where you'd add this royalty expense back to non-GAAP. And then, on AbbVie 951; we picked up a decent amount of KOL excitement around this asset in Parkinson's. I know Phase 3 is expected later this year, but I wonder if you could maybe talk about the launch -- your launch expectations on this and maybe contrast it to the Duodopa experience just from our feedback, it seems like this could expand the addressable PD population pretty sizably and Rick maybe frame how this sort of factors into your long range $10 billion neuroscience guidance. Thanks. Yes, Chris, I'll take your question on Contingent considerations and yes, we did account for this as a business combination. So that means each quarter we do a mark-to-market, the fair value of the future milestone royalty payments and you did see us take a fair value write up this quarter. Based on the higher sales outlook as we communicated during the Immunology Day event in December and you see in the guidance provided today, obviously the outlook for Skyrizi continue to increase. And so we're recognizing that liability going forward. We also take into a consideration because it's a fair value measure what the market is assuming. So it's not just our own forecast. It's also what street expectations are and those have also increased as we've seen a very nice ramp. We are starting to see obviously the confidence from the street increase that's translated into a higher outlook for Skyrizi which then translates in a higher future potential royalties. One of the reasons I wanted to stress, also on the free cash flow in my remarks today is because there is some confusion over that's how we account for, but it's important to keep in mind that when I talk about free cash flow in $21 billion [ph] this year that accounts for the royalty payments of 2BI, and so you can look at a few different ways, you can look at it from a -- you can track the consideration [ph] accretion that we're recording and the liability on the balance sheet as an indicator of the future outlook, but also as we monitor our cash flow pretty carefully what does that contribute to overall cash flow. So we would not be going back, we made a determination as a business combination. We don't -- should not anticipate that we would reverse that but we'll provide obviously more clarity on what those royalties look like going forward given the size of the asset. I also say in that time period when we did BI it was an absolute requirement on the account, right. Well, that was really, it wasn't like a judgment call or something thing to desire to do the accounting, said to be accounted for in that fashion. It's since been changed going forward. But the window in which we that occurred that was the required accounting treatment. So number two, Jeff and I will cover number two, sort of a high level look and then Jeff, maybe can give more specificity around that. If you look at Duodopa I mean this is a -- this is a therapy that has absolutely phenomenal efficacy and you can see these patients who cannot move early and you turn on the pump and you start giving them the drug and within a very short period of time, they will gain their motion. The challenge is a very difficult treatment to the patient to basically deal with and the caregiver to deal with on a long term sustainable basis; you have to do surgery, insert a G-Tube, you got to maintain that G-Tube opened, so that does somewhat limit the population is able to use it. And so we view this as a way to significantly expand the market. Jeff is obviously far more familiar with it. So I'll let him, give you a little more specific, but that's the general concept. I think this could be a significant -- wanting to be a significant treatment for these patients who need this kind of therapy. And two, I think we could expand the market pretty significantly. Yes, I think just to add on that. Rick, it's we hear the same thing from our KOLs, they're very, very encouraged and with the perspective you look at Duopa or Duodopa, about $0.5 billion product with a really difficult challenge on on-boarding for these patients. Right. You have to do the J-Peg surgery. You have challenges with the size of the pump. Nonetheless, it's still remarkable that we do get that level of sales. So if I give you some perspective on the market. If you look at the advanced Parkinson disease market, 90% of it is really old generic orals where the patients just have to take more and more oral medication before they can have any -- any relief. And then, they are still in big trouble. So, only a minority about 10% ever get to let's say more advanced device-aided therapy, which is Duopa or Duodopa and deep brain stimulation. So, as we studied the market we agree that as we look at the ability to sort of move from a more convenient way a simple way for neurologists to get a more advanced therapy without doing a procedure, whether it's brain surgery or the -- or the GI surgery we think we can start to move upstream into that 90% of really non-workable oral segment. So, we are encouraged at the recent feedback from our KOLs and our study sites and are anticipating and planning for launch in the coming years. Thanks, Chris. Operator, next question, please. And our next question is from Gregg Gilbert from Truist. Yes, hi, I was curious if your Botox Cosmetic guidance in the US assumes that as you've always on the market or off the market this year and then longer-term curious about Botox Cosmetic versus therapeutic many years ago Allergan started to explore the idea of separating the two from a reimbursement and pricing standpoint, I believe it involved litigation with the government at one point, but I don't know if that's still ongoing or if you're still thinking through that possibility since it has implications longer-term about keeping those that together possibly spending Aesthetics someday if conditions warrant. Thank you. Yes, so I don't know that we're going to specifically comment on what we've assumed as it relates to [indiscernible]. I just don't think it's probably appropriate. First of all, it's not that large of a product to begin with. So wouldn't have a material impact on Botox Cosmetics. I'd say on the -- on the -- on your second question, I will tell you emphatically we have no interest in spinning off the Aesthetics business. We have a program in place where we manage the differences between the reimbursement associated with Botox Therapeutics and the cash pay portion of the Cosmetics business, it's been in place for quite some time. We're quite comfortable that we can manage it quite effectively. So It's an important thing that you -- that you track carefully, but we have a good system in place to be able to do that, but we have no interest in getting off the Aesthetics business or any aspects of the of the Aesthetics business. Thanks, Gregg. Operator, next question please. Our next question is from Geoff Meacham from Bank of America. Hey guys, it's Austin [ph] on for Geoff. Thanks so much for the questions. A couple of quick ones. So -- and within the context of the Xeljanz's data, do you guys have an early view from the field as to whether docs are differentiating Rinvoq and -- sorry, Rinvoq and Xeljanz's safety profiles? And then quickly on the mid to early stage pipeline there's obviously a lot going on in your Heme-onc space but just going to want to get a sense of how strategically important some more newer disruptive technologies are to AbbVie such as cell or gene therapy. Thanks. Yes, I'll take the early view from the field. I think it's important, at least, we've heard from our teams that some of this data is not really new. It was available in the interim analysis that helped -- led to the label that we have and so really the early reports from our -- from our field particularly from the KOLs and the big prescribers is a little bit of a shoulder shrug like not that, not that new news. I would say, from the standpoint of the comparison between Rinvoq and Xeljanz. I mean if you look at the penetration of the jack-class really across the world, and particularly in the U.S., there has been a significant lift that we just talked about with that in play share. And so really what we're -- what we're hearing from the -- from the field and from the prescribers are they view Rinvoq as a differentiated asset in terms of the overall risk benefit and that's why that share is moving so quickly and so that's really what we -- what we hear in the early days from our -- from our teams that are connected to those big rheumatologists. So, this is Mike. I'll take the question on the heme-onc portfolio mid stage and newer technologies, but I would say is there is a lot going on in our heme-onc portfolio. Obviously with our late-stage molecules in the mid-stage. I think you'll see a focus on T-cell redirection, which is of course a newer technology. And I think a very attractive approach to harness the immune system to control these cancers and you see good progress with our CD3 by CD20 and our BCMA T cell redirecting therapies. And so, that is clearly an area of focus for us now and I think we'll continue to be in the future. With respect to gene therapy, gene therapy is not a single thing it can be used in different ways. Gene replacement is not an area that we've been focused on. Gene delivery is an enabling technology for other therapeutic approaches like cell-based therapies and we have early programs and cell-based therapies in heme-onc and in other areas. Solid tumor oncology and potentially other areas in the future. And so that's something that we are keeping a close eye on and making sure that we have access to the enabling technologies we need to prosecute those targets. I think that for those sorts of approaches we're probably one generation away from things that are broadly applicable. But we are exploring possibilities that we think can fulfill that next generation need. And so we are keeping up a broad eye and are essentially therapeutically agnostic. What I mean by that is we look for the best tool to do the job. We don't find it tool and then figure out how to use it. And so in each of these cases we're going after strong biology. We're going after things that we think will raise the bar on the standard of care. And I think a number of the newer technologies that I mentioned fit that bill. Thanks. Operator, we have time for one final question. Thank you. Our final question today is from Luisa Hector from Berenberg. Hello, thank you for taking my question and thank you for the guidance on the cost lines. And I just wondered given that we have various layers to consider with COVID and then the Allergan inclusion and the synergies could you comment on the implied cost ratio for 2021 and how representative are the combined entity. And is there anything else we should be thinking about for those cost line as we look out to 22 COVID related savings may be sticky ones that may reverse? And could you tell us the level of synergies you achieved already in 2020? Thank you. Hi, Luis. This is Rob. So I think now that we have first full year with combined company and you're looking at these profiles. I think you could assume they're indicative in the range of what you'd expect going forward. And so that is a cleaner guide then say when you have a partial year like we had in 2020 as it relates to the synergies we achieved in 2020 which is about $600 million of synergies about $400 million that was an R&D and $200 million SG&A and you see we've now increased that to $1.7 billion in 2021 with about a little bit roughly half of that coming from R&D about in the 40% range SG&A and about 10% from cost of goods. Thanks, Luisa. And that concludes today's conference call. If you'd like to listen to a replay of the call, please visit our website at investors.AbbVie.com. Thanks again for joining us. Thank you. This does conclude today's conference. You may disconnect at this time.\""
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "text_transcipt = ''\n",
    "\n",
    "for speech in transcripts[0]['transcript']:\n",
    "    #print(speech['speech'][0])\n",
    "    #print()\n",
    "    \n",
    "    text_transcipt = text_transcipt + ' ' + speech['speech'][0]\n",
    "text_transcipt"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "id": "e78ff4b8-9430-4d81-bf93-75e001bb8145",
   "metadata": {},
   "outputs": [],
   "source": [
    "text_transcipt = ''\n",
    "\n",
    "# Here we loop through all statements, \n",
    "# here one could add a check if the person speaking is e.g. an analyst, \n",
    "# since the speach  object has a \"name\" attached to it as well. \n",
    "for speech in transcripts[1]['transcript']:\n",
    "    # here we create a new string from the old string + the last statement (speach)\n",
    "    # We add a space in between to prevent it from adding the first and last word together\n",
    "    text_transcipt = text_transcipt + ' ' + speech['speech'][0] "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "id": "af2f9518-2370-40ab-aeda-ab91460ff8a1",
   "metadata": {
    "scrolled": true,
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "' Good morning and thank you for standing by. Welcome to the AbbVie Third Quarter 2020 Earnings Conference Call. All participants will be able to listen-only until the question-and-answer portion [Operator Instructions] And I would now like to introduce Ms. Liz Shea, Vice President of Investor Relations. Good morning and thanks for joining us. Also on the call with me today are Rick Gonzalez, Chairman of the Board and Chief Executive Officer; Michael Severino, Vice Chairman and President; Rob Michael, Executive Vice President and Chief Financial Officer; and joining us for the Q&A portion of the call is Laura Schumacher, Vice Chairman, External Affairs, Chief Legal Officer and Corporate Secretary. Before we get started, I remind you that some statements we make today may be considered forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. AbbVie cautions that these forward-looking statements are subject to risks and uncertainties, including the impact of the COVID-19 pandemic on AbbVie‚Äôs operations, results and financial results that may cause actual results to differ materially from those indicated in the forward-looking statements. Additional information about these risks and uncertainties is included in our 2019 annual report on Form 10-K and in our other SEC filings. AbbVie undertakes no obligation to update these forward-looking statements except as required by law. On today‚Äôs conference call, as in the past, non-GAAP financial measures will be used to help investors understand AbbVie‚Äôs ongoing business performance. These non-GAAP financial measures are reconciled with comparable GAAP financial measures in our earnings release and regulatory filings from today, which can be found on our website. Unless otherwise noted, our commentary on sales growth is on a comparable operational basis, which includes full current year and historical results for Allergan and excludes the impact of exchange. For this comparison of underlying performance, all historically reported Allergan revenues have been recast to conform to AbbVie‚Äôs revenue recognition accounting policies and excludes the divestitures of Zenpep and Viokace. Following our prepared remarks, we will take your questions. So, with that, I will now turn the call over to Rick. Thank you, Liz. Good morning, everyone, and thank you for joining us today. I will discuss our third quarter performance and highlights, as well as our full year guidance, which we are raising again this quarter. Mike will then provide an update on recent advancements across our R&D programs and Rob will discuss the quarter in more detail. Following our remarks, we will take your questions. AbbVie delivered another excellent quarter with adjusted earnings per share of $2.83, exceeding the midpoint of our guidance range by $0.08. When I look at our business and the actions we have taken to position AbbVie for sustainable performance, including the acquisition of Allergan, I feel very good about our long-term outlook. The fundamentals are strong and there is considerable momentum across our legacy and new portfolios, which are both demonstrating robust growth, despite the COVID pandemic and together have the potential for significant long-term value creation. I‚Äôd like to specifically highlight our recent progress across several aspects of our business, including the launches of RINVOQ and SKYRIZI, which are performing well ahead of all comparable launch analogs in their initial indications and continue to exceed our expectations. Our hem/onc franchise continues to deliver robust performance and is expected to generate more than $6.5 billion in revenue this year, representing strong double-digit growth. New indications and novel combinations, including our recently announced collaboration with Genmab and I-Mab provide opportunities for further revenue expansion. While it is still relatively early in the integration of Allergan, the strategic merits of the combination have never been more evident. We are already demonstrating that we have created a stronger, more diverse company, with robust cash flows and multiple new growth vehicles for the long-term. We now have the leading aesthetics franchise, which is demonstrating a strong V-shaped recovery, as well as a highly attractive neuroscience portfolio which delivered double-digit growth on a comparable operational basis this quarter and has significant momentum with VRAYLAR and our expanding migraine franchise. And our pipeline is advancing nicely, with numerous attractive late-stage programs that we believe will allow us to maintain a growing and vibrant business. We are on track for the approval of more than a dozen new products for major indications over the next two years, which will collectively add meaningful revenue growth. This includes a total of six additional indications for RINVOQ and SKYRIZI, expanded indications for VENCLEXTA and several other near-term product -- new product approvals, including atogepant, Navitoclax and 951. Clearly, this is a very exciting time for AbbVie and I am pleased with the progress that we are making towards our long-term strategy for sustainable growth. I remain confident that we will continue to execute as we have in the past and deliver outstanding shareholder value going forward. I‚Äôd like to look further at our business performance. I am pleased with the recent trends across our key growth areas. I will start with immunology, where we established strong trajectories for RINVOQ and SKYRIZI. As I previously noted, both continue to perform well-above expectations. In their initial indications, these two brands have clearly demonstrated superior efficacy to HUMIRA, as well as other novel agents on the market or in development, resulting in significant in-play market shares, a leading indicator for long-term commercial performance. The in-play share for RINVOQ in RA, which includes both new and switching patients remains strong at approximately 16% and has now reached parity with our market leading HUMIRA. In psoriasis, SKYRIZI has already achieved the leading in-play market share at 33%. This level of share capture at this stage of the launch is unprecedented, and if sustained, will ultimately lead to total market share well in excess of what was contemplated when we communicated our expectations for 2025 sales. This strong performance and trajectory, despite the impact of the COVID-19 pandemic is a testament to our differentiated product profile and our commercial execution. Our focus since the pandemic has been on driving accelerated patient activation and we remain encouraged by our current prescription trends. Our recent performance continues to give us confidence in the near- and long-term potential for both RINVOQ and SKYRIZI, which we now expect will deliver $2.2 billion in combined revenue for full year 2020, well exceeding our original projections for this year. In addition to outstanding commercial momentum, we are also making excellent progress with RINVOQ and SKYRIZI in new indications, which we expect will further strengthen our leadership position. We have already started planning and preparing for the forthcoming approval of three additional RINVOQ indications next year, including psoriatic arthritis and ankylosing spondylitis, giving us complete coverage across the more than $40 billion rheumatology segment. We also expect approval in atopic dermatitis, another large and growing market that has the potential to be multi-billion dollar peak revenues for RINVOQ. In the coming year, we also intend to submit regulatory applications for SKYRIZI in psoriatic arthritis and both agents in the area of inflammatory bowel disease, a more than $20 billion market today with high unmet need. Overall, I am extremely pleased with the progress we are making on both RINVOQ and SKYRIZI. I‚Äôd also like to take this opportunity to announce that we will be hosting an immunology focused Investor Day in December, where we intend to further discuss our strategy, progress, and expectations for this important growth area. Additional details will be forthcoming. Turning now to hem/onc, which delivered robust double-digit growth again this quarter and remains an important therapeutic area for AbbVie‚Äôs long-term performance. IMBRUVICA has a strong position across multiple indications including CLL, where it remains the clear market share leader across all lines of therapy. IMBRUVICA sales increased 9% on an operational basis this quarter, despite lower new patient starts within CLL, where the market remains below pre-COVID levels. VENCLEXTA sales increased nearly 60% on an operational basis this quarter. The penetration across our approved indications remains strong, especially in AML, given the potential aggressive disease progression of that cancer. In the quarter, we also announced a strategic collaboration with I-Mab, further expanding our oncology portfolio with anti-CD47 monoclonal antibody, which has potential across a wide range of blood cancers. The I-Mab opportunity adds to our already-attractive oncology pipeline, which includes Navitoclax, Genmab CD3xCD20, expanded indications for VENCLEXTA and several promising early-stage programs. We also now have another high performing franchise in neuroscience, which further diversifies AbbVie‚Äôs sources of long-term growth. VRAYLAR sales increased strong double-digits again this quarter on a comparable operational basis, with annualized revenues of more than $1.4 billion. Given VRAYLAR‚Äôs benefit/risk profile relative to other atypical anti-psychotics, we remain confident in its long-term growth potential, which we believe is multi-billion dollars across the currently approved indications of bipolar disorder and schizophrenia. BOTOX Therapeutics, which has nearly a dozen medical treatment indications, including chronic migraine, is also performing very well. Revenues were up nearly $100 million sequentially on a comparable operational basis, demonstrating a rapid COVID recovery. The launch of UBRELVY, our leading oral CGRP for acute migraine, is exceeding our expectations. Commercial access is ramping strongly and increasing DTC investments have resulted in encouraging new patient starts and market expansion. When you consider our overall scale with BOTOX Therapeutics, UBRELVY‚Äôs acute treatment profile and the promising development of atogepant for the prevention of episodic and chronic migraine, we see substantial room for long-term revenue growth with this best-in-class migraine portfolio. Within aesthetics, our fourth major growth platform, we are seeing robust demand trends and a rapid V-shaped recovery. Total global aesthetics revenues of more than $950 million were up 70% sequentially on a comparable operational basis, illustrating the significant underlying demand for both BOTOX cosmetics and JUV√âDERM. We remain focused on supporting clinics through the COVID pandemic and expect consistent investment in consumer promotion to expand the aesthetics market, which remains under penetrated globally. Our dedicated R&D and business development are expected to sustain new innovation and rapidly expand our aesthetics portfolio for long-term growth, including the recently announced acquisition of Luminera, which provides us with a complementary dermal filler portfolio and pipeline. Overall, we are very pleased with the momentum that we are seeing with our aesthetics franchise. AbbVie‚Äôs business continues to remain resilient and demonstrates strong underlying growth throughout the pandemic. Based on the performance this quarter and our progress year-to-date, we are raising our full year 2020 EPS guidance. We now expect adjusted earnings per share of $10.47 to $10.49, reflecting growth of more than 17% at the midpoint. In addition to the excellent progress we are making across the portfolio, the integration of Allergan continues to go very well. Despite the size of this transaction and the timing of the COVID pandemic, the transition has been seamless. We are performing very well against both our synergy and accretion targets, and it is becoming increasingly clear to us that there are also opportunities for revenue synergies across various aspects of the business. We are now six months post-close and the strategic merits of the transaction are extremely evident. Allergan is providing additional growth platforms, robust financial benefits and greater diversity of our business. We remain confident that the newly combined business will generate significant earnings and cash flow to support continued investment in our innovative R&D platform, as well as a strong and growing dividend, while also allowing us to rapidly pay down debt. To that end, as noted in our news release, today we are announcing a 10.2% increase in our quarterly cash dividend from $1.18 per share to $1.30 per share beginning with the dividend payable in February 2021. Since inception, we have grown our quarterly dividend by 225%. So, in summary, we continue to demonstrate strong execution across our portfolio and remain encouraged by the overall recovery trends. We have assembled an impressive set of diversified growth assets with significant growth potential giving us a high degree of confidence in the long-term outlook for our business. With that, I will turn the call over to Mike. Thank you, Rick. We continue to make great progress across all stages of our pipeline and this morning I will highlight key events since our last earnings call. Starting with immunology, where we achieved several major milestones, including submission of our U.S. and European regulatory applications for RINVOQ in ankylosing spondylitis and atopic dermatitis. We expect regulatory decisions in the first half of 2021 for both indications, as well as for psoriatic arthritis which was submitted for regulatory review earlier this year. Within the rheumatology segment, both psoriatic arthritis and ankylosing spondylitis are large and important markets and represent a significant growth opportunity for RINVOQ. We will highlight the growing body of data from our rheumatology portfolio and the -- at the upcoming virtual ACR Congress, where we will present 35 abstracts from multiple assets across our portfolio, including six selected for oral presentation. Atopic dermatitis is a new disease area for AbbVie and also represents an important area of growth for our immunology franchise going forward. Based on the data generated in our registrational program, we remain very confident in the benefit/risk profile for RINVOQ in atopic dermatitis and believe it will offer meaningful advantages over products on the market today or in development. Beyond the Phase 3 studies that support our regulatory submission, we are also evaluating RINVOQ in a head-to-head Phase 3 trial against dupilumab, which if successful, will help further support RINVOQ as a highly differentiated therapeutic option for patients with atopic dermatitis. We look forward to seeing data from this head-to-head study later this quarter. In the area of inflammatory bowel diseases, we remain on track to see induction data later this quarter from our Phase 3 program for RINVOQ in ulcerative colitis. We will see data from a second induction study in ulcerative colitis, as well as results from the maintenance portion of these studies next year. We expect to file our regulatory applications in 2021 as well. We are also making great progress with the development programs for SKYRIZI and later this quarter we expect data from several new indications across rheumatology and gastroenterology. We will see data from two Phase 3 studies in psoriatic arthritis and results from the first Phase 3 induction study in Crohn‚Äôs disease, supporting regulatory applications for both indications in 2021. Outside of immunology, SKYRIZI will also be evaluated as a potential treatment for COVID-19 as part of the NIH ACTIV program, which is a public private partnership aimed at accelerating potential therapies and vaccines for COVID-19. SKYRIZI was selected through a prioritization process that evaluated immunomodulators with acceptable safety profiles as potential treatments for COVID-19 complications caused by the cytokine storm observed in some patients. SKYRIZI will be included in the ACTIV-5 Big Effect trial, which is a Phase 2 study designed to evaluate a number of drugs that are either approved or in late-stage development as potential treatments for COVID-19. In our early-stage immunology pipeline, earlier this year, we toplined positive results from a proof-of-concept study evaluating our novel TNF steroid conjugate, ABBV-3373 in RA. We recently completed the Phase 1 PK and safety study for our second TNF steroid conjugate, ABBV-154. Based on these data, we have selected 154 to move forward into larger scale trials. We expect to begin a Phase 2b definitive dose ranging study for 154 in RA for the first half of 2021. As Rick mentioned, we will be hosting an Immunology Day for investors in December, where we will provide an update on our immunology strategy and long-term outlook for the franchise. We look forward to providing additional updates on our immunology pipeline at that time. In oncology, we continue to advance our portfolio with several important Phase 3 studies beginning in the quarter, including VENCLEXTA in high-risk myelodysplastic syndrome and navitoclax in myelofibrosis. We also recently received full FDA approval of VENCLEXTA in combination with azacitidine, decitabine or low-dose cytarabine in newly diagnosed AML patients, who are ineligible for intensive induction chemotherapy. This approval is supported by the Phase 3 VIALE-A and VIALE-C studies. Updated efficacy and safety results from VIALE-A were recently published in the New England Journal of Medicine and showed that the combination of VENCLEXTA and azacitidine extended overall survival compared to azacitidine plus placebo. Additionally, following the publication of the VIALE-A results, the NCCN guidelines were updated to recommend the VENCLEXTA and azacitidine combination as the Category 1 preferred treatment for AML patients who are ineligible for intensive chemotherapy. Importantly, the VENCLEXTA combination has the Category 1 designation irrespective of mutational status. Also in the quarter, we announced a collaboration with I-Mab to develop and commercialize the anti-CD47 monoclonal antibody, lemzoparlimab. The emerging data for lemzoparlimab is very encouraging and provides AbbVie access to another potentially differentiated asset in the immuno-oncology space. The data generated to date show that lemzoparlimab effectively blocks tumor-specific CD47 interactions, but with much lower binding to red blood cells, potentially leading to a better safety profile. Lemzoparlimab is being studied in multiple cancers with a focus on hematological malignancies. In neuroscience, we recently presented new data from several clinical programs at the virtual Migraine Trust International Symposium, showcasing the breadth and strength of our migraine portfolio and demonstrating AbbVie‚Äôs commitment to providing multiple treatment options for the acute and preventive treatment of migraine. In total, 15 abstracts were presented for BOTOX, UBRELVY and atogepant. Included in the MTIS presentation were the detailed results for atogepant in the Phase 3 advanced study, which demonstrated a clinically meaningful and statistically significant improvement over placebo, with all atogepant doses for the primary endpoint of reduction in mean monthly migraine days. Significant improvements were also observed for all secondary endpoints in the 30-milligram and 60-milligram dose groups. Treatment with atogepant resulted in 56% to 61% of subjects achieving at least a 50% reduction in monthly migraine days, compared to 29% for the placebo group. We are very encouraged by the strong benefit/risk profile that has been demonstrated for atogepant in migraine prevention and believe that once approved, this new oral treatment option will be competitively positioned in the prevention market. Together with BOTOX for chronic migraine prevention and UBRELVY for acute migraine treatment, the addition of atogepant creates a market leading portfolio in migraine that represents significant long-term value for AbbVie. In aesthetics, we continue to make good progress with our portfolio of facial toxins and dermal fillers. We have several ongoing programs for new indications for BOTOX and for the JUV√âDERM collection, as well as a pipeline of innovative toxins and dermal fillers, which we expect to reach the market over the course of the next five years. BOTOX has been the leading neurotoxin for over two decades, with R&D efforts in aesthetics primarily focused on the upper face. To support expansion to the lower face region, we have several programs ongoing, including studies in masseter and platysma prominence. We recently had a positive data readout for our Phase 2 study for the reduction of masseter prominence in the lower face. This study met all primary and secondary endpoints, demonstrating that the severity of prominence was reduced following a single treatment of BOTOX. Based on these results, we plan to begin Phase 3 development next year, which will support registration in the U.S. and Europe. We also recently announced the acquisition of Luminera‚Äôs dermal filler portfolio led by HArmonyCa, which is an innovative dermal filler developed for facial soft tissue augmentation. Luminera‚Äôs assets are highly complementary to our JUV√âDERM filler franchise and we look forward to expanding their development to markets around the world. And in eye care, we recently announced positive topline results from the Phase 3 GEMINI 1 and GEMINI 2 studies, which evaluated our topical eye drop, AGN-190584 for the treatment of symptoms associated with presbyopia. In both studies, 584 met the primary endpoint and the majority of secondary endpoints, with data from both studies demonstrating that treatment with 584 resulted in significant near-vision gains in low lighting conditions without a loss of distance vision. Based on these results, we plan to submit our regulatory application to the FDA in the first half of next year. So, in summary, we have continued to make significant progress advancing and accelerating our programs this quarter, and we look forward to many more important pipeline milestones in the coming months and through 2021. With that, I will turn the call over to Rob for additional comments on our third quarter performance and financial outlook. Rob? Thank you, Mike. Starting with third quarter results, we delivered strong top and bottomline performance. We reported adjusted earnings per share of $2.83, above our guidance midpoint by $0.08. Total adjusted net revenues were approximately $12.9 billion, up 4.1% on a comparable operational basis and ahead of our expectations. Immunology global sales were approximately $5.8 billion, up 15% on an operational basis, despite the impact of COVID on new patient starts across the immunology market. U.S. HUMIRA sales were approximately $4.2 billion, up 7.7% compared to prior year, reflecting continued demand growth plus price. Wholesaler inventory levels remain below half a month in the quarter. International HUMIRA sales were $951 million, down 8% operationally, reflecting biosimilar competition across Europe and other international markets. SKYRIZI sales were $435 million with leading in-play share in the U.S. psoriasis market and robust sequential growth internationally. RINVOQ sales were $215 million with continued strong in-play share in the U.S. RA market. Hematologic oncology delivered another strong quarter, with sales of $1.7 billion, up 16.4% on an operational basis. IMBRUVICA net revenues were approximately $1.4 billion, up 9% driven by our leading share in CLL. VENCLEXTA revenues were $352 million, with strong demand across all approved indications. MAVYRET sales were $414 million, down 41.1% on an operational basis, as treated patient volumes have remained below pre-COVID levels. Aesthetic sales were $967 million with BOTOX cosmetic and JUV√âDERM both experiencing a faster than expected recovery from the COVID pandemic. Neuroscience revenues were more than $1.2 billion led by VRAYLAR and our migraine portfolio. VRAYLAR once again delivered strong growth with revenues of $358 million. BOTOX Therapeutic continues to experience a rapid recovery from the COVID pandemic, with sales of $523 million in the quarter. The launch of UBRELVY is also going very well with recent direct-to-consumer promotion driving new prescription growth. Sales of UBRELVY were $38 million. We also saw a significant contribution from eye care, which had sales of $840 million. Turning now to the P&L profile for the third quarter. Adjusted gross margin was 81.7% of sales, adjusted R&D investment was 11.7% of sales and adjusted SG&A expense was 21.1% of sales. The adjusted operating margin ratio was 48.8% of sales, an improvement of 40 basis points versus the prior year. Net interest expense was $620 million and the adjusted tax rate was 11.7%. As Rick previously mentioned, we are raising our full year adjusted earnings per share guidance to between $10.47 and $10.49, including accretion from the Allergan transaction of 12% on an annualized basis. Excluded from this guidance is $6.58 of known intangible amortization and specified items. This guidance now contemplates 2020 adjusted net revenue of approximately $45.7 billion, representing an increase of $200 million from our previous estimate. At current rates, we now expect foreign exchange to have a modest unfavorable impact on fully reported sales growth. Included in this guidance are the following updated 2020 assumptions. We now expect international HUMIRA sales approaching $3.7 billion. For SKYRIZI, we now expect revenues of approximately $1.5 billion. For RINVOQ, we now expect sales of approximately $700 million. For IMBRIVICA, we now expect revenue of approximately $5.3 billion, as new patient starts in the CLL market remain below pre-COVID levels. For Aesthetics, we now expect post-close sales of approximately $2.5 billion with BOTOX cosmetic and JUV√âDERM both demonstrating a fast recovery. For MAVYRET, we now expect sales of approximately $1.9 billion, as treatments remain below pre-COVID levels. We now expect LUPRON revenues of approximately $750 million, as we work to resolve a near-term supply issue, which has impacted availability of certain formulations. Moving to the P&L, we continue to forecast full year adjusted gross margin just above 82% of sales and adjusted operating margin of approximately 48% of sales. This guidance includes approximately $600 million in expense synergies for the partial year in 2020. We remain on track to deliver greater than $2 billion in expense synergies by 2022. As we look ahead to the fourth quarter, we anticipate adjusted net revenue approaching $13.8 billion. At current rates, we expect foreign exchange to have a modest favorable impact on reported sales growth. We are forecasting an adjusted operating margin ratio of approximately 46.5% of sales. We model a non-GAAP tax rate of 11.6% and we expect the average share count to be similar to Q3. We expect adjusted earnings per share between $2.83 and $2.85, excluding approximately $1.73 of known intangible amortization and specified items. Finally, AbbVie‚Äôs strong business performance continues to support our capital allocation priorities. We generated $12.7 billion of operating cash flow in the first nine months of the year, and our cash and investments balance at the end of September was $8 billion. Underscoring our confidence in AbbVie‚Äôs long-term outlook, today we announced a 10.2% increase in our quarterly cash dividend, beginning with the dividend payable in February 2021. We also remain on track to pay down $15 billion to $18 billion of combined company debt by the end of 2021 and expect to achieve a net debt-to-EBITDA ratio of 2.5 times by the end of next year, with further deleveraging through 2023. With that, I will turn the call back over to Liz. Thanks, Rob. We will now open the call for questions. Operator, first question, please? Thank you. [Operator Instructions] Our first question today is from Chris Schott from JPMorgan. Great. Thanks so much for the questions and congrats on the results. I guess just two for me. First, 2021, I know you are not giving guidance yet, but can you just talk through some of the pushes and pulls we should keep in mind as we think about next year‚Äôs numbers and it seems like the core business obviously has a lot of traction here. I am just trying to get a sense of from your perspective what are the uncertainties as you think about that guidance number for next year? And my second question was on RINVOQ in atopic derm. Can you just elaborate a bit more on how you are thinking about the size of that opportunity? I know one of your peers has a single indication JAK in AD they think is a $3 billion peak sales opportunity. I know that‚Äôs well above your risk adjusted numbers you had a few years ago. It sounds like now you are talking about potential multi-billion dollar opportunity. But just help us flesh out a little bit about how big of an opportunity could this be for the product? Thank you. Okay. So, Chris, this is Rick. I will talk a little bit about 2021 and then Mike maybe can talk a little bit about how we view RINVOQ in AD and Rob. So when we look at 2021, I think, you have to step back and say, how are we performing this year? And obviously we are performing very well. There‚Äôs still some COVID impact built in. It varies a bit by therapeutic areas, some areas are impacted more than others. So as an example, CLL has been impacted more than other areas, HCV has been impacted more than other areas. It‚Äôs usually places where the therapy can be delayed without significant consequence for the patient is where we are seeing most significant delays. So as we move through the fourth quarter, we will see whether or not that recovers more and that‚Äôs certainly one aspect of it. I would say, even without much recovery, the underlying performance of the business looks good. I think you can look at the dividend increase that we put through and that should give you some flavor for the level of confidence that we have, because obviously, we would want to tie that to what we assumed that we could deliver from an overall performance standpoint. I‚Äôd also say that, as we look to consensus, we are comfortable with what we see in consensus in 2021. So we want to see a few other things just play out primarily around COVID, how much improvement we get. We have launched a number of programs over the course of the last couple of months to try to activate patients more, to go to their physicians and seek treatment out. I think those programs, some of those programs will be successful and we will see some of those increase, particularly in immunology, because dermatology is another one of those areas that the new patient starts are still off a little bit. Now, obviously, SKYRIZI is performing extremely well and HUMIRA continues to perform well. So, I‚Äôd say that‚Äôs the single biggest issue. Rob, Mike, do you want to talk about RINVOQ? Certainly. I will start and then pass it over to Rob, if he wants to add a little bit more detail. We view atopic dermatitis as a very attractive and a very substantial opportunity overall. It‚Äôs an indication that I think for many years was underappreciated by the industry. Now that‚Äôs changed recently and you have seen a lot of focus in drug development in atopic dermatitis. We feel very good about the profile that we have demonstrated, coming out of Phase 2, when we made those statements about the risk-adjusted potential in atopic dermatitis, we felt good about our data and those data were sufficient to get a breakthrough therapy designation. We are in the fortunate and not always that common situation where our Phase 3 results have actually outperformed our expectations based on Phase 2. And if you look at the Phase 3 results, they are really strong across the board. They are strong in total response. They are strong in repeated response and they are strong on components like itch, which is the most troublesome symptom to patients in the majority of cases. And so, when you couple that with the safety profile that we have demonstrated, which we think is very favorable. We see this as something that has very real potential and when we look across studies, we feel very good about our results. And of course, we have a head-to-head study with dupilumab, which is coming up later on this quarter and so that will be important additional information, and we are very optimistic about those results. Rob, I don‚Äôt know if you would like to add anything further? Chris, this is Rob. So if you think about atopic dermatitis, it‚Äôs a $3 billion global market with very strong growth potential. In our 2025 risk adjusted guidance of greater than $10 billion for RINVOQ and SKYRIZI, we included $1 billion of revenue for RINVOQ AD, but we feel pretty good that we can achieve that expectation. And the only other thing I‚Äôd add is, I think atopic derm is a market very similar to several others, in fact, psoriasis, I would say, is a similar type of market. But as you get more competitors in the market driving promotion, it has a very large population of patients. So the question is, activating those patients and getting them to go into the physician‚Äôs offices to seek treatment. And so, obviously, when you have one company doing that, they have the capacity to drive a certain amount. When you have more than one company, you are doubling or tripling the amount of promotion activity, particularly here in the U.S. and that tends to activate more patients to seek treatment. I think if you looked at the total available market of patients who would qualify, it‚Äôs a huge market, it‚Äôs north of $5 billion easily. So the question is, how fast can you activate them and how broadly can you activate those patients? From a profile standpoint of our drug, I think we will compete quite effectively, and I think, in particular, the performance around itch is going to give us an advantage. So it‚Äôs a very attractive market and it‚Äôs certainly one that we will focus a lot of attention on to drive. And Chris, this is Rob again. Just to clarify, I said exceed or achieve, but we expect to exceed that $1 billion risk-adjusted number for RINVOQ AD in 2025. Thanks, Chris. Operator, next question, please? Thank you. And our next question is from Geoffrey Porges from SVB Leerink. Thanks. Rick a question to you. With the dividend going up, it looks like you have got about a 6.5% dividend yield. The core business is performing well. And my question is, what are the -- and you are now a $50 billion to $55 billion topline company. What are the pipeline assets that can really move the needle, I know all the new indications for the existing NMEs, but what new NMEs can be really substantial to move the needle on a $55 billion topline, because I think, that‚Äôs part of why you have got an industry high dividend yield? So, Geoff, this is Rick. I think if you look at the business, you have to look at it in phases, right? So I‚Äôd say the phase between now and call it 2025, 2026. That growth is going to be driven by expansion of RINVOQ and SKYRIZI, continued strong growth in the neuroscience pipeline, continued strong growth in the aesthetics pipeline and continued strong growth in the hem/onc. Starting in that 2025 timeframe and beyond, that‚Äôs where the earlier to mid-stage pipeline will drive a significant amount of growth. Now there will be assets like Navitoclax, like 951, atogepant, that will come in prior to that and help boost growth right around ‚Äò23 and ‚Äò24. But I can tell you, we are very confident that we have now built a portfolio that can sustain growth and drive growth on the other side of the LOE. In fact, I would tell you that, when I look at RINVOQ and SKYRIZI, and I look at the in-play market shares that we see with those assets today, when we gave guidance of 2025, we assumed that on average, we would achieve high single-digit market share across the indications. So as an example, if you look at SKYRIZI right now, SKYRIZI‚Äôs in-play share is 33%, the market leader by a wide margin. The next closest product is at 16% in-play share. And its TRX share is now at 11% and climbing rapidly. So it‚Äôs already above what we had assumed the peak would have been out in 2025 from a market share standpoint. And if we maintain that 33% by then, it will have an overall share of about 33%, so it will be three times what we had assumed for psoriasis. So when you look at the speed at which we are bringing the new indications, when you look at the breadth of those indications across the revenue base that HUMIRA has today, we have covered all of the major indications for HUMIRA plus one more that HUMIRA doesn‚Äôt have, which is atopic derm. And if we can achieve that kind of market share in each of these indications, then we will obviously double what we assumed that 2025 number was and that gets you pretty close to covering all of HUMIRA in the U.S. So I am very encouraged about that. And I think that, along with the other assets and the four major growth platforms, gives us a tremendous amount of confidence that we can drive growth on a sustainable basis at a very high level. Thanks, Geoff. Operator, next question, please? Thank you. And our next question is from Vamil Divan from Mizuho. Hi. Thanks so much for taking my questions. So maybe just sort of following up on what has been asked. For 2021 on Chris‚Äô question, can you just talk a little bit about how you are thinking about drug pricing pressure, either U.S. or globally just to think about our modeling for next year, I think, that would be helpful? And then maybe building on Geoff‚Äôs question, I think one of the other concerns that investors have is around potential tax reform that may come out of D.C. depending on how the election plays out. I know it‚Äôs tough to ask just a few days before the election. But I guess based on what you are seeing especially from the Biden side, I guess the Biden plan right now. Is there anything you can share with investors at this point in terms of how your tax rate may change going forward and I appreciate there‚Äôs probably not much that you can give, but any insights I think would be helpful, because I think it is investors seem very concerned about at this point? Thank you. Yeah. Well, Vamil, obviously, it‚Äôs still unclear as to what the landscape will be on the other side of the election, so we obviously have to let that play out. Having said that, I think, we assume that there will be continued pressure on the industry as it relates to drug pricing. As far as what our expectations would be in 2021, I think our expectations in 2021 from a price standpoint will be similar to what they were in ‚Äò19 and ‚Äò20, and is we weren‚Äôt reliant on price. I mean, fortunately our business is primarily a volume-driven business. It‚Äôs typically in areas that are very serious diseases and have strong value propositions. And so that gives me confidence that we will be able to fare reasonably well even if there are changes. I‚Äôd say the second thing is, it‚Äôs unlikely that you will get changes that have a significant impact early on in ‚Äò21, because there‚Äôs going to be a lot of debate here about what those changes are. What I would hope the debate ultimately transitions to is co-pays and out-of-pocket costs for patients, because that is the fundamental issue and it‚Äôs particularly the issue when you look at Part D patients. They have to pay far too much of the burden of the cost from an out-of-pocket cost standpoint. And they are really the only group of patients in the U.S. that have that kind of burden associated with them. If you look at the overall performance from a cost standpoint of Medicare Part D. It‚Äôs performed very well. In fact, if you go back to the original CBO estimates over the last 10 years, it‚Äôs come in 45% below the original estimates for what it would grow. And if you look at Part D, it‚Äôs grown at about the rate of other healthcare services inflation, not significantly higher. And so the affordability problem is really around those co-pays. We have to drive those co-pays. And then I think the other thing that has to be played in here is, I would hope as this debate goes on, they are going to look very carefully at our industry and the value of our industry both from a societal standpoint, as well as an economic standpoint and this is tremendously value industry. Just look at what we have done as an industry as it relates to this pandemic, whether you are talking about vaccines or you are talking about therapeutics, look at what we have done in advancements with cancer. And then from an economic standpoint, this industry supports directly or indirectly 4 million jobs in the United States, typically high paying jobs. It produces a tremendous amount of economic output for the U.S. And so it‚Äôs an industry that you don‚Äôt want to damage in the process and I think that has to be part of the debate. But the short answer to your question is, I think, you should -- we should -- we are not assuming we will get a lot of benefit from price in ‚Äò21. We are also not assuming that across that year we would see a significant change that would have a dramatic impact on that calendar year. Tax reform was your next question. Vamil, It‚Äôs Rob. So based on a very high level of information on the Biden proposal, we would see an increase in our tax rate like most U,S, companies, but it‚Äôs really difficult to provide a rate impact without the details. That said, AbbVie would still have a favorable profile versus our peers and we wouldn‚Äôt have raised our dividend if we were overly concerned about the implications. And the only thing I‚Äôd add, Vamil, on that one is, we obviously did flex what we thought the tax rate could be and we just don‚Äôt know that much about it, we know what has been said. But we flexed it against this dividend increase and made sure we were absolutely comfortable with payout ratios based on that and we are or we wouldn‚Äôt have moved forward with the 10.2% increase. Thanks, Vamil. Operator, next question, please? Thank you. And our next question is from Steve Scala from Cowen. Thank you so much, and congratulations on another impressive quarter. I have several questions, but three of them are short. Can you be more specific on where SKYRIZI patients are coming from? I think it‚Äôs notable that COSENTYX was a bit light this quarter and Novartis cited competition? Secondly, what was the non-GAAP interest expense number in the quarter? Third, you provided guidance for HUMIRA OUS, but I don‚Äôt think U.S. So can you tell us what you think the U.S. guidance would look like? And then, lastly, we have tracked clinical trial activity during the pandemic and it shows AbbVie recruiting trials were up 14% year-to-date. That is industry-leading two times greater than the next closest competitor and much better than the average, which is down, and I am just curious, what accounts for this? Is it a deliberate strategy to capture patients when other companies are taking a wait-and-see approach or is it something else? Thank you. Yeah. So, Steve, I will handle your first question. Rob will handle two and three, and Mike can handle number four. So if you look at the in-play share, about 25% of that in-play share is coming -- on SKYRIZI is coming from HUMIRA. The other 75% is coming from competitors. I‚Äôd say it‚Äôs primarily the 17s but some coming from the other 12, 23s or 23s, but I‚Äôd say the bulk of it is coming from the 17s. So that might answer your question about COSENTYX. If you look at the capture of the type of patient that we are getting with SKYRIZI, it‚Äôs very balanced. It‚Äôs about 50/50 between first-line and then second-line. So that‚Äôs a nice balance between IE patients and patients who have failed other therapies. So I think the asset is performing the way you would expect a high-performing, high-efficacy asset to be able to perform, is -- it has quickly become the preferred product by prescribing physicians. It has a great profile. It‚Äôs quarterly dosing. It‚Äôs got great efficacy. The efficacy improves over time. There aren‚Äôt any assets that have that kind of a profile on the market. So I would expect that SKYRIZI will continue to increase its in-play share. It‚Äôs jumped about 3 points over the last maybe two months and I would expect it will continue to increase. Hey. Steve, this is Rob. On your question on interest expense, for non-GAAP and GAAP, it‚Äôs the same number. It‚Äôs $620 million in the third quarter. We are no longer specifying any interest expense, because we have now closed the transaction, so that negative carry on the bond is no longer is applicable for the specified. So $620 million is the number for both non-GAAP and GAAP. On the U.S. HUMIRA question, so we did not change our guidance, it continues to be 8 -- for the U.S. HUMIRA 8% growth with a low single-digit price contribution. This is Mike. I will take your last question on clinical trial activity. The first thing that, I would say is, the increase in clinical trial activity reflects what‚Äôs going on in our pipeline and there‚Äôs a lot of activity in our pipeline, and a large number of molecules that we are advancing, and so that‚Äôs a big part of it. Another part is that, we made the conscious decision to leave decisions around enrollment in the hands of investigators rather than making them centrally, because they understand the situation in their hospital in their community better than we do. And there was a small group of studies that we paused at the time of the initial COVID impact, but the majority we allowed to continue. That doesn‚Äôt mean that there weren‚Äôt disruptions from COVID. But it does mean that investigators decided when it was time to pause enrollment and when it was time to resume enrollment. And I think the evidence shows that they made those decisions better than they could have been made centrally. And that has allowed us to advance our portfolio, to advance our clinical trials with minimal disruption and with safe conduct for patients and the staff at the site, which are also critically important considerations. And so, I‚Äôd say, it‚Äôs a combination of those factors. Thanks, Steve. Operator, next question, please? Thank you. And our next question is from Navin Jacob from UBS. Hi. How are you? This is Jon Lim on for Navin Jacob. Hi, Jon. Yeah. Sorry‚Ä¶ We just had a few questions. You guys pass along [ph]. We just had a few questions. First, regarding the HUMIRA question in the U.S., within the markets in which a biosimilar is out there, what percent of the molecule is now brand versus biosimilars? With now almost two years of biosimilar experience, how does that affect things? And next for SKYRIZI and RINVOQ, can achieve the type of uptake that you have been seeing in the U.S. and in the international markets? We would appreciate any commentary around in-play market share achieved in markets you have been approved in. And lastly, if we could talk about VRAYLAR MDD timing? Thank you. Okay. This is Rob. Just to clarify, the first question was on international HUMIRA, how much of that is now a biosimilar? Right. Within the markets where there‚Äôs a biosimilar, how much is‚Ä¶ Yeah. ‚Ä¶ brand versus biosimilar, help us visualize that question‚Ä¶ I think he wants what‚Äôs the molecule‚Ä¶ [Inaudible] Yeah. Yeah. We are at about 60% molecule share across the Board. So that‚Äôs of all of the international markets, on average, it‚Äôs about 60% molecule share. And then on SKYRIZI and RINVOQ, I don‚Äôt have the numbers right in front of me on each of the markets. I would say typically in the international market, it is a slightly slower uptake than it is in the U.S., but still doing very well. So maybe the best thing would be to get back to you with some more specifics around that. But I think you can assume that the in-play share there probably averages between 20% and 30%. But it depends obviously on the country that you are talking about. And then on VRAYLAR MDD timing, Mike? Yes. On VRAYLAR MDD, we would expect to have the study‚Äôs readout in the second half of next year and be prepared for regulatory submissions shortly thereafter. So it‚Äôs possible we would have an approval in ‚Äò22. And I think that‚Äôs an important point to make here. If we look at VRAYLAR, VRAYLAR is growing very rapidly. And as you know, the atypical anti-psychotic market is very, very large. I think VRAYLAR‚Äôs share is something like 3% and it‚Äôs tracking at $1.4 billion at 3%. So if we look at the current indications, as we indicated in the comments, of bipolar and schizophrenia, we think we can drive VRAYLAR alone in those indications to a multi-billion dollar product and that‚Äôs just driving that market share penetration up to like 5% or so. And I think that‚Äôs very doable based on the profile of VRAYLAR. VRAYLAR has a very unique profile in that market. So MDD, if we are successful, obviously, will open up a whole other channel and allow you to increase that market share even more significantly. And so typically, many of the drugs that achieved MDD were drugs that had $5 billion, $6 billion of annual revenues. So this is a nice opportunity. Without MDD, VRAYLAR is still going to be a very important product and a very significant product. With MDD, it becomes a major product. And so we will see how those next two studies play out. The first study was positive and I think we are hopeful that we will be able to get it. Thanks, Sriker [ph]. I think that was you. Operator, next question, please? Thank you. Our next question is from Randall Stanicky from RBC Capital Markets. Great. Thanks. Rick, early in the pandemic, you were one of the few to identify or build an impact for potential headwinds from higher unemployment associated with loss of health coverage. What are you currently seeing right now and anything on the patient assistance program numbers that help you inform on that? And then secondly, I just wanted to ask on BOTOX migraine. This has been historically a roughly $600 million high margin product for Allergan. We have been watching CGRP inhibitors now been in the market a couple of years. Do you see this as a growth product or opportunity for you and what are you seeing overall with respect to BOTOX in migraine? Thanks. So on the unemployment, we did identify back, I guess, it was in the first quarter call, that we were going to build in a level of risk associated with patients who would have to move to some type of an assistance program, because they lost their jobs. We have not seen that impact play out to any significant level. We have not seen it in our patient assistance program and right around the pandemic we made a decision to proactively go out and advertise our patient assistance program just to make sure that patients knew that if they couldn‚Äôt afford their AbbVie drugs that they could get them from us. So I think we proactively tried to drive it in an effort to make sure that patients were not exposed, but we haven‚Äôt seen very much at all. We still have some coverage left in the fourth quarter for it. But I‚Äôd say at this point, I think, we are questioning whether or not we are going to see it. Now, I can‚Äôt tell you exactly why. But I can tell you we are monitoring it carefully and it‚Äôs definitely not happening, at least in our business, because we would see it in the patient assistance program. On BOTOX migraine, if you actually look at what is happening with patients on BOTOX migraine, when the injectable CGRPs came into the market, you did see a tick down in patients, but then BOTOX recovered. And it has roughly the same number of patients that it had back then. It‚Äôs slightly lower than it had back then. So what the CGRPs ended up doing was expanding the market to some extent. And we are seeing a very similar phenomenon on the acute therapies as well. If you look at the scripts, the NBRxs for the acute CGRPs, you can see that it‚Äôs actually almost doubling every quarter the number of patients. In the last quarter, it was about 90,000 to 100,000 NBRxs. So I think these assets can significantly expand the market. I think two-thirds of our patients are patients that have switched on the acute, have switched from triptans to our agent and one-third of them are naive patients that we are bringing into the category. And again, that‚Äôs all about making it visible to patients who have this condition so that they go to their physician and ask for the therapy. It‚Äôs all about building markets essentially. And so I think one of the things these assets will do is they will expand the market. Now, I think as you expand the market, obviously BOTOX therapeutics, some of those patients will ultimately if they don‚Äôt get the kind of relief that they are looking for on an injectable CGRP or the acute therapy, they would eventually probably try injectable BOTOX. So we could see a little bit of growth there, but the biggest part of the growth that we are going to see in this market is from UBRELVY and ultimately atogepant. It‚Äôs a big market and I think these agents will allow us to be able to significantly expand the market and I think this is clearly a multi-billion dollar market. Thank, Randall. Operator, next question, please? Thank you. Our next question is from David Risinger from Morgan Stanley. Thanks very much. Excuse me, so I want to start with a high-level question, Rick. Could you please discuss long-term immunology net pricing and formulary positioning prospects in the face of increasing competition in coming years? And then second, just had a high level question about cash flow, I was hoping that you could discuss prospects for operating cash flow, CapEx and free cash flow? Thank you very much. Yeah. Thanks, David. I will take the first one. Rob will answer the second one for you. So if I look at long-term immunology, what‚Äôs critically important is that you have the kinds of assets that allow that managed care organization or PBM to be able to cover the greatest number of patients. This is a category where not every drug works on every patient. So you have to have multiple options that are available in the formulary and that‚Äôs just -- that is the appropriate thing to do to make sure that patients have the drugs that they need to be able to be treated. I would say, we typically do very well with formulary access. That‚Äôs driven primarily by the fact that our assets tend to be very attractive assets from a clinical profile. They establish significant market share positions and that‚Äôs important for the managed care organization or the PBM. So I don‚Äôt see anything significantly impacting that going forward. I would assume we will maintain very high levels of formulary access. Net pricing, there‚Äôs always some level of impact on pricing when you renegotiate the contracts. I don‚Äôt anticipate that you will see a significant change going forward. So I think it‚Äôs more of the normal kinds of competitive activities that we see in the marketplace. And David, this is Rob. I will answer your question on cash flow, so if you look at AbbVie and Allergan in 2019 on a combined basis, generated about $19 billion almost $20 billion of operating cash flow. CapEx runs close to $1 billion, and so if you look at this year, again, we have a partial year of Allergan, we are probably trending towards the $16 billion operating cash flow number with a little bit less than $1 billion of CapEx. So you need to annualize that and also consider the fact that we are going to generate earnings growth going forward, but that should give you a good number to work with. Thank you. Thanks, David. Operator, next question, please? Thank you. Our next question is from Terence Flynn from Goldman Sachs. Hi. Thanks for taking the questions. I was just wondering first, maybe on the IBD front, I know you have a number of readouts coming up for RINVOQ and SKYRIZI here. Maybe you could just outline what current usage of targeted drugs in IBD is on a percentage basis and how that compares to rheumatology and dermatology? And what you see is a potential here to boost that uptake in IBD further? And then to your TNF steroid conjugate program, what were the criteria that were key that led to your choice of 154 as a go-forward asset? And then lastly, on the Allergan integration, I know you said everything is on track there. It‚Äôs going really well. You talked about some revenue synergy opportunity, Rick, and I know you have laid out your expense synergy target of $2 billion in 2022. Maybe you could just talk about some of the puts and takes for 2021 as we think about the Allergan synergies on both sides? Thank you. Okay. Great. On IBD usage, if you look at the penetration, I‚Äôd say, IBD is an area where you have reasonable levels of biologic penetration, because the disease particularly Crohn‚Äôs is the disease is a pretty severe. I think the challenge in IBD is that, with the current therapies that are available, you still get sub-optimal clinical efficacy for these patients and durability of that efficacy. And so what physicians tend to do is they rotate patients through various treatments to try to maintain them in control for a longer period of time. So it is a market that is right for higher efficacy agents and a market that is right for more agents to be available to allow for better treatment of those patients and that‚Äôs the key driver in that segment of what gives significant uptake. So when we see the data around IBD that will be important for us, obviously the early data looks good. And ultimately I think these assets, along with HUMIRA, will be able to provide the market with a significant new alternative and I think that uptake will be good based on that. This is Mike. I will take the question about 154. So, 3373 and 154 represent our TNF steroid conjugate molecules that are in the clinic. They are very similar, similar to the extent that we view the biology as being translatable between the two. But 154 includes some improvements in linker technology that relate to manufacturability and ability to formulate at high concentration, ease of formulation. And so those can be very important advantages for a successful molecule. We previously toplined the positive results from 3373. We wanted to see that 154 gave us the PK performance and the exposure to achieve the pharmacodynamic coverage we think we need in the next stage of development. And as I said, we viewed the biology as translatable between the two. So once we saw that PK performance and it matched our expectations and showed that 154 would give us the coverage that we were seeking at acceptable doses in the clinic, we made the decision to advance that molecule into larger scale trials. Hey. Terence, this is Rob. I will take your question on synergies. So while we are not providing guidance for 2021 today. I think a good way to think about the expense synergies is to run rate the $600 million in partial year synergies, which gets to about $1 billion. And then, as you think about that ramp to greater than $2 billion by 2022, I think it‚Äôs reasonable to straight line that. So if you think about what‚Äôs going to drive the ramp? It‚Äôs things like systems integration, leveraging procurement spend, will result in more synergies over time, as well as network optimization. In the near-term, it‚Äôs really driven more from immediate redundancies like corporate infrastructure and R&D portfolio optimization. As it relates to the revenue synergies, look, as we have now had a few months with the combined company, we see opportunities as we think about investment in aesthetics, where we have really amped up our DTC investment for JUV√âDERM and BOTOX cosmetic, it give o the ability to invest more in aesthetics. Similarly, invest more in neuroscience, whether that‚Äôs VRAYLAR, BOTOX therapeutic. And then we look internationally given the infrastructure we have, the integrated brand team approach, we think there‚Äôs opportunity to really leverage our market access capability, our international affiliate structure to really drive that international growth for the company going forward for those Allergan brands as well. Terence, the only thing I would add, maybe to give you some perspective on the investment side. Allergan tended to what I would describe as pulse invest in particularly DTC, but even in social media. So they didn‚Äôt -- and typically what we do with brands when we want to drive maximum speed of market penetration is we invest at a steady state and continue to do that for an extended period of time. So they might have invested heavily in one quarter and then gone dark in the next quarter and then invested again and gone dark again. We don‚Äôt use that kind of a strategy. We tend to invest for the full year. And in our experience, what that does is it gives you, the fact that you have constant coverage, gives you maximum speed of penetration. So we clearly think that‚Äôs going to be an advantage, particularly in areas like aesthetics and neuroscience. Thanks, Terence. Operator, next question, please? Thank you. Our next question is from Gregg Gilbert from Truist. Thank you for getting me in. Good morning. Rick, it sounds like you think the neuroscience franchise might be one of the sleepers of the Allergan deal and you have already framed the potential for VRAYLAR particularly if depression hits. But I was curious if this development in neuroscience has taken on sort of a new sense of urgency given the heft that you have now in that franchise or whether you think you have enough going on there already? And for Mike, I was hoping you could let us know when we will see Phase 3 data for 951 in Parkinson‚Äôs and give us a sneak preview of what you are looking for there profile wise? And lastly, can you frame for BOTOX therapeutics, Mike, what you have decided to pursue in terms of indications versus ones that you have taken off the table now that you have had some time to work with that? Thanks. I‚Äôd say on neuroscience, the way to think about it is or at least the way we are thinking about it is, there‚Äôs a significant opportunity to drive VRAYLAR to be a very large product, I mean, doubling or more depending upon the ability to get MDD. And I‚Äôd also say in migraine, when we get the full portfolio of migraine assets. The migraine market is a big market. If you look at the acute market today, it‚Äôs probably about $1.5 billion. We believe it can grow to $4 billion or $5 billion by 2025 with the right kinds of assets and the right kind of promotion. And then if you look at the preventative market, it‚Äôs about $3 billion, so we believe that one in real high-single to low-double digits with the right kinds of assets and the right kinds of promotion. So the first phase of neuroscience is nothing more than taking the assets we have now, getting atogepant to the marketplace and then we have a full portfolio of migraine products, and then maximizing the market share position of those assets in the market, that‚Äôs sort of Phase 1. But I would say now that we have infrastructure in place, Mike‚Äôs BD team has been now been starting to look at assets that would be complementary to that. And we didn‚Äôt in the past because for a single anti-psychotic, we wouldn‚Äôt have wanted to build-out the infrastructure, it just wouldn‚Äôt have made sense for us. But now we can basically add those kinds of assets to the infrastructure we have. So it does give us another opportunity from a BD standpoint to be able to build the business longer term. I will take the second question and agree with everything Rick said, the only thing I‚Äôd add on BD in neuroscience is neuropsychiatry is now clearly an area of strength for us and can be an area of interest and that can go beyond the anti-psychotics as well. There‚Äôs tremendous potential and unmet need in areas like generalized anxiety disorder, still in depression despite there are many agents on the market, many, many patients remain inadequately treated, so we would look broadly across that space. With respect to 951 and data timing, we would expect to see results from our Phase 3 study in the second half of next year. And what we are looking for is really DUOPA like efficacy, because DUOPA is a transformational product but it‚Äôs also a product that is challenging to administer, and the nature of that product, the fact that it requires the placement of a gastric tube that‚Äôs then threaded into the small bowel and has to be maintained limits the size of what‚Äôs effectively an addressable market. Not the market by the labeled indication, but the proportion of patients within that population that would consider a therapy like that. And 951 has the potential to substantially expand that. It has an insulin pump-like device, subcutaneous delivery device. We think it will broaden the number of patients within that labeled population, who would consider such a therapy and this is really a very substantial market. So for example, if you look at DUOPA, despite all of its challenges, it does about $0.5 billion in sales. If you look across similar therapies for advanced Parkinson‚Äôs disease, the market is probably $1.5 billion or more and that probably represents only a small part of the potential because much of it remains untapped. So we think that 951 can address that and we think the profile that it will take to address that is DUOPA like efficacy with a more patient-friendly subcutaneous delivery device. With respect to BOTOX indications, there are a number of indications, both for BOTOX and for other toxins, for novel toxins that we are considering in the therapeutic space. I think there‚Äôs more work that we can do in the migraine space. Although, that has been an area of strength, episodic migraine has patients that may benefit from a therapy like BOTOX and there‚Äôs still much more to do on the neurology side with respect to specificity disorders that might be secondary to stroke or other conditions where there is still room to expand those indications. When we look more broadly, there are a number of potential interesting indications for neurotoxins. They might not be BOTOX. They may be novel toxins. Those could be things like prevention of afib, for example, and we are continuing to explore indications beyond that. Thanks, Gregg. Operator, next question, please? Thank you. And our next question is from Tim Anderson from Wolfe Research. Thank you. A high level question for Rick, despite Allergan being a very reasonable solution to upcoming U.S. HUMIRA LOE in 2023, the multiple on AbbVie is lower than it‚Äôs ever been. The entire drug group is out of favor, but your multiple is about half of the peer group average. To me what that multiple says is that investors remain worried about what AbbVie looks like past 2023. So two questions related to this, the first is why not give updated granular extended guidance that goes beyond 2023? You have given long-term guidance in the past sometimes and that‚Äôs resonated well with the market. So can we expect you might do this at some point soon? And second question, why not go do more M&A in the near-term, we just saw Bristol do a $13 billion deal not far after closing Celgene and layering more product into your pipeline would help give investors assurances that there‚Äôs life beyond 2023. And by virtue of how you answered an earlier question, you yourself basically said there‚Äôs not much new NME flow until 2025 and beyond? Thank you. Yeah. I think if you look -- Tim, this is Rick. If you look at the PE of the whole sector, obviously, the sector is under pressure from the political environment and concerns about the political environment. And you are correct, we are at the lower end of that PE and I think that is driven by uncertainty about what the growth rate will be on the other side of the LOE. What I would tell you is obviously, we have a 10-year LLP, so we know what we think that growth rate is on the other side of the LOE. And I can tell you that when I look at that growth rate, it‚Äôs robust. Now, the market has to come around to that point of view. I‚Äôd say, we haven‚Äôt always been right, but in total revenue, we have always been right. In fact, we have always beat for the most part what our expectations were. And so we obviously challenge it pretty hard and we have knowledge of what we believe the erosion curve will look like. We have knowledge of what we think our pipeline will deliver and what the additional indications will deliver. And look, I remember there was a tremendous amount of skepticism about when we gave it was either $10 billion or $11 billion of risk adjusted revenues for RINVOQ and SKYRIZI back a year or two ago, something like that. There was a tremendous amount of skepticism, that‚Äôs impossible. I don‚Äôt hear very much of that now that these two assets are $2 billion and growing like rockets. So I‚Äôd say our ability to assess what we can do with our assets is pretty high. Now, that doesn‚Äôt mean you shouldn‚Äôt go out and get more things and we constantly look and where we find opportunity, we will clearly go pursue those. They have to be opportunities that make sense and fit into our portfolio. You have seen us do transactions to continue to build the long-term future of our hem/onc business with Genmab and I-Mab. And those two assets combined with what VENCLEXTA and IMBRUVICA can continue to do, I think it is going to give us a very robust long-term performance in that franchise. I think in immunology, we are in pretty good shape between our internal pipeline both the additional indications on SKYRIZI and RINVOQ and then what we have earlier on that we think will play out in a positive way. When we look at neuroscience, we just talked about that we have the ability to be able to grow that. Certainly, we are going to invest heavily in aesthetics. We have a tremendous amount of assets, new toxins that we are working on and we are going to accelerate many of those, new fillers and other kinds of opportunities that will build that aesthetics business to be able to grow rapidly. And so I feel pretty good about where we are. In fact, I‚Äôd tell you I feel very good about where we are six months into the Allergan transaction. Certainly Allergan has given us more growth as we mentioned a moment ago. When we look at neuroscience, neuroscience has clearly been I think a nice positive upside for us and one that I think we can execute very well. As far as guidance is concerned, I am not saying, we will never give guidance, but we want to give guidance when we are able to do it with a high degree of certainty. Because the last thing we want to do is provide a level of guidance that you don‚Äôt have a high degree of certainty and you know it‚Äôs going to, it has some variability to it. You probably remember, we did that on the international biosimilars and we were off by not that much, but we were off by some and the market didn‚Äôt like the fact that we were off. So you need to be awfully careful about how you provide that guidance in a way to make sure that you meet or exceed the guidance, and at the point which we have that level of confidence, we may go out with longer term guidance. Thank you. Thanks, Tim. Operator, next -- we have time for one final question. Thank you. And our final question today is from Josh Schimmer from Evercore. Last question. Thanks for squeezing me in. Just a couple of quick ones, can you provide any color on the SKYRIZI royalty and can you comment on what you see as the incremental markets for the lower face toxins, the new dermal filler and presbyopia, if you view any of those as material? Thank you. Yeah. Josh, so on the SKYRIZI royalty, well, keep in mind that we account for this as a business combination, so it comes through consideration so you don‚Äôt see it on a non-GAAP P&L. We don‚Äôt disclose our royalty rates but a good way to think about it is reasonable royalty you would pay for a late-stage asset is probably a good way to think about what the royalty burn would be on -- the cash royalty burn will be on SKYRIZI. And I‚Äôd say the lower face toxins and the lower face fillers that we are working on, probably the best way, rather than trying to characterize individual indications for toxins or fillers is, we are trying to build a portfolio and a market activation strategy that will allow us to grow the aesthetics business at a consistent double-digit rate. And it is both that internal pipeline and activating more patients, and some BD effort that will give us that. So, certainly those lower face toxins and fillers are designed to be able to support that growth going forward. The eye care product, I would call that product sort of a modest product. I don‚Äôt remember the specifics. Do you, Rob? Yeah. I‚Äôd call it sort of a modest size product. Yeah. Thank you. Thanks, Josh. That concludes today‚Äôs conference call. If you‚Äôd like to listen to a replay of the call, please visit our website at investors.abbvie.com. Thanks again for joining us. Thank you. This does conclude today‚Äôs conference. You may disconnect at this time.'"
      ]
     },
     "execution_count": 39,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "text_transcipt"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0d95fefe-0cbf-4500-80ac-b1fd5d210184",
   "metadata": {},
   "source": [
    "# How we prepare our text for analysis:¬∂"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "id": "1c549f84-b667-4bc7-94f4-e35adf624937",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Here are the first 100 words that are kept.\n",
      "['good', 'morning', 'thank', 'stand', 'welcome', 'abbvie', 'quarter', '2020', 'earnings', 'conference', 'participant', 'able', 'listen', 'question', 'answer', 'portion', 'operator', 'instructions', 'like', 'introduce', 'ms.', 'liz', 'shea', 'vice', 'president', 'investor', 'relations', 'good', 'morning', 'thank', 'join', 'today', 'rick', 'gonzalez', 'chairman', 'board', 'chief', 'executive', 'officer', 'michael', 'severino', 'vice', 'chairman', 'president', 'rob', 'michael', 'executive', 'vice', 'president', 'chief', 'financial', 'officer', 'join', 'q&a', 'portion', 'laura', 'schumacher', 'vice', 'chairman', 'external', 'affairs', 'chief', 'legal', 'officer', 'corporate', 'secretary', 'start', 'remind', 'statement', 'today', 'consider', 'forward', 'look', 'statement', 'purpose', 'private', 'securities', 'litigation', 'reform', 'act', '1995', 'abbvie', 'caution', 'forward', 'look', 'statement', 'subject', 'risk', 'uncertainty', 'include', 'impact', 'covid-19', 'pandemic', 'abbvie', 'operation', 'result', 'financial', 'result', 'cause', 'actual']\n"
     ]
    }
   ],
   "source": [
    "# Remove stop words, spaces, punctuation\n",
    "# Lemmatize\n",
    "# Convert to lower case\n",
    "words=[\n",
    "#     word\n",
    "#     type(word)\n",
    "#     word.lower_\n",
    "#     type(word.lower_)\n",
    "#     word.lemma_\n",
    "#     type(word.lemma_)\n",
    "#     (word.lower_, word.lemma_.lower())\n",
    "    word.lemma_.lower()                 # Lemmatize and lower case\n",
    "    for word in nlp(text_transcipt)   # Tokenize\n",
    "    if not (\n",
    "        word.is_space                   # Remove spaces\n",
    "        or word.is_stop                 # Remove stop words\n",
    "        or word.is_punct                # Remove punctuation\n",
    "    )\n",
    "]\n",
    "\n",
    "# Lemmatize\n",
    "print('Here are the first 100 words that are kept.')\n",
    "print(words[:100])"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "07ee725a-c6a4-4505-86fc-34cfc55ae94b",
   "metadata": {},
   "source": [
    "### Explanation:\n",
    "* Tokenization and Stop Word Removal: The code starts by tokenizing the input text using nlp(text_transcript), which breaks the text into individual tokens (words and punctuation marks). \n",
    "\n",
    "These tokens are then filtered to exclude unwanted elements:\n",
    "* <u>word.is_space</u>: This checks whether the token is a space or a newline, and if it is, it is excluded from further processing.\n",
    "* <u>word.is_stop</u>: This condition filters out common stop words such as \"the\", \"and\", \"is\", which are generally not useful in most NLP tasks since they don‚Äôt add significant meaning.\n",
    "* word.is_punct: This removes punctuation marks, ensuring only meaningful words are kept for further analysis.\n",
    "* <u>Lemmatization and Lowercasing</u>: After filtering, the remaining tokens are lemmatized using word.lemma_. Lemmatization reduces each word to its base or dictionary form (e.g., \"running\" becomes \"run\"). This helps in treating different inflections of the same word as a single entity. *\n",
    "* After lemmatization, the words are also converted to lowercase with word.lemma_.lower(), ensuring consistency in analysis and avoiding case sensitivity issues.\n",
    "\n",
    "List Comprehension: The entire process of filtering and transforming the tokens is performed in a Python list comprehension. For each word in the tokenized text, the code checks if it is a space, stop word, or punctuation, and if it passes these conditions, it adds the lowercased lemma of the word to the list. The result is a clean list of meaningful, lowercase, lemmatized words."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "697a0a64-9dc0-4766-b9a0-4ce2efbe8866",
   "metadata": {},
   "source": [
    "# Lets create a function that does this, so we do not have to write all this code more times."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "id": "7c83943e-00ad-427f-8243-8d32cd3098e1",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Putting all in a function so that we can use it later \n",
    "def process_text(text):\n",
    "    # Tokenize\n",
    "    # Remove stop words, spaces, punctuation\n",
    "    # Lemmatize\n",
    "    # Convert to lower case\n",
    "    words=[\n",
    "        word.lemma_.lower()                 # Lemmatize and lower case\n",
    "        for word in nlp(text)          # Tokenize\n",
    "        if not (\n",
    "            word.is_space                   # Remove spaces\n",
    "            or word.is_stop                 # Remove stop words\n",
    "            or word.is_punct                # Remove punctuation\n",
    "        )\n",
    "    ]\n",
    "    return words"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6abec32d-170b-42d8-8c5f-ac0b8970094a",
   "metadata": {},
   "source": [
    "### What does the function do? \n",
    "Let's test it with a very simple string to check"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "id": "0651c3ef-c1b4-4610-80bc-cb07de5e639b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['hi', 'welcome', 'earning', 'conference', 'apple']"
      ]
     },
     "execution_count": 42,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "process_text('Hi and welcome to the earnings conference call of Apple')"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2054f650-a8fa-4b15-b72f-b65ec6b9bcd9",
   "metadata": {},
   "source": [
    "If we want to do anything with what the function returns, we have to save it in a variable:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "id": "9ee18b52-3a14-4df6-8aed-89170178dc2a",
   "metadata": {},
   "outputs": [],
   "source": [
    "apple_word_list = process_text('Hi and welcome to the earnings conference call of Apple')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "id": "f338db9e-f015-4adb-aa92-ff530df05490",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['hi', 'welcome', 'earning', 'conference', 'apple']"
      ]
     },
     "execution_count": 44,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "apple_word_list"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "10fe3fbd-3464-4a05-a60e-c374470f1a3e",
   "metadata": {},
   "source": [
    "# We need to save the amount of words for later. \n",
    "So that we can turn X positive words into a ratio of total words"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "id": "12ab4815-fbc3-4967-9b0a-a96c1c854e61",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "5903"
      ]
     },
     "execution_count": 45,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# We the save the amount of words for later. This will show us how many % of the words are e.g. positive. \n",
    "number_of_words=len(words)\n",
    "number_of_words"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f715b8cc-6f08-4a5d-b601-d4ba73f7c51a",
   "metadata": {},
   "source": [
    "# Getting the Loughran & McDonald word list "
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6d822d5b-90c4-43e4-8e18-72d18a76200a",
   "metadata": {},
   "source": [
    "# **Preparing Word Lists and Processing Text for NLP Tasks**\n",
    "\n",
    "In this section, we will simplify the steps to load, process, and convert the word lists into formats suitable for Natural Language Processing (NLP) tasks. We will use three word lists:\n",
    "- **LM_positive**: For positive words\n",
    "- **LM_negative**: For negative words\n",
    "- **LM_uncertainty**: For uncertainty-related words\n",
    "\n",
    "Our goal is to prepare these word lists, process them, and ensure they are in the correct format for further analysis.\n",
    "\n",
    "---\n",
    "\n",
    "## **Loading Word Lists into DataFrames**"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "id": "d33c5d33-2878-4569-bd33-3d5a8132de30",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "LM_negative=pd.read_excel('LoughranMcDonald_SentimentWordLists_2018.xlsx', sheet_name='Negative', header=None)\n",
    "LM_positive=pd.read_excel('LoughranMcDonald_SentimentWordLists_2018.xlsx', sheet_name='Positive', header=None)\n",
    "LM_uncertainty=pd.read_excel('LoughranMcDonald_SentimentWordLists_2018.xlsx', sheet_name='Uncertainty', header=None)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "891a21d5-5fe5-4c64-aaed-e5341d090b68",
   "metadata": {},
   "source": [
    "# **Inspecting Word Lists**\n",
    "After loading the data, we will inspect the first few rows to verify that the lists have been loaded correctly. It‚Äôs important to check for any inconsistencies in the data such as empty rows or duplicates, which we might need to clean later.\n",
    "pect what is in these lists"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "id": "8780494a-bdae-4797-88bc-93bf0dc7303b",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "            0\n",
      "0        ABLE\n",
      "1   ABUNDANCE\n",
      "2    ABUNDANT\n",
      "3   ACCLAIMED\n",
      "4  ACCOMPLISH\n",
      "              0\n",
      "0       ABANDON\n",
      "1     ABANDONED\n",
      "2    ABANDONING\n",
      "3   ABANDONMENT\n",
      "4  ABANDONMENTS\n",
      "             0\n",
      "0     ABEYANCE\n",
      "1    ABEYANCES\n",
      "2       ALMOST\n",
      "3   ALTERATION\n",
      "4  ALTERATIONS\n"
     ]
    }
   ],
   "source": [
    "# Display the first few rows of each word list to ensure correct loading\n",
    "print(LM_positive.head())\n",
    "print(LM_negative.head())\n",
    "print(LM_uncertainty.head())"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "dd264818-53a3-4767-b4e4-60c79811e79c",
   "metadata": {},
   "source": [
    "# **Converting DataFrames to Lists**\n",
    "The next step is to convert these DataFrame columns into Python lists. This allows us to process the words more easily using Python functions. The `.squeeze()` method is used to flatten the DataFrame into a Series, and `.tolist()` converts it into a list.\n",
    "\n",
    "Converting these DataFrames ensures that we can process and manipulate the data for further analysis."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "id": "a68cf6d5-0f8f-4dc7-9540-88174bf3427e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(354, 2355, 297)"
      ]
     },
     "execution_count": 48,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Convert DataFrame columns into lists\n",
    "LM_positive_list = LM_positive.squeeze().tolist()  # Squeeze is used to flatten the DataFrame column\n",
    "LM_negative_list = LM_negative.squeeze().tolist()\n",
    "LM_uncertainty_list = LM_uncertainty.squeeze().tolist()\n",
    "\n",
    "# Check lengths of the lists to ensure they are loaded correctly\n",
    "len(LM_positive_list), len(LM_negative_list), len(LM_uncertainty_list)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "29aa85f5-ec92-492b-a046-d6f7f6c819a5",
   "metadata": {},
   "source": [
    "# **Processing the Word Lists**\n",
    "We will now clean and process the word lists using a custom function `process_text()`. The function will:\n",
    "- Remove punctuation.\n",
    "- Convert all words to lowercase.\n",
    "- Tokenize the words (split them into individual tokens).\n",
    "\n",
    "This step is essential for normalizing the text so that it can be used for natural language processing (NLP) tasks.\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "id": "51c0cd41-0706-46f5-8a6c-10f18cd55c4a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(298, 1816, 238)"
      ]
     },
     "execution_count": 49,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "LM_positive_set = set(process_text(' '.join(LM_positive_list)))\n",
    "LM_negative_set = set(process_text(' '.join(LM_negative_list)))\n",
    "LM_uncertainty_set = set(process_text(' '.join(LM_uncertainty_list)))\n",
    "len(LM_positive_set), len(LM_negative_set), len(LM_uncertainty_set)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2c157bfb-71d8-4021-92e8-21cf9d29f5ad",
   "metadata": {},
   "source": [
    "Here you see a set(). This is another type of list used to make the process of extracting what positive, negative and uncertain words are in the the text. It also remove duplicates, which we have and need to remove."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f9d7f9c7-386c-4eff-b57a-27b0b819e50d",
   "metadata": {},
   "source": [
    "# **Using `Counter` to Analyze Word Frequency**\n",
    "Once the word lists are processed, one common task is to analyze the frequency of words. The `Counter` class from Python‚Äôs `collections` module is a useful tool for this. It counts the occurrence of each word in a list, providing a simple way to measure word frequency.\n",
    "\n",
    "### **Why Use `Counter`?**\n",
    "- **Frequency Analysis**: It helps you quickly understand how often certain words appear, which can be useful for identifying common themes, sentiments, or even noise in the data.\n",
    "- **Efficient Counting**: The `Counter` is optimized for counting elements and returns a dictionary-like object where the keys are the items (words), and the values are their counts.\n",
    "\n",
    "We will now use `Counter` to calculate the frequency of words in each of our processed word lists."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "id": "dea9662c-f0ee-45c9-87ea-5b5c78c6c525",
   "metadata": {},
   "outputs": [],
   "source": [
    "from collections import Counter"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b56c904b-ba7a-40de-91d9-5265a1481fd8",
   "metadata": {},
   "source": [
    "# **Using `Counter` for Word Frequency Analysis**\n",
    "\n",
    "In this section, we are using the `Counter` class from Python‚Äôs `collections` module to count the frequency of words in our processed text.\n",
    "\n",
    "### **What is `Counter`?**\n",
    "`Counter` is a specialized dictionary subclass designed specifically for counting hashable objects. It takes a list or any iterable as input and returns a dictionary-like object where:\n",
    "- **Keys** are the items in the list (in our case, words).\n",
    "- **Values** are the counts (i.e., how many times each word appears).\n",
    "each word used in out text?\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "id": "bfbbacac-af63-45a2-bb9b-3d1ece403bec",
   "metadata": {
    "scrolled": true,
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Counter({'$': 88,\n",
       "         'think': 83,\n",
       "         'market': 80,\n",
       "         'look': 65,\n",
       "         'question': 61,\n",
       "         'billion': 58,\n",
       "         'patient': 57,\n",
       "         'thank': 55,\n",
       "         'growth': 50,\n",
       "         'year': 44,\n",
       "         'share': 38,\n",
       "         'indication': 38,\n",
       "         'quarter': 37,\n",
       "         'like': 32,\n",
       "         'skyrizi': 32,\n",
       "         'expect': 32,\n",
       "         'go': 32,\n",
       "         'sale': 31,\n",
       "         'rinvoq': 30,\n",
       "         'asset': 30,\n",
       "         'revenue': 29,\n",
       "         'strong': 29,\n",
       "         'new': 29,\n",
       "         'continue': 29,\n",
       "         'term': 28,\n",
       "         'study': 27,\n",
       "         'result': 26,\n",
       "         'guidance': 26,\n",
       "         'include': 25,\n",
       "         'long': 25,\n",
       "         'significant': 25,\n",
       "         'migraine': 25,\n",
       "         'botox': 25,\n",
       "         'abbvie': 24,\n",
       "         'business': 24,\n",
       "         'product': 24,\n",
       "         'remain': 24,\n",
       "         'high': 24,\n",
       "         'phase': 24,\n",
       "         'good': 23,\n",
       "         'portfolio': 23,\n",
       "         'potential': 23,\n",
       "         'number': 23,\n",
       "         'million': 22,\n",
       "         'performance': 21,\n",
       "         'drive': 21,\n",
       "         'program': 20,\n",
       "         'opportunity': 20,\n",
       "         'play': 20,\n",
       "         'treatment': 20,\n",
       "         '3': 20,\n",
       "         'rob': 19,\n",
       "         'forward': 19,\n",
       "         'impact': 19,\n",
       "         'area': 19,\n",
       "         'level': 19,\n",
       "         'profile': 19,\n",
       "         'allergan': 18,\n",
       "         'vraylar': 18,\n",
       "         'pipeline': 18,\n",
       "         'humira': 18,\n",
       "         'come': 18,\n",
       "         'u.s.': 18,\n",
       "         'datum': 18,\n",
       "         'know': 18,\n",
       "         'today': 17,\n",
       "         'give': 17,\n",
       "         'increase': 17,\n",
       "         'see': 17,\n",
       "         '2021': 17,\n",
       "         'basis': 16,\n",
       "         'approximately': 16,\n",
       "         'obviously': 16,\n",
       "         'thing': 16,\n",
       "         'right': 16,\n",
       "         'rick': 15,\n",
       "         'provide': 15,\n",
       "         'adjust': 15,\n",
       "         'demonstrate': 15,\n",
       "         'covid': 15,\n",
       "         'lead': 15,\n",
       "         'aesthetic': 15,\n",
       "         'neuroscience': 15,\n",
       "         'time': 15,\n",
       "         'immunology': 15,\n",
       "         'rate': 15,\n",
       "         'start': 14,\n",
       "         'perform': 14,\n",
       "         'expand': 14,\n",
       "         'important': 14,\n",
       "         'low': 14,\n",
       "         'able': 13,\n",
       "         'operator': 13,\n",
       "         'pandemic': 13,\n",
       "         'deliver': 13,\n",
       "         'cash': 13,\n",
       "         'grow': 13,\n",
       "         'therapy': 13,\n",
       "         'great': 13,\n",
       "         'talk': 13,\n",
       "         'want': 13,\n",
       "         'kind': 13,\n",
       "         'risk': 12,\n",
       "         'mike': 12,\n",
       "         'expectation': 12,\n",
       "         'achieve': 12,\n",
       "         'atopic': 12,\n",
       "         'base': 12,\n",
       "         'synergy': 12,\n",
       "         'dividend': 12,\n",
       "         'drug': 12,\n",
       "         'operational': 11,\n",
       "         'progress': 11,\n",
       "         'franchise': 11,\n",
       "         'early': 11,\n",
       "         'atogepant': 11,\n",
       "         'development': 11,\n",
       "         'support': 11,\n",
       "         'filler': 11,\n",
       "         'second': 11,\n",
       "         'international': 11,\n",
       "         'bit': 11,\n",
       "         'build': 11,\n",
       "         'yeah': 11,\n",
       "         'additional': 10,\n",
       "         'gaap': 10,\n",
       "         'regulatory': 10,\n",
       "         'double': 10,\n",
       "         'recently': 10,\n",
       "         'flow': 10,\n",
       "         'venclexta': 10,\n",
       "         'efficacy': 10,\n",
       "         '2025': 10,\n",
       "         'overall': 10,\n",
       "         '1': 10,\n",
       "         'toxin': 10,\n",
       "         'assume': 10,\n",
       "         'standpoint': 10,\n",
       "         'industry': 10,\n",
       "         'fact': 10,\n",
       "         'say': 10,\n",
       "         'probably': 10,\n",
       "         'investor': 9,\n",
       "         'earning': 9,\n",
       "         'robust': 9,\n",
       "         'announce': 9,\n",
       "         'company': 9,\n",
       "         'multiple': 9,\n",
       "         'stage': 9,\n",
       "         'allow': 9,\n",
       "         'add': 9,\n",
       "         'dermatitis': 9,\n",
       "         'disease': 9,\n",
       "         'therapeutic': 9,\n",
       "         'acute': 9,\n",
       "         'trial': 9,\n",
       "         '2': 9,\n",
       "         'expense': 9,\n",
       "         'point': 9,\n",
       "         'maybe': 9,\n",
       "         'get': 9,\n",
       "         'way': 9,\n",
       "         'update': 8,\n",
       "         'comparable': 8,\n",
       "         'take': 8,\n",
       "         'despite': 8,\n",
       "         'digit': 8,\n",
       "         'combination': 8,\n",
       "         'recovery': 8,\n",
       "         'total': 8,\n",
       "         'large': 8,\n",
       "         'investment': 8,\n",
       "         'month': 8,\n",
       "         'close': 8,\n",
       "         'pay': 8,\n",
       "         '154': 8,\n",
       "         'face': 8,\n",
       "         'net': 8,\n",
       "         'biosimilar': 8,\n",
       "         'similar': 8,\n",
       "         'little': 8,\n",
       "         'change': 8,\n",
       "         'tell': 8,\n",
       "         'molecule': 8,\n",
       "         'mdd': 8,\n",
       "         'invest': 8,\n",
       "         'financial': 7,\n",
       "         'non': 7,\n",
       "         'help': 7,\n",
       "         'current': 7,\n",
       "         'exceed': 7,\n",
       "         'feel': 7,\n",
       "         'generate': 7,\n",
       "         'represent': 7,\n",
       "         'advance': 7,\n",
       "         'believe': 7,\n",
       "         'track': 7,\n",
       "         'approval': 7,\n",
       "         '951': 7,\n",
       "         'clearly': 7,\n",
       "         'make': 7,\n",
       "         'agent': 7,\n",
       "         'confidence': 7,\n",
       "         'ubrelvy': 7,\n",
       "         'half': 7,\n",
       "         'big': 7,\n",
       "         'positive': 7,\n",
       "         'clinical': 7,\n",
       "         'single': 7,\n",
       "         'margin': 7,\n",
       "         'tax': 7,\n",
       "         'work': 7,\n",
       "         'try': 7,\n",
       "         'particularly': 7,\n",
       "         'pretty': 7,\n",
       "         'ibd': 7,\n",
       "         '2020': 6,\n",
       "         'answer': 6,\n",
       "         'statement': 6,\n",
       "         'consider': 6,\n",
       "         'covid-19': 6,\n",
       "         'follow': 6,\n",
       "         'turn': 6,\n",
       "         'r&d': 6,\n",
       "         'position': 6,\n",
       "         'value': 6,\n",
       "         'launch': 6,\n",
       "         'attractive': 6,\n",
       "         'major': 6,\n",
       "         'strategy': 6,\n",
       "         'brand': 6,\n",
       "         'focus': 6,\n",
       "         'coverage': 6,\n",
       "         'need': 6,\n",
       "         'penetration': 6,\n",
       "         'approve': 6,\n",
       "         'anti': 6,\n",
       "         'benefit': 6,\n",
       "         'cgrp': 6,\n",
       "         'juv√©derm': 6,\n",
       "         'promotion': 6,\n",
       "         'dermal': 6,\n",
       "         'adjusted': 6,\n",
       "         'transaction': 6,\n",
       "         'end': 6,\n",
       "         'decision': 6,\n",
       "         'evaluate': 6,\n",
       "         'head': 6,\n",
       "         'mean': 6,\n",
       "         'group': 6,\n",
       "         'operate': 6,\n",
       "         'average': 6,\n",
       "         'chris': 6,\n",
       "         'lot': 6,\n",
       "         'view': 6,\n",
       "         'certainly': 6,\n",
       "         'activate': 6,\n",
       "         'activity': 6,\n",
       "         'tremendous': 6,\n",
       "         'typically': 6,\n",
       "         'royalty': 6,\n",
       "         'morning': 5,\n",
       "         'report': 5,\n",
       "         '10': 5,\n",
       "         'past': 5,\n",
       "         'discuss': 5,\n",
       "         'recent': 5,\n",
       "         'outlook': 5,\n",
       "         'novel': 5,\n",
       "         'mab': 5,\n",
       "         'maintain': 5,\n",
       "         'near': 5,\n",
       "         'confident': 5,\n",
       "         'trend': 5,\n",
       "         'ultimately': 5,\n",
       "         'psoriatic': 5,\n",
       "         'arthritis': 5,\n",
       "         'rheumatology': 5,\n",
       "         'multi': 5,\n",
       "         'dollar': 5,\n",
       "         'application': 5,\n",
       "         'day': 5,\n",
       "         'cll': 5,\n",
       "         'oncology': 5,\n",
       "         'access': 5,\n",
       "         'prevention': 5,\n",
       "         'rapidly': 5,\n",
       "         'begin': 5,\n",
       "         'safety': 5,\n",
       "         'topline': 5,\n",
       "         'dose': 5,\n",
       "         'well': 5,\n",
       "         'improvement': 5,\n",
       "         'endpoint': 5,\n",
       "         'primarily': 5,\n",
       "         'care': 5,\n",
       "         'price': 5,\n",
       "         'versus': 5,\n",
       "         'interest': 5,\n",
       "         '2023': 5,\n",
       "         'physician': 5,\n",
       "         'tend': 5,\n",
       "         'vamil': 5,\n",
       "         'sort': 5,\n",
       "         'pricing': 5,\n",
       "         'relate': 5,\n",
       "         'significantly': 5,\n",
       "         'sure': 5,\n",
       "         'uptake': 5,\n",
       "         'assistance': 5,\n",
       "         'ability': 5,\n",
       "         'infrastructure': 5,\n",
       "         'conference': 4,\n",
       "         'vice': 4,\n",
       "         'join': 4,\n",
       "         'uncertainty': 4,\n",
       "         'exclude': 4,\n",
       "         'highlight': 4,\n",
       "         'raise': 4,\n",
       "         'detail': 4,\n",
       "         'momentum': 4,\n",
       "         'hem': 4,\n",
       "         'onc': 4,\n",
       "         'expansion': 4,\n",
       "         'integration': 4,\n",
       "         'navitoclax': 4,\n",
       "         'pleased': 4,\n",
       "         'key': 4,\n",
       "         'commercial': 4,\n",
       "         'ra': 4,\n",
       "         'psoriasis': 4,\n",
       "         '33': 4,\n",
       "         'accelerate': 4,\n",
       "         'encouraged': 4,\n",
       "         'plan': 4,\n",
       "         '20': 4,\n",
       "         'imbruvica': 4,\n",
       "         'line': 4,\n",
       "         'pre': 4,\n",
       "         '60': 4,\n",
       "         'cancer': 4,\n",
       "         'psychotic': 4,\n",
       "         'substantial': 4,\n",
       "         'fourth': 4,\n",
       "         'platform': 4,\n",
       "         'demand': 4,\n",
       "         'cosmetic': 4,\n",
       "         'reflect': 4,\n",
       "         'size': 4,\n",
       "         'timing': 4,\n",
       "         'quarterly': 4,\n",
       "         'advantage': 4,\n",
       "         'successful': 4,\n",
       "         'option': 4,\n",
       "         'later': 4,\n",
       "         'induction': 4,\n",
       "         'tnf': 4,\n",
       "         'steroid': 4,\n",
       "         'conjugate': 4,\n",
       "         'azacitidine': 4,\n",
       "         'viale': 4,\n",
       "         'show': 4,\n",
       "         'compare': 4,\n",
       "         'category': 4,\n",
       "         'lemzoparlimab': 4,\n",
       "         'space': 4,\n",
       "         'specific': 4,\n",
       "         'secondary': 4,\n",
       "         'eye': 4,\n",
       "         'associate': 4,\n",
       "         '8': 4,\n",
       "         'experience': 4,\n",
       "         'ratio': 4,\n",
       "         'specify': 4,\n",
       "         'modest': 4,\n",
       "         'approach': 4,\n",
       "         'issue': 4,\n",
       "         'guess': 4,\n",
       "         'sense': 4,\n",
       "         'ad': 4,\n",
       "         'example': 4,\n",
       "         'couple': 4,\n",
       "         'seek': 4,\n",
       "         'type': 4,\n",
       "         'available': 4,\n",
       "         '5': 4,\n",
       "         'loe': 4,\n",
       "         'hi': 4,\n",
       "         'ask': 4,\n",
       "         'far': 4,\n",
       "         'debate': 4,\n",
       "         'hope': 4,\n",
       "         'cost': 4,\n",
       "         'steve': 4,\n",
       "         'lastly': 4,\n",
       "         'respect': 4,\n",
       "         'david': 4,\n",
       "         'formulary': 4,\n",
       "         'terence': 4,\n",
       "         'reasonable': 4,\n",
       "         'challenge': 4,\n",
       "         'bd': 4,\n",
       "         'duopa': 4,\n",
       "         'portion': 3,\n",
       "         'liz': 3,\n",
       "         'president': 3,\n",
       "         'chairman': 3,\n",
       "         'board': 3,\n",
       "         'chief': 3,\n",
       "         'officer': 3,\n",
       "         'reform': 3,\n",
       "         'information': 3,\n",
       "         'measure': 3,\n",
       "         'ongoing': 3,\n",
       "         'note': 3,\n",
       "         'exchange': 3,\n",
       "         'underlie': 3,\n",
       "         'excellent': 3,\n",
       "         '2.83': 3,\n",
       "         'midpoint': 3,\n",
       "         'range': 3,\n",
       "         'sustainable': 3,\n",
       "         'acquisition': 3,\n",
       "         'aspect': 3,\n",
       "         'ahead': 3,\n",
       "         'initial': 3,\n",
       "         'collaboration': 3,\n",
       "         'genmab': 3,\n",
       "         'strategic': 3,\n",
       "         'shape': 3,\n",
       "         'highly': 3,\n",
       "         'late': 3,\n",
       "         'meaningful': 3,\n",
       "         'previously': 3,\n",
       "         'switch': 3,\n",
       "         '16': 3,\n",
       "         'capture': 3,\n",
       "         'sustain': 3,\n",
       "         'combined': 3,\n",
       "         'original': 3,\n",
       "         'addition': 3,\n",
       "         'ankylose': 3,\n",
       "         'spondylitis': 3,\n",
       "         'segment': 3,\n",
       "         'peak': 3,\n",
       "         'submit': 3,\n",
       "         'bowel': 3,\n",
       "         'extremely': 3,\n",
       "         'nearly': 3,\n",
       "         'aml': 3,\n",
       "         'cd47': 3,\n",
       "         'annualize': 3,\n",
       "         '1.4': 3,\n",
       "         'disorder': 3,\n",
       "         'chronic': 3,\n",
       "         'rapid': 3,\n",
       "         'oral': 3,\n",
       "         'ramp': 3,\n",
       "         'dtc': 3,\n",
       "         'scale': 3,\n",
       "         'global': 3,\n",
       "         'clinic': 3,\n",
       "         'luminera': 3,\n",
       "         'complementary': 3,\n",
       "         'date': 3,\n",
       "         '17': 3,\n",
       "         'target': 3,\n",
       "         'combine': 3,\n",
       "         'innovative': 3,\n",
       "         'debt': 3,\n",
       "         '10.2': 3,\n",
       "         'degree': 3,\n",
       "         'submission': 3,\n",
       "         'present': 3,\n",
       "         'select': 3,\n",
       "         'pk': 3,\n",
       "         'mention': 3,\n",
       "         'plus': 3,\n",
       "         'placebo': 3,\n",
       "         'effectively': 3,\n",
       "         'strength': 3,\n",
       "         '15': 3,\n",
       "         'primary': 3,\n",
       "         'reduction': 3,\n",
       "         'course': 3,\n",
       "         'effort': 3,\n",
       "         'prominence': 3,\n",
       "         'readout': 3,\n",
       "         'meet': 3,\n",
       "         'majority': 3,\n",
       "         'condition': 3,\n",
       "         'comment': 3,\n",
       "         'prior': 3,\n",
       "         'competition': 3,\n",
       "         'treat': 3,\n",
       "         'fast': 3,\n",
       "         '620': 3,\n",
       "         'estimate': 3,\n",
       "         '1.5': 3,\n",
       "         '600': 3,\n",
       "         'partial': 3,\n",
       "         '2022': 3,\n",
       "         'favorable': 3,\n",
       "         'derm': 3,\n",
       "         'peer': 3,\n",
       "         'ago': 3,\n",
       "         'okay': 3,\n",
       "         'actually': 3,\n",
       "         'competitor': 3,\n",
       "         'population': 3,\n",
       "         'broadly': 3,\n",
       "         'nme': 3,\n",
       "         'geoff': 3,\n",
       "         'speed': 3,\n",
       "         'cover': 3,\n",
       "         'pressure': 3,\n",
       "         'concern': 3,\n",
       "         'depend': 3,\n",
       "         'election': 3,\n",
       "         'biden': 3,\n",
       "         'co': 3,\n",
       "         'economic': 3,\n",
       "         'job': 3,\n",
       "         'handle': 3,\n",
       "         'nice': 3,\n",
       "         'enrollment': 3,\n",
       "         'small': 3,\n",
       "         'injectable': 3,\n",
       "         'capex': 3,\n",
       "         'device': 3,\n",
       "         'tim': 3,\n",
       "         'remember': 3,\n",
       "         'josh': 3,\n",
       "         'listen': 2,\n",
       "         'instructions': 2,\n",
       "         'executive': 2,\n",
       "         'michael': 2,\n",
       "         'corporate': 2,\n",
       "         'private': 2,\n",
       "         'subject': 2,\n",
       "         'cause': 2,\n",
       "         'indicate': 2,\n",
       "         '2019': 2,\n",
       "         'annual': 2,\n",
       "         'filing': 2,\n",
       "         'require': 2,\n",
       "         'understand': 2,\n",
       "         'release': 2,\n",
       "         'find': 2,\n",
       "         'website': 2,\n",
       "         'commentary': 2,\n",
       "         'historically': 2,\n",
       "         'remark': 2,\n",
       "         'advancement': 2,\n",
       "         '0.08': 2,\n",
       "         'fundamental': 2,\n",
       "         '6.5': 2,\n",
       "         'merit': 2,\n",
       "         'evident': 2,\n",
       "         'create': 2,\n",
       "         'v': 2,\n",
       "         'dozen': 2,\n",
       "         'execute': 2,\n",
       "         'outstanding': 2,\n",
       "         'establish': 2,\n",
       "         'trajectory': 2,\n",
       "         'reach': 2,\n",
       "         'contemplate': 2,\n",
       "         'differentiated': 2,\n",
       "         'execution': 2,\n",
       "         'activation': 2,\n",
       "         'prescription': 2,\n",
       "         'prepare': 2,\n",
       "         'forthcoming': 2,\n",
       "         'complete': 2,\n",
       "         '40': 2,\n",
       "         'intend': 2,\n",
       "         'inflammatory': 2,\n",
       "         'unmet': 2,\n",
       "         'host': 2,\n",
       "         'december': 2,\n",
       "         'clear': 2,\n",
       "         'leader': 2,\n",
       "         '9': 2,\n",
       "         'especially': 2,\n",
       "         'monoclonal': 2,\n",
       "         'antibody': 2,\n",
       "         'wide': 2,\n",
       "         'blood': 2,\n",
       "         'promising': 2,\n",
       "         'atypical': 2,\n",
       "         'currently': 2,\n",
       "         'bipolar': 2,\n",
       "         'schizophrenia': 2,\n",
       "         'therapeutics': 2,\n",
       "         'sequentially': 2,\n",
       "         'episodic': 2,\n",
       "         'room': 2,\n",
       "         'consistent': 2,\n",
       "         'consumer': 2,\n",
       "         'globally': 2,\n",
       "         '10.47': 2,\n",
       "         '10.49': 2,\n",
       "         'transition': 2,\n",
       "         'accretion': 2,\n",
       "         'post': 2,\n",
       "         'newly': 2,\n",
       "         'continued': 2,\n",
       "         'payable': 2,\n",
       "         'february': 2,\n",
       "         'summary': 2,\n",
       "         'impressive': 2,\n",
       "         'milestone': 2,\n",
       "         'upcoming': 2,\n",
       "         'virtual': 2,\n",
       "         'abstract': 2,\n",
       "         'presentation': 2,\n",
       "         'dupilumab': 2,\n",
       "         'ulcerative': 2,\n",
       "         'colitis': 2,\n",
       "         'crohn': 2,\n",
       "         'vaccine': 2,\n",
       "         'process': 2,\n",
       "         'acceptable': 2,\n",
       "         'observe': 2,\n",
       "         'design': 2,\n",
       "         'fda': 2,\n",
       "         'ineligible': 2,\n",
       "         'intensive': 2,\n",
       "         'chemotherapy': 2,\n",
       "         'extend': 2,\n",
       "         'designation': 2,\n",
       "         'develop': 2,\n",
       "         'potentially': 2,\n",
       "         'breadth': 2,\n",
       "         'advanced': 2,\n",
       "         'monthly': 2,\n",
       "         '30': 2,\n",
       "         'milligram': 2,\n",
       "         '50': 2,\n",
       "         'facial': 2,\n",
       "         'neurotoxin': 2,\n",
       "         'masseter': 2,\n",
       "         'europe': 2,\n",
       "         'gemini': 2,\n",
       "         'symptom': 2,\n",
       "         'presbyopia': 2,\n",
       "         '584': 2,\n",
       "         'vision': 2,\n",
       "         'loss': 2,\n",
       "         'internationally': 2,\n",
       "         'mavyret': 2,\n",
       "         'volume': 2,\n",
       "         'contribution': 2,\n",
       "         'p&l': 2,\n",
       "         'gross': 2,\n",
       "         '11.7': 2,\n",
       "         '12': 2,\n",
       "         'intangible': 2,\n",
       "         'amortization': 2,\n",
       "         'item': 2,\n",
       "         'foreign': 2,\n",
       "         'aesthetics': 2,\n",
       "         '2.5': 2,\n",
       "         'certain': 2,\n",
       "         'formulation': 2,\n",
       "         'move': 2,\n",
       "         'forecast': 2,\n",
       "         'anticipate': 2,\n",
       "         'capital': 2,\n",
       "         'balance': 2,\n",
       "         'open': 2,\n",
       "         'mind': 2,\n",
       "         'core': 2,\n",
       "         'perspective': 2,\n",
       "         'sound': 2,\n",
       "         'place': 2,\n",
       "         'delay': 2,\n",
       "         'recover': 2,\n",
       "         'consensus': 2,\n",
       "         'comfortable': 2,\n",
       "         'dermatology': 2,\n",
       "         'pass': 2,\n",
       "         'situation': 2,\n",
       "         'response': 2,\n",
       "         'itch': 2,\n",
       "         'real': 2,\n",
       "         'clarify': 2,\n",
       "         'yield': 2,\n",
       "         '55': 2,\n",
       "         'needle': 2,\n",
       "         'boost': 2,\n",
       "         '11': 2,\n",
       "         'bring': 2,\n",
       "         'helpful': 2,\n",
       "         'appreciate': 2,\n",
       "         'concerned': 2,\n",
       "         'let': 2,\n",
       "         '19': 2,\n",
       "         '21': 2,\n",
       "         'pocket': 2,\n",
       "         'd': 2,\n",
       "         'burden': 2,\n",
       "         'carefully': 2,\n",
       "         '4': 2,\n",
       "         'short': 2,\n",
       "         'flex': 2,\n",
       "         'cosentyx': 2,\n",
       "         'secondly': 2,\n",
       "         'curious': 2,\n",
       "         'account': 2,\n",
       "         '23s': 2,\n",
       "         'hey': 2,\n",
       "         'leave': 2,\n",
       "         'investigator': 2,\n",
       "         'centrally': 2,\n",
       "         'pause': 2,\n",
       "         'disruption': 2,\n",
       "         'decide': 2,\n",
       "         'critically': 2,\n",
       "         'consideration': 2,\n",
       "         'navin': 2,\n",
       "         'jacob': 2,\n",
       "         'jon': 2,\n",
       "         'ph': 2,\n",
       "         'slightly': 2,\n",
       "         'randall': 2,\n",
       "         'identify': 2,\n",
       "         'unemployment': 2,\n",
       "         'roughly': 2,\n",
       "         'proactively': 2,\n",
       "         'happen': 2,\n",
       "         'extent': 2,\n",
       "         'nbrxs': 2,\n",
       "         'prospect': 2,\n",
       "         'manage': 2,\n",
       "         'organization': 2,\n",
       "         'pbm': 2,\n",
       "         'marketplace': 2,\n",
       "         'run': 2,\n",
       "         'usage': 2,\n",
       "         'period': 2,\n",
       "         '3373': 2,\n",
       "         'biology': 2,\n",
       "         'translatable': 2,\n",
       "         'leverage': 2,\n",
       "         'optimization': 2,\n",
       "         'team': 2,\n",
       "         'maximum': 2,\n",
       "         'heavily': 2,\n",
       "         'dark': 2,\n",
       "         'gregg': 2,\n",
       "         'deal': 2,\n",
       "         'frame': 2,\n",
       "         'depression': 2,\n",
       "         'parkinson': 2,\n",
       "         'pursue': 2,\n",
       "         'one': 2,\n",
       "         'basically': 2,\n",
       "         'label': 2,\n",
       "         'subcutaneous': 2,\n",
       "         'delivery': 2,\n",
       "         'address': 2,\n",
       "         'pe': 2,\n",
       "         'sector': 2,\n",
       "         'political': 2,\n",
       "         'environment': 2,\n",
       "         'knowledge': 2,\n",
       "         'skepticism': 2,\n",
       "         'internal': 2,\n",
       "         'certainty': 2,\n",
       "         'final': 2,\n",
       "         'burn': 2,\n",
       "         'conclude': 2,\n",
       "         'stand': 1,\n",
       "         'welcome': 1,\n",
       "         'earnings': 1,\n",
       "         'participant': 1,\n",
       "         'introduce': 1,\n",
       "         'ms.': 1,\n",
       "         'shea': 1,\n",
       "         'relations': 1,\n",
       "         'gonzalez': 1,\n",
       "         'severino': 1,\n",
       "         'q&a': 1,\n",
       "         'laura': 1,\n",
       "         'schumacher': 1,\n",
       "         'external': 1,\n",
       "         'affairs': 1,\n",
       "         'legal': 1,\n",
       "         'secretary': 1,\n",
       "         'remind': 1,\n",
       "         'purpose': 1,\n",
       "         'securities': 1,\n",
       "         'litigation': 1,\n",
       "         'act': 1,\n",
       "         '1995': 1,\n",
       "         'caution': 1,\n",
       "         'operation': 1,\n",
       "         'actual': 1,\n",
       "         'differ': 1,\n",
       "         'materially': 1,\n",
       "         'form': 1,\n",
       "         'k': 1,\n",
       "         'sec': 1,\n",
       "         'undertake': 1,\n",
       "         'obligation': 1,\n",
       "         'law': 1,\n",
       "         'reconcile': 1,\n",
       "         'historical': 1,\n",
       "         'comparison': 1,\n",
       "         'recast': 1,\n",
       "         'conform': 1,\n",
       "         'recognition': 1,\n",
       "         'accounting': 1,\n",
       "         'policy': 1,\n",
       "         'divestiture': 1,\n",
       "         'zenpep': 1,\n",
       "         'viokace': 1,\n",
       "         'prepared': 1,\n",
       "         'action': 1,\n",
       "         'considerable': 1,\n",
       "         'legacy': 1,\n",
       "         'creation': 1,\n",
       "         'specifically': 1,\n",
       "         'analog': 1,\n",
       "         'relatively': 1,\n",
       "         'diverse': 1,\n",
       "         'vehicle': 1,\n",
       "         'nicely': 1,\n",
       "         'numerous': 1,\n",
       "         'vibrant': 1,\n",
       "         'collectively': 1,\n",
       "         'exciting': 1,\n",
       "         'shareholder': 1,\n",
       "         'superior': 1,\n",
       "         'indicator': 1,\n",
       "         'parity': 1,\n",
       "         'unprecedented': 1,\n",
       "         'excess': 1,\n",
       "         'communicate': 1,\n",
       "         'testament': 1,\n",
       "         'near-': 1,\n",
       "         '2.2': 1,\n",
       "         'projection': 1,\n",
       "         'strengthen': 1,\n",
       "         'leadership': 1,\n",
       "         'aggressive': 1,\n",
       "         'progression': 1,\n",
       "         'cd3xcd20': 1,\n",
       "         'diversify': 1,\n",
       "         'source': 1,\n",
       "         'relative': 1,\n",
       "         'medical': 1,\n",
       "         '100': 1,\n",
       "         'strongly': 1,\n",
       "         'encourage': 1,\n",
       "         'class': 1,\n",
       "         '950': 1,\n",
       "         '70': 1,\n",
       "         'illustrate': 1,\n",
       "         'focused': 1,\n",
       "         'penetrate': 1,\n",
       "         'dedicated': 1,\n",
       "         'innovation': 1,\n",
       "         'resilient': 1,\n",
       "         'underlying': 1,\n",
       "         'eps': 1,\n",
       "         'seamless': 1,\n",
       "         'increasingly': 1,\n",
       "         'diversity': 1,\n",
       "         'news': 1,\n",
       "         '1.18': 1,\n",
       "         '1.30': 1,\n",
       "         'inception': 1,\n",
       "         '225': 1,\n",
       "         'assemble': 1,\n",
       "         'set': 1,\n",
       "         'diversified': 1,\n",
       "         'event': 1,\n",
       "         'european': 1,\n",
       "         'review': 1,\n",
       "         'body': 1,\n",
       "         'acr': 1,\n",
       "         'congress': 1,\n",
       "         '35': 1,\n",
       "         'registrational': 1,\n",
       "         'offer': 1,\n",
       "         'maintenance': 1,\n",
       "         'file': 1,\n",
       "         'gastroenterology': 1,\n",
       "         'outside': 1,\n",
       "         'nih': 1,\n",
       "         'activ': 1,\n",
       "         'public': 1,\n",
       "         'partnership': 1,\n",
       "         'aim': 1,\n",
       "         'prioritization': 1,\n",
       "         'immunomodulator': 1,\n",
       "         'complication': 1,\n",
       "         'cytokine': 1,\n",
       "         'storm': 1,\n",
       "         'activ-5': 1,\n",
       "         'effect': 1,\n",
       "         'proof': 1,\n",
       "         'concept': 1,\n",
       "         'abbv-3373': 1,\n",
       "         'abbv-154': 1,\n",
       "         '2b': 1,\n",
       "         'definitive': 1,\n",
       "         'myelodysplastic': 1,\n",
       "         'syndrome': 1,\n",
       "         'myelofibrosis': 1,\n",
       "         'receive': 1,\n",
       "         'decitabine': 1,\n",
       "         'cytarabine': 1,\n",
       "         'diagnose': 1,\n",
       "         'c': 1,\n",
       "         'publish': 1,\n",
       "         'england': 1,\n",
       "         'journal': 1,\n",
       "         'medicine': 1,\n",
       "         'survival': 1,\n",
       "         'additionally': 1,\n",
       "         'publication': 1,\n",
       "         'nccn': 1,\n",
       "         'guideline': 1,\n",
       "         'recommend': 1,\n",
       "         'prefer': 1,\n",
       "         'importantly': 1,\n",
       "         'irrespective': 1,\n",
       "         'mutational': 1,\n",
       "         'status': 1,\n",
       "         'commercialize': 1,\n",
       "         'emerge': 1,\n",
       "         'encouraging': 1,\n",
       "         'differentiate': 1,\n",
       "         'immuno': 1,\n",
       "         'block': 1,\n",
       "         'tumor': 1,\n",
       "         'interaction': 1,\n",
       "         'lower': 1,\n",
       "         'bind': 1,\n",
       "         'red': 1,\n",
       "         'cell': 1,\n",
       "         'hematological': 1,\n",
       "         'malignancy': 1,\n",
       "         'trust': 1,\n",
       "         'symposium': 1,\n",
       "         'showcase': 1,\n",
       "         'commitment': 1,\n",
       "         'preventive': 1,\n",
       "         'mtis': 1,\n",
       "         'detailed': 1,\n",
       "         'clinically': 1,\n",
       "         'statistically': 1,\n",
       "         '56': 1,\n",
       "         '61': 1,\n",
       "         '29': 1,\n",
       "         'competitively': 1,\n",
       "         'collection': 1,\n",
       "         'decade': 1,\n",
       "         'upper': 1,\n",
       "         'region': 1,\n",
       "         'platysma': 1,\n",
       "         'severity': 1,\n",
       "         'reduce': 1,\n",
       "         'registration': 1,\n",
       "         'harmonyca': 1,\n",
       "         'soft': 1,\n",
       "         'tissue': 1,\n",
       "         'augmentation': 1,\n",
       "         'world': 1,\n",
       "         'topical': 1,\n",
       "         'drop': 1,\n",
       "         'agn-190584': 1,\n",
       "         'gain': 1,\n",
       "         'lighting': 1,\n",
       "         'distance': 1,\n",
       "         'bottomline': 1,\n",
       "         '12.9': 1,\n",
       "         '4.1': 1,\n",
       "         '5.8': 1,\n",
       "         '4.2': 1,\n",
       "         '7.7': 1,\n",
       "         'wholesaler': 1,\n",
       "         'inventory': 1,\n",
       "         'operationally': 1,\n",
       "         '435': 1,\n",
       "         'sequential': 1,\n",
       "         '215': 1,\n",
       "         'hematologic': 1,\n",
       "         '1.7': 1,\n",
       "         '16.4': 1,\n",
       "         '352': 1,\n",
       "         '414': 1,\n",
       "         '41.1': 1,\n",
       "         '967': 1,\n",
       "         '1.2': 1,\n",
       "         '358': 1,\n",
       "         ...})"
      ]
     },
     "execution_count": 51,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "counts=Counter(words)\n",
    "counts"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2b228fb2-f1a2-4f0d-b25f-bc302f9c0433",
   "metadata": {},
   "source": [
    "# **Scoring Words Using `keys()` and Predefined Sentiment Sets**\n",
    "\n",
    "In our text analysis, we are using two critical components:\n",
    "1. **The set of unique words from the `Counter` object**: These represent the words that appeared in the text we're analyzing.\n",
    "2. **The predefined word lists** (like `LM_positive_set`, `LM_negative_set`, and `LM_uncertainty_set`): These are sets of sentiment-bearing words (from external sources like the Loughran-McDonald dictionary) that help us classify the words from the text into sentiment categories (positive, negative, and uncertainty).\n",
    "\n",
    "By using both of these components together, we can:\n",
    "- Identify which words from the text match the words in our predefined sentiment word lists.\n",
    "- Count how many times those words appear in the text to calculate sentiment scores.\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "id": "ec080a20-49eb-4f89-9f6a-8cbf1a3b0490",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Positive Score: 228\n",
      "Negative Score: 119\n",
      "Uncertainty Score: 92\n"
     ]
    }
   ],
   "source": [
    "# Initialize the scores\n",
    "positive_score = 0\n",
    "negative_score = 0\n",
    "uncertainty_score = 0\n",
    "\n",
    "# Loop through all unique words in the Counter\n",
    "for word in counts.keys():  # keys() returns all unique words\n",
    "    if word in LM_positive_set:\n",
    "        positive_score += counts[word]  # Add the count of the word to the positive score\n",
    "    elif word in LM_negative_set:\n",
    "        negative_score += counts[word]  # Add the count of the word to the negative score\n",
    "    elif word in LM_uncertainty_set:\n",
    "        uncertainty_score += counts[word]  # Add the count of the word to the uncertainty score\n",
    "\n",
    "# Display the scores\n",
    "print(f\"Positive Score: {positive_score}\")\n",
    "print(f\"Negative Score: {negative_score}\")\n",
    "print(f\"Uncertainty Score: {uncertainty_score}\")\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "66da45ab-ecdf-4da1-997d-7d32c3755cb4",
   "metadata": {},
   "source": [
    "# **Making Sentiment Scores Relative to Text Length**\n",
    "\n",
    "### **Why Make Scores Relative to Text Length?**\n",
    "\n",
    "When working with texts of different lengths, comparing raw sentiment scores (i.e., the total counts of positive, negative, and uncertainty words) across these texts can be misleading. For example:\n",
    "- A text with 10,000 words will likely have more positive or negative words simply because it contains more content.\n",
    "- A text with only 100 words will have fewer words overall, which could result in lower raw scores, even if it is more positive or negative in tone.\n",
    "\n",
    "To make these scores **comparable across texts** of varying lengths, we need to **normalize** the scores by dividing them by the total number of words in the text. This way, we express the scores as a proportion of the total word count, giving us a better understanding of the sentiment **relative** to the length of the text.\n",
    "\n",
    "---\n",
    "\n",
    "### **How Does This Work?**\n",
    "\n",
    "We calculate the **relative score** by dividing the total score (e.g., positive, negative, uncertainty) by the total number of words in the text. Then, we round these relative scores to make them easier to interpret and display.\n",
    "\n",
    "Here‚Äôs how it works step by step:\n",
    "1. **Calculate the total number of words** in the text (`number_of_words`). This can be obtained by summing up the word counts from the `Counter`.\n",
    "2. **Divide each sentiment score** by the total number of words to get a relative measure of how frequently that sentiment occurs in the text.\n",
    "3. **Round the result** to a set number of decimal places (4 in this example) to avoid overly precise numbers, which might not add much value in analysis.\n",
    "\n",
    "This method ensures that the sentiment scores are **comparable across texts**, regardless of whether the text contains 100 words or 10,000 words.\n",
    "\n",
    "---\n",
    "\n",
    "### **Example of Relative Scoring Calculation**\n",
    "\n",
    "In this example, we:\n",
    "- **Round** the sentiment scores to 4 decimal places to keep them readable.\n",
    "- **Normalize** the scores by dividing them by the total number of words in the text.\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "id": "788d254e-ef9a-4ed3-b85c-cbb915f06bd3",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(0.0386, 0.0202, 0.0156)"
      ]
     },
     "execution_count": 53,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Lets round these number since they will have very many decimals otherwise\n",
    "# Again, there is nothing forcing you to use the score divided by the total number of words. \n",
    "# It's one way, if you think you have a better approach, test it! \n",
    "pos_score = round((positive_score / number_of_words), 4)\n",
    "neg_score = round((negative_score / number_of_words), 4)\n",
    "unc_score = round((uncertainty_score / number_of_words), 4)\n",
    "pos_score, neg_score, unc_score"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2d50d91c-f110-468e-8fd5-a1aac4dc637d",
   "metadata": {},
   "source": [
    "# **Applying Sentiment Analysis to Multiple Transcripts**\n",
    "\n",
    "Now that we have successfully extracted sentiment scores (positive, negative, and uncertainty) for one transcript, the next step is to scale this process up so we can calculate these scores for multiple transcripts efficiently.\n",
    "\n",
    "### **Creating a Function to Automate the Process**\n",
    "\n",
    "To process a large number of transcripts, we will encapsulate the steps we followed into a function. This function will:\n",
    "1. **Take the transcript text as input**.\n",
    "2. **Process the text** to extract positive, negative, and uncertainty scores.\n",
    "3. **Return the sentiment scores** relative to the length of the transcript.\n",
    "\n",
    "By creating a function, we can avoid manually repeating the same steps for each transcript, making the process efficient and reusable.\n",
    "\n",
    "### **Why Use a Function?**\n",
    "- **Automation**: Once we define the function, we can loop over a collection of transcripts, applying the same sentiment analysis steps to each transcript.\n",
    "- **Consistency**: By applying the same function to each transcript, we ensure that the scoring process is consistent across all texts.\n",
    "- **Scalability**: The function allows us to handle large datasets of transcripts without manually processing each one.\n",
    "\n",
    "---\n",
    "\n",
    "### **Looping Over All Transcripts**\n",
    "\n",
    "Once the function is defined, we will use a loop to iterate over all the transcripts. For each transcript:\n",
    "1. **Extract the date** (if available), since we will eventually want to associate each transcript with a specific event or date.\n",
    "2. **Apply the sentiment analysis function** to calculate the sentiment scores (positive, negative, and uncertainty).\n",
    "3. **Store the results** in a structured format (like a dictionary or a list), so we can later convert them into a DataFrame for further analysis.\n",
    "\n",
    "### **Matching Transcripts with Dates**\n",
    "\n",
    "Most likely, each transcript corresponds to a specific event, conference, or communication. For example, if we are analyzing earnings conference calls (ECCs), each transcript might be associated with the date of the call.\n",
    "\n",
    "We can match each transcript with its respective date, and store the sentiment scores alongside the date. This will allow us to later analyze how sentiment changes over time, track trends, or correlate sentiment with external factors (such as stock prices, economic events, etc.).\n",
    "\n",
    "### **Organizing the Results into a DataFrame**\n",
    "\n",
    "After looping through all transcripts and calculating their scores, we will:\n",
    "1. **Create a DataFrame**: This will store the sentiment scores and dates for all the transcripts.\n",
    "2. **Organize the Data**: Each row will represent one transcript, and the columns will include:\n",
    "   - The **date** of the transcript.\n",
    "   - The **positive score**, **negative score**, and **uncertainty score** for the transcript.\n",
    "   \n",
    "The resulting DataFrame will provide an organized view of the sentiment analysis results, making it easy to visualize or further analyze the sentiment trends over time."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8c4f2bea-edde-4979-a931-2d00ead6c33e",
   "metadata": {},
   "source": [
    "# Lets get the dates for all ECCs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "id": "a28ceb70-217b-477c-9020-5d71b8c8343b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'2021-02-04 00:59:09'"
      ]
     },
     "execution_count": 54,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# We're going to need to know what score is from what time, we can do the following to get this information\n",
    "transcripts[0]['time']"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "24c557e2-f253-46b7-9af8-0b84d5013e86",
   "metadata": {},
   "source": [
    "\n",
    "Now we can create a loop that creates to lists, one with the dates and one with the complete texts. Here is where you could get creative later when changing if you look at only CEO or only analysts and so on."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "id": "4bd069c9-b429-4b72-8ba3-074892e87a11",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(48, 48)"
      ]
     },
     "execution_count": 55,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "transcripts_texts = []\n",
    "\n",
    "# We also create an array of all dates that we can add in the end to know when each earnings call was held.\n",
    "times = []\n",
    "\n",
    "for t in transcripts:\n",
    "    text = ''\n",
    "    for speech in t['transcript']:\n",
    "        text = str(text + ' '+ speech['speech'][0])\n",
    "\n",
    "    transcripts_texts.append(text)\n",
    "    \n",
    "    times.append(t['time'])\n",
    "    \n",
    "len(transcripts_texts), len(times)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "43c57217-cd4d-4f0b-90a9-eba87965933d",
   "metadata": {},
   "source": [
    "Now that we see that they are the same length, we know that the score at index 10 will be for the time at index 10."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "20c96d92-e2b1-4c6e-847b-428e08045fed",
   "metadata": {},
   "source": [
    "# NOTE: If your kernel is crashing, do not forget to kill other kernals that is taking up memory and compute power! "
   ]
  },
  {
   "attachments": {
    "63379bf6-0a94-4604-81e2-68c8e37c435a.png": {
     "image/png": "iVBORw0KGgoAAAANSUhEUgAAAtQAAAJICAYAAABBiXPIAAAMP2lDQ1BJQ0MgUHJvZmlsZQAASImVVwdYU8kWnltSIbQAAlJCb4KIlABSQmihdwRRCUmAUGIMBBU7uqjg2sUCNnRVRMEKiAVF7CyKvS8WFJR1sWBX3qSArvvK9+b75s5//znznzPnztx7BwD1E1yxOBfVACBPVCCJDfZnjE1OYZC6ARnQAAWQgAOXly9mRUeHA1gG27+XdzcAImuvOsi0/tn/X4smX5DPAwCJhjidn8/Lg/ggAHglTywpAIAo482nFIhlGFagLYEBQrxQhjMVuFKG0xV4r9wmPpYNcSsAZFUuV5IJgNplyDMKeZlQQ60PYicRXygCQJ0BsU9e3iQ+xGkQ20AbMcQyfWb6DzqZf9NMH9LkcjOHsGIu8kIOEOaLc7nT/s90/O+Slysd9GEFq2qWJCRWNmeYt1s5k8JkWBXiXlF6ZBTEWhB/EPLl9hCj1CxpSILCHjXk5bNhzoAuxE58bkAYxIYQB4lyI8OVfHqGMIgDMVwh6FRhASceYj2IFwryA+OUNpslk2KVvtD6DAmbpeTPcSVyvzJfD6Q5CSyl/ussAUepj6kVZcUnQUyF2KJQmBgJsRrEjvk5cWFKmzFFWezIQRuJNFYWvwXEsQJRsL9CHyvMkATFKu1L8/IH54ttzhJyIpV4f0FWfIgiP1grjyuPH84FuywQsRIGdQT5Y8MH58IXBAQq5o51C0QJcUqdD+IC/1jFWJwqzo1W2uNmgtxgGW8GsUt+YZxyLJ5YABekQh/PEBdExyvixIuyuaHRinjwZSAcsEEAYAAprOlgEsgGwvbehl54p+gJAlwgAZlAAByUzOCIJHmPCF7jQBH4EyIByB8a5y/vFYBCyH8dYhVXB5Ah7y2Uj8gBTyHOA2EgF95L5aNEQ94SwRPICP/hnQsrD8abC6us/9/zg+x3hgWZcCUjHfTIUB+0JAYSA4ghxCCiLW6A++BeeDi8+sHqjDNxj8F5fLcnPCV0EB4RrhM6CbcnCoslP0UZATqhfpAyF+k/5gK3gpquuD/uDdWhMq6LGwAH3AX6YeG+0LMrZNnKuGVZYfyk/bcZ/PA0lHYUJwpKGUbxo9j8PFLNTs11SEWW6x/zo4g1fSjf7KGen/2zf8g+H7ZhP1tiC7ED2FnsJHYeO4o1AAbWjDVibdgxGR5aXU/kq2vQW6w8nhyoI/yHv8EnK8tkvlONU4/TF0VfgWCq7B0N2JPE0yTCzKwCBgt+EQQMjojnOILh7OTsAoDs+6J4fb2JkX83EN2279y8PwDwbh4YGDjynQttBmCfO9z+h79zNkz46VAB4NxhnlRSqOBw2YUA3xLqcKfpA2NgDmzgfJyBG/ACfiAQhIIoEA+SwQQYfRZc5xIwBcwAc0EJKAPLwGqwHmwCW8FOsAfsBw3gKDgJzoCL4DK4Du7C1dMFXoA+8A58RhCEhNAQOqKPmCCWiD3ijDARHyQQCUdikWQkDclERIgUmYHMQ8qQFch6ZAtSjexDDiMnkfNIB3IbeYj0IK+RTyiGqqLaqBFqhY5EmSgLDUPj0fFoJjoZLULno0vQtWgVuhutR0+iF9HraCf6Au3HAKaC6WKmmAPGxNhYFJaCZWASbBZWipVjVVgt1gSf81WsE+vFPuJEnI4zcAe4gkPwBJyHT8Zn4Yvx9fhOvB5vxa/iD/E+/BuBRjAk2BM8CRzCWEImYQqhhFBO2E44RDgN91IX4R2RSNQlWhPd4V5MJmYTpxMXEzcQ64gniB3Ex8R+EomkT7IneZOiSFxSAamEtI60m9RMukLqIn0gq5BNyM7kIHIKWUQuJpeTd5GPk6+Qn5E/UzQolhRPShSFT5lGWUrZRmmiXKJ0UT5TNanWVG9qPDWbOpe6llpLPU29R32joqJipuKhEqMiVJmjslZlr8o5lYcqH1W1VO1U2aqpqlLVJao7VE+o3lZ9Q6PRrGh+tBRaAW0JrZp2ivaA9kGNruaoxlHjq81Wq1CrV7ui9lKdom6pzlKfoF6kXq5+QP2Seq8GRcNKg63B1ZilUaFxWOOmRr8mXXOUZpRmnuZizV2a5zW7tUhaVlqBWnyt+VpbtU5pPaZjdHM6m86jz6Nvo5+md2kTta21OdrZ2mXae7Tbtft0tHRcdBJ1pupU6BzT6dTFdK10Obq5ukt19+ve0P00zGgYa5hg2KJhtcOuDHuvN1zPT0+gV6pXp3dd75M+Qz9QP0d/uX6D/n0D3MDOIMZgisFGg9MGvcO1h3sN5w0vHb5/+B1D1NDOMNZwuuFWwzbDfiNjo2AjsdE6o1NGvca6xn7G2carjI8b95jQTXxMhCarTJpNnjN0GCxGLmMto5XRZ2poGmIqNd1i2m762czaLMGs2KzO7L451ZxpnmG+yrzFvM/CxCLCYoZFjcUdS4ol0zLLco3lWcv3VtZWSVYLrBqsuq31rDnWRdY11vdsaDa+NpNtqmyu2RJtmbY5thtsL9uhdq52WXYVdpfsUXs3e6H9BvuOEYQRHiNEI6pG3HRQdWA5FDrUODx01HUMdyx2bHB8OdJiZMrI5SPPjvzm5OqU67TN6e4orVGho4pHNY167WznzHOucL42mjY6aPTs0Y2jX7nYuwhcNrrccqW7RrgucG1x/erm7iZxq3XrcbdwT3OvdL/J1GZGMxczz3kQPPw9Znsc9fjo6eZZ4Lnf8y8vB68cr11e3WOsxwjGbBvz2NvMm+u9xbvTh+GT5rPZp9PX1JfrW+X7yM/cj++33e8Zy5aVzdrNeunv5C/xP+T/nu3Jnsk+EYAFBAeUBrQHagUmBK4PfBBkFpQZVBPUF+waPD34RAghJCxkechNjhGHx6nm9IW6h84MbQ1TDYsLWx/2KNwuXBLeFIFGhEasjLgXaRkpimyIAlGcqJVR96OtoydHH4khxkTHVMQ8jR0VOyP2bBw9bmLcrrh38f7xS+PvJtgkSBNaEtUTUxOrE98nBSStSOocO3LszLEXkw2ShcmNKaSUxJTtKf3jAsetHteV6ppaknpjvPX4qePPTzCYkDvh2ET1idyJB9IIaUlpu9K+cKO4Vdz+dE56ZXofj81bw3vB9+Ov4vcIvAUrBM8yvDNWZHRnemeuzOzJ8s0qz+oVsoXrha+yQ7I3Zb/PicrZkTOQm5Rbl0fOS8s7LNIS5YhaJxlPmjqpQ2wvLhF3TvacvHpynyRMsj0fyR+f31igDX/k26Q20l+kDwt9CisKP0xJnHJgquZU0dS2aXbTFk17VhRU9Nt0fDpvessM0xlzZzycyZq5ZRYyK31Wy2zz2fNnd80JnrNzLnVuztzfi52KVxS/nZc0r2m+0fw58x//EvxLTYlaiaTk5gKvBZsW4guFC9sXjV60btG3Un7phTKnsvKyL4t5iy/8OurXtb8OLMlY0r7UbenGZcRlomU3lvsu37lCc0XRiscrI1bWr2KsKl31dvXE1efLXco3raGuka7pXBu+tnGdxbpl676sz1p/vcK/oq7SsHJR5fsN/A1XNvptrN1ktKls06fNws23tgRvqa+yqirfStxauPXptsRtZ39j/la93WB72favO0Q7OnfG7mytdq+u3mW4a2kNWiOt6dmduvvynoA9jbUOtVvqdOvK9oK90r3P96Xtu7E/bH/LAeaB2oOWBysP0Q+V1iP10+r7GrIaOhuTGzsOhx5uafJqOnTE8ciOo6ZHK47pHFt6nHp8/vGB5qLm/hPiE70nM08+bpnYcvfU2FPXWmNa20+HnT53JujMqbOss83nvM8dPe95/vAF5oWGi24X69tc2w797vr7oXa39vpL7pcaL3tcbuoY03H8iu+Vk1cDrp65xrl28Xrk9Y4bCTdu3Uy92XmLf6v7du7tV3cK73y+O+ce4V7pfY375Q8MH1T9YftHXadb57GHAQ/bHsU9uvuY9/jFk/wnX7rmP6U9LX9m8qy627n7aE9Qz+Xn4553vRC/+Nxb8qfmn5UvbV4e/Mvvr7a+sX1drySvBl4vfqP/Zsdbl7ct/dH9D97lvfv8vvSD/oedH5kfz35K+vTs85QvpC9rv9p+bfoW9u3eQN7AgJgr4cp/BTBY0YwMAF7vAICWDAAdns+o4xTnP3lBFGdWOQL/CSvOiPLiBkAt/H+P6YV/NzcB2LsNHr+gvnoqANE0AOI9ADp69FAdPKvJz5WyQoTngM1RX9Pz0sG/KYoz5w9x/9wCmaoL+Ln9F42ofF3DjmhqAAAAlmVYSWZNTQAqAAAACAAFARIAAwAAAAEAAQAAARoABQAAAAEAAABKARsABQAAAAEAAABSASgAAwAAAAEAAgAAh2kABAAAAAEAAABaAAAAAAAAAJAAAAABAAAAkAAAAAEAA5KGAAcAAAASAAAAhKACAAQAAAABAAAC1KADAAQAAAABAAACSAAAAABBU0NJSQAAAFNjcmVlbnNob3R3OBGfAAAACXBIWXMAABYlAAAWJQFJUiTwAAAC22lUWHRYTUw6Y29tLmFkb2JlLnhtcAAAAAAAPHg6eG1wbWV0YSB4bWxuczp4PSJhZG9iZTpuczptZXRhLyIgeDp4bXB0az0iWE1QIENvcmUgNi4wLjAiPgogICA8cmRmOlJERiB4bWxuczpyZGY9Imh0dHA6Ly93d3cudzMub3JnLzE5OTkvMDIvMjItcmRmLXN5bnRheC1ucyMiPgogICAgICA8cmRmOkRlc2NyaXB0aW9uIHJkZjphYm91dD0iIgogICAgICAgICAgICB4bWxuczpleGlmPSJodHRwOi8vbnMuYWRvYmUuY29tL2V4aWYvMS4wLyIKICAgICAgICAgICAgeG1sbnM6dGlmZj0iaHR0cDovL25zLmFkb2JlLmNvbS90aWZmLzEuMC8iPgogICAgICAgICA8ZXhpZjpVc2VyQ29tbWVudD5TY3JlZW5zaG90PC9leGlmOlVzZXJDb21tZW50PgogICAgICAgICA8ZXhpZjpQaXhlbFhEaW1lbnNpb24+NzI0PC9leGlmOlBpeGVsWERpbWVuc2lvbj4KICAgICAgICAgPGV4aWY6UGl4ZWxZRGltZW5zaW9uPjU4NDwvZXhpZjpQaXhlbFlEaW1lbnNpb24+CiAgICAgICAgIDx0aWZmOlJlc29sdXRpb25Vbml0PjI8L3RpZmY6UmVzb2x1dGlvblVuaXQ+CiAgICAgICAgIDx0aWZmOlhSZXNvbHV0aW9uPjE0NC8xPC90aWZmOlhSZXNvbHV0aW9uPgogICAgICAgICA8dGlmZjpZUmVzb2x1dGlvbj4xNDQvMTwvdGlmZjpZUmVzb2x1dGlvbj4KICAgICAgICAgPHRpZmY6T3JpZW50YXRpb24+MTwvdGlmZjpPcmllbnRhdGlvbj4KICAgICAgPC9yZGY6RGVzY3JpcHRpb24+CiAgIDwvcmRmOlJERj4KPC94OnhtcG1ldGE+CuJXWToAAEAASURBVHgB7J0HmBXF0oZrlyXtkrOiIoISDCiYRUVUUFRAzFkxXHO84v3N1ywmFC7Xa0DFLIqCEQNgFgUxIIKKgEoOknZJG/7z9VKzfWZnTo57vnqeszOnp7un+53ZOdU11dV5J510UoUEZObMmdhQSIAESIAESIAESIAESIAEoiCQH0VeZiUBEiABEiABEiABEiABEnARKGjfvr3k5eVJRYUxVLsO8ysJkAAJkAAJkAAJkAAJkEAoAgVQpKlMh0LEYyRAAiRAAiRAAiRAAiTgTyAvoEzTNO3Ph0dIgARIgARIgARIgARIICSBfOrTIfnwIAmQAAmQAAmQAAmQAAmEJJAP/2kKCZAACZAACZAACZAACZBAbARMlA9aqWODx1IkQAIkQAIkQAIkQAIkkF9eXm6ifBAFCZAACZAACZAACZAACZBA9AQ4KTF6ZixBAiRAAiRAAiRAAiRAAg6BAmcvw3dmzZol48ePl06dOplP586dM7zFbB4JkAAJkAAJkAAJkEAuEMgrKyuryM/P/AUTBw8eHHQ9Ro0aFfSdX0iABEiABEiABEiABEggHQQCunTmK9OwTrvFK82dh99JgARIgARIgARIgARIINkETBxqTExMhxT//LXoJ9rzz549O9oizE8CJEACJEACJEACJEACCSeQkEmJQ4cOjci3Gcrz8tdHmE4Uz5xSrTNFXfeRws57mfSWgy4LOj5u3DjBBzJgwADzCcrALyRAAiRAAiRAAiRAAiSQBgJ5Aet0RTyLu9iKLiYKDhkypFo3lo0dLsvGVirS1Q6GSGg56FJxK9YhsvMQCZAACZAACZAACZAACaScgFkpMVELuyAChy1QpGee3ikmZRr1QAmvLD/crpb7JEACJEACJEACJEACJJAxBEzYvHgs1HC/gMCn2VaoY7VKe5FR6zat1V50mEYCJEACJEACJEACJJBOAsaHGhbqeJRqdwfCKdPwlVZRn+mSWd+YJC/fas1LFxAlwS0JkAAJkAAJkAAJkECmEEj4wi5uZVqV5xbHXipFXfaOuN+oB6LWaXuflmqDhn9IgARIgARIgARIgAQygEBConxoP2xlGop0tEq01uPe2vXiWLsbno1KOXfXx+8kQAIkQAIkQAIkQAIkkCgCCXX5wATCRCrS7k6qYo1ztLt+tPswv5MACZAACZAACZAACZBAygkkzEKtLhqpcMfAuQq77EMrdcpvF56QBEiABEiABEiABEjATaDWzTfffCsS452UWBJYtCUVyjTaWhRQpjcvXyB1WrbF1xolq1evlscee0ymTp0qXbp0kbp16zr9e+ONN+THH38031u1auWkcydyAmVlZTJ27Fj56aefpH79+tK0aVOn8Oeffy6PP/64FBUVyTbbbOOk5/IOmeTy1WffM5XAF198IV999ZUsXbpU2rdvn6nNDNuuTZs2Sa1atcLmQwas6PzSSy+ZBd7atWsnTZo0iagcM1US+PXXX2XixIny888/m4hs+fn5RLOFAO4tfOJlkjALNa9MMAEoxX/99Vdwos+3fffdV/r162eOPvjggzJiROUiOFgk58ILL3RK7bDDDmb/8ssvlyuvvNJJr0k70XDbaqut5KKLLoqq+2vWrJHdd9/dlLnjjjvk1FNPNfsYyOyxxx5mHwr1119/bRTuqCrPkMxffvmlvPvuu6Y1Z511lnTo0CFsy+bNmyejRo0y+fr27SsHHHCA1CQmYQEkMEOoe7hOnTqyyy67yK677moUoXgf4AlsdkZWpSxxD+Ne9hPc77jvIVAwzznnHL+sNSL9H//4h3zwwQfSo0cPGTNmTNb0ad26dfL666/L+PHjZdasWVJcXCzNmzeX7t27m/+Lnj17Os9hd6c+/fRT5x446KCD5Omnn3ZnyZrv+H156623om5vgwYNPBfPi6SiZ555Rv7973+brGpQiqRcTc0zbdo0+eijj+T777+XH374wdyL0AG6desmuA979+4ddddNlI9Eh82LuhU1sMA777xjLlIkXcMIXRVq+02BvR9JPTUhTzTcsDJntAp1rIzefPNNmTt3rnn4n3baabFWk5JyDRs2lOeee86cK9IHMH7ktMyxxx6bknbW1JNEeg9vt912Mnr0aMGW4k1AWcLo4KdQT5o0SS655BJTAQbDeJNHyTwCkydPlssuu8woLnbrVqxYYQYHGCA89NBDxliE6+m2XIcbfP73v/+VzZs3G4Xo4IMPtk+RcftYt0Oft9E0Dve312rU0dSR63mh7z7xxBNy9913V0Mxffp0wQeDtdNPP11uvPFGgREkUkl42LxIT5wr+fAPsPfeocMF7rTTTg6OwYMHmwcJLmKmK25Oo5OwEwm3RCoijRs3lmeffdY82DG4gTuILfiRxg83rF+Zfl1gAUU7MQCA9eqaa66p9uNk9w2vutTKBaZqwQ/HxK6D+9UJ4B6GpcMWvKLHAxvyxx9/yHHHHSfPP/+82M8AOz/3QxMAy3PPPdfJ9OKLL0b0RsYpwJ2UEMDz8+qrr3bOhecMBu5t27YVvDWExRSDesiwYcPk22+/lZEjR0phYaFTZr/99pO77rpL8DZN3yw6BwM79913n/mKgVemK9RwKTzkkEPs5pt9uGMsXrzY7MMK7x5UwFhCiY8ArPQwZKgcf/zxAuMcdC4MdHCv4s0JBjzwMtA3t5o/1NYo1LloCQ0FJZHH8Gr3ySefjLhKKDFw6ch1iZZbInjBzQGfmiCnnHKK+fGB9QevtkIN6r777jvnIX7yyScHzaeoSUxSfV1xD8Nq5paSkhKBaxce1Lg+9957b1TPCHd9ufr9t99+kzPPPNPp/gsvvGDcBpwE7mQEAQwcbWUa7opeFmhYXi+++GIz4Pzkk0/ktddekzPOOMPpAyzUeD7VBIEy7aVQ2y6fcHeKxjpaE7gkuw8YjKkyjUEd5kztuOOOQafFvYkPBuuTA29Vfv/9d1F326CMHl/yYZ2CCZxScwisWrXK+KfhQYZJH7kqUFYw4l++fHnOITj66KOdPofz1cNrdZVjjjlGd6PaQkmEgoOJLxjdU/wJwOp2ww03CCxuELz5KC0t9S+QgCPr1683zwQ8G2qCwIoHZVrvtf/9738Ct5BQgt+6JUuWGGsoymOCcrQyf/58wzFc2ZUrV8ovv/wi4B6pwF0Bz2z4Fv/999+RFsv4fHfeeafTxqOOOsq4fbgtr8jQunVrgZ+vvnnEYDQcZ6fiHN7BvYZ7Bs/gWGTZsmXmdxL1RCrQGRcsWCBz5sxJ+rMr0jZFkg/+0ioXXHBBNWUax9q0aSO33HKLZhO4e4YSW98KDPrygyxSoQryWPIJYOY2RkP44J8kGnn//feNLzYmeMBtoVevXuZVBn68oVzmikBBwcS6vfbaS/AAh3V2//33N/8YoQaPeI0I7pdeeqmD6tBDDzVpqBMCNwq9Pur37mTOoB08FPDKEIJXqfix9hL8YL388svmEBQ8vIK1xYuJfRz36Pnnn28sg3369DHcYZmF6xJe49oCBUPZwV/SLbCk63FEYnELXsfpccxWz2bBW0Hcoyo2KwwCtZ9TpkzRLEFbTKLRPHg9roKHu6bjuiMaxAknnCA777yz82zA/4IXf60j07eYLIvX+vpqfOjQoXL44Yf7Nhv3OKx9++yzjxnEYNAIBnBt+s9//uOptOH+Uo5QovEWAc8TWBXxfw/XHYidD8owFEI8M/bcc0854ogjDHfwx73rJ1Bkbr31VhN5Ac9s1I/Jhrg/dHKxX9lMT0ff9F6DJRAcQ70Rx5yPK664wnQL1/fDDz90urhx40bnmqj/MfLoddKMuAaaBheRmij4P//Xv/5lJjfjXsM9A1c/3HsPP/yw5z1tc8DvIJ4PuKfxf4HfSa3n448/trMG7YM33iLstttucuCBB5r/O7ir9e/fX/yeVUEVpPkLJsWqbL/99rpbbYv+wQUUbxH9fue99K38UApGtbMwIekE7BG5vR/uxLi4iAjipYTDrxCjsWisJeHOl6nH8U8Nn0pYSm3BgwAPavyw+okqnbpFvlDM8IDPZIF/LgRWvM8++8yzqVC41MoHXzK3KAvd2sehaEBZwExpt+BVGV7PIo8KIjXArxiCWe5usduoAxg7D0JJqqift37Pxm1BQdUUFvtesv/v7X27j3Y6LK8q9j54YWINBiq24H8BUSKycfLehg0bzLNM/79hLPC6b+3+YvLRPffcU82ogPv+gQce8JycZL8xeOSRRwQWcC+jhJ0Pr5Lhn4lBty3gf+SRRwb9L+hxPF8wINXX0JqOLfqIV88TJkywk7Nq3x74nnjiiUE+0X4dgXKGiB74QGlTse9tvf91q3ncW/v6uI9l63fcFxhAvvLKK86zW/uCew8KNdxqQr2dxkASc2vc9zT0B0TIsQfpWjdcIHDe9957r9p5Z8yYIXAz9LqPtXwmbGHsUYFeFOr+gbsjBrhulxCU99O38jFapFKtiLNzi9jUGl4PlklYATCyh08hbnII/hngo2Y/lLKzt/6txgSC8847z8kAX/RXX33VPAAwWxfhmbx8Wp0CHjsYxcOfDyN5CPjiOz74h8xkgbVCxc/tw06HhTlSgYUEVmhVxnFvIRQWXo9dd911phocgyUReSF4zauWRMS3doutmEMhdz/s8PYGAutBs2bN3MWz7rs9qEhG3HPcnxjAQGnEAAUf25cVr+KhoGaL4H5A+7/55hvTZFjK7AmJXv3AhE+dVASXEPz/49569NFHHRcRHIc1yk/wDIAbAl4D43mCT8uWLatlRz0IuwW/TITwgysVLH8qeC7bgmcx/m/wbIbgWY324tkNqzueNRBEMsIbiWwUvJVSwcSvSATPCbwpw8eelOhVFqFT9XmsxwcOHOikqbVbj9WELQZ4qgjjdx++5rincc9o6Ne3337bvJ3y6y/+D/B7iHsaAzbc0/h/UsGAGwNvW4YPH+487xGNBUo0XCieeuopUxfyYmJorK4n9rmStY+1PdSoA0YYPOC5GGrw4W5LKH3LmEhCvYJxV8bv0RHAja8/AF4lEU0Cr2riEVVgcKPgh0HjDuO1F35E8EOE0azeQHAJyXTBTRvuYYh/BttSiVnhquDhFao9YQmvpdDvQYMGRdV1+PVB8CoSguuVDOXHVJ7gP/gxglUI1x5Kwe233x70AwXrmEb3gDVbHzSRNAMKiVri8IC3fbbhXgBuUH7wGhyLMeiAD24osIzCEgJFWxdngJ87HtAquI5QIvQHAoN+/GhAYokPagpmyB/0BT+CGIBA0Mett946Ka0De1wPFbgz4TU8wkLh2YRJOpEqOlpHuraw/sI6pmIPDjTN3sIP+aabbjJJeMYiVJYqaFCQYYHCGxbci1As8Ealdu3adhVmHxYqGCeggIQS5INSjYnlEPwPwFoIpRJWRVhcbcH9jGcyBG8SbrvtNucwnt0YOMJtBHL//fdnvPXPaby1o64xSEpGJBu4rLqfx+DvTrOalNW7eFMIhRWWU7gF4Q2GCu5p+56B3oF8foJngP1swO8jnsdwk8GzAc94/I5CEIlFn78YxA4YMMCk4w8iquANDqzeeLbBr9q2BDsZM2AH/9+wouvbW7wVxQe/fXANhdsLfqNsLu5mh9K3CgCACrUbWeK+40F60kkn+VYIKwReu8cq+OdSNw8ooKpM2/XhRwVKFQS+mtmgUEOhCjcZAD6GtkKNaBUQPGhsZdokBv4gLxjhRy5XBKGp9Nrj9aut+MKyowKrTjSibgTwKbXr1DpQHx7YUIrtiSA6EQ/5YJnTme66KAeuHSxTUDbxoFOFGjOtdbBkvwbW82XiFv/7cDVQgUUSgwjwwDEVWCmTIfj/8PphgNUU1wby559/ZoVCjbcT+obCNDzwB33AWxI/mTlzpnPIPZjEAfyI/t///Z8T3xqTamHBcsvZZ58dVplGGYTTVGVa64DCh/8FWO5w/0LJ19VZbatzYMViLeJsoYDCaghDAf5XcP+gvmwSTHiDgLWXVR8+rbCs+gkMQn4+rH5lanI6FMJQUcNwz2DwCOOEPS/DzeSf//yn57MByjLeWuLe1FWZUdaeRAqFGYq9PfiEThGqXe7zp/M7flNg1EFEFf0NxP+mvsXD/yoGxxjk4n/a/p8Lp28VUJlO56WVuMPi2JNdMIoMNzHA/idJb89Dnx0PYPt1qVdunQ2OY/BB1YGFumd4lcEqSLkkYIFBG17fYYBiK7/jxo0zKGB5CxchwWYGv0RVqKEg+t1zap2yfZ9htYNFFNcKFhRVqNV6BzcVtBcKNVxAsBAERM+H+wJWmGwQWHlC+ewjVjgUPUwKSob43eutWrVyTqeDFCchw3dw7VURxUqn6CMGYV5iv/GAIut1n+IaqUAB8VKodVCn+fy2fm8a4ZagAt6qUKsBAMf0/tZ8utUIRSiHwQ+W3M4mUSUa7fcaECBdJxh69QvKDBVqLzKVaZigi8g1GJjg93/t2rXOmz6veS9ak989DX0QVlr8j2EQh7fbUKbx3MX/Ge5TWKrx5gSGQkzuxf+MrXDrOTJ5i+cIBuT6u4jfH3sODwweeGsFfQlzMLR/4fQtY6GGldrWwjMZRLa1DTchfIz8RC+U3/Fw6bYVBkuW67LlfuVsa6FfnkxIxysj27oXrk2wLqmEerXoNcFAy9XELf6v8eCDVR6z7dVChgexvj7H8WjuQ1goVPDQVT99TXNvobTAzUD9nuGyAYUaDzD169doBrA+q8KHh7q2V5WhXoFXmNG01d2WVH/XSCt6XrWI4DssQe4FhDRfIrYtWrTwrCZbY9vi2uPVMn7Q4eMJgSsR7h2vvtrGg1CWbIWkA3L9rtt69erpbsit3t/uTF688ZtrK9Hh/odQJ37Ms02hhuuKCgbY6heuabj/3aE6oXirK4zm47aKAPjAtRNuY/agsSpH+L2OHTv6ZrJ/P+HWp3nxG4KoT3DjQ7r9+wzXKbhTJss44NvYOA/gfsSkYHwweMAgF9ZrzGWAwLcc/UdQB0g4fctYqBNhpV42dri0HFRpTTJnTvKf+XedKe2uH53ks8RfPV6LqP9t/LVVr8GexQyLrVoE3Dnx8MaoNFm+mu7zZer3RNzrmdo3v3bhB0vdXKBUw6/angBo+8P51WGn2/cc0v0shLjnvO5JKM14jY0fA1hVYHmDpQqWclg7MAhQSyRcQWChUkU001dAsznB6g8riC14ta8WObwxwLWgREYAxgI8TzGxFQoy/JUxWIMbF/wi3QMt20Lnd4/izLhPcVznS0TWmvhyQaHGPa/i1z4MRKG84Hgyf0e0HYne4i2MCiL+uBXqRo0aOc8mzYfngSrU7vyaJ1e3uKfhBmQ/v2E9xu86/J/x0TCFoRhF+juI+1QF54ARBq6DmJNjtwFzcfBBUAC4UUVav9adCVs8P/B/hs9hhx1mJiyiXTD8qEJt//Z5/bYl1Ic6FUp18c9fy/LXR0hh58qoC5lwIdLZhq5duzqnx8QVvK7JRdFRNPpuzyx3s7B9V93Haup3WIkwmII1GaNvKHHYQvCaOlqrvc0avnj27PBIGNqvG9EmtQxCUdI3ZXD9gIUaijT8gPXVfLavZIlJgapQw1cPbk34QfQTv9nndjxVv7I1KR2DE51QiH7hzQZciXCPYNCFibFXXXVVUJcxKFPlAhYnL0txUIEUfsF9jvkEaDu2ahFLYRNScirbog6raiQWTNty36lTp5S0M1tOAjaqyMJdDhN13RMw4ferc1L8+oXfQa+3Oshv/37abxhwDG9rYODAB8ol3KRgxdX7FxN/4QaCt0mZKHBRhCW6bt26IQeoMNzo/6ftChJO3zJh8xLRcVinS2Z9IzNP7yRQrJMhqHf+nWcYZTqV1vBk9CVRddoz9O1XnImqP1vqwT+IsrAfyO72236L7mORfMc/YzYKXslBMLELDPQhEYuFFKyhrEBicSGCYqOLmsCPWhcSsK3P6iqBHw+NkgPF3/ZHNQ3Isj9wZ9HoNRgk4AfILQ0bNnSSdFKXk7BlRyOsuNNz5TvuIYTx0sEI9uEKYos9IdNWEuw86dxXH3cMCrL1uRKOH1z3dACNMIJYtCiUuN097MF7qHL2MduKaKfXhH19bqMvsAS7lWnMJQqnTKOs3+8gLNI65wXPePdbH5RVQRx93MOYB6IKNY7Z4UA1b6Zs4bKCeUV4K4t7LZTo/AV9xiCv6hjY99K38nHANuvje6zS4tjKFeaWjR2RMMUaFmko0pWK+ohYm1Zjy+HHV1+rYdaq7d+qncaPMmaaQ4nBD09NFVXyoIB5xZWF8qeuD9EyUOsW/MfUWhptHenMr+G30AYE/VeJdcKPRleBBdCOZa31QkHAhELcc5g57hZVmOH/qtEb7ImRsJzjQQbWGjvcjqvtri+bvoOHPqRxP7rjvW677bZOd9TP3UkI7CB2NEJa5bqAE2Jsq+B+Qyx6FduahDj0XvFxoXzgHsXHrZBrPcnaamgxuH7A0uglmNSq7dMfeK98mZqGV/9YfEcFMbX1jZSm6RbPDCiJaoHFGyv7f0HzhdtmskIXru3hjttKoNf9jDCZkQjejnlFAcF8LwzwIPqMxz4WMoFRBvNtVOFGuorqIPhuGwT0eKZsNVweDBIattSrbZikqG+zbXescPpWPi5QovxdirrsHfCjrlSq0UhVrOHvDKUYynEkgnwoYz4BizTqUUH9tE4rjcotRogQPJjPOOMMs+AIbgb8uMAqgH8E/JMgLVtemWPmMpSJUB/3SBwxOVVRwQxdvAbWEGVQsO1FXyrJRf7XfrAjXiyUQPvHO/Ka0pMTvnUaNQWDAgh+qP0mUoVrJSaDaVxeLKCjob2gHOK6IGwh/CBxz3lFXdH7UC2tUKbtkGOwjGB1OYjm6dmzZ7hmZcVx+MLaofIwELYF7gA6uEAoJ4QV04Ec2OKtglsJt8vn0j4WI9IJh3j+waVGV53E2wB1A8HzD3HrMfhbuHChMTzg7QBej+MeRZrXfZpMllAYdWAJNyAsJY0fcjz7ML8A4U4x8Qvtg3+33yv6ZLYxEXUjpJr97MEgHgNCvEnEHApMtkRoT1wfjYuP57j+rkXaBrUeghcGqmCYjcaPUP21Q4ZiEIZBINwYcH8jfrTfwMyrTkzEw30HIxxc78AMkXMg4K9rB+A7DBy4XjBW4Tph0KPuE1DMNRoT8uJ3JVPFngCLOPZYLRIDMI2UAn0BrrNYkEwFYTNt0fvSS98qUJ9Fu0A8+6rs2kpw8cwpgo9IlWKMcxR1rQoXVXk89JmpTHvzgc8SfpRxg+CH1rYI2CWuv/76rIhBjTZDiQrnm4sHKAYMKlB6sUoZXutAhg0bZj56HFsof1C0oxVYePX1PCaT4YNRuVpToq0vHfkxC1sn++D8iFEdq2CyEF7zYcSPBwseQl6Ch6vXQAYTOvBR5V7D59l1wA8P/nkq2RA/XdsabgtLD+K2ov/oIx7gtosC/of14Q/lw22RhlJi3/vhzleTj9v+1FAssAKkLpICBXvRokVmcSEoA+o+5OaBCY46GHcfS9Z3vDLHREsMkGC1hVKpMePtc+L/BBbFbBa8SYC7lj5DQ8WexkAdyp1G+4m031iyXK3fKI8PlCGvGN+R1plp+fAMxMAP9zGUYB1MajvhFofIKfg/CCX6O+jH5plnngmaQIoJiVCw8RzC8x7KuJcgj9vv2itfutJwT8G4hnaiH5hciY+f4B5y+4OH0reMy4dfZbGmQ6m2LdV+9aiiXROVafU9wkMzGrEHOFqHu7ydR4/BpQMX32uCGf4BMRL1Umy0fKZs/frs1T4vtrDsQam2X0GhLB7SWC7Vdj9wn0u5utNRHg8yvH61raRe50feTBVYN1RpwNb9oPBqdygmCK+EFeS86oESgB9NuBj5ccJMahXb8qJp9iIwcPeINHyZlk/XVu8fv36jXXAhwoROFfcgD8o1Xt/arxuRF9cNyqL9v6zXCMf99nFMxc6jbdVjmbbV9oVjaftT41mHSAQQvH2FRQmWan2jYvcRg0os9e22Tut5kdfmZZfFfiT57PJ2fpTH2wpEgsEqjW7BtYa/PSYQuyOQaD123e7ymfQd9zsMOhhEqiXZq31QEPFWBkqLW+y+2vuaD8/2W2+9Neg30Cuf5s/ErV5XtM3LcwDzV6AQYtERfZZrP44//nhzTO9zuy7ksVkg7CSMIJpX64D+gMGll/ECA1cc87p+8JPHMfvNm9aZaVu8HYWropcRR9uK/sAlRI0amq5bP30rL+C3VGGD1gKJ2MLNw7ZUx1InrNjwzYY7CSUyAojdC387/ENh1Tn8E+aaYF4AfMcRdgoLKWBk6vWAioULfNcw8QWWAHu1qFjqqillMNqHJRCCH/9M9qPLNuZwYYAlGz+gYOv+ocy2/qSrvfDRxTMBr6pxf+ItSyaxxHXGq2c8X+DeAWUnUc+sdDH3O+/69esFawfMmzfPXAtYNfFblajrAVcSsENkmETV6deXdKXjNw4hBvFbBOt/LDHtUQfuOaxLAPc/3HeR3HM4J1wekRcTI7OVMZ4J6AfcjuD+jPsQn1ADePf1tvWtvADQqkCD7pwJ+h6LYk1FOkHwWQ0JkAAJkAAJkAAJkEBSCeQFtHKjU8drpYbvks6aROxIr8UioFhDEF4PYrt6qD814ksXdtmHFmlDiH9IgARIgARIgARIgAQynUDCLNTwl9QJAeg0/Gwi8adBRA+6c2T6bcL2kQAJkAAJkAAJkAAJ+BHIT4THx7hx44KUaZwMyrWtYPs1gMq0HxmmkwAJkAAJkAAJkAAJZAMBs1JiIpRqr87C0ZtCAiRAAiRAAiRAAiRAAjWZgAmbF8mszlAQ4DPtJX7pXnmZRgIkQAIkQAIkQAIkQALZSMAo1PFaqOEv7Z6EiO9e8QqzERLbTAIkQAIkQAIkQAIkQAJ+BMykRCjU8Vqp9QTwm6YirTS4JQESIAESIAESIAESqOkEEhblo6aDYv9IgARIgARIgARIgARIwItAQlw+vCpmGgmQAAmQAAmQAAmQAAnkAoGETErMBVDsIwmQAAmQAAmQAAmQAAl4EcjH+uXxTkr0qphpJEACJEACJEACJEACJJALBOhDnQtXmX0kARIgARIgARIgARJIGgH6UCcNLSsmARIgARIgARIgARLIBQIFU6dOFbh9rFu3Lhf6yz6SAAmQAAmQAAmQAAmQQEIJGAt1fr7ZJLRiVkYCJEACJEACJEACJEACuUAgb9WqVRVY1KWsrCwX+lutj9OnTzdpvXv3rnaMCSRAAiRAAiRAAiRAAjWXwMSJExPSufxatWolpCJWQgIkQAIkQAIkQAIkQAK5SMCEzaPLRy5eevaZBEiABEiABEiABEggEQTyc9ndIxEAWQcJkAAJkAAJkAAJkEBuE8jHoi60UOf2TcDekwAJkAAJkAAJkAAJxE6A4T1iZ8eSJEACJEACJEACJEACJCBGoYbbB4UESIAESIAESIAESIAESCB6Asblo7S0NPqSLEECJEACJEACJEACJEACJCAmbB59qHknkAAJkAAJkAAJkAAJkEBsBEzYvNiKshQJkAAJkAAJkAAJkAAJkIAJm0cMJEACJEACJEACJEACJEACsREwPtQInUchARIgARIgARIgARIgARKInoBx+eDy49GDYwkSIAESIAESIAESIAES2GOPPSonJRIFCZAACZAACZAACZAACZBAbAQK4O7BONSxwWMpEiABEiABEiABEiCB+AjMmjXLVDB+/Hjp1KmT2ce2c+fOvhWjTKjjvgWTdMAo1OXl5UmqntWSAAmQAAmQAAmQAAmQQHUC48aNE3xsUeVa0wYMGCD42IIys2fPziiF2kT5oA+1fZm4TwIkQAIkQAIkQAIkkCwCUJqHDh1aTZn2Oh+U58GDBzt5vZRwr3KpTivACblSYqqx83wkQAIkQAIkQAIkkHsE3Aox3Dbg3qGuHviOPBDd6j6s0m4LtsmYAX8K4D+NlRLp9pEBV4NNIAESIAESIAESIIEaSsCtTHu5c6Dr6uKBrV0mU5VptNmEzeOkRKCgkAAJkAAJkAAJkAAJJIuAbXH2U6bd50a+TJp86G6ffg8Yp/OlrKxMv3NLAiRAAiRAAiRAAiRAAgklEIsyjQagXCZbphVSPnagVFNIgARIgARIgARIgARIIBkE3Ap1JOdAGbtcJGXSlcdo0rRQpws/z0sCJEACJEACJEACuUNA/aPD9TiblGn0xUxKDNcpHicBEiABEiABEiABEiCBWAjEYmVG1I8hQ4bEcrq0lDELuzDKR1rY86QkQAIkQAIkQAIkkFMEIrVQZ8NERPvCGZcPhsyzkXCfBEiABEiABEiABEggGQSyYYJhLP3Or6ioEK6UGAs6liEBEiABEiABEiABEghHQBdtCZcvkuNQyDNRKTcKNS3UkVxC5iEBEiABEiABEiABEoiHAFY7jFXgi40ly/HJNKU6H4u6cGGXWC8ty5EACZAACZAACZAACYQiYPtDx6tQ63nsOjUtnVvjQw23DwoJkAAJkAAJkAAJkAAJJIOATkaEZTmWqB92Ga0rGe2MtU5joaZCHSs+liMBEiABEiABEiABEghHAEqwWpWhHNsKcriy7vwZqVCjE5yUGO5S8jgJkAAJkAAJkAAJkEA8BPr37+8UdyvJzgHXjjtfJirTaHIBJiTSh9p19fiVBEiABEiABEiABEggoQRgoYZCrNZpVZZVSdatTjgcP3580ORDHNc8CW1YAiorgHWaUT4SQJJVkAAJkAAJkAAJkAAJhCSgCrEq1cis+7r1qgCrJqrLiNfxdKflQ5nGSokUEiABEiABEiABEiABEkg2ASjVo0aNisjarHkzWZkGrwK4e5SVlSWbHesnARIgARIgARIgARIgAYcAlGV84OKh4fSwVV/rTFeinY4EdgoQ4QMWarp92Fi4TwIkQAIkQAIkQAIkkAoCUJyzSXn2YkJfDy8qTCMBEiABEiABEiABEiCBCAkUIF8ionzMmTMnwlOKdOjQIeK8zEgCJEACJEACJEACJEACmUzAuHyUlpbG3MYJEybI+++/H1X5Pn36SN++faMqw8wkQAIkQAIkQAIkQAIkkIkE8hE2L9YoH7Eo04AABRxlKSRAAiRAAiRAAiRAAiSQ7QRM2Lx0dIJKdTqo85wkQAIkQAIkQAIkQAKJJmDC5iHSRywSjd+0V/1QqqN1F9F64DbSsWNH+mMrEG5JgARIgARIgARIgATSQiAfynSsCnVaWrzlpFDER44cmc4m8NwkQAIkQAIkQAIkQAIkIMblA37U2Sr0xc7WK8d2kwAJkAAJkAAJkEDNIGAmJWZzV+J1O8nmvrPtJEACJEACJEACJEAC6SdgXD7S3wy2gARIgARIgARIgARIgASyk4BRqLnseHZePLaaBEiABEiABEiABEgg/QTysUpiNvtQpx8hW0ACJEACJEACJEACJJDLBPLR+XhWSsxleOw7CZAACZAACZAACZAACdBCzXuABEiABEiABEiABEiABOIgYMLmwe2DQgIkQAIkQAIkQAIkQAIkED2B/IBIWVlZ9CVZggRIgARIgARIgARIgARIQIwPNZRqCgmQAAmQAAmQAAmQAAmQQPQEjCZNC3X04FiCBEiABEiABEiABEiABEDATEokChIgARIgARIgARIgARIggdgImIVd6PIRGzyWIgESIAESIAESIAESIAHj8sGVEnkjkAAJkAAJkAAJkAAJkEBsBIyFmislxgaPpUiABEiABEiABEiABEjAKNS0UPNGIAESIAESIAESIAESIIHYCJhJiVzYJTZ4LEUCJEACJEACJEACJJDbBKZPn14Zh7qioiK3SbD3JEACJEACJEACJEACJBAjAWOhzmaFukOHDjF2ncVIgARIgARIgARIgARIID4CvXv3rrRQxzopsW/fvvG1gKVJgARIgARIgARIgARIIMsJ5GNCYqyTEmEd7tOnT9oQ4NxU6tOGnycmARIgARIgARIgARIIECiAdTpWhRoEodDiM2fOnJQCpatHSnHzZCRAAiRAAiRAAiRAAj4ECqBMY6XEsrIynyyRJVPBjYwTc5EACZAACZAACZAACdQsAmZSYrzKdM1Cwt6QAAmQAAmQAAmQAAmQQOQEzMIusFBTSIAESIAESIAESIAESIAEoidATTp6ZixBAiRAAiRAAiRAAiRAAg4Bo1BzpUSHB3dIgARIgARIgARIgARIICoCxuWjtLQ0qkLMTAIkQAIkQAIkQAIkQAIkUEkgH2Hz6EPN24EESIAESIAESIAESIAEYiNgFnaJrShLkQAJkAAJkAAJkAAJkAAJmLB5xEACJEACJEACJEACJEACJBAbAeNDXVFREVtpliIBEiABEiABEiABEiCBHCdgXD7gR00hARIgARIgARIgARIgARKInoCZlBh9MZYgARIgARIgARIgARIgARIAAePyQRQkQAIkQAIkQAIkQAIkQAKxETAKdXl5eWylWYoESIAESIAESIAESIAEcpyAifJBH+ocvwvYfRIgARIgARIgARIggZgJFKAkV0qMmR8LkgAJkAAJkAAJpJJARbmUrVkiZWuXSa0GLaRW4zYiefmpbAHPRQLVCBTk5eWZlRLp9lGNDRNIgARIgARIgAQygUB5mayf+b6s+/oF2bzwp2otqt2qozTsfbnU69iz2jFNWPHipbJp/lSp1XRbafWPMZqcc9uKss2yZFgfqdi83vS9Sf/bpH7XPmE5bFo4Q1aMPs/kazrwLqnXuXdQmUVDA+zLS6Vwj2Olcd/rgo7lwpcCKNIFBcZQnQv9zZg+lpWVyeTJk+Wdd96RP/74Q5YtWyYtW7aU9u3byzHHHCP777+/hHPFeeyxx+Stt96SGTNmyFVXXeXkLyoqkt122026du0qdevW9e0zzj1v3jzf43qgd+/e0rlzZ/1qtmjvmDGVD6Ru3brJAQccEHRcvyxZskRee+0187VDhw7St29fPRTR9vPPP5fvv/8+orzI1LZtWxkwYIBn/k2bNsmTTz4pv/32m8yZM0duuukm6dGjh2deOxHnnzBhgjz66KOy1157ycEHH+wcbty4sXTq1El23HFHwX44mT17tnzyySfmmuG6ob277LKLuV59+vQxg9twdfA4CZAACeQSAVijVzx/kZSumOfb7c1Lf5OVL10uddvvLc1P+U8g5EL1cMDlJX9LRekmwTaXZcPPH0r5+tUOgnVfPB2RQi2bNxp+KFi+qdgprzsVm0rMbvn6NZqUU9uC/Px8gXJHSR2B+fPnywUXXCC//vpr0EmhWE+bNk1effVVo2RBYW7TJvAqy0fuuece58hDDz3k7Ns7UBrPOeccO8nZx3mg1IeTrbbaqppC/ddff8n999/vFJ00aZK0a9fO+a47ULw131FHHRW1Qv3mm2/KK6+8otWF3fbs2dNXoYZyft999zl1PPDAA/LCCy843/12pkyZYpRpHP/mm2/MxyvvyJEj5YgjjvA6ZNLAe8iQIUHH586dK5999plJO/TQQwVtatSoUVAefiEBEiCBXCVQtnqRLP3vsY4iB0W5aPeBUme77lKrYSspW7dMNsyaKOsDSiJk49yvZcXLVwaU6kcC3/JMGv8EEyj+5sWghM2LZ0np8rlS0KJ9UDq/REfAOB1BqaakhgAU0aOPPrqaMg3LtC2wXsJSvXz5cjs56v3bb79doJgnW6644oqM98UfN25cEIavvvpKFi1aFJQWyZfttttO8HHLxRdfLF9++aU72XwfO3ZskDLdvHlz6dWrV9BA5aOPPpLzzz/fszwTSYAESCDnCAR8pVe+fIWjTNduvZO0uepDadzvBqm/y5FSp10Pqb/zEdL0uKHS4qxRDp6Ncz53FGwnkTuGAKz9mxbMMPu2m8e6Kc+TUJwEjCZNC3WcFCMsjiXer7vuOikurnpV8uCDD8r06dMFytTUqVPlzjvvdGpbsWKF3Hrrrc73UDuwdv/+++/y008/yf/+978gSzAs2WvXrg1VXEaNGiU//PCD5weKfThB2UcegUUgsYL+u9tln+GLL74IOo6+e8m6detk/Pjx1Q7B7SUaufrqq41VH5Z9MIfV2R4M4Tp6iX3uyy67TKDMgznO//rrrwvcdCCwgOMNBoUESIAEcp1AyY9vC1w5ILUatZYWZz8l+fW9XevqbLu7NDnqRgfZ2k8SYUiqCHKNcCqPZCcwGLDdKiIpYueBawo+iZbiaa86VTboeZ7hioSS78cFfKo3OMe4Ez0BMykx+mIsEQsBWJ1tC+a9994rAwcOdKpq1qyZnHLKKUbhvuuuu0w6FC4oWF7uFE5Ba6d+/fpy+OGHC9wHTjjhBKOs4/B3330nBx54oJUzeLewsFAaNGgQnBjltxEjRhhf6n322SfKkv7Z69Wr538wcKRhw4aOMhoqo63oXnPNNca1Avnh333uueeGKup7DD7u3bt3l4suusixPs+cObNa/pKSEuM3rQcuvPBCx98dafBBv/766+Xll182WX788ceIr7fWyS0JkAAJ1DQCJd9Wzr9Bvxodfo3k1a4fsouF3QbImg+HGf/pgmbbGYU0r6BOyDLVDgYmP677arQUfztWylYtqDwccDOp3WpHKepxgplwV63MlgT4EK/99HFZHxgIlK3b8nY5ULag+fZSb6de0ujgCz19u7W+stWLZfX798nmBT865RHFBO4tjfteK/lFzTVrjNsKKfm2UqHOq1MY6FNHKex+nKydPDLgFF0mGMAUBb5TYiNgFnahy0ds8KIt9e677zpFDjroIKPwOgnWDhQ8TCpUef/993U34i2u6X777efkhxU8FXLppZfK6tVVkx1Scc5IzmG7e/Tv31/69etnis2aNUt++eWXSKrwzYOJlyqYYOgW98TQTz/91J3FDKTeeOMNwQcuQRQSIAESyGUCFRuLZdNfPzgI6rsiSjgH7J2A8tr66g+lzTWTpNkJD0i0ynTZ2qWy5JEjZc3E4VXKNOoPKJvwM1719u2y/NnzpXzDGvusZr8iEN0Cx9Z9+YyjDJsDgbKly+bIus+flKWPDvK1Wq//6T1Z8p9jZMPsSUHloZgjusmS4UcJXFniEfiXq9W8MOAyAyns1t+psjgwkKDETsC4fDBkXuwAoymJCA8qiBbhJwhluOeeezqHY1X4/v67aiYzJhaGEriXrFy50vMTqhyOQUGFRRyCem68seq1m0lM8x9MjNTJl1B4t9122yCXmLfffjviFsKnHVzxwSAF/umI/gGB28YZZ5xRrS5YsuEvrQILNfytoeRjIipcgSgkQAIkQAJVBErVOhxIgrtHpHGm82pFaZHWUxp/7SsdZbag2bbS9Ni7peW5z0mTo2+W/LoNTM5N86fJ6vfu1VLOtmTaa7J50c/mO3y7W5z5RCA03ysBy/IQQV2Q0pV/Ssn0sWbf/oP0v1+/3ijuSC/a+1Tj3gK/cOxD4P6ByZaqEJvEKP8Uf/OSU6IwYG2HYGJnnW0qDXhox+ZF1d+yOoW4E5JAAX7M8YNPpTokp4QctCfAIdRaKLHD1NkW0FBl7GMI9fbii1UzecOFh7vkkkvs4kH7CDMX6i0GjsF9BSHxoFBDQUVoueOPPz6onnR9ee+995xTq2XaDn2H8H+YVBmqj1rB6NGjBR+37LvvvsbfHcq6l2CQAVcO8IGgTdouTFA87rjjjGXay8LtVR/TSIAESKAmEyhbW/Xmr6Blx6R3tXj668YKjRPVabuLND/zScmrVduct/ZWXU3M5WWPHm8U7vUz3pWiPU8MKKLdnHZt/P0LZ7/5icMkr27lvBi0He4eS4ZXvhWFK0mD/c9x8mJn1du3Od9hWa/X6RDnO3zD8fn7tSFG4V7zwYPSpP+/neOR7pRvWCsbfvnYZK/VpK1ggqcK+qJvA9Z9OVqaDrpHD3EbBQHj8kFlOgpicWSFL61K06ZNdddz26RJEyfdnsToJLp2ELINllKEqIO1+Nhjj3VyIEayPXHOOZDAHfh/Y4KlCsLDZcrkOo2DjbapJR2h6Q45pPKhtXjxYuNjrm2PZYtJhjfccIMgiouX7LDDDiZuNxRnt0DJhqUbln7EyaaQAAmQQK4TqFhfNZG+VuOAhTrJsvHXT5wzwCKtyrQm5tdrJI2P/D/9avyknS+BHdu/e/1PE+xDZiXHFuc8Iy3Pe0FaXfBy0LHyklWBxWammbQ62+0RpExrxvpdDjP+zvheMuMdTY5qu/6HN538RXtWWqc1oV6gfo3bDfcSKN+U6AmYSYlwMaAkn0Dr1q3NK36cCVbfUFZjHFdp1aqV7vpu/eJQQ5l+/vnnJdw1vvLKK80CJV4niMRyi3KY9HjeeefJE088YaqB1ffmm2/2qjJlaVDqESVEZeHChQIFGmL3C1E4MMEwnGDSKPoF2bhxo/z555/y3HPPGWszYoiffvrpgtjZmCzplu23397Ewf73v/9tJiniLQJiY2OyqgqivCCfKv6azi0JkAAJ5BKB/MIqo1LpivlJ7/rGLUotJgH6WcTrderltGNzwC/aFhyDMgpZ9c4dsvrDB82qjfU6HxrYHhCweu9qZ3f23YvVrPdTmLdYy+HPDSXc5uNUFmKneGqVIl+4W5XfNIrATQY+1SU/vGVqKPnuDWmw7xkhauMhLwIFSKQPpxeaxKdhVTyERYNgMlwo+fnnSl8s5EG5aAS+vFjgBH7asFSHs4ajbrgs7L333tGcxjMvImhgoRL0D4psuv2psZKkLX6L3MCKDQtz7dqVr/jsMvY+fNHtAQ5cPDD5E+4t8KmGTzSuce/A6pJ+gogqWABGF4HB4AkDEZSFgB8Vaj96TCcBEsgFAvkB316V0i2h8/R7wrcBJVVX+avVZOsQ1ecFIm00k/LilYFVG4OV/Po79zVuE+qnjPqgYKuSDTeSBgeeH1CuDwyq31aoN/0xXfAJJyhTp3D3cNmc45uX/mr8tzVh8bDDdbdqG2CgUvzVs1SoFUYU24KNA/aMInvNy6pjxmW3J75vLSf9ElQpInsgigME8YsxOQ1Wa7dgOXBYOVWgHIcTxEQOt1R5uDoScRwRLR5++GFn0l+4gUMizhmqDl0ePVQeHINbDazF9uTBcGX0OKz/22yzjROiEKHzbIUay5yrlRxvDNx+0h07dpR//OMfRqFHnchPIQESIIFcJlDQdBun+5iIhxjJebXrOWl+O1BoESmjbof9zeIvmHQXVgLzgBzJs/adxKqdPD1uKaCVR/PMBESctyTgj42IHHYcaSymsvKlK6Rhz3OlYa+qOUvlG9c5lSMqSd6WyY9OotdOYAJlNFL8TZV12pSr1vbg2hBZZOO8b6Tu9v7BE4JL8BsIGAs1UaSGgPrs4mxQ4BBiDhMHCwqqLgP8rKFcqcDavP/+++vXrNhCacQKjVj2PJ0CVwq1+qIdXqEDn3nmGRk2bJhpJtw+YlGoEUXEHgDtvPPOQd1GGEFY7iHwZcdkRLcl3PY3T8SbgqAG8AsJkAAJZBkBKM+IlqH+xZv+mBZQkg8I24u1nz1hLMhQCOFmEZFCHViiHAvGQHEvW1PpEuh3orKSyuhZ+YXe86DqdexpXD0koPRuCsST3jB7siAkHlYohKz97EkpCrhTwCcbUtCsndniT6NDr5SivU52vidip6Jsc8Dfe8ub2kBYwSaBVSb9ZOPcKYG2Vvp/Y3IiFWo/Ut7pVZqc93GmJpBA48aNzUqIcC2AwOf2sMMOkz59+kjXrl0FPrVwUdBIEMhz3333SZ06MYYBQgURyuOPPy4TJ070zI3IGHZcbM9MrsRTTz3VhKqzF1RxZUn6V9vd44ILLhDwdwtcNVShxtsDDAR01UJ3XnyHAg5rNASDnylTplTj5g6JuMcee5ilyqHcz50717h6YDEYKNerVq0SxBm3LemRvJEwDeAfEiABEqjBBAp3O8ZRqFe9c6e0vjSgGKqF2KPfiL4BdwyILojikc0zqaB5O+OygcVVyotXeC6ismnhDCe0nYbCM5UFlOd1X78opQHXioIW7aXBfmeZdiIKCD6NDr1CVjz3D2P1Rf6Nv38luuw38qts/P1LX4W6+OsXzKqROG/h7sdG7EO9YdZEx1KOWN6Fuw/U01Xb1tvxIEehhoXdj0O1gkwwBKhQp/hGOOmkk8wrfSw7DYGSpZP43E256qqrHD9b97FEf4fi66f8IsRftAo13CDsUHqJbm+4+srKyswqiJoPq0d6ydZbb236pi4ZGFSEWmodgx0sP+4nWPrcveIkWGAJdSw5jjcTUKoRBcVLBg8eLLvuqo5IXjmYRgIkQAK5QaBwt6PNyoNYsRCK7ooXLpZmCEnn4fqx6c/v5O83qqyvDfY/OypIdQO+zRo6Dgu7NDnmVlf5ClkzYaiTVn/nI5x97KydNLxKcd2lX8Ay3jLoeEHLHRyF2l4+vSDgs63W8Q2/fmqs2u4JjJv++DawguL9lfUFrMxFe50SVHeoL8XfVIXPLex+fKisxj+8bvt9BJZqSPHUMdIQqztSIiIQ2lkooiqYKRoCiCyBiXpYptvtS6v1IPoHFG4oYMmUcJE/9Ny2S4qm2REyNM29dYfSS5SPt21B9msH3DvU0o/8u+/uP4HjqKOOcpqOpd7d4ncOzQeLNBRhuHL4Ke5wJUF8bkz+9JLttttOEKkF90aiOHmdh2kkQAIkkDUEAtbopgPvdJqLlf6WDOsTULIfEyjQpct/D8RWnmxiNC9/ZrCTD0ph0d6RK50o2GC/M41ii/2S78cHlPMbpWztMnyV0r//kuWjzwsouwELdUBqt+ks9bpULmZmEgLtrNelymiz8pUrxViGN68PHK6QDb99JsXTXjVZEZ6ubrs9K/fxN1AWYfpU0A+cHz7jWC1y/Y/vyMoxlS6DyFO050meAwotb2/hZqKDBCxMU3d767x2Rmu/aK+TnG+wisN1hRIZgbylvXbkMm2RsYo6l3tSolcFsFAvWLBA1qxZI4g9DXeCaKN6eNXLtMwlsHnzZmOlRsg9RGCBz7lXmL3M7QFbRgIkQAKpI4DIF8ufu8Bxtwh15tpbdZEWZz3luez4sidPM6sZIlJHm6s+rFYN/K5hBUdoOj+p3apjYBXDpyWvTmFQFoSyW/rfY8OuZNi473UBC3OV0qqV/D3upmqxrfWYbmtvvXOgb6OqxcjW4+7t2skjAz7bT5hkrLjYuM8/3Vmqfw8o0IvuO8iJetLsxED4v516mXzwZ8fy6hAsLgOXHFsW3lEZerZ+IASfPRCy82Tivp+7azRtRSACunxEQywJeWGZxIeSOwQwIXGnnXYyn9zpNXtKAiRAArERwIInrS97WxDOrXjaGMe1wq4Ny5M3OuzqgG9ylaXYPm72A9ZgiBOpw3yr+oNJeK0vf1dWjbsx4PbwddWBLXvwezaLvriUaRxGXOiW5z5vliXf8Nun1cpidcKmASW0znbe6x00HXC7wMd51Vu3VVfKA1bthoHVFRsccE7EyjQaUGIv5tJ9ULU2eSYEGMHP2linAxmKA0uqq0Jt+6/nBdrkK1s4+x6voQdooU7ihY3EQp3E07NqEiABEiABEqhZBAIWVIR1K1u9KLCi3xqpVdRcMKEwr05RYvsZsFKXrpgrpasWmgmOBc23r2aV9jsh3DXgjgKXi/yALzWW+cbiKZEKXD0QO7piU7HUCoQPhDKel0/7Z6T8os1HC3W0xJifBEiABEiABEgguwkErJ8IhRdZOLw4uhqwwGLFRL9VE0PVjEmTtbfqaj6h8vkdy6tbJHW29Z/341eO6eklwEmJ6eXPs5MACZAACZAACZAACWQ5ASrUWX4B2XwSIAESIAESIAESIIH0EqBCnV7+PDsJkAAJkAAJkAAJkECWE6BCneUXkM0nARIgARIgARIgARJILwEq1Onlz7OTAAmQAAmQAAmQAAlkOQEq1Fl+Adl8EiABEiABEiABEiCB9BLwDWzIGMqVF2bZITul9wrx7CRAAiRAAiRAAiRAAhnOo4ruAABAAElEQVRNgBbqjL48bBwJkAAJkAAJkAAJkECmE6BCnelXiO0jARIgARIgARIgARLIaAJUqDP68rBxJEACJEACJEACJEACmU6ACnWmXyG2jwRIgARIgARIgARIIKMJUKHO6MvDxpEACZAACZAACZAACWQ6ASrUmX6F2D4SIAESIAESIAESIIGMJkCFOqMvDxtHAiRAAiRAAiRAAiSQ6QSoUGf6FWL7SIAESIAESIAESIAEMpoAFeqMvjxsHAmQAAmQAAmQAAmQQCYTmDhxolChzuQrxLaRAAmQAAmQAAmQAAlkPAHfpcczvuUJbuD8+fM9ayz0TI0s0a/OyEozFwmQAAmQAAmQAAmQQKYT6NGjBy3UmX6R2D4SIAESIAESIAESIIHMJVC3bl2hhXrL9WnXrp3nlVrmmRpZol+dkZVmLhIgARIgARIgARIggWQSmDNnTtzVFxQU0EIdN0VWQAIkQAIkQAIkQAIkkLME8vPzqVDn7NVnx0mABEiABEiABEiABOImQIU6boSsgARIgARIgARIgARIINcJMGxert8B7D8JkAAJkAAJkAAJkEBcBKhQx4WPhUmABEiABEiABEiABHKdABXqXL8D2H8SIAESIAESIAESIIG4CFChjgsfC5MACZAACZAACZAACeQ6ASrUuX4HsP8kQAIkQAIkQAIkQAJxEaBCHRc+FiYBEiABEiABEiABEsh1AlSoc/0OYP9JgARIgARIgARIgATiIkCFOi58LEwCJEACJEACJEACJJDrBApyHUA6+z906FCZNWtWRE0YNWqUyYf8KBdONH+4fDxOAiRAAiRAAiRAAiQQHwFaqOPjF3PpcePGRaxMx3wSFiQBEiABEiABEiABEkg6AVqok47Y+wRQqFU6d+6suxFt3fkjtXJHVDkzxU3giy++kAULFkiLFi3kkEMOibs+VkACJEACJEACJJDZBNKiUHspgG4lMbOxJa516PeQIUMirhD5bVaptnQ/9thj8tdff0mHDh3krLPOirjduZTxmWeekQ8++EB69OhBhTqXLjz7SgIkQAIkkLMEUqJQqwI9fvz4sG4OUBY7depkPrbimLNXKETHoUzblu4QWRN26J133pEffvhB9t13XyrUCaPKikiABEiABEiABLKZQFIVaijSkSjRNkCUUQUc6QMGDDAfOw/3xSjStjINTrNnzw5iR04kQAIkQAIkQAIkQALJJ5AUhToWRdqvq26l0S9fLqW7LdM66Igk+kcucWJfSYAESIAESIAESCAVBBKuULuVvUR0gkp1FUU3X1Wmq3Jkx15JSYn88ccf0qpVK2nWrFlKG71y5UpZvny5bLvttlK/fv2Izl1aWipLliyRtWvXSrt27SIup5WXl5fLvHnzpEGDBqbPmh5uu2rVKlm8eLEUFhZKmzZtpE6dOuGKBB1ftmyZLF26VLbffnspKioKOsYvJEACJEACJEACiSGQUIU6mrjKsTRfFWsokbko2a5Ml5WVyeOPPy4vvfSSUab1GjZv3lwOOuggufnmm6Vx48aabLbPPvus3HLLLWYfbz68FErE3L7jjjtMnl9//VVq1apl9idOnCjnnXee2Z88ebJMmjRJRo8eLXPnzjVp+IOJgygLv30v+fvvv+WRRx4RTDS0Bf79/fr1k4suusg5n31c99esWWP69dFHH0lxcbFJhmJ81FFHyb/+9S/fsu+//74MGzasmgvPKaecIldffbWAmS1QvLt3726SHnjgAcnLy5P//ve/Ah6Qhx9+WI455hizzz8kQAIkQAIkQAKJJZAwhTrZyrR2G0olfIWjiYyhZbN5G4ky3b9/f8EnE2XDhg1y8sknmwmN7vatWLFCXn/9dZkxY4ZRXKFwqsAyrAIrr5fYeezjdjoUaa/FbqZNmyZHHnmkUbZhebZl/fr1RiGfPn26nWz21df/22+/lYceeqjaQACZNm7caBTuL7/8Mqg8LM5PPvmkQNm+++67JT8/OBw8lOkLL7wwqIx+efHFF42S/dxzzwVZyW02H3/8sZm7oGW4JQESIAESIAESSC6B4F/yGM8FZc+eSBhjNREXw7lyyV84EmUa8GA11U/EMFOUcezYsY4yffjhhwssz5999pkgDJ8OAmBNheKbDIEyvcceexgLORRcRCuBlVjl3nvv1V2zhTX9yiuvFFWmkRfWdVi577//funZs6fJB8v3f/7zn6Cy+gUDBJzrggsukNdee83sQ5HWAcOYMWNMmubH9scff3SUaeRDuz788EN54YUXBNZpCNqEAaWtRJsDW/5gIjAE7QfnN954Qw444IAtR7khARIgARIgARJINIG4LdRuZS/RDfSrD0o1zl3T3T/cfLPVZxr+0r169TKuCrfffrvUq1fPXNqtt97apH/++ecCSzUWRUmG7LjjjsZCrS4lrVu3Nm4Qv/zyi3GL+PTTT4NOCxcNxJKGHHrooSavWpJhyT766KONCwUGAbAaQ3mFn7NbLrvsMrnqqqucZJzXHkRA6baV3euuu87khb8zlGHE+4bssMMOJlQhFP1XXnlF3n77bTnnnHMcNw+TyfoDi3+3bt2sFO6SAAmQAAmQAAkki0BcFmq3spesRvrVi/On0jLu145kpbv5hlOmYbUfPHiw+SSrTbHWC39hWInvu+8+R5nWugoKCuT44483XxHj2s/yqvlj2Z522mnV3DKgIA8cONBUB/9m+EuroB0qsEirMq1p8OUeMWKEsRRfcsklZrKiHrO3Z599tv3V7O+yyy6OlRoWaRVM1NT7+YorrnCUaT2O7U033eR8/emnn5x9ewe+0lSmbSLcJwESIAESIIHkEojbQp3c5oWvHa+3a+ICMNEq0+FJZU4O+BZjtUVEzMBn3bp18uqrrzoNrKiocPYTtQMl1ku22morJxlKddOmTc13dfVAObVqOxm37MDqjY+fbLfddk597jzt27c30TtsJR5zA1TgXz1lyhT96rm1lXE7w1577WV/5T4JkAAJkAAJkECSCcSsULsVviS307d6WPTwqUlKtZttOMu0L5wMO4DJcvAhhu90qsUvNJ9X1BBYyHUiYdeuXWNuasuWLX3L1q1bt9qxmTNnOmmwfuMTSr7//nvPw+pO43mQiSRAAiRAAiRAAgknEJdCHWlroOz6hSULVQcUy0ikJlmpa6oy/eijj1abSAorLRTdRo0amcl+kVzrVORByDn4MMNinQz3E78+2FFJYN32U8gRmQQTLOF/TiEBEiABEiABEkg/gZgUavXzjKT58VhXI11KuyZZqcFL+x0Pu0iuTarywDdYo7IgcgXiI++6665BfsmIlIH4yaHEVjjtfHAZSaRAoUZ86k8++cSE8ktk3aHqsq3h8Nvec889Q2XnMRIgARIgARIggQwhENOkRNvXM5n9iMWqncz2pKpuhETDBwp1TRBYVFUQ9QIT5tyT/Pz8hRs2bKhFzYp/zhdrRxcvsZLi3oUFGILBmu3nbFf8559/mkVqEOUDPs/xiu225OcfHe85WJ4ESIAESIAESCDxBDJaoY6muxp7N5oymZzXVq4yuZ2RtA2h3lR0tUD9ji18gf38qrt06eJkRQxot0CZnjBhgjs57u+woKsg7J3dB6Rv2rRJEN3j+uuvl7vuuqvaAEHLRrPF4AFuMJAHH3xQ5syZU604lhJHZJK+ffvK8OHDqx1nAgmQAAmQAAmQQOoJJN3lI1VdisYNJVVtqsnnWbJkibz33nshu7j99tubyaJ77723kw9LYLdo0UL2339/E90Dk//sUHBOxi07HTt2dJLuvPNOE3HjwAMPNL7NU6dOldtuu805nsidgw8+2CwtjgVg4PqBMHaDBg0y/YH1GAvVIIY05IwzzpAGDRok5PSI0X366acb/23UC4s+XD/q169vFsaB6wxiekPs+NUJOTkrIQESIAESIAESiIlATAp1TGdKQSEo1TXJspsCZDGfYu7cuXLxxReHLH/WWWfJLbfcYhY8wVLamJgIC/XVV19drVy/fv3M6oXuA4iGgdUCdcETryXnsfKiLsLiLh/r91q1apmY2Rg4wGUFijU+btl3333NSoju9Fi/Y6AB6zQYYYnyG264wbMqWMa7d+/ueYyJJEACJEACJEACqSUQtUJNS3BiLxB46oS9eGtOxbWBohmp2HmhCCMqxciRI42iqHVg8h+UbvhQeymsyHfCCScYFwssS277S8M9AhZdhJvzUqjt87t9tvX8drqdH8dhFcaqhrCqu5dEx7mxHPnll18uWJjGFq3Hrts+jn3No1v7OFw6kI6weXZ/kQcxpmEth+Jti30ue9/Ow30SIAESIAESIIHkEMhb2mtHz1U0Wk76xfOM0SqA8USqcIeQ82yQlQilLdEW6mWH7GSdIbpdP4aoBUp0shTgeJhH18PYcmOJcXxatWolTZo0iaqS1atXG4UcbiPNmzePqmw8mTdv3iyLFi2S9evXyzbbbGPC6sVTX6RlMSFy+fLlRsFu27ateMWvjrQu5iMBEiABEiABEggmMHHixOCEGL717t1bgk1rMVTCIrERgPIf7YAhkjNlujKNPkARjlUZxqqFfisXRsIn1jy1a9cWxIZOtWDlRl29MdXn5vlIgARIgARIgAQiI0CFOjJOScmVDcpvUjrOSkmABEiABEiABEigBhGIKWxepvY/0e4emdpPtosESIAESIAESIAESCBzCEStUFNpzZyLx5aQAAmQAAmQAAmQAAmkn0DUCjWanIlKdSa2Kf2Xly0gARIgARIgARIgARJINoGYFOr+/fsnu11R15+ry5RHDYoFSIAESIAESIAESIAEEkogJoU6mhbMnj07muwx56VCHTM6FiQBEiABEiABEiABEoiDQExRPuBegU8kcZSRB+HhohUo4pHUr/XS5UNJcEsCJEACJEACJEACJJBKAjEp1Ggg3D4iVXhjUaijgYDwcxQSIAESIAESIAESIAESSAeBmF0+1Eqdjkbb52QsZ5sG90mABEiABEiABEiABFJNIGaFGg3NxMmJqQbI85EACZAACZAACZAACeQ2gbgUalip0+luQet0bt+87D0JkAAJkAAJkAAJZAKBuBRqdABKbTomBFKZzoTbh20gARIgARIgARIgARKIW6EGwiFDhqRUqU63ZZy3DQmQAAmQAAmQAAmQAAkogYQo1KgMSnUq3D+gTONcFBIgARIgARIgARIgARLIBAIxh83zarwq1MkKk0c3Dy/qTCMBEiABEiABEiABEkgngYQq1OiIKtXYT5RiDas0Ioqkw1cb/aCQAAmQAAmQAAmQAAmQgB+BhCvUOFGilGoq0n6XjekkQAIkQAIkQAIkQAKZQiApCrV2Tl00sKIilhKPZDlxVaJRBy3SSpJbEiABEiABEiABEiCBTCWQVIVaOw3F2K0cey1b7s6j5bklARIgARIgARIgARIggUwlkBKF2qvzVJ69qDCNBEiABEiABEiABEgg2wgkLGxetnWc7SUBEiABEiABEiABEiCBRBCgQp0IiqyDBEiABEiABEiABEggZwmkzeUjV4kX//y1lPw8JSXdL+yyjxR12Tsl5+JJSIAESIAESIAESCBXCVChTvGVhzK9bOyIlJy15SChQp0S0jwJCZAACZAACZBALhOgQp3Gq1/UdZ+knL14ZqUFHBZqCgmQAAmQAAmQAAmQQHIJUKFOLl/f2qFMt7t+tO/xeA7Mv+tMUaU6nnpYlgRIgARIgARIgARIIDwBKtThGTFHGAJlZWWSl5cn+fmxzXHdtGmT1KlTJ8xZ/A9v3rxZateu7Z+BRzKOQLz3DDq0evVqeeaZZ6RWrVpy5plnSsOGDTOun5E26IsvvpAFCxZIixYt5JBDDom0GPORAAmQAAlkCAEq1BlyIbKtGXPmzJF3331Xpk6dKp988okUFRXJvvvuK3vuuaecfPLJ0rhx45Bd+uOPP2TEiBHy2WefyeLFi035XXfdVc4///yIFIovv/xSPv74Y/nqq6/khx9+kObNm8tBBx0k++23nwwaNCgq5f7333+Xp59+2mkvFJpEKzW//vqrPPvss+Yc/fv3N5ycE/rs3HPPPVJSUmK49uvXz8ll13XuuedKu3btnGPhdj744AO58847BfxPO+00MxDSMlBMd955Z+nevbu0b98+6JjmiWcb7z3jPveTTz5p7iGko+0XXnihO0vWfMfAANemR48eCb/3sgYCG0oCJEACWUyACnWGXLyZp3eKqyVdn5sdV/loCkOJPuecc6S4uNgphv2PPvrIfMaOHWssh23atHGO2zuffvqpnHXWWXaSqQvKMT4nnnii3H333b4KHZSPf//730HlV6xYIa+//rr5QEkfOnRoRFZvWEqvvfZamT59ulNfs2bNEq7UwPr43HPPmXNgIALlqUmTJs45vXaef/55wwWWf1uhtus6+uijo1Ko0U8o0xDU7ye4dmjvDjvs4JclqvR47xmvk+GtiIq9r2nckgAJkAAJkECqCFChThXpGnKeb775Rk466SSnN+edd57ssccesnLlSnnnnXcElmNYUGElhoJdv359Jy92cMxWpgcPHiz77LOPsVI/8sgjAsX4lVdeke22204uvvjioLL48vjjjxtlG/vIc9xxx0mnTp0EVuYxY8bI3LlzZfz48QJFefjw4cgWUqCc28p0yMwJOog+3nLLLfLwww8nqMbYqoEVXl1tysvLZdGiRTJjxgxTGd4a4Dq//PLLcSvV8d4zfr3DvQPLNPoAazuFBEiABEiABNJFgAp1ushn6Xltq+arr75q3AO0K3D1uOaaa4xCC4UMVskDDzxQD5utrUTCpQHWaJUjjjhCevfubayy999/vzkGn1IVKH2PPfaY+brjjjsaC2rLli31sJxwwgmmDJTqt99+W+66666QfrXz58+XO+64w5Tv27evTJgwwakr2TtvvvmmHHbYYXLMMcck+1S+9YMlFFJb4GICV5xHH33UDG4uvfRSM1Cy80S7H+8943c+uBVdfvnlfoeZTgIkQAIkQAIpIxDbLLKUNY8nyiQCsPrC6gzBJDD42toC5eyqq65ykuDaYcuff/7pKGdQiGFdtgXK8WWXXeYkwVJtyy+//GKUPKRdeeWVYivTSIMf9UUXXYRdI19//bXuVttWVFTI9ddfb9Lh/33bbbdVy5PsBJwfVuFMksLCQhkyZIjAzxsya9Ys8/Yh1jbGe8/Eel6vchgsoD+4D9GuVAjOg7cyGGDinotGUBbuObjvbfeqaOpgXhIgARIggdQQoEKdGs414ix//fWXtGrVykxYc1uetYNww1CBBdiW3377zfn6r3/9q5p1FAfPOOMMoxhjf+bMmdg4gvKYLIePW5nXTHD/UEF7/eS1114z7ik4DmXarZz7lUtE+tlnn22qgZL0z3/+M2XKXTRth7VfZdq0abob9TbeeybUCeFvDx9vfKAoq6xatcpJh189FFow32WXXYwv+sEHHyy77767cblxK9Z77bWXKWu7NWm9ul24cKFTv/3GBYMQtAX3NvJggi0Gjnj7sf/++0uHDh2M5b+0tFSr8txC8Ue9KNurVy/BmxudsAvXJgoJkAAJkEDmEaDLR+Zdk4xtEaJJqIXar5HLly93DnXu3NnZxw5cMVQQzcBL4HMNn2r4Y0MRsgUT8PAJJZiwp9KxY0fdDdrCh1knNSIyyMCBA4OOJ/sL3DzWrVsncJmBzzn8uOEPnEmCgZPKvHnzdDfqbbz3TKgT2sqwvQ/XIJWff/5Zbr755moWXgxmoLSuXbtWbrzxRs0uAwYMkFGjRgn8vmFV9ppYiwmlKnDbUdm4caPZXbp0qZm0675/cRCTZcET7k5eghCQmDuAyDluwf/eTz/9ZNyZmjZt6j7M7yRAAiRAAmkkQAt1GuHXxFMjlJnK3nvvrbtmqwo1XCwaNWoUdMz+su2225qvUEhsRcnO47WPvPD9VenatavuBm3hW62v0GGdTkeEiJtuuslR1uDHPXt26qK0BMHw+WJb9xFKL5kS6p6J97xPPPGEudYYsMCX+8MPPzRhA/GWAwLlGQMbFSjUKrbirGnYYtIrBBZkLzaTJ082g0G4zsBXHjGmobzjvofAlQmKvpcgBCSUaQw4H3zwQUFd6IP62kPJh197OCu3V91MIwESIAESSB4BKtTJY5tzNWMSok4aRASJAw44IIgBfEEhqswEHbS+tG3b1vlmK3ZOos8OIoBAIYHAP9nLigeLMNwANI/tomISU/QHi5AgqokKfM+xwE0miHtgAveIZEm4eyYR50V8alihEaMcLhmnnHKKUaRVwYXiqwM3uFbo/amKs90G+LxrVBh7Qq2dB/uwQOO8ULhh5YZCjIm2KqHcaHBPYpCBNyfYx0Tdhx56SA499FBTHPewn7Kv9XNLAiRAAiSQWgJUqFPLu8aeDb6diE0NgaKC1+xuUf/Prbbayn0o6Hvr1q2d77YLh5PosQMXEbxOh8DVxA7Np9nxSl5f7yOP+jLr8VRvsQiOhgaED/CwYcNS3YSg88FVAn7qaBNcHiBwicFExWRIJPdMvOeFcozIM26BKwp8nVVsf39Eq4FA6YVF2BZbkfVzP8L9f/zxx9vFzL7tHhLKjQaKt/sNDmKR2wq5n4W72kmZQAIkQAIkkBICVKhTgrlmn2TZsmXGB1jdKGAp9lq9Tyf+YdJYKIFfq0q4FReRD1ZOvAaHwBr41FNPeS5FDqufup1gtcCCgvRPIUDYN0yWg8BdJVRkEpMpgX8wsRST3vQDn/M+ffo41k+0y550l8BTS6T3TLznhOuEOzSg1tmtWzfdDZrUqO4VOGgr0PgOFw4IBhr2wM8kbvmDc0IBdgvaoT7Z8KH3E70f3MfxvwA3E4jGC3fn4XcSIAESIIH0EKj+1E9PO3jWEATa3fCsYCXEoq77hMiVnkOrV6821mBdfQ9uDFiC3EtUGVBLtVcepNluHttvv71fNpMOS51tGcfy3l6KDkKlqYUPr/yxGE0mCBYleeCBB5ymIBygPaBwDiRhB9ZXXDf92KeAewFYRjKgsctFsh/NPRNJfaHy2FFf3Png/qFiR5SB0guFGWK7fcDdQ1013CEftR5sEb7RT3QhHb/jsKjXq1fP77Djs61vEHwz8gAJkAAJkEBKCaTfRJfS7mbXyaBAt7t+tNNo7C8bOzzwGeGkpXNn/fr1gpUSNWTZrbfeGjIKB8KGQRBlA9EMateu7dl8VaihmKifq1dGvKaHH6taxkePHm1Ck3nlxUREFSjU7lf5egxbtE/bsPXWW3taG+388e5joIGoI1g9Ee3CRMn77rsv3mrDlr/hhhuCrgEsqF26dDEW83CKX9jKfTJEe8/4VBNxcqwTTqEwY3Kgun1AycaERhX1Z9bv3JIACZAACeQ2ASrUGXr9Ww66VFoOqlrkRJupaelWqhFlAG4WarHDxC4s9hJKdLIX8sCHVC3W7jI6eRHKnZ8sWbLETC5TZfqFF14IaXWGW4iKLlqi391bRIPQ1f0+/vhj0agj7nyJ/I6lsxEWDUocYmSnQmGDD7mfO0Qi+6Z1xXLPaNlYtzrY8ypvvylxR4Sx+cPtA/HR1VqNQVyy/MrhkrRhwwZfKzXC5kH8wk569ZNpJEACJEACySdAl4/kM476DHDxUMXZqzCOIU+6BJPXrrvuOpk0aZJpAtwUENEgnNjuG/Cz9hJEMNBIHTvttJNXFoEPNpR3tTIjjrOfm4lnBRmYCJ9bRIZQizwmBupgIQObG3WTYr1noj6RqwAGfBrBw3VIvv/+eyfJ7RoChVmjeECRxr2mg8djjz3WKZeMHVWa3XXDVUZjW/v5WbvL8DsJkAAJkEBqCFChTg3niM5iXDwCinJRl+D4zV6FkSddftWIm6yh56BIY2JdJAIroIapQ+xft/UQStfdd9/tVNWvXz9nX3ewity5557rKBaI0eu3aqOWwfbll182i8UgGojfR/NjlUDNA5ePVAncCjRSSarOmarzxHrPYLluDLLefffdmMIKwuKLkHNugbuQvbiKPdjTvIMGDTK7UKSffvpps49rhNUUkyl42+P2o8f/BtJVvOJf6zFuSYAESIAEUk+ALh+pZ+55Rj8XD8/MVqL6VVtJSd3FpENVLnAixO197733PM8J/1WEClO3AmwRbxkfyBVXXGFCxcG1AwoE/IY1ekHPnj2rLS+OOM2w3GocYFjpkOZ3fsShxqqLEHsCmkkI8Qdh/dyrPIbIntBDRx55pMB/F24fkQgWDVm5cmXIrHBf8PNXD1kwQQfjuWfAQRVJuMXcfvvtUbdq5MiRgpCJhx9+uJmwOmXKFPnf//7nvAHAIE7vUbtyhDWEAg3rtMZXx5LkXhE87HLx7mMQgLkJp59+ulkifc6cOcbdRCOO4G0M+kIhARIgARLIHAJUqDPkWoRy8QjXxHjKhqvbPo7Jeu5YyZdccomdpdo+FGTb3xT+y/Bnho8yXl8fddRR1cpAidGIHPZBuJjYSzKjbo3jbOfTfUTyiFQx1TKZsMUqip9//rnj0hKqTfbiMH75oEBqyEK/PMlKj/eesd0yYgkpiHjkcAlCyER7RUbtL1yHoCR7CRRnxKS273k7pJ5XmXjTdtttNxMlBPe6VyQP/G+MGDEiI0I+xttXlicBEiCBmkSALh816WomuS+xRExwl8F3RAO59tprPVt7xBFHyJgxY6RVq1bVjrvrqpbBlRCrJTHWcq7TB321LaDh6seiHrYS546XbdcVdBKfL3Z+d10+RRKWHO01w4ntMlB2NQzdRRddFNQum6PdRzsTXCPgvoM3Hm7BYEwX+nEf0+/24i0YoIV606Ft0K3WYW/1mPuNgabXrVtXhg8fLpddVn1CMlYfRSSbZs2a2VVynwRIgARIIAMI5C3ttWOFVztaTqpcJtrrWC6lLTvEe2JcJAy8GGrYO3dIvEjqizTP/LvOlOKZU8zExUj8sSOtN9H5MMlq9uzZgogdDRo0MMqK14IwiT5vtPVhUpvfxLZwdUFRUmUpXN5MPB7PcuhQGm3lONb+IToIfKndSqhffXCBgbsGBD7pumohJnkuXLhQEBIQvvGR1Pftt9865bEYEEIupkpwzyF8I0JMYoDpXj0xVe3geUiABEigJhOYOHFi3N3r3bu30OUjboyxVQCFF4pvMgR1Z4Ng0ZC99w4/ATPdfUG85ldeeSWmZuAV/htvvBFT2XQXgjKnC5zE0pZRo0ZJr169YikaVCZRVnVEUPEL1Rh0wi1foMTrJFmUHTBggFe2pKVhIJaJA8ykdZgVkwAJkEAWE6BCncaLly2KbxoRZcSpoVjFKojOkK0Sb9vj4ZZOZj/++KOJQIPIIhoqD5Fs7LkA6Wwfz00CJEACJJB5BKhQp/iaYAJhYZfULCGeye4eKcYe1+mwtDl8u2ORZCzdHUs7YimDJdy9JvJFWle3bt0izZpR+bDkOsI6qsDKjggjFBIgARIgARLwI+CrUMfjO+x3MqZXEqCim113AkLopSuMXjpJYYIcJsJlm9SvX99ZaCiW69ahQwfZb7/9ZJttthG47CDSRzb7wWfb9WN7SYAESCAbCfhOSszGzmRam70mJWZaG9keEiABEiABEiABEshVAomalMiwebl6B7HfJEACJEACJEACJEACCSFAhTohGFkJCZAACZAACZAACZBArhKgQp2rV579JgESIAESIAESIAESSAgBKtQJwchKSIAESIAESIAESIAEcpUAFepcvfLsNwmQAAmQAAmQAAmQQEIIUKFOCEZWQgIkQAIkQAIkQAIkkKsEqFDn6pVnv0mABEiABEiABEiABBJCgAp1QjCyEhIgARIgARIgARIggVwlQIU6V688+00CJEACJEACJEACJJAQAlSoE4KRlZAACZAACZAACZAACeQqASrUuXrl2W8SIAESIAESIAESIIGEEKBCnRCMrIQESIAESIAESIAESCBXCRTkasfZbxIgARIgARIIRWDZITuFOsxjJEACGUSg5aRf0tqagnrjp0leXp5s3rw5rQ1J18mnT59uTt27d+90NYHnJQESIAESIAESIAESyGICBeXl5UahzuI+sOkkQAIkQAIkQAIkQAIkkDYC+bVq1UrbyXliEiABEiABEiABEiABEsh2AvmwUOfnc25itl9Itp8ESIAESIAESIAESCA9BPLhP11WVpaes/OsJEACJEACJEACJEACJJDlBPIrKipooc7yi8jmkwAJkAAJkAAJkAAJpI8AfT3Sx55nJgESIAESIAESIAESqAEEjEINtw8KCZAACZAACZAACZAACZBA9ASMy0dpaWn0JVmCBEiABEiABEiABEiABEhATNg8RvngnUACJEACJEACJEACJEACsREwYfNiK8pSJEACJEACJEACJEACJEACJmweMZAACZAACZAACZAACZAACcRGwPhQI3QehQRIgARIgARIgARIgARIIHoCxuWDy49HD44lSIAESIAESIAESIAESAAECqhM80YgARIgARIggcQSaDnpl8RWyNpIIAcILDtkp6ztpXH5yNrWs+EkQAIkQAIkQAIkQAIkkGYCRqEuLy9PczN4ehIgARIgARIgARIgARLITgImygfdPrLz4rHVJEACJEACJEACJEAC6Sdglh7nSonpvxBsAQmQAAmQAAmQAAmQQHYSoIU6O68bW00CJEACJEACJEACJJAhBEzYvLy8vAxpDptBAiRAAiRAAiRAAiRAAtlFoCA/P1/KyspS3uo5c+bIhAkTpEOHDubcffv2TXkbeEISIAESIAESIAESIAESiJdAASpItVINRfr99983bYdirUKlWklwSwIkQAIkQAIkQAIkkC0EzKTEVFqobWXahgQFG8coJEACJEACJEACJEACJJBNBMykxFQ12E+Z1vNTqVYS3JIACZAACZAACZAACWQLAbOwC1w+ki1w7VA3j1DnolIdig6PkQAJkAAJkAAJkAAJZBoBo0mnYqVETD7s06dPRP2nUh0RJmYiARIgARIgARIgARLIAALGQp3MlRLh5qETDzHpkEp1Blx1NoEESIAESIAESIAESCBhBIxCnSwLtfpMjxw5kkp1wi4ZKyIBEiABEsglAhWbSmTTwhlStmZJLnWbfSWBrCJQgEVdkrGwiyrTSgNK9cUXX2ziTmt4vEh9qlGHltH6uCUBEiABEiCBmkpg85LZsmbicNm88CcpX7+6qpv5taR2qx2lXsee0vDgC0XyvOdAlS7/XZY9caop17jfDVK42zFVdaR4b8OsiVJ3p4MCTTWReqM6e9mqhbL00UG+ZfJq1ZG82vWkVrNtpXD3Y6Vw136+THwrybEDFWWbZcmwPlKxeb3peZP+t0n9ruFdcjGoWzH6PFOm6cC7pF7n3kHkFg3tKVJeKoV7HCuN+14XdCwXvpi7u6KiIqF9dSvTWrlbqVYl2S+/llPFW/NrerZtly1bJmPGjDHN3nrrrWXgwIHVuvD111/L1KlTTTomiw4ePFjq1KkTlO+xxx6T0tLSoDSvL6eddpo0btw46ND3338vn3/+eVCafkGbdt55Z9lhhx0klBvQO++8I/PmzTPxy8866yypX7++VhG0feutt+SPP/4waSeddJI0b9486Di+xNMXbQfqGTBggLRt2xa7Ucns2bPlk08+kRkzZpgP6thll11kt912M+5JqZiwG1WDmZkESKDGE1g35TlZ88GD3v0sL5PNi2eZz4bfv5Tmp4yQ/PrBz3kUrCjdZD5mf2Oxd11JTi1dMU/+fuMG2bzoZ9nq2k9F6kavUFeUVfXDq7nop2xcJ2XrlsumP6bLmo+GGWWuftfDvbIzLUBgw88fBg3S1n3xdEQKtWze6NxT5Zuq31N4kwIpX7/GbHPtj7FQJ9LlI5xybCvVChuKcseOHQXH/KQmKNV//fWX3H///aaL++67bzWF+ueff5aTTz7ZQXD77bdXU6Zx8J577nHyhNo5+uijqynUU6ZMcdrgV7aoqEgef/xxQRu95NVXX5XJkyebQwsWLBC000vGjRsnH330kTl02GGHeSrU8fTFbseee+4ZtUKN8kOGDAlq+ty5c+Wzzz4zaYceeqg88MAD0qhRo6A8/EICJEACySKw4bdPg5Tpuu33lno7HSK1GreW8g3rpHTpr1I89WWj2MB6vXTkQGlz1YeBFdpqJatJMddb8u1rRpmOuQJXQQwc6u14oJNaERhcVIDJ6oVSuqxykbjy4pXy99jrpKBpW6m9VVcnL3eqCBR/82LVl8AeBmily+dKQYv2Qen8Eh0BM1yENTIRSnU4ZTpU0xAFBB+dwOiVtyYo1V79QtqSJUvkzDPPdA6fd955AgtzOqS4uFhOPfVUGTVqlPTq1StkE55//nk56KCD5PDDs8saMHbs2CBlGtbzXXfdVRYvXiyzZs0yfcZg4Pzzz5eXX345JAMeJAESIIFEEVg/o2qBs6bH3Sv1u1R/tjY86B+y9H/HS9nqxcbSuHH+VKnbfp9ENSFj66m7/V4C9wQvKS9eIX+Pu1k2Bqz2kJUvXymtLn1L8gqC3/B6lc2lNPjhb1oww3QZbh7rZ1auWr1uyvPS5KgbcwlFwvtaAEU6ET7U8SjT0fSqJirVJSUlRnFbsWKFQQGL/XXXReZ/NG3aNKldu7YnwsLCQs90Tbz66qvl0ksvNV/RBlidR4wY4SiUsFKHU6hRGPV8+OGH0rp1a606pm08fYn2hOPHj3eKXHbZZXL55Zc7bi5wizn99NMFA4tvvvlG5s+fL+3atXPyc4cESIAEkkVgwy+TTdW1mrT1VKZxMK9OoTQddK8sf+osk3f9T+9FrlBXlBvf2bw6RaZsTfmTX9Q84P4yXJYHfHw3/fmdcQFZ/f5QadIvMiWxfMMaya/bIKP8r+FCkVdQN6FvH4qnvepc8gY9A6z++t5Mdi35fpw07vNP44/uZOBOVAQKEmGdjlaZRn5MUHRLOAu15q9JSjWWfb/mmmuM/y76B9/dBx980FHutM9+W7gjhPJ39ivnTofy3a9fP+MicsYZZ5jDX375pWzcuFHq1g38Q4cQKJ7XXnutPP3008avOkTWkIcS1ZeQJwkcxOABftMqF154YRDDbt26yfXXX+9Ypn/88Ucq1AqLWxIggSQSqAi4cmw09ZetWSxGoQooz15Sp+0uUrv1TkbZyqvtPY/FLrf+5w9k3WdPyma4RgRcJfKLmknd7bpLw0Muk4LAhD63bA64lvz9aqVLXOMjhkjdHfZzZ5G1nz0h6394W6RWgbT6R+X8IGQqXTlfVr50ZUBRW+SUWfr4yWZSYuO+10rdDvs76QndCUzQbHrs3bLkkSNNtet/eCukQo3By9qPHxX4ehtf7EApsKi3U68Al0sEEx5tKZ76ihR//aJJanbig9VcJGDlLdmisDY+8l/VBjnrf5pgzocKmp/234AbTxtT1+oJQ2XjnC+NO0uDnufK6gn3yaZ5X5tBATKgTYU9TpQG+8T71rpCSr6tVKgxKKvdqqMUdj9O1k4OuNsG7omSH9+WosB3SmwE8mGhjmfiVbTKNJoJtw6Ucwsss7kWpxo+usqiTZs2xnfZb5Kfm1cyvvfo0SOoWrhARCLwO37qqaciyZr2PO4BwqefBibLuOSUU06RN954w3zgi04hARIggeQTyAsoYVvmrgQUnL/H3SRwZfCWPGl5/kvS8tznA5PwgueCuPNDYfr7tetk85JfjOKE4/A1Xh+YnLb8ydMEkTTcUhGYWAbFGB9M+POS0uXzKvNs8V/WPBWBSZAop0oq0stWLaisy7c/Wjq+ba1GrQWDDQjOj35Wk4CVfsXzF8rKV642TOx2lq78U9Z99awsHX60YFBhS60mW1f2N9C3DbMn2YfMPnzGlRkGMG4p+e71SgaBgcb/t3cm8HZN1x/feXmROQgJNQUxz/OsYooURWNq1VR0MJW2+PsrLS2i5vlvqPxLVWsoqn/zVDVPVRRFglBjCBEhIS/vf387WSf7nXfOHc4d3h2+6/O575yzzx6/97xz11ln7bV7DxkenZb/t8rNePVBN/nS3d0X/7qtC3P16dO7z8p9h/m/56jClJ2Zrz8RTUYcsNqch44Ba+4U5Z7+2FXRPjulE2iTu4espFkkizJt7YS+0qrHjltJqb7uuuvcJZdcYkjclVde6YYNGxYdF7Pz4YcfuilTpnT7fPpptlm2jzzySNSs/IqXWmqp6Dhp5/TTT4+STznlFPfCCy9Ex6XuVHosae3Loh+6sshCrTcmmkSpqCSVjnqT1g/SIQABCMQJDFxv9yhJStt752zrJo/fx1uDNXnM5ZTBUmV2LgqGpP/qO+QsuKe6QZseEEUG0bmPbzq21Crz5m9faGknC25o1V5w55N9Wr9lq2SdDno039Lz/Mm9RT44p91P7z3fSbmUyMdaId6GHXi1G7rbmbmJjCv7dD1ETLnm0OgBRIneT33u5E9zzfGZc39mz5jmLd12PHPivN9SpSlU3cxJT/vT/VbcMtG1xB5eZJFeYMdfuKG7n5ULQTfWqvQPQAqHmFWmP/mnqOiAdedcZ70HD3fzLbGGT5fi/tW7L0Z52CmNQLuUB1moS52UWI4yndTFMPqHlGqJuXYk5bc0y2NlLL3et4899pjTx0TK6/LLL2+HRW833rj7azgV3myzzdxVV+V/2vzss8+c+W1rX5PwwjKaaFjIv36dddZxRx11VBQ5RL7ICpeXxcpezliKBjY34/HHH+/kymHjv+OOO5w+En0Xu+66q5NlWiH0EAhAAAK1ItBv+a97xXPKDUdHypyieejjX83nFLq+I9bNhTnbzvXPWRkVg7kYWWCnk6JY1P1XdW5wzrVAyrpfNGbuJLVi6ikmj9wJ5DbxZU6BtEmC/VbYwvXqO7CY4mXn6T1o4agORUXRZEYTKa2fzbXEqp/DD7nZWX5FBem34ign9nqYkVI97eHxbvDm3/fFe/Xu45VqKcua2CfLtk16nPnavN9zZfYTRj//2LUNWNCXlQuH3Cok/Vedo+P4g9gfKfRS7nMatz8j5but/xCn0HYSuY0M3uJgv1/KHyn8M155wBeRf753F5pbwcD19sj5Uj/njz579Kqcf/5ppVRN3rkE2rKQqLQybX2QUh23VMtyWMgNREq1+tTIIsXu7ru7vyKq5pgUA3r99df3ny233NKdfPLJUdzoZZZZxv3gBz8oqvkf/vCHvg5lVti5U089tahyPZlJsbYVE1yKc1z0XYjNTjvt5K644or4aY4hAAEIVJWAlNHhOXcOxVI2hS1qMKeUybr6ya2/zinE2zgtmlJIpKTFF3aR33W/5TaNinYmxBWOTjbYTq++A6Iez/r47WhfOzMnzlN8h4w6JFKmo0w5P+wFvnFcdPj5s7dE+9oJF0D5MhddxWTGq3Pm5fiJjXMTZ77+uJ321mV/oAeiPD7k84/R24I5yrQVDhXw2TklPYt88dxfo2LhWxAl9lt5m2jio6J+SPlGSifQriKFrJBhtdVSpq2NJEu1JivKAq3Je2kipVqxrJW3kUSKq5RQiaJlSKmWL3WxoqgcSZMSF1xwzlNxsfWE+WQplivK4MGDw+TUfbWviZRjxozxkTEUSm+LLbZIzZ92ohpjSWtL6UsvvbQ744wz3EknneQnKdqiN1rkxURuLMqnmNQIBCAAgVoRaB820kfyyDkLeGvozJzCNmPCwz5msPVB1uUpNxzl3Tj6rzrGkrttQ2tkeLL3kK9Fh7O//ML1bpLIH6FPuE38s4HOlKV4rqQxaxu0kPfDlhVak0NDkaXdREq0KcczJzzkkweu/21vAZf1esarD+Ws0XO+lxkv/82f77v0Bt0mO1p92mqiYFzaF1giSpLrSBZR7HKTAWvM85tWmiZfyqf689wkTsnn/7zZDdpoH7/Pn+IJeJePYlbdK77K8nNOmDAhUTGWpdpcPJJakbKfFD0kKW89pGkSn1wm9LCgyX+KlqGHBrldJCnJSX1W2WLzxsvvvvvubrfddvPJf/rTn9xNN93k99WPQYMGxbPnPdYKg+PGjfPh55RR1m09LJQi5YyllHbieRXhRA8D+kh0/SkOuK3yqAmXKNRxahxDAAK1IdArp9yt7j+DRx3qQ95pMuHUO37j3TXUh0/vOz9S3JL6JJ/mRMlF52hGUdQOk3gEk1lT3rRTPtJJdBDb6b1gbv6QXGFybwQ6pk12vQcP8zm0uEyfRVeas1JlzoVCFuVZH/8nmuzXN7ck/Je5lSFnTnw49ybhMV9Gkw5t+fj+q835nYk1N+cwZ71OithSrFtPYp25RE2ulH+0yXvnbmu787Zz3VGUMD03KROFeh6aYvfapIyVEuXDXDKKbaCW+RrJOi0/XVlxZQW+4IILIkwKVaf4z7WQJZdcMnL5UNg7k+eeey7yJ7a0YrbyOTYFXfnN8l5M2Vrm0TWshwd9Qmu09UFvOuTGYlLP17z1kS0EIND4BL58+/ncKojX5SYgytWsM3FAUrjkvrHIj2+Lwq7JX1cLdqSJj2WcdrKc9M45PsHlVFGNsrM+mhRV277gktG+dopVTnvl5pZFEpsIasuai7mUbbNOa7VKRRix1RwVYUR5vgjccuTOkya9cuWrIdOfnGed9vVLeY5/goblOz7zjSeDFHaLIeDD5hWT0fLIilhtaQUFJpyAqFB1msxnosgZUmprKXIzCZXI3/zmN+6rr0p/tfSLX/yiYGSQWo4rqa2pU6f6NwF6G3DEEUckjlOLuZhssMEGtssWAhCAQNUITPv7ZTnL82m5yYcX5RYneTZvO239hrgBa+0S5QldGaLESu10zEqsSUuh15t89f7L89xicgpq71zEjFDacxPyTBTeL01m5cL8mShmdyj9gtUrZ+aWile4O4nieueCbXfxTdekzBlzQ+j1WWxV19avOFfKsL1y9uUi8sXzc1w5pPArekjaJ/TV1uREpDQC7fKfLiVMmKzAhVwvSutC99xSqOW+ESrvSsvn7qE+hfm711rfKVqxUCsVmiItBfvWW3NB1gfmnxUtN4v29uTXdlKQS/Gl1jLbl156qQcldweF9St1+XO5ipx77rlu7NixJQMvZyyy6t93X/LkHI1B1niTtdde2yv9GqOs6HL1OPjgg72LyieffOKvM01YNFHEFAQCEIBAtQn0WXRF7yqgduTHOt+Sa+VtsouvcEzpy1uwiJO95usf5ZqdMmFx1uQJUZ562fnkll9GXRm0wV7d/JXbhy0bndekwX4rbRUd207nV1/4qCo6ViQQRfcIpX3BJXJxpBeZa32+33355pxweHL3kCiKhlxD5ObxeW4y4FcfzOFk/tRhXdXe16RVi7PdPzfW8CEs3rYizCiKiEQuK4qBrhUokeIIeB/qUhRqVWuKaz4Ft7jm03OpbinRUuC11SdNGl2Z1rikFGti3zbbbOOHKWVPk+XCOM9J4x8/fnxSsk/ba6+9SlKohw4d6o488kivEKuC0047ze2yyy4Flfp4B9Zaa60uofTi59OOyxmLQv7pkyS6PkKFWg+RJ554otOS4/IXl1J9zDHJAfMPOOAAt/rqqydVSxoEIACBihKQsvNZLkybRNEl5J4w/+icO17OshiXGTnLqFa285I73yfnZ11J6ZWzgJt88fxtuVX69rZDv5WimM/NxGdqm2fsUeSI3lUMmyflTysO+sVr5vZ00Cb7z92bt9EkQq2OKJl695m58H65SYYxvgpRFyqh80rP2+u30ta5VROviR6AdKZfEL2j78hN/QItX775TFSov6Jp1FimP/nHqMUB68yZMxUlxHb86pnLbJjz/X7cn5n+1PW5EH0/iuXiMI2Ad/nIMqlNSrUUlWqKWaWbRZku5KuuUG6y0prccMMN7p577rHDkrdJlutCfdh///0jBVrK5jXXXNOt3WKiwoSh9FRBlmssbDhpLMX0I63tUaNG+TcAG220UdhMtK8Fbc455xyneNXl9j2qlB0IQAACeQjI8jlo4/2iHPKnfv/CHXMh8k72Fmsp0Z89eqWbcu0RuaW9j4jiGquMXEAqKe25VQEtBJwWlJl6+6lu1oev+8VLPnv4ChdagtPaDeNOf3r/hT7EX0ElPK2yXLp8zD+997zoIwVaLCZftod777wx7osX745KK+62xYCOEnM78y2W83HOxXaWyPdcS6LPsSB3OoWk+/Tus920B+fMY5J1etDmP/B543/C8Hk6p7yKzGLSb/k51mo71uRIWbVrKWJt8aX1XfZder2CzQ9cf88ojx4YsiwkFFXQYjvt5SgL5ViqwwmEmgSWxdrdaJbpNddc07322mt5L7E999zT6ZNPCtWRr6yiV+iTJkOGDPELnqSdV3oxsZl1XV17bWwiREKl5YylmH4kNBklSWnWA4N8xWWlfuutt7xFX/7txYYMjCpjBwIQgEAFCAzZ+gjXPnQpH2da1Ukp+vyZG/0nqfoh2/60m/U4KV/JaTlfYK2oqAgikulP3+A/YT1SEsPoEeE57c+XWyjFRMtp6yOr8ZCt5s0ZsvPFbMVCDxSFZIGdfpWbuLljajbFmZ6cWxFQ9SkChxTyuCj+txZY0UNOksy3xOo+RrhZsv0qikHGaAn5uWlaiKfWoqXQTfr7JcZ72WHqVm4fejhQSEatoqnQgPkmUqZW1IIn2kp194gzymKpjivC5pcdrzvfcbyOfHk5B4F8BPr06eNWWGEFHxpPYQxRpvPR4hwEIFBtAgPW/pZbeL/xfoU/sxKHbUrZ03LRC+11UboynVOIIwn3o8ScVTVIT3rjJ+V3gR1O6La4jPq0wI6/zK0g+MOgtu67cq+Iu4pIgS1JAreRxHI5dw1ZfhVdQ4r6oj+9L68yrToUZ3r4oX9xihkdd/fQebEddtA1LjXcoDLlFl8xS7eOwkVydNw2YAHvS619Sf9V87zRt+8hbaw5N8VIenV3/4nOxXbklmMycJ0i5zXl+hL6WU9/ep5SrgmXJnkjkgT5LH8rbHvlJmF16h+po6OjrPGWsuDLWWedldhWvoVbwgKVVKafeWaOf9NWW3WfmBC2yT4EIAABCLQWgclbrpB5wMPufyVz2XjB2Z9/kotc8VLu9Xuna1942ShcXjxfNY87clEvvvrwtdzCIyuU7LqgSX4d0z7ITe7rmys7PKeLzlPMqtnnYuvW5M6vPpyYc3EZnFOiRyS6ihRbF/nKI9AT/3NpAQ1KGYl0SB/lQ6/ny1Woy3H/KKXTlVSmS2mXvBCAAAQgAIGeICBrZ99lN+6JpqM2FblCnyyi2NntQ0dkKVqTMr1z/uL6IBAoh4B/TKzUSonFun/km2SYbzAo0/nocA4CEIAABCAAAQhAoCcItMndo5yJifFOF6NUyz0kLklpYR6U6ZAG+xCAAAQgAAEIQAAC9UKgffbs2akLg2TtZCH3D1mo5S8tJdms1bZNahNlOokKaRCAAAQgAAEIQAAC9UCgXXGJy/WfThpIIaVaZYoJlYcynUSXNAhAAAIQgAAEIACBeiHgfagLLfaRtbPFuH/kqxtlOh8dzkEAAhCAAAQgAAEI1AMBr1BXw0Jtg8uqVKNMG0G2EIAABCAAAQhAAAL1TMBPSqx2B0tVqlGmq/2NUD8EIAABCEAAAhCAQKUI+JUSq+XyEXayWKUaZTqkxj4EIAABCEAAAhCAQL0T8C4fivRRCymkVKNM1+JboA0IQAACEIAABCAAgUoS8BbqSsahLtS5NKUaZboQOc5DAAIQgAAEIAABCNQjgfbOzk5XKwu1AZBSbaL40zoeOXKkJbGFAAQgAAEIQAACEIBAwxBo10qJ+tRaQqW61m3THgQgAAEIQAACEIAABCpFwPtQy0qNQAACEIAABCAAAQhAAAKlE/Bh81CoSwdHCQhAAAIQgAAEIAABCIiAt1DXclIi2CEAAQhAAAIQgAAEINBMBNo1IbEnfKibCSJjgQAEIAABCIQEJm+5QnjIPgQg0OQE2rBON/k3zPAgAAEIQAACEIAAsMeX3AAAOQhJREFUBKpKwFuotVJiR0dHVRuq98onTZpU712kfxCAAAQgUEMCA2rYFk1BAALlEehpPc5PSmx1Zbq8r5DSEIAABCAAAQhAAAKtTMAv7CILda0Xd6k36CNGjKi3LtEfCEAAAhDoQQKTe7BtmoYABEojkFWP0wKDlRAf5aMSFVEHBCAAAQhAAAIQgAAEWpGAV6iJ8tGKXz1jhgAEIAABCEAAAhCoBIE2Leoya9asStRFHRCAAAQgAAEIQAACEGg5Aj5snnyoEQhAAAIQgAAEIAABCECgdAJtrT4ZsXRklIAABCAAAQhAAAIQgMA8Aj5s3rxD9iAAAQhAAAIQgAAEIACBUgh4H2r5USMQgAAEIAABCEAAAhCAQOkEvMsHy4+XDo4SEIAABCAAAQhAAAIQEAE/KREUEIAABCAAAQhAAAIQgEA2An6lROJQZ4OXpdT0l55wn7/0eJaiJZcZsPKGbuDKG5RcjgIQgAAEIAABCEAAAsUT8Ao1kT6KB1ZuTinTk2+8sNxqiio/bKxDoS6KFJkgAAEIdCcw7P5XuieSAgEIQCCBQLus0/Kh7ujoSDhNUjUJDFxlw6pUP/3FORZwWagRCEAAAhCAAAQgAIHqEmhX9ayUWF3ISbVLmR5x3FVJp8pOm3Tqvs6U6rIrowIIQAACEIAABCAAgbwEvIVaKyXi9pGXEyfzENDbDb3pyLri5pdffunmm2++PC3kP/XVV1+5Pn365M/E2boiUO41o8FMnTrVXXnllf4N27777usGDx5cV2MspTOPPPKIe/vtt93CCy/sttxyy1KKkhcCEIAABOqAQLsU6fZ2b6iug+7QhUYhMHHiRHf77be7p556yv397393AwcOdBtttJFbb7313Le//W03//zz5x3Km2++6S688EL30EMPuffee8+XX3311d33v//9ohSKRx991D3wwAPusccec88995xbaKGF3Ne//nW38cYbu7Fjx5ak3L/22mvud7/7XdRfKTSVVmpeffVV9/vf/963sdNOO3lOUYMpO6eddpr7/PPPPdftt98+yhXWdeCBB7oRI0ZE5wrt3H333e6UU05x4v/d737XPwhZGbl+rbrqqm6dddZxyyyzTJdzlqecbbnXTLztK664wl9DSlfff/SjH8WzNMyxHgz03ay77roVv/YaBgIdhQAEINDABNplVcR/uue/wRf3XrGsTqxy9ctllS+lsJTo733ve2769OlRMe3fe++9/nPjjTd6y+Giiy4anQ93HnzwQbfffvuFSb4uKcf67LHHHm7cuHGpCp2Uj5NOOqlL+Y8++sjddNNN/iMl/fTTTy/K6q1r/+ijj3bPPPNMVN/QoUMrrtTI+nj11Vf7NvQgIuVpgQUWiNpM2vnDH/7gueh/NFSow7p23HHHkhRqjVPKtET1p4m+O/V32WWXTctSUnq510xSY2F0onA/KS9pEIAABCAAgWoS8KZplOpqIm6uup988km35557RoM66KCD3Nprr+2mTJnibrvtNifLsSyoshJLwe7fv3+UVzs6FyrTBxxwgNtwww29lfr88893Uoyvu+46t9RSS7lDDjmkS1kdXH755V7Z1r7y7Lrrrm7FFVd0sjJff/317vXXX3e33HKLf0i84IILlC2vSDkPlem8mSt0UmP85S9/6c4777wK1ZitGlnhzdVGb6reffdd969//ctXprcG+p6vvfbaspXqcq+ZtNHp2pFlWmOQtR2BAAQgAAEI9BQBr1Bjoe4p/I3XbmjVvOGGG7x7gI1Crh4/+9nPvEIrhUxWyc0339xO+22oRMqlQdZokzFjxritttrKW2XPPPNMf04+pSZS+i677DJ/uPzyy3sL6rBhw+y023333X0ZKdW33nqrO/XUU/P61U6aNMmdfPLJvvx2223n7rzzzqiuau/89a9/ddtss4375je/We2mUusXSymkocjFRK44l1xyiX+4Oeyww/yDUpin1P1yr5m09uRW9OMf/zjtNOkQgAAEIACBmhFo41VpzVg3fEN68JLVWaJJYPK1DUXK2U9+8pMoSa4dobz11luRciaFWNblUKQcH3744VGSLNWhvPLKK17JU9qRRx7pQmVaafKjPvjgg7Xr5YknnrDdbtvOzk533HHH+XT5f//qV7/qlqfaCWpfVuF6kgEDBrhjjjnGyc9b8u9//9u/fcjax3KvmaztJpXTw4LGo+uwVkYEtaO3MnrA1DVXiqis3HN03YfuVaXUQV4IQAACEKgNgTbd5LNGZ6hNF2mlXgj85z//ccOHD/cT1uKWZ+uj3DBMZAEOZcKECdHhscce2806qpP77LOPV4y1/+KLL2oTicprspw+cWXeMsn9w0T9TZM///nP3j1F56VMx5XztHKVSN9///19NVKSjjrqqJopd6X0XdZ+k6efftp2S96We83ka1D+9vLx1keKssknn3wSpcuvXgqtmK+22mreF32LLbZwa621lne5iSvW66+/vi8bujVZvbZ95513ovrDNy56CFFfdG0rjybY6sFRbz822WQTN3LkSG/5LxSmVIq/6lXZUaNGOb25sQm7cm1CIAABCECg/gh4lw9C5tXfF1OPPVI0CbNQp/Xvww8/jE6ttNJK0b525IphomgGSSKfa/lUyx9bilAomoCnTz7RhD2T5ZZbzna7bOXDbJMaFRlkl1126XK+2gdy8/jss8+cXGbkcy4/bvkD15PowcnkjTfesN2St+VeM/kaDJXhcD+8n7300kvuF7/4RTcLrx5mpLROmzbNHX/88VEzO++8sxs/fryT37esykkTazWh1ERuOyYzZ870ux988IGftBu/fnVSk2XFU+5OSaIQkJo7oMg5cdH/3gsvvODdmRZccMH4aY4hAAEIQKAHCXgLddyPsgf7Q9MNTkChzEw22GAD2/VbU6jlYjFkyJAu58KDJZdc0h9KIQkVpTBP0r7yyvfXZJVVVrHdLlv5VtsrdFmne8Lt6YQTToiUNflxv/xy7aK0dIGRchBa9xVKr5qS75opt93f/va3/rvWA4t8ue+55x4fNlBvOSRSnvVgYyKF2iRUnC1NW016lciCnMTmb3/7m38YlOuMfOUVY1rKu657iVyZpOgniUJASpnWA+fZZ5/tVJfGYL72UvLl117Iyp1UN2kQgAAEIFA9Al6hDi061WuKmpudgCYh2qRBRZDYdNNNuwxZvqASU2a6nAwOFl988egoVOyixJQdRQCRQiKRf3KSFU8WYbkBWJ7QRcUn1uiPFiFRVBMT+Z5rgZt6kPiDidwjqiWFrplKtKv41LJCK0a5XDK+853veEXaFFwpvvbgJtcKuz5NcQ77IJ93iwoTTqgN82hfFmi1K4VbVm4pxJpoa5LPjUbXpB4y9OZE+5qoe84557itt97aF9c1nKbsW/1sIQABCECgtgT8pMSesNDVdpi0Vm0C8u1UbGqJFBW9Zo+L+X9+7Wtfi5/qcrzIIotEx6ELR5SYsCMXEb1Ol8jVJAzNZ9n1St5e7yuP+TLb+VpvtQiOhQaUD/C5555b6y50aU8P1vJTV5/k8iCRS4wmKlZDirlmym1XyrEiz8RFrijydTYJ/f0VrUYipVcW4VBCRTbN/UjX/2677RYW8/uhe0g+Nxop3vE3OJrnEirkaRbubo2SAAEIQAACNSHQplZKnX1ek57RSMMQmDx5svcBNjcKWYqTVu+ziX+aNJZP5NdqUmjFReWTlVOvwSWyBv7v//5v4lLksvqZ24lWC6yHFUIV9k2T5SRyV8kXmcRnquAfTSzVpDf7yOd89OjRkfVT/Qon3VWwaVfsNVNum3KdSHNpW3PNNaPqw0mN5l6hk6ECrWO5cEj0oBE++PnEuX/UZtJEb/XDfLLlQ58mdj3Ez+t/QW4mEosXHs/DMQQgAAEI9AwBb6FGoe4Z+MW2OuLnv3daCXHgKhsWW6Rm+aZOneqtwbb6ntwYtAR5kpgyYJbqpDxKC908ll566bRsPl2WutAyruW9kxQdhUozC59e+WsxmnoQLUpy1llnRV1ROMDwgSI6UYUdWV/1vdknbELuBWJZzANNWK6Y/VKumWLqy5cnjPoSzyf3D5MwooyUXinMktDtQ+4e5qoRD/lo9Wir8I1pYgvppJ2XRb1fv35ppyOfbXuDkJqRExCAAAQgUFMCPsqHLCf4UdeUe1GNSYEecdxVUV7tT77xgtznwiitJ3e++OILp5USzbp34okn5o3CobBhEkXZUDSDPn36JHbfFGopJubnmpRRr+nlx2qW8auuusqHJkvKq4mIJlKo46/y7Zy26p/1YbHFFku0Nob5y93Xg4aijmj1RPVLEyXPOOOMcqstWP7nP/95l+9A94GVV17ZW8wLKX4FK0/JUOo1k1JN0clZ3dmkMGtyoLl9SMnWhEYT82e2Y7YQgAAEINDaBNqlSGf90WltdNUd/bCxh7lhY+ctcmKtWVpPK9WKMiA3C7PYaWKXFnvJJzbZS3nkQ2oW63gZm7wo5S5N3n//fT+5zJTpa665Jq/VWW4hJrZoiR3Ht4oGYav7PfDAA86ijsTzVfJYS2crLJqUOMXIroXCJh/yNHeISo7N6spyzVjZrFt72EsqH74piUeECfnL7UPx0c1arYe4avmVyyVpxowZqVZqhc2TpIWdTBonaRCAAAQgUH0CbbX8Qa3+cJqjBbl4mOKcNCKdU56eEj2E/dd//Ze7//77fRfkpqCIBoUkdN+Qn3WSKIKBRepYYYUVkrI4+WBLeTcrs+I4p7mZJFZQh4nyuVVkCLPIa2KgPSzUYXdL7lLWa6bkhmIF9MBnETxip9yzzz4bJcVdQ6QwWxQPKdK61uzh8Vvf+lZUrho7pjTH65arjMW2TvOzjpfhGAIQgAAEakOgTT90SRNoatM8rYQEvItHTlEeuHLX+M1hHttXnp7yq1bcZAs9J0VaE+uKEVkBLUydYv/GrYe6FseNGxdVtf3220f7tqNV5A488MBIsVCM3rRVG62Mttdee61fLEbRQNI+ll+rBFoeuXzUSuRWYJFKatVmrdrJes1ofocesm6//fZMYQVl8VXIubjIXShcXCV82LO8Y8eO9btSpH/3u9/5fX1HWk2xmqK3PXE/ev1vKN0kKf61nWMLAQhAAAK1J9Aud480C07tu9O6Laa5eBQiYn7VhfJV6rwmHZpyoToVt/eOO+5IrF7XlkKF2VsQbRVvWR/JEUcc4UPFybVDCoT8hi16wWabbdZteXHFaZbl1uIAy0qntLT2FYdaqy5KwgloPiHPH4X1i6/ymCd7RU994xvfcPLfldtHMaJFQ6ZMmZI3q9wX0vzV8xas0MlyrhlxMEVSbjG//vWvS+7VxRdf7BQycdttt/UTVh9//HF36aWXRm8A9BBn12hYucIaSoGWddriq2tJ8mobIPQQoLkJe++9t18ifeLEid7dxCKO6G2MxoJAAAIQgED9EGiXBUg/ELKAID1HIJ+LR6FelVO2UN3heU3Wi8dKPvTQQ8Ms3falIIf+pvJflj+zfJT1+nqHHXboVkZKjEXkCE/KxSRckll1WxznMJ/tK5JHsYqplamHrVZRfPjhhyOXlnx9CheHScsnBdJCFqblqVZ6uddM6JaRJaSg4pHLJUghE8MVGW28ch2Skpwkui8qJnV4zYch9ZLKlJu2xhpr+CghutaTInnof+PCCy+si5CP5Y6V8hCAAASaiYCPQ91MA2Is1SOQZfJqvIyOFQ3k6KOPTuzomDFj3PXXX++GDx/e7Xy8rm4ZYglZLYlZy8Wa73IYWkAL1a9FPUIlLh4vO6yrSyMpB2H+eF0pRSqWXOp3pobDMlJ2LQzdwQcf3KVfIcdwjGEmuUbIfUdvPOKihzFb6Cd+zo7DxVv0gJbvTYf1wbZWR7i1c/E3Bpbet29fd8EFF7jDD+8+IVmrjyqSzdChQ8Mq2YcABCAAgTog0Cs30aVTP0wKY9aKYu4DWt63FmJh7+Ih8SrZ9qRT93XTX3zcT1wsxh+7km2XUpcmWb388stOETsGDRrklZWkBWFKqbMaeeUSldUtSoqSKUvV6Fu16yxnOXQpjaFynLWvig6iN2lxJTStPrnAyF1DIp90W7VQkzzfeecdp5CA8o0vpr5//OMfUXktBqSQi7USXXMK36h7sx4w46sn1qoftAMBCECgmQncd999ZQ9POqR3+dAPFlJbAlJ4pfhWQ1R3I4gWDdlgg8ITMHt6LIrXfN1112Xqhl7h33zzzZnK9nQhKXO2wEmWvowfP96NGjUqS9EuZSplVVcElbRQjV0anHsgJd4myarszjvvnJStaml6EKvHB8yqDZiKIQABCDQwgXbdtOU/ndUC18Bj7/GuN4ri2+OgergDUqyySiPPTSi37+Vwy8q7EuWef/55H4FGkUUsVJ4i2YRzASrRDnVAAAIQgEDzEPALuzTPcOp/JJpAOGDl2iwhXs/uHvX/Tc3roZY2l293FqnG0t1Z+pGljJZwT5rIV2xda665ZrFZ6yqfllxXWEcTWdkVYQSBAAQgAAEIpBHwYfMa1ZKUNqh6T0fRrfdvqGv/FEKvp8Lode1JbY80QU4T4RpN+vfvHy00lOV7GzlypNt4443dEkss4eSyo0gfjewH32jfH/2FAAQg0IgE/KREKdTlvt5txMGrz7WelNionOg3BCAAAQhAAAIQaDYClZqU6FdKxPrSbJcH44EABCAAAQhAAAIQqBWBNpTpWqGmHQhAAAIQgAAEIACBZiTQhv90M36tjAkCEIAABCAAAQhAoFYEvELdqv7TtYJMOxCAAAQgAAEIQAACzUugTSuZ4fbRvF8wI4MABCAAAQhAAAIQqC6BNlXPSonVhUztEIAABCAAAQhAAALNSwALdfN+t4wMAhCAAAQgAAEIQKAGBHzYPLl9IBCAAAQgAAEIQAACEIBA6QTacuI6OjpKL0kJCEAAAhCAAAQgAAEIQMB5H2op1QgEIAABCEAAAhCAAAQgUDoBr0ljoS4dHCUgAAEIQAACEIAABCAgAn5SIiggAAEIQAACEIAABCAAgWwE/MIuuHxkg0cpCEAAAhCAAAQgAAEIeJcPVkrkQoAABCAAAQhAAAIQgEA2At5CzUqJ2eBRCgIQgAAEIAABCEAAAl6hxkLNhQABCEAAAhCAAAQgAIFsBPykRBZ2yQaPUhCAAAQgAAEIQAACEPA+1J2dnZCAAAQgAAEIQAACEIAABDIQ8BZqFOoM5CgCAQhAAAIQgAAEIACBHAFvoWZSItcCBCAAAQhAAAIQgAAEshFo14REfKizwaMUBCAAAQhAAAIQgAAE2rBOcxFAAAIQgAAEIAABCEAgO4E2WahZKTE7QEpCAAIQgAAEIAABCLQ2AT8psaOjo7UpMHoIQAACEIAABCAAAQhkJOAXdsFCnZEexSAAAQhAAAIQgAAEWp6Aj/JRCQp33nmnmzhxYiWqog4IQAACEIAABCAAAQg0DIF29bScKB9Soi+++GI/4LvuusuNHj3abbfddv5Y56RoV0sOOeSQalVNvRCAAAQgAAEIQAACECiKQLsWdZk1a1ZRmZMyxRVmKdWmUCs/VuskaqRBAAIQgAAEIAABCDQLAR82Dx/qZvk6GQcEIAABCEAAAhCAQK0J+IVdyml05MiRXazQcvkIRecRCEAAAhCAAAQgAAEINCuBdvlPy+0jq8i9Y7nllnMTJkzwVYTuHlKm8XPOSpZyEIAABCAAAQhAAAKNQMD7UJejUGuQUpyxRDfC100fIQABCEAAAhCAAAQqTcCvlMjy45XGSn0QgAAEIAABCEAAAq1CwE9KbJXBMk4IQAACEIAABCAAAQhUmoBfKbHSlVIfBCAAAQhAAAIQgAAEWoWAV6hnz55d9nhZKbFshFQAAQhAAAIQgAAEINCABHyUD/lQd3R0ZOo+KyVmwkYhCEAAAhCAAAQgAIEmIeCXHmelxCb5NhkGBCAAAQhAAAIQgEDNCbQpDjVRPmrOnQYhAAEIQAACEIAABJqEgF8psb3dG6ozDUnxp+X2YcJKiUaCLQQgAAEIQAACEIBAKxBob2try+w/LUCslNgKlwljhAAEIAABCEAAAhBII+BN0+Uq1ayUmIaXdAhAAAIQgEB5BL766iv34YcfukGDBrnBgweXVxmlIQCBqhDwCnXWCB9V6RGVQgACEIAABFqcwAcffODuv/9+9+abb7rJkydHNPr27euWWWYZt/zyy7tNN93UySCWJB999JG76KKL/KmxY8e61VZbLSlbTdJeeeUVt9xyy6X2NV8npk6d6s4777zULPPNN58Tk2HDhrm1117brbLKKk5zw5B0AtL5zj77bPfFF1/4TLvvvrtbeeWV0wvMPfPuu++6yy+/3B99+9vfdiussEKXMqeccor3eNh4443dtttu2+VcKxz4sHmtMNCeHqNuCn/4wx9K6sa3vvUt97Wvfa1Lmcsuu8wVE5Xlu9/9rpt//vm7lH322Wfdww8/3CXNDhZbbDG36qqrumWXXTbvJFXV8eCDD/obo27k3//+9/PmnzZtmvv973/vm+ns7HRbb721W2mllazZaBuO60c/+lG3G2/Y9zFjxvh+RoWDnWeeecY9+uijPmXzzTd3q6++enA2eVf5Ve5//ud/3IEHHugOP/zwvGNSLfqBu/76632FYrfLLrskV54nVVan2267zf3rX/9yzz33nPvkk0/8j55++MRpqaWWylOaUxCAQLMSePLJJ6P7S3yMM2fOdP/+97/9R/OX9txzT9e/f/94Nv878dlnn/n0L7/8stv5WiRMmTLF/eUvf3EvvfSSO/nkk52U31JFyp+NI19ZKXu6jy6yyCJuhx12SPydyVe+lc69/PLLXR7S9BtYjEIt3cO+i6RrSnqOZMaMGa2EMxpru5QcKUaVWNwlqpWdbgQ+/fRTd+aZZ3ZLz5ew0UYbdVOoTzvttHxFonM77rhjN4X68ccfL9iHgQMH+idQtZ0kqkNPtiYrrrii23LLLe2w2/b222/v0ubiiy+eeKMLx/XDH/6wWz1h3//v//7P3XTTTd4qEc8oxdg464GiGIV63LhxXqlVXeeff77T0/WGG24Yr7rL8X/+85+oHbEqVaGWQn7IIYe4p59+uku9r776qh/br3/9a6eHjG222abLeQ4gAIHmJiAl2R7WNVJZXXWflauHlBhZrmXUkGLz4osvugsvvND97Gc/62aEqAdKuh9Lma6UyAodKn7SX6S8ffzxx27ChAm+mffff9+NHz/e/fSnP3WLLrpopZpuqnr0wBaKHtD0RmOhhRYKk9kvkYB/V1QJZZqVEvOTLyeSSv6aK3t2+vTpbq+99nJ/+9vfiqr4T3/6U95811xzTd7zWU7qn/+MM87IUrRbGd2EZSEORQp7NUUWl5133rmLMr3GGmu4r3/9604PNCY/+MEPImu7pbGFAASam4CUZJMDDjjAfec733HrrLOOd/HQW0QZMP77v//bLbnkkj6bHs7feustK9LUW7mNyFhkn29+85tO7gq6V5544omekwH44x//WNTbXMvfKlsZ91544QU/XLkMmTzxxBO2yzYjAW+hVhzqrEo1KyUWR16uG88//7zTE7XJ1Vdf7U4//XR/qBvnkUceaaf8Nuk1XphB1s0+ffqESdH+gAEDov2kHT29H3bYYf7U559/7hVoWTqkrErkJzVq1Ci/n+/P3Xff7WQR0Gu2uKguvYKrhsgCscUWWzi5dZQjt956a7fiN998szv++OMTLeDdMmdIEJP33nvPl5QFRdeBXG0kep2rV6PmHnTjjTd6i7k/yR8IQKDpCdg9Uy5fSe5xAqD7/m677ebOOeccz0MK0ogRI4pio98guZtlcb8oqoEeyqTfPLm/aGz6rZULyD333OPkIliMyNItX+x68r/WWKSfpfnJFzOueJ5//vOfUdImm2zi3njjDff222+7Rx55xPs9N4rxLxpEHe14hTqrMq1xyDIdyl133eVD6VlaGKPa0lp1G1ofxSA81j+yZnCXIkOGDCno61tMfboRbb/99t5FZJ999vFF5FMl5U79KiTykZOFIC433HBDPKmix3oouOOOOzK/ptIPy7XXXuv7pO9C/tNy+ZCVXq9Uq+Vu8fe//z3iIOuKKdNKFG9Zn/QwopupbnQIBCDQGgTMhUGjlaFC94A0o4kexjUpTApXMcqx7ikPPfSQmzRpkr+3ywiie48MJwsuuGA3wLJ82z38G9/4hlt66aW75ZESpvkt6kP4GyAXDL29VB0mcmFTPim4mlRZDZEyLPc7KdQSWV3zKdR6Q6m3se+8807kG6xxyq1EbwzV31D+8Y9/OLkfSvbYY49uvz1PPfWUM3cK/abGH3Lk/qL2JJrnpN9wiRR/ufvJtUcuhzpW3/RQIFGfNthgA7feeuv546x/dH1Z/+USKRea9ddf3//O6Pdeb2vXWmutrNW3fDk/KbGensha/hvpQQDrrrtul9ZlRY3fELpkmHsgt46DDjqoy1O0nvZNWU0qU4k0+Xwde+yx3tc4yzWsJ3WzFGsSi340pFBL9JBQLYU6DHulHyT5jIdvFLQf+lBWghV1QAAC9U9A9zHN+5BiJgXnr3/9q1cIw/uDjUJ5dd8tRmTo0gTBUKSw66MJagcffHC3OTe6h7/++uu+iE1EC8trX/dgyxOeU9/j6YpWIpHBopqi+6tcY2S1V7/1BjbOT0ZE/T7Jxzsustjqo9+Hvffe2yudlmeBBRaIxiUFOO5zrLfGNm4pz/HfT9Wp8/Hwh/KLt3J6QDFF2tq1Psm1R8EKskoYMcaUc7kb6q2sRL9HKNRZ6Trnw+bpqSWrsFJiVnLll1Nc0iTrhV7Z2JNvKa3on8lEN4pCUSbkMiI3Ef2T6qk8nMinJ2y7cWry3cUXX2xVl7095phj3BVXXOFv5vfee6+TQq+n/VIldPfQAkWyDmjMGo/OKQRQFo6F+qFJRia6AUtx16tK+bMp5FP85m952UIAAs1PQP7SUqgljz32mP/oviBrtH5vhw8fXrJbginTsrqqDilwst7KgqxzUqj222+/isHV74ciQOn+JquuRPXLkq6oSNUWWcDNT1i/k/HfsgceeCBSpqXcyidb/ZJ/sSJhSRmWUit3vCOOOCIyFklB1ltEPTDoQSScvK+08I28FO7QOq65M+YfL6U1yQhkSrUs0ptttpmP3iJLtcInSvTmWN9hXJEvlqddV8pvv0MavyJLyTotxV1GJiZzFku0az5voS7H5YOVErsCreWRXg0lif4Rr7rqqqRTUZqe3GVdkGhfimlYRjEkk/7howpyO/rH1sQP1XPdddd1Uah1LNE/qp6AKylDhw718VUVB1Nywgkn+NdhistarCj8T2hBN5a6sZryLyblWAPS+qKbqdxL9FAg0Q1McVYt1qq+P722HD16dMluQGltkg4BCDQGAU28k/vElVde6RU39VqKmCljUuikYMsKq22xPq/77rtvFItaLg3yn9UcHoU6M+WzUoRk6NH92KzSqlfHxbimVKIPofukHh5ChVruKIo+JZHbg+YumfulFEn1U3NX5BohpVoPNWIlkQuIftP0oCBm+h0x/qYM+4y5P7ImK86zzYUyVxud1/eWJvpu9t9//+j3V/2RkcUMQLoOsswdksJv7h7ioQczE1mrbXK+8mjSPFI6gTYVifsJlVqNnnilWOuDNAYB+bPJd0ofzRrXRDi7+enpPvSHSxuRrhvdpCUKY2cxKFWPfPUkihhSDZE/meJFm8iKoBtGsaInfbOga6Z4v379fNEwGL3GVA3Rg8pxxx3nFBpPN8u4iN1RRx3lb2rmkhLPwzEEINC8BKRUS9GTIhcqhxqx7nNyVZD19De/+Y3ToimFREqaFMFQpPRKKTdJiits5xptGyruiu8fSqj4SmcxZdry6P4cWpbNwm7nQ2U4jK4iS7JEBh8TWXxNbMK/Hojy+ZCr7bgxS9+fiS3GYsfFbs2vXPn1+xmK3s6qXxJZ6Ev5LQ3rafX9dlmn419eq0NplPHL3SLpYShpgkmxY5Kl9pJLLil6eVtZcG2mucLNyfUiVEQ1MUNP+NUQKdR6dadZ8bpZKf50fCGctHZvueWW6JQsDJqEKNFrORMptmkRTCxP1q3+58RKH/VdCr5u3JqwYoq+bvyK/qLFXxAIQKC1COi1vt5UyVqoB2u5EEhpM8VMNGTE+O1vf+u+973vdYnPHCeVFIVJecLFvzQBMlRE43U00rEZd9TnuNteqFCHynE4PinZ5oet34BQQiOIvhNTji3etlz35KKhN7/6vkwZtrcAqjfpd9vaWHjhhW032sp326SYhd0sb7gNw+LF12dQf+SyaRPm5ccdV7rDuthPJtAukOW4fCRXS2otCOjpOt8/Zr4+KLqEwi5JNBvblGApc3GLSL56llhiCe/6oX9EhXqTG4YsJxK1Eb+Z5aur1HNShOUmYQvLyIWiGPcSTVL585//HDWnsdv4o8S5O4oiUknfwnj9OlZoLH30o6gfNa3YeO655/qs+vGUn6NmYyMQgEDrEdDDtwwF+sjNTvcI+e9q4rQpjpqzYopbEqE0n9tKhmNLaren0sydUe2HFmMdh+fyzVexcrLWSjm230W9zdT9WvdmKdFyzZMV3CKaKHKKXEXkr2xvD9SmnY+/KVCfTGQlTpsXZXmybNX2G4G1/NRTT+1WTWiVlpUahbobooIJbVKmm/WfquDoWziDFgUwl4+jjz46IiFrr5TIUkQT6iS6wchqbjcsKdTVFk0SsVjeastiuOZr97777st3usu5UPHucqKMA83cNyU+tIirSt1MDz300C6TTsLXimU0S1EIQKDOCUgRkzuH3lilBQvQPUJKmVZHtMVddI/QhLo0SVLS0vKWkp7Wx1LqqEZeTUQ0ib+xLdYKH765jxsdzbKtsKZStm0yohRiPfjIZUci6/a0adP8A5D1J7RwW5ptq/U9hZMR1ZaU5/jH+qCtrkNzAQ3T2c9PwE9KjP+o5y/C2WYjoIkYCt126aWX+qHJL0+RJ4r9595qq628H5qs2zaxTpMe4mH4qsVNlna5ftikjULtyLJjogVcdt11Vzv0W/0/WEghTdR47bXXusSK7pI5w4GUdHu1pofZ+AQQTZqxhxJVn8/ylKF5ikAAAnVKQK5npvzoHrr44oun9lSWUt1j7YFbClA+62dqRUWciCuUVkSh9epNNAnR3GKk4IbuEuprqGDLbzxNwQ59r+N+1uGCO1Km5foh0b1a93TNKzORi4m5e0gRN19lO1/trX7PLDa22s5n6JIV2+Y/yVUznMxZ7X42Q/1+YRddAGn/MM0wyGYdw7hx46IZxvExSkEObxzx8/FjhTgyhVo3ZkXpKDYUnf5JtTyufPlMFL8zfMK39GptNalSN4BQEU1qSyGiFL3DRD7goR+hpWvstlqhfMN//OMf26luW032OO2007qlK0EWdLEJRQq8KdQ/+clP/CIE8rtT/FTdmM8+++wouxZdsFniUSI7EIBAUxIIfZ3lx5pPoRaAUOnL576QBVZoUAndAcK6ZMmsNwnnx8jYE3eLDN3npEAqHGFc5FYjQ4pEvw/xOqSk67uRhVruN+baYZZplVE7crXQW1NTuKv1wBPvf3isvsmKLtEDWD63SPXfFGo92CnqVaWvq7Bvzbbv41A326BaZTxafjtNFF2jFIVa/mKaVW6+u1IQNSEm/mSe1p6sxKFCHbe6ppWrVLpuYBdddJH34c5XZ7iyp8LTpTGShd4UaoVQ0gTItAcEWeYVNSVJ5PMYV6hV99Zbbx0p9voek75LvTnQwjUIBCDQGgTWXHPN6E2bJihrnojuF0lumbKMyjVEIqNGpeM7W+Qj1S+jgVwEQ9Hbu0IruYaKqKzZadbgsN6s+5obowVsTLlVPWGcaKvXJhHqWL8HUiLjfGWcMSVU30mSSDnW+O2NgvKElmlZsU2htvKKplFrMeu02lWM83wi5Vl5LLKJtvqdRIoj4MPmpSkKxVVBrqwEwn/i0BqQtb6wnMXGDNPC9sJ021fsS1OgpSRqwZS4hHWEN0s95duTr8L+hFaAeB1ZjsN208rHQ+klMZC12SQMjWRptg1vxLLYWwxYO19Mf5Q3ZGRlZXGWAi53E+Nt52yrCadyYUmynlgethCAQHMRkOVTkZFMNNnwggsu8HGTZemUEq04wVoSXG8UzXIspTtUgK18OVtNKLeJeXKhkLKqN4B6yydFPly3IK2dUIGWW56U3Xy+3mn1WLruxXrQsI/4iMXll1/u9MY2XJxMIV2T3u7Jx9nu73KXkSFIiq/8wRWSTnNsNM9FIkNNmkIZun1Y3nDyp1mrfUW5P0vnFmsJV8m19Gpu5b9t8aX1XZrPfb42zd1ReWStrlc/+Xxj6Klz3uUjaxiWnup0s7RrYdNKGY+9hiqljOXVMrX5lqrVDTSMVWnlwm2+Omz50jC/9jULulC/C53P127Ynlwo9EkTszqnnbd0WXzy9UlWi3znrZ60rR5iFRJPH02gUXgl3cw1Q1yRU5IU8bS6SIcABJqHgNy8pPxYtCRZQfNZguUTG7ceV4KGjAaKoGQTs6W86hOKlES5TaSJlFcT+Yfrs8MOO7gtttjCkkvaFmJhlSkyUxhj29JtK4OFlGnVp3vvGWecYaeiraJ6aEn2uA+2ZdAbAeUxS3ZcwRabUOKh6sJz1drXUucmukaKMZ7qN0gPEoogo4cnPcTFHw6sTrZdCURh85iY2BUMRxCoFQHFHU2KPVqr9mkHAhCoLwJ626d5G5prIausFJtQpMhJYZNLWVxxs3yh8hTu23ltwzdtSXkUm1hWXhlLTHFUOSn8UoxVPp9CLfcKvQkMI0fJGlyKhH1MKifjh+6fUnyl1IpdkmU6LKs3g4cddpiPFy3LuVn6LY/cOTQ+s9BbergVL616az7HcaVTfdCkPn1/knyTy22MxRhSkr6nsF/hvrluKE19LUbUF1nwzT1SddjYwratz0l1hvmSzjdrWq/cU0inBteqCrVCFEk0eQGBAAQgAAEI1BsBvb1SCDa9fpdbQTXj+6eNXRZLvU2TO1+p7WuSnxRyKYx6GMinjKW1X810G5uUc/EtpJBXsy/UXXsCpYTSTeuddEgfNg8fmTREpEMAAhCAAAR6loAUvDRLdK16JjcAfbKI5gilTQDPUl+ly5Qztkr3hfoal0CblGkU6sb9Auk5BCAAAQhAAAIQgEDPEvArJRbjt9Oz3aR1CEAAAhCAAAQgAAEI1CeBNpTp+vxi6BUEIAABCEAAAhCAQGMQ8C4fjdFVegkBCEAAAhCAAAQgAIH6I+AVapYdr78vhh5BAAIQgAAEIAABCDQGgTbFC8TtozG+LHoJAQhAAAIQgAAEIFB/BPzS46yUWH9fDD2CAAQgAAEIQAACEGgMAlioG+N7opcQgAAEIAABCEAAAnVKwIfNa9VlIuv0O6FbEIAABCAAAQhAAAINRCC3Amhbyy473kDfE12FAAQgAAEIQAACEKhTAt6HWko1AgEIQAACEIAABCAAAQiUTsBr0h0dHaWXpAQEIAABCEAAAhCAAAQg4PykRDhAAAIQgAAEIAABCEAAAtkI+IVdcPnIBo9SEIAABCAAAQhAAAIQ8C4frJTIhQABCEAAAhCAAAQgAIFsBLyFmpUSs8GjFAQgAAEIQAACEIAABLxCjYWaCwECEIAABCAAAQhAAALZCLRrURcWdnFu0qRJ2QhSCgIQgAAEIAABCECgpQl4H+rOzs6WhsDgIQABCEAAAhCAAAQgkJWAt1Dj8uHciBEjsjKkHAQgAAEIQAACEIBAAxKYOHFiRXrtLdRMSqwISyqBAAQgAAEIQAACEGhBAu2yTuND3YLfPEOGAAQgAAEIQAACEKgIgTas0xXhSCUQgAAEIAABCEAAAi1KoE0WalZKbNFvn2FDAAIQgAAEIAABCJRNoE3uHh0dHWVXRAUQgAAEIAABCEAAAhBoRQJ+YRcs1K341TNmCEAAAhCAAAQgAIFKEPBRPipREXVAAAIQgAAEIAABCECgFQl4hZooH6341TNmCEAAAhCAAAQgAIFKEPAuH7NmzapEXdQBAQhAAAIQgAAEIACBliPgw+bhQ91y3zsDhgAEIAABCEAAAhCoEAEfNq9CdVENBCAAAQhAAAIQgAAEWo6AD5vXcqNmwBCAAAQgAAEIQAACEKgQAe9D3dnZWaHqqAYCEIAABCAAAQhAAAKtRcC7fLD8eGt96YwWAhCAAAQgAAEIQKByBPykxMpVR00QgAAEIAABCEAAAhBoLQLe5aO1hsxoIQABCEAAAhCAAAQgUDkCXqGePXt25WqkJghAAAIQgAAEIAABCLQQAR/lAx/qFvrGGSoEIAABCEAAAhCAQEUJ+KXHWSmxokypDAIQgAAEIAABCECghQhgoW6hL5uhQgACEIAABCAAAQhUnoAPm9erV6/K10yNEIAABCAAAQhAAAIQaAECbTlxHR0dLTBUhggBCEAAAhCAAAQgAIHKE/A+1FKqEQhAAAIQgAAEIAABCECgdAJek8ZCXTo4SkAAAhCAAAQgAAEIQEAE/KREUEAAAhCAAAQgAAEIQAAC2Qj4hV1w+cgGj1IQgAAEIAABCEAAAhDwLh+slMiFAAEIQAACEIAABCAAgWwEvIWalRKzwaMUBCAAAQhAAAIQgAAEvEKNhZoLAQIQgAAEIAABCEAAAtkI+EmJLOySDR6lIAABCEAAAhCAAAQg4H2oOzs7IQEBCEAAAhCAAAQgAAEIZCDgLdQo1BnIUQQCEIAABCAAAQhAAAI5At5CzaRErgUIQAACEIAABCAAAQhkI9CuCYn4UGeDRykIQAACEIAABCAAAQi0YZ3mIoAABCAAAQhAAAIQgEB2Am2yULNSYnaAlIQABCAAAQhAAAIQaG0CflJiR0dHa1Ng9BCAAAQgAAEIQAACEMhIwC/sgoU6Iz2KQQACEIAABCAAAQi0PAEf5aPlKQAAAhCAAAQgAAEIQAACGQl4hZooHxnpUQwCEIAABCAAAQhAoOUJeJePWbNmtTwIAEAAAhCAAAQgAAEIQCALAR82Dx/qLOgoAwEIQAACEIAABCAAgdxKiQqbV0uZOHGi0weBAAQgAAEIQAACEIBAMxBol/90Z2dn1cciJfrOO+/sokyPHj3abbfddlVvmwYgAAEIQAACEIAABCBQLQLeh7oWCnVcmdaA7rrrLnfxxRdXa2zUCwEIQAACEIAABCAAgaoT8C4f1V5+PEmZtpHhAmIk2EIAAhCAAAQgAAEINCIBPymxpzsuhRuBAAQgAAEIQAACEIBAIxLwLh/V7jiTEKtNmPohAAEIQAACEIAABHqKgFeoax3po6cGS7sQgAAEIAABCEAAAhCoNAEf5UM+1B0dHZnrtggeaRUUslDrfNrkxJEjR/pqiQaSRpd0CEAAAhCAAAQgAIGeJNCuxstZKVGKcCGFuZgBptVh6doecsghxVRFHghAAAIQgAAEIAABCNSMQJviUGeN8pEvekelRyCF2pTrStdNfRCAAAQgAAEIQAACEMhKwIfNk1LdCEI0kEb4lugjBCAAAQhAAAIQaC0CbTnJ7D+Nxbi1LhZGCwEIQAACEIAABCDQnUCbkqRUIxCAAAQgAAEIQAACEIBA6QS8Jl1OhI/Sm6QEBCAAAQhAAAIQgAAEmoeAn5TYPMNhJBCAAAQgAAEIQAACEKgtAb+wCy4ftYVOaxCAAAQgAAEIQAACzUPAu3ywUmLzfKGMBAIQgAAEIAABCECgtgTaOzs7fRzqLEp1fKEVhbW76667qjYCRRWxFRVZQbFqmKkYAhCAAAQgAAEIQKAEAl6hzqJMJ7Wh5cH1qdTqiUltWKi+cKs2TcFOKkMaBCAAAQhAAAIQgAAEqkXAT0qs9MIuUnBrJVKsWfClVrRpBwIQgAAEIAABCEAgTsD7UMvto5Iia3EtLcZSqs1iXclxUBcEIAABCEAAAhCAAAQKEfAW6kor1IUa5TwEIAABCEAAAhCAAASahYC3UPfu3bvi46m1xbiWFvGKw6JCCEAAAhCAAAQgAIGGJdCuCYmV9qGutTI9evTohv0C6DgEIAABCEAAAhCAQGMTaKuGdbqWkwRlma7lJMjG/rrpPQQgAAEIQAACEIBApQl4C7VWSuzo6CirbrNKW5zosirLUzh07SBcXh5QnIIABCAAAQhAAAIQqAmBdrl7ZFWmqxlvOmn0Uqbji8kk5SMNAhCAAAQgAAEIQAACtSLQpggfslAjEIAABCAAAQhAAAIQgEDpBGquScvKHLptlN5lSkAAAhCAAAQgAAEIQKB+CLSrK5WO8pE0PCnRcZ9n+V1rAqP5XyeVIw0CEIAABCAAAQhAAAL1TMC7fMyaNavqfZTvc9wyrWN8oquOngYgAAEIQAACEIAABKpIwIfNq7YPdaE40SjVVfyGqRoCEIAABCAAAQhAoKoE2rSwS7WlUnGi4xbuaveb+iEAAQhAAAIQgAAEIFCIQFs5/tMoyoXwch4CEIAABCAAAQhAoNkJeB9qhc7LIrIY18pqrHYqpcBnGStlIAABCEAAAhCAAAQgkETAr5TY3t7usrp+yP/ZlhovJ1pHPsU8Hh0kaSCkQQACEIAABCAAAQhAoCcItPfu3bvsdithOWZiYtlfAxVAAAIQgAAEIAABCPQAAe/y0QPt0iQEIAABCEAAAhCAAASagoBXqLO6ezQFAQYBAQhAAAIQgAAEIACBMgj4KB+VcPsoow8UhQAEIAABCEAAAhCAQMMSaFPPa7FSYsMSouMQgAAEIAABCEAAAhDIQwALdR44nIIABCAAAQhAAAIQgEAhAn6lxHIWdynUAOchAAEIQAACEIAABCDQzATacuI6OjqaeYyMDQIQgAAEIAABCEAAAlUj4H2opVQjEIAABCAAAQhAAAIQgEDpBLwmjYW6dHCUgAAEIAABCEAAAhCAgAj4SYmggAAEIAABCEAAAhCAAASyEfALu+DykQ0epSAAAQhAAAIQgAAEIOBdPlgpkQsBAhCAAAQgAAEIQAAC2Qh4CzUrJWaDRykIQAACEIAABCAAAQh4hRoLNRcCBCAAAQhAAAIQgAAEshHwkxJZ2CUbPEpBAAIQgAAEIAABCEDA+1B3dnZCAgIQgAAEIAABCEAAAhDIQMBbqFGoM5CjCAQgAAEIQAACEIAABHIEvIWaSYlcCxCAAAQgAAEIQAACEMhGoF0TEvGhzgaPUhCAAAQgAAEIQAACEGjDOs1FAAEIQAACEIAABCAAgewE2mShZqXE7AApCQEIQAACEIAABCDQ2gT8pMSOjo7WpsDoIQABCEAAAhCAAAQgkJGAX9gFC3VGehSDAAQgAAEIQAACEGh5Aj7KR8tTAAAEIAABCEAAAhCAAAQyEvAKNVE+MtKjGAQgAAEIQAACEIBAyxPwLh+zZs1qeRAAgAAEIAABCEAAAhCAQBYCPmwePtRZ0FEGAhCAAAQgAAEIQAACuZUSFTYPgQAEIAABCEAAAhCAAASyEfBh87IVpRQEIAABCEAAAhCAAAQg4H2oOzs7IQEBCEAAAhCAAAQgAAEIZCDw/0K/EtayYUhBAAAAAElFTkSuQmCC"
    }
   },
   "cell_type": "markdown",
   "id": "5e5333bf-6336-441c-8d99-03da418cad0f",
   "metadata": {},
   "source": [
    "![Screenshot 2024-10-16 at 08.53.25.png](attachment:63379bf6-0a94-4604-81e2-68c8e37c435a.png)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "65d842c2-ac99-4a08-8e58-918d9a6f7f0b",
   "metadata": {},
   "source": [
    "### After this, sometimes you have to select a new kernel, if it says \"No Kernel\" in the top right. See image\n",
    "1. Go to the top right and click \"No Kernel\" \n",
    "2. Select the Python 3 kernel and click select"
   ]
  },
  {
   "attachments": {
    "a52ecb72-4827-47b6-984b-56d0ed64b8c1.png": {
     "image/png": "iVBORw0KGgoAAAANSUhEUgAACFYAAAPUCAYAAACNBS/8AAAMP2lDQ1BJQ0MgUHJvZmlsZQAASImVVwdYU8kWnltSIbQAAlJCb4KIlABSQmihdwRRCUmAUGIMBBU7uqjg2sUCNnRVRMEKiAVF7CyKvS8WFJR1sWBX3qSArvvK9+b75s5//znznzPnztx7BwD1E1yxOBfVACBPVCCJDfZnjE1OYZC6ARnQAAWQgAOXly9mRUeHA1gG27+XdzcAImuvOsi0/tn/X4smX5DPAwCJhjidn8/Lg/ggAHglTywpAIAo482nFIhlGFagLYEBQrxQhjMVuFKG0xV4r9wmPpYNcSsAZFUuV5IJgNplyDMKeZlQQ60PYicRXygCQJ0BsU9e3iQ+xGkQ20AbMcQyfWb6DzqZf9NMH9LkcjOHsGIu8kIOEOaLc7nT/s90/O+Slysd9GEFq2qWJCRWNmeYt1s5k8JkWBXiXlF6ZBTEWhB/EPLl9hCj1CxpSILCHjXk5bNhzoAuxE58bkAYxIYQB4lyI8OVfHqGMIgDMVwh6FRhASceYj2IFwryA+OUNpslk2KVvtD6DAmbpeTPcSVyvzJfD6Q5CSyl/ussAUepj6kVZcUnQUyF2KJQmBgJsRrEjvk5cWFKmzFFWezIQRuJNFYWvwXEsQJRsL9CHyvMkATFKu1L8/IH54ttzhJyIpV4f0FWfIgiP1grjyuPH84FuywQsRIGdQT5Y8MH58IXBAQq5o51C0QJcUqdD+IC/1jFWJwqzo1W2uNmgtxgGW8GsUt+YZxyLJ5YABekQh/PEBdExyvixIuyuaHRinjwZSAcsEEAYAAprOlgEsgGwvbehl54p+gJAlwgAZlAAByUzOCIJHmPCF7jQBH4EyIByB8a5y/vFYBCyH8dYhVXB5Ah7y2Uj8gBTyHOA2EgF95L5aNEQ94SwRPICP/hnQsrD8abC6us/9/zg+x3hgWZcCUjHfTIUB+0JAYSA4ghxCCiLW6A++BeeDi8+sHqjDNxj8F5fLcnPCV0EB4RrhM6CbcnCoslP0UZATqhfpAyF+k/5gK3gpquuD/uDdWhMq6LGwAH3AX6YeG+0LMrZNnKuGVZYfyk/bcZ/PA0lHYUJwpKGUbxo9j8PFLNTs11SEWW6x/zo4g1fSjf7KGen/2zf8g+H7ZhP1tiC7ED2FnsJHYeO4o1AAbWjDVibdgxGR5aXU/kq2vQW6w8nhyoI/yHv8EnK8tkvlONU4/TF0VfgWCq7B0N2JPE0yTCzKwCBgt+EQQMjojnOILh7OTsAoDs+6J4fb2JkX83EN2279y8PwDwbh4YGDjynQttBmCfO9z+h79zNkz46VAB4NxhnlRSqOBw2YUA3xLqcKfpA2NgDmzgfJyBG/ACfiAQhIIoEA+SwQQYfRZc5xIwBcwAc0EJKAPLwGqwHmwCW8FOsAfsBw3gKDgJzoCL4DK4Du7C1dMFXoA+8A58RhCEhNAQOqKPmCCWiD3ijDARHyQQCUdikWQkDclERIgUmYHMQ8qQFch6ZAtSjexDDiMnkfNIB3IbeYj0IK+RTyiGqqLaqBFqhY5EmSgLDUPj0fFoJjoZLULno0vQtWgVuhutR0+iF9HraCf6Au3HAKaC6WKmmAPGxNhYFJaCZWASbBZWipVjVVgt1gSf81WsE+vFPuJEnI4zcAe4gkPwBJyHT8Zn4Yvx9fhOvB5vxa/iD/E+/BuBRjAk2BM8CRzCWEImYQqhhFBO2E44RDgN91IX4R2RSNQlWhPd4V5MJmYTpxMXEzcQ64gniB3Ex8R+EomkT7IneZOiSFxSAamEtI60m9RMukLqIn0gq5BNyM7kIHIKWUQuJpeTd5GPk6+Qn5E/UzQolhRPShSFT5lGWUrZRmmiXKJ0UT5TNanWVG9qPDWbOpe6llpLPU29R32joqJipuKhEqMiVJmjslZlr8o5lYcqH1W1VO1U2aqpqlLVJao7VE+o3lZ9Q6PRrGh+tBRaAW0JrZp2ivaA9kGNruaoxlHjq81Wq1CrV7ui9lKdom6pzlKfoF6kXq5+QP2Seq8GRcNKg63B1ZilUaFxWOOmRr8mXXOUZpRmnuZizV2a5zW7tUhaVlqBWnyt+VpbtU5pPaZjdHM6m86jz6Nvo5+md2kTta21OdrZ2mXae7Tbtft0tHRcdBJ1pupU6BzT6dTFdK10Obq5ukt19+ve0P00zGgYa5hg2KJhtcOuDHuvN1zPT0+gV6pXp3dd75M+Qz9QP0d/uX6D/n0D3MDOIMZgisFGg9MGvcO1h3sN5w0vHb5/+B1D1NDOMNZwuuFWwzbDfiNjo2AjsdE6o1NGvca6xn7G2carjI8b95jQTXxMhCarTJpNnjN0GCxGLmMto5XRZ2poGmIqNd1i2m762czaLMGs2KzO7L451ZxpnmG+yrzFvM/CxCLCYoZFjcUdS4ol0zLLco3lWcv3VtZWSVYLrBqsuq31rDnWRdY11vdsaDa+NpNtqmyu2RJtmbY5thtsL9uhdq52WXYVdpfsUXs3e6H9BvuOEYQRHiNEI6pG3HRQdWA5FDrUODx01HUMdyx2bHB8OdJiZMrI5SPPjvzm5OqU67TN6e4orVGho4pHNY167WznzHOucL42mjY6aPTs0Y2jX7nYuwhcNrrccqW7RrgucG1x/erm7iZxq3XrcbdwT3OvdL/J1GZGMxczz3kQPPw9Znsc9fjo6eZZ4Lnf8y8vB68cr11e3WOsxwjGbBvz2NvMm+u9xbvTh+GT5rPZp9PX1JfrW+X7yM/cj++33e8Zy5aVzdrNeunv5C/xP+T/nu3Jnsk+EYAFBAeUBrQHagUmBK4PfBBkFpQZVBPUF+waPD34RAghJCxkechNjhGHx6nm9IW6h84MbQ1TDYsLWx/2KNwuXBLeFIFGhEasjLgXaRkpimyIAlGcqJVR96OtoydHH4khxkTHVMQ8jR0VOyP2bBw9bmLcrrh38f7xS+PvJtgkSBNaEtUTUxOrE98nBSStSOocO3LszLEXkw2ShcmNKaSUxJTtKf3jAsetHteV6ppaknpjvPX4qePPTzCYkDvh2ET1idyJB9IIaUlpu9K+cKO4Vdz+dE56ZXofj81bw3vB9+Ov4vcIvAUrBM8yvDNWZHRnemeuzOzJ8s0qz+oVsoXrha+yQ7I3Zb/PicrZkTOQm5Rbl0fOS8s7LNIS5YhaJxlPmjqpQ2wvLhF3TvacvHpynyRMsj0fyR+f31igDX/k26Q20l+kDwt9CisKP0xJnHJgquZU0dS2aXbTFk17VhRU9Nt0fDpvessM0xlzZzycyZq5ZRYyK31Wy2zz2fNnd80JnrNzLnVuztzfi52KVxS/nZc0r2m+0fw58x//EvxLTYlaiaTk5gKvBZsW4guFC9sXjV60btG3Un7phTKnsvKyL4t5iy/8OurXtb8OLMlY0r7UbenGZcRlomU3lvsu37lCc0XRiscrI1bWr2KsKl31dvXE1efLXco3raGuka7pXBu+tnGdxbpl676sz1p/vcK/oq7SsHJR5fsN/A1XNvptrN1ktKls06fNws23tgRvqa+yqirfStxauPXptsRtZ39j/la93WB72favO0Q7OnfG7mytdq+u3mW4a2kNWiOt6dmduvvynoA9jbUOtVvqdOvK9oK90r3P96Xtu7E/bH/LAeaB2oOWBysP0Q+V1iP10+r7GrIaOhuTGzsOhx5uafJqOnTE8ciOo6ZHK47pHFt6nHp8/vGB5qLm/hPiE70nM08+bpnYcvfU2FPXWmNa20+HnT53JujMqbOss83nvM8dPe95/vAF5oWGi24X69tc2w797vr7oXa39vpL7pcaL3tcbuoY03H8iu+Vk1cDrp65xrl28Xrk9Y4bCTdu3Uy92XmLf6v7du7tV3cK73y+O+ce4V7pfY375Q8MH1T9YftHXadb57GHAQ/bHsU9uvuY9/jFk/wnX7rmP6U9LX9m8qy627n7aE9Qz+Xn4553vRC/+Nxb8qfmn5UvbV4e/Mvvr7a+sX1drySvBl4vfqP/Zsdbl7ct/dH9D97lvfv8vvSD/oedH5kfz35K+vTs85QvpC9rv9p+bfoW9u3eQN7AgJgr4cp/BTBY0YwMAF7vAICWDAAdns+o4xTnP3lBFGdWOQL/CSvOiPLiBkAt/H+P6YV/NzcB2LsNHr+gvnoqANE0AOI9ADp69FAdPKvJz5WyQoTngM1RX9Pz0sG/KYoz5w9x/9wCmaoL+Ln9F42ofF3DjmhqAAAAlmVYSWZNTQAqAAAACAAFARIAAwAAAAEAAQAAARoABQAAAAEAAABKARsABQAAAAEAAABSASgAAwAAAAEAAgAAh2kABAAAAAEAAABaAAAAAAAAAJAAAAABAAAAkAAAAAEAA5KGAAcAAAASAAAAhKACAAQAAAABAAAIVqADAAQAAAABAAAD1AAAAABBU0NJSQAAAFNjcmVlbnNob3QrIj0uAAAACXBIWXMAABYlAAAWJQFJUiTwAAAC3GlUWHRYTUw6Y29tLmFkb2JlLnhtcAAAAAAAPHg6eG1wbWV0YSB4bWxuczp4PSJhZG9iZTpuczptZXRhLyIgeDp4bXB0az0iWE1QIENvcmUgNi4wLjAiPgogICA8cmRmOlJERiB4bWxuczpyZGY9Imh0dHA6Ly93d3cudzMub3JnLzE5OTkvMDIvMjItcmRmLXN5bnRheC1ucyMiPgogICAgICA8cmRmOkRlc2NyaXB0aW9uIHJkZjphYm91dD0iIgogICAgICAgICAgICB4bWxuczpleGlmPSJodHRwOi8vbnMuYWRvYmUuY29tL2V4aWYvMS4wLyIKICAgICAgICAgICAgeG1sbnM6dGlmZj0iaHR0cDovL25zLmFkb2JlLmNvbS90aWZmLzEuMC8iPgogICAgICAgICA8ZXhpZjpVc2VyQ29tbWVudD5TY3JlZW5zaG90PC9leGlmOlVzZXJDb21tZW50PgogICAgICAgICA8ZXhpZjpQaXhlbFhEaW1lbnNpb24+MjEzNDwvZXhpZjpQaXhlbFhEaW1lbnNpb24+CiAgICAgICAgIDxleGlmOlBpeGVsWURpbWVuc2lvbj45ODA8L2V4aWY6UGl4ZWxZRGltZW5zaW9uPgogICAgICAgICA8dGlmZjpSZXNvbHV0aW9uVW5pdD4yPC90aWZmOlJlc29sdXRpb25Vbml0PgogICAgICAgICA8dGlmZjpYUmVzb2x1dGlvbj4xNDQvMTwvdGlmZjpYUmVzb2x1dGlvbj4KICAgICAgICAgPHRpZmY6WVJlc29sdXRpb24+MTQ0LzE8L3RpZmY6WVJlc29sdXRpb24+CiAgICAgICAgIDx0aWZmOk9yaWVudGF0aW9uPjE8L3RpZmY6T3JpZW50YXRpb24+CiAgICAgIDwvcmRmOkRlc2NyaXB0aW9uPgogICA8L3JkZjpSREY+CjwveDp4bXBtZXRhPgqwNydeAABAAElEQVR4AeydCbyuU73Hl2M4h+M4ZDiGdISQkqkMt1KUkHuJqESJyo2KikwZGowlXUmGlNtEEuKSoZtKs1uGSlFEyjwd8+xc36f+b2s/+3nnd+/3fff+/j+fdz/TGr/PsJ9nrd/6r3mOPfbYuUmTgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAhKQgAQkIAEJSEACEhhFYMqoPe6QgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAhKQgAQkIAEJSEACEigIzNeMw8orr9wsiMclIAEJSEACfSdwww03FGU49VcL9b0sFkACEpCABCTQjMB71n+0WRCPS0ACEpCABCQgAQlIQAISkIAEJCABCUhAAgNCQI8VA3IiLIYEJCABCUhAAhKQgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAoNHQGHF4J0TSyQBCUhAAhKQgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAhKQwIAQUFgxICfCYkhAAhKQgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAhKQgAQkMHgE5hu8IlkiCUhAAhKQQOcETnjfqp1HNqYEJCABCUhgnAhcddVV45ST2UhAAhKQgAQkIAEJSEACEpCABCQgAQlIQALdEtBjRbcEjS8BCUhAAhKQgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAhKQwIQloLBiwp5aKyYBCUhAAhKQgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAhKQQLcEFFZ0S9D4EpCABCQgAQlIQAISkIAEJCABCUhAAhKQgAQkIAEJSEACEpCABCQgAQlMWAIKKybsqbViEpCABCQgAQlIQAISkIAEJCABCUhAAhKQgAQkIAEJSEACEpCABCQgAQl0S0BhRbcEjS8BCUhAAhKQgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAhKQwIQloLBiwp5aKyYBCUhAAhKQgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAhKQQLcEFFZ0S9D4EpCABCQgAQlIQAISkIAEJCABCUhAAhKQgAQkIAEJSEACEpCABCQgAQlMWALzTdiaWTEJSEACEpBAFwTmXH5OeuJv13eRQv2oU5dfNS260bb1A3hEAhKQgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCUhgYAj0RVhx2223pVtvvbUhhFe84hXF8WZhl1tuubTssss2TMuDEpCABCQggXYJIKp4/OY/tBvN8BKQgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAhOMwLgLK0488cSWEIaw4v/+7/8S4opGprCiEZ3Oj1133XXpnnvuSTNnzkxrrLFG5wkZUwISmBAEeBZ3+rztJm6/4c189TZp2uzVe1KMx//6h/TAT87tSVomIgEJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAhKQgAQkMD4ExlVYgUgirNXOuXK4ZiKLSL/Z8pJLLkn33ntvWnrppdMmm2zSLPikPP6DH/wgXX311WnllVdWWDEprwArLYF/EeD5/etf/zq9/OUvTyF8+9fRxmvdxG2c8vgcRVQxbfZqPcusl8KKZ555Jk2ZMiXNM888HZXvqaeeSvPPP39HcYn09NNPp/nmG9dXiY7LasR/EOj2miGVhx56KJ177rnFtbfNNtuk6dOnDy3eK6+8Mt15551pscUWSxtssMHQ1sOCt05g7ty56Y477kgPP/xwEWnhhRcuvgc6fY62nrMhJSABCUhAAhKQgAQkIAEJSEACEpCABCQggWEm0JfeEMQSW2+9dUvc8g48RBXnnXdeS/GaBaKD8Oabb06rrrqqwopmsDwuAQlMagI8e3lmYrHMn82N4ISoIuI6fVMjWq0du+WWW9KPf/zj9Lvf/S7Bd6GFFkprrbVWIYDbcsst04wZMxomdPvtt6evfe1r6Te/+U26++67i/irrLJKeutb39pSx/JVV12VrrjiikJ4h2ejRRddNK233npFGTbffPO2RB5/+9vf0tlnn10rLx3bve7c/utf/1qIAMjkda97XUtCwZNPPjk99thjRZ1e+9rX1sqXp7X99tsnrudW7Wc/+1k64YQTEvy32mqrEZzmnXfeQsT40pe+ND3/+c8fcazV9BuF6/aaKad91llnpa9//evFbsq+ww47lIMMzfY555yTODew7/W1NzQQJklBufd47l1//fUJgVFuXMd8E6y77rppmWWWyQ+5LgEJSEACEpCABCQgAQlIQAISkIAEJCABCUigINAXYUUn7MuiCsQZvfJe0Ul5jCMBCUhgshDgeYunihBVxLKZuCIXVcCKNMpeiIaN4V8Pf0dHRZ79sX90QncUOYuEmGL//fdPjz76aG0v6z//+c+L38UXX5yOOeaYtMQSS9SO5yucu49+9KP5riItvBPxe+Mb35j22Wefuh37dEIff/zxI+LPmTMnXXrppcWPTsv99tuvJS8YdGweddRR6Q9/+EMtPaae6nXnNiPTQ5SJIOWrX/1qWmSRRWp5Vq2cf/75BRe8geTCijwtvF21I6ygnnTsYqRfz5Zccsn02c9+Ni2//PL1grS1v9trpiqzfGR/vl4V1n0SGAQC3Pu/+tWv6haF5xH3KL/1118/veY1r6kb1gMSkIAEJCABCUhAAhKQgAQkIAEJSEACEpDA5CQwFMKKsqgCbxd02GkSkIAEJDA+BEJEEaKKWMb+cimqRBX1wpbjul1N4Le//W3aa6+9agff8pa3pNVXXz0hbKDTEE8SeFTYY489Cm8CU6dOrYVlhWO5qAKPC2uuuWbhtQKxAel873vfK8QvO+6444i4bJx55pnppJNOKvYzohvvFCuuuGLCG8JFF12U/v73vyemkKKD8tBDDx0Vv7wDkUYuqigfH4tt6njcccelgw8+eCySbzlNxCMxBcuzzz6b7rrrrvTnP/+5iI8XkT333DN9/vOf71pc0e01U69C2223XWKEP9PA4H1Dk8AgE7jgggvaetYgwGC6m3//938f5GpZNglIQAISkIAEJCABCUhAAhKQgAQkIAEJSGCcCQy8sKJKVDFII56feOKJdM899yRG2TJH83gac0M/8MADidGtCyywQEtZ0+FFHFyctxMvEmdeauYiX3DBBYs6x/5my0ceeaTotKOczGNOZ0w7Rpn5LbXUUmnatGntRDWsBCTQIwIhjAhRRSxjf2SjqCJI9HaZezn4whe+kF7ykpfUMqAD8MgjjyyEDXTM46UADyG5/fd//3dtE4EF3inCNtpoo/SOd7yj8NJw6qmnFsd4Vofx7P/Wt75VbM6ePTsde+yx6XnPe14cTltssUUhBkBc8aMf/ajwejF9+vTa8fLKrbfemr74xS8Wu1/96lenn/zkJ+UgY7Z92WWXpX/7t38rpgUZs0yaJHzYYYcVwoQ8GP+XmV7jjDPOKP5ffvzjH09f/vKX8yBtr3d7zdTLkOlm3vnOd9Y77H4JDAwBRGedCLiIw3Wu54qBOZUWRAISkIAEJCABCUhAAhKQgAQkIAEJSEACfSfQXu/2OBd3UEUVjC7F7TmNtYgqwnAtzuhh5hpnzvvcfvjDH6bTTz+92HXiiSdWCgu+//3vp29/+9tFmFNOOaXmip0Rp+F6/Ygjjig6zOgYQuAQtvLKK6eddtqprltyhA10sBAvN+Zyp/ONTjFcntczXM1T/muuuSY9/vjjRTA63YjLyNV6cRlBTb50tuVGJ96b3vSmotE63085P/ShDxW7dt1114IBI6Fj2pf3vve9ab311sujuC4BCYwjgRBRhKgilrFfUcXYnAz+7/ziF78oEt9mm21GiCrYifeAXXbZpRBWsM15yIUVTEGB4AFDGLHZZpsV6/EHkQTCipNPPrnYheeK3GvFTTfdVHT2c5B8clEF+/h/QPijjz6azeJ/BeKFKkOkwVQXGP8reeaPp7CCfBGGrLHGGoVYj+1BMASLu+22W+G9As8ff/nLXwrmiy66aEfF6/aa6SjTOpF4b+D/OHVEIMn1OtaGkPRvf/tbQuDD1DjtTFkCO96xKPesWbNGvdONddlNvzcEeO41mv6jWS7EXWWVVRIeejQJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAgMrrGgmquiX14qnnnoqffrTn04333zzqKvnwQcfTL/85S8Lt+gf/vCHU94ZQiN9GJ1KVZaHyY/TORCGQAMBRtluuOGGxOhWhBd4osjtySefLFyK00lTNgQP/IiPaKEsCCE88RGDXHfddSOi33///UVZEF3svPPOozotEFXEiOQREZ/buPzyy4t899577xHeNnI21157bVcN4uU83ZaABHpDIEQUIaqIJann63TsR9je5Dx5U6GDEDEDv1wwkRPJ/y/iESI3pgEJe9/73lfZsY1gg+k+mC6D/wm5ER8hHpZ7ysjDvPCFL6xt3nHHHbX18soll1xSTFvCfqY2KYs0yuF7ub3tttsmpiDh/9ZRRx2VjjnmmLrCwF7m205aCB0RVmD8H3zlK1/ZTvRa2G6vmVpCFStXX3114j0Hw6sGU8JgvAcxXRt2wAEHpFVXXTWdcMIJI6Zv4z2DaWwQg+YCC64/rr2XvexlxXQtRSKlP4gd3va2txV73/WudxXvHmwgSGEqFbyw4EmDaVR+/vOfj4jNOw75NvKYhdcQ7gGmxskNkRD3zfLLL5/vdn3ACfzmN7/puoSk4ZQgXWM0AQlIQAISkIAEJCABCUhAAhKQgAQkIAEJTAgCAymsaCaqgHy/OutoqA9RxVprrZU22WSTYjQjoyIZIczoNsqPZwg6cHptiCrowKDzYIUVVkhMB3LhhRfWOi2+853vpN13372WLWKNL33pS8XIV3bCbf311090wNFxhhAEd8e///3vi3S23377WtxYueWWW4pVRjivs846afHFFy/EI7gsR1zxs5/9rEjzxS9+cURJdMKFqIKRzMzBjlcNpvO44oorCmEFQg9c09PZUTWSNEYZ0kmz0korFSNdGXWqSUAC/ScQz+AQUsQySqaoIkj0ZrnccssV00Q0So3ncRjPzNz4HxX20pe+NFZHLKdOnZr4v4ZnCzxU5Lbxxhsnfo0s96KEV4wqo4zhgYlraNNNN60KNmb7Xve61xWiiosvvrgQd5x99tmp6v/emBWghYTz/3Nlb08tRK8F6faaqSVUsZILPvP1XCB64403FgIJRCy5sc3/ft5f3v/+99cOvf71r0+8w+ClC29gOYcIxPtGWO4RBQEodu+996b99tuveAeJcLHkXQjBEdPgVNnTTz+dDj300Nr7VB6Gdz+EG6TB1G/a4BNAqHv99dd3XVDS2HLLLSvfU7tO3AQkIAEJSEACEpCABCQgAQlIQAISkIAEJCCBoSIwcMKKVkQV/STM3PV0SjHtB6Mt559//qI4jLhl/x//+MdixCbLsTAEEYzwDc8SNPAjTKCzAHbleaSZuoORpdiaa645QsSAZws6tj71qU8VcfEigQCCzrWyMVovRqFyDBfqH/jAB4q4bCOkyIUVdJpg06ZNSx/5yEfS0ksvXWyzZAQrnS8//elPiw4MOrrKnYBF4Of+HHjggSkfBR37XUpAAv0nUBZXRIkUVQSJ8V2eddZZtQwZ9Z9bdNDzv2PhhRfOD41Yj2c1z3Q6zHOPAiMCljZ4pp9xxhm1vS960Ytq6/nKSSedVAgb2IfHgypRXR5+LNb538UodP6fIwBcd911ax4XxiK/dtPE00RYPY5xvNtlo2um27RjajOmC0MEgVCCdxI8QnA9IqLgf//mm29eZBXCCjZ4P2C6sLKFJw+EO1VsQpDJexHPJ4SdCDWYegZBB1PcIHqteucIr1y8y/EuhGcW7oP//d//LcSyXC+f+MQnCq9ljbxelMvsdn8I4DUnF/10WgrSIC2nA+mUoPEkIAEJSEACEpCABCQgAQlIQAISkIAEJDBxCEwZpKq0I6o477zziukp8BIxnkYHAcIG5pgPUUXkTwdUjKDEq0U+rUWE6Xb5mte8piaqiLTomNpggw2KTeYDZxRoWHjXYHvXXXcd1YlF58B//ud/Fh0NeMEgfpUhfijbC17wgqLTgv10PoQ98cQTRacJ23ROREddHGf51re+tbYZHjFqO/65QqeIoooyFbclIAEJjCbwu9/9Ln3rW98qDvD/ALFAbvG/AC8GjSx/XjeazqOcBp3l0TGN1yTEh2VjeqhLL7202E2YfnVUTp8+PR188MG14h1++OGJab4GwcoClVyw2OvyNbtmepHf29/+9sIrxdprr11Mo4FIkylYQhx69NFH1zq/EV3GdDMhoMjLcNddd9XEo3gQqGd4pCBfhBeIOfAshheLMDx01TOuySOPPLLwpIKQdcMNN0wHHXRQ7d2Oazj3mlEvHff3n0D+LtxtaXqZVrdlMb4EJCABCUhAAhKQgAQkIAEJSEACEpCABCTQPwIDI6xoR1TRP1wjc6Yjho4nXKbjKYIRsPmc3mMhrKjnXp1RmWEIG8KYbgNDBBEdGXEslnQeMKc7vyoX13RM1BvhPGvWrCKZvNEZ7xlhjBD905/+NOqXiylyUUbEY7nKKqvkm65LQAIDRgBhW3kKEIrIvvEWvQ0CmmkrrN6XYjDNx/7771/kzXMejwxli2fuUkstVT40YjuffiGf2mNEoNIGU4eccsopxV6mqqqaBoupGo499tiGYUrJjukmXpd23HHHIg/+T5522mljml+zxHlf4H/hIYccUnhYIDziwgUXXLBZ1I6Ot3LNdJRwFgmRBILOsiHu2W233Wq7ef8LQ3iBIX5gOpDcckFDvWlpuP55lynbK1/5ytqu/B2ltvOfKwcccMCo9x3Eq3F/EYwpTjQJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAhKYfAQGYiqQYRNV0OD//e9/vzZycjwvmxkzZlRmV/aeQSA6amIEMcKKTm3RRRetG7XKHTYdNmEXXHBB4tfIEKZUWVWdqsK5TwISGH8CZVEF039gIbSIZUwXMv4lHL8cEVTM2vGAIsM5l5+THvjJueOW+X333VeMxkfEhuF9ocorBdNVzZkzJz300EMNy/bII4/Ujtf7f1ML8NwKXg+YHgFjeik8EFT9X2DKiZiOZO+9964MUyQyjn923nnndMUVV6Q///nPxTQmePooT6EyVsXZYYcdRjDIp/8gT7wt5F41elmOVq+ZbvNkSo16U8nknjgQKiy//PJFdniXYLoYrDwdyGWXXVbs55mSC4CKnf/8w/QdVdPLUA6uT6bzyK/xPC7r9QSd3AsIWxG/IBbVBp9APUFwJyXvZVqd5G8cCUhAAhKQgAQkIAEJSEACEpCABCQgAQlIYDAIDITHinz04NZbb53woDCodtFFF6XjjjtuhKgCrw0rr7zyuHXItMNm2rRpRfCx8J5Rrxz5nNZ0fsCm6kd8RjdXdQLWS9v9EpBA/wlUiSro7OQXAgtKORk8V8x89TY1UQV1XnSjbRP7mtnU5VdtFqTpcUQSTHsQnfJ4O1hrrbUq462wwgrF/vBcURnouZ359B/Nns10iMdIfjwFHHPMMZUd3pTv1FNPLbLEI8Hqq/fHs0e5zoj3Pvaxj9V2H3bYYQ073WsBe7BCBz9c4pcnyZRin/3sZ1MrwpY8Xivr7VwzraTXKAz/3+tZLva84YYbasEQP4QYK58OhGlAYgqPzTffvBa+vJJ77yofqxL85GHwsDF16tR814j1EF0gJtIGnwDTGtUT9rRTetLIp0hqJ65hJSABCUhAAhKQgAQkIAEJSEACEpCABCQggYlFYCA8VkQjOp04gyyqYIqNc845p7gCaLxnjng6q/LRkRdeeGH67ne/2/AqQXhQ5Y3h8ccfbxiv3YOUa6WVVkrXXnttMcqy3fidho+Rp8R/97vfXYgqOk3LeBKQwGARqCeqiFLG8zw8VsQy9ke4ibCctdPH0rTZq42qCuKKabNXT3d+4/BRx3q1g/9HBx54YIrpnvbcc89Ub3oE8oxppPBa8fTTT4/wlpCXKUQaeCqqN30U4RFEkmd4yvjMZz5TTDmVpxXrJ554YqymrbbaqvAaUNtRWnnggQdq4g5Ei/n/11LQnmzCZa+99ioEk4gdjj/++JpYpCcZ1Elkjz32GHEOpkyZUvyvpPO+6v2gTjJt7W73mmkr8R4GRjjBcyamA0GgmU+zhvBEk0AzAjw7Vl111RFC6GZxqo6Txlg/h6rydZ8EJCABCUhAAhKQgAQkIAEJSEACEpCABCQweAQGQlgBlmHodMvn1WbU7Qtf+MJRZ7Sei+h8nnQ6tqpGv+XzjI9KuMMdjBhFWIEL9ocffnjU3OEkyzzmf/zjH4upQxht3qgzrZViMOozDLfZeKvQJCCB4SfQTFQRNYzneYgqYhn7I9ywLpn6Y+artqkUVUSdEFzM/tjX053fPDI9fvMfYndPlggjPv7xj9dG8O+2225pm20ae8nIn8uIIkJoUS7QzTffXOxq9Nzmf8aHP/zhmqjic5/7XEMvFPkIf8rayM4777zEDzv99NPTMsss0yh4T47hKYuOe67vSy65JI1Hx/22227bk9H0rQLo5JppNe164UL0U3U8nzKsfK3l/GM6kPBe8cY3vjGFJ66qdLvZx3sS4pN6Xivi/Y7pRrThILDuuut2LawgDU0CEpCABCQgAQlIQAISkIAEJCABCUhAAhKQAAQGRlgxDKfj2WefrRWTxvey3XTTTXUbcPNOLTqZysIKRBVXXnllOcmut/GoEYYrdkbm5iPv6GxhNDHu4emsWG+99SJ4x0tEJIw0vvPOOwvvHXRClOvLqOQvfOEL6cknnyxENQhVNAlIYHAJtCqqiBqEiCJEFbGM/RFu2JZM84FHilZt1o4HpDmX/8PTUatxGoVjWie8Q/zyl78sgu2yyy5phx12aBSlOJZP6/Gtb30r7bfffqPiXHXVVem6664r9uf/O/KADz74YNpnn31qXicoS73pR/J4g7zO/8R999037bzzzoVY5NBDDx3k4rZdtk6vmbYzKkXA4wQeuqqmY0DMGVaeMoR3EQQU3/ve9xKCile+8pU1EdEb3vCGiDYmyz//+c/ppS996ai0mUIFoSgWU4KMCuSOgSOAMGv99ddPv/rVrzoqG3HHQ9zVUeGMJAEJSEACEpCABCQgAQlIQAISkIAEekRgp/P/5XG4R0majAQmLIFJL6zAe0QzQQMiATqlXvSiF9UuhPPPP7+Y//zFL35xeuyxx9L111+fvvGNb9SOl1fyhtlvf/vbafr06QnBAZ0OzC9+5plnlqP0ZHuNNdZIeKGgUxPPFaecckracMMNE0IPOgkYpYuoAsONfK9Ggu60007FHPFMb3LssccmhBPwW2CBBRIjor/zne8UnjLIF4aaBCQwuAQQfoUwglLyTGlFIBFhIi7LQZ/yqdlZaEdUEWl1EifilpcI0i699NJi99vf/vb0zne+sxykchuvAPwfYqqPiy++OG2//fYp79Cm8z2fsuO1r33tqHT4X3fAAQfUOpiPOOKI4loYFbC04/Of/3x66qmnSntHbjJtFLbFFluk7bbbrlhfaqmliuV4/GG6CcQVeAKZaNbpNcM1cfXVVyfENHiRaHeKEjxAnHbaaek973nPCKR4TDn55JNr+3LRT+zcbLPNCmEF4oyYgm3JJZdML3vZyyLImCyPPvrodNJJJxXvaJEBHNgflr8Lxj6Xg0vgNa95TUIY84c/tOc5aPXVV0/E1SQgAQlIQAISkIAEJCABCUhAAhKQgAQkIAEJBIFxFVbQeE7HGp104eo7CtLuslfTZuBVIe9MqirHJptsUowIxj00nT4XXXRRQjDw5S9/eVTwEDGUD9AhwWjYr371q8UhOhvKxqhfOjF6aYzEZUQzAhIEHPCPTs48H+aQpiOjV7baaqslOspgdP/996evf/3rlUm/5S1vSSuttFLlMXdKQAKDQWDZZZetCbRaFVVEyXNxBXFJS+uMwNe+9rVaJzMpMHL+8ssvr5vYq171qjRlypTiOF4Ddt1113T44YcX25/85CfTwQcfXDx/H3nkkfSlL30pMVof4zyVpztAGIEnh+icpHOZffXynzlzZlpzzTWL9JZffvli2cofOs9zwUcrcXoVhk5U/g8yHUgr9pvf/Kb439ooLIKE+eYb11etEcXp5pqBQwgKttpqq2L6lxGJt7DxzW9+s/BMxbW4+OKLp2uuuSadccYZtWlk8H5S5dECUSjXwt13353wsIJtueWWIzxutZB920EQgxx44IGJ6WEQfSI8xWvGz372syIt3tPwoKENFwHEvTNmzGjZcwWeKhRVDNc5trQSkIAEJCABCUhAAhKQgAQkIAEJSEACEhgPAuPa2p93qPVKGBGddu3Cis6mVuLljf7Mi/685z2vGEmJYCCM0cC4Y8dzRQgX8ik3CEfHAh4qLrvsskJcEnHxiIGHB+YcrxJW5GUtpxlp5PvzdY7jJeIDH/hAwssGeedG3jCk0TmvJ2Ei33J6efyIE2HzYxtssEGRxoUXXjiivoShU46OGgQYueV5VaWZh3VdAhIYPwI8Jzr1NtFN3PGrYf2cHv9reyOd66eUUqdp8f+mLMhr5l0BEWDuheh1r3tdYioq/hfgsajsSYBy05m9//77j6oCU48wHUwYIoxGU2Yw2vuEE06I4EOz5H8lXqzo0G9miBaa2dlnn128MzQLNxbHu71m8uk6EES0a7wv4W3irLPOKn7l+Ntss00hlijvZ5t3Ad5L8mseketYGu8jiy66aDHNzm9/+9tRWXFvcM33UygzqlDuaJkAQgnEaAiieFfnfTw33mcRGa+77rpO/5GDcV0CEpCABCQgAQlIQAISkIAEJCABCUhAAhKoERhXYQW57r777iM6Z2olaXOl0w6+yAZ35p0aLtL54VoYF9k0xDO1B/aCF7wgbbrppnWTpmGX36OPPlp4clhkkUWKUXREoFG/Ki6jfhlN3MjWWWedhmEoH8IP3L/T2fLkk08Wo0fzTrdy+pyrZkYnVCNbb731Er+HH3644EVnCaNW67kUp5zN6tooP49JQAJjRyAXx7WbSzdx282r1+Ef+Mm5iV8/LRedtVqOchy299xzz8QUG6eeeuqoZDbaaKO0xx57FM/o8sFyWuXj5e1OhXEh1iun1812nmazci288MLpoIMOSnvttVeRZR6XHeXtZuXK82s3brO0mx1v95yRXh4HDxF4JMHj1Y477jgiu1bqheAUr1V4BQvBaSRCeu9617tis3LJ9GQhrECo08jzSbDNy1VONMKUhRGxHxEqwgk8apRFMwhF3/e+9xXve+V03R4eAkyHhGCHa/uOO+4o3k0pPff90ksvPeL6H55aWVIJSEACEpCABCQgAQlIQAISkIAEJCABCUhgvAjMc+yxx85tlBkN45oEJCABCUhg0Akw3RG29tpr96Socy4/pyfpVCUybfbqadrskR57qsKN1T6EgTfddFPhmQFBG53WCBYHzRhV/uyzz3ZULDrZo9O8owT6HImpVjo1xAO5SKLTdJ5++ukialmMUC89RBh4osD23XffYvo01hGT3nXXXYWoEk9ZraR37bXXFt62iL/33nsXHeKsj4dx3dHxTv0Rg9LxrklgLAhcddVVY5GsaUpAAhKQgAQkIAEJSEACEpCABCQggZYJ7HT+iS2HNaAEJjuBcfdYMdmBW38JSEACEhgOAotutO1wFLSDUs6YMSO97GUv6yDm+EZ5TvxZTL3VSa54gcJbwjAanfp4merUjjrqqLT++ut3Gr0WrxUBRC1wg5WFFloorbDCCg1CjDw0d+7cdNJJJxU7ifv6179+ZIAx3kKQM4hCozGutslLQAISkIAEJCABCUhAAhKQgAQkIAEJSEACEpBAAwIKKxrA8ZAEJCABCUhAAv0jQAd7p4bXgWG1bupNnbuN3y9u119/ffrLX/6SfvzjH6ff//73RTHe+c53pkbTlvWrrOYrAQlIQAISkIAEJCABCUhAAhKQgAQkIAEJSEACk4uAworJdb6trQQkIAEJSGBoCGy33XZpo4026qi8eOUYVmP6iSOPPLLj4uOtYxjtu9/9brr44otrRcfrxtZbb13bdkUCEpCABCQgAQlIQAISkIAEJCABCUhAAhKQgAQk0C8CCiv6Rd58JSABCUhAAhJoSGDFFVdM/CabLbDAAmmDDTYYumovuOCCtSlMVlpppbbLP3v27LT22munpZdeOiEO2XLLLRPTcmgSkIAEJCABCUhAAhKQgAQkIAEJSEACEpCABCQggX4TUFjR7zNg/hKQgAQkIAEJSGACEJg6dWrabbfdOq7J2972tsRPk4AEJCABCUhAAhKQgAQkIAEJSEACEpCABCQgAQkMGoEpg1YgyyMBCUhAAhKQgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAhKQgAQGhYDCikE5E5ZDAhKQgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAhKQgAQkIIGBI6CwYuBOiQWSgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAhKQgAQkIAEJSGBQCCisGJQzYTkkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAhKQgAQkIAEJSEACEhg4AvMNXIkskAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAhKQgAQkIAEJDCyBb2y1+8CWzYJJoF0CO51/YtMoeqxoisgAEpCABCQgAQlIQAISkIAEJCABCUhAAhKQgAQkIAEJSEACEpCABCQgAQlMVgIKKybrmbfeEpCABCQgAQlIQAISkIAEJCABCUhAAhKQgAQkIAEJSEACEpCABCQgAQk0JdB0KpAbbrihaSIGkIAEJCABCUhAAhKQgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAhORgB4rJuJZtU4SkIAEJCABCUhAAhKQgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCfSEQFOPFWuvvXZPMjIRCUhAAhKQgAQkIAEJSEACEvgHAb+zvBIkIAEJSEACEpCABCQgAQlIQAIS6DuB8zsvgW0bnbMz5gASaOFe0GPFAJ43iyQBCUhAAhKQgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAhKQwGAQUFgxGOfBUkhAAhKQgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAhKQgAQkMIAEFFYM4EmxSBKQgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAhKQgAQkIAEJDAYBhRWDcR4shQQkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAhKQgAQkIAEJSEACA0hAYcUAnhSLJAEJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAhKQgAQkIAEJSEACEpDAYBBQWDEY58FSSEACEpCABCQgAQlIQAISkIAEJCABCUhAAhKQgAQkIAEJSEACEpCABCQwgAQUVgzgSbFIEpCABCQgAQlIQAISkIAEJCABCUhAAhKQgAQkIAEJSEACEpCABCQgAQkMBgGFFYNxHiyFBCQgAQlIQAISkIAEJCABCUhAAhKQgAQkIAEJSEACEpCABCQgAQlIQAIDSEBhxQCeFIskAQlIQAISkIAEJCABCUhAAhKQgAQkIAEJSEACEpCABCQgAQlIQAISkMBgEFBYMRjnwVJIQAISkIAEJCABCUhAAhKQgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJDCABBRWDOBJsUgSkIAEJCABCUhAAhKQgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCQwGAYUVg3EeLIUEJCABCUhAAhKQgAT6TuDpp59O/DQJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAhL4F4H5/rXqmgQkIIHeEbjlllvSz3/+8yJB1l/5ylcWv97lYEoSkIAEJCABCXRDAAHFVVddVfy//u1vf5vuueee9NBDDxVJzpgxIy2++OJpzTXXTBtuuGFaZ5110nzz+enQDW/jSkACEpCABCQgAQlIQAISkIAEJCABCUhAAsNLwNbR4T13lnzACCAe6MZe8IIXdBN94OIiqsiZ/OxnP0t/+9vf0tve9raBK6sFkoAEJCABCUwmAnPnzk2XXnpp+spXvpLuuuuuyqo/+OCDid9NN92Uvvvd76allloq7bLLLmmzzTZL88wzT2Ucd0pAAhKQgAQkIAEJSEACEpCABCQgAQlIQAISGC8CeT8keY51X6vCivE6s5M4n7iox/pi7ifib33rWyNEBJ2UBcHBsDGKc1uuLwKKOEadYp0lAovll1++HKXYHrb6V1bCnRKQgAQkIIEBJoBXioMPPjhdd911I0qJWGK55ZZLL3rRi4r9f/7zn9Ott96aEGFgCDCOPvrodN5556VPfepTaYkllij2T4Q/t99+e7rtttvS9OnT0wtf+MI0derUiVAt6yABCUhAAhKQgAQkIAEJSEACEpCABCQggQlFgH5G+iDzfshyBelrpB8ST/q9NoUVvSZqejUCVWKDiTgdBEKBEA7UKj/BV6hv2SNFvSqHh4q4HuDVyIZRYNKoPh6TgAQkIAEJDAoBxBQHHXRQuvfee4siIabYZptt0iabbJJWXHHFtOCCC44o6uOPP55uvPHGdNlll6Vzzz23EFmQxvve97502GGHpdVWW21E+GHceOqpp9KVV15ZE5A8++yzafXVVx/GqlhmCUhAAhKQgAQkIAEJSEACEpCABCQgAQlMWAL0LzbrY6Ty9GHyI2yv+6X7KqxoFUCzK8CO2GaExv94dKKXc+acdzIdBDcAaeY2KOc9v4m7UT8Nk7eGRkqw/BzldeIctmIINvJ4rcQxjAQkIIFeEXj00UcTI/rpXJ01a9aojuZe5WM6EhhvAvwf3meffdIjjzxSZL3MMsuk/fbbL6255pp1izJt2rT0kpe8pPhttNFG6aijjkp33HFHIcwgrS9+8YtD/z/7ySefrIkqAPHEE0+M4PH000+nq6++uti31lprpfnm6+vn04iyuSEBCUhAAhKQgAQkIAEJSEACEpCABCQggYlOoKqPmDpHX+K//du/FX3P7Cv3X4YWoVd9yn1rGYyKUMlujQ73XgHptizGT4UCKO9E58LG5UoIEOIG4Jy1YhG+HDZumPL+fm1Tnm6EFf0qdyf5xrmkzjywsCoPFpy7T3/607WHWzmvqvj5tVMO77YE+kUgrkuu85jKhmWj5xBxGh3vV13MdzSBO++8M11yySXpggsuSHffffeIAIsuumgxop9R/TNmzBhxbKw3vva1rxVeAuaff/707W9/e6yzM/0JTODBBx9MBx54YE1UscUWW6QPfvCDo4RD1157bTruuOMKEnvttVchqAgsCDC+8pWvpOOPPz5ddNFFRVof+9jHCnHFeN8bUaZeLJn+A5EJ04EwBcjs2bNHJDtnzpxCTMJORBYKK0bgcUMCEpCABCQgAQlIQAISaIPA3//+98L7X0ThW4opF6dMmRK7KpcM/uCbju8TjO+WAw44oDKsO9sngGdHBtlUGQMO+G7kXK2zzjrpNa95jdNHVoHK9jGgY++99y72vPWtb00bb7xxdnTwV5kK9ZBDDikKussuu6T1119/8As9QUr49a9/vdaPSP/ha1/72oY1u+qqq9LJJ59chPnIRz6SVllllYbhuz34v//7v+k73/lOkcy+++5beH+tlyZT7NLGRlsSRl1a7ROtl+Yg7qcP5IgjjiiKtscee6SXvexlPS9mlZ6gygtFuS+mHA8tQVW8dgvcV2FFFLZc2djfaBmdXBFmIokrom6dcAke/VxGpztl4OESxgVLJzsWdYxj9ZaEK3uqIOxEfADVYzDo++M6pcO5njU6363Er5duv/fffPPNaYUVVuh3Mcx/DAmU//mSVfl6rvpnTDyUkXF9j2ERTbpLAhdffHHRiFEvGRotTjvttHTmmWcW/8MYvT9e9vDDD9caTcYrT/OZmAROOumkdOuttxaVQyDx0Y9+NDENSNn4X86HH8Z6+XpnqhDi3nbbbemaa65JNAryAYv3imG2ddddN+G5AhFTmQvP8rD4GI5tlxKQgAQkIAEJSEACEpCABNohwFSECN/DWL/hhhuadgYSJm+Puu+++yIJlz0gQNtPfl7yJPP9v/3tb4u+iu233z5tvvnmo74f83iTeR0hUHB77LHHhg7FM888Uys/U6Rq40fgoYceqrE/5ZRTinapJZdcsm4BaMuJa431sTau51byo23t0EMPrRXnVa96VXrLW95S255IK/n/tbIX2F7Uk/99eZ8z/S0M9m6l3yX6bfI+HtabDZhtVu6+CSuiYFS+k07y6KCPdFhOBHEFF0kICeDSysWRM+j3ev6Cx0VbNuoTYVg2ql/OIk9nWLhEx2rUN69Dq+tx47ca3nDjS4B/FGeccUahVF522WXHN3NzG1MC3Ld0KrZy/8Y/5rhfY7vR821MC2/iLRPAIwSiiTDc/DOSf+mlly52cf4RVNB5zBQhiAX/67/+K73oRS+KKC4lMPAE/vrXvxYeWSgowgim/yiLB9qpBHFJ493vfnfigxLvFTQqlT09tJPmWIadO3duw/ryAUgYjHVGiuGVgoY1ngEhSOE4o1ZiKpVFFllklMcPwmgSkIAEJCABCUhAAhKQgATaIfCrX/2qqbDil7/8ZTtJGrYLAltuuWUtNgIB2n8feOCBhIdHOtn5Maqe72tGoGsTj0DeZpKvT7yaDn6NGMyDt9RhOg9lUQXPife85z1NPRMN/tnoTwmjv5zco/+l3ZJEXzX9Nhhp5k4B2k2v78KKdgvcLPxEEFc0q+OwHM9H+EWZUQK10lFJmPyGifjDJKqImzTK3smSNLpVT3WSr3FaJ8B1/o1vfCNtsMEGifnnJ6JVCdnaqWc3/6TayadXYUMYEekhkOA+5IexHfd3LNnPOtdDK884wvfTKGs7z5Z2w/ezbq3mzSiDXFRx2GGHjZrOCddlb3zjG9NnPvOZhGcLxBXHHntsOvHEE1vNxnAS6DuB008/PdEYhO2+++7FtBfdFoqpM0iL+4G0ERnuv//+3Sbbs/hM73PjjTcmvL4wYmHeeedNCyywwIgPcdy4vuIVr0i4cWQ0ShgjIdZbb73005/+NHbVln/4wx9q62usscbAiklqhXRFAhKQgAQkIAEJSEACEhh4ArS57LjjjnU73fjm+tGPfjTw9ZgIBVxqqaWKc1FVF74bGVjANzbGaPoXv/jFadasWVXB3TfEBBhwRXs/Nkwd+kOMvG7RaYe57LLL0ute97q6YQbpQFlU8YY3vCHtvPPOXkcdniT+P4Z1KqrI4+d9N6QdgosI0+pywgkrqHi3apNW4RluNIF8hHZV52J+I+Rh85SGXVSR14X1Tm/OYMWo+Xqsynn1cxv3O/wmq6Ecxy0f8+yttNJKkxXD0Neb+y7uPSpT7x923Ncs8zhVz71BhMJLBOWuV79ymdsNX44/iNt0CIfhmi3OaeyLJaPXmRfyj3/8Y2Lk/3XXXZcQZTSaL47RDHTkMuq9HWP0P52/xG3XGGmPMZWBJoEggCeGGNnEu8R//Md/xKGul6TFvJI898ijmWeIrjNsMQFGEd10000jQtMAVnY/yv0ZHipyYUVE5Dh1yo/l92a+HnFcSkACEpCABCQgAQlIQAISaJXAcsstV3jIw608nXGrrrpqZVQ6FmM6gmnTptXWKwNnO/mWIR5x2v1+4VsIkfrUqVOzFJuvdponA1nwANFJJzZtMLSF0H4zlgbDf//3fy/y+upXv1pkxcCbQw45pGHeCGP49myXJRkQl/PAOWzHusmTfOK6aTXPbvPje53z34l1cv4pL3VcaKGF6mbZ6vXUad27uebrFnqCHvjyl7+cGNyC8Kkb47nGtdbovHeTfllUwWA9RHOtPtc6vQ+4B5o9Xzp9pseUuO22cXfDMY9b7qfJj3WyTv9l9N+QdjsDT/P82mvxz2O6LoE6BGi4j4uTke50VuVKoIhGmLJggH3D7Kki6kZ9MepXr7MuwtZb5g+NemEGaX/5XA5S2carLPfcc086++yzE/PX4+Kp2T+08SqX+bROIL/vWhUd1HvGtZ5r/0JGfVt9TrUbvn81a5wzL7qIJLDVVlutEEQ1isHL49vf/vZ05JFHFiPcyx20xGW6EFxB/u53v0u33357kdyKK65YPA/e8Y53pMUWW6wyi3vvvbeYbuTCCy8sPGLwco9oo5V593jmkOfvf//79Je//KWWJ1OaoIZmqgJtchOgAS7mfuRa77WRJu9uuEUlr5e85CW9zqKt9PiYzEUVq6yySsIDBdN3cJ/wQUhj2IYbbpimT59eNIgxeuCKK65Id999dy0vPnqZL5d9uOUN23TTTdsWTEVclxKQgAQkIAEJSEACEpCABHICfJcgVsf4JqknrAixPG0FMWVhnk6+/utf/7oYSEObxx133FE79MIXvjBtsskmxS/v5KNd4YQTTijCffCDH0w333xz+uEPf1ib9uJ5z3teWn311Yup3FmvsnbzjDTI67zzzkvXXHNNrSOfb8ptttmm6EvASwffc3vssUdEqS3xUHjBBRcUgpT77ruv2M/338tf/vLC82irneK1BNtY2WyzzQrPh0wb+ac//SnhMRGvjrkhpPif//mfYmAOYTD4UUbqF15x8zjHHHNM8e2KeAMhBe1EDO4JkcOrXvWqtNVWW6Ulllgij1Zb7ybPrbfeukiXPGnXgill4Juf8tabEvf//u//inJGHRELrbPOOolv52ZGG+NPfvKTgmHUkfw23njjou2tHP+cc84pykabF+nTBs/AiuiHgi1xGfRYZfDhmuKXtxtw31F/2vPj3qD+xx9/fJEMx8gzt05YE58BtN///veLNknqjNF2SBngvPDCCxf7/PMPArDnGYHhIaaTKUEQvvBM+/GPf1wMiiWtuLa5VtZff312dW1lUQXnk2lzm1m798FZZ51VtL+tu+66ianp8SDLs4jrH9EA91+3z/T7778/nXvuucW9GfcXfX946Nl2220THmDHw6Ifgrxa7btoVq7or4206cftpF9TYUUz0h5vmwDTdSCOiJsuLtJyQoTJp/Yg/EQQVZTr6fbkI8AHAf9MEVe89KUvnXwAhrTG+bOqVVEFVSVePO+GseqUn1+rdW43/CAyoQ5hNCzEh1Psq1ry0YbbuapRHt/97nfTcccdNyoaYgd+l1xySTr44IOLKYPyQHxEMVVOiCI4hmKdRhN+jRTUv/jFLxLTlxA+t8gTN3mf+MQnGnrWyOO5nor7uN2Xae79duOMJ+v82bTyyiv3PGvSvPTSS4t0yavfwgoatMJo0OHDEkPYxCgfxB+MoKIxctFFFy2Ocf+3O/qniOgfCUhAAhKQgAQkIAEJSEACXRCgE5XpCemcpp2iajoQxOF0xmK029DxXWWEwzPn1VdfXXW46Ehm1DfH8coZRrvE9ddfX2zSgUmnb250MDNNIuKJT37yk+n5z39+7XCneZIAg1MOPPDAWlqsUJbf/OY3xY+R6XfddVeigy83Rl3TBkPnYtno3OeHSGWvvfZKiy++eDlIz7Zf//rXp/BaweCaXFhx2223pc9//vOj2gphGe0973rXuxIi/9zCMwmd9nk7EWFgwzSWeFA9/PDDi4ECedxu8+Qa4xyTTxjrXC/8PvCBD4zyVM118cUvfjGCF0s6ePnl7W4jAjy3QTvWl770pRGDGAiT50eb+i677DLCKyvpxrVKm1je3kH8OP+wI25utAEgXClzJQxpMjgY0Qp9VRiDNiIvBpLk1inr888/v7LvK9rxYMYUqyussEKe3aRepxOf65Jzz/3xgx/8IHHvtWqcOwbJla+V/Fpjevf3vve9HXtMoSxlUQWCCoQVjazT+4BnJ9cmg/7yenH9z5w5sxDCxbXb7jOd8l511VWFqCh/FrCfvPhx733oQx8qRFfsH0uLwevk0SthRaQVz6g8j3bq0ndhBSeDB5c2sQjwT4iLMy7QerUriyvK4XLhRfmY2xIYZAL8c/ze975Xmx6k3mj1Qa7DZCtb/rxq9Z91K8+5YeEY9W+n7tSt1fCDxIGX0LBWO8XpfK0SVaDkz0UVu+22W6EOpoHh8ssvT9/+9reLj8YDDjig+ICKuTdpDPjMZz5T+6hDuMHUCuSBep5GgrJoIspM53HeALHrrrsWog3SZHT9V77ylaLjmDzPPPNMFe8BrsEy7mWu51av6YjDNRQf3w2y6MuhvBGq3giTbgqWp5nn1U2a3cTFM0VY2WtU7rawyutMxHMpAQlIQAISkIAEJCABCUhgvAjQqYewAk+DdIyVPQ3S5hAdXIxQriesoMM+RBXhFWHppZcu4uL1gLYB0kG4gLeHqmmMQ1Sx3XbbFSPo8WaBkJ7R/cQl7//8z/+soek0T77b6OQOI7+11167aAMhP3ggqqgyRBMhqsBLJ95FGfH/0EMPFaPS6exnqmY67umkHivLBy7Q6csocYzR8Z/73OeKjmC28TJBRzADZ+hA/+///u+CJUu8iOTf1ITHovN/yy23LAb40B7F4Bk8YMCF0ej77LNPbfqRXuQJNyxG8Iegh3OMnX766UW7U3gC4ZoIUQUDFRAyzJ49u/CSQth654+0aCcLz5CcO84/bWV4WMELBfWnXYzrF7FD2aLTmOt8iy22KEQmeKhEuIBxHTMFQ7S/se/UU0+tcSXPN7/5zYUHEYQqXNfcf8Tn/it7pyB+WKes4REDimlD2mmnnQpvLIg0YEH7YZRhzz33jOwm/ZIpfnbfffd00EEHFSxo72RKkPzc1oNEG+nJJ59cEx9wveABAy843LN4euC8cI3Tb4O34U6sLKrg2momqiCfbu+DEFXgCYdnCd5bNtpooxFVaPeZzjOftuowBCI8m2HJ/xeevVyn9Od/4QtfaDggMNLoZhl1bLXtvp28SJP0I4924hK278KKdgts+OEhEJ0TcXHGxRr/RKImubiCjok4rqgiCLkcZgJ8FIX3ClTo2uATaLdTdfBr1HoJo6M4nt/NYrYbvll643U8d/lf5X6xnXKgfA7j4xYXmWGM3udj+4gjjih2cZwRHhjs+DDG+FD88Ic/XKzzhzR40Y+P1NqBf66cdNJJtV00RtC4EsaHAi4E99tvv6JR4pvf/OaIho8I5/JfBHhP4XxgsWz2HIhrnzjEj3cZtgfJaFwKw4NDO8YHVTPL08zzahZvrI6HFwrSR3XOKCdGKVE2GtfCuL80CUhAAhKQgAQkIAEJSEAC/SZAp1UYgoKysILRwdh6663XsBProosuKsIhNkBQkHvlo8ObjsP/+q//KsLQVlklrOAgni/zzn4EAx/96EeLzjRc6TOYJLx+dponHYrR8Y5nidwVP+0hp512WuGdoShs9gcvAkyHilE/2mPygWy4qef7j1HadJgz8jrnmyXV9WruCp9O2jCmHIjt8lQAePvAszGiCIQqiCs+9alP1QQSkQZLOmf5he2www7FtJS456eDEyFEdKL2Kk9EKkxDEkZbE+UkP7xtML0MHbhY3l7FeYiObvp/OIdcg8QpG+0n4fWScAwaCrEGXj9oR6PTFu8EtLO8+tWvHnGOIz3ED1yXcS3CFQ8wiDqwK6+8shBdsM6UM2xjUbYYeMG9we+oo44qjnONNxJWdMqaey4MbyVxn8ON/Gi/QKxCJ/973vOehvd6pDNZlghhuJe49jFEU61MCcKzM8RmXMt4WYgBc9yLTK3E845rkmcZ11q73kK4TmM6pzgfMT10bFcte3UfcD0HC0Q/3A/x/Il823mmx/1DXO7N3BM79z7n4uijjy6e/xBChAAAQABJREFUC3gO4pkxVgajsG7b7iOdekvyale8MaVeYu4fOwKcqHq/3PUI6/XCsX9YjIsyLkyWVaM6+UdJneK4oophObuWsxUCqPp48UIJ2co/11bSNExvCURnajup8k+dZ1W9H/OaDavlncat1KHd8K2kOZZhcjd+9eYIbSV/7ue4pzfffPMRooqIz8iEeBFl7kgaAjBGjIShVC/bm970ptpUBfkxOohR7mO4RsxFFcXO5/7Q4MK8olgo9osN/1QS4N0jF1I0u56rjg/q/V6vsacSxHM7o1GC4zR28IGW3y/lePkHW55XOdx4bSOYoCERw30qjRKMPmH0R3iAWWCBBcbUJex41dV8JCABCUhAAhKQgAQkIIHhJ4BAAK8VGN+adI6F0X4QngQafXMy3eHGG29ceMGkfSEXVURauViCzvIqY0BYHo4wfOdFmwbbTLGIdZMnnZEYA1FyUQX7+CbFg0GVES866xEa5KKKCE9bShg8x8pyxvmghBhAw3dp1ah12qAYNY/RkR5tSnk5STsXOMQxvDBEvvnAgV7lSbtWbpyLaFtif3iI5PqJtgCmMwlRRcRF4FBVd47n5+Sd73xnTVQRcflef8tb3hKbhTimtpGtvPWtbx3RfsGhXETz8MMP10IjCAkjXogqYh8d7OGpo1nHeqesqVcYAio8goTBmU5/png55ZRTFFUEmGzJfR0De3gOhCeGLMioVbyYhDHNUogqYt+CCy5YeA6Jbc5Lu1YWVRCfaXV+9M9223rpjcV9gEApb9Mj73ae6dzf4aGG53L+3I96rLnmmoXHELaZmmiYrdH/1FbqpceKVij1MAzigfDI0CzZ/AarCjus4oMQTwQHtjG2h7VOVefHfRIoE0AshbKaD6ZQFZfDuN1/AnkHa6PSxLOrUZhhPsb/IK7ZVl808vCDzoYP2fiw4iM2FPftnq9oDCAeyuYq46UWAUS80PPxicI3PoJZrxo9j7s7PuwYaZEbrhFzi7lW832sx4cincmIMQah07tcxkHajvs+3r1iGfujrOyPY7FvkN9d8oYmrrlGIy+oDw0pCAFxR4lxfb373e8uRpvkDSrFwef+4JEpLM8r9o33kuueZxaNHdHgl5eBBh8+Dssfm3mYRut5I2ejcB6TgAQkIAEJSEACEpCABCTQKoENN9yw6NAqTwdyzTXX1JKgQ6ue0WHIoI7c6LjFWydTidK2k6fFALAqq9eWk7dZIKjAOs0TsUh0ytf7PkWUwEjsvM2FPPP2ENo5mNakyogPyyrRQlX4TvaFwIO4MWAHroglMAQQOfNi5z//5FNT4rkjOowjDJ2a5aktOTZ9+vRC+ML0MDFdSK/y5NxHO1KUg+USSyxR2wwxANdTGKKEKstFDvnxaGtgH3XPPcpGuBiQxDbXb5Xh3aJseVnjOiVMPkC5LByKNPIpbmJfedkNa7yphOEdgXYXvMFwD8CQeyy/zyKsy38QKE8JgrcXnollUU/OC681GNc208pUGR5SwvJrM/a1uvzABz6QEM8ce+yxRRQEMgjH8IxRZXle3dwHyy67bFXytX3tPNPDi1BErvd8DYEKAivEGDyXxtrGwmNF/hzrpPwKKzqhZpwxI6C4YszQmrAEJNAigfCe02Jwgw0hgfxjhfPdqbAi/0hv9DKfHwthBR/CWL2Xe47l5WQbiwYI1lFA82tmND4orGhGKdW8VoRwIpYhrhg2UQU1zj+iQszTiAQffbhVZE7YUJ/fe++9ad999y2mtImRVJFGnmaeVxwf7yUNHcwriaiCOWxpzKFRhgYiPvYYkdCO8fGeG/c8bkJJn7yqGrvy8K5LQAISkIAEJCABCUhAAhJoRiDvnL7iiitq0wTENCAMzmrl2wPPCXge/PWvfz1ChNAs/zjONBpV1ijvdvP8+9//XsuikTifaR3Lwoq8k71qpHgt4X+uIHLgu61TYX05vXw7FwREm8+cOXNqQeik/OxnP1vbrreSi0UiTC4QiH2xjHOEsALhf+5hsps84V1luacFWGKtnMN8ms483bxNKzqh8+Pl9bwDOo4hWsnLFfvL3++x/8YbbyxWG7W/RdhGy27OL21yTF3ymc98psiCTmkGssRgKTrhN9lkk2KA1Vhcr43qNSzHylOCME3ywQcfXFl87o0QP8X9WRUQ1gibuC7z67oqbL19eBvBczDGOQyvJscdd1w67LDDKp/dvboPmoka4nlRLnvVMz0XVvzqV79K/JoZcTptU2+Wdn6c+2QQ2hzzMg28sAJgjDwLBUk0cueVGKZ16sPIxnpGPaOONOQ3UuMM2sVUr07l/WWvHblqkLCKK8rE3J4oBLifGblepaqdKHUc1no0eta2W6d4pg3rMzrqy/+g6FCOF/04VrXMw1cdH6R9+UtfeK5oVj46Ug855JBCccz0G3TYhgtG4jb68In5IgnHyz0fozEtAfvqWdULcj6ygQ/VmTNn1ote258r9Ws7XakkENd8vIvFksD5OtuD7KmC8mGM8uEaobEln37mH0er/yJIYAoQXAYyBy/XHIKE/L6JmJEmeZBXv437Ob4ZUNHzsYqogl/Ug/smRuJwb9AgljdGobhHQIGwCRem3NvRgIQgisY94vHxXW8UTr85mL8EJCABCUhAAhKQgAQkMDwE6OR61ateVUz7QfsL03nQ8RodW2WBe1XN+E6hE69stFswspvvufAeXQ4T2zESObabLTvJM7weNEu76njejlL28lAVnn20wbRbr3pp5ftzkUcIIThnubVSxioxQDvl7UeeTLsZFt/KsR3LvB0s9rFs9xzyTV62KlFFOUy+jfcSrN14eRqsd8ua9gMGseCtgikX8o5sBq3ww8vCHnvsUWuzKJdhsm8zxQziM9p6rr/++mJAUFW7aN5Gm69X8Yv7rZO20912260mqiDtd7zjHYXHYs4tZfzmN7+Zdt1111HZ9uI+iGlwRyWe7Yi6ZbvqrubtzaTdygC9evd/3UzaODDW/SrRdkiROslroIUVeYN1Xrlyw3Yb52MgguZ1aVQgOvpaDdsonX4fyzsZy6KKemVTXFGPjPuHkQD/wBFU0EmlDT4B/rF2+uzl/1P8j8r/hw1+rf9VQuqOoLFVBu2G/1dO/VvDreLJJ59cFOCqq65KzOvYzJhrLxS7qN35IMoV/SihUU9XWT6SgU5dngnEJ+/8WDluPk9nHMsV9rvvvntiPkuttwQQV/AciPeXuKfzXIbl/uZaoxHukksuKaa/weXkFltskVel7jrXFmIJRpEwv2tZ5f8///M/NUbk0exjtW5GPTxw//3311LDNSy/KuO5tcYaaxQNI4zmyo0PXFweMr0PH+iMHMmnPImP7fyjM4/vugQkIAEJSEACEpCABCQggXYJ8E3105/+tJjC4k9/+lPCcyCGMKJqrvs8fb5NclEF33KMoMYjYXS+8Y0bwopedIZ1mme5HSWvR76edzrH/rw9ZJ999hn1jRrhxnqJsCA8PJLXCiusUGQZAgs2mNq1leklioilPyEEKO0uNuO64DsV8UKv8qzKq94+vDiG5YMUYh/LsgghjjHYkPpxXYb3hjg2VksELngGqbqmIk8GWDz88MPFtC5VYhfC9YI17Sq0J/FDnIPHTdokrr766qIoCC7oQ8i92EQZXf5j2mOEJwwGwpgSZLvtthuFhvYpnhec96q21TxCXBcxpU9+rNl6/kwiLCI5pgVhYB7Gc4LpRmiHzq0f90Gef9V67jV5xx13rDvldVXcsdpH2x1ts9E+28t8Is1W+z/KeQ+ssIJG7apKlUcSlivk9uAQ4GUtLtBGpeIfCRYvdxFWcUWQcDnMBFZZZZXiZbqRe7thrt9EKXv+/yZXLLZbv7wDNk+z3XT6FZ4yxzO5lTK0G76VNMcjDCM1aGDAzRsfLwgmyi+5eTn4aD799NNru7baaqtiPfc+g6r85S9/eS1MvhIfSOyLRgQ6rBFW0GEbH5V5HNbLbi/Zl8+fx3yd9YQVF198cSEO4CWfj7JWlMakr/2DAPdBvfcYjg3T/b3DDjuk73//+8VInRNOOKG4TvMPpkbnnPukyj0nHh1OPPHEIiqNOeQxCLbSSisVH84hfqhXJt5Pacjhfqo3x2p4pFl11VWL+xbxFJ5r2I9Ayv/r9ei6XwISkIAEJCABCUhAAhJol0AunmBgR3hEwJNFeNyrl2YuBP+P//iPyu8zvuHC8OLQrXWaJ99SYdRz2223HSXSp7O+qj0k78Qk/7L4n3Sp29lnn114qaD9BX69NtpbojMWwX4IDeiQp3OWb8c//vGPRVmqPDdQdtqhcNO/1lprjfJsjLCmypjmMrgjrMB6lWdVfvX25e0hlLXKk2M977CIHPA0QDsYA42q2iYYMHHBBRfUBjp06x2T734GTyD2qJfnOeeckxiIgsVArHL9u2FN+x0eKRAk4ZEG4/rlx/QRP/jBD9KXv/zlYj/XvsKKAkXlH9p03/zmNxf3OQHqTQvEoHWEFUybw6CbqnZR2oZCBBTttZWZtrGTexOxR5SL6wnxVf686sd90KwKefl4fjHYqMp+/OMf17y8Igis8rZcFa+TfZzD6F+mzyW0AZ2klcfJ+2869WI+JU9wkNYbVajRsUGqw2QuS73OiDKT6Jyo1znXajrldN2WQL8J4Er9jW98Y3rTm95k50u/T0aL+cc/Z/5h5/9gW4w+Ik6k1WrcQQjH85hfq9Zu+FbTHa9we+21Vy2rT37yk4W7vdqObAU3lUyHEB/1fPTF3Hn874pGga9//euVKmg+GH/0ox8VKeLRIsQYiK7CzjzzzFitLVGtI7woGy/6dHZj3/ve91LMFZmHY3qGo48+uhCDMOdg1dx5eXjXqwnEO0p+tGpffnwQ12nkCS8VjMLodlQIo5u4vsJjA2lHQ1K/68+cpyGqoIGLH8IIPmLz0SWUk4YcXIFyvOqX3zeIKBBtvPjFLy5c6Cqq6PeZNn8JSEACEpCABCQgAQlMLAJ8m+DlAKOD98orryzWN9xww2LZ6E94MSBMVech327nn39+LYn4Zqrt6GCl0zwZSR6DVWh/u/zyy0fkzvfmWWedNWJfbOSiePoMEBqUDW+N5557btGpGVOplMN0ug23Sy+9NJ1xxhm1JKIusWOdddYpVhFe0FleNjwkfvazny3ac2hHqqoDHcEM3ikbeUcncD5VZy/yLOfVaJupQkPkct55542YWjPicQ6qjNH7YfkAptjH8itf+UpxD3COuxn8FmmuttpqsVoINmob/1zhnEQ7MG11VfdQxOmUNekj+KEdD5FF2YIn++lT0BoT2HrrrYvpWRuFysVqCHXKVn7W1BssV47Xyjb9QSF+4p49/vjjUz4NUj/ug2blRugV1yHt2FXiKJ5NCEX4f8I0J91Or9OsTLkOgHsoRBbN4jU7Hvc74TrtwxlYYUWufCuDaHSsHNbt8SdQvsg5X1UXaLlzgnDsK5viijIRtwedAHMXvve9723qqm/Q6zHZysdzKv6/8BzL/8k2Y1EOX/XMa5ZGv47Hszfq3qwc7YZvll6/jvPCvOmmmxbZ8xGF0ALXmczVhycLRgEwCoFpQvjwCTv88MNr83PS8frBD34wDhXzIPKBxMsyH8c0EHzkIx8ZcTw2mG4lVP18TH71q19NdHrzoU4Z9t133wg6YkkjxIc+9KHavj333LPIh5H0NJZwLVLGMP6vjvWLbuQ1EZf5u0q+Pmx1xQVpzO/KqKDPf/7zlQ04zerFNYYwIxoCEPl06t60WV6dHGcECMYoIcQe/Gh844MaJX24wSUMjUGaBCQgAQlIQAISkIAEJCCBQSFQ9qTJ9wsi8GYWgy8IRwciAzDw3ED7Ah1hn/70p4tlpMOUB91aN3luueWWtezppKM9BE+ffKvyvXnZZZfVjucrDHTZZpttil14hTj00EOLelFXvBz88Ic/TIgVwvJ8Yl+zJQJ8pr2MH8IBphs45phj0vvf//5iPdIg/byDlP2MVA/vh6eddloiPm09lJGBN1/84hcLkT9h8cTAIIAqY4APU0RwDmlfuvDCC2uCDuLlgpte5VlVjnr73vWud9UOfeITnyjOAx3V8GOAT5UwhAh8l8dAI4QvdDjHVA20xdEPhHcJDI71Rs0XAVr8Q9tbeL3Amyd5xD2AZ5jjjjuudk7wHtHIOmWd39tc7z//+c9rU5fiVSEX60RbYaNycIy2R6adeN/73jdiKqCIR704xq88TSrirTiWe9mNuIO+xIsPU4I0Ms5lCAW4n3k2cH1iXHO0i8W1hueYXnoJwVMNz4swnsPhwYJ9/bgPoiz1lrQ377rrrrXD3Ne0T+PFmWcQz6MvfOELteN4R6o3bU4tUJcr9EHk/RXcN91a3t/TTf/NwE4Fgvokh5YD65UyJU/T9d4RyC/OvGOIC5UXubCq88s+Oi74B5cb24PaoRE3YK6gysvu+uQhwGhY1OWMatWGkwCd3fE/Jp5lcY/XqxHhIixhmoWvl04/9lPWdsrbbvh+1KmdPPfbb7/Cm0MolxlNUDWiINI86qijRk0bsPHGGxcuHBk5gEvBXPQQ8VgeeeSRad11163t4iOAl1Q+BPh45EOdXytGOttvv30xigNRCI0JVcb1PChTNFSVb1j28f7R6L10GOrBiIsjjjiiuN5o1GH0CI1W+++//6iGoHr1QUzBPcBHP4a7P0Q8jUZz1EtrrPfTyEZDzsyZMxONOzRi8eEcH9F85OZuDse6PKYvAQlIQAISkIAEJCABCUigGQEE4XQmh1eCjTbaKFVNJVFOh3ZIOo7xtMk3z8EHHzwiHcLj/ZJjpB2C9HI67Wx3kyffkLSH4LmBMuFlgl9YzqBcfzxEUE9ECnynH3TQQRFtxJK2kNxTwYiDDTbgk3dy1wtKOWgrKBtiGAYf0KmN4aG0ykspgwHyjtdyOpSjalpOziPtTvn0ML3Ks1yGRtt0QtMJi3cJ2gjK5yE/h3k6dN6+5z3vKdoW+G7/xS9+UfzyMLH+0Y9+tGfeGxCCMJiK643R9rkHl8iPNn3uuUbWKWs8XdBGR8cwvKKDuszp9a9/fWq1j4l2DhhisczLjtiI+mK5twS2aUuMY1VeUwgz6FaeEqRc3nnnnTftvvvuRXss9xNikpjuJQ+Lp1MG2+X3VH6803XanHgWxNQyXHN4QWVAbr/ug2Z14X8QHtgZYAgzBF5VxvVc9tZTFa4X+3jORp8yz3z6YNrpy8jL0Ms+nIH1WNFIfdILF0A5UNd7RyA6JEmx6gLPxRR52LwEIa7I97GOuKJenHLY8dyOjsa8buOZv3kNBgGUhrxQKqoYjPPRaSm4j/NnF/9w+edd/sfLs4gfzyWOhcXzILYHdclLOi8meV0blbXd8I3SGqRjvGTjUYIREXzg1DNEDHRE5wrzCMvL8AEHHJA+/vGPV84NyYc8Ixt4RpSNxgSmVKg69va3vz3tvffe5Si1bQQZpJuPEomDuA3k+CGHHNLzD4PIY7ItJ8L/eOrANYN7PwxBDx5XTjjhhKJhio+msrGPaWkYRfLhD3+4JqogDdIaNC58pHJfYzyjf/e736Xf//73Rf1iDlw8uCBOokFEk4AEJCABCUhAAhKQgAQkMJ4EcqFAvk4Z6NjL2yaq2grieyeWxCMdvFnGVCLsi+87Om4ZZU+7xxve8AYOFd9K8X2UlyFfLwL+80++nzYQrJs8iY9nQYT6dOKFBwNGlzPKnLLGvvJ3G55DEY7svPPOld90eGrk25XR1L00yoaYAJaf+9znKkUVkR9tR4Shw7bKNt988/SpT32q7tTRdO6/+c1vHhWVzkzanxZeeOFRx7rNM7+e8sTz/fl1QBhEAO96TrDANZYb54Apd2N/XDMRhnYs2lqJX2XUk4EhfN/nFmXppAOcPBHyVAknKCdt+nifDsvrmq9zvBPWMNhtt92KQVLBhbTiPuX6ohM+9xjA8UZWLlc5bM69HLbRsXI6470d57mVfJkSJG+XyutFfJ4ziAPy52qe7mabbVa0C+dTwebHq9Zzls3KyjP5Fa94RS0ZBFdxzju9DyL/WNYS/+dKvj9fz8Pl+8vMdtppp3TggQfWvH3k8bh23/GOdxT/b/K652nkaedxu1nPRWzlPppW0q3qw8nTbCWNcph5nlO+zS3vzLdbdT2Tx2llPVQmjcJWdVC1Ci73lNAoj0E7FieZcnFy8wfDoJW1qjx5+Sl7+QLNz1+z+uVp5Xk1i5eH7dd6iECqGLRaprhHukmj1bzaDTcWZQtmlGVY7l/U0cx5+NrXvjYts8wy7WI0/AATyJ9VrRZzGJ5NrdZlsoZDpc2oduYK5QURdTEdyPkLYjM2uNdDAMooeUYS4KqyFSPP22+/vZieYIXnXEHmL6jN4jM9A3nych55thO/Wfoen1gEuMZpiLruuutGVIzrnA+7mAeS6XBuvfXW4lrOAyIWohEIL02DaNwHuPOcM2dO4bIQt4W4J2TqDzxYLLvssi2N+hrEulkmCUhAAhKQgAQkIAEJSEACjQjgoRBvmrQT0Fm72GKLNQrek2Pt5slIeb7PGrmRxysD4g9c9DdqJyYtPADQmcc3Kt987bTh9ARAg0SYyoPy8X2Klwp+9Tpx6VTne5bOWDrZ8UhA/wjftLT1ULdWrJ08W0mvWRi8IVBHzgVtCmUxTKP4tJ3RHsY3PIIR2tAYLDSWBlfyw8sD1wx5dtoZ3Alr8ucepW2GgR8MZsvFFmNZ90Zpv+QTuzU63PDYtYee0vD4IByEO88UrjfuJc57vXtxvMvbj/uglTrSTn7bbbcVU4HQPs6v03ullfwahanqq6nSD5TT6CReK/fCwE4FAoCodIgL+Ecy0S3vRI96D1Od8zJXnS/OaVgeNvbly2BBh3tubNuBmRNxvV8E+Oerm/1+0R/bfOMfc/wfapRbhG0UxmPDQYB7GmU9v04NLxQxd2M7acQLajtxIiwNEjGaI/a5lEA9AjQcMK8rrlaZ8zVGKvEhh0Cnnmc4GnJ22WWXhKJ/kBqqyvWkQWL27NnFr3zMbQlIQAISkIAEJCABCUhAAhOZAFM28htPazdPvDkwWG3VVVctPG2Wvy8ZxBbfqc08A9OJ305H/nhyIS8GvXTazkQHJgNv2rVu8mw3L8LjQQJBRSfGuaeNgt94GVwZINmLQZKdsCZ/BnI5Pel4nfF/5AN3xGb8Bs36cR+0woB2cqZcGQSj/wURUt5XHP029CNzDGMZs2FU9U/3ql+5b8IKQOSd7I1OThWARuFJe5itmeBg0OtG+eOc4dmA80Ejfeyj/K2eI8UVg362/+E+bvBLOTYl7OTldmxKYqpjRYBnFT+eX9HZyDJciA3783qsuJmuBCQw2AT4aMP9KK43abRiXtNrrrmmUO7jdQVDJITgh/kfN9xww4Q7zk5cbg42CUsnAQlIQAISkIAEJCABCUhAAuNJACE8wgp+F154Ydp4440LMQieD2666aZ0yin/Gv0+Vt7Ux7O+5iUBCUhAAt0ToB8GD0YhqIgU6bfJ+55jf76MfuZ8XzfrfRVWUPBWxRWtVjI6wVoNb7jeE0D1k0/rUD7HXMStCisoXVz0uRqp96UeuxTL9R+7nMYvZc5JPLCaPbTaLVU710a7aRteAp0S4Jrnp0lAAhKYSAQQSqy33nrFL+pFYxamiCKIuJSABCQgAQlIQAISkIAEJCCBXhHYdNNN06WXXlokd/rppyd+0dac5/H+978/rbjiivku1yUgAQlIYJITCA0A/a7lAf05Gv6v4MGCX6/7dfomrKCCASCvrOsTgwDiCi7ssqiAC5hj7RrxGs2n1m56Yx2em7VXwgPSGjRjtH6vBRXUMR52g1ZfyyMBCUhAAhKYLAQUVEyWM209JSABCUhAAhKQgAQkIAEJjD8BpsY49NBD09e+9rXCQwUlyNuZcdW/7bbbtjUwc/xrYY4SkIAEJNBPAvkA7fx/CGXqtZCiXM95jj322Lnlnfm27pZyGq53QiAu6rG+mDsp21jGYRqUbg1mnQhRus231fhxblsN3yzcZLtGmvHwuAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCCBiUZg7ty5haDirrvuSnPmzElLLbVU4aGCaSkno8Hh2WefTQsttFBaZJFFJiMC69xHAi/5xG4d537tof+avqfjRIwogQEh0Mq90FePFQPCyWKMMYHJ2lke8/10incsXNR0WpZ68Sbrua3Hw/0SkIAEJCABCUhAAhKQgAQkIAEJSEACEpCABCTQmMA888yTZs+eXfwah5wcRxGWaBKQgAQkMPgEFFYM/jmyhENMIHdHM8TVsOgSkIAEJCABCUhAAhKQgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJi2BKZO25lZcAhKQgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAhKQgAQkIAEJNCGgsKIJIA9LQAISkIAEJCABCUhAAhKQgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJDB5CSismLzn3ppLQAISkIAEJCABCUhAAhKQgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJNCEgMKKJoA8LAEJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAhKQgAQkIAEJSEACEpDA5CWgsGLynntrLgEJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAhKQgAQkIAEJSEACEpBAEwIKK5oA8rAEJCABCUhAAhKQgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCUhAApOXgMKKyXvurbkEJCABCUhAAhKQgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAk0IKKxoAsjDEpCABCQgAQlIQAISkIAEJCABCUhAAhKQgAQkIAEJSEACEpCABCQgAQlMXgIKKybvubfmEpCABCQgAQlIQAISkIAEJCABCUhAAhKQgAQkIAEJSEACEpCABCQgAQk0IaCwogkgD0tAAhKQgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAhKQgAQkMHkJKKyYvOfemktAAhKQgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAhKQgAQk0ITAfE2Op6uuuqpZEI9LQAISkIAEJCABCUhAAhKQgAQkIAEJSEACEpCABCQgAQlIQAISkMAQEXhJF2W1D7kLeEYdOAKt3At6rBi402aBJCABCUhAAhKQgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAhIYFAJNPVasssoq6Zlnnil+FHru3LmDUnbLIYGuCTz66KO1NMb72n7ggQfSLbfcku6444503333pccee6xWFlamTJmSpk6dmmbNmpVWX331tNRSSxXHn3jiifTII4+kO++8M910001pzpw5I+IN+gb1WGONNYp69bOsjz/+eMGdJTZ9+vSiTCw1CUhAAhKQgAQkIAEJSEACEpCABCQgAQlIYGIRiDZVlv002yH7Sd+8JSCBXhKYPXt2L5MzLQmMIhB9oAsvvPCoY73cMc8887SUXFNhxfzzz5/mnXfeQlAx3h3PLdXAQBLogsCzzz5bEwtxfY/nNY5w4qmnnkpPPvlkUQPus7Jx7Omnn07zzTdfWmCBBWqHiRfhET4Nm/FcyevTj/Jz7ikDS4x1ftOmTetHccxTAhKQgAQkIAEJSEACEpCABCQgAQlIQAISGEMCtKnS/seyn2Y7ZD/pm7cEJNBLAvan9JKmaVURYAA6NijXWlNhBZ23dABrEpiIBBAtYCGqGE9hRYiWuMca3WccKwsriBvxh+3+rKpPP64tBBUwDGEK6/FR04/ymKcEJCABCUhAAhKQgAQkIAEJSEACEpCABCQwdgRo+4t21bHLpXnKtkM2Z2QICUhgOAjwXNUkMJYE+J+JDcq11lRYUe60Hc+O57E8EaYtAQjE9R3CCvaN1zXOwwClFQ8DylF2M4MAgeMLLbRQLQzlIxzhEVuQxqCotChbK0Z9KXuwbyXOWIQJjsGd8sRvLPIzTQlIQAISkIAEJCABCUhAAhKQgAQkIAEJSKB/BKLtL9oD+1WSKAdLTQISkMAwE/A5NsxnbzjKHtdYLMeq1K2+GzQVVpBQ3tHcasJjVTHTlUAvCcT1HNd5fq33Mp+qtBAXMJ8ewomHH354lLACUcXiiy+ellxyyUJgEWXl4cE6wgvihteNqjwGcR9lpu5Rn36VkfzjRxlivd/l6hcP85WABCQgAQlIQAISkIAEJCABCUhAAhKQwEQmMCjtf4NSjol8rq2bBCQwPgTsTxkfzpM5lxBUxLLfLJoKKyigN0a/T5P5jxWBfl7beJuYOXNmevLJJxPTUiCkYFoK1rEZM2akpZdeOi2xxBKjhBXEXXjhhdOsWbOK5VjxGYt0qTN17Sd76kX+8avaHou6m6YEJCABCUhAAhKQgAQkIAEJSEACEpCABCTQHwLRFjho7ZL9oWGuEpCABLon0O/nafc1MIVBJzBo11hLwopBh2r5JDCMBBAXIJpYcMEFCxHFQw89lB599NH01FNPFdVBWLHccsulRRddtBAiRB3x9oDXB8QViyyyyNB5rKDclF+TgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAhIYTgIv+cRuw1lwSy2BDgkorOgQnNEk0C2BmMoDocECCyxQiCQeeeSRmlACwQWiirIIAXUWcRQodHsGjC8BCUhAAhKQgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCUigOQGFFc0ZGWISEJg7d27fahkeKPBgwfQeURaEF+zTJCABCUhAAhKQgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCUigfwQUVvSPvTkPAAFEDHiA4BeChvEuVu6BYrzzNj8JSEACEpCABCQgAQlIQAISkIAEJCABCUhAAhKQgAQkIAEJSEACEmhMYErjwx6VwMQmgJgiBBUIHDQJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAhKQgAQkIAEJSEACEpBATkBhRU7D9UlHILxVTLqKW2EJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAhKQgAQkIAEJSEACEmiJgMKKljAZaKISCC8VsZyo9bReEpCABCQgAQlIQAISkIAEJCABCUhAAhKQgAQkIAEJSEACEpCABCTQGQGFFZ1xM5YEJCABCUhAAhKQgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCUhAApOAgMKKSXCSraIEJCABCUhAAhKQgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAp0RmK+zaMaSwMQiMHfu3L5X6JlnnklPPPFEevbZZ9N8882X5p133mLpNCV9PzUWQAISkIAEJCABCUhAAhKQgAQkIAEJSEACEpCABCQgAQlIQAISmMQEFFZM4pNv1VNCUDEowgVEFffcc0966qmn0vTp09OCCy6YFlpooTT//PN7qiQgAQlIQAISkIAEJCABCUhAAhKQgAQkIAEJSEACEpCABCQgAQlIoE8EFFb0CbzZSgBRx9NPP52efPLJ9Oijj6YHHnigJqxAUDFjxoy02GKLFSKLqVOnFh4soBbxEGAQlzSGyRCKKBgZpjNmWSUgAQlIQAISkIAEJCABCUhAAhKQgAQkIAEJSEACEpCABCQwuQkorJjc53/S1z68VbAc7+lAEEQgqLj33nvTLbfcku67775iKhDKwTQgCCtmzZqVllxyybTEEksUYgROWMRDiEHcRx55ZKjO48yZM9MLXvCCxFKTgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAhKQgAQkMOgEFFYM+hmyfONCYLxFFVQKjxOII+666650++23pzlz5oyo62OPPZaeffbZNGXKlLTIIovUhBXsQ1yBoIK4pDFMRtmXXnrpYSqyZZWABCQgAQlIQAISkIAEJCABCUhAAhKQgAQkIAEJSEACEpCABCYxAYUVk/jkW/WRBMZbXME0Hnic4PfEE0+MLMxzWxy/5557EtOALLvssqOOP/PMM4XHi4ceemjUsUHesfDCCyfKrklAAhKQgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCUhAAhIYBgIKK4bhLFnGCUkgvE7geaJKaMA+vFYwXUjV8fBcgQBjmAxPHZRdk4AEJCABCUhAAhKQgAQkIAEJSEACEpCABCQgAQlIQAIS6B+Baw89pX+Zm7MEmhC4//77ixAzZsxoErI3h+mTxW688cbKBKdU7nWnBCYhgXnmmWcS1toqS0ACEpCABCQgAQlIQAISkIAEJCABCUhAAhKQgAQkIAEJSEACEpBAIwJ6rGhEx2OThgCiivGeCmTKlClpgQUWSPPPP39ivWzzzjtvcXyhhRZKrJeNOPPNN18RpnxskLfr1XeQy2zZJCABCUhAAhKQgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCCByUtAYcXkPffW/DkCiCn65akCscSCCy6YEE489NBDo84Hooslllii+E2dOnXUceITl6k1hsnqCUWGqQ6WVQISkIAEJCABCUhAAhKQgAQkIAEJSEACEpCABCQgAQlIQAISmDwEFFZMnnNtTQeMAJ4bZs6cmZ588sn0zDPPJMQTLJ999tmipMwXNGvWrLT44ouP8EoRniqmT5+ellpqqcRymIw6IxrRJCABCUhAAhKQgAQkIAEJSEACEpCABCQgAQlIQAISkIAEJCABCQwDAYUVw3CWLOOYEQhvFeM9DQgVQkiBRwq8ViCiwGvFo48+WvNAwb7lllsuLbrookXYgMD0H3h9QJixyCKLpKeffjoODcWSclN+TQISkIAEJCABCUhAAhKQgAQkIAEJSEACEpCABCQgAQlIQAISkMAwEFBYMQxnyTJOSAIxlQdCAzw4IJJ45JFHakIJBBeIKsoiBMQgxFGgMCEvCyslAQlIQAISkIAEJCABCUhgKAgwQIFfeF3kWxUPi1gMYhiKilhICUhAAhKQgAQkIAEJSEACEpBACwQUVrQAySASGEsC4YECDxYLL7xw0TBFfggv2KdJQAISkIAEJCABCUhAAhKQgAQGiUCIKvCg+NRTTxXiCr5t4zdIZbUsEpCABCQgAQlIQAISkIAEJCCBXhBQWNELiqYhgS4I5B4oukjGqBKQgAQkIAEJSEACEpCABCQggZ4SCI8UCCieeOKJwsMiHirYfuaZZ4rlk08+WQwQYHBACCtYsh2/8NTIdjsW+SPewMMjS4z0p02bVnh/ZD08ZbST9jCHhUtMCwrT8ap/CGo45/n5aJVl7skkPJxQdurANRLXz3jVp9VyG274CHCtxnOD6xVjH9br5wfp8jwkn8cee2zEcwpvtHipJc/8+i8K8s8/cT9FObn+45nJgKt2n5t52q5LQAISkIAEJCABCfSWgMKK3vI0tSEmEB9YQ1wFiy4BCUhAAhKQgAQkIAEJSEACEugZAUQUdPY99NBD6b777iuWdBwisuBHZyI/LDrK6UCkI5EORaa25MfUl0x1yb56nYtVhSZ/Okfvv//+dMstt6Q5c+YUwfD2OGvWrLTYYoulGTNmFPlVxZ+o+xBVIGygHWP69OlFJ2w7XDvlQn7kzXn461//WjsfraYX1whLOov5ca3ENcK5pD7sG4/6tFpuww0XgWjfe/jhh4vrlGcXz6nYz/Nj6aWXTs973vNq11s3NQxRBfn87W9/Sw8++GCRHNdzng9iiSrjXr7xxhuLZyzHEVPwbOO3+OKLj5oiuCoN90lAAhKQgAQkIAEJjA8BhRXjw9lchoAAH1jxkTUExbWIEhhBIK5fGh1p6IzRSyMC9WAjRnawpBGsXmMX+T/66KNFI2wPsi1Gd9AIS0MEedbLNxpeyZ8G4GjkbVYG0mNUCPWKX9SvXl6N0oxycD74lctBPWg8JK9O0o9nFXWsOt+UncaYqEuzEV/1zleUs14DUDCI+pa5RzloGA2eEafRMtIr8yMN0qI81K1ZvRrlwTHOS+RB2R9//PGCJ3w5P9EZQH6dnKfIn/SiTuRBXlhcd9QpzlfEGaslZaHedIRw/VCW+LGfclIu6gxvlvyCezvncazqYLoSkIAEJCABCYw9gXh34Z2eTkI60u+9996asIL3iHrv2/EOEe9TdJSTDu8aCCzivZ5aNHvHincX4t99993Fj3iINEiftCnrRDc48OPdlfc4OmIfeOCB4p04eHO8Gc9uOcX54BskPx+tphvvv7zHxzsn75mcSzrBuT74sY1HEt5De/He32r5DDcxCMS9wjV11113FT+eE/Gs4BqLb2W+w7gGu7HIj/vynnvuKX6khzACEQfPKZ579Yx7mufrHXfcUdznXP+kSblmzpxZL5r7JSABCUhAAhKQgAT6QEBhRR+gm+XgEOBDno8VTQLDToDrmM5RGj1vv/322giJXtcrRobxcc9HPo0RVUbDJyM1aOyjbN3eZzR8LLPMMkWjAnnWazCkoZHRdHBgVBsNfq0YadKgQgNG3vBBHSl7vfzqpR3loP5RDtKIH/V5/vOfX9Snk/TJl/NNXW+77bZR55tGG0a2cJ5ixFe9srK/3vki/vLLL1+k04hB1LfMnbyXWGKJIj5s610v5bKRHmlFeogRMOpF4xTl6sXIRPKhk4DzBEsa3RgJyTnh/FD32bNnFw33nZ4nyk0DHh0P5ENjGQ18WFx31IcRl63yKSJ38Ic68ON80+DHtUlZqDtL7heY0IDNfRA/Oi64nmDOORjrcnZQNaNIQAISkIAEJNBjAvGexDsD75u8M4UoM8SYLKss9v8/e3ff5NxRHnh4xi+AWXZJAuEdx2AI2c37v1u1u98wHyv736ZStUkFWLDD2lRIcGxwsLENnuWnzW0OQpqRZjQzkubqqvNII53Tp/vq1jx97u45mvFFY6AZb/3+7//+alzfuKIFAbukmRCdxaAd0/MpR+Obc0/VccbIjVmbhM00x7l+ueui410NK0ttkn/tsG+a64oe61ONTesr/bV/iym6bmj8WV/pcZfrmX3LYP/zFqhftsih65z6VwsXSvO7ouvL6W9di9Xn7prmc7Hp91Tvzbk3naf3+ny39Xz5+23T/l4jQIAAAQIECBB4PIHNM2KPVx5nJvBoAnNxf93FzqMVzokJ3CBQYKuL74Jrr7zyymqC+IZDbvV2k6tNuhbwum5ytSBGt4YtCFu66+fqc5/73CrYUVCtgOG2oGEGTca3uOS11177rQUH2yo9E9zLhRWdqyDl/DVc9d41+LupHPM7pseChE1Qt3DjugUq28pbwCXjH/3oRxf/5//8n1VgdfbNusUH9YmpV+e4Lm1rrxazzAKN8p06rOe1qb7tk1+3Pi2fL33pS6vA77Y8lnmWX0Gwaceel2ahR+0wfsvj9n3eQoLO0VZgrUUPLQiqrp0z54LV8/3du7b/ejlqi4J5LWTo89kERal2Kf9ZNFSfu49UfSpD9e13RH9dWJ0LyM/Ciurb+9nXb2ZRReXLvX5Qv20BSAuDWoh0W4/7qKM8CRAgQIAAgcMING5oPNAYoTFL46Mm8vu51Di8scJcD/TzcnzXmKM8ZpKwCcx+bgK918q7Y5qUb5zRmGKXVL6ztf88L++2c0+5NUHcApeuAWqbxvA55PpQBnOeHqcNxr6x4Wzbrtfat2OXx1f+mfiunzVGrq7TX+pf5Vfey7425/VIYF2gz0vXN8UG6luz2Gv26/dR73X9Ne+v/y6bfXd9XO/XHTefkd67Ls3nYcq563HX5ek9AgQIECBAgACB+xGwsOJ+XOV6IgLLi5su0Jc/n0gVFJPARwIFDwoOfP/737949dVXP3r9kE/6K/4mV/su0ia2t6WCfJWjSf9DfK5eeuml1R0EOncLHLalAiRNHLeg4zvf+c5HE9jb9p/XC6JMsK78Z0FCE95/8id/srpzQQssdp1IXpbju9/97m+V48tf/vJqsrpAchPWnW+fVPCnyfEWr3z7299eBbyXx7eYofYpWN0k+E1pW3sVCP/Wt7510+Ef3Y1h3b0ytFDhG9/4xm8sjLkpIFoQdRbI1Ieqa2nafxa83FiwG3ZY1rtFD52zIG6pBRCVs0U9Bdz2af/10xYgy7KFDH13bialfPosdZ4XX3xx/bCD/Vxgrj6Z49/93d+tfj/0vGBjZZugdc/bt89CFvXLtj4T9dUWx/zpn/7pxde//vVVuQ/xl10Hq6SMCBAgQIAAgYMIzAR+i05ff/311fihxZeTGhu06LLxWGOkWWzZ+KFxRMc37miCvPFVY6tea+u1xhuNZRuHfe1rX1tNot80NpxzP+XH/Bqf1S4trsiv144ldZ3UgogW3NQ3tl2zdW1YH5gxaH1hFlFUl16v/1THxs9t5TvbvtdNx+KjHA8r0PVNcYG2nq+nPjv1u1lc3j712V2v99fz8zMBAgQIECBAgMDTEdhvJufpuKgpgQcXmABTwaiCBV3Q9SjI9OBNcZInLEBV3ynwVABzJqIPXZmCpwVW66+db1uaYFh/3XaIVPC2oFvnvG6hRuWqfAUdm8S+rUOfuz6DWRYkLtDSV0I0CV5Q76aAy5SjQM2mcvTZLlBdvTK9bpHKJr8s+ku1Juj7K8L1elbGgq2V+zqvyXtbe/U1Hr13U5r6rrtXjgzyalK+ifhd/jKx/KpjwfelX/n0WmW6rv/dVN5MJrjfnRtynHzn2M5R/825dq/sBYpvk+Z89c2C4dNe5Vlfy+i+AuOdu6Bh/aTFTi3E6etOaquMS/Xx5f872c7nfNl/MqpNJ3WcAORoeCRAgAABAuch0DissUMTkk1u9/9/qbFCY9YW7TY26nHGR43RGtPMmGfGcY2dJo/GFo1Ny79xVvl1J6zGhj133Xt9/xm3HLvm22WMfn2Oh323PtAim7nT2bbrm/pIY83GvvWH6tJ1y7JevVcfamu8WZ6NObsr3/S1w5ZebuciUP9qq+90vTPXWfWbWeyz/D1Uv+t3XL/zWhDUfhIBAgQIECBAgACB6wQsrLhOx3tPSqCLr8dMXfh1O88u8maitUDVXPw9Ztmc+zQECkYWeJLuLtDvg4KXTYL/7d/+7Sqw3M+lAsnbAoW7nrkAYhPd5dXdJfZNHT9fYVEw6FhTQdECpS1Q6M4dBapefvnlnW/5fF/1qlzrEwa9tp4KWLcIogUm3S3j1NL8v9YCof/1v/7XalFF/88UYOz/mklNZjSpUb/u/5zqXSCyvlW/n3x67X//7/+9suuYtrvcyWPO75EAAQIECBA4HoHGCE00rt8RoXFCd6/rbl5NdHet2lig64/lNUiT5m2Nc1s40SLZFnX2OGOLxho9bzzW4+R1PApKsq9A4/ziGC1+6Ppm213zGlcut/pbWwt5Gnd3/dXzWTgy1z2Vp4UbLdbpeAtx9m2hp7F/faPruvpN1zz9LuvnFod33VJqsddc2/de/a3fQfWv5SLypyGmlgQIECBAgAABAvsKWFixr5j9CRxIYC74ChjMBN8srOiirkmughIFJ+b2qp16jiv40LGbJgMPVMR7yaZJu+pnwchheQssZVoAqzsrbPtLi/rLBDHnjgaVpKBowdL623XtU5CsflnAYds5rqtZ5+irLzrPPqmvzpi/ZlsGbnfNY/rd1G8CJn2e5jPV56kATJ/H+Wxl1VaacudTPe6SOk+LDQo4d74CO9XrpgDh/HVXAaICjwWoK+uxpspb+Qpevfqrr6fpd1kBreljt+lDh6hrvz8rU4HbPgfbDGun7lhR2/f1F/WVm9roEOU7VB75T1372pgmNVrE1+v1t/4qq4mR2mTZLhPcLsjYVn/LomPrd31+ugPJTKrc9k4eh6qnfAgQIECAAIHDCXS90P/985fejX1m0ryFpi2WaEw94+ltZ55xdtcZjSPKtzFvY+seG381Duvnxojtd8jU+Sed0vhtynxqjxl3zdW4sOu2bQsr1utVO9Uf6lP1gfpaY9Xpf3MtUX/r2qm+0jkO1V+W/aSy6SvrLfTrn5dWx+o0v2Nm0dZc59U3i2NU7q5put5ZXqt2fdr7PR5r3X7dEp4RIECAAAECBAg8psBhr1wfsybOTeCOAl08LS8U75jdjYcXWOpib/6Cpwm+LvAqQ8GEghEFrQpe9dfSXeCV5rgmuzq2YNQppSbiXnzxxdWE3CmV+9jLWp+Zyc7//t//+0f9Yr1PF6DqTgdNsL7yyiuryeXqNn+BVtu0MKN22pTqh00yNyF7m2BWx/7X//pfV31gn4BFgbY+CwXRquu+qXL3Hc7Vbdn/8in40mexz2B3kWgCukVOywn3Ar59XUT1nsUl+5ZhuX8Bns7RJHVt0md/uYBque/yeZ//ytWigO5CMAHH5T7H+Dy/1157bRVs7fdajgWubtOWh6jfLBDIv+fbUu8tF8DMgoR9+u62vB/i9fpLfaT+Uh+vPlOH+lt9+c/+7M9Wn4mC332+qttMdlT3733ve6vPxA9/+MPVJEvlngUnBbf7/2nXwPlD1Nk5CBAgQIAAgbsJNH7oLlXzl96N1xojNH7r//yZAL/pLDNeahzemKMxyEx2duyMUzpPeTY2OVSaa6DOOeWYx0OdQz6HE6iP1Qe++MUvrvpB7VYb1jeaAG8MW59s7N6+XRfe5lp0W4kb+5bKu/PqK78tlct8rvI5Vqf6S9c/9ZeeTypW0kLy+k39quvxrmlm4U7xkBaOl461blMXjwQIECBAgAABAo8rYGHF4/o7+xMW6CKvxRFNXDXR3cTXMjURORNgBbBmYUWvzeRqx5bHKaXKXmBNOqxAwY2CBC2IKOg5waj1szQZ335Nzr/++usfvd1fcHRswaxvfOMbW7/2oL9yn+2jg/d4UsCsxQ1/9Ed/9Bu3DL4pi85ZoKt63ibQNYGUgiXf/OY3V5PBnbOgSYG0PFpYkUHn6XxNJM9fuMwEewtDCsDcNdjSOfuM9/ntvAV+CvR07utSvzdqwxZlTEDouv2P5b0JnHf3hxb0zF+Z1e+yvk2b3qVuszCg36E9L1WGyjN3IynwP4G52qkAXa/1/iEDuXepx03Hzv8z/f9Sf5ug8Xze5/PQoqP+j5l61b/7HdLCiV7LJqc5vjbLI5faViJAgAABAgTOR6AxQGPf+b9/xmqNUxtDtO06dpvxVePc8msRc+OpUmOMztV4pcfbpsmjfBu7NzZpzNLWe5Whc1X+qUPXBjPGuakuMy6qnNVhxj7l1WKQ8ur5TflUnvJomzJW545fjsPGofO2tX/juK4X2qZdZr/y6vXyqa2q1z7lmnwe63HcKn99q1R9q1ft2ZZdr/WHJdWta7aJj+xa7izLM89lP6mPlH/vV5bpJzm2TZ+/qY2nH04bl2epPOb6YT5Lm8q87fjO27VT5biuDB1f/dr6/K6ffz6349377TfHTFkrb22Rx9K//du310vjND7zWB0fM1XGrlH6TPS8VJkqX3GS6T/zWc6gvlU8oN8h/dy+1U8iQIAAAQIECBAgsEnAwopNKl57MgJz8fwYFe4itcBAWxdv66n3mzztwm9Wzi/36cK2C78mt04pdTE7F/mnVO5TKmtBgG0BjQIlEwRZ7lOAZQJJE0DaVOcJxPTe8vmmfTe91jGTf893zWP2m8dNed/2tTwmmDkBvV6byfTyLUA2d4koCFPgKr+7lqfPfpP7/dV/AbO261JBnwLSbZXj1FK/r/7hH/5hFZArINqdeR46cNXv/XFsUVuOtWNt3iK2vju89u3OJfWBfl+1fwtgWtTSfvXhU0j9PzLlrg9Pqp+1wK2v2Jlb3lavSXnUv/N4+eWXVz5jkV9tlkv91+/zUfNIgAABAgROX6D/5xsH9f97j/NzY4r5f7/XSruOgxtjNMZucrmxX3l17EwW93zXvDYJN3napGhjnbmjW2O3fp4xe9fUna8xf2Vo8WjXpY1pbjp3eVTmxkItEm5xc6m8unPC/BHETePDKV8TvrGC/MwAAEAASURBVI2Jy7PUmPirX/3qKp/VC//+T84d03kb+xc36NxT19m3mEB31uv9xm8tZN+nXJPPMTxOv/jc5z636oO153iPRfXr+b6pfpJV/o2Pa4P6dO3Qe7Vz569P1Fdr3/pI7Vt/6bXaZFt/qUzlXXu1zbVaeTTurp2vu+6Z+s3xla00/azjZ4HGprrP56Djq1+fgVL9vT+e6Pj66JS//Nuv/etTvd65qm8LofKoT/V+ebVVp86zdKp+5T1bn7XHSrXPfFa7du95n4nqXbnaqmPXP9VlFlL0+6596xPT5stro8eqj/MSIECAAAECBAgcp8BpzAwcp51SnYnAXBz3+JBpLny7iN00MdVrXbx2sbfp/S50y6MLwFNKBQwqu3Q/AhMomcf1sxQgaNv0/iwU6LHtPlLnLe8JVGwqx32cd1uec/6CXG1jUFClwNWkPoPzmSwI1Wev/ef42W/fxwI6BUoL1hVA3Jbm99Psf6oLK7JrIUm2LWAosLX8qqNt9T/U6/3u6XdQAdoJJPZzwbaCtJWlr4rp9+rcESj73Lv1cEHqgpOV+xRS9c28bfn/SP28Ok+/n8/jsk717YKP3aUlo4KTBVrn/8yO6b3HDJ4uy+s5AQIECBAgcBiBxgmz2LixRGOIxr6NhxojN2aaRRGd8abxcO83bpgJ/44tNQ7pea9vGousdrrmn8rVtXJjlM5R+XpeGbuObvzSPuU9Czsagzae6b3Ge00GV4aO31aPxj7Vv3M1HmyyvzTHdnzjocZW16XJo+P7A4rK2Dl7fdN1wNi3X+dtq8zt3zap15oAb1K//PYt1+RzLI/1i9oo7/pG7Vl9a8uJj/TzXB9ta7epT/t2XHGXFgnUR7oO6HqgPlNfWOZXO9ZPOndb5WifXHu9vjTXjHOOHuc6o/PUVpW71CKFrh3qI/XFbX29c1S+jl0ujMhixuyde1s/qw6ds77QdUz1q5zl25h9PS3377x5dq76U8fkXVnyqk5ZLa8pxqmFCPN+x5THLp+H9fLc9efK3/krZ3Wv3fo579qtNsivz2ttWZn7HE6q3jnU5u3vGmdkPBIgQIAAAQIECKwLXH/lt763nwmcmcDyIrznc3F+ZtVUHQIEdhSYQF4BoU1Bq4IzBV0KKhWkKVh1l1SQr7sm9FczfUVJv4OWv5eWeXfuAkDtf6oLK6pDqWBhd66orgWtCl5tq/fS4K7PCxIWdJ4AYe1YELTzt2iivxbsDkE5F3ib1H5zZ5H+4utUUqb147alb324oH5bfXCCjpvqVT9v4c9f/MVfrPr99NHyKzBZsFgiQIAAAQIEzkNgxg5NlraYtDHCbI0ZumND+zRuap9tk8TrGh3TxGYLaxuP9XNbxzdOuc0kZuOz+Yv6JonLtzHOlLfHUo/z+kywNx6sDn1F4aax0rL8jX0aL5ZHk7VN2pY6bvJd7r/t+Uy8V4byabxZaiJ3yrp+7JS9/dvKo20Zt2ifJpMrS2nfcq2f8xh+nj5RH8y7rfrVzrNV75v6X0651W9nwcLk1fFtmzxro/pT+zbZ3rVLixO6Tmjs23XC+rm7Lqzc9euZ3M+y/epvtXP9vOvNTWmuUxqft3/9e1KftT4/PW77rMxCia5zKnPHd+7yXZZt8qze06fri1mUeq36dtwsUlpazfG9tnSqzOXTIqHPf/7zK4vZ9yEeK898TipX9ei12qqFFG2zQGV+v9Vek6pvdl0Xdu0jESBAgAABAgQIENgm8OtR5LY9vE6AwL0IdHHbRV4Xd5smZ7sI7v0uoNcv2ivQXBy3zymlbfU9pToo6+0FCm4V4CjwU9DppjT79DjbTcfc9f3KuAxWTn59DtumTPP6Po/1/z7TpQI/BXDmr9YKXBUAa5/1z/wEiiawV+Cq1zblt0957nvfylcQMbMJvFXugpTdsriJ+YJvBbByWQa37qNsBdjWFxR0ngKUBddbNFEgsGDilKfyFhxtYUUB1epRIPKh+uNdHOpH2ea87FP1u/pSi3ReeeWVVV+qndqvNuv/lfafY7KYfnuX8jiWAAECBAgQOH6BxgItMm681kTpTPD22EKGxsmNJdpnrmcbw7XN+KFr1fUxc+93zKHSTCSXX+XpfJWncV3l6OfGbO3X+43pGgtWj8ZzpSZYK1cT+NsmrNuvfNrKpzxKPS/vXt907bDaae2fytAx5bHMpzw2peox4/3GanPsnLdj2qfxXvuV2m/GcqsXTuyf6TfVp7o0Bp32yjnDsW/f6r8ptV9t3Zi3hRVzN7rcO678c8tq+mvtkO3k3/Va557rtvpKqUXx6+ctj/pQ+ZXPtO8ssuiztK3/z2eqz1zXhB1TGUpzfO9tuvNE+8zxHVt9O6b6V8e2ylqdx3aOqa7TpzpfdejYyj99tWO6Rpi6d67lce3f1vEd1/7Vs2PGtfPdd6pMGc81deUv1R6Vp20s5tpz2r9jK3/H9juh+vTauN132eVPgAABAgQIECBwWgIWVpxWeyntPQp0gfiQqYu0uaDrAm49dQHYbenbNgV5Or4gw1xwrx9/rD9X5souPU2BCTIVrNg10NJ+bQVzlsGg+xAsANZfqrQtP1v12Qm+TYDvNv24/t9XTZR+8IMfrP4aKYt+BzSZXyCsv4Jaz3sC2XPb4AJF/c5az6/jjyll9bWvfW1Vn9dee23lWvlyLjBf+f/xH/9xFXhrUUNB7ftMOfbXam25T+p3bL9rW1TRXygVSCuoVkCw/ea4gpkF7Hr/IfrjlO+2j/XZZSBx8qlvtzjn1VdfXQWKW1yRf4tLChR3TPXPZb0vTh4eCRAgQIAAgfMUmPFDE7nLW+U3fmis2SRzY6nGcY0X2mZ83GuNn7qWbQxxn2P3ritmvN7zrq0bxzSerBxdPzTmbOw25e7nxtEd1/i7u8BVxsq76Zr7MVs4v9qiv7Tv+qF6NX5rqz7VpVS9u5NC+1Xn/OfrJ055HFfZJ17StdmkuZ6s/jPZP+8tH3u/66sWVNSPM2sMX3t3XH22Bd6Ne2v77Hq//j13jajv1Fe6FpgytE/7ty3795S3Mk//n8UJ5TnXEMsy9rxruunL7dfWOSaVR8euvz7vTxyrcvaZbev4ylDd6jf1o2VZ59jlY+fpHDmUZ/Wpjjn1uZrP1BjVD/OdRS+dP6OOqbz9Xui8D9UHa+/auHJVlkm19ThMf+mxcmYzZh1TXSp7j+WX4Rwz+XkkQIAAAQIECBAgYGGFPkDgkQQmSNIFWxexXdj12EV1qYu8JvmayOuCblIXul3cTSCgx1NKBXyW9Tmlsivr3QUKVLSgoH5eX74pTUCnYEgT3gV0bps6Z1ufs2WwqsBRP/dZLIj2+uuvr7YJEnW+ylFwqHIUrOznm4JTm8rZsV/4whdWxxbgm8BXLgWom9guGNfvg2UqmFdQsL+2qlydu98h83uiehUYPrZUPVqwMIG4fq6eBe2qRwbf//73V78T2ief+wpe1c4tksgwq0wn9Tup/pV/v1MngNjvq/pLZa3ME8iuvdrn2H+XZVkfqW5tBTsnKFv9JzBav++92ma5sKI2mf5Y29U+PU4b3eYzMOYeCRAgQIAAgeMU6P/5xr2NCboWbQzVWGiuW2dRcOOg5aKKxkYznmu80Fi1vNpmgrXnXQMcagzRGLg8O3fjtibKW1TQ+KXzVObGbZWrsU5jnurScdWjieHGNx13jKlrjsreeDrv6tQEcHWqbqVer50ax/Z+1vn3esefaqrsm+pR21X3tuW4dOpZf50+27VG11Atomn/fGrvubYs3jLXd/XJGRvXf9qvheAdO5PunTvf2qN9lsZzfVaZOrb3OmfXEjN5X/6Vbdn/y7P8G5u39XyZOmauReb43p88yq/XO7Y+Pefsc9Hns2uBnt+UJp+M2r86zDVEvwuqb23Subqe6OepS+eunm31zeqba/s/RB+sHNW7hRVtGebTuatHvx/aqte41U6VsfKO21jX5rl1/C52N9l6nwABAgQIECBA4LwEbh5dn1d91YbA0Qh0ITcX5F20dfHWBepcSPfal7/85VVgqH0ndWFXcKUL+i4Eu/g7pVS5K7/0NAUKXv7P//k/V31gghrXSRSwKZDz0ksvXfz5n//5rftOAasCPRO0KvBSWgaACpzNVyN0d4UCQpP6DBawbOv5LmWfY5ePBdgKUBWwKrjT56FUMKfJ/t7r90Kf7WWa99un5/0emIB3PgWzJq/lcY/9PKfKNXY9/s3f/M3qd11ly/i73/3uKihXvSc4f+hyF2wrFZSsjcdxzlMZC8LPwq/auOB0W8G2jivlXD9p65ja85hTZawvFTTuziH1+/p2C0RKfS6q00wytKioOtW/2uqj0yebcGirDWun3pcIECBAgACB8xPo//iu1/o/v9R4vDHCjJunxl2HNpZrnNQxMwk5j01oNmZY3xpnzYTs5HWXx8rXHRvmzmOVfcYpnafxf2O6JtlnEruyT/mrwzFeU8/1RuO5DCt7ZW2s1rXEpOramK0xX6+31QbLfWbfU3qs/tOXluXOoTFtW8/X07R5VnO3isa7eWTVeL9xcX0it/HsfOVX/8myLfvK0KKczlc+5ds1bcd1Hdb7pY7v3B1TLKdtJvk7pm1iPcv+3+eqOFCfo56vp8rUe20d3z5zzvbt53m/Mk4e1XU+e/N5WM9708/Tn/LpTildC1TXzjlG2WTXvtV3Fs6XX5+lrp/a+qz3/n2mLKdP1E5tOVXefgfVnv2OmHaeslSu+kLl7FpoUsfWbnNcdZAIECBAgAABAgQILAVExZcanhN4QIEu9LpY64Kui7wuTruom6BOF39zC89lsbqY7Zi2jpcInJJAQZ8Cs7umAjZN5vbYgoLbpgIkBUw6d5+hgmylgjB95gpmNVne3Qx++MMfroJlBc7at89qgbECtt1togDNbVN59dkujxYSFGAr+FPdOneBq5dffnlVrs5dKjjW74ZlYLDfGQW7C3hVttIxBk+rQ+UqqDd/6dSihvpB5gX/CkzWLn0lSL/Tci5AdsiUYedqAVv9oIUFvVZ7FCzr92+OtU2v5ZttWwsxJtUnCsrPnR2q1zGn7KtL9gWQJ9BaX6oNMqn/1/82fb7qpx1bX+3zUVs1adHP9b/aK6/pq8dsoWwECBAgQIDAbgL9v961ZuOcxhJtjRd6rbFQ44eZ4O35pjTjqZnY7bGxVlvj+sZcjcGamL3tOKJydXx5N2brmqH8G/ssU+PK2RoDNf5uHFqdKn91aozUPrcty/J8h3xeedpmTFfd1sdevV/bbHrvkGV56LyqV3Wt7j2fNJPo9cFN1wy9X5vWxtPWHZtPfaXrrRnnr1vOOeaaYPp5eU0/aQzd9Vv71JeX14bTFtPvu4abz0yPbeW57Pf1vfKfPlkZqnOpulTH9pm+2mOfncpemuOXsaRe7xyVr/F6z3dN9aXiUBk15u86aek/+VTG6lJ58phUmbuuqK49v+80NmPYeUvT3v1OWHpNeTLpverXvpOqU9eLtW99JcNN9Z/9PRIgQIAAAQIECDw9gd1H10/PRo2fmEAXS5suzO+boQu6Lna72OsCfMrQhXKvSQQI3F2gQEt/qd/E8He+851V8LFc+7xNsKogTEGggmUTROtz2OezSeSXfnXXjK9+9aurn+9aovJsAUGBqM7ZhH8LK5rELgBYoLffDQWjKk9/NdOEfkGeylYQqOO/+MUvroJ5HX/MqQBdfxHUYwtHql9fCVO9SpX/7//+71dtMcH2+V14iHplVsAvv7wLwJV/v2PnTgwTQO18vV6bty0DbfWR2qnX/+AP/uAQRbv3PPq/rf9bvv71r68Cgz3PvsUsfR76bOSzKfV6Zu1TvV955ZVVoLW6/8Vf/MXqrkr57BOs3XQerxEgQIAAAQLHJzDXqY0l+v++8U9jh8Zvjd0aUzWm2zRmm8nOFrM2jui48mgSuknbFivPpGXjw9ukyte4sfwaQzc+3jQmmUnRztM+lb0xTmUvVf7Z+nn277n0eAK1wyyqWLZJ10e1XW24aeK+vtf1U1vPJ9X/WijQgoGuxWZhwry/fOx8sxC+87Soeq63Onf9ur7XdcR6qg/OwooWJk+qLH1m2jr/LJ4ov8rawoj26fX5TCzruKxX55jyd3zHLhdW9F717Tw31XXKN49dB+XU1vOl/ezT49Qzh+Xnrs9S7VJ5N/1uWOZxiOedp7Zpy2JShl1/zjXovD6Plbmyt7VvZuWV+SycmcUh0w/nWI8ECBAgQIAAAQJPW8DCiqfd/mp/BAJdqHYhNxfPR1AkRSBwbwIFeApu9LgtSLM8eZPdBXHnmOV7+zyfANh8BcJNxxZYKZDUX7D0F/otBmhRRQHgyn6XNIG6FkUUrOkOGQVvCobN5H/lLPBbcKfgdcHogkUF4kqVrUBeZTuFVDCqMhegbIK/BSXVpyBibVO9ujNE7d1XIBUcb59DpfIqsNnilM41Qb5+7xb47LxZF/gvtX/vVd4JWvZ67TV3rFgGP3fpyx3/WKk+m+kEYatzn6nqMhMeBRGXWwbTNtPv6ocdk0N5VO8mRnouESBAgAABAucl0P/zjYcaxzWWaFzUeK6J2sapsziz8UNjhsZSsy1/btxQKp/GIo3/Gou1b48zMdv7+6TGaI3hOr7H68bo1aVzV4e29XM1Edy2HPftUxb7Hl6gvrFp4cRNZ6rv1Tc3LayYRTj1gZvG7/WX+nlj/vp8/au823qtc9SH11N9aCbsy2NS+1amjiuvea/85s4aPe/1ji91nsbk83mZei37+xzfvj3v/MvP675xpo6v3m1TxqnD8rHP0Hyelp+babfaruf3nfr90/VMW88nVe+u5ds2GdT+OWVZ+/Y4faa2yrOt31/L9pr8PRIgQIAAAQIECDxdgV+P8p+ugZo/YYEu9G66oH7CPKpO4OACTeb+5//8nzf+dc+mkxXEKNDRX8z0+FCp4EuBt75X9s/+7M8uXvrV3Spa4FEZloGj25anoHSLIgqOFZCaVOCmv4jqL6mqe0Gd7hTQNpPb7dvxcwvbuevD5HHMj/l1t4OCftVp+ddFBa6q+3e/+91V/7hNIHVb3bPr1s9tE9yfffs/oPJ0Z4b5/yD3WWSwLEevtV+LCwqAlldtcYg+MeW5r8fqln8LeurbLXCpDvWfthb19FhQsuctoqhNspigaM/rs32dy9/+7d+u6l8Q0sKK+2o1+RIgQIAAgccXaAK1sXETrY1bG5c3JmrCtzHWTBY3bmicMI+9v0yNqRpzzQRo+84Yo4nkxr77pMrVOKzj1hdKbMqnsVATxdVlxnyzX+WYssxrHh9XoPaov9TXluPx2rp2bNvU7o1Xp0/2fFLj9casbbuO3duv/lXfb9zcVpnq223Lcs15Kldj7vr08jwdN5+N8ptUGXu9vHve+VoQXR8t//ncdHyfmbauqSf1+pSt4zt/dewcs6Bgvb/PsZsep84du8l3jpl22LTfQ36e6h9zPdPzSdUjg7ZM1lMmlTPvro1mUUWPpXHt91Xvb8pjPU8/EyBAgAABAgQIPA2B3x5dPo16qyWBlcDyAlMgRacgcP8CTcI2sd52XaBmSlJAZIJTywUI8/6uj+XTucujAOwERgqYFBCebYJvlW2CLN2p4itf+crqmF3KvEuZyruAW4s1+iuayjbB6SatuzNGW+XpTg69VhmnHgV3CrgVNCu4diqpwFtl7y4HL/1qsUqBq3/8x39cBcOqfxP6/VxwsGBkQcba6LZpfq9n10KO9YUV5d05WtDR/wc5T+rY9QUttUdbC0IK4PVYm7SdQqrfT4Cx8mZe/QsYzuKK5cKK2qM61h71s4KVmfXa//2//3fVRi2UyqTPxvL/1FPwUEYCBAgQIEDgZoH+f5/xTuPoUuOk/v9vLDGTvfM4k8QtQG3c0PihsVjPmyTumLZS473Gh42N2/ZJlWuO22WMPvXYNGapPrMZz+zTCve3b32lvtNW20yqfRrTtm1qq/plfa+t55Pqw/Xftl3G7pN3/bNrtbauXeq706/Lf8o2+9e/6pedp2vPnrd/W5+Ntp5Pf6t+fXb6jJRfZZvFAPO5ad/ea7/l8WPU67MwoHN2fNeJlX3KNQ43PVb+yrDNd44v3/bbZjkus/+hH8u/+tfOc72S66S8smpR/LYytm925bFe3tq566NZJHOXWMSUySMBAgQIECBAgMB5CFhYcR7tqBYECBA4CYECTP2VW1/3sEuQp30K7hTYKTB021QgrMn8tu4UUaCpVBCmhQtNoLcVfClN8KpgzS6BpdVBe/xTnbIo6JVHd0Ao6FPwrPK0+OBrX/vaKujWV4X0Wu9NPbrrQHW4KeC1R5EeZNfaM9sWkzQhX6reBa1KBbZee+211QKL/hKrQGOBrrukCapNO89fIZVnprX7LOjIc5l6f8q2fL1A29xZpDapLU8xVd8mNCp/3l/60pdW5tWvuvf1KT/4wQ9Wi11effXVjywmMNznpzZr/4LG1wUtT9FHmQkQIECAAIHNAjOpOv//N/nY+KBxV4+N4RpLzMRmi1sbN/Re4+tSY7zGwOXR2LcxyT6pcUfXB22NrfdJu1yH7JOffQ8vMIsG6kvTZzpLbX1du3et0dh0/bjps/uOV+d8y+uu+nlb56hPr19DdI76dX26z0bj5fbr89CC5Z5Xzo6vrH0WeizP8ur6oon8jptz9F7H91rPx6fP2frxXSfOteI+LVO5q2+Ped30OZnP3U377VOGXfet/pl1bZfLLCyZ43P+/ve/f/H6669fW5d8O3YM5/he7zq1tuh6XSJAgAABAgQIECAwAr85gzCveiTwBAW6GOziViJA4P4EChQVXGpivfRQQZiCbzNx3FcgFLwtFeCd713teUGZUsGqCQYXlOl5wbH1oNlq51v8U70rU8G2z33uc6sJ7AkI9RUMTfYXgC5gVMC5if+COwXIWhzSwoqCPA/ld4sqbj2kMtcHqkOBwSbue8y/4Fh3TJgAYZn02m1TQcvynjsy1JbLNAHKaffle9c9L/DWworaqK9kmf583TGP8V71z6++s0z14xZTTNC3vl2bTOr/wrbqNpMcLbLIbwK55Vs7TSCyPMtPIkCAAAECBE5ToP/75//5xqBtpZlYXv9/vjFd//+vj49nHNFYobFDY9aObezRmKyxQ3k3Pmn812uNrXqtPPcZ35Zv59/1mF33O80WPK9STx+pH01fnP7Y2LVrqU3tOf2vY3q+TO2/6ZjlPuvP279+1rY8tvxn6zzz3jxWvhbR18dn0r7rkrb6fuP0Xu/z0M999kr15z4zjcF7r/F2n6P26efZv+Pn54yWx3dsW2XeNVXutj7v83yXY6e+u+x7yH2qf9dw2WTUz8uUSdfVu6SxW+5bfuU97dfP631gub/nBAgQIECAAAECT0fAwoqn09ZqSoAAgScrUBCkAFXBrb5Co6/gKPVzQaeCYX0FxaQCJwVRWtTQ10O0KKNJ5vXA8ex/28f+EqkFBv01TIspOmcBoibs+wubyjWLKgr4FJCeO2+c8u1Ipz1aVNKdKwrIffvb314tMMly/Of5bX0LqLUgoK3nh0oF7+YrW77xjW8cKtuD51Od60sFBetLbaUW6NSfe+y19YDo/Nz7L7744ipYWX/s81Ca4GOPWbTVHwsgSwQIECBAgMBpCvT/emOHJnvbGo/N+LNFyTPhelPtZhwxE8uNXxtzN47oq8QalzUh3KR0j000z/n2XSTRueav5m8q17G8P+OxYynPsZYjp/pjCwrqK5Nq8/pJ/WtT2/f+cpvj7uPxurasjI2l27oD3oyZ6/PzOZuF9TO27hqp4xpXt+i5z03j+F6bz2f5ZNJnpvfKo8/qpPKYhRUdt2uaz9Im013zeMj9qvMsns9jU8qsel2XtrVhfS7jfj9NOxVP2Mf0uvN6jwABAgQIECBA4HQFdh9ln24dlZwAAQIEnrhAAZWCIP11UwGR+ev8fi7YW7CrieYWOBQ8KVBTwKvXu6NCAbECVB17U3BmH+qCZi0uKNDc8wkgtpjilVdeWWXVYosCO5W/MnQr0haGVO6CPaeYpj2600NfeVIwrL8oKtBYnSZweNe6lVe2bbXnpNo9y/pB7tcFyGqT+sRMApRHeVXe8p1gZkHMQ/aNKetdHgu8tmCnu2v0fIK2LS6atC1AWF1mQqT+v8mofWaS5djqPvXzSIAAAQIECOwm0DihcWdbE7aNoxqDNg5oTNBYYNfxTuOC9m2b8Xevle9yYnjGfJ2r8VXjin0mdk9p/NGYMs8e26TNAuNUf2gMPotwZu/6VP2xbVP7T9+rv673pbHfdNzkv/445Zm2m/fLY8bB89rysfMvFziUz7K/V7flwoj5rHRt0memx7le6b3S8viuQVpYMNcilaVzdtzksV7/ZflO+XmW9Y+u1TNYLqyoX1T/LPZJtW++xQHKr+dt/b7qHMvfg/vka18CBAgQIECAAIHzE9hvpHl+9VcjAh8JdHEmESDwtAQmgNVf4b300kurwF1/SVfwpFSgqgUOBWe+9KUvXfze7/3e6vV9gnGrA7b8U9CsSe4WSzTJX3kK4BRomzto9LzXK8PccaM7aBQ0Kgh9yqk6ff7zn18FrLoDRIHTFgFU50OkfLpjQ4sLCopNKkj58ssvX3z1q19dnb9A2bbU/w31ib/+67++eO2111a7FXArENoCmPpK5a399g3gbTvnoV6vztX9e9/73kcLV8q7u55MH85/W7kLMBZYLHCZ5QQZp3wdl139cgK+855HAgQIECBA4LQE+r++RcaNnXpsHNE4qPFvY6fGbS3s3TZuuK62M5ZtDNv4um3GsTN52fka394m/+vOfZ/v7RNDaN/GVusT9PdZvlPMO59ZVNEin8bZjb1L9aO2rqHqJ5sWDjTGnfdnvNux+c/Wz8v3+nlbqjwz2b7e3lOeTXlVvj43jZWXfXqu9TqmhQHVr9fKq31n/46ZPwjovUlzfGXp+K5Jeq39Z1xe/a9b9DF5neLjtMEsrMhgFlbk1DVZ1zpZ7JNq465F63P9/su0VN5d89WW83twn3ztS4AAAQIECBAgcH4CFlacX5uqEQECBI5WoABIgYomezcFoLYVvCBrQZKCRB23z7Hb8uz18ikI1Z0T+sqDAlPdmWAWVhTwbaK/hRfdnaBFEJWj8hwiFfwpQFOQubwrR2WYQNGco6BaQe0WYDSJPQ7z/qk+TgCwu4V054oC6m25TzDrNnWboOks1KjtJnhffrVhiyq+9a1vrb6KJdNNafLJu8UJBdUqX4G32qhJgfpzr1eXtn3SBI7Lp37XhMUuqUBpfad+uO2OE8t8qnsGBR5LlT2D6lewsDugzERGn4ler44Feqtbd22ZoG3Hd+5M6rudv+e9JhEgQIAAAQKnKzDjgsZPs3C02vR/fD8vJ3z3qeWM2xu/NN5oW58Qb9x3l7HfPuW5zb7VYbb143ddKDG+jb16Lm0WaAxaf2sM2li0cWupcXbjzvphfWjb2HP6WePTZT/LvLzarjt+WaqOqV82/u+46aPl2/nbludYHtt7je2XY+X6Snk09u+xSfyeV+fq19i6MXrPy7fj22as3TFzfOWZhRVzfDbjM5+7ZZnO4fl8jmqT7Pp9lcl4d13dwvEe90l9LsurvlG+5V/q9Zxrm67F57N7rr77mNmXAAECBAgQIPBUBfabAXiqSur9JAS6MJqLpCdRYZUk8AgCBSm+//3vr4JkBYt2DUi04KCJ8BYfFOzY9bhdq1jA6ytf+coqiPftb3/7o8MK0hRUKbD3+uuvrxY1dOeKynCIVD1yKID2xS9+cXWe7o5QoGyZKl/vd+6eH7r+y3M9xvMWNnzzm99c/QVfC1lmAUD+t0kTcGsxQPm1aGFp2l9bFnCbv2a6qT3rf/WPgp8//OEPV4sMKlcLFvqrzlnwUjvukwqClmd36/jOd76zWqSxy/EFWwuyttimOmxbGNI+1bP6t5hpXAtW/8M//MOqv7UwpL7VZ6uAYUHJCdhWtz6v9cn2m1Rwt3O3IKP+2DESAQIECBAgcNoCjUn7P75xUs8nzXilMUtjnd6/TWpSuUnK8uv5MjWWONbxxIzX18ffjTcbM/W4SxyhfRs7tq3Xf2nx1J937dUYtG0mtzOZ8Wdj0OmD623SftOPG98v+3H+TZy39fpN/W3atf7aAo+5s0THNhZf5r+pHL3WPpW18XLj8upTfl0Td20yC5h6bfab8XjHd57qPVvH9Bnqs9j7je0rV8d3jo7tuqDjzjWNX9d5fZb6ubbKumu2rk+6rtl3YUWfyXzLq743Ke/aqd99tV/96Ka+M8d6JECAAAECBAgQOE+B8x1tn2d7qRUBAgROWqAgUl9x0STtMtB1U6WaPC5QUqCoQMY+x96Ud+8XrCoA87nPfe6iuyf867/+6ypINcHfglb91X7BqoI0/SVQaVMQbfXGHv+UR4GwWVjRQoCCN8tUIC6Dtp6fWyqQmHuBwT/4gz9YBTxz6OfbpAk4tiCmwGMB1FJ9Z4Ju3YWktlwGRbedq/aZBQr1jQJ5peXCiha97JsKzBWga+FDCxiq8y4pr8pePeu32xZWjGt9q/5bvypg2DZ38agMOZVPAcOMei37gop9Xitf56qv9tmr/3/5y19eLfTpmEN8Dnapt30IECBAgACB+xNoDNBYt3HPcmK2MUBj4cYVjUMbCzR2Xu5zXamaqGzyszFP1wJtjTUmzfis/A49xp9z3PVxxkDLfKpDY8Hqdd1Cid6b+jcm7Zhl/Zd57vJ807jruvPvkudj7lP/KGWUTePSxqldL9b3Js31Wgsrer7JoX3rT8u+OseXV2PhxrG9Xx7XpdqoMXP9tXbrec710z4jbZ1rWzl6va1rjT5XjZmrY1vXJ/X18q7O5Tufv/brHMvje63PXmWa4yt75RqjjumaoHP1/FzT1D/D2mT6z/Iab36P7WNQPvWL2iTv+kfnqm1qo66N2jJf/x25z3nsS4AAAQIECBAgcPoC5zvaPv22UQMCBAicnUCBiNdee20VYKpy2wJR6xUvaNJXRRTcuCkItn7sLj9P0KvJ9s5T8OTVV1/96C/8C7A08d25+8qQ7lBQ8OtQaRZONGm/aeFEQZ4m9lv4sen9Q5XjsfLJvwBgk/t//Md/vAo0/s3f/M2tF1bUfgVkZ/HA1KuAW+coIFvArZ936YP599dPbT2fVCC9O0GUX+csILdLfnN8+xcgbaFGd4XYNQhasK8+WFk677ZUf63MLfpoqx+3SKLPYWk+jzm17wSHp1zVrwBiAdvK2fuds/p+4xvfuPj617++ctx2fq8TIECAAAECpyPQuKhJ5xYz93xS4/DGqI0FmgzuccbCu4x7Gr83nmhxRuOQHsuz1NiiczW+bTvWhRWVs7It67uc4G28tS3NftW7Md9NCzG25TPnnsfZr3Fbk7/TPuvvz37H/FjZZ5za2HoWuWc3qX4yC6Ovux6srZr4brzc80n1uca85dMChPa5zqrxb4s8WuDRmLmyZD0LGMpjl7F7+/S5apuJ+RZ4dO7yrO6Tb2WeBRtT7urQdUtbfaexf4sKSkuf9uv49tulXJP/qT3WLn2W2mZRSXWoXVt4vv77a5/6ZdjvofKZ31nzuyrr2m18z9l4HzP7EiBAgAABAgSeooCFFU+x1dWZAAECawIFdmZbe+ugPxaQmEDQPhk3GV5Qo6Dhdem2dZjjCpS0cKJASoG3gicFujp3geC+sqG7ChQ8LZi2Lag3+W0ra+8vU/lUx4LUBd36Oav2ayK74E7vFyg6xiDOTfVd1nXT8zk+077ypYBh1gUxa4tl0GzdblN+tVfttL6wIsvarm2f4P20TwsKCtpNWgZcC5R33t7fNCmwrdzTvzp215RPZcqnYOy2VF+pT3c3kBZBlArW1pcLXnfOPo83fSYLMnZc/S+7Fh91Z5FzXeizzdPrBAgQIEDgnAXm//uZBG6s0JijsUZjjlJji35um4nljmtbLjzo/cbtbR3bJGhjsyaqZ/xSXo0vOl/jsn7eNIZ6bPPKVP0q35RxFjI0/qtujaUaZ877lbkxXuP59mnsVf0b12Zz2zTGy3Fl+ZVv58lxxqKb9r3teXc5rvo2Nm58WXkyW0/tM1uGY9QxlT+juTvcjP8zrZ+0qKKxaM835T3nqt7tM4sM6sdTrq7t5toqw/Ybrzk+z8rTvt29rbZrQUNlLe+O32WBx+RX/vOZqm7Vu8/VMpVv9az91q9Rer3xfFufn46vfJOqRx6Vq/p0/HU+c9ypPeZfyq62aevzVcqva6Occ8ps3zSfqfLp2rt+0++qsZ7rvvpVv/uylggQIECAAAECBJ6mwP6jzafppNYECBA4K4EJHCwr1WuzLV8/lueVraDJTekudShQ0lccFBz9zne+swpKFVwrkNNjAZYf/vCHq2BLAZsCL9vSpnLMaz0u0wTMZgFFwZrK0OsttuhuFb3W+XYxWOb9UM+nbnc5X4HHApV9dcXLL7+8Cpb1FRYFrEtzjpsMCn4WmC0Yugxc5pdnW8HHXdOUq7L1fFJ9onPVVgX36h8F9Lb1iyn/HH+Xx8mrx+tSgdXK/Sd/8ierBRYtsnj1V3djeeWVV1Z/gTf9+7o8qk/HtejoW9/61kd3bblt4PK6c3mPAAECBAgQeByBxhSNc/r/vbFnE7izGKASNcHYJPMslJjJ4iYYG1c1Xmjc0XFNQjYGm3FSxzVemkUV5df+ywWvxzoZnMuM+ytzRtWvSd0WEDRZnln1buK/ie1SXr3fQt/XX3/9ozsfrN68xT8z9mscvBz/dZ7uqpBfbdL1TO1ROSv3ct9bnHbnQ2Zc3Lg9p8bFyzQT4+03fpW9flK/qK/02M+9P6n+NXdfy/mmftL7nT+LuatcZZrz1F7t07nq57VZVr1W2Xq9BQz1/a77su3Y3PPMt3xb9N5xN6XyrdyVp+frafKtzNNuy2udjumcbZ1/PfV+Rp2j4zfts37Mqf7cZ6626HdJC3H6Oavaoc9dDm2bnHetc3nVJ+q//d6aNJ+z8m9xef35oT5bUwaPBAgQIECAAAECxyHw26Py4yiXUhAgQIDAPQgUaClQUBCpW/kXFCo1oV/AatcA0U1FK7DTJOyhUosdKmPlvy6AMYGQJuYLZDaBXpr69XhdAKz3moTufPkUnFpOPPdeQbHKcJtyfOELX1gZFzhbBszKq3NXvu4G0M8FiwoKNaHd3QFaWLEeJMoj6+rZQoTatlSQuoBP7+0SXNvWXrVh792UtrnXv2ZRyHXuk38mmXdcd1iovnnPworJr9euy6/32ifv8isAV+r4fCtTr++aKkdBtFxzXj935+n9bWnq1eer81+377Y8lq93fHWpja+rx/TR9p9gY2Xv57YCyxPYrp+3TarfVO/KnmV9rLuJ/OEf/uGqT5bPsg/PcR4JECBAgACB0xRo3NDWGKH/91so0ORh44UmvZvEbNK5CcZZMNE4ccYZjQ0aO6wvrGhMOxPbycy4qnFRY5nO1Thlxi3Hple5GvM0fp/Fz03s5tBW/VrM25iqydj265j5uYn5JmjnLg6NsZbXF7vWtzwz7vilVWWojWqfxmxtXRPUNk3GP9R4rTrVL2rr+k0O66m+0X6VdcagjdM7rp/Xx6LTFxtrNw7fpZ9kk1F175hpp/Lv/LVDiybmfLXftFnvz8KKTNv6uTw7d9dq9deuCbctdFivc/29favLnGcWmbRv7VPebfMZWuZRXTq2PMprPfV+bd3W8cu+sb7vKf9c36gt+ozN76Hqk2k21T/DjO5ikGefoeUfNdQv6rOdu8/+/D5s37uc65TbQ9kJECBAgAABAk9ZwMKKp9z66r664B+GLm6XF7jzukcC5yRQUKZFBwWFmiCeCeeCMBN86/GuqcUA/+N//I9V8OGueXV8wZImkptE3hRQmnO031e+8pXV4oVvfvObq0Ba7xVwmfq1z7ZUYKQASRPv/+2//bdV4G35u2Hymby25bOtHAV7CiL3fubrqff+8i//cnVXgIJ9Bdqqc/vPoonlMb1XwLB2bTFIQZ5SrxcMqpw9vylta6+O773SdUGjbfXt3AWmyqe675ra/6WXXloF2//Lf/kvq8Bnx+6aX8HOP//zP18tjpmg6fL4ypvZrqm61xb1i039urw6Z+Wu/6yn2rr2aLFIbTzttL7frj93jgki9lneJVWH6l0/qQx9PiYo2WNB5gLPBS3Lvzq11W6599jxtec5B213sbQPAQIECBA4Z4HGGI27+/++MUDjge640AR0qUnGmQifxQKNk5Zj9PZpW06ij1n5NVHeooq2xrid85hT46hxqe5dQzVuKvU4d+TILItS1xBNxvZ+x+RT3UuNvXpvn9TxtUfbnKPjG+u2eKP2aQzXmDPfxvCVp+0h0vSL6lX9tl075NK+87jsK8tyZtXC/6lL9do0zl4es3yeU9dJ5d+E+LRD5avf5tYkeXnmWXkrU32296aNe31cW3ReeRp/57qtjstyTLtVn44pr8rQuUr93DVEY+yer6fpNx3f8/XUMbMQYNPx6/uf6s+1SXcIrM16Pqk61x77tMkcu+kx46552rr+Kf/aq37Uefss91mrP7bPQ32+NpXVawQIECBAgAABAo8j8Nuj9scph7MSeBSBuXh+lJM7KYFHECgwUBCgrUni+0oFGbrLwkOn6ldwdtMihF3K0u+EtoJTbbdNty1HwZsWvuyaloGf/nrqtumu7XXb+m4rbwGqFiq03SYVSD10/65fFPRs2zcVrJ1AeIsaHiutt9MEjgt+txVALmjYfvXFArg9TsAwA4kAAQIECBA4b4GZyG38MlsTii0saHK657Ngop+vS40dyqOxReOJ8mh81+T0/OV/Y6S7pn3GKPvsuyxX5WwcV/0bM5VPj/08Y6nl/j2fujd+7PjG3E3Szra+/3U/1y6Ny8qra7nOmX9t0daEb6nyNIZrv10X4F533vX3tvnNooTKkstNafrWGNU3pp9U16xbWFE/6bqs9/dJ5ZVT5WlhRedpUn4WE/fYti1NuWqzLFuo0vXFLDrq/V1SXtWn8pdXbVjb1QdKlbP8e6/91lPn6dj6zxhVp+XCjLl2La990npb9vNs++Szad/1vDfts89r9evar8UVY9fx/V6Z6/+5Ztkn3/V98y6f+QzVLvWfWQBU364c9a3a46ZzHspzvZx+JkCAAAECBAgQeDyB/Ubdj1dOZyZwbwLrF3xzgXpvJ5QxAQIECBA4AoEJHE6gvoBh/wf2eq+19by0/n/lERRfEQgQIECAAIF7FGjCsMnDxgNNIL711lurOyM0sTl3bWiys/HDptTYoYnejm2SsryalG7CvMUVTQbfNCm5zHfTWGTTa8tjls/bd9v+215fHl9ZK3djo+rVhGtfAdIkaxO963GEGWc16dvigLFs//7ivcn1fVLt0Dnza4K/8/WVFuv59HoLLtq2tc0+592073WWm/Zff23GmTMxnedMZNcvsuqxBQctRNh3wcCcr/OU10u/uhNebZdXdxeZr/hogcK21DkrQ322RRW14W3vipDXfJ7qD8uFNZVx6r6tnu3T8bV/Hn3+ZnHBlDOrbcdvq+Oy39+1Tbed41Cv97um3z1tPZ+Uyyys2Lf+k8f647RXfWYWMM05c68M009ru0lLz3mtx2O3XZbVcwIECBAgQIAAgZsFLKy42cgeBAgQIECAAIGzEyjIN4HtgpISAQIECBAgQGAEWhjQX8nPpG4TiE3qNqE4CyuavG+icf6au2MbX3TsHDcLK5r8bFFAE91NEO86CVp+7dsxTW7PceXTVhk7302p8lSHJksrdxPRpSbOJ4/OtS2NR/WYMpVnHk265jCLK9q3cpZvZWxifs5XGdq/+pSqU0Y3pTln+ZRf52j81l/Td9629qmNWgDQY+U7dOocnbt6VPZ9z9GxU5dZWFE9sqpueWbcz+XdvrdJc1znaCu/aZPK3uKWFlbM3R/Gb+rX/tNn864dK2flv02qDPW1zlPesyCmc/SVJdV9k+XUo/Zsv1Kfv5no7zNVe1enTcdvK2sWWU//6zNR/SpjZb0pVa6pS3lMql9Xpn0+43PsdY/VrTpO375r/a87V+9Ne/W7Las+Z6X5HbjeF/Jov/l89n6p9s25/K7rO72/dKyuOZZf+UoECBAgQIAAAQLHI3D5V3/1V///i/22lKnvepcInKvA8taPXRTOdq71Va9fCxTImL9U6dUudrslbQETiQABAgQIECBAgAABAgQuVtfITT63cGAWUszPPfbavJ5Xk4dNKjZR2GMTom3rr82E8U3GXaM3udkt+OdrHDqmycYmOZukLu/rJi3bv7I2GVs+TUz3c6lydi1YPqWbylVZyqc6l1eP83PPS+W53Mp7Jkfbt2vRPGffWSCyeuGGf8a8OrR1zl7LqbJnkUtbk7Nz3huy3fntiZlU9yabp867ZjC+PdZmbT2vj1TW2fq5NPvvmv+m/SrzuFXettphtn4ev84/fbV2m63Xp6ybznHTa7X39JfON/2vfGun+bxs68eVtf5fHtPenbPjmnzvcZ/yVZ65G0PP69dZV9/J76Y69X7l6S4s1alUu1WW8umx+h0iVf/pb4eo/01l6hzTXmPeMdNPq1+fsanfso9VzspbmvZt/55va9+HclwVyj+rPvtP//RPqwVWj8khDvmY+s5NgAABAqck8Oabb66K+1BzdzNv/L3vfW8j02FGuBuz9iIBAgQIECBAgAABAgQIECBAgMCpCjTZ2oRgWxOJk2YicSaMZ7JzJlbnmG0TiZPPTY8z6d5fwM9dHm46ZtP7lautOvRX77dN1adJ0rYCe01IZ9BE6kwuzyTqponUzn+XgGB1aCK+fGqDOf8sDKh87dPjIRYlrDuVZ1tlaDuFVHmnP04fGrdpt37OrP1aEDD95VCGc/4WLdwmtdjjLv12/ZyV5y79cPKbz8L8fF+P1b+7zTxUqv33+Z2zqY/tU9aHctynTPYlQIAAAQIECBDYLGBhxWYXrxIgQIAAAQIECBAgQIAAAQIECGwRaPKxCcUem9gv9XPbfU3sbynKo708E6rVt8nfh6p/5ylNGwzAnH/en9c9/qZAPi0umHbr3bF7Kn33N0X8RIAAAQIECBAgQIDALgIWVuyiZB8CBAgQIECAAAECBAgQIECAAIGVwEzcN7Hf9lTTcjL+oQ2WbfDQ5z718z1mu526nfITIECAAAECBAgQeMoCzzzlyqs7gRGYv66Znz0SIECAAAECBAgQIECAAAECBAgQIECAAAECBAgQIECAAIEELKzQD560wCyomL/0eNIYKk+AAAECBAgQIECAAAECBAgQIECAAAECBAgQIECAAAECvyVgYcVvkXjhKQm0sMLiiqfU4upKgAABAgQIECBAgAABAgQIECBAgAABAgQIECBAgACB/QQsrNjPy95nJjDfq3lm1VIdAgQIECBAgAABAgQIECBAgAABAgQIECBAgAABAgQIEDiQgIUVB4KUzWkKzFeAzONp1kKpCRAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQOC+BCysuC9Z+RIgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQInL2Bhxck3oQoQIECAAAECBAgQIECAAAECBAgQIECAAAECBAgQIECAAAEC9yVgYcV9ycr3pASurq5OqrwKS4AAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIPI2BhxcM4O8uRClhQcaQNo1gECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBA4EgELK46kIRSDAAECBAgQIECAAAECBAgQIECAAAECBAgQIECAAAECBAgQOD4BCyuOr02U6AEFLi8vV2ebxwc8tVMRIECAAAECBAgQIECAAAECBAgQIECAAAECBAgQIECAwAkIWFhxAo2kiPcv4CtB7t/YGQgQIECAAAECBAgQIECAAAECBAgQIECAAAECBAgQIHCKAhZWnGKrKfO9CFhccS+sMiVAgAABAgQIECBAgAABAgQIECBAgAABAgQIECBAgMBJC1hYcdLNp/AECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIDAfQpYWHGfuvI+KYHLy8uTKq/CEiBAgAABAgQIECBAgAABAgQIECBAgAABAgQIECBAgMD9C1hYcf/GznACAhZVnEAjKSIBAgQIECBAgAABAgQIECBAgAABAgQIECBAgAABAgQeQcDCikdAd8rjEbi6ujqewigJAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBydgIUVR9ckCkSAAAECBAgQIECAAAECBAgQIECAAAECBAgQIECAAAECBAgci4CFFcfSEsrxKALzFSDuXPEo/E5KgAABAgQIECBAgAABAgQIECBAgAABAgQIECBAgACBoxewsOLom0gBCRAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAgccSsLDiseSdlwABAgQIECBAgAABAgQIECBAgAABAgQIECBAgAABAgQIEDh6AQsrjr6JFJAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBB4LAELKx5L3nmPTuDq6uroyqRABAgQIECAAAECBAgQIECAAAECBAgQIECAAAECBAgQIPC4AhZWPK6/sx+RQAsrLK44ogZRFAIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECByBgIUVR9AIivB4ApeXl493cmcmQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAgaMXsLDi6JtIAR9KoEUWFlo8lLbzECBAgAABAgQIECBAgAABAgQIECBAgAABAgQIECBA4DQELKw4jXZSynsSWH71h0UV94QsWwIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECJywgIUVJ9x4ik6AAAECBAgQIECAAAECBAgQIECAAAECBAgQIECAAAECBAjcr4CFFffrK/cTEljeveKEiq2oBAgQIECAAAECBAgQIECAAAECBAgQIECAAAECBAgQIHCPAhZW3COurAkQIECAAAECBAgQIECAAAECBAgQIECAAAECBAgQIECAAIHTFrCw4rTbT+kPKHB5eXnA3GRFgAABAgQIECBAgAABAgQIECBAgAABAgQIECBAgAABAucgYGHFObSiOhAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQL3ImBhxb2wyvRUBK6urk6lqMpJgAABAgQIECBAgAABAgQIECBAgAABAgQIECBAgAABAo8g8NwjnNMpCRyVQIsr+hoQiyyOqlkevDC1/y9+8YuL999//8HP7YQECBAgQIAAAQIECBAgQIAAAQIECNyvQLE/MeD7NZY7AQIECBA4ZwELK865ddXtRoEWVEyyuGIknubjL3/5y4uf//znT7Pyak2AAAECBAgQIECAAAECBAgQIEDgzAWK/RUDlAgQIECAAAECtxGwsOI2ao4hQODsBD788MOLDz744OKZZ3xD0tk1rgoRIECAAAECBAgQIECAAAECBAg8eYFif8UAJQIECBAgQIDAbQTMIN5GzTFnKeA2cGfZrCpFgAABAgQIECBAgAABAgQIECBAgAABAgQIECBAgACBOwm4Y8Wd+BxMgMC5CHSniueff/7iYx/72LlUST0IECBAgAABAgQIECBAgAABAgQIEPh3ge5W4W61ugMBAgQIECBwWwELK24r5zgCBM5K4Nlnn734xCc+cfEf/sN/OKt6qQwBAgQIECBAgAABAgQIECBAgAABAv9foBigRIAAAQIECBC4jYCFFbdRcwwBAmcncHl5efHcc8+5Y8XZtawKESBAgAABAgQIECBAgAABAgQIELi4eO+99y6KAUoECBAgQIAAgdsIPHObgxxD4BwFDKrPsVXViQABAgQIECBNmp4WAABAAElEQVRAgAABAgQIECBAgAABAgQIECBAgAABAncTsLDibn6OJkCAAAECBAgQIECAAAECBAgQIECAAAECBAgQIECAAAECBM5YwMKKM25cVbtZ4Orq6uad7EGAAAECBAgQIECAAAECBAgQIECAAAECBAgQIECAAAECT1bAwoon2/QqnsDy6z8sstAnCBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQGBdwMKKdRE/EyBAgAABAgQIECBAgAABAgQIECBAgAABAgQIECBAgAABAgT+XcDCCl2BwL8LLO9eAYUAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECCRgYYV+QIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBDYImBhxRYYLxMgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIELKzQBwj8u8DV1RULAgQIECBAgAABAgQIECBAgAABAgQIECBAgAABAgQIECDwGwIWVvwGhx8IECBAgAABAgQIECBAgAABAgQIECBAgAABAgQIECBAgAABAr8WsLDi1xaePXGBy8vLJy6g+gQIECBAgAABAgQIECBAgAABAgQIECBAgAABAgQIECCwLmBhxbqInwkQIECAAAECBAgQIECAAAECBAgQIECAAAECBAgQIECAAAEC/y5gYYWuQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBDYImBhxRYYLxMgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIELKzQBwgQIECAAAECBAgQIECAAAECBAgQIECAAAECBAgQIECAAAECWwQsrNgC42UCBAgQIECAAAECBAgQIECAAAECBAgQIECAAAECBAgQIECAwHMICDxlgaurq4+q3/Plzx+94QkBAgQIECBAgAABAgQIECBAgAABAgQIECBAgAABAgQIPFkBd6x4sk2v4glcXl6CIECAAAECBAgQIECAAAECBAgQIECAAAECBAgQIECAAAECWwXcsWIrjTeeisD64gp3rXgqLa+eBAgQIECAAAECBAgQIECAAAECBAgQIECAAAECBAgQuFnAHStuNrIHAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAg8EQFLKx4og2v2gQIECBAgAABAgQIECBAgAABAgQIECBAgAABAgQIECBAgMDNAhZW3GxkDwIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQOCJClhY8UQbXrUJECBAgAABAgQIECBAgAABAgQIECBAgAABAgQIECBAgACBmwUsrLjZyB4ECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIDAExWwsOKJNrxq/6bA1dXVb77gJwIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAg8CsBCyt0gyctMAsqLi8vn7SDyhMgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIDAZgELKza7ePWJCLSwwuKKJ9LYqkmAAAECBAgQIECAAAECBAgQIECAAAECBAgQIECAAIFbCFhYcQs0h5yPQHeqcLeK82lPNSFAgAABAgQIECBAgAABAgQIECBAgAABAgQIECBAgMChBSysOLSo/E5KYBZVzONJFV5hCRAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQODeBSysuHdiJyBAgAABAgQIECBAgAABAgQIECBAgAABAgQIECBAgAABAgROVcDCilNtOeUmQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIE7l3Awop7J3aCUxC4uro6hWIqIwECBAgQIECAAAECBAgQIECAAAECBAgQIECAAAECBAg8sICFFQ8M7nTHJWBBxXG1h9IQIECAAAECBAgQIECAAAECBAgQIECAAAECBAgQIEDg2AQsrDi2FlEeAgQIECBAgAABAgQIECBAgAABAgQIECBAgAABAgQIECBA4GgELKw4mqZQkMcQuLy8XJ12Hh+jDM5JgAABAgQIECBAgAABAgQIECBAgAABAgQIECBAgAABAscrYGHF8baNkj2ggK8EeUBspyJAgAABAgQIECBAgAABAgQIECBAgAABAgQIECBAgMAJCVhYcUKNpaj3K2Bxxf36yp0AAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQKnKGBhxSm2mjITIECAAAECBAgQIECAAAECBAgQIECAAAECBAgQIECAAAECDyJgYcWDMDvJKQhcXl6eQjGVkQABAgQIECBAgAABAgQIECBAgAABAgQIECBAgAABAgQeUMDCigfEdqrjFbCo4njbRskIECBAgAABAgQIECBAgAABAgQIECBAgAABAgQIECDwmAIWVjymvnM/usDV1dWjl0EBCBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQOB4BSysON62UTICBAgQIECAAAECBAgQIECAAAECBAgQIECAAAECBAgQIEDgkQUsrHjkBnD6xxWYrwBx54rHbQdnJ0CAAAECBAgQIECAAAECBAgQIECAAAECBAgQIECAwLEKWFhxrC2jXAQIECBAgAABAgQIECBAgAABAgQIECBAgAABAgQIECBAgMCjC1hY8ehNoAAECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIDAsQpYWHGsLaNcBAgQIECAAAECBAgQIECAAAECBAgQIECAAAECBAgQIECAwKMLWFjx6E2gAMcicHV1dSxFUQ4CBAgQIECAAAECBAgQIECAAAECBAgQIECAAAECBAgQOBIBCyuOpCEU4/EFWlhhccXjt4MSECBAgAABAgQIECBAgAABAgQIECBAgAABAgQIECBA4JgELKw4ptZQlgcXuLy8fPBzOiEBAgQIECBAgAABAgQIECBAgAABAgQIECBAgAABAgQInI6AhRWn01ZKes8CLbKw0OKekWVPgAABAgQIECBAgAABAgQIECBAgAABAgQIECBAgACBExOwsOLEGkxxDyuw/OoPiyoOays3AgQIECBAgAABAgQIECBAgAABAgQIECBAgAABAgQInIOAhRXn0IrqQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECNyLgIUV98Iq01MUWN694hTLr8wECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgcHgBCysObypHAgQIECBAgAABAgQIECBAgAABAgQIECBAgAABAgQIECBA4EwELKw4k4ZUjbsLXF5e3j0TORAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIDAWQlYWHFWzakyBAgQIECAAAECBAgQIECAAAECBAgQIECAAAECBAgQIECAwCEFLKw4pKa8Tk7g6urq5MqswAQIECBAgAABAgQIECBAgAABAgQIECBAgAABAgQIECDwcAIWVjyctTMdqcAsrpjHIy2mYhEgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIDAIwhYWPEI6E55PAKXl5cXbaV5PJ7SKQkBAgQIECBAgAABAgQIECBAgAABAgQIECBAgAABAgQIPLaAhRWP3QLOT4AAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBytgIUVR9s0CvbQAr4K5KHFnY8AAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQLHL2BhxfG3kRISIECAAAECBAgQIECAAAECBAgQIECAAAECBAgQIECAAAECjyRgYcUjwTstAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgcPwCFlYcfxspIQECBAgQIECAAAECBAgQIECAAAECBAgQIECAAAECBAgQIPBIAhZWPBK80x6fwOXl5fEVSokIECBAgAABAgQIECBAgAABAgQIECBAgAABAgQIECBA4FEFLKx4VH4nJ0CAAAECBAgQIECAAAECBAgQIECAAAECBAgQIECAAAECBI5ZwMKKY24dZbt3gaurq3s/hxMQIECAAAECBAgQIECAAAECBAgQIECAAAECBAgQIECAwOkKWFhxum2n5AcQWH79h0UWBwCVBQECBAgQIECAAAECBAgQIECAAAECBAgQIECAAAECBM5MwMKKM2tQ1SFAgAABAgQIECBAgAABAgQIECBAgAABAgQIECBAgAABAgQOJ2BhxeEs5XTiAsu7V5x4VRSfAAECBAgQIECAAAECBAgQIECAAAECBAgQIECAAAECBA4kYGHFgSBlQ4AAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECJyfgIUV59emakSAAAECBAgQIECAAAECBAgQIECAAAECBAgQIECAAAECBAgcSMDCigNByub0Ba6urk6/EmpAgAABAgQIECBAgAABAgQIECBAgAABAgQIECBAgAABAgcVsLDioJwyI0CAAAECBAgQIECAAAECBAgQIECAAAECBAgQIECAAAECBM5JwMKKc2pNdbmTwOXl5Z2OdzABAgQIECBAgAABAgQIECBAgAABAgQIECBAgAABAgQInJ+AhRXn16ZqRIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBxIwMKKA0HKhgABAgQIECBAgAABAgQIECBAgAABAgQIECBAgAABAgQIEDg/AQsrzq9N1YgAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBA4kICFFQeClA0BAgQIECBAgAABAgQIECBAgAABAgQIECBAgAABAgQIECBwfgIWVpxfm6oRAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgcCCB5w6Uj2wInKTA1dXVR+Xu+fLnj97whAABAgQIECBAgAABAgQIECBAgAABAgQIECBAgAABAgSerIA7VjzZplfxBC4vL0EQIECAAAECBAgQIECAAAECBAgQIECAAAECBAgQIECAAIGtAu5YsZXGG09FYH1xhbtWPJWWV08CBAgQIECAAAECBAgQIECAAAECBAgQIECAAAECBAjcLGBhxc1G9iBwkgItEPnFL35x8eGHH67K/8wzz1w899xz7tJxkq2p0AQIECBAgAABAgQIECBAgAABAgQIECBAgAABAgQIPJaAhRWPJe+8BO5ZoEUV77zzzmpxRadqUcUnP/nJi+eff/6ezyx7AgQIECBAgAABAgQIECBAgAABAgQIECBAgAABAgQInI+AhRXn05Zq8sQF5g4VH3zwwcX777+/WlTx9ttvX7z33nsrmRZUtLDiE5/4xMXHP/7xi4997GOrx2efffaJy6k+AQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIEtgtYWLHdxjsETkpg7lDxk5/85OKNN964ePPNNy9aWNEii9Ll5eVFiyg+9alPXXz2s5+9+MxnPrN6bLGFRIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQKbBSys2OziVQInJ9CdKlpU8S//8i8XP/rRjy7eeuut1V0ren2ZXnjhhdVdLHq9u1z8zu/8jq8IWQJ5ToAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAgYWAhRULDE+frkALDE49dWeK7lSxXFTRXSzWU/v9+Mc/vvj5z39+8dOf/vTi85///MWLL7548elPf3p9Vz8TIECAAAECBAgQIECAAAECBAgQIECAAAECBAgQIEDgyQtYWPHku8DTBmhBRV+R0Xaqiyt++ctfru5AMV8Bsu1OFdPS7f/uu+9etOiiRRbPPPPM6mtB+kqQ5557bmUx+3okQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIDAUxd45qkDqP/TFmgxxSyoaHHFKab33ntvdQeKm+5UsV63Fla88847F2+//fZq6/mmO1ysH+dnAgQIECBAgAABAgQIECBAgAABAgQIECBAgAABAgQIPCUBd6x4Sq2trr8lMHer+K03TuiFuQPFv/3bv62+3uODDz7YqfQtKGnfFlS8+eabFy+88MLF888/v9p2ysBOBAgQIECAAAECBAgQIECAAAECBAgQIECAAAECBAgQeAIC7ljxBBpZFbcLzF0q5nH7nuf7Tne8eOONN1ZbXw0iESBAgAABAgQIECBAgAABAgQIECBAgAABAgQIECBAgMCvBSys+LWFZwROUuDDDz+8aEFEd5/o+b6pO1787Gc/W22+CmRfPfsTIECAAAECBAgQIECAAAECBAgQIECAAAECBAgQIHDuAhZWnHsLq9/ZC8xXgfSVHj2XCBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQOBwAhZWHM5STicscHV1dbKlv+sdK0624gpOgAABAgQIECBAgAABAgQIECBAgAABAgQIECBAgACBBxCwsOIBkJ3ieAVOeUHF8aoqGQECBAgQIECAAAECBAgQIECAAAECBAgQIECAAAECBM5H4LnzqYqaEDhNgRZ3/OIXv7j44IMPLt5///3V831q8tZbb128++67q+Nus1Bkzl8e5bVreuaZZy6effbZix5LPf/4xz++etw1D/sRIECAAAECBAgQIECAAAECBAgQIECAAAECBAgQIEDg2AUsrDj2FlK+exW4vLxc5d/jbRYlHKJwLap45513Ln7yk59cvPHGGxc/+9nP9sq2BRE//vGPV3mU175pzl8epRdeeGGnLD72sY+t9u1xjvvsZz978clPfnKn4+1EgAABAgQIECBAgAABAgQIECBAgAABAgQIECBAgACBUxCwsOIUWkkZ713gMRZVdIeKFlS0kOLtt9++ePPNN2+1sGIWRpTfbVJ179jK0fPnntvt18Lzzz+/WkTRY+lTn/rU6vjf+Z3f+Y3Xb1MmxxAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQOBYBHabQT2W0ioHgXsUeOjFFS2q+MEPfnDxL//yL6uFFf383nvvXfzyl7/cq5aV+zZ3qlg/ySzQmLt4rL+//nNfAdKCkPkqkE984hMXP/3pTy8+//nPX7z44osXn/70p9cP8TMBAgQIECBAgAABAgQIECBAgAABAgQIECBAgAABAgROTsDCipNrMgU+dYEWTrSA4q233rr40Y9+dPHP//zPqztX3PaOE4fymDtX3Da/n//85xfvv//+aqHFZz7zmdVdK7r7xa4LNW57XscRIECAAAECBAgQIECAAAECBAgQIECAAAECBAgQIEDgPgWeuc/M5U3glAQeagFAiyp+/OMfrxZVtLiiO1Uc4o4Tj209d7zoLhZt51Kvx3Z1fgIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIEHlfAHSse19/Zj0SgRRUP9VUg3bHi3Xffvfi3f/u3i+7y8Nh3qjhUE8wdL1pQ8eabb1688MILF88///xqO9Q55EOAAAECBAgQIECAAAECBAgQIECAAAECBAgQIECAAIGHFnDHiocWd76jEnioxRRHVel7Lkx35HjjjTdWW18NIhEgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQOCUBSysOOXWU/aTFPjwww8vWnDQnSp6fm6pO3L87Gc/W23n8BUn59Y+6kOAAAECBAgQIECAAAECBAgQIECAAAECBAgQIECAwH4CFlbs52XvMxPoK0BKD3nnivkqkL4yo+cSAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECByvgIUVx9s2SnamAud+x4ozbTbVIkCAAAECBAgQIECAAAECBAgQIECAAAECBAgQIEDgiQpYWPFEG161CRAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAgZsFLKy42cgeBAgQIECAAAECBAgQIECAAAECBAgQIECAAAECBAgQIECAwBMVsLDiiTa8av+2wNXV1W+/6BUCBAgQIECAAAECBAgQIECAAAECBAgQIECAAAECBAgQeNICFlY86eZX+aVACyssrliKeE6AAAECBAgQIECAAAECBAgQIECAAAECBAgQIECAAAECFlboA09a4PLy8knXX+UJECBAgAABAgQIECBAgAABAgQIECBAgAABAgQIECBA4HoBCyuu9/HuExJokYWFFk+owVWVAAECBAgQIECAAAECBAgQIECAAAECBAgQIECAAAECOwhYWLEDkl3OV2D51R8WVZxvO6sZAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIEbitgYcVt5RxHgAABAgQIECBAgAABAgQIECBAgAABAgQIECBAgAABAgQInL2AhRVn38QquKvA8u4Vux5jPwIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBA4b4Hnzrt6akfg+ASef/75i09/+tMXv/jFLy4+9alPXXzwwQe/Uchf/vKXF++9995qe//99y/6+ZRSC1Sq27vvvnvx1ltvfVT0Z5555uLZZ5+96LHU849//OOrx4928oQAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQJHJmBhxZE1iOI8nsDl5eXFQ9y14pOf/OTFiy++ePGFL3xhtWjiww8//I1Kv/POOxc//vGPP9paoHBKqUUVU4fK/cILL6yK/7GPfWz1vMd5/bOf/exFHhIBAgQIECBAgAABAgQIECBAgAABAgQIECBAgAABAgSOVcDCimNtGeU6W4G5Y8W2CrYoocUH3c2h7Sc/+clqoUJ3r2jRwkMs/thWtl1er3zdheNnP/vZqqzPPff/f81U7xZR9Fjqbh3t2907qm+vt28LXCQCBAgQIECAAAECBAgQIECAAAECBAgQIECAAAECBAgci4CFFcfSEsrxKAJN7B/bRH6LKbqTw3/6T//p4ktf+tLFv/7rv1784Ac/uHjjjTdWCyzWvzrkUeB2OOncuWJ8+wqQt99++6OvAvnEJz5x8dOf/vTiM5/5zGprgcVy4cUOp7ALAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIE7l3Awop7J3aCYxeYxRU9HkN69tlnVwsM5isyWmjx85//fHW3iu5acSoLK/K8rqzVqfq0zdehdNeKuaPFMbSFMhAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQMDCCn3gSQvM3RRC6PmxLK5YNkpfk9FdHd57773VHR7efffd5dsn+3zuaDEV6I4W3aVjFpTM6x4JECBAgAABAgQIECBAgAABAgQIECBAgAABAgQIECDwmALPPObJnZsAgZsFuoNDX5Pxu7/7ux99VcZyQcjNORznHnNHi3feeefirbfeunjzzTc/+qqTY1zgcpyKSkWAAAECBAgQIECAAAECBAgQIECAAAECBAgQIECAwH0LWFhx38LyPxmBY53Mf+6551YLKv7jf/yPF23d0aHXziXNnSvefvvti7YWWvSaRIAAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAgWMQsLDiGFpBGQhcI9DdKbprRV8J0taiinO4Y8VUee5c8f7776++7qRFFR9++OG87ZEAAQIECBAgQIAAAQIECBAgQIAAAQIECBAgQIAAAQKPKmBhxaPyOzkBAgQIECBAgAABAgQIECBAgAABAgQIECBAgAABAgQIECBwzAIWVhxz6ygbgYVAd3bobg5tx/q1JYvi7v107szRHTmeecavpr0BHUCAAAECBAgQIECAAIH/x959gFtT1Icf35cOLwhIiwVBTTQak2hiEjUW7AVUUBRRFCtiQ1FsoFJUxAaKHbsiGrFgwV5Q7CXRWLCh0VhiQUGagvD++e7fuc6ZM7tnz57de/bc853nufe0rZ/dnZ2Z/e2sAgoooIACCiiggAIKKKCAAgoo0IuAVy97YXWiiygw9MdrXHbZZcVFF11U/hFcsdbSxhtvXGy11VblH8EVJgUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUGAIAl69HMJWcBkUqBEIPVX88Y9/LPi79NJLa4ZevJ8IqNhss82Krbfeuthiiy2KTTfddPFWwiVWQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQIE1K2CPFWt207piTQQW4ZEa9E4Reqqg14q1lgiq2HHHHcu/zTfffK2tnuujgAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAILLmCPFQu+AV382QTix38MNciCHirOO++88m8t9VaBPY/8oKeKnXfeudhhhx3Knitm26KOrYACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCnQrYI8V3Xo6NQU6F7jkkkuKc845p/zjUSBrJRFUsdVWWxXbbbddscsuu9hjxVrZsK6HAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAmtMwB4r1tgGdXXaC9CDwjx7rWDePPbj8ssvL1ciPALkN7/5TfGrX/2q7LGC7xYlhR4p4l5BWPaNN9644JEfBFVss802xU477VQGV/DZpIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCgxNwMCKoW0Rl2dpBUIgRQie4PEfP/nJTwoCKy666KKCnivCb4uAFHqk4DVO69evLx/7sf3225eBFXw2qCIW8r0CCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCgxJYPSK55CWzGVRYI0KXHrppSuBEpdddtlKDxXhe15Jv//974uf//znZU8Vi0QReqogYGLHHXcsttxyy5HFD4EV2267bRlQsemmm4787gcFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBgSAIGVgxpa7gscxVYrceA0PsEPVGcc845ZYBFCKTgESAEWoTlCIEWc0VpMfPQUwVBFde85jXLx3zEk+H3zTbbrCCgIu3NIh7O9woooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooMAQBAysGMJWcBmWSoCACR7z8atf/ao4//zzy0d8rCWA0GMFPVVst912Za8Va2n9XBcFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFgugY2Wa3VdWwWqBQgIMCmggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKBAL2GNFrOF7BdaQQOg5IgSM8IiRP/3pTyuPGllDq+qqKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAr0JGFjRG60TVmC+Aptsskmx1VZbFbySCKq46KKLCh5FYlJAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUaCZgYEUzJ4dSYPACoYcKAik233zzMqhim222KTbbbLNy2UNgxR//+MfisssuKwMseM/39mQx+M3rAiqggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiigwJwEDKyYE7yzVaBrgdBDxbbbblvssMMOxfbbb1/EgRU8CoSACoIp6LnivPPOK84555zy1Z4sut4aTk8BBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBdaKgIEVa2VLuh5LL0DPFARU7LzzzuUrARY8CmTTTTcdseFRIARSrF+/vuzZgoAMeqzwESEjTH5QQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFSgEDK9wRllqAXhxC4n38OXy/KK8EUVzjGtcornKVq5SP/yCggqCJNIWeLfj9Sle6UrHFFlsU559/fnHhhRemg/pZAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUWHqB8auuS08iwDIJrFu3bqGDKdhWG2+8cRlIQQ8VV77ylYvtttuudhOyzgRV8EcwBj1V7LjjjsUll1xS9mRhzxW1fP6ogAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAJLJrDRkq2vq6vAmACBBvHf2AAD/4JHgBAYwd/mm28+9dKGni7o7YL3JgUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUECBvwjYY8VfLHynwEIKEExBUMUOO+xQ9lwx7UrwaBB6u7jgggvKXiymHT8dfqONNiqnQ8AH700KKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKDAIgt41XORt57LrsAVAiGwom2PFV0j8mgSer7Ycssty8eUdD19p6eAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgqspoCBFaup7bwUuEKAHiLWr19f/hGEMGsKgQwEM7SZHr1KsEybbrpp+UiUWZfHHitmFXR8BRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRQYkoCBFUPaGi7LUgjwiAwe28EfvU3MOxFUQVBG28CMeS+/81dAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQX6FDCwok9dp61ARoCeIbbddtti++23L4MZuuopIjOrRl+tW7eu7K2C5aC3ibYpTGeLLbYott56ax8F0hbS8RRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQYFAC7a+iDmo1XBgFZhPYsGHDbBOYYuzQQ8Q222xT8EdPEXy36Cms13bbbVfssssuxY477jiIHjkW3dXlV0ABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUECB+Qos/tXc+fo59wUXIKCCnhb4W63gitCzw/r164uddtqpuPzyy4tzzz23+MMf/lBq8vmyyy4rv2/CO2tPE2Ee9FbBtHhUyTRp4403LgMoCBAhUIR1IriCzyYFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBg0QUMrFj0LejyzyQQgilWO7iChSbw4BrXuEZxpStdqfjlL39ZXHDBBeW6XHrppcVFF11U8NokMR2CG2ZNTCMER0wzLQJEdthhh/LRJgRW8NmgimkEHVYBBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBYYsYGDFkLeOy9a7QAio6H1GmRnQO8S2225b9hLBclx88cXlUJdcckn5ntcmiWlM28tEbrpMgwCJaR9LEgIrWA4CKlgvkwIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKLBWBAysWCtb0vVoJUBAA4nX0HtFqwnNMNLmm29e7LjjjuXjP5hMm0eBdNFDBNOgB42mPWWEVSYQg6AMAiqmDcoI0/BVAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUGKqAgRVD3TIu19IIhEdwzHuFQw8a814O56+AAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoMSWCjIS2My6KAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCgxJwMCKIW0Nl2VuAvN6DMjcVtgZK6CAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgo0EjCwohGTA61VAQMq1uqWdb0UUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUECBbgQMrOjG0akooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiigwBoUMLBiDW5UV6m5wLp168qBw2vzMR1SAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUGAZBAysWIat7DpOFPCRIBOJHEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRYSgEDK5Zys7vSOQGDK3IqfqeAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgost4CBFcu9/V17BRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFKgRMLCiBseflktg3bp1y7XCrq0CCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiigwEQBAysmEjnAMggYVLEMW9l1VEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBaYXMLBiejPHWEMCGzZsWENr46oooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCnQtYGBF16JOTwEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQXWjICBFWtmU7oibQTCI0DsuaKNnuMooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACa1/AwIq1v41dQwUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRoKWBgRUs4R1NAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUECBtS9gYMXa38auoQIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgq0FDCwoiWco609gQ0bNqy9lXKNFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQVmEjCwYiY+R15LAgRWGFyxlrao66KAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgrMLmBgxeyGTmGBBdatW7fAS++iK6CAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgr0LWBgRd/CTn9hBAiyMNBiYTaXC6qAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgqsioCBFavC7EyGKhA/+sOgiqFuJZdLAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUmJ+AgRXzs3fOCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKDBwAQMrBr6BXLzVE4h7r1i9uTonBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQIEhCxhYMeSt47IpoIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiigwFwFDKyYK78zH5LAunXrhrQ4LosCCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiigwAAEDKwYwEZwERRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBgmAIGVgxzu7hUqySwYcOGVZqTs1FAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUWEQBAysWcau5zJ0KhOCK8NrpxJ2YAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooMBCCxhYsdCbz4WfVWDdunUFf6TwOus0HV8BBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQYO0IGFixdrala6KAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACHQsYWNExqJNbXAEfBbK4284lV0ABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBfoSMLCiL1mnq4ACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAILL2BgxcJvQldAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBfoSMLCiL1mnq4ACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAILL2BgxcJvQlegK4F169Z1NSmno4ACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiwRgQMrFgjG9LVUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQIHuBQys6N7UKS6QwIYNGxZoaV1UBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQIHVFjCwYrXFnd+gBOLHfxhkMahN48IooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACgxAwsGIQm8GFUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQIEhChhYMcSt4jLNRSDuvWIuC+BMFVBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUGJ2BgxeA2iQukgAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAkMRMLBiKFvC5VBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUECBwQkYWDG4TeICzUtgw4YN85q181VAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUGKiAgRUD3TAulgIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgrMX8DAivlvA5dgIALr1q0byJK4GAoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACQxEwsGIoW8LlUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQIHBCRhYMbhN4gIpoIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiigwFAEDKwYypZwORRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBgcAIGVgxuk7hACiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKDAUAQMrhrIlXA4FFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUGJzAJoNbIhdIgVUU2LBhw8rceB9/XvnBNwoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACSytgjxVLu+ldcQTWrVsnhAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAApUC9lhRSeMPyyKQBlfYa8WybHnXUwEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFJgsYI8Vk40cQgEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQWWVMDAiiXd8K62AgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCkwWMLBispFDKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooMCSChhYsaQb3tVWQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAgckCBlZMNnIIBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFhSAQMrlnTDu9qjAhs2bBj9wk8KKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgpcIWBghbuBAn8WILjCAAt3BwUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUECBWGCT+IPvFVg2ga222mrZVtn1/bPANttsU+y88856KKCAAgoooIACCiiggAIKKKCAAgoooMASCNAeyJ9JAQUUUEABBRRoI2CPFW3UHEcBBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFlkLAwIql2MyupAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgq0ETCwoo2a4yiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKDAUggYWLEUm9mVVEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQIE2AgZWtFFzHAUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRYCgEDK5ZiM7uSCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKNBGwMCKNmqOo4ACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAJLIWBgxVJsZldSAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBdoIGFjRRs1xFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUGApBAysWIrN7EoqoIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiigQBsBAyvaqDmOAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiyFgIEVS7GZXUkFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUaCNgYEUbNcdRQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAgaUQMLBiKTazK6mAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACbQQMrGij5jgKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoosBQCBlYsxWZ2JRVQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFCgjYCBFW3UHEcBBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFlkLAwIql2MyupAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgq0ETCwoo2a4yiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKDAUggYWLEUm9mVVEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQIE2AgZWtFFzHAUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRYCgEDK5ZiM7uSCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKNBGwMCKNmqOo4ACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAJLIWBgxVJsZldSAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBdoIGFjRRs1xFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUGApBAysWIrN7EoqoIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiigQBsBAyvaqDmOAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiyFgIEVS7GZXUkFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUaCNgYEUbNcdRQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAgaUQMLBiKTazK6mAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACbQQMrGij5jgKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoosBQCBlYsxWZ2JRVQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFCgjYCBFW3UHEcBBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFlkLAwIql2MyupAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgq0ETCwoo2a4yiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKDAUggYWLEUm9mVVEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQIE2AgZWtFFzHAUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRYCgEDK5ZiM7uSCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKNBGwMCKNmqOo4ACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAJLIWBgxVJsZldSAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBdoIGFjRRs1xFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUGApBAysWIrN7EoqoIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiigQBsBAyvaqDmOAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiyFgIEVS7GZXUkFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUaCNgYEUbNcdRQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAgaUQMLBiKTazK6mAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACbQQMrGij5jgKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoosBQCBlYsxWZ2JRVQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFCgjYCBFW3UHEcBBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFlkLAwIql2MyupAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgq0ETCwoo2a4yiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKDAUggYWLEUm9mVVEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQIE2AgZWtFFzHAUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRYCgEDK5ZiM7uSCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKNBGwMCKNmqOo4ACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAJLIWBgxVJsZldSAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBdoIGFjRRs1xFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUGApBAysWIrN7EoqoIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiigQBsBAyvaqDmOAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiyFgIEVS7GZXUkFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUaCNgYEUbNcdRQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAgaUQMLBiKTazK6mAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACbQQMrGij5jgKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoosBQCBlYsxWZ2JRVQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFCgjYCBFW3UHEcBBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFlkLAwIql2MyupAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgq0ETCwoo2a4yiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKKDAUggYWLEUm9mVVEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQIE2AgZWtFFzHAUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUnhDkHQAAQABJREFUUEABBRRYCgEDK5ZiM7uSCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAIKKNBGwMCKNmqOo4ACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiiggAJLIWBgxVJsZldSAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBdoIGFjRRs1xFFBAAQUUUEABBRRQQAEFFFBAAQUUUEABBRRQQAEFFFBAAQUUUGApBAysWIrN7EoqoIACCiiggAIKKKCAAgoooIACCiiggAIKKKCAAgoooIACCiigQBsBAyvaqDmOAj0IXH755cVvf/vb4rzzzisuu+yyHubgJGcR+P3vf1987GMfK772ta8VbCuTAvMQuOSSS4rPfe5zxZlnnln88Y9/nMciOE8FFFBAAQUUUECBJRaYtTx64YUXFr/73e+Kiy66qLXiz372s+KDH/xg8T//8z+tp+GICiiggALVAhs2bCi+9a1vFR/5yEfKPLt6SH9RYO0KWN5Yu9vWNVNAAQVmEVh3/PHHb6ibwI1udKO6n/1NAQVmEPjmN79ZfOUrXyl++MMfFj/4wQ9GpnTCCScUu+yyy8h3fqgW+PKXv1y85S1vGRngSU96UnHVq1515Ls2H5g22yOknXfeuXj+859fbLrppuErXxXoXeBXv/pV8ZSnPKX4wx/+UM5riy22KI488shit912633ezkCBaQSOOuqo4txzz10Z5YY3vGHxwAc+cOWzbxRYVIG3ve1txRe+8IWVxScfPu6441Y++0aBtSxw6qmnFp/97GdXVpFyMOVh0/wEfvnLXxbPfe5zR4K+99133+LmN795bwvVpjx68cUXlxfmqPOeffbZ5c0EYQFvdatbFQ9/+MPDx0avp5xySvH+979/Zdhb3vKWxcEHH7zy2TcKKKDAIgn02ZbV1oGbiZ7+9KcXP/rRj1YmcdBBBxV77LHHyudFfmN9dZG33uot+xDKG8u6rxLYRVDLr3/96/IGVG52pO697bbbln/XvOY1i80333z1dgbnpIACcxcgMJ+0zTbbrMqyhJsAqL/m0ia5L/1OAQVGBT7zmc8U73jHO8ovaUwiXe1qVyuOPfbY1hfXzzjjjOKkk04qp5X7RyHC1FyA3j7Ctglj/elPfwpvZ3p9z3veMzI+86Hye7Ob3Wzkez8o0KfAJz7xiZWgCuZDgMVHP/rR4qEPfWifs3XaCkwt8L3vfW9kHHpiMimwFgRo3InLGjTumBRYFoFf/OIXI/v/sqz3kNeTgIX/+7//G1lEvuszTVsepSGc4I/44ly8fNP21Mj04qAKpvXpT3+6uOc971nstNNO8aR9v0YEaBc55phjRu6Yv8UtblFuc1bxi1/8YvHWt751ZG2f/exnF+vXrx/5jg8EQ8bHzK677loceuihxUYbTdeZL8vEPH7zm9+szGOogcTpOm+33XYFF+qaJBqUr7gZb2Q9GQ/bo48+uthkE5uUmzhOGqZpWxZlULZn3IMqwevseyRuNKKdKiRuMuJmozbpv//7v8fy7dNOO60gGG7dunVtJjmocayvDmpzDHJhhlLeWLZ9lQunH/rQh8pgbvLGunSTm9ykuN3tbldc//rXrxvM3xRQQIFeBCwF98LqRNeaAI+AiBvSWT8a17/+9a8XN77xjadeXe72qguqyE2QyjvdrsaJO8WmbQSIxx/ye4Ii4oY2Km+bbbbZqi8yy8HdVWmi21kDK1IVP08jQIPIpZdeOjJKXcR1rkE67elmZGJ+UECBpRVIHxVEw/fGG2+8tB6u+GQB95nJRg6hgALF2IU2TKrKo5R1uYAbX8ie1ZBeOnLppz/96VhgxbLVn3Mua+E72gG++93vjqxK3C7C/pW21VRd8KcOz8WykBjvAx/4QLHXXnuFrxq9sm99+9vfHhl2qIHE6To3vfmEtpgTTzxxbD1ZaXoyqDIeQfFDpwLsu2l+yr4Y0k9+8pORY2HrrbcOP039yrTSxPHCo5xmmW46zS4+m9ePK1quHzeZ9ptpyhvTTntIww+l7Z3jmICKN7/5zY156EmSP9rmDzzwwFW7i73xAjqgAgqsaQEDK9b05nXluhCgMJVGiIbpnnnmma0CK3j8Ry7927/9W8FjJmg82H777UcG4c70N7zhDSPfcZcE3V+ttUQlnm4GwyMPWL9/+qd/Kg477LBVX1UaDOjukB5G4kRkrEmBWQRoqPrSl740Mgm6GqxK3Jn1jW98Y+Rn7hgxKaCAArEADeiHH354/FVx//vfv7jzne888p0fFAgC7jNBwlcFFJgkME15lBsR0ouATJ+eH693vesVW265Zfk6aZ7x79e+9rXL+nJ8IZ3eg/7u7/4uHqx8v0z157GVX2NfsI3jtoE4GD1388U0j+yk/nWDG9yg2H333deY2myr8/rXv76g14I0PeYxj5n6uE2n4ed2AvF+H6YQ7//xe36fpWc12iZ5BF6caJMbWlAFy2deH2+lorBcP+rR9tM05Y2285j3eENqez/55JOLD37wg61IPve5zxUE2B5xxBEGV7QSdCQFFGgjMF1/d23m4DgKLLhA/CztdFXoZu/8889Pv574+ayzzhobhmcUP/axjy3233//4j73uc/Ys8LazGdsJgvyBYW7uOFk3ou99957FyGQ4kpXulK5fa51rWvNe7Gc/4ILnHvuuVOtwb/+678Wd7nLXVYaSOjyzsCKqQgdWIGlEOBOMpMC0wi4z0yj5bAKLLfANOVRLu6k6Za3vGX5aJAHP/jBZb03dGGfDlf1md4aH/awhxXXuc51ykG4yeDRj350tmfDZao/V3mtle/TC8bx59zF42l79STgPb3De63YtVkPHoXKY3/SdL/73a+46U1vmn7t51USiPf7MMv4uzTwIndshPEmve6yyy4F+fSVr3zlclCCKminHGIyrx/dKpbrRz3afpqmvNF2HvMebyht7wRUTAqquMY1rrHSFppzo5edF77whUXci09uOL9TQAEFuhKwx4quJJ3OmhTghPzJT36ydt0IrrjNbW5TO0z8I933xd1P8tt1r3vd8s6deDjfD0eAXkQOOeSQ4pGPfGT56JVpG2qGsyYuySIL0GhywAEHrDRo2P3qIm9Nl10BBRRQQAEFFFg8gWnKo7nACnq8mLUuRe8U/HEhPL2QuHiiLnETAS4Qx20o8XaPLywzrTYXk+lZ5e1vf3vZw1eT5VnLw3Dn73/8x3+MrSI9n+25555j3/vF6gmk+zpzjo+FdN9PP0+7pNzIQVsnjy+N5zPtdBxegUUVsLzR/5a76KKLilNPPTU7o3vd617lYz522mmnlbIjZQFuVqVXpbhcwATobZxrNAQBmxRQQIG+Beyxom9hp7/QAmefffbIMwpzK/PpT38693Xld+ecc87Yb//yL/8y9p1fDE+AC9mzNgQOb61cokUTYD80qGLRtprLq4ACCiiggAIKrB2BJuXR+HEdYc3/9m//Nryd+dULfTMTLswE0gvE8QXm+D0rtNVWW7VaL+6WzT36otXEFnSk73znO8VLX/rSsaXnsRD0VmGar0C6r7M0cT4Yv+e39Ljhu2kT7V/pdKedhsMrsOgCHgP9bcHPfvazYz1W01P0M5/5zGKfffYp6D0nbofnN85J9Pr9D//wD2ML9oEPfGDsO79QQAEF+hAwsKIPVae5ZgQ+//nPj63LvvvuO/IdEZG//OUvR76b9sM222wz7SgzD09vHDxuo69usuhSrK9pz7Lyfa93btkuv/zyQXct2tfycRcZ0+4rtZk+43S5X7ZZhr48pplum23+pz/9qbxbZZr51A3b9fSYF3fTMN21kNpso0Vbb7YXf12mPs9rXS3nIuYbHFeXXHJJVwRTTacPrz7yn6Yr1Wc5pA+rpuvVZrgh5HN9LMM8968222Go4/TpyHHI9Numro+1PvOFtuvYx3g0hm+88cZ9THow0+wjT+ljml2D9b2M6QXi+HN6wWvLLbdsvXovf/nLWz3qtfUMrxix6/yk7bL84he/KJ73vOeNjc5jdx7xiEeMXNgaG6jmiz7Xj/2OvzaJfJdl6zL1fRzkAivi7+L3rFd6bHS5rtNOi3PuLOfdaefX1fB91Ff7PCa6Wu90Omy7vuuCHD8cl/NKfbRhsz5t86hpHfrYV6ddhjbD/+///u/YaPSWc+1rX3vs+/gLrqM86EEPir8q33ONZtq8huG7bpdiYfqa7thK+4UCCsxFwEeBzIXdmS6CACfA9DEgN7nJTQq6L33HO94xsgoEYOy9994j38UfiPw/44wzyq9++tOfxj+V7z/60Y8W3/rWt0a+P/jgg4t3v/vdK0EbuZ4x6C6LBqqQuANojz32CB/HXlkOnpX5ox/9qPjZz3628vtf/dVfFbvttltxq1vdqoz4jKNBVwb68xu6dP3Qhz408vXd73734ipXuUrxzW9+s/ztBz/4wUqXXLe//e2zhZ2RCVzxAZf3v//95de5Ci7TfOUrXzkyGndNNAlKIfCFbfmlL32poJvPkHjExz//8z8Xt771rYurX/3q4eux16997WvFF77whZHvH/CAB1TeDUN3ZAz/1a9+tfj+97+/En3L8ykpHGLN341udKPWDRQjCzPlh76Wj23Efs7+RcMMFzhJ7KPsH6wvx8/2229fu8R0P5reLfTwhz+8HIfvP/zhDxfsy2H617rWtcrH6dztbncrtt1225Fp060cdx/RVdwPf/jDlXHY54lyvu1tb1vsuOOOI+PUfWD/4Xj97ne/W/z85z9fmR7b9mpXu1r5zFmeO5trxKCi9upXv3pl8hT405Tu4yzf3/zN35SDsR+fdtppI5VNKhx//dd/vTIZ1veUU04ZqUjc+MY3Lvg777zzio9//OPFZz7zmZXjgOXm2dQ3v/nNS4+VCf35DfkSx86Pf/zjlTyDhkzyGvILuthbt25dOlr28wUXXFDuHxwX7B+h2z72D7YH0eYci5P2j3ji5Bsc12GaYZ9gW7BeHGc0BgbDeNym7zGP8w3G4/my22233cRJfOUrXyn4ixP7xz/+4z/GX5Xv2Xbs++QdzO+3v/3tyjCsD+tC/k53lHXmv/vd78qujONGiTvc4Q4Fx0ldyuVz9773vVeeq1s3btPfaFSga0b2Kfb/sL3Yp1g+1o99Km0UrJo++9B//dd/FTxPk300PsbZr5gm+z7T3Hrrrccm8853vrP49a9/vfI9rjxLeNNNN135ruoN+RB5XZzuete7Zh/rNUu+EU+/7j3HwX/+53+Wg+TyFo57jELi3Fl35yF3GVPuIM/lfThe2VZXvepVyzyX7bXrrruGSXb2Sr7DcfP1r3995Nhje/LHsXCDG9ygvHul6Uz7yH+azpvhuih/pfPjGKeMwfHEvsh2io8pnkPLvs9f7jzX9T6TLl/uM3n2t7/97fKYpTzJMRsS5yO2K+UynuM968XXqrIExzk90n3sYx8rvvGNb6zktSHPYB+ju/P169eHRZv4Ouv+xZ1V5GMhcX6pe44559D3vOc9YfDyNS4vjPzw5w+UheI8AIdQtsoN38V3nNfe9ra3jTXEV9VXZnUMy0w97Te/+U34WOZZlBF5BjtlOOptcT3ohBNOKPOTujLUxRdfXJafPvWpT42U/yhrcKxRprzhDW+4Ms8mb/rIF5rMd9Zh6sqjnOff+ta3rlyYpnwWJ84laVmXPIpjfppUd8x0XX+etFysU9f1vlnySurRb3nLW0aOO3pwoO7aJJG3kMfE6R73uEdBvTlOfax3PP30fRxIwW9xWTF+z2+5ehjfN0ms12tf+9ricY97XJPBWw3TVZ251cwrRmK9n/vc566UI8Jg1NEOO+ywEe/wW9VrF+XeuvyYOjh5AHWXUF9iOY8//vhykeraqzg3UG7iPBDqd+xblC35o85EObdpos2Q8hTlbJYr9NLDNGn/oO2H8zPT7iLleq2M9/90349/m3b+tF286U1vGgk+uf71r1/c8pa3HJlU1TmX8wF1E9ofKe+xj5HYVnhQp+UxI3VtjyMzSj70ldd3XV9lsbs4JpLVH/vYdbm+q7pg3fFIXYbl5o+6TDgmafugbEVb1/Wud72xdZ32i7plmNSGXVfeyC0H60RdlnY3zuWhvBnapyjz0D5ByrXb0H4+KaAgzLftvspy9dX2HpZtmlfyzjTl2svSYfhMbxZcp0nb68lvqFtWpa7qHOn0+5puOh8/K6DAMAQMrBjGdnApBihAY2tooA6LxwmbZ3txIZMKcUhcTCa4oOpiF5W+XGBEGJ9pxdPjexo7uaiQu0ASxmO6caLixIWONFFQednLXjZ2ESgMRwGWvy9+8Ytlo8ljH/vY8qJk+D1+peE3XRfmyXdpIy/j0RDZJHHRN51uPB4Fo/R3nrc2KbG8T3nKU7KDUVmgoZk/LjDd5S53yW5DLqKn895vv/3GAisoRNNgSyNyuu+wAFT8+ePCIokLydz9kQYDlD/28K+v5aPxjS5D04uMYRXYdvzhiM0d73jH0jvXMMA4HHup90Me8pDijW98Y1kxD9MNr1TU+aOR5DGPeUwZwMFv7M+55+7xG/s7+yvjHHXUUWUFn++rEo07r3nNa8YK7GH4sG1ZdhogiJwmiCROVHzS9Yp/5336O/tICAqgIZsG/TgRrBIHVnDRgMaLONGoQ6XiWc961th+GZabhm/yt4c+9KHlfs32wjvXaw/7NnkPf3vttVdx3/veN57d2Hv2Oxo+0oC0MGDYP8jrGIbjkGnWNbLQaEzD/Uc+8pEwmZFXKrD80chF4oI3+UXVPjcycvKBC1HsS3GquigUD8P7008/vdzv4+9psIsTPu9973uzzzIOw4X14UIhDduPetSjVvaLMEx4peEg3U+ovHOxsC5xHKf7H9u3rkJaN730N9aTwKJ02RiOfYqLrfxRyX/84x8/1oCfTo+Aipe85CVj+3QYjv0q7Kcnn3xyuW/f7GY3Cz+Xr1xcTc+jTS6OcSzz7Ok0nz/wwANHpt9FvjEywZoP3OmRbr94cPLnOI9mP8oFVnDO5oIC+1ousc4hz+XcSQMr++M0AVG56fIdedzrXve68hyQGybMN/zGfP/93/89fMy+9pH/ZGdU8WWX5a94FjSIcd6NL8bHv7OdyFP5Y/8/9NBDi/Sxc13tM/F8q95zzHBsUwaoSpyP2If5ozGVcjAXrdumXFnioIMOKs9ruW7O4zyDoAsCnCddKO9q/2I70agcJwK20wuJ4XcuVKTHO3doh/JCGC5+pczDOoZE0GGfifM0dz6zbnEi76EMHaeuHMM02X7xupJPkbcfeeSRI9+H4dk/SVVlqL//+78vy1BxHhrGDXkr5zYCTg844ICJQTl95Qthmfp+rSuPkvdQ9qlL6b7LRcxpAys4R3FOCIkLdSEYqav6c5h21Sv7bdf1vi7ySsq6lH/TMgoXa6gT1CWOW8o3cSIfon4QUh/rHaZd91p3wTi9eFyVd9ZNP/6N/Dgc0/H3s77vus486/KE8dnuL3jBC1aCAsL3BBw+9alPzQYnh2Hi1y7LvVX5MUGXdP+epnPPPXflq1x7FcH7HF9Pf/rTx44NjhXaKfijbkk+fqc73am2LsrMCAKmfSA+34SFYJrh/MA5iTr9Ix/5yJGbosKw07zm2hvjYyN+z3RnORYIGiGPixPTSwMrcudcghnf8IY3lEGs8fi8j9seOR/QHjYpb0qnwec+8nryty7rq10eEzmD+LuuyvVd1wWrjkf2ZY4f6v9pCm0ftEVRXqV9epa6Zm4ZmrZh15U30uWmfHTiiSeO1LnDMGGdOD9Tv+BmDupzadsIAeZNAitm2Vf7ansP6zrtK0FcaSJAoWmizhj3XMF5ouqRYLh13TbJcvY13aYGDqeAAvMR2Gg+s3WuCgxf4MwzzxxbyBA1yd3dceICfRoYEf8+z/dEyz7taU/LFu5yy8W6HHHEEWN3WeeGDd9R2MwFVYTf5/V6zjnnFMcee2yj2XNnT9oTR6MRo4G4YEAFMm3IigYZecudwE9+8pPHLryODNThhz6Wj4uS7C+5xuaqRedOby7yxw0gVcOG77mzPA0YCL+FV9xpaKFCw37/4he/ONvQEYbnlYYQAisYpypxZwuN8WkUdNXwLMcrXvGKsmGSAva8E5HwuaCKdLlYP/YRGp2oEOaCKtJxuFCWNsDGw9BQx8XvqqCKeNjwnrsCuBhTFZTFNNnOVUEVYTrx6/ve977imGOOWbmrKf5t0vs0v2f49AJYbhrsWzTQxYmG/zjAgXV50YteVGsYj8978mj2RwL6FilRgU0bDnLLT8PHM57xjIKGqFyikY+L7+wDTfNahuNCajr/NPiJ+YVeH3LzDt/FPeaE79hP4q6nFzHfIB8kP68KqgjrGr/SGEajO0EqsyQaWdmvuRjeNBEwetJJJ1V229lH/tN02Riur/IX++iTnvSkyqCK3DJyRz7ltHmckwiY4Bm5dUEV6TKTD7Avxj0spMO0+cz+mguqSKdF/s15iB5BqlKX+xcXXNJUd0zljhOCzaoSx3Z64WdS0EjVtJp8T1e67HO5oAry97hxvEvHqmWjwZY7sVODquHj7znnUJ5sUs7lHEOZpy71lS/UzdPf+hHoul7VVV7JBQXuAk9Tk/JNLm+hrBQHJne93ulyVn1OLxjHn9PAirg8VjW98D3lci5wpelVr3pVbf0wHX7S59WqM09ajvR36n3UW3NtWdycwk1FTdJqlHspK+aCKposH+1Cz3nOcxrVHQhIDXdzV02bADJ6yGh6XqHd5/DDDy97taiaZtPvCXiJU3x8psdC+jker8/3lDkJuJiU2O8o71XV+yaN3/XvXdVXWa7VOCa6Xv/VqgsSOHXcccdlgyrSdaIsefTRR3eaHzOPrtuwubmFumyT8iLnA9qpKQO3TV3uq22XoavxcucZevygDN4kUR6gN87wVxVU0Vedo6/pNll3h1FAgfkKGFgxX3/nPlCBCy+8cOwiKne6hgo8UaRpanIRMh2n6jOR4Llo9Krhw/dpRDoF42c/+9mNKpBhGuGViiIRtE1Sk0pTk+lMO8yk7tqpeDet7DLvN7/5za0L7BSOuXibS9x5WXVnIMtHYy/7XJ+pj+Uj6poLD00vbsbrRwWJixs05jRJ3NHfNNE4NKlhO54W24BAglyiMM/2YV2nTTQopHflTTuNaRoGq6ZNAELTbcSxzMWQ3J0DVdNnPasu6HBMNQ1IiadP4xO9jeQSlciq5aP3DrpZzCUabmgknTZxwSvNWzmeJjUAMUyauJs1TgRihR5s4u+bvOeCMhdoFiHR48c0wTUck1UXYcln255z0kby3B2y3EUyKV9KuzZnG8Q9J8w732iyT6T7NA0C5HU0Wk+b2F6UNbj7pU3iYj/nA6aTJpaTu83TRuQwHAFGBGPlUh/5T24+ue/6Kn8RcMBdpW0SQXD0qNQ2pftMk+mwbXlefRpk1mRchuF8NOl4bDothmsabBumSc9NVcEoXe5fdIedpqqgDo5VzpFpIugufrRR/HsuSCM3z3ictu/ZXhzP6TLS+xF3Cqe9IHXpWLXM7H9t8jamR2Bv7nxeNS/Wu6pM1Fe+ULUsi/J9F2XdWda1Td7Wdb2q67wyLpMEm7T3tfB9/Jor38S9fXW93vG8J71Pt1Nol2G89OJx/Nuk6fI7j2rIBZtRp+ziHLSadeYm6xsPQw+AuYBxgip23333eNDK96tV7k0DpCsXKPMD5yWCl5om6iHcnJBLXJDlppxpE/On7YTz+CwpPhbi90wz3ffTz7PMt+m41NPrbrxIp0M7Be0JfafUKp1fl/XV1Tom0nWY5nPqsZp1QeoGlFubJoalva6L/DjMs217Qhg/fsWO+lmuLhsPF7+nXErgbpvU5b7adP6T2t6bTic3XK6HQoJBCb6Z5ma83LTj7/qqc/Q13XjZfa+AAsMU2GSYi+VSKTBfAbr1SxPd5Ie0ww47lBfK4zuxaNyn+/o4YjwMTzf0PB+ORBdtaaQ93a3H3cOHQi7P9qRQTuLCQdqjAl2ixd2E8UzmkGigSZ9hy29Mm+ek8hxrLvhToKPyc9ppp41VNhmfu7zruuQP8wuvdDVNEAEXN7nw2LRbP7ovDhe3udPtCU94Qphk+Uphi66sQ6JgV3WhJQwTXrkThS4Lr3vd65bd87LOXOSLt18Y9rOf/WzpEz43fcUvTVjQdSqRsyQK3DTuUvCKL9RTmeSRFOwHfaWul49KDY1NuUTXj3S3SeQx25Kuepl/ehcU+x3dS/JokKaJ555zMZTnxXMscUykF9nj7UqX0zxagkc3cGwSQU4jedrAzvcEEl396lcfWRQq+fG2Cj+yjnQNzX5LN3XcwU5U9VlnnRUGKV+5KMOxxoUE7iCLK09cMCKyPU7x7wRXkddUXdQJ4036PQy36667lvkMFuyLuJ1yyinh55XXuFGVLhJ5jATjUqGlgkP3/2kKXRrG33PRP9fLCN1x3/SmNy2fl8k24ZigQS/tgYFpMlzc0EmekguyIU+j23SMSVzgZX8jOCMOKuE7LlbFj0+Jlzn3nmUk/0h7yODiCetSlXIBE5xHwvbCOddASCMmjy0hvyK/plGPfIljKF4X5kujBA10VVH58bKF+cbfxe9zv/Nd7vt4vGnfcwxzoZz15G4Vnmua2w9p7OCcGjcIsv6nnnrq2CzJa7mIwHblTmgC1WhwoNEzNeM43X///ctp0BDPPh7vewxPEE5Vl/p4sD3ixHbiOA9WbKtcvkFZgEAdlpNlbJJvxPOpe08+Grrm5Zhi34gTv5MXhsQ+E5aX797+9reP5Yt8zz7OcpMHkCfRjTX5dtoYhRvdufIYl2kTeVHcpTvjY0q3njyHNiTmTRAreXicaLxl3eLyVx/5TzzP+H3syPd8rit/cUE7LX+ljfeMz91ZcfmL8iC9dOQS24g7lDk3XnLJJWVvFjhxfMWJHqPYTzj+Zt1n4ulWvWfbpudohg3nUMp2XFRl/clj0/yd8w5dPfPYqy4T5YhQXsWY8gR3qKaNvOyX5NXhWchhGer2Ly5C8jzocH4jL4rzGKYRzm9hvXg+MOWVeP7kD7mUu6s4DId1GsDHb3G5iM8cX3H9ge+6SOz7BP2l5z/KQNzFR5kmTl07xtOues+xxzHI+rPv0QiO/6SE2Z577lmWJ3l0Bfss+VHusRec08K2DdOdlC/0VS8L81+tV0xDfY550qV6Wv6Pf2eYNNiG72ZJs9Sfm86363pV13kleSu9pMX1HfIO9tu4x5h4fenZhfwqTmyb+OaArtc7ntek9+SRHL8hxQE5vI9/4xidJlG+edjDHla2P8TlRvJO6oL77LPPNJMbGXZedeaRhaj4QHkul4dR/sr1pFQxmdIoV+4N53rK1JR7qSdTN0zLBdSXqVdPkxdQl+BcS3kG47i8VLWcfM9+wnmS+jCPYyXgjaDtXAAdvVbc//73H5kcdUzKu2nimONxOywX5zrKD5zjKF/HifM8NwmERxfFvzV9z7w4J5HSR8rSHhgfC1XHe9N5zTocbZycc2mPozdKyjb0PJgmtgF1xLg9Mx0m/dxnXs+ysNzsX9RXOY9V1Vd5tGJcX2U5m7QhdX1M8PiaUAakLpjWGfg9rQvGptSx43NG+C3UBdmv4rpg+piYUBdM23HDdOLXOJ+lLk7bIXUY9hHyB841aSAU7XW0mRII13UKdYJp27DDcnBMp8vLb0yP8wd5IMcsvZjQ/pO2K4XptHlts6+yPKEs1nXbe5t1oO5EG3ma2Bd4hBLtgeyHnJfa5ml91Tn6mm5q4WcFFBimgIEVw9wuLtWcBXKPAaGyFydO/nFDJYVDCtxpQxrjrF+/fuV5uxTM00RDAQXJNMUVC6aRpqrxGI4LoBSo00RXe3FjKg0P/FEJ5JEhcSGXCiEXD+MLm+n0wmeCHBg/vTAdfp/0ygWuYMBFgTRRgAq/p7/VfeYCFuscV3aYDuvLhae0y3MaSblIO02iMh/vC4yLB5U9Kh8hsQwUBnHiWZJxotDYV2BFH8tHo3l6IYz1oSvVEETEZ9aZRg8a5egKPHXighgXg5pEQKfTpiEcTx6lkGsMCftkvN+wr3PBmm2QRpTT5Xi8//J7egGPdXrgAx9YNpzwnsS+SQAAF2oIRIqDJTieqDjReMK+EC9LencV04p/53NXicZV1nnrrbdemSSNMlSQiQTPJY6De97znis/heOGC7KpS+4CUK5yRIXoMY95zMhxwSOW+CMogovecWI+cf7DhdU08QiGeDn5nUYmvmd900A28sVpAiuYHvl9WgEmAI/1ySUCV+IAFYbhGCDPDinXOMPv5FdxoASNjOHCdrouNJDTwMDFnkVIBAPGF8pZt912260MSqB73DRxTo0vaOb2M1wf/ehHj1xU53xJvkJjBsdknLiTOARW8D0BGelFT7ZdVWAFx3ead9AYFBp0+e1d73pXPMvyfZpvcPw3yTfGJlTxRVzOoJE4TQS6VeUv7Ee5gCn270MOOWRkUuSRPMOUfTS9CI4bF26mPb5yXaY+4AEPGNlXWAgCNcmXKCOkPUSxXeL59pH/jEDUfKgqf7GPV5W/0md+58pfnHcJAEhTum/RcMdxwSNaaLxO81WCK7hoMss+ky5D1ee01wKGIz/bb7/9RkYhL+A8yX6V9lZDcEiubD0ygSk+0Oh80EEHjZyHKE9Qzie/SPdHegmJ8yFmVbV/cbzE5b5wfiPIIg1G4vwWrxdliDiAGrvcxaL0glS86uSZoVE9/p5GvzhxXg15Vvz9LO8JHODiWNpTF2Ux9u9cN799ONatA43PBxxwwMg2qhs+/MYxddRRR41drOJCEWUp7oSOExcYyaficl5VvtBXvSxentV8P6msi2XVuair5Zyl/txkGfqoV3HspomL0unF12nySsom9EYQJ+pLfJ9LlLHidgCG4YJXyNP6WO/cclR9Rz25qq7MTQxV9Zmq6aXfU5971KMeVbzwhS8c+YmLjdQ34/P3yAATPsyjzjxhkcqfKQ/negek/pQ7j1RNs66+HN84RH5IfYqeX9NzbVxfrppP/D31iao6WDxc+p56L4+jSutZBFnQi2B6oTjX1kH5Mz1OqL/Rw0e4mYb5Uo/gj/JF2pMm5WfKQrn2vXSZc59Z/6pEkN6sx0LVtKf9nrJmui9Rj6C8Fd8wFabLuTPOv8P3Va/xsDnLurbSqmnyfbp/hfoqy03ZOk1pfXUexwTLNEu5nrpgrgdAbgqpqgsS0DZrXZA6JQFJIZEP015Hmfiwww4bO9bIj6njh/NSGK/ta2gvjNsAp50W+UHqwDRofyNIPs5vyCMoN/LXpifVdNna7qvkx6Es1mXbe7p8TT/TdkcQW65ewDQou4T2Xo5H2vKp9/PadNvlph3aOuL9aZq6G8vW13SZtkkBBYYvsNHwF9ElVGB1BehGN220pIIZX5hnidJGVr7LBWTw/TxSescJy0AFpqpRgAJsLro41zVkuj40klFobFqoScfv6zMF5Sc+8Ylj24750aCcNlbxPRU6GoenSUSbp4nG1riAFv9OwRFrCo/hj4aGvlIfy5d79A3HSRxUEa8PF80p+LOvxImKSK4xMR6G9zTs5aZNpaDqLiIu4IceH9im4Y/vcg1zVCjDMLymF8ZZDhrl48of34VEHkEFkP0uTtyZyvTmmZ785CePBFWEZaGBgMbCNBF8kgYrhGHoGSJNwS58TwBEegGQyg8NLFXHBRcHaQyKEw1a8R28ua4A47ty4nF5T8WI6YbjjFcqstMmlj0OimB8grKI8M+l3D7NM6pD4kJd7o4Q8ui48h2G55ULYbmgryGdd+LlTd8TzBAHVcS/E1yRO77jbc/w5J3k2/Ef+UrcU0E8XfZj8uI4pXfU0ZiaHrO582eYRq6L97jLbS6epWno+Uauly4ag7j4XJXoVYWguTTV2aXDhs/kH2kiKKYq4Rkf07yPG7P7yn+qlif9PmdAoOW05a/0rv/ceZeyQ9U5ieUi/6ORMk6hYSr+rq/3rHN8vBIwc+9733tsduHcm8sHuLsr/D7tazojGuC4Kzl3HuIczn6dpp///OcjX7F/kYfHiXPEwQcfnJ0uw7EdON/GKT2/pb8zbDofvqvbfuQ/XPyME71qpfle7rwfj9PmPYGyaQAieSv1g1yPEH05Vi07d2qSV+S2fdU44Xt64qkqaxAgl55nGI/9Nk65fKGvelk8X993L9BHvSrNKw888MBsXhnWJpfvp/sc+2aa0vNK/Huu/BL32NnHesfzH8J7LvrnzkNcGCdouk3Knbv7rDM3WUburE6DtcN4nPNCj6nhu7rX3H5DOS0OqojHn7W+THmqTVAFbRDUh3P1LM4LuXovN13EifMr9fo4MV0utsfl0Ph3jsN99903/qp8n6tPjA20wF9QZ02DKsLqUCYgcCxNab0v/X01PtNbYtX+RX01l/emy73ax0QXLrlzw6S6IOV5ytVpypV30mH4TA96OU9+4+J5rm2aoJU0AJrh26Su2rBzQeRMm3boXH7DsnJsxL2HtFn+LvbVNvPtaxzK6Zw7JiXOX+TDBMM96UlPKm+woQ6S6zEkTKuvOkdf0w3L7asCCgxfwMCK4W8jl3CVBb7whS+MzTFuVAg/Utjjok2cGDfX6BAPsxrvqfinlT4uCtLFWV2iuzsK0HFinSZdFKaBNtdoGk9nHu+JdK6q5LI8ROmm25DvedzANIm74tMLczR85+6uDtOl4YaCY/ijgaWv1PXyEQyRC7h5yEMeUrsKXNyh14k05Y65dJhwV2fuogqV3FziQkdVyjWQpw1muYawST0DsI5pfsFFw9zFkapl6/p7LlCmQQHxPLiwnKa6iy4EJeVs6UI4pNyFWiqPaYBaGJ5Xppvr2pFu4EMiACxNdClbVZGioYwKOxW18JdrAEinmX5mOrnGoapjPBeUE+e/ucYLGt1y+2W8LAQRpduSAJZckEY83hDeVzVShWXL/U53u3EiKIY7vOK/+G6leNjwPhfwF194ZL/bY489wuDlKw1kVcdsml9xzoyDdRYx30h7bgKBx1jRKFSVcMsFXrQJJMttI+6aqgpcIsAmHM/hNS6D9JX/VFnE33MeSR8V06T8Rb5UV/6iXJLLV9hOdYntRGAD+U/4o9yTnu/qpjHLb8wzPl55/AjLVJW4+y0tTxEY0FUiuIv8PFeWYB654AYazeKUy78pG7Q5v8VBErnyKI+uihO93sUNygTcxXkn5bM078o9OoTyfpeJO/XSu/XYjjz+Iz4243n25RjPI36f5vPxb3XvyQfrvNif4vN7mFZ8oWW162VhGXztR6DrehVLyT7Ehcbw1yavTNsgqOemZV7ynFw9lzwxPXdRtonPz32sdz9baLap0q1/WtbmeObxctOmedSZp13GdHiC/rhI1TTlyr25Gxji6VFfTgN/qMul5694HN6TH+dubkqHy30m2D4NNI2H45yVHi9sv/h4Ofvss8d6rSNwvuo8F6bPHfZpyp0D02EW+XNVMH1Yp9C2Ez7zmutxL/59Nd7HZarc/HK/p/XV1TwmcsvY5rtcXZBA5DZ1QW76mNR+zPFGbxV1ibJX7kJ7XHauG3/Sb121YeeWh0DtSY/EJjAirfNMWub499y+OOn3dF+Nh5/3e8rTBEATPMe1lqaJcweP3qEHU3o9jNskwzRy+W0Xdbe+phuW21cFFBi+QHXL1vCX3SVUoBcBulVPU3oXdfg9vks1fJdr0A+/rdYrvW6kiW6hm6T0gikVytzjS+JppZXQ+Ld5vk/XJbcs6YUMhsl1h5YbN3xHITBnQDeXPG6EwvZqXcQIyxS/dr18cWNxmA+Nb3UXFcJwu+++e3i78vrTn/507CLHyo9/fsOdXFUVNB4jkjaUsO3jLpjT6U1qAGH49GIEFct0Pul0+ZwL9Mgdk7lx+/gud1d5PJ/0mef8NunYqbubnPHjCz98Jk0KGmCYXXfdlZeRFDeycLymFXyCCrgjgAZPtll80XxkQjN+SBsAmVwuv+curzTwiECqOMgrvXuYacUX5/mcS1yQzA039MAKtlmuG/h4HUN3lPF3nH9mSeS73NkyKeW2be5OMvbFdNulF+sWMd/INWTn8rHUkQsP6fGId9wInY6T+5zLb7jbiW6Veb71tPt3X/lPbtnT73J5fdVjZdJxOc/Fif0/BBXkpstd8k3OuwRu0kgV/zUZL16W1XjPOZ5nKzc5ZtsuTy7/DNNi/uSx6XmeZeK38NfX/sVdbWlwRfpIvzSYj8AKLhbFKe11Lw3O4LidlB/H05v0nq7T08e3kC/w+I+6RmUe35OmLsoJ6TT5zPLEF4hzw1R9R/Ap5ei6lCtHxeX+3PHbZ72sbln9bXaBrutV0y7RNHll3FtamE+uVzWOxzTv5W7iOM17veNl6fM950d6PUwTj3PKlQ3T4eLPXdeZ0zJoPK8u359++umN1zU9x5DfpufR3LLlypm5vDIel+DHuuDMeNj0fVrGSn/ncxpQw3dxXp72YMHvdeUKficRBJ6Wl9PesP7/kGvn/6Rzbu7C6az1vln12EaTyke583263Kt5TMy6zmH81a4LUjdqUhdJy8Usb1f5YK79NnhM85rL55vkN+Rlk9rpqpajq321avrz/J6grBNPPLEMlOBGyWkSQd48fjrOtxm/rzpHX9OdZp0dVgEF5iuwyXxn79wVGJYAjaVpAz6NClUXaLlYxvOr40SEbu7O5niYvt/nIlG5izTtxaLpctDQUhdNm7sY2nTafQ7XpIF20t3OTZePIJv0TmbGjd25CEIBnuhrgnV4PMZqpS6XL214Yx2aWDNcLqAhPeYYLk3coTxNqup2L0xjkj3BNWklmc/cxdQm5R5h0WY6bcbJNVxMms6kiu4kv1zX/jwmpU2Ke6OgUZe7ftJngLJt+C58zx0IVMS54NSkwavJcrHvciHke9/73srgBFDQXXPcyMfv6b6T9khzzjnnrEwjvMn1xhF+i1851tIuNue5f8XLVvU+1yiSDjvtMc74OOJ91llnld2uEwTIhWjyqHQbpPOLP2PKeSx+fA13G9397nePBytyXbvGd4ssYr5Bw0Nqxfl+Uh4aYDi+8I8T/rlnHcfDxO8J1CLoLm2c4NzA8+H5owGJ45kGKO5yywXihGn2lf+E6de95spf3AWc3glcN434N6ZHUFbuvJu7KBGPO8T3dFVPWZu7PrlAwXqxjgQvpPthH8vfpLzKBaHcPhSWJ/dbrrviMHzdazot9u04mOKb3/zmyOjpBVHKk2kdhS6J4+6F00AL6i5dpte//vVjk6Nr3kkBmPG5PUygK8cwvfBK+Ts+T4fvm7w2KUPU1ZGYRy5fiOsHTZYjHobjZtI84+F9371Al/Wq3NLFeSXnRso37EcELk6TV9ITRvocd8qucdmF+efKN7k7zvte75zFPL7johh3HJ966qkjs+eRICeccEL5aLqRHyo+5M7dTevMuZs/0h6UKmY71dc8+oR9Il1W1pXHheQuJIcZVJV7uRO7TZpUn5ml3EM5c1KaVBfJ5eUnnXRSwd+0KVcXnHYaQx2egOlJ59whnsNyvXimxpPaDlf7mEiXr83nWeuClLHSsib5SV1dsMnxyLrk2kdyx2Gb9W5SJ2gy3Vx5dlIZOEyXMmbarhN+q3vtYl+tm/68fyP/4HGX/HFMceMKdUdeqQvVlYNoG3rjG9840rNmbht1Uefoa7rz9nf+CijQXMDAiuZWDrkEArmG709/+tNTPWeSQiXR9pOinfvknFQpnXbeaUU7HX9SxSkdfrU+p43Nufl2tew0VPN87Ve+8pW52ZTf0bUmf9yBy0UiLhATuNO0gaVywg1+6HL5cvtX3TpwZ1VIm2yySdndeRxMQcGYLtsmXawP01iN10n7/LTL0PX0pp3/ag8/6Y6jaZYn3d/233//8iJcrnehMF0uLPFHgygNk3tc8agHghua3EEVppF75c6/OLCC7UolL74jPdc4nd5RnGtMq7tQHC9LrqKeGsXDD+E9+V2XiQuzr3jFKzq7Y4VlIyDy5JNPXllMgizSc3naEwkBI/HdbV0f511Pb2Xloje5eeR6kIhGGXlL3p8GVtDgVXen+sgErvhAwNThhx9eHHvssWPBFWFYzhM0PPHHM1UJsOB45NFLaSBYn/lPWJ6q166PxbB9co2IXTUIVq1Ll99zEZlehcL6dDntaaZFD1eT0qRyYZf7VxpYkfaQhxd3woV8Jj6/cFEinA84z4VyFec+Gsk5LnicThyowbrnHncyyWTa3ynnkj9ybFclLhx3lVLHrqbLdJrUJSbNr698YdJ8/b0/gS7rVfFSkldSFukqryRIkgsTcTfvBI5SZ43zw/TmAAKUc2XmvtY7NhjKe4Jr6aEi7omMssirX/3qoukFmdyxX1dnjtd9NerM1I/ojp9Am2c/+9nx7MsLVwRXPOMZz6i8SN7VfhpmPGl6s7QVxPt7mF/6Oun83+W5hn2JXg7ZzmstdXHenIdJWp9oswyT9uFpp9n19HLzz81j2rpgGlgxqS44qUeTsJy5ALPcxeww/DSvk473ptNK83nK53VBJfF0c4Ej8e9V77vYV6umPbTvyU+4OTH0MELbMgGn9Ar94Q9/OFteOuOMM4q99957pf7UV52jr+kObRu4PAooUC3go0CqbfxlyQS4sPuJT3wiu9Y0RlT95UbIPVcvN1xf31U9l7zt/PrqWr/t8gx1PIIkuEuvSaM1lWnurqer8zZRym0Mulq+3HPr0gp06DI7DqoIy5y7E5qGhSGlro+hnMOQ1rfrZcntI23nkdpRCX7IQx5SPPCBD1y5qFQ3bS420U05F2557MwsKfcc9fhCF8uaBujRaJlWflMfAg+aVu5zQQrp9GZZxyGPiy/dzj/taU/rNKiCdeYCfZriZ6bSaBIH1TBs2jvVIuYbuX0n3V9Tl/hzbn9sk5/TAMUxete73rXRndgEc3CH4HHHHTf26JHcOsXLPM37NP+ZNG6bda+bZih/5dapyUWCummvxm9c4OciFIFQuYbb1ViGrueR2xZt55HuX9zBlx5T4aIejyKKG5Pju8m52BmnMA4Nj2lqcpdbOs60nzkvvu9976sdrctjJXWsnfEcfuz63BDyhTmsirOMBLqqVzFJ8krOaTxCsuu8Mu01jfnFF8FyjznLjcN4pC7X+/9PcZj/KZc/6lGPGls48reqNqN04Nz5Iq0zp+PEn/usM/MoKepTBMDR+1HaSxvLQbn3ne98Z7xII++XLW/jzukuU27/6HL6Tmv1BRbxmMjth9PUBXPDTirj5cbJba1cMNXQykBpPs05fNL6h3VNgzLC975WC3DOoqePffbZp3jxi19c3PnOd84O/OUvf3nl+6bbY2WEmjdxnaOv6dbM3p8UUGBgAmsvPHZgwC7O4gjQ3S4Xu7tIREje7W5362JSraaR61qPxwHc4Q53mDg9CoIUVuh6OqRwp1z47Gu1AI0U/BG9SjAOd7qkdwumY1MgfPSjH13eUZT+1vXnLpYvt3/xnNC4kFm13AxDrx1palq5Ssfr63O8/8fzuM997hN/zL6nssfF/DgCfZqo/+xEF+xLulJNG4ab2LGaBD/EdzHk7pgjj7r97W9f/tF7Acca3QLGj3JIyVieI488sjj66KNHpp8OV/eZ/YLgiriixl1+++23XzkaF7HS9abb5DSlPpx76Oa5ar+Lx889kzd3TMbjrJX3NGTTW0EucZ7iDn5suUhPIwd/uW7qc+Ozn3GHJnd7h0TQG/sZ6etf/3r4euX1xje+8cp73lRtvyb7/rzyjdwy556zO7Ki0YdcsFLb/ZHthtW9733vcjvgz3Fdd4cgjf7cZckdleE8kh5fLG6TbcBwTfIfhqtKOU/2rTve8Y5Vo6x8z91d5G2xXyh/sU5pyuUF6TDz/kwX9FXBoxyvnCcxC8csr695zWvmvdi18+9z/+JCHs8T5pwWEvs4d5ynPcPEQby8P/3008Mo5UVTLpSFAIvwA3d7pYEb4beuXwlopDenqudH0512er5creO063WdNL34mA7DWi8LEov92kW9CgHyyrTXiCBDDwchr6RcQz7JH0FrTRL5A8d93M7x1a9+tXy8FuPHAcJhemmwVvg+vHa13mF6Q33lMYAPf/jDxx6n8trXvrbslWfScueO/abn7r7rzIcccshIb5H77rtv8a1vfWvsvPHud7+7zMfTHpVY91yZh++b5OWsH/XluIezuAdApjO0lCuLEUCfu6s+XXYe48L+FAfSL0KAbLoefq4XWMRjIrfMfdcFyQc5j0xKuTpgLl+dNJ0+f6c8Fwc+My/Wr0nvRLkA6D6Xda1Nm7r/AQccULa9x+1zrCdBoyH1Vefoa7phuX1VQIHhCxhYMfxt5BKukkB6l/Ess6WSyMW+Js/lnWU+VePmCpt08TjPYI+qZV2r39OtP978EclKoZlGcRrN2DfSRO8VNJyvVppl+XKNCnUXtON1Sisd/NakMSKexmq8p8EyTXS5zd3UpskCVDDTfYKGp1zFffLU6ocgnw15Lc+eJnCHi7Hk6WllnEZlullu0uBXNVcePxBX3OimPVyMTRunyYtzdwfzvOLUhwa3Jj65C9m5YzJe/rgxPf4+fp87NuPf5/2ewAMad9PEnZM0Blc9A5r8lmDHJok7NOPACvLsEPCSPgaEc2qaT6SfmefQ8430LhuW+Wc/+1njxzPlAuVyZRCm2zTR6Bwu2jAO+yYXiAlU5PFsaQrn19BAt5r5T7osuXWnN5RZzx25Y5z1HnKiLJwLquDZ6zzTPQTCpOvA3bFp3p0OM8/PXe5fBNKkiUdHxYEVXOgixXkTn0OXuLznsRtxorede93rXsV3vvOd+OtGjdgjIzT4wHHHXd3PfOYzi7QhnsDh5zznOdlHCuCYDn/rW9+60XmwwWINapBcvmC9bFCbaOaFmaVeRV6ZC6ogryS4sy6vbFJ2445fjq0PfvCDK+tJWZie3zjfpvk0ZaEtt9xyZdi6N7Osd910h/QbvZNR/kjLgccff/zExcydu3Pl+NyEco8N7KrOTP6bBtmxn3CjB71ppvUG1vWFL3zhWF5eVe5dq21Oue1JMGQaaJ3bnn63HAKLeEzMWhfMtW1OatNoWofJBaLljsN57l20QaSBzLTzNAmsSMeb53rMa9702EUbXpzYf5o+Jom6FGWcuH2OacV1yb7qHH1NN7bwvQIKDFtgo2EvnkunwOoIXHzxxeXFtnRuPNbhiCOOmPgXd8cbptFloEaYZtNXTvBpOvvss9Ov/LxKAhQK6bGACyvcWUujRZq4OMV+OI8Ulm+vvfYqnvWsZ1UuHwVe7i4hMjdNTSsFucoRd28MLVFAD3cKh2XjYiMFf9NkARpa05QGEqS/d/GZhgHuqNp///2LF73oRdmuAcNFqrbzo1eDtDGSBldSfDGMzzTGxncm8R0p3bf4rmlDa3ohinFzvXrwfUhNGt5p2B9yooE5riCzrNwJfdBBB1UGVTBM3N01n+tS7g5Neqogb44fC8I0cj2RLGK+wTLnGuqb7A/kh+k2wSZ3EZHv2ybKNJSzuGv0la98ZXGd61xnbFLxY1rmlf+wUH2Vv3LHOA2ZnJMnJXrQ4jjgj/wv1wA6aRptfs+VC+55z3sWe+65Z+WFQvan3D7VZv59jdPl/sX2S//igAnWgbIHvZnEeRDHQNx4z4VXzk0hsY0ZhyDDONGLRdfp0EMPLZeF1/TcSI8UJ554YpHrtjnnmDu/db2885heX/nCPNbFeU4WCPWqpvW+XF5JwCj1sqqgCvLJJmW7sLRpmYUL57QNMJ34/MnwbQP9p13vsGyL8MojM9KyTZNyUu7c/f3vf7/RKufqzLnyWqOJNRyI+gllrTSxv7zsZS8by8sXsdybrts0n3NB3D/+8Y+nmYTDrnGBRTwmZq0L5s5Fk4IfmnUfgBwAAEAASURBVNZFcu1HufLjPHerXNmam+YmtRtyQ85aLfdOsz0+9alPlQHaBGmHv6aP2wrzyT2CJw7uye0zXdj3Nd2wXr4qoMDwBQysGP42cglXQYDuMNN0m9vcpryzi4LSpL8HP/jB6ejlszdzDYljA87wRVVhjQa8NEKWRhMa1yclhuHRFeGv6cW+SdOd9ff0zolZp9fl+JhR6I//6i520GCV3l3I8vRlXbd8cYN+MLnpTW9au3w0Eu1+xXPA48T2oVBclzge3vve944Nwp0eQ0y5gKnc4wDSZScAJRw/vNKAVrc/xOPnnnEZ/74o7290oxuNLWoaRT42wBVf4EReFfvFxz4XmOLjjN4iqhINvPe4xz3GfiaIqen2GBv5ii/otpVeEuLEnYY0sKaNrBxLucQdyWmiG/eqPD0MyyOr0gZ4LmRd+9rXDoNk7/ad1HjB8z3T3jZWJjiQN7mLrXRvTWNQVWL/qNtH0vGwTJ8rzh2K6cVJhsttQ6Y3j3wjXY/c57p9i8fbpOl973tf+tXY5/e///1j33EXdi6YaGzAP39BQ0h8TPO+7nmzNJLwqJA0xft4X/lPOs/cZ8pfPOIiTk3LXwQPxXlfXCYgoPFa17pWPNnyjtKPfexjI9+lH3geOD0GENTJ37HHHlsGUDYpn9btM+l8cp9zDa25xsd4XPK4oae+9y/2IXq6idNHP/rRkTuIc/lPulzsG/H5k3xrt912iyfbyfvQlTlBsjSIpol9+u1vf3v6dZEuLwN85StfGRsu/WJSOSEdfgif12K9bAiubZdh1rytrl6VW6ZJ9b5czwST8sq0XJKbb/wd54/0ojztH2lPOOQT8WOG4ml0vd7xtIf+nrLHIx/5yKkXkzpz6FUvjDz0OjPlONrB0kRw5nve857068GWe8cWtIMvco9Dof5E76STEhfx4jJerow0aRr+Pp3ArHn9dHP7y9CLWBfMLXPbuiA99U2qC9KmM6ntkPpgLs/JHYd/0V/9d7m2TOqlPDKqKlHffcELXlD189y/j+sPfS9Met2C+dFm3KSuGpYt7XmL7+Ob9/qqc/Q13bBeviqgwPAFfBTI8LeRS7gKAmeeeebYXHKFy7GB/vwFdzCkz2anMEKjR67xs2o6dd/TPWOauIiX62ae4bg4dMopp4yMQoM6XfXGd7nFA1x44YXFUUcdNXIHDOv2ile8ovbiVTyNLt7n1pULDBSuJhXSu5j/tNOg0kGjd5zuf//7Z++WD8PkulhN74QJw876mls+nkV35zvfuXLSk5aP/Svtwu+kk04qAy6qGu7p3jt39/hQu89kudILh3RrTa8eaSNZgKTBH4c0iOB5z3ve2IUSLvyniYvA8bNm098X5XOuQfgjH/lIecEx11gX1oth3vSmN4WP5St3iYVxqICmF8rJs6qeybvZZpuNPVea46zuYvzIzCs+0EjOsobEsfDhD384fCxfuTBWdSzQIEDjdVxpJT9/zWtek70wxQRpgDvhhBNG5sEHgjzifDGOzg8DU9nkOZNxBTP8xuupp54afxzke7Zlmnh8SlXignJ6DqwaNv6evI0uskPiwkMaiIN57vhlnL7zjbBcda+5ZauzohE9bTyjXMRd8eHYS+dH+eZd73pX+nVBY9o06YILLii7nY7H4ULEcccdV2y99dbx1yvvOXbSFN8Z1Vf+k86z6jP70Fvf+taRnwluOOaYY2rLX0ceeeRIbw3kVS9/+ctX8ivynfTRK294wxvKgIs4uCqe8WmnnTYW8EXX8nGewfDT7jPxPKre5+60Jp/LBZYyDS7asbxDT6uxf9FQR6NzSOmxxjkkzpc4p6XLRZkrTuRN6XaPf+/iPb3+0AV8GkTLZ/KTuPE5XV7mz3n06le/enHb2962cnE4977xjW8c+f2hD31oZV41MuAcPyxyvWyObDPPOlenrKs/N5lhrl41S70vd07rI6+kq+z43ERQ8FWvetWRVWaYnBkDdb3eIzNegA+09VB3jh+p0mSxOfbj4E/GedWrXtWqzpzrWa3JMkw7DPszdXb2wzhRX6C3uLj9ieDctL5Mr4EEc9bVlzFI68vPf/7zx+rL8fzn/Z46Fo+/inuQYtvSmxqBhVX1S8puT3va00YWnzJdrhfTkYH80Fggl2/Nmtc3nnky4BCOiZxHrhecsOi0fadlNx6/WFcXJDAvLWsyvaZ1QfIA2kp2T27YYhq0+770pS8t6PksTUMLrCB4lvJtepMK7QnUZe9+97sXoZ5K2Z06NO2FQ0m5faVJ2zvb6JOf/GT5uGvKMdxQlCvbT1rP3Pan3YugbHrvytVR42lyHkl7jeX3OGAjt1xd1Dn6mm68fr5XQIFhC2w07MVz6RToX4CTdnrXBwWD3EmybmlydyZ3+TiQXNfxNEBXRbvT5WfaUEPlgguTFJTiBlnWi7vqCbpIp3eHO9yhspJY5zHLbxTuKKDGiUI1Xaqlyx0PM6/3uYsEb37zm8e6Vg3Lx34RV8jD9zvttFN4W75yt+FLXvKSlT8usOQqFyMjZT7klu/kk0+eafnY39P9i1nTkJI2HtELA+uSu2BCo0Lu0SKZ1Vj1r3h8S3qHMAtBYAXPLU/vTuGOM7ZX2kiEf3r3KdNJ7xzjOxqs5nV3BfPvKnERnC6Q00TkPncnpM9RZJ2pmKdBFYwfV85zd9ER7HL++eensyq4E/5tb3vbSPACA1U18o1NoOYL9o00T44DLRiVx4BUJSqId7rTncZ+plL4jne8Y2wfIO9mPeNAjDByeuGbfCQXpEVwT3pscicIx+wZZ5wRJjfY11z3u1z8p9EiPS+wXlzITo/FJivHuT/1SxtKyLeqUt/5RtV84+9z3VLixJ1yuUSDBg1naeJ4pceO9I4RGtvZb9JEQMS0waSMkx5L9E5CY1s6X+bHb7mAmbiXiL7yn3R9qz5Xlb94Pnld+SvtlYUAiLiRnv0ud94l4CrtyQY7tnnuTq899thjbNGn3WfGJpD5Ii3TMAh5fBqUyffkTU9/+tPHLuLw29DSauxfuXNdcGAfSMsm5IFcIE3zrjAOr/GjQuLvu35PjzK5cicN5AT4hYQjQRhpqisncH5MgyoYPy4npNMbyueqfGG16mVnnXXWSn0i1C2aPpJgKIZtliM9vzCNuvpzk3nk9u9Z6n25vJL9PJdXhgu06QXvJsudHicEKqf10Vx7Rph21+sdprtIr+Rvufpb3TpU1Zk5d6fl8lBnfve73z02ScoAlJlWIxEY+bjHPS47K8p/cXtEVbmXdqWq+jKPiErL6FX15exCzPFLymZpov5GHpC2o3FupixG20Ga0vpb+rufpxPoI6+fbgn+MvQQjolpy/W0j+Tqgtz0wQ0aaZ2sqi5IG+40dUHKQPQIG9flOY4IVsrdkEUdJhe4/Rf9+bw78MADszP+0Ic+VDziEY8obyJ44hOfWL7n5oE0r8iOvEpftm17p45JmZ38j0d3EEzXpOe5dLWo19zudrdLvy4DfXg0O70Zpu2uDIwh+2fuxiPyg3g/7KvO0dd0xzD8QgEFBiuwyWCXzAVTYJUEPv/5z4/NiTsLcpGbYwNGX8R3YYWvqUg96EEPKnJ3/4dhmr7mKgs0iBDpTgMrvVBwQSg0UlLxpoDHxYk4cWGFAgoFGCLuuXuNhv7cM8YYZl6VPiJM0wInF1MonHKRmruRH/vYxw7iojzbnsbsuJEBc+6kZ1lpzOYOPNaHhs1cJYHnjqd3EhKAkV4Io6eJaRN3PuaW7+ijj15ZPpYzLB/LmCYeqRAvH8EQ3CFIQ3mc2Ce5I4MLdVSsOI5Yh9SGcdi/HvCAB8SjD+o9F7R4zuyTn/zkkeXi4jaNRSQK7BxrHEPpha0wUu5xFPyWa5ij4krlkuh97Die6y6whHkM8XWfffYpK+JpDxNE6PNHowPHOb9jlwsawG6rrbZaWT3upPv4xz++8pk3XIw8+OCDy8YA7mBge3DxhopdruF5zz33HBm/zQf2DQIn6np6SBuw0/nsvffeZaNifFcyw9CYyt1w17/+9cuLqtzRn+YDYVr3ute9xh47wLLRo0J69xgWHJv40CsKd4en2yZMd4iv3CWW9gzFctKjEl7cQcd5gUbc1HSa9SGfy/mFaeDHvluV+s43quYbf88y5hI9JpDXE6RCueSQQw4pBwvL/IQnPGFsNAJ6KH+QJ9Hgz7FV5Ut5pE1jF0FGaVAVwSzcMcn5lTsjabggn6Vclcsr2GZx6iP/iadf9x5/zm3p3Ugcx5xPOPdx7iCPD49BSaeXK39xt1PuvEseSG8Xu19x3g3lI/LUNFCDeZBH5s490+4z6fLmPlMmZT3i7cX7I444olx/gmEod9Bglisj5KY5lO/63r+qemFi/Tkm4vJYMOE45i7J9BwZfp82YDyMN+0ry0be8tSnPnVku7LtuZjGvsrxTMKRu+bTcxF1F/5COeHXv/51GQAe70thuSg/x+WE8P3QXjnG5lkvo2yf1nnrLqIPza/t8kxbf24yn67rfVV55eGHH17W1ckrCd6eNa8kgIOyZa4eynpjVdX7Eb93vd5Mc9ESZRzyN7ZN01RXZ+Z8yAVN8odJdeaqC3dNl2Pa4aij8bjb173udSOjcr7moicXCTnv8Ec9jPalOJFfU+4k0eaEQ119mbx8ERLtKrQVUh6NE21U/FHGIkiE+huBM2l7FuNwAZt6i6k7gT7y+rZLN4RjIr1JLaxLaP8LdUHaU0lhmR//+MeHQVde+6wLcnw897nPLdsqaZ/guKmqZ1Kn2G+//VaWa0hvOL/yuChuhMulXFs7w+2///4jPUnlxl2N76Zte6dNIO2tleUkD2zTGzFtfrk6Pu1X9LpN4hinTZ1zC0GmuTpBOeAV/+jpIq0r9VXn6Gu6YV18VUCBYQvYY8Wwt49LtwoCuTt16RZ72hS6BkzHoxvxLlJoMM9Ni4IFvW5woSxOXGioumuaggiNmUSYVhX0uHtwXr0JUGHNJQrfrCsXKCjQDSFRyCcSOZeoGHDR79WvfnV5R36uMYsGlbvc5S5jo//4xz8e+Y4Amrq7EUcGvuIDkd/8sXw0eORSWD6ifelqOhdUwb6XWz4aZKu6a+YuKy6McTdK1QWTQw89tMg9tiC3nPP6jsL7QQcdVDl7giDIQ6qCKrgIVtVdYVWlg2OT/Zt9hcrloqbQ+Mj+l0uYEd1OQ3GuYkQekAalcKxUNbx973vfK/dhIucJKsgFVRAo1tXFpboLEjSW5XpYiB14Lj0XonM+eHD8cP6oCqqgkTIE0sXT5f1ee+2VnS6/cbGVfSu9kMUFuaEn7hTMeZHfkM9yQTFujGHYNg2XdduWfYjGp7rUZ75RN9/wGw0JVXkzPnTdmt4lSUNw1XmMfYW8nH0y9g3z45WGrrhr6Pi3Se+5S6XqbnrmSVAlj7yg56NcXsFyp+eSPvKfSesR/075Kw32CL+zDgTRUf4isCKXCILKlb8mnXcJyGRb5YIqOJcTLJhLbfaZ3HTi79gG97vf/eKvVt5z7iSfxiAuI3CxYZpyzsoEV/lN3/sX0686Jqq+h6AqEJOAm6rgmT7omFdorI+nT75Dj2khsZ4Ml8vXGSaUEyj35479XDkhTHuIr/Osl+Xybi6yr/XUpv48yYT9tep8ifO09T6Og6rAeXqU4BEcXeWVt7jFLSpXj/2zrnzT9XpXLsjAf2Cfuu997zvVUtLbRO6OXCZCvjipzszFzrScM9UCtByYsmSufsB+efrpp69MdVK5l+Hr6ssPe9jDKuvLKzMZ0BuCXLgQmUvUP+mdkTpcLqiC8/Fhhx1We6zlput39QJ95PX1c6z/dd7HBOX6qjynri5IcEAudV0XTAMkqAvQ5pErq4TloV0tPFIjfDekV8qkBJw1SZxPGTbtga7JuH0MM23bO3lbXH8Ly3TeeeeFt1O9UuclILsusQ9yrqQdK1cnCOMSVJFbn77qHH1NN6yPrwooMGwBAyuGvX1cup4FuHCdFt4o5LS5EMOi5u5QpqvyLhJdx1ddHK+aPo0jXBS+z33uUzVI9nsusBDNzEXMeSUaIFbrOaJdrCN3nx5//PFTF465OMpdL2mvJjzaIC0wcqdQ0xR3p8c4LB/dkE9beGe83PKF5eBOlmnvoKHBnW76qwIOwrSH8kpw0lOe8pTKhv/ccpKPcOzRw0JV2mWXXQbdY0fVck/zPXkI25pGpGkSzzDmAmCugZdgC7bHtBffeDTJ/2PvTsDlqOq8j5/crARCQshCCBIiEJBNYNgEBBTCbhgYUGQYURBxBB4FRnBFccFX2dzYQQZxEFFQEUFggIiKLCOy7yGBhC2ELEACgRBffoWnOX3uqbWru6u7v/U8/VTVWf7n1Kf63lu3+vQpvV/LWnT+QlNmKn7SjWu3fd2U0yM6dDMoz6Jj0ewC/kh8G0M3X5Wv92GWRT/DoSmes9RtZRm9n/S3Kcu517HrfeI/PzxLf3U+Qt/qV92kQRdu7Gb93nDbSNrW3/28H6TqJoQGVGZ939j29e3NuEE+tkzSWt/S1M2lvB9UqJ8anBS6eaL2mvH7J+k43LxGrr8021XS9Zd+j2k2jzyLrqlOPPHEfo9Zc2MUec+49UPbGohkZ0YJ5btp+pnTh0d5339ujFZuN/v9FTeAImlwYNwH5e24ntb/UqGfaQ2Qcv83asRR/xeFrhNa+T7I01Yjvxca/b/M/39X75VOmOkjj2+obJH/n0Nx/LSy/+/T78rQYCS/Xe038rsy9CG5bUN/J9KWso87rb2q5usLB3G/b+P6rL/dH//4x+Oyg+n61rmmjW/X/8z6naUPM0PX3Rr06j5OaKeddmrK/8tBmDYnaqZY/U7O+2Us/V3XfZWVVlqpzUfQfc0363d9I1Lt/pnQdX3czBVxx6X/qfT/Qt5rcf392meffeLC9kvXYPw897b1hawsf6P6NdTiBM1ooxl9NKto6Pemzof+Z9asvypblSXvvXd9gSj0HkmacS/tWFVXjxOJG7SWVl/5+hvrfzHLrdes/zmaFdftO9sIIFBNgUHV7Ba9QqA1AqHZA/SBWNyHVWm9Cn3wrW9ZaXpyO+2tvqXsL6GLEr+M9jU9pz6818wCmube/+Ddf/ad6ugfYl28qW/6drim54pbdKNGFyK6sIoz0D8trVp0AX3zzTdHL83K4S/u4IFQvzR6tIwldM5CseWnf7L1Lcy///3vRt+gj1s0oGLXXXeNpsYMlXGfQ23z476JaPO1dk3cdG2rf/rARv3TN0fS+qdniKqfaYuOQ33TN1HivlGsGJrKVmX1/kp6z4e80/pQRr4/uMWNqePTz94tt9wSTXsX+jawyusfqN122y06ziw3rFVWgw70rR99izxp0YeP/uL3OVTGr+Pv+zH8/Kz7cb8zNG2fHp2ib1FrysDQz7JtQx9G6xEZoek8bRmtdT40baSet673cdy3vvU+22qrrYwe/6FvjpS96EP20M9R3Gwkofb1j6l+b8jnhhtuiJ2hQnV1410v/fOWtuiGr/45lZE//betq4EhemSB4unbVWUtcnf/PpX1HlP/dB51XHoMix774c+8oTIamKObOxpgUnTWKA2K+vnPf65wtUUD0zRNadalWb83srSv3z8atHPVVVcFH8kTF0M3uvT8bE3Hef311wd9VVe/6/Q3Qj+zabOzxLXlpuv3h35O9aGx+qxvcIbOrero94MGsuqDjbRvcJb9+8e/1kh6b+v6S4OgdONM11+hKVOtgf4+ayrRpOsvW1ZrPT5FN+gVV9dJ7s+bW05/d/WNNX3rVP1JWoq+Z5JiKk8fPOgmrf7OPfDAA/36qt8X+uaafrfJ1//b6e+ntWfzi15L5Gmv7PeX7bvWoQ/SdL2QdJNcH/bo97r/dylpMIbbZtq2//5PK6+faX0D0f89rEc46QNeey2ogYp6Bv0dd9yR+TpBdeIWxQ19ky6uvE3Pe3y2XtLvAVvGrlvxf5nfH/1/6M9OmOX63vbZX4ec/DZtHf/nMM/Pl40RWueJW+T/51CbflqZ//cptn5X6lE5+j8t7nelPiizvyv18+4ucefALSN//ezpmtNddH2j48mylH3cWdoss0zo/Zs3vq5Z9KGgHn/h/v1NOwf2f2b93U76n1kfLGX5nzlrv/1jTuunG1fXWZ/73Odqj/Vw8zRLoAZ+2EXXJXrevf6n0DVkaMYGlbX/L+v/4LjfCX6fbRtZ1kXr2r9JWdrQvSANHNXPqs6l/n7FLfqfTB+0Jg1iD/U5dL8pro1WpYfeO0X+5ha5Z5F2jHl/16vfeX5+09oP5Zf5MxGKn5Smny37v2DosWtxdfW/oB7/of8F9b9L3P9j+jnW76mi/wtqliT9bFx22WXRrEyh/uh/Tf2/l3TNF6rnp4V+vvwycft5rjcUQy76n06vpUuXRrNK6zpM/zP4P9MLFy7s12zo/7VWvFfz3HvX30ANhtf9UfszpL9b+j3XyKJ7Unr0h+656vdq0n1D2468t9tuu2jG1ixfKin7fw7bj2bFtfFZI4BANQUGvPWL8B9JXavSKLqkfpKHQK8J6AN0XYjpQkYXiroA0xRaaReNGuSh57TqH11d6KmeLvL0XDg7+KOKluqrjlcXccuWLYtG+qd9oNLu49A5kvUzzzwTDa7RP5C68NMHg/5Ftd9XTed95pln1pJ1Ma3Hdej445akQRWhOiqv94HbP5lm6V8ontJ0bnTMeumcaV8fAugiN+nDgLh4VUzXP0Y6Pr0fdeNeP0M6Pv0c+Tc58/Rfj7ZRTK310jnXdIdJ5zxP/KqU1TFqYIoM9TOhb+3o94+ONfSPZJZ+y0uDkfTS+dHPl/1Za6bfFVdcEQ10c/uoG+NZv6Ht1rPbek/Jxt6M1LHo/TVmzJjU3xs2hr/WI2WeffbZ6P2lmwP6Odc/f93wjSnN7qNnNus9oA/49XPYjJt1vmne/Wb93sjaD70H9NLPg37363oh7e+Q/Ruh96J+buWq33H2/djMny0dl/6G6O+TphXVtt63OseN3Fxrxu+frOfAXn/p95+u3cq6/tLfWT0KTudJcbWv36f6ndHIoJci75k0C72nXnjhhdqj63QudW1Q9Hd/Wnutzm/n+yvLsXaKs35G9NJ72l4n6P2s31udcgxZzofK2N8LOlb9nivr94Lbvn4/+Nclmk1s0qRJbrGe2NbvIP2c5v3/OQuOYuv6zf2/yl6Lpv299eMrlj7Mso/51GCGsn5XapC9P/hKsynETRvv983fL/O4/djdvN/t/zO71726jtM1Yxn/L1f1PbFkyZLatZjOrQYg6P9b/e1q9vVyVU3a2a9m/q4velzt/pkocl1vf7/rmsz+L6gBG/pZ1vs7y3tbH5JrFgd30SBCd6CRfmb0GB39bVY/9XOj+Hn/drptdMK2vsShx325i75AkuVLNG6dsrd1ParzrfOrc6N7RqF77/q9p//r9D7RYP6y78GoDxqgrWtk3SNTO7rno2srvTSYY623Zhpt5H+DZv3P0ay4ZZ9r4iHQaQL62dIS+p3UjGPR7zktM2bMCIZnYEWQhUQEEECgvQL6wFYvu+hbrJryPG7RRSYLAgi0TuCNN96IPqjwvxWrx09opgIWBBBAAAEEqibQyM3Hqh0L/ckmoG9U60a9XXQzWrOG8F6wIr2z1swluk71l/PPP7+hweF+PPYRQAABBBCQQJaBFZ0spQ/59AhWd9HscSeccELidZYGJKiMBpO4y7nnntuyDwzddtlGAAEEOkGgagMr4r/63Ama9BEBBBDoUgH/WcihKXs1mMK+upSBw0KgkgL6xskll1zSb6pxzZYQmr69kgdBpxBAAAEEek7AXjcyILd3Tr1mrHIXPR6SQRWuSG9sL1682OgDG3/RTBWNzLjnx2MfAQQQQACBXhHQ7B0asKoBEvalR/xefPHF0axkIQc98vK0007rN6hC12et+hZ2qF+kIYAAAgjkExiUrzilEUAAAQRaITB79uy6ZtznY3MzvI4m0w5mmZgolCBw4403mldffdXoH+F77rkn2vaL2+dK8n7zZdhHAAEEWiPAB8bZne3fKsyym3ViSX9gxXvf+95OPAz6nFNAj5m5+uqro6m8H3roIXPfffcFI+y1117BdBIRQAABBBBAIF1gjz32iAZSuCWvv/76aLaObbbZxkycODF67LYeF6aZo+6++263aG172rRptW02EEAAAQSqL8DAiuqfI3qIAAI9JqBvw7szVugZexoJrcXeBO8xkp497l47z1U+3ptvvjkaVBHXx0022cToH2cWBBBAAIH2CTR6ndSLgwxk1ovH3b53aWtbdv+nUMvuYO3W9oTWWimgR9b96le/SmzywAMPNOPHj08sQyYCCCCAAAIIxAtMnTrV3HnnnebBBx+sK6QZLKZPn16XFrdzyCGHGD1ChAUBBBBAoHMEeBRI55wreooAAj0ioOftuctmm23WU4/80A1+/+V6sI1A1QTWXnttc/TRR/PBVNVODP1BAAEEcgr41x/a74XFHncvHGuvHeOsWbNqh6yb9iuttFJtn43eFdAjQD70oQ/1LgBHjgACCCCAQAkCfX195vjjjzfbbrtt7mjDhg0zn/zkJ81uu+2Wuy4VEEAAAQTaK8CMFe31p3UEEECgn4Bubus5fZrCVYu+Cd/NS698aNHN57BXj22NNdYw22+/vdl9993N4MGDe5WB40YAAQS6WsC/Tunm2R10rN18fF39Rg0cnM6nntdt/6fYcsstA6VI6iWBddZZx+y9995mq6226qXD5lgRQAABBBBomsCQIUPMUUcdFQ2QuOaaa8xjjz1m5s+fH9veuHHjotlOdR9p1KhRseXIQAABBBCorsCA008/PfFrOPqmNAsCCCCAQOsF/Bv5re9Bc1rs1uNqjhZRqyIwc+ZMs2DBArPCCitEA580dfKgQYxPrcr5oR8IIIBAuwS6dSBCtx5Xu94ntItAKwX0aMmHHnrILFu2LHq2+9ixY82qq67KwKlWngTaQgABBHpc4M033zR6NJW7aBCCZnno9mXp0qXmueeei16LFi0yK664YjTYVX+PJ0yY0O2Hz/EhgAACpQvonrwWfXGgFcuSJUuiZmbMmBFsjk8EgiwkIoAAAu0V6KbBB910LO19V9B6OwUmT55s9GJBAAEEEEDAFfCvc7plQIKOq1uOxT1fbCPQCwL60GrDDTfshUPlGBFAAAEEKiowcOBAo1cvLkOHDjWTJk2KXr14/BwzAggg0O0CDKzo9jPM8SGAQMcJ+DfoO+4A3upwNxxDJ7rTZwQQQAABBBBor4B7DdTpAxMYXNHe9xKtI4AAAggggAACCCCAAAIIIIBAtQS6f+6lannTmwoLPP300+baa681s2bNqnAv6Vq3C7g34zvpWNVv99VJfaevCCCAAAIIIIBAMwTca6NOvsZrhg0xEUAAAQQQQAABBBBAAAEEEEAAgU4TYMaKTjtj9LcpApdeeqm5+uqra7F32GEH8+lPf7q2zwYCzRbotJvtndbfZp8/4iOAAAIIIIAAAmkC/vVTp8xoYfvdKf1NOw/kI4AAAggggAACCCCAAAIIIIAAAkUEmLGiiBp1ukrgpZdeqhtUoYO75ZZbzAsvvNBVx8nBVFfA3qyubg/ffrSH+mlfVe4rfUMAAQQQQAABBDpBwF5X2XXV+6x+siCAAAIIIIAAAggggAACCCCAAAK9KsCMFb165jnumsDzzz9f23Y35syZY8aOHesmsY1AqQKdcHO6E/pY6klxgvXysTsMbCKAAAIIINAWgV6cHcFee1T52Duhj215w9IoAggggAACCCCAAAIIIIAAAgh0vQADK7r+FHOAaQJrr722GTdunJk7d26t6LBhw8yGG25Y22cDgbIF7E3psuOWEa/KfctzfN1yHHmOmbIIIIAAAgh0i0Cjf8erPDgh7Ry5x17V41Afq9q3NF/yEUAAAQQQQAABBBBAAAEEEEAAgSICPAqkiBp1ukqgr6/PHH744WbKlCnRcU2ePNkcddRRZsiQIV11nBxMNQR0E9q9WV6NXr3diyr3TT20/cu6rpItfUEAAQQQQACB1gpkvV6w5Vrbu+ytVbl/Ve5bdmFKIoAAAggggAACCCCAAAIIIIAAAtkEmLEimxOlulxAs1PotXTpUjN06NAuP1oOr10CuvlcxYV+VfGs0CcEEEAAAQQQaKWAfz1UtdkYbP+q1i+dI/Wtiv1q5fuHthBAAAEEEEAAAQQQQAABBBBAoPsFGFjR/eeYI8whwKCKHFgUzSxgb4RnrtCiglXrV9X606LTQDMIIIAAAgggUEEB/7qkKgMHbL+q0h976qraL9s/1ggggAACCCCAAAIIIIAAAggggECjAjwKpFFB6iPgCWjWi+XLl3upybuqY29GJpdMz1Xbilfmor7lPaY87Sv+a6+9VppBnrabXbas81p2P6vQL/XBfZV9jMRDAAEEEEAAAQTKEnCvWapyHVXWsZUZpwo2ZR4PsRBAAAEEEEAAAQQQQAABBBBAAAErwIwVVoJ1Twtcc8015qmnnqoZjBo1yhx44IG1fW3ceuut5t57761LO+KII6J9pV933XXm4YcfjgYIKPHd7363WW+99cy0adPMyJEj6+otWbLEXHvtteahhx4yTzzxRK3OaqutZrbeemuz8847mzFjxtTViduZM2eOefDBB6P+z5o1K4pny44ePdpstNFG5l/+5V/M5ptvbgYOHGizEte6IfrAAw+YG2+80Sj+008/HZWfOHGimTx5stlqq63MFltsEaUtWLDAXH755XWDIqZOnWrWXnvtxDZkddNNN5mZM2fW4quCDCZNmmR23HFHs8kmm5i+vs4d/1XFG8vt6lO72k18E5KJAAIIIIAAAggUFAhd27R6Fgnbh1a3m0amflWtT2l9Jh8BBBBAAAEEEEAAAQQQQAABBBBIExhw+umn/yOp0GabbZaUTR4CXSHwla98pW5Agj7cf+tno+7Yzj33XPPHP/6xLu3iiy82emmAQNwybNgwc/TRRxv7s3T77bebiy66yLz00ktxVczKK69svv71r0eDDOIKaQaJq6++2lx22WVxRerS11xzTaOBIBoYkbQ8//zz5oc//GE04CGp3KabbmoOPfTQaODF9773vbqixxxzjNlyyy3r0uzOM888Y84888zU+Co/btw489nPfja1zzZ2ldb2RndV+tTq/rS6vao40w8EEEAAAQQQQMAKtHpwQavbs8cZt65af+L6SToCCCCAAAIIIIAAAggggAACCFRTQF/u1jJixIiWdFBfjNcyY8aMYHsDd9ttt68Hc/6ZOGHChKRs8hDoCgENjLA/nDqglVZaybz1s1F3bH/729/Mk08+WZemwQ1/+MMf6tL8nWXLlkWzXWy//fZR/VNOOSX1UR16lMdf//rXaHCC+uIv8+fPN4rjD/Twy7n7ixYtigaAaKYJzcgRWjTjxbe+9S2jwRVpy3PPPWf+/ve/m/XXX99osIi7vO997zOa3cJfNAvGt7/9bTNv3jw/K7i/ePHiqM+awWL11VcPlqliYpUGFbSqL61qpx3nu5uPrR2etIkAAggggECSQDd/GN+qY2tVO0nn0eZVqS+2T6wRQAABBBBAAAEEEEAAAQQQQKAzBF577bWoo0OHDm1Jh994442oHfczY7fhzp1j3z0KthFok8BVV12VueWzzz7b/OhHP8pcXjNaaOYIf9GHvGeddZZ55JFH/KxM+2eccYbRgBB/0WCOU089NXEmDb+OBlf84Ac/8JOD+xqsoUEV9pdgsFBMomYP0SNJOmGpyofw6kez+2LbaHY7ZZx3t695t8tonxgIIIAAAgggkE0g799pt3y2FtpXqlV9te2070jfaVl9YUEAAQQQQAABBBBAAAEEEEAAAQS6QWBQNxwEx4BAuwX22GMPs/nmm5sxY8aY2bNnR7NYPPjgg3XdevTRR2v7esTFnnvuGc32MGjQoOixGFdccYXRQAV3mTlzZjSgYI011qglK64fW5nTpk0zG2+8cfTYjBVWWCGageP66683/uCPuXPnmnvuuaf2aBIb+Ne//rXRTBj+opkn9t13X7PuuusaPdZEs01opgzFzrrohuo555zTr7ji7bfffmajjTYyelSJjl/H9pvf/KZfX1T/G9/4hunrq+54sCrcOG5FH1rRRr83S0xClfoS00WSEUAAAQQQQKBFAlmvC6owi4LtazP70oo2spxa9aOZx5mlD5RBAAEEEEAAAQQQQAABBBBAAAEEGhVgYEWjgtTveYFDDz3U7LLLLjWH8ePHm0022cR8//vfN3fffXct3W6svPLK5itf+Uo0CMOm6TEX6623XpSumSrcRY8fcQdW3HfffW52tK1BFQceeGBd+ujRo6O04cOHm8suu6wu7/77768bWKFZJPwBGKqw2mqrmZNOOskohl30HKPJkydHr3PPPdcmJ67vuuuu4AwbX/7yl83aa69dqysHvTbYYIPIwp3d4oknnjD33nuv2XTTTWvlq7Rhb1y3q0+taL8VbYT82tVuqC+kIYAAAggggEDnCyRdW7R6AIDtSzPbbUUbae8K9aGZx5jWPvkIIIAAAggggAACCCCAAAIIIIBAowLV/ep3o0dGfQRaILDTTjvVDaqwTQ4ZMiSa5cHuu+ujjz66blCFzdNsF3vvvbfdra395/hoIIIGUdjXIYccYj784Q/XyvsbU6dO9ZOiWSfcRA1Y8BfNJvH5z3++blCFW2bHHXeMZt1w0+K2b7/99n5ZxxxzTN2gCreABlccd9xxblK0fccdd/RLI8G07JEfrbDWTXf/1Yp2aQMBBBBAAAEEEJCAfx2i/VYstt1mttWqY2nmMRAbAQQQQAABBBBAAAEEEEAAAQQQaJcAM1a0S552u0Jgs802iz2OtdZaK5inR2rELXochr+8/vrrdUlbbrll3X7ajh4Lolky3JkwFi9eXFctNLPGAQccYCZMmFBXzt856KCDzJ///Oe62H6ZpUuXRmXcdD0KJe04Ntxww2jGDPfxKLfddps5/PDDK/dtt3bdpG52u82Or/dEK9pw33tsI4AAAggggAACeQX865Vmzrxg22pWG82On2Srtpt1XEntkocAAggggAACCCCAAAIIIIAAAgiUIcCMFWUoEqNnBdZZZ53YYx88eLDR4zjcReU1m0XcoseIlLno5uWrr76aOPBB7c2dO7dfs+4jOvpl/jOhr6/PvOc974nLjtJfeOGFfvlTpkzplxZK8H31aJCXX345VLRtafbmdKs70Mx2FbtZ8W1su261G+0hgAACCCCAAAKNCtjrGLtuNF6ofjNjqz3Fb8fSrnbbcay0iQACCCCAAAIIIIAAAggggAAC3SXAjBXddT45mhYLjBw5MleLw4cPTyw/cODAxPxQ5rx588zMmTPNjBkzzKxZs6KBB4sWLTJLliwxGoiQZZk/f36/YhMnTuyXFkqYPHmyCT3qw5ZVX/xFs1zoVWTRzBuagaOXl2bdkO60uGW/B0LHH0oru13iIYAAAggggEC9QGhWg1Bafa327bnXC2X308YuO660FLsZcdt3JmgZAQQQQAABBBBAAAEEEEAAAQQQaJ4AAyuaZ0tkBJoqoIEJP/vZz1Jno8jSiYULF9YV08CFFVdcsS4tbmf11VePy4rS/diJhTNkuo80yVC8qUXsje6mNuIFb0abVY5ZRt/KiOGdBnYRQAABBBBAoIkCob/dobRQF8oYKNBIDLefjcTxj83GLTOm2lDcsmP6fff329Gm3wf2EUAAAQQQQAABBBBAAAEEEEAAgbwCDKzIK0Z5BNossHTpUnPxxReb6dOnl9YTzaThzm6hwQvLli0zgwal/4pIGzjxxhtvlNZPBVq+fHmp8YoGsze3i9YvUq/sNqsaL2u/spYrYk0dBBBAAAEEEOhMgazXB0mDCdwYSeXShMqK47ZjYzbSLzeethWzzHh+/NB+O9oM9YM0BBBAAAEEEEAAAQQQQAABBBBAIKtA+qemWSNRDgEEWiJw7rnnmttuuy3Y1pprrmk0g8SIESOMBkto1gm9zj///GB5mzh69GjjPw7kmWeeMYqXtujxI0lL6LEdam/XXXdNqhblaYCHbvLqeOwybtw4u9lTa3sTvYyDbkesRtpspG4ZXsRAAAEEEEAAge4TiLu+8AcYxJULifh13TJunKRybp2kbRuvjFhqR/HKipXUb/IQQAABBBBAAAEEEEAAAQQQQACBThVgYEWnnjn63ZMCzz33XHBQxUEHHWSmTp1qhg4dGnS54oor+g2ccAuuuuqq5vHHH3eTzOzZszMNrPDr1QV5ayc0sGLrrbc206ZN84t2zL69kd2KDpfZVitjFW2raL1WnAvaQAABBBBAAIHuFwhdi2QdcODXjatny8Xl51Guaqwsx6C+l2GQpS3KIIAAAggggAACCCCAAAIIIIAAAo0KMLCiUUHqI9BCgdAghv3339/svffesb1YsGBB4qAKVdxwww3N7bffXhfjmmuuMVtssUXsYA0Vvuuuu8xTTz1VV8/f0ewU/jJjxgw/qWP27c3rVnS4rLZaFadIO0XqtMI+ro1O62/ccZCOAAIIIIBAlQSq/uG6//c/a3/deqE6afl5zpGNFWonTxyVVawy4mRpt5VtZekPZRBAAAEEEEAAAQQQQAABBBBAAIE4gb64DNIRQKB6Ai+++GK/TmlQRNJy3333JWVHeZtvvnm/MjNnzjQXXnhhv3SboBktTj31VLsbu9bACv+RIo8++qiZN29ebB2boTKPPPJI7TVnzhyb1fVre3O80QMtI45iJMVJy/ePwZZPiunXKXvf7UOe7bL7QTwEEEAAAQQQePuD/Dx/j23ZdtnZ9rXOutg6ceXT8uPq+el5+uTXdffLiuPGZBsBBBBAAAEEEEAAAQQQQAABBBDoZAFmrOjks0ffe05g2LBh/Y5ZjwdZb731+qUrQQMTfvOb3wTz3EQNftDgCs1A4S5//vOfzUorrWT22WcfM3LkyChLN1k1WOO8885ziyZub7/99ubSSy+tK3PyySebb37zm2bFFVesS7c7ixcvNl//+tfrZtvQY0XOPvvsln2DzvbFrlt1g7msdhqNk1Y/Lb/Vbu1qz7bLGgEEEEAAAQRaK5DlWqTZMy/4fUhrz5aPK5eWn0VYMeLiZ6lvy5QVx8aLW7eqnbj2SUcAAQQQQAABBBBAAAEEEEAAAQSyCDCwIosSZRCoiMDYsWP79eTiiy82kyZNMmuttVZd3hNPPGG+973vmZdeeqkuPW7nkEMO6TewQmX/8Ic/RC/NOvHmm2+al19+OXNM29Z2221nrrzySvPaa6/ZJKMBIZrx4rDDDjMTJ06su/n72GOPRbNlzJ8/v1ZeG7vuumtdubrMJu/Ym9xNbiZxZog8bTfS37i6cemhfuUpG6qfltbs+Gntk48AAggggAACnSGQdM1QxuADX8FtLym+W04x/LI230/324vbV/2idd2YZcVxY4a2W9VOqG3SEEAAAQQQQAABBBBAAAEEEEAAgSwCDKzIokQZBCoioMd+aNYKd4CCtr/0pS+ZTTfd1LzrXe8yelzI/fffn3vwgwZtfOYznzFnnXVW8GifeuqpYPpHP/pR8/Of/zyYZxNXWWUVo4Eb5557rk2K1nrMx/HHHx8dk/rf19dn9LiPUFs67g9+8IN19Vu1Y29sN7u9MtppJMby5csbPsRG2o9rvBkx49oiHQEEEEAAAQR6RyB0jVHGYAQraONniWnL2rp2bdN1nZx3sXWztJ8UW3EajZEU3+a1qh3bHmsEEEAAAQQQQAABBBBAAAEEEEAgjwADK/JoURaBNgsMHTrUHHzwweaCCy7o15O7777b6OUvU6ZMiWaHyDJzhR7ZoUdznHLKKX6Yfvsa6HD00UebIUOG9MsLJeywww7m4YcfNn/84x/7ZWtwyG233dYv3U346le/akaNGuUmtWTb3pBudmNltFM0huoVrSuXRuqGXMuOF2qj6mkYVP0M0T8EEECgNwRa8WF61ST9v8FlGLgxi8bTAFjVLVJf7Rep556bMmK48eK2W9VOXPukI4AAAggggAACCCCAAAIIIIAAAnEC+b/2EheJdAQQaImAZm347Gc/m6mt1VZbzRx77LHRjBCZKrxVaLPNNjPnnHOOOeCAA8zKK6/cr9ro0aPNtGnTzI9//OOobL8CMQm6mfupT33KHHjggTElwsk6hpNOOslMnjw5XKALUt2b7UUPp0gM1dFN+iJ11U/VK1rXP04bq6x4fvws+24f2r2dpb+UQQABBBBAoNkC7f576Lbf7GONi192H2y8uPaS0lW36LWb6ja6lBGj0T5QHwEEEEAAAQQQQAABBBBAAAEEEGiXADNWtEuedislMHjw4Lr+DB8+vG5fO36ZfgWalLDCCiv0i7z11lubr33ta+bqq682DzzwQN2jQVRYs0loAIMGYQwaNCiahcINEorp5mtAxb777hu9li5daubNmxfdxB03bpzRrBnusnDhQnc32o77RpzSNShj8803NzfddJP5wx/+0K+uTdCAiv32289su+220SNCbHor151y8zhvP215u85rWrSe204ZMdx4cdutaieufdIRQAABBBBAoByBPH/T465FG+2J34dG2rGxisSwdXU8eeqrXp7yjXoVrd8p/Sx6fNRDAAEEEEAAAQQQQAABBBBAAIHOFBhw+umnJ351Rd9eZ0EAgeoK6Mbj3Llzo8EP6qUGJGhWiVbdNP35z39ufve739UBffvb3840w8Trr79uXnzxRTN//nyjARzqswZvjB07NvMjRuoaLnHHvWFdYth+oRptJ099W9au+3UmJaFoPRu20fo2jr9uVly/HfYRQAABBBBAoPMFmnWN3GjcovVtPbvOcobylA3Fa7R+KGYorVXthNomDQEEEEAAAQQQQAABBBBAAAEE2i+wYMGCqBMjRoxoSWeWLFkStTNjxoxge8xYEWQhEYHOEdANx/Hjx0evor3WL6bjjjuurvqUKVPMCSeckDhA44UXXjA33HBDXT3tjBkzpl9aKGHIkCFmwoQJ0SuU3+1pjQ4IyFrfLeduZ/UtUkexi9aL61fZ8eLaIR0BBBBAAAEEulcg7nqi0Q/x/bh549n6ReqpTp76Kpu3Hfcd0Wh9NxbbCCCAAAIIIIAAAggggAACCCCAQKcIMLCiU84U/USgiQKrrLKK0eM/NPOFXe69915z8cUXm4MOOig4e8TMmTPNueee2+8xJHrMR6tGjtm+lr22N6bLjuvGa7SNLPX9Mv6+25/Qdt7yNkbRera+XZcVx8Yre131/pV9vMRDAAEEEECgTIFGPtgvsx82lv93vdH+2Xh54xSppzq2naz13TrWIM+60fpZ2mpFG1n6QRkEEEAAAQQQQAABBBBAAAEEEEBAAgys4H2AAAKRwB577BENpHA5rr/+enPLLbeYbbbZxkycODEaYKFHdzz11FPm7rvvdovWtqdNm1bb7sQNezO6mX1vtI20+n6+v5/l2FpVx+1LkTbd+kW329Vu0f5SDwEEEEAAgW4QKPr31w4gaLaB37+i7do4eeurXp46fjv+fsgrbxt+jEbr+/FC+61oI9QuaQgggAACCCCAAAIIIIAAAggggIAvwMAKX4R9BHpUYOrUqebOO+80Dz74YJ3Aa6+9ZqZPn16XFrdzyCGHGD1ChCVewN7kji+RnJNUP5QXSktqIW95xSpSx/ahkbo2hrv24/n7blm2EUAAAQQQQKDzBLL8bfcHJPj7RY7abbdIPFs/T92iddw20mIo3y2f16bR+nnbozwCCCCAAAIIIIAAAggggAACCCDQLoG+djVMuwggUC2Bvr4+c/zxx5ttt902d8eGDRtmPvnJT5rddtstd90qVbA3npvVp0bjJ9UP5YXSko6tSPm8ddS+6thXWn9subT18uXLjV5+uaT45CGAAAIIIIBAdwr41wNx1wl+OXc/SSZruVAMWzeUF5emOnmWUPlQmo2ZlGfLJK0brZ8UW3nNjp/WPvkIIIAAAggggAACCCCAAAIIIICABJixgvcBAgjUBIYMGWKOOuqoaIDENddcYx577DEzf/78Wr6/MW7cuOgxIbvvvrsZNWqUn81+iQJJN5RDeaG0uO7kKasYecun1ckTL0/ZuOPt5PReP/5OPnf0HQEEEKiyQCMzFlT5uPy+xf0dDR1/1rJuuVAcvw9239bLWqdIeT+2Yvhpbn/i8mwZ1ggggAACCCCAAAIIIIAAAggggEAvCzCwopfPPseOQIzAuuuuaz772c9GuUuXLjXPPfdc9Fq0aJFZccUVzYgRI8zYsWPNhAkTYiKQ7AvYm+F+epb9pLqhvFBaXDt5yipGnvJxZePSQ33MUzZUv8y0KvWlzOMiFgIIIIAAAlX4G9fOD/X940/qS1JZNy8phvuOU52sZVUvT/lQ2VCa7U9Sni0Tt26kblxM0hFAAAEEEEAAAQQQQAABBBBAAIEqCTCwokpng74gUEGBoUOHmkmTJkWvCnavtC7pZnCzlmbFDsUNpcUdVyvLZm0ra7m4Y8qa3qp2svaHcggggAACCPS6QJG/zXkGJOTx9fuS1I5b1i1n0920uD7kKasYKp8lblzZPPXj+hxKb1bcuOMI9YE0BBBAAAEEEEAAAQQQQAABBBBAoFkCDKxolixxEUAAgRIE7I12P1QoPZTm17P7WctmLae4fll/37btr7OW8+ul7Tcrblq75COAAAIIIIBAawSS/tZnHXiQpaduO0lxQ+VsWlI924e8ZbPEVGzF9cuG0uLK2v6xRgABBBBAAAEEEEAAAQQQQAABBHpZgIEVvXz2OXYEEGi6gL1BXqShuLqh9FBaXJtZy2Ytp3ZUNm/5uP7lTc/Tbt7YlEcAAQQQQACBzhSIuz7wBxjkPTo3blIst5xtI6m8LaO16mYpm7VcXMy4+nHpbh/jthupGxeTdAQQQAABBBBAAAEEEEAAAQQQQKAKAgysqMJZoA8IINBWAd0ArtoS6lMoTf2OS/ePqexyir98+XK/mdj9rO3HBngro4wYSfGL5FWxT0WOgzoIIIAAAgi0QiDLgIFm9iP0d7ton9xYaTFU1pbv6+tLPURbNktcBUsrpzKK6ZeLaydUVjHauVSxT+30oG0EEEAAAQQQQAABBBBAAAEEEGitAAMrWutNawgg0EMC9kZ13kMO1QulKW5cut9mWeVsHLv22wnt5ynr12+krh/L7odihtJsedYIIIAAAgggUJ5AI39z/UEB6lUoLW9v/T4ViWljZKlrB6basnYd6rfiJuXbOo2WC9UPpdn2ktZF6yXFJA8BBBBAAAEEEEAAAQQQQAABBBBotwADK9p9BmgfAQTaKqAbv1Va/P74+25fk/LKLOe24267bYS285R16+epl7Vs1nJuP9hGAAEEEEAAgWoJhP6eu2lZBiDoiNLKFYlppWzdtDZU3pa1dbUO1VO5ULpbT9uNlrP9cdvKGtPvS7P2q9afZh0ncRFAAAEEEEAAAQQQQAABBBBAoHoCDKyo3jmhRwgg0AUC9sZ0I4fSyhihtvw0fz/u2LKWc+uH6oTS3Dqh7SJ1QnFIQwABBBBAAIHOE4i7DnAHCuio4sq5R2zruGVtmlsubtvWy1JHZW25uHpumbg2lZ61XCfESOojeQgggAACCCCAAAIIIIAAAggggECrBRhY0Wpx2kMAgcoI2BvXVelQnv5kKVukTFyduHTXLkuZuPJ569o4RevZ+s1eV71/zT5+4iOAAAII9KaAHSRQlaP3/x5n6Z9fxz+WLDFUx8ZJK69ybhlbTzFsuk2z+8oLLX6somVsvSzxbNlWrKvWn1YcM20ggAACCCCAAAIIIIAAAggggED7BRhY0f5zQA8QQKDLBOxN7zyH5dfx991YSXm2XN4yceXj0m07dp21nMqrbJ7yRdqwdYqsi/StSDvUQQABBBBAoFsFyvxbmjZ7rjCxAABAAElEQVSIoIhhqH9Z2nHraVt1stRTH235pP7a+H5MPz1rLD+O33ZSHD/P3/djhfaL1AnFIQ0BBBBAAAEEEEAAAQQQQAABBBCoggADK6pwFugDAgi0XEA3equ6JPUtKc8eT94yceXj0m07WmcpY8tlLVskvlsnbbtIP9Jiko8AAggggAACzRFI+7udNngga6/cdrLGVB1bT3XS6rllk/qlcqFYbrq7HRer0TJZ6se13ez0Kvet2cdOfAQQQAABBBBAAAEEEEAAAQQQaI8AAyva406rCCDQRgHdiG3WUiR21jpZy6Udm41j16HySXkjR44066y9tll1zBgzcODAUHXSEEAAAQQQQAABBGIE3nzzTfPivHnm8RkzzKJFi4KldC0WN7hCFZQXVyYYMCExa5ys5dymitRx6ydtNzN2UrvkIYAAAggggAACCCCAAAIIIIBAbwr09eZhc9QIIIBANQR0Q9gu2nb3bXqedVp9m2/XodhJeRpUsfXWW5tx48czqCKERxoCCCCAAAIIIJAioIGpupbSNZWureKWpGsym2fXRWLE1XHTFd9tw912y7GNAAIIIIAAAggggAACCCCAAAIIdLsAAyu6/QxzfAggUCfQzJvBjcROq5uWr4NMK6N8+6pD+edOUp4tr5kqmKXCarBGAAEEEEAAAQSKC+iaStdWSUvS9ZnN0zppSctX3bQyafmNtp9UPymvkX4lxSUPAQQQQAABBBBAAAEEEEAAAQQQ8AUYWOGLsI8AAl0r0Mwbr0Viq459JaFniZ1WJq2drPX1+A8WBBBAAAEEEEAAgXIEdG2Vdp2mlpKu1Rqtb48kqQ3bhyxt2XjuOi22WzbvdjNj5+0L5RFAAAEEEEAAAQQQQAABBBBAoHsFGFjRveeWI0MAgYoLlHUTOC2O8pPKJOWJ0M1ntoqKv6noHgIIIIAAAgh0lIB7beVec4UOIilfeUn5ipeWH2ozlFZWnFBs0hBAAAEEEEAAAQQQQAABBBBAAIGqCjCwoqpnhn4hgECpAs28AVwkdtY6WcvFYal+UoykPMW0+Wlx4tonHQEEEEAAAQQQQCBZwL3OstdecTWS8t04cfXT0pPiu3Wzlmu0jls/abtIf5LikYcAAggggAACCCCAAAIIIIAAAgj4Agys8EXYRwABBFogkOXmb6NlVD8pRlKeCGz9tHIt4KIJBBBAAAEEEECg6wWyXnslXZvZGHFYSXVtnbLK2HisEUAAAQQQQAABBBBAAAEEEEAAgW4QYGBFN5xFjgEBBBIFstwcTgyQkFkk9vLlyxMiZs9Kalt5aflJLamPSfWT6pKHAAIIIIAAAgggUFxA12Bp14tJ12nKS8sv3rt3aqb18Z2S72wl9eudUsW2mhm7WI+ohQACCCCAAAIIIIAAAggggAAC3STAwIpuOpscCwIIdI1A2o3hpHzlJeUnIalekZvkSTHJQwABBBBAAAEEEMgv0MhA17TrwbRrxbT8/EdDDQQQQAABBBBAAAEEEEAAAQQQQKCzBRhY0dnnj94jgEAbBYrccM4yaKFIXMugumn14/LT6sbVs22zRgABBBBAAAEEEMgvkHSNlXR9llRPvUiqm6WXafEVI8u1rd9Wlrh+HfYRQAABBBBAAAEEEEAAAQQQQACBdgswsKLdZ4D2EUCgZwTKuokcFycu3QUOlVGafbll3e1QPTefbQQQQAABBBBAAIHiAknXWvY6LVQmlOb3Iq5MXLpfP22/rDhp7ZCPAAIIIIAAAggggAACCCCAAAIItFOAgRXt1KdtBBDoGQHdcM5y0zmtTCjfjR3Kt8ihPJtm17asu07Kc8uxjQACCCCAAAIIIFBcIOmay+bZtdtKKM3m2zyt7bbN0zqUliffxkiL48ZkGwEEEEAAAQQQQAABBBBAAAEEEOhEAQZWdOJZo88IINB2gTw3j/OUzXtgbmx324/j52nfptm1X0f7bp67HSpLGgIIIIAAAggggEB+Afcay932I9k8re22LePv23St3Tx32y1Txnae2HnKltE3YiCAAAIIIIAAAggggAACCCCAAAKNCjCwolFB6iOAAAIJAvamsV0nFK276R0q58fw90N1QmluPXfbL2vztLbbfhn2EUAAAQQQQAABBBoXcK+3kq673Dx3O08P/Hr+vh8rLV/lbRm79mOwjwACCCCAAAIIIIAAAggggAACCHS6AAMrOv0M0n8EEKisQCtvLCe15ebFbfuItpxdK9/d9suzjwACCCCAAAIIIFBMwL3Gstt2HYro5sVt+/Xccn5e2futbKvsvhMPAQQQQAABBBBAAAEEEEAAAQQQiBNgYEWcDOkIIIBAjECWm8VuGXc7JmTqoAU/hr+fJW6eOirrlne349oiHQEEEEAAAQQQQKCYgHutZa/D3LSkqG45dztrHZVLq5eW78fIWz6pr+QhgAACCCCAAAIIIIAAAggggAACVRBgYEUVzgJ9QAABBHII+Deq/X0byk13t5Xv77t1/Dy7b9e2LGsEEEAAAQQQQACBxgXsNZZd24ja99PcPLuttVvO3Y4r49dxy7GNAAIIIIAAAggggAACCCCAAAIIINBfgIEV/U1IQQABBBoSiLuZXTSoG8/dVjx/P9SGX8bft3WWL1/eL54ta9e2LGsEEEAAAQQQQACB8gTstZZd28ja1zVaaAmVDZVz05Lq+HluvSLbZccr0gfqIIAAAggggAACCCCAAAIIIIAAAmUJMLCiLEniIIAAAgGBLDeUs5RR6Kzl3LJ+HX/fdjmUbtPs2pZljQACCCCAAAIIIFC+gL3msmu3hVCa8v10u2/Xboy47axls5TLUiauH6QjgAACCCCAAAIIIIAAAggggAACVRZgYEWVzw59QwCBhgXKvrmbFi8tP+8B2Xh27dYPpeXJt2UVx49l99213bb1WCOAAAIIIIAAAgg0LqBrLHud5a9tdLeMTYtb2xh58m0du46rmzc9LV5aftnt5Y1HeQQQQAABBBBAAAEEEEAAAQQQQMAKMLDCSrBGAAEE2iCQ5WZyljJu11U+VCcuzU9P23fbYhsBBBBAAAEEEECgHIG0azDl+2XUclxaKD2pp1nKZymT1AZ5CCCAAAIIIIAAAggggAACCCCAQKcKMLCiU88c/UYAgcoJ+Dea/f28HU6qXzTP7UNSDJXT87zTyrjx2EYAAQQQQAABBBBoTEDXXroGS1qyXp8llSual9Qvm+fH9vdtOdYIIIAAAggggAACCCCAAAIIIIBAJwkwsKKTzhZ9RQCBtgq046Zw3jbjbsT7cey+XVtYux8Xx5ZjjQACCCCAAAIIINA8AXstZq/NbEt23679dLtv1zaO3U9b+3HTypeR3442y+g3MRBAAAEEEEAAAQQQQAABBBBAoLcEBlX5cJ96Yam59m/zzENzlpg3liV/a2fwoD7znjWGmz3+ZYxZc+zQKh8WfWuBwPPPP9+CVmii6gJl36RNiufn+fshq7Qycflx6Uk3zt06dtuu/b7FxYlL9+uzjwACCCCAAAIIIJBdQP+79PWFv/MQlz5gwICoAbvWjrvtt54Wxy+fFCutLRvLj+Hv23JZ47nl07aT2kqrSz4CCCCAAAIIIIAAAggggAACCNQLjB8/vj6hR/cqO7BCgypO/+1TqQMq7HnTwIt7Z70SDcI4dp81GVxhYVgjgEBHCsQNeog7mKTybp677cdKyvPLso8AAggggAACCCDQfAF7fRY3UED5Ns/d9nuWlOeX1X7e8qEYpCGAAAIIIIAAAggggAACCCCAAALdJFDZgRWaqSJtlorQiVAd1T1i94mhbNJ6TGDUqFE9dsQcrhXQzeCyl7iYofRQmt+fpDJxs0OE6igtlK723PS4bZWz7blllG4X5cfl2TKsEUAAAQQQQAABBPILjBgxIhockTarhJ9vB1Soxbhttzcq45azeaE05fnt2fJax9VJKxNXLy7djZd3uxkx8/aB8ggggAACCCCAAAIIIIAAAgh0ssDChQs7uful9z0832jpzeQPqMd/FF0aqVu0TeohgAACViDLAISkMkl5tg27zlo2qZzNs2sb264ZVGElWCOAAAIIIIAAAs0R0HWYHejqt2Cv0ezaz9d+Up5bPmu5tJhZ4mQp4/aNbQQQQAABBBBAAAEEEEAAAQQQQKDKApUdWFFktgoL3UhdG4M1Agh0rkAzbuLGxYxLb0QvLmbRdL+eu69td9/vd1q+X559BBBAAAEEEEAAgWICadddfr5/DWf37drvRVnpftw8+3n7kCe2XzauLb8c+wgggAACCCCAAAIIIIAAAggggEAWgcoOrMjSecoggAACvSyQ5WZxUhk3z922pkqL++akLcMaAQQQQAABBBBAoDyBuJnC3Gs1d9tvOSnPls1SxpZljQACCCCAAAIIIIAAAggggAACCCDwtgADK3gnIIBAVwm08kZx0baS6mUdyJAUQydU+aEyNs1f+28C5Wfti1+XfQQQQAABBBBAAIHiAnGDKxTRv4az+25rSgul+2Xc/bjtpOvBtDbiYhatFxcvKb2VbSX1gzwEEEAAAQQQQAABBBBAAAEEEOh8AQZWdP455AgQQKDJAnluyOYpm6fbcXHzpqtNW8df2/7YdLtv13HpNp81AggggAACCCCAQH6BuGssP93u++tQi7aMn5c33a+fdz+uvVCcPGVD9UlDAAEEEEAAAQQQQAABBBBAAAEEmikwqJnBiY0AAgh0q0AzbvxmjZlWLi5f6XF59jzZfP/biUr302ydousXPjClaFXqIYAAAggggAAClRYYe/Ojmfuna6y+vj4zYMCAWh2bpmswN71W4J8b9totVCZL3VC9UBtZyvn1kvbT+pZUlzwEEEAAAQQQQAABBBBAAAEEEECgHQLMWNEOddpEAAEEPAHdXLY3xr2sul23jLvtFopLd8vYbbes3bZrW0brUJqbzzYCCCCAAAIIIIBAcYHQtZZNs2tFd7fTWosr66a723HxVCZLubj6pCOAAAIIIIAAAggggAACCCCAAALdIMDAim44ixwDAghEAp1ww7dIH/PUiSur9Lg84cXlKV3fmIzL562HAAIIIIAAAggg0LhA2jVX0rWY8uLy49JDPc5T1tYvUsfWbdW6E/rYKgvaQQABBBBAAAEEEEAAAQQQQACB4gIMrChuR00EEOgBgVbciM3aRlo55ceVCaXbNLvW6dS23bfrHjjNHCICCCCAAAIIIFAZAXsN5l6XqXNuut9ZmxdKj8uzZdPy85az5Yuss/alSGzqIIAAAggggAACCCCAAAIIIIAAAo0IMLCiET3qIoAAAo5AK28E52lLM074i61v13H5Srdl7Novyz4CCCCAAAIIIIBAcQF7jWXXiuRuu5Ftul27eaFrPjff3Q7Vd/PL3G5lW2X2m1gIIIAAAggggAACCCCAAAIIIICAK8DACleDbQQQQKDFAvZGs137zdt0u/bz7X5avi1n1yrv17H7dq2y7g16N93GYY0AAggggAACCCDQmIB7jRW69nLz1ZL2/bS0HqSVt/l27cez6Xbt57OPAAIIIIAAAggggAACCCCAAAIIdLsAAyu6/QxzfAgg0PUC9ga3XbsHHEpTflnpbltsI4AAAggggAACCBQTKOvaLBTHptl1sR5SCwEEEEAAAQQQQAABBBBAAAEEEOhtAQZW9Pb55+gRQKCFAv7NbH8/rit+OX8/qV6orPtNSFvXlrNrpdttre22Lc8aAQQQQAABBBBAoDwB93rLve6y23btthh3TRcq69az2345f9+W89d+OX/fL88+AggggAACCCCAAAIIIIAAAggg0A0Cg7rhIDgGY55f+Jp5dv6r/Sjes+ZIM3RQ+eNn5sxbYua9tLSuvb4Bxmy81igzYMBbGywIdLFAlW4el9kXP5b2/bQuPq0cGgIIIIAAAggg0HYBe+3l/k+lNHe/kU6WGauRfqhulfrS6LFQHwEEEEAAAQQQQAABBBBAAAEEul+AgRVdco7/7/EXzfT7nu93NMfss75ZffTwfumNJtxw97PmwdmL+oX59n9saoYMYmBFPxgSOlLA3tjO0vk8ZRXPLe9uu20pPS7PLefHC+3b8nExQ+2E0mwc1ggggAACCCCAAALNEQhdgynNH1yhtFC6euWn+/txPVc5LX5bSnNjuNvKS1vylM9TNq1d8hFAAAEEEEAAAQQQQAABBBBAAIGyBBhYUZZkheKsvMLgtwY3vD1LxdBBA5vSs/Gjhpm5b82SoWXBK6+bN/95A64pjREUAQSCArrpnLT4+dr301Q/NI10KC1UN6l98hBAAAEEEEAAAQTSBXSN5Q9k0LVYX1/9zIOhNHt95tYPxXN7kZbvlmUbAQQQQAABBBBAAAEEEEAAAQQQQOBtAQZWdOE74TN7TjGrrjy0qUe25xYTjV5afv7HWeauJ+Y3tT2CI9DpAvamd57jCNUJpfkxs5Sxddyy7rbN19qm27WbxzYCCCCAAAIIIIBAYwK6xtLACLv2o7np7rZfzt/PUjZUJpTmx/b3i9TxY7CPAAIIIIAAAggggAACCCCAAAIIVFmg/iswVe4pfUMAAQQqIKCbxlVY8vYjVF5poXR9G9JP9/erYEAfEEAAAQQQQACBbhHwr7W0HzeDmF9WBqG0JJu85ZNiNZJXlX40cgzURQABBBBAAAEEEEAAAQQQQACB3hBgYEVvnGeOEgEEKiRQ9g1kN57dtmv3sENpbr62Q2VCaX499hFAAAEEEEAAAQQaEwhdc4XS/FZCZWyaXauOu+3HKLJfdrwifaAOAggggAACCCCAAAIIIIAAAggg0CoBBla0Spp2EECg4wWacfM4LmboG4oWMK6OzffXofJxaX66v+/HZh8BBBBAAAEEEECgPAH/2kv7fppay5qW1LNQDFs+7lo0qY6tm3fdjJh5+0B5BBBAAAEEEEAAAQQQQAABBBBAIE1gUFoB8hFolsCs518x9z+1sBZ+lRWHmO02GFfbZwOBThFIuxmcll/WcYba8dO0b9PsWu2727Y/oTSb1+712JsfbXcXaB8BBBBAAAEEulzghQ9MacsR6hpswIABdW27aXbbXqu5ZW2eWzmU5uaXtZ3WTlp+Wf0gDgIIIIAAAggggAACCCCAAAIIINAMAQZWNEOVmJkEZjz3svnj/XNrZRlYUaNgo4ICuhFcxtJInGbWjYsdl16GBTEQQAABBBBAAAEE6gV07eUOlLC5celZ82250DotdqiOTWukro2hdVlx3JhsI4AAAggggAACCCCAAAIIIIAAAmUK8CiQMjWJhQACbRPQzdgyl7Lj5elbUtt+nt23a7Vjt+3abTspzc1zt21MP82NyzYCCCCAAAIIIIBAMQFdY/nXWe6+3bZrt5WkNDfPbtu1jeHv23Stk/Lccs3YLrvtsuM145iJiQACCCCAAAIIIIAAAggggAAC1RZgYEW1zw+9QwABBFouELrxHEprecdoEAEEEEAAAQQQ6FKB0LVWKK1LD5/DQgABBBBAAAEEEEAAAQQQQAABBCovwMCKyp8iOogAAu0WaPVN7bzt5S0vT1vHrtttTPsIIIAAAggggAAC6QL22s2u02u8UyJvnbzl32mp2Far2yvWS2ohgAACCCCAAAIIIIAAAggggECvCgzq1QPnuNsvsNGaq5iVhg2udWSlFXg71jDY6EoB/2axv6+DDqVZjKQ8W8au3bJ2e/ny5TY7dm3LqoDdtuvYSmQggAACCCCAAAIINCyga64BAwZE12Baa7FpScF1jdfX11dXNks9GzOpbCjPT/P3bVzWCCCAAAIIIIAAAggggAACCCCAQDcJ8El2N53NDjuW8asMM3qxINCogG7mdvuS9RizlpOXW9bddi3j0t0ybCOAAAIIIIAAAgiUI6BrLzuowo3oprvbbpnQdtayWcuF2uiUtF44xk45F/QTAQQQQAABBBBAAAEEEEAAgU4U4FEgnXjW6DMCCFRGQDdok5a0/KS6aXmKHYqflhbKV1s23a799uPS/XLsI4AAAggggAACCGQXiLvGsul27Ud0091tWy4uLZRu6zS6Toudlt9o+9RHAAEEEEAAAQQQQAABBBBAAAEEmiXAwIpmyRIXAQS6QqCsm7+Nxmm0vn8yyo7nx2cfAQQQQAABBBBAoHkCZV/LNRqv0fpWqqw4Nh5rBBBAAAEEEEAAAQQQQAABBBBAoCwBBlaUJUkcBBBAoEGBZtxIVswscf0y/r4OLZTW4CFTHQEEEEAAAQQQ6HmB0DWWn+bvh9BUJku5UN2ktGbETGqPPAQQQAABBBBAAAEEEEAAAQQQQKCKAoOq2Cn61BsCf3pgrvn9nU/XDnbC6BXMZ6etX9tnA4EsAs240duMmFmOJW8Zv5/a99OyxMxSJ0uZLG1RBgEEEEAAAQQQQKC/gK61BgwY0D/DSclSxikebdprODd2kTh+3FbsN6OfzYjZCgvaQAABBBBAAAEEEEAAAQQQQACB9gswY0X7z0HP9uD1ZW+aN9+6gWhfi19b1rMWHHh3C9gb2lmOMlQ2lJYlVqiMYvnx0vYVxy8Tik0aAggggAACCCCAQDGB0LWWnxba99OKtf52rVCsUFpcG3nKxsUgHQEEEEAAAQQQQAABBBBAAAEEEKiqADNWVPXM0C8EEOgpgbw3orOWz1ouCbuMGEnxq5T33HPPmSeeeMLMnTvXLFy40IwePdqMGzfOTJkyJdpuR19/+9vfmmOPPbbW9FVXXWU23HDD2j4bCLRTgPdnO/VpGwEEuk1A11zuzBJFji9rjKzlbB/ylrf1WCOAAAIIIIAAAggggAACCCCAAALdIsDAim45kxwHAgj0lIBubvtLKC2tjF/H3/frd+P+66+/bi644AJzySWXmNtuuy32EHfbbTdz2GGHmf3337/hDz1iGwlkvPzyy9FgD5u1dOlSu9nzaw0y+da3vlVz+OEPf2i22Wab2n7Sxpe//GVzww031IoMGzbM/P73vzcjRoyopbGRLsD7M92IEggggEAjAro2cwdbpO2H2vLrqEwoLVSXNAQQQAABBBBAAAEEEEAAAQQQQACBtwUYWME7oW0C7g1CdWJgX/IzhdvWURpGoM0CuvFdZClaz23LjeFuu2U6eVsDKQ455BDz6KOPph7GddddZ/TaaaedzEUXXWTWWmut1DoUeEdA75+HH3649liZiRMnmpEjR75ToMDWiy++aO68885azZdeeqm2nbTx3e9+15x88sl1Rc477zwGVdSJsIMAAggg0CoB/Y20/xu520XbLxqjaL2i/aQeAggggAACCCCAAAIIIIAAAggg0EkCDKzopLOVsa//74oHaiX/6183MONXGVbbL2vjf6bPNHfPXNBQuA9usprRiwWBbhbQDerQEpful81azq+nfb+uv++XCeWH4nZL2u23327e97735T6c6dOnm/e///3mz3/+s5k0aVLu+r1a4ZprrjF777137fAvv/xyc8ABB9T2W7Xx05/+1HzhC1+oa06DLA4//PC6NHYQQAABBBCoioCu0ZIGXrj56rO/n+c4staNKxeXnqcPlEUAAQQQQAABBBBAAAEEEEAAAQSqKNBXxU7Rp/IE3vzH8vKCOZFeX9acuE4TbCLQ8QK6sZxlyVouS6w8ZdLatfn+Ok8bVS37yiuvmKlTp/brnj7ov/DCC81f//pX89RTT5lbbrnFnHXWWWa77barKztnzpxoUMDy5fwurINJ2KnCI0yuvfbaaIYSt5vHHnus+eIXv+gmsY0AAggggEBLBfxrLbsf14m0/Lh6jaZnbTdruUb7Q30EEEAAAQQQQAABBBBAAAEEEECglQLMWNFK7Sa29YGNx5st1lm1XwtjRw7tl1ZGwv7bTTJLli6rCzXgrSd5DBnEWJ06FHaaKtDum7btaj/UbiitqfgdHlyPfXj55ZdrRzFixIhoQIU/g8K73vWuaHYKzWZw2mmn1c10oEdQXHnllWb//fevxWGjugJ33HGH2XPPPes6+PGPf9yccsopdWnsIIAAAggg0I0Cula0s17Y4wul2bxmrtvVrj2mdrdv+8EaAQQQQAABBBBAAAEEEEAAAQQ6S4CBFZ11vmJ7O3zoIKNXq5YRKwwyerEggEA1BXTD2F38fTdP235+2r5fv9P2NSDCXTQrhT+ows0fNGiQOeGEE8yiRYvMd77znVrWVVddxcCKmkZ1Nx577DGzyy671HVwn332Meeff77p62NAYB0MOwgggAACbRHQtZc78CFt3+9k3vJ+ffYRQAABBBBAAAEEEEAAAQQQQAABBJIF+GQ82YdcBBBAoG0C/uCGRjvixnO33bhx6W6Zbti+99576w5jr732qtuP2znyyCPrBlb85S9/iStalz5//nzz+OOPmyeffNIsXrzYrLHGGkazYay77rpN+2B/9uzZZtasWVGb+qBmzTXXNJMnT47arutcxh0NKtExKK6OZ5VVVjHjx483m266qRk+fHgwymuvvWZeffXVKO+ll16qK6MZQxYsWFBL06whGsBS9vLss8+aD37wg3UzlLz//e83l156aa72lixZUjuHL7zwghk3blxkqnO4wgorJHb7jTfeMHr8jBadi1GjRtXKP/LII0YDP55//nkzbNgws/POO5vVVlstype5fdyMjIcOfWcWKr2H9X5SXyZMmBC9l9Zaa61cx2Q7UfZ7xcZljQACCCDQuICuzdwBFzaim+5u2/xG1mXHa6Qv1EUAAQQQQAABBBBAAAEEEEAAAQSqIlD+JxhVOTL6gQACCHSYgG5iF10aqVu0zU6t9+abb9Z9yK4P9N0PupOOa+LEiWb69OnGDhIYPHhwUnFz3333mdNPP93893//d7DclClTzOc//3nzsY99zAwZMiRYJm/itddea0499VRz0003BatOnTrV/Nd//ZfZddddg/l+4v33329++MMfRrM7+Hl23z5SY8yYMTYpWv/0pz81RxxxRF2a3TnssMOMXnb5whe+UDdoxaY3stZ52nvvvc2cOXNqYTbZZBOjmUbiBoPUCv5zQwMezj777Og8uo+PseX0/jnuuOPMZz7zGTN27FibXLe+/vrro37YRD1GRu+lgw8+uN95uvrqq40d6KMBIXfddVdU7UMf+lDU7z/96U/m05/+tHnwwQdtuLr1j3/84yh/4MCBdemhnbLfK6E2SEMAAQQQqIZAI4MlGqlbjaOnFwgggAACCCCAAAIIIIAAAggggEDjAsx/3bghERBAAIHCAmUMiGg0hl/f3de2u1/4QCtUUR84a8YCu+jDcn8GC5sXWu+4445GH3Lrtfvuu4eKRGk/+9nPjD7EjxtUoUKPPvqoOfzww6MP3TU7QSPLsmXLzNFHH2323HPPfh/Wu3FvuOEGs9tuuxkNZLCzIbj57rb6vvHGGycOqlB5ldtss82igSRu/TzbCxcuzFM8tezSpUujx7TYgQmq8O53v9tokEPWgTR///vfo3N40kkn1Q3GcRvX++frX/+62XzzzWMHO7jlta1ZJj7ykY8knie/jmYJ0ft0hx12SGznqKOOMh/4wAeMZguJW5rxXolri3QEEEAAgewC/nWXfw3m72eP/HbJRusrShkx8vab8ggggAACCCCAAAIIIIAAAggggEAVBBhYUYWzQB8QQACBjAJZbmb7ZeL2/fSMXeiKYvrg2V3222+/6DEPbloj2+eff775j//4j8whNNhBsxPokRFFl0MOOcRotoKsy3e/+91o5oq48or1iU98IpitR5n4i2aF0EASDVywS19f9suMPGVt/Li1BowceuihRq520aM7/vd//zd6fIlNS1prQIYGS8ydOzepWC1Px7/NNtuYJ554opYWt6EZQzTzRGiJmwVFgyo024i7aLaM0KLYP/jBD0JZUVrZ75XYhshAAAEEEGiKgL2Gs2vbSNq+Leeu/TpuHtsIIIAAAggggAACCCCAAAIIIIAAAu8IZP/E4506bCGAAAIItFGAG+CN47szViiaPgzXh+jf/OY3zUMPPdRQAzNnzjSf+tSn6mLsscce5le/+pWZN29eNHji9ttvj9pyC+mDfD02pMii2JdeemldVc1coIEES5YsiWZbuO6664we2eEuZ5xxhrn11lvdpGj74Ycfjma/cDM0aECPQdGghdmzZxvNenDzzTdHgwnccpo1w75HP/nJT0bb2r/iiivcYubyyy+v5Sn/zDPPrMtvZEePV3E9NADhxhtvNJMnT84UVgNc/EElemyLBsw8/vjjUb9ldN555xkN2LCLZq/QI0Hs8dt0f20f46GBKHrMym233WY0I8Vjjz3Wb/CEravYdpCH2lX7muVEj7bRoIvtttvOFo3WmpHkueeeq0vTTtnvlX4NkIAAAggg0DECaX+vOuZA6CgCCCCAAAIIIIAAAggggAACCCDQAoFBLWiDJhBAAIGOFGjnzeZG285aP61cWn5Hnti3Or3zzjubffbZx/z2t7+tHYI+uD7xxBOjlz7w1mCIrbfe2my11VZm4sSJtXJpG/pQ31122mkn8+tf/9oMHTq0lqyYek2YMMFo8IFd9GG4BmWsssoqNil1rUc+HHnkkXXlvvjFL5qTTz65Lm3XXXeNPrTXB/GXXHJJLe9zn/ucueOOO2r72jj22GPr9vUIjWuuuaauX3qkio5Ngy1kqYEbWvR4Ew240Awc7VhOO+20fgNUNIvGRhttlLk7GrjgPh5GgycUY9KkSbUY6623ntFL53HTTTetpctBM2XIO2nR7BNXXnmlWWmllWrFspz3m266KXrUh600YMCA6HEtOg/vfe976x4TovM6bdo0WzR6PEjZ75VacDYQQAABBEoRSLv2Ur5+96ctWcvFxWm0flzcLOntbDtL/yiDAAIIIIAAAggggAACCCCAAAK9KcCMFb153jlqBBBoo4BuFmdd8pTNGpNyJvpA4uKLL44GBIQ89KG6HpWhR4TosRdrr722Of7444OzO7j1FyxYUDczg2Y50EwN7qAKt/xhhx0WxXXTNIAhz6JBDHYmA9X78Ic/bL71rW8FQ+iDGM264M5ucOedd5onn3yyVl6zHFx77bW1fW385je/qRtU4Wbq2C688EI3yZxzzjl1+63aueCCC4KPN9HsDnkWvTfc5fe//33doAo3T4MZrr76ajcpmhWiLsHb0XvqqquuqhtU4RUJ7urxLP5jbGzBQYMG9Tvvml3DXcp+r7ix2UYAAQQQ6A6BPNeeecp2hw5HgQACCCCAAAIIIIAAAggggAACvSzAwIpePvscOwII9BMo8wZxmbH6dfSfCWlt+Pn+vhvXz0vbd+t24vbIkSOjGQN+8pOfGM3IkLToUSGnnHJKNCBBMxT85S9/CRbXB/DuotknRo8e7Sb12z7uuOPq0txZNOoyYnb8R2woXl9f/J93DYTwZ9VwB3P87ne/q2vpq1/9ajQjQl2it6MZPRRDM2HopVkw2rH88pe/DDarx3q4M1AEC/0zcdasWUaDTeyy1157mS222MLuBtcqs8EGG9TyLrvssuiRKbUEb2PPPfc0w4YN81LTd+MGVdiaem+6ix4t4i5lv1fc2GwjgAACCBQXSLvm8vPdlvw8f98tq+20fL98kf0y2ygzVpFjoQ4CCCCAAAIIIIAAAggggAACCCBgBeI/ebElWCOAAAIIdLwAN6XDp1ADEPSh+yOPPBI9ykIDAtIGWehD9+233958//vf7xf0rrvuqktzHxFRl+Hs6DETW265ZS3lgQceqG1n2fjrX/9aVyzLIy/8D+jdD+Dvv//+unibbbZZ3X7cjh6dcvDBB0evbbfdNq5Y29L33Xdfs2jRotT277nnnroyaYMqbGH3kRt6rMz8+fNtVr+179+vQEyCHj2StIwfP74u+6WXXqrbL/u9UhecHQQQQACBtgpwrddWfhpHAAEEEEAAAQQQQAABBBBAAIEeEBjUA8fIISKAAAI9I8BN9WKnWo9R2HXXXaPXGWecYfQ4jL/97W/RzBT6lv+jjz7aL/AxxxwTPSLkQx/6UC3v2WefrW1rY5dddokeJVKXGNiZM2dOLXX27Nm17Swbfvm0D99DMd1+u9sq687EEKpbxbRLL700Gqyy7rrr1rqnWUf06BXNapH0bPrnn3++VkcbJ510Ur9HndQV+OeOew6VpMezjBkzJlTUaDBN3mWbbbYxAwcOTKym9/GIESOMBnaElrLfK6E2SEMAAQQQqJaArg2T/u5Vq7f0BgEEEEAAAQQQQAABBBBAAAEEEKiuAAMrqntu6BkCCLRRoIoDFMruU1o8N9/dbuNpaVnTq622mtHjHfQ6+eSTzcMPP2xOPPHE6EN5txOnn366cQdWPP300252tO1/4N6vgJegD8XffPPN1A/RVe3111/v9yF63vYUR4MA7PLMM8/YzWi99tpr1+1XfUcDYz760Y9G3dQgigMOOKDWZQ2S0UwjGhQTt2hQjb8UMU2ascKPn2U/bVBFWoxmvFfS2iQfAQQQQCC7gK617AAIdzsUIS0/VCcprex4SW1lzatin7L2nXIIIIAAAggggAACCCCAAAIIINCdAjwKpDvPK0eFAAIdIKAbxlVdqty3dpitv/765vLLLzc//vGP65qfPn26Wbp0aV1aGTtZ/bOWy9OnwYMH1xVftmxZ3X6Vd/QYFz3OxS7777+/Oeqoo+xutD722GOjmUjqEpuw04xz00g3q9afRo6FuggggEAvCFT593aV+9YL7w2OEQEEEEAAAQQQQAABBBBAAAEE2iNQ2RkrBg/qM28sW15IRXVZEEAAAQTiBfwb4v5+fM3ezjnyyCPNlVdeaW666aYaxN1332223nrraH/ChAm1dG1opouxY8fWpWXZ0SMdsixDhw6te/SDHgMxa9asLFXryrjtrb766nV5egzKJptsUpdW1R1/4Iv6ecopp5hbb73V3HXXXbVu77fffubee+8148ePr6XZDT/tggsuMPvuu6/NzrzWuajS0oz3SpWOj74ggAAC3S6gazU7o4WO1d/v9uPn+BBAAAEEEEAAAQQQQAABBBBAAIF2C2T75KYNvXzPGsPNvbNeKdSy6rIggAACvSIQNyjCT/f3s/oUrZc1fqvL3XbbbcZ9tMM+++xj/Fkakvq088471w2sePzxx2sDKyZOnFhXVY8GWW+99erSyt5517veZR588MEorB4jMmzYMDN8ePG/g/7gkPvuu69jBlaEHpchj1/84hdm3XXXrdHr0ScHHXSQue6664w7qEQF/IEVeq+MHj26VreTN8p+r3SyBX1HAAEEqiigay538ETWPvr1/H0bJy7d5rNGAAEEEEAAAQQQQAABBBBAAAEEEIgXqOzAij3+ZYx5aM6S3LNWaLYK1WVBQAILFy4EoosFdHO47MXGtOuk+Gllli9PnnXHr+/u2227Vj/stl3bvrn7dltru23r+v1x85Vn921du7b1bb5tt1PXl156qfnRj35U6/6vfvUr82//9m+1/bSN119/va6IOxDBn9lBs1l88IMfrCtf9s6WW25ZG1ih2A888IBRWtFliy22qKuqgSj//u//XpcW2vn9739v5s+fH72P1llnHbPtttuGitXS/PdjLaMJG+rPL3/5S3PAAQfUomvWkW984xvRq5b41sZGG23k7po777yzbr+Td8p+r3SyBX1HAAEEqiSggZEaUGEHVdhtu1Zftd3X987MjLasPQ7luWl+XVvOLWPjumt32y3rbrtltB1a3L6G8v14SWWylA3VT0prRsyk9shDAAEEEEAAAQQQQAABBBBAAIHOF3jnzkzFjmXNsUPNsfusaTZZayWT5dEeKqOyqqO6LAgggAACCIQE3ve+99Uln3rqqXX7STuvvvqqufDCC+uKTJo0qba/11571ba1ccYZZ5hnnnmmLs3feeONN6IP97/0pS8ZvX7729/6RRL39VgLd/na175mFDNpefLJJ6O2bJt6LIZd9txzT7sZrfV4DffRJ3WZ/9y59tprzd57720+9rGPmUMOOcT84Ac/CBWrS5s3b17dfrN39t9/f3PUUUfVNfPNb37TqO/uokEY7gAZDRhJO37V/8lPflIz1Xmv4lL2e6WKx0ifEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBBBohkBlZ6zQwWqAxBG710+r3gwEYnafgD+Ve/cdIUckgWbMoGBj2nWSdFqZuG/k23p2bdtw9+22Xdvj9fdturu2235Ztz/utspr35a3edr3Xyrb6csHPvCBukPQjAyf+cxnzMknn2xGjRpVl+fuaDCCZm5wHyOiD+Df/e5314qNHTvWaHCFPozXorJ77LGHueWWW8zIkSNr5eyGrI8//njz/e9/3yZFgyz0eJKsyy677GJGjBhh9G1XLRoo8OlPf9pccMEFdd9ctfEWL15sDjzwQKPjtstuu+1mN83KK69sDj74YPOzn/2slvav//qv0awYa6yxRi3Nbjz//PPmIx/5iN2N1sccc0zdvnbGjKmfTUomRx55ZL9yzUw45ZRTzK233mruuuuuWjPquwaWrLXWWrU0DQ457rjjavt6/Ms999xTN+CilvnWxhVXXGEOO+ywWtJOO+1kQga1Am3aKPu90qbDoFkEEECg6wRWXXXV6G+2ZlFwXzpQO/OD0u22BXD3te3OwmDj2LI2z18rP62sLWNjufs2npunbbdvfp724+q5ZW0Zu3bzGt1uRsxG+0R9BBBAAAEEEEAAAQQQQAABBBCotkBlZ6yoNhu9QwABBJonYAc4FG2h0fpF2+2Uequttpo56aST6rp79tlnm/XWW8+cf/755v/+7/9qjxHSYIU77rjDnHnmmWbjjTc2f/nLX+rqfeUrX+n3wYA7SEKF9aH9DjvsYE4//XTzt7/9zSxbtsw8++yz5vrrrzfbbLNN3aAKldegiDzL8OHDzbnnnltXRbMnaHDGRRddZB5//PGozSeeeML89Kc/jQaCuIMq9HiIHXfcsa7+d7/73Wiwhk2Ug8r84he/qA3geOWVV6LZNXbddddamsrrmPTyl8mTJ9clXX755dFglkceecTMnTvXvPbaa3X5zdgZNmxYdAwaiGIXHduHP/zhuvY14GODDTawRaL11KlTjWYDufHGG40Gp+hRU3pvaJYOzYbhLhosU8WlGe+VKh4nfUIAAQQQeFug0WvCRutzHhBAAAEEEEAAAQQQQAABBBBAAIFuEqj0jBXdBM2xIIBAbwmUfSO67Hj+2Wh2fL+9du9//vOfj2YuuO6662pd0Yf7n/rUp2r77iwQtURn4z//8z/7faCubD1K4pxzzqkbIKHBFe4MCE6Yus0rr7zSaNaLvMtHP/pRc9VVV5nLLrusVvV3v/ud0StpGTdunLnkkkv6FVl99dWjR55owIFdNDBDM10kLTI77bTTgkUUc8qUKebRRx+t5X/5y182emk59thjY+vWKpSwofOjgScHHHBALdqdd94ZnR8NoNEydOhQc/HFFxsNOrGL3h/f+MY37G7sWudZs5RUdSn7vVLV46RfCCCAQLcJNPtaTfHLnMWh7Hjddj45HgQQQAABBBBAAAEEEEAAAQQQ6DwBZqzovHNGjxFAoMkCWW5cZynT5G6WFr6bjiUrygorrGB+/etfR4+8iKtjH60RytdjHn70ox/FfgBxxBFH1A1yCMVw0zQg4Ze//KXZd9993eRc2xogkWXwhg2qR5hMnz49mqnDprlrDTxwB564eaFtzfCgR2xsu+22oWwzcOBAc9555wXzlLhkyZLYvLIzNMPE0UcfXRf2rLPOMv/zP/9TS9tiiy2ix3+EHn9SK+RtfOELXzB63EjVl7LfK1U/XvqHAAIIdItAN12zZTmWLGW65dxyHAgggAACCCCAAAIIIIAAAgggUH0BBlZU/xzRQwQQ6AGBsm8c+/H8/aykRetljd/OchpcoQ+Yb7nlFqPHPGRZ9HgNDR7QYz00UCBp+chHPmIee+wxo9kx3EdPuHWUrseSPPnkk8HZL1R28ODBbhWz4oor1u3bnUGDBplTTz3V/OlPf0qcWUKzRmg2hocffti85z3vsdWDaz3mY86cOebEE0+MPYbtttvOnHDCCUaPF9FsEEmLHieicnvttVdSscx5WW1CAb/3ve+ZzTffvC7r4IMPNosWLaqlbbLJJtGjXM4444zoESq1DG/j0EMPjc71d77zneBgG7+fXvXY3SFDhsTmNZJR5nvFP7a492cj/aUuAggg0EsCRa+9/Hr+fqOGZcdrtD/URwABBBBAAAEEEEAAAQQQQAABBFotMOCtD4f+kdToZpttlpRNHgIIINA2gWbc4FXMLHHTyiTFsXXtWoBp2zbfX7t13Ty7bU/O8uXL69rQvl1U1t13y9p0ldHrE5/4hK3W8PqFD0wpHGPsze88TqJwEK/iggULokEWGkigxz7o2PWhsR6XMWnSJPP+97/frLTSSl6tbLuvv/66efrpp6PX0qVLzahRo6IP6ldZZZVsAQqUWrx4sZk9e3Y0MELHMWbMGDN58mQzfPjwAtGMWbZsWdR/+egYJkyYYNZdd12jD+mLLIonZ7vIuWgsG6OZa70fnnvuucjzlVdeiR4XIk85lDl1ejOPIS522e+VuHZIRwABBDpNoFXXKhdddFH0t8T+Penre/v7D9q327LTti1j962pX1bpSrPl/bXNT1q7eXHbNq7y3cVt2013t+Pq+mWylHPrZNluRsws7VIGAQQQQAABBBBAAAEEEEAAAQSyC+hzGy1xX17NHilbSTuz9owZM4IVin0aEgxFIgIIIICAFfAHNth01tUV0CAHzUjRjEUzD+hDeL1atWjmgPXXXz96ldGmBj1ogIleZSyKt/rqq5cRqiUx9GGW+ttJfc4KU/Z7JWu7lEMAAQQQ6F4BXQszeKF7zy9HhgACCCCAAAIIIIAAAggggEAvCvAokF486xwzAggggAACCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAggggAACCGQSYGBFJiYKIYAAAuUKlD2jRZ54SWWL5pWrQzQEEEAAAQQQQKB3BIpefyXV8/XylPXrhvbLjhdqgzQEEEAAAQQQQAABBBBAAAEEEECgSgIMrKjS2aAvCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAggggAACCCCAAAIIIFApAQZWVOp00BkEEECgfAG+UVi+KRERQAABBBBAAIGqCXDNV7UzQn8QQAABBBBAAAEEEEAAAQQQQKCbBBhY0U1nk2NBAAEEcgpwAz4nGMURQAABBBBAAIE2CnDt1kZ8mkYAAQQQQAABBBBAAAEEEEAAgZ4WYGBFT59+Dh4BBBCIF3Bv3Lvb8TXIQQABBBBAAAEEECgi4F5rudtFYlEHAQQQQAABBBBAAAEEEEAAAQQQQKB8AQZWlG9KRAQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBBDoEgEGVnTJieQwEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQKB8AQZWlG9KRAQQQKAUAaaBLoWRIAgggAACCCCAAAI5BLgGzYFFUQQQQAABBBBAAAEEEEAAAQQQ6BkBBlb0zKnmQBFAoBMEmnEjuxkxO8GSPiKAAAIIIIAAAr0k0IxrvmbE7KVzwrEigAACCCCAAAIIIIAAAggggED3CDCwonvOJUeCAAJdKlD2De0i8YrU6dLTwWEhgAACCCCAAAKlCxS51ipSJ6njZcdLaos8BBBAAAEEEEAAAQQQQAABBBBAoNMEGFjRaWeM/iKAAAIIIIAAAggggAACCCCAAAIIIIAAAggggAACCCCAAAIIIIBAywQYWNEyahpCAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAgU4TYGBFp50x+osAAggggAACCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAggggAACLRNgYEXLqGkIAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBDpNgIEVnXbG6C8CCCDgCPzjH/9w9t7eDKX1KxRIKFovEIokBBBAAAEEEEAAgZIEil6jheqF0krqJmEQQAABBBBAAAEEEEAAAQQQQACBrhZgYEVXn14ODgEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQaEWBgRSN61EUAAQS6QIBvLnbBSeQQEEAAAQQQQKDrBbhm6/pTzAEigAACCCCAAAIIIIAAAggggECFBRhYUeGTQ9cQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAoL0CDKxorz+tI4AAAggggAACCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAggggECFBRhYUeGTQ9cQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAoL0CDKxorz+tI4AAAggggAACCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAggggECFBRhYUeGTQ9cQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAoL0CDKxorz+tI4AAAggggAACCCCAAAIIIIAAAggggAACCCCAAAIIIIAAAggggECFBRhYUeGTQ9cQQACBdgn84x//qDXtbtcS2UAAAQQQQAABBBAoVcC95nK3S22EYAgggAACCCCAAAIIIIAAAggggAAChQQYWFGIjUoIIIBAZwpwk74zzxu9RgABBBBAAAEEQgJc24VUSEMAAQQQQAABBBBAAAEEEEAAAQTKF2BgRfmmREQAAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQACBLhFgYEWXnEgOAwEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQTKF2BgRfmmREQAAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQACBLhFgYEWXnEgOAwEEEMgrwDO584pRHgEEEEAAAQQQaL8A13DtPwf0AAEEEEAAAQQQQAABBBBAAAEEek+AgRW9d845YgQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQAABBBDIKMDAioxQFEMAAQQQQAABBBBAAAEEEEAAAQQQQAABBBBAAAEEEEAAAQQQQACB3hNgYEXvnXOOGAEEEEAAAQQQQAABBBBAAAEEEPj/7J0FuB7F1ccHL9KvUKBAgeIQvLgWd3cJIUET3CW4S3AL7u7uFiC4FUshxR0KQVqk+Mdv2rOdu3dmVl+795znuffdnZ0d+e/s7Myc/5yjCCgCioAioAgoAoqAIqAIKAKKgCKgCCgCikBOBJRYkRMojaYIKAKKgCKgCCgCioAioAgoAoqAIqAIKAKKgCKgCCgCioAioAgoAoqAIqAIKAKKgCKgCCgCvQ8BJVb0vmeuNVYEFAFFQBFQBBQBRUARUAQUAUVAEVAEFAFFQBFQBBQBRUARUAQUAUVAEVAEFAFFQBFQBBSBnAgosSInUBpNEVAEFAFFQBFQBBQBRUARUAQUAUVAEVAEFAFFQBFQBBQBRUARUAQUAUVAEVAEFAFFQBFQBHofAkqs6H3PXGusCCgCioAioAgoAoqAIqAIKAKKgCKgCCgCioAioAgoAoqAIqAIKAKKgCKgCCgCioAioAgoAjkRUGJFTqA0miKgCCgCioAioAgoAoqAIqAIKAKKgCKgCCgCioAioAgoAoqAIqAIKAKKgCKgCCgCioAioAj0PgSUWNH7nrnWWBFQBBQBRUARUAQUAUVAEVAEFAFFQBFQBBQBRUARUAQUAUVAEVAEFAFFQBFQBBQBRUARUARyIqDEipxAaTRFQBFQBBQBRUARUAQUAUVAEVAEFAFFQBFQBBQBRUARUAQUAUVAEVAEFAFFQBFQBBQBRUAR6H0IjNn7qqw1VgQUAUVAEVAE/Ah8uzsyfgAAQABJREFU//33Zuyxx/ZfrCn00ksvNeQzzzzz2L+akm1ZMvfdd595++23zWSTTWZWXXXVlpWjXTKu+nxffvll8+yzz5rXXnvNjD/++GannXZqeJtsF+x++eUX8+OPP5qxxhqrVJG4d7TRRjNjjDFG6ftHH310w59KZyBQtc1Qy59//tmce+655pVXXjHbbbedmXHGGTuj8p5S/u1vfzOPP/64fQ/69+9f+l3wJK1BioAioAgoAoqAIqAIKAKKgCKgCCgCioAioAgoAopAr0dAiRW9vgkoAIqAIqAI9F4E3njjDXPFFVeYZ555xjzyyCPmH//4h5l55pnNoosuav8222yz0kreEKqbbrqpvXTggQf2CGLFqaeeam666Saz2GKLKbHi1ydb5fkOGTLEDB48uEvT2XrrrTuCWDF8+HBz5ZVX2rIffPDBZtJJJzVDhw41KHonn3xyc8ABB3Spl5x89tln5rLLLjPcf+edd5p//etfti0tueSSFss+ffpIVO/vP//5T3PCCSfY9/jvf/+7jTPXXHOZrbbaygwcONCMM8443vskEGX6tddeax5++GFz1113md/+9rdmqaWWMosvvrgB+4kmmkii5vqlLK+//rqNC0HjxBNPNGOOWd9w+7vvvjN77LGHJQPMN998Zosttsgs13nnnWfJOr7ncOyxx5q33nrLgPOOO+6YmZZE4Lnuu+++9t3/y1/+Yuacc065ZH9nmmkm+xz//Oc/196HVm0zXQr668m9995rBg0aZIOpF+2wUwWiG2QsZMMNNzTjjTdeoap88MEH5ogjjrD30JctvPDC5u6777bPmcCjjz7aviOFEtXIioAioAgoAoqAIqAIKAKKgCKgCCgCioAioAgoAopAD0GgvpXeHgKIVkMRUAQUAUWgdyCAMm2dddaxily3xihn+bvwwgvNRRddZK655hozxRRTuFF61DG7m1GcIShsiyriehQYLawMin2XVLHMMsuYOeaYw/zmN79pYanyZz1ixAhz+umn2xt23XVXS6y47bbbzB133GHJSj5iBUrc5Zdf3pIv3JwgOfEHaYc0UNz75J133jELLLCAJUS511944QWrXOYdRtE84YQTupeTYzBfZZVVuvQBEDtuueUW+8f7z7sx5ZRTJvfEDqjr7rvv3iUKZJm6iRWnnXZaksdss81mld9JgOcAwgj9GKSx9HMg/KmnnrJkkiLECqzUQKhCIMXwF5Ibb7zRrLnmmqHLhcKrthlfZmqh5H+oQFqR95h3C2LF888/n4TRfiAfqSgCioAioAgoAoqAIqAIKAKKgCKgCCgCioAioAgoAr0RASVW9ManrnVWBBQBRaCXI4AycYMNNkhQwIUFCiQIFCNHjjTXXXedwZoFyl12XBMWUs4miXTowaOPPmoOOuggW3p2+CuxojUP8sknn0wyfvDBB80SSyyRnHfCgdtuxh13XFtkIYVMMMEE3arw8ccfm4UWWsi899579hq74yGTQEIYNmyYOf/88y3hARxwjYLrHFe+/fZbS8rAygzCOzxgwACDRQcsZUAY4j7ec4gFuAhxBSKAizGECPqATz75xFqwuP/++y3hgzDef7d+bjpy/MUXXxgs3DRbNtlkE6v49mHczLKsvfbaSXaffvqpee655xLCylprrWWuv/5648ZJIhc4qNpmQlnR7s4++2zz6quvJpYrQnF7eri8u9RTjt22L+90T8dB66cIKAKKgCKgCCgCioAioAgoAoqAIqAIKAKKgCKgCPgQUGKFDxUNUwQUAUVAEeixCPz0009mt912S+rn202NK4NddtnFnHPOOXY3PErBPCb3k0T1QBEoiMCLL75o72A3OG5VOk1ECUu5Rfkqyv7xxx+/W3VuvvnmhFSBBYbtt98+idOvXz+DmwsJ4/1LEysuuOACa1mGmyBlXHzxxcn9G220kbXAADHqnnvusa4dVl555eQ6B2eeeWZyTjzc/4jgAgSSxuWXX27LiGWLFVZYQS57f/fZZ5/Ecsb6669vLUR4I9YcCAEMUshZZ51Vc8r5k/MRgX7++Wdz6aWXWhxJCetAECP+8Ic/5E84FbNqm0kll5xisYJnrvI/MgVYyDstv26YYqUIKAKKgCKgCCgCioAioAgoAoqAIqAIKAKKgCKgCPRGBEbvjZXWOisCioAioAj0XgTYIS+75NnN7jNRzw7dk046KTF5zu75mGA+HfcDr7/+ut0xH4ub99rXX39tXn75ZbtrHvcEReTzzz83L730ksFVQidIlbpSv6+++sr89a9/NR9++GG0uj/++KPBZQXP/5dffonGdS824vm66XP8/fff26DpppvOjDHGGOnL3c7lGb/yyiuJZYBukSIBYAGZg136dYhP+Sph7o53yQvCA4J7CiFQyDV+t9tuu0QJj0I9LUcddVQSdPjhhyfHHGD14rjjjkvC3GMCIVfh7gPZYYcdupAqCOP+Qw45hEMr4ipHztO/Dz30UELUwFXCIossko7S0HOsLUh9GppRgcQhK/Tv399agpDbHnvsMTks9Vu1zZTK1HPTDz/8YK2Y8O598803nhiNCYJEw/vKu1tUPvroI2vZBIssMZF3ljjy3rph44wzTux2vaYIKAKKgCKgCCgCioAioAgoAoqAIqAIKAKKgCKgCPRoBJRY0aMfr1ZOEVAEFAFFII3AP//5zyRo1llnTY7TByiV2Il9++23myOPPDJ92Z5j7WLuuec2E088sf2dccYZ7W79QYMGJbvXvTdGAiForLHGGobd/rPNNpuZffbZzf/93/+ZVVZZxZIHIream266ye70//3vf2/mnHNOM80009h7SY90XUGZjXsEdruL4AqFMP4w519VvvzyS6tkljRvu+22LkmWqSuWDEhvq622Ms8884xZfPHFLQFm3nnnNYceemiSvhsPggkYjDXWWGaOOeYwU089tUHxe/TRRxuUpCFpxPNN58WzpT5YR0DARPCabLLJ0tGtSwXqJs+YNkwayy67rG2v3W74NWDvvfe2aVJvCBlYDwCLueaay6y00kpdbnn//fct+aRLYI4TsVJBVFG+iqUKUdC6ybz77ruWVLHhhhu6wV2OcRWCpNsudRBy1F577WX+9Kc/dbmPE1x4rLvuujb8qaee6nL9zTfftG5/IHWELFHMMMMMyT2vvfZacpw+wCXJ5ptvboNJb999901Hadj5lltumaSNSxAsQrSbUC4R+tMqUqXNxPL997//nbxzp59+epeobj8CwWrHHXc0Y489tunTp4/h3aON8/zTpC5IJfIeu9+cLon/ekI7I57rlsZ9X3Fts+222xr6AuLSxnh3SX/UqFHp5LqcQx675JJL7L307bi1wmII36w777yzS1w5kXeXc3mnXWKFxNNfRUARUAQUAUVAEVAEFAFFQBFQBBQBRUARUAQUAUWgNyKgxIre+NS1zoqAIqAI9GIEXDLFFVdcYWI7eHE/gAsBV+kl0KF0X3vttbspfbnODnIsYRTdzYwCF6KAb/f5HXfcYZZcckkTUvLiLmGttdYyzz77rBTR/mLtgvRQphFHJEYoIA67+qsIykSU9o8//rhN5sorrzSrrrpqkmTZuqIERVCOQzbBjYNPJN4HH3xgn6EPU9w3oLT0SSOery+fWBhKe1euueYaSxZIP2Pi3H///db9xaOPPureYo/lWUN0wW3GDTfc0C0OAbSxqaaaypJPXJKKN3Iq0CVPiMUNUcwKwcK9BesFI0eO7EKGca9zzHUEkoQrWIYR8b2bcg2yCcI78I9//EOCDQQo0uZv9dVXT8LdA5ekAAElJMccc4zBkgCCZRupcyh+neEo2XGJglBHCF1FLLHUWZZQWrQL3NsgWHioIlXaTCxf3JaIpPs96UcgVSy//PIGtzVpufDCC21/776vfBtEeK98gpUdaTu4jxFx31dclOC2xm2/xIMwgfsasXQj97q/RxxxhCVgpO+FqMR3zddXuO1XCBUSJs/RzUOPFQFFQBFQBBQBRUARUAQUAUVAEVAEFAFFQBFQBBSB3oSAEit609PWuioCioAioAhYM/+iTP373/9ulbYoxlCc5ZWnn37akiqIjyL6vPPOs0rDYcOGmYEDB9pkIBSwk9lV2sXSJ3+IB+L2A2sKWGRAiT5kyBB7K9dWXHHFbmV9+OGHk9357Eg+4YQTLOED0gE76EUhxg5+URiTJuQEdkeLoLgkjD/SKSuUE9KDkCpQ5LuWCarUVcoEkQCFIXhfd911FivX+obEQ6n5t7/9zeA6AiyxdAChRjDh2T3//PMS3f424vl2ycA5wd0LeAvpBGW5PAOuiTzwwAMG1zUIz+bUU0+1zxhrDLQVEcgs7n0Szi/PBashKIhRyFPPq6++OokCjiKXXXaZHOb6xcIK5cLKigjn/P3xj3+UoNy/t956q+H9RCivKy65yGetQuK619x75Hrsl3dIJETeoF0dfPDBNhquSxZbbDG5pWm/m222WfLuY7Emy21R0wr234ywLiJ92oILLtjQ7GNtpmrG9GH0H7yn1157rXX7xLtDf4zwHtIGRCAuSB8DIconLsFpvfXW6xYF3CBQ8Iyx9gFJjH5AiD68H+ecc063+ySAPo/375RTTrGuoeR7INchf2ChxhUs+Uw//fT2Pt5pZMIJJ7TnWE9SUQQUAUVAEVAEFAFFQBFQBBQBRUARUAQUAUVAEVAEejMCY/bmymvdFQFFQBFQBHonAiijlllmGatwZ8ewmPJHMYrFCK7xN+aY/s+kmOBHcXbPPfdYs/AgOcsss1irAex6RmGP4m3nnXe2O4uzkEY5LopkrDu4RAQsZ6CcxtoA5cUixuDBg5Mk2akugrKOncwiHOMWZOONN7ZBKNS5d6KJJrJ/KN5Epp12WjP55JPLaanfr776yiofxZIErlRQMrpSpa5uOmeccYbZZptt3CDv8bnnnmvkmRFho402sub8xVUEZcWih4jErfP5Strp3ymnnNIG/e53v7O/7A7nOaQF1y0iYIqLApH555/ftkEslqCM3W+//bpYJ5F4/Pbr18+SKnxtGzxotwhtrYig7BXSjty3yy67GP6KCunIM6B9pgkz8p6QLsSmkOD6RIR73PdCwn2/EJWOPfZYewlF+nLLLdctGpYhpO1RRqwDtEqwaDB8+HBLNMJFDpZtsMrRDnLyyScnxaBvbZRktZk68uX7QP+KKw4EAsJqq61mvxmQLiDo8Z7yPvIeQ4iAAAVhCQs+uOxxRchLtDFcdfhkwIAB9p2E8IAQD3KUtG0IF27fkE4Dlx98P0R4B3AjtMcee9j2Ql9MGV1xLcIQjsWY9LvtxtdjRUARUAQUAUVAEVAEFAFFQBFQBBQBRUARUAQUAUWgtyCgFit6y5PWeioCioAioAgkCOCvHosHKL5cQcGOJQd2IaPwhoDAjmtXvv7668T9x0EHHZSQKtw4J554YnKKufc8ImbZUbK5pAq5F4X4AgssYE+ffPJJCbaKdHbOI1in8CmPIRKgfGUH8wwzzJDcW/cB2GANBCUvct9993UjVRBetq7cKwLpQayDSJjvl3hCnHGvr7HGGsmpa82gUc83yazEAWQJecaHHHJIF1KFJIfrGSFDCKlFrrm/uD/xkSqIAwGGHeyQEPbff3/3tqYd4z6HNiTuC4YOHWqEdCKFcJ8XBKGQuJYy3nrrrVC0LuG4B8HaCkLbOemkk7pcl5NLL700aeeUkV39rZJJJpnEXHTRRUn2tIMff/wxOW/FAYp4+k/aKwKWCy20UEOKkqfN1JHx5ZdfnpAqJD3cZUCoEHGt32yyySYSbN3sJCe/HrhuQCBPhARinpAqJA5kIrHiMmLECAnu9gvZxyVVSITddtst+ZZgtUZFEVAEFAFFQBFQBBQBRUARUAQUAUVAEVAEFAFFQBFQBPIh4N+Km+9ejaUIKAKKgCKgCHQsApArsN7AjmpM6N9yyy3W3LoodPmFZIEriXvvvddMOumktq4vvvhiUucvvvjC3pMEeA7yKK5++OEHI8rwUaNGBdP88MMPbQ4SlxNXkecjVUiRXKsWElbnLwQUyAqYqkfY9e9zjVClrjbh//7D5UVa4ehel2Mw8cWDXICCEtcg7CYXacTzlbTL/rplEnKNLy0U17gOoO3iNsAlFhAf5fass87quzUJS9+TXGjCAWSAvn37WrcKZHfkkUcan4sEeReJ891335lxxhmHw27y5ZdfJmGQD7Lko48+sqQKcV1x8803ey0/4MpGrARARvGVMSuvuq/zPuy4447W+gAueOi7sFzSDMFCBtYbRD755JPE/QdhtDvIVvzWLXnbTNV8sUriupZx03NdZDz33HPJJVyf4NoHohLuQFzC3I033mjjgQlkupDMMccc3ktSFrfvSkdcZJFF0kH2fLTRRrNWNnBfQlsBwxDZypuABioCioAioAgoAoqAIqAIKAKKgCKgCCgCioAioAgoAr0UASVW9NIHr9VWBBQBRUAR+A8CmGdnh7fs9n/55ZcNSi+sO6BgfeGFF+w1TKojrgWKww8/3PAXE9e6RCjeK6+8klxC0bXUUksl574DFOcoL1Ewu+VxFXy++xoZhkUFsapAPiFFXZW6uuXH1H4ecV2dpOOPPfbY6aAueNb1fLtlUjDAfcZ9+vQJ3j3bbLMl1yDcpEkS7K5HqdqO8vPPPxvIP5CckB122MFgXcMnuNwRgRgTssLy7rvvSjQvQSK5+OsBxCAs1eBqB8EdT+g9POCAAxLiwCmnnGLjt8M/3DrcddddicURyBauy5hGllFwS+cx77zzGlzxuK520nHKnhdpM2XzkPtihCaIW7jLoO9+4okn5Bb7rm2xxRbWckfaHQgWTxCsWow33njJPe4BfZe4HXHDOQ6Ridx4MRKV+6149dVXMwlXbrp6rAgoAoqAIqAIKAKKgCKgCCgCioAioAgoAoqAIqAI9FYElFjRW5+81lsRUAQUAUXAiwDKKP5wvYHyCXIFykrZGe+a2GeXNj7vfYJVCZRtsrPYF0fC3DQJ81l6IJw003mOMcYYXLLy008/yWHLf7Fewe7tND5V6tqMSrnlS2Pt5l/k+br3VT3OS4xA6dxJstdee5nzzz/fFnn99dc3rjuddD1mmmmmJChGrHjnnXeSeDPOOGNynD4QVxKQqJBTTz21i3UBNz4kl9NPP90GbbnllgaCD2Vw5dNPP01OcUGC4hx3JjG3JckNFQ7IB3cV888/v00F6x8uKadC0tFbsbgAiUOENsq7g8WERrpIKdJmpGxlf31Wb/KktfHGG1tiBXGxfoTVCkhPQkThO9MoydtX/PLLL40qgqarCCgCioAioAgoAoqAIqAIKAKKgCKgCCgCioAioAj0KASUWNGjHqdWRhFQBBQBRSALga+++sqgSEVRFnMPMPXUU5u9997b7L///jZJfNmz+/rPf/5zksVFF11kTaonASUP3J3FRxxxhNl3331zp0SZRChjaPe+xGnk70svvWRJKLvvvrt1R4GC/P777zeuZYgqdW1k2SXtRjxfSbvsr1smLKpMO+203qS4JjLPPPPIYdv/Ymnh+OOPt+VcffXVDbv5QxZPiOSSJEaOHGlwReETF48QZrim2WCDDRJXPJQFaxkhcV09nHfeeYa/mIhlAEgYWG5otGChAhcq9CG4oBg8eHCjszQQHJZYYomG5+NmULTNuPeWOXYtUaTvh8SEtQokbdkCYt3yyy9v7rnnnsQdyA033GDj4ooo5K7DRqj4DwtCuLzyCd8KEdyVqCgCioAioAgoAoqAIqAIKAKKgCKgCCgCioAioAgoAopANgKjZ0fRGIqAIqAIKAKKQM9B4KCDDrLKJtxopHeap2s5atSoJEjMtc8111xJ2DPPPJMcVzlg17so5PK4DnHzcsuDFYWQXHvttebss8829913XyiKQclcViB4oETeddddDTvlEcrDuStV6uqm06hjF8+6nm/Vsrpleuqpp4LJiXIXFwJpNyDBm1p84ZxzzklcfuCK4+qrr+5CxPEVb8opp0yChwwZYr7//vvkXA54d4cOHWpPcZHiI2qgEIfwcNttt9l4hxxyiCVTSRqd+rvnnnsmVm+wvnHNNdd0alW85S7TZrwJFQjE/ZLrWsa91XWB5CM09e/f30YXdyCXXHKJPR84cKAl+Llp1Xks/UE6TSxUPPzwwzaY747v3Ujfo+eKgCKgCCgCioAioAgoAoqAIqAIKAKKgCKgCCgCioAiYIwSK7QVKAKKgCKgCPQqBDbaaKOkvliHCLnPwI2Au8N8mmmmsfdh0l92+B5wwAHmlVdeSdKTg48++sgsuOCClmhw2GGHSXD0d6GFFrLXb7rpJnPVVVd1i4uLCszIQ15YbbXVkusQPkTxfswxx5iHHnoouSYHKPSwHjFo0KBkZ7VcG2ecceTQVCESjDvuuDYdzM9D4JAy4TYhvau/bF2TgjbwoFHPt0qRf/vb3xrIAQjEoGeffbZbcjfffLMRhW3IlUy3m1IBKFyHDRtmIOHg+qbRQj4ol5FlllnGXH/99da1Rla+WJvZeuutbTRcKrjvqdx71FFHWTc+nG+66aYS3OUX0o9ghmWHAw88sMt138naa69tXTngziH0t+OOOya3PvbYYzbeoYcemoQ1+gBFOdZ0eqKUbTNggQWTCy64wLiuWopgtMkmm3Qjn/373/82AwYMSJKRfi8J+PVgzTXXTE755ogbENyENFKwWuJzBXPSSScZIWhJX9zIcmjaioAioAgoAoqAIqAIKAKKgCIQR4C5OJZVcUXLXFzd9cXx0quKgCKgCCgCikArEVBXIK1EX/NuKwS+/vpr8+CDD3ZbNKeQCy+8cNCccplKkNe9997rvRX3A65pf28kDewIBJgIoeRmYuQK4TxnnwLGjafHjUGAHbooqdllfOaZZ1oyAcrqPn36mCmmmMK8+eab5tFHHzW4s5Bnh9JViAOUCrLAcsstZ69j5h2CxeKLL24gOaCwIr4oz5ZddtlcFeEeduuzMxryx+uvv26VzbQVTPoffvjh1q0GiaUVxWeddVZiUh7SBTvvV1hhBbuT/4EHHrDKeCmEKLLlHFP1IrgQgGgCeQPyCArsMjL++OMbzN3jwgIMt9pqK5smfSlSpa5lylP0nkY836JlSMc/7bTTbHsgfOWVV7YkgKWXXtouuvA9wR0DAgkD5W0ZQRm/+eab21u32WYbc8YZZ5RJJtc9lBmyj0i/fv3MHXfcIafdfnE1gZUZEdz0YLkAoT1hoQM3IlihuPDCCxPXIuCx7bbbym3JL0SHU045JTnHhQYEJJ9AFkI5PsYYY5gJJ5zQ/vniSZj7TtHPi7Ubud6MX1wCQSKQ55mV5wcffBCsv9w700wztfS7VaXNvPrqqwk5afrppzecF+3fhg8fbtssmM4999yW4ASpR4hOtGGxPCSY8Usb3GKLLcz5559vIL8hkJ9clzY2sAH/1lhjDWsRBuLSF198Ye688077fSArysV7pNL7EGC+8+2339qK07+JTDzxxEbJNoJGZ/2+8MILdvyaLjXjMcarKoqAIqAIKAK9FwHWn1gT+Oc//9kNBDaPuG4nu0XQgIYhAEH76aeftn9s1vE9H9aYtttuu4aVQRNuPQK4GmXzAOuHWHfFAiKE/t///vetL5yWwIvA+++/b9eRfeQnrLDyHFUUAUWg5yOgxIqe/4y1hjkRwMQzft19gqIURSVKlTrkq6++8u5IJ218xSuxog6UW58GCmoUKT5ByaHECh8yzQljd/8GG2xgFWK8364FiHQJIFikrU5AlmCnOwQH3IlgCcInxx13nFl00UV9l7qF4d4ANx3Eh4yw3377dYtDADvmKZMrEBZuvPFGs9Zaa9l7d9ttN/dycnzFFVd0UU5zgck6CjbyBIv11lvPxsfqxmSTTZbcW/QA5SUTRCYWCIppJo2QV6rUtWg5ysRvxPMtUw73HkgUV155pSXdQL7ZYYcd3MvJMeSEWWedNTkvcvDEE08k0X2WT5KLNRzsvPPOXVJB8RyTu+66y5KFJA7EAb7ZKLNpu7wXPrn11lsNVkhcAT/IVK64JA83XI75bqOg6iTZbLPNDH0dJKcsgbwl734oLpY4XDJKKF6jwqu0GdcaD4tWn3zySaH+DdIOZDcsCvGXFsZtENxcJbUbh3bqjgey2rt7b9ljLLBAINp+++29SUCymGqqqbzXNLBnI3D77bdbok26lpBOlViRRqUzzunnR44c2a2wuAZTYkU3WDRAEVAEFIFehQDrUkJIT1ecTSJKrEij0vjzESNG2E0Mn332WTQz5qAqPRcBrAsee+yxSQUh22DxkjEdhPxWbNBICqMHQQRYN2Ot0ydsCFJihQ8ZDVMEeh4C5bai9jwctEaKQBQBFuF9C+nRm/SiIqAItC0CKGXxMb/TTjtZUoGvoFhsgDwBOcLngx5FGUQFcdHgpvGXv/zFWqVJEyDcOD6i1hxzzGGtUmCRIC0QFVDM4SZkrLHGSl+2xAX6qTQxC9IERB4Ui64bFElgookmMuzERgnrSkhB6MbhWLDx7f7GasaQIUPsLSizwUykbF0lPx9+kja/eeJJHB+ejXi+bvnSx1IfKVP6Oue4gmEC5yNl0eZw4+FzA+J7Nr70sSyCEgbZZ599fFFaFib4uAVgJwfuQ3zKYTCiXTOxTUvetu3eV+Qet6xF7nPzCx27z9LNJxQfZb88U1/bypOGpO3e797nHkvcdvh1y7XqqqsmfSOkJJc05mLqHrt1wFIJ7xeWXNLSt29fc8stt0QXvmiH8hy4P0QE4lqoDFwTkbqNPfbYEmR/3XuxRoEVGjdfIvHNQrGel/TXJQM9UQQUAUVAEVAEFAFFQBFQBBSB0ghgOQ8Lk1mkitIZ6I0dg0BIOU/bYL1SRRFQBBQBRaB9ERjthBNO+CVWPEwQqSgCvQEBTK9l+UDneh2mmz/++GODb3efYLEitPvdF783h/nMblXFgzQxJc9ufZ9MMskkVqmdlTdp/Pjjj2bLLbf0JWMV3a47B0lPfrlJjuXXFybX5Jc45O2KnBNH/rgu90iYe56+R87r3GX7ydIzu8UsdDzpsL8Xip8VGTP4L730kp3cTjfddNZtxQQTTJB1W3L9008/tS48UHZhTrMOhjK78LGGgeDmIL3rPsncczBq1ChDPzPOOOMY6uMq2zzRkyB8eWIeHGVdM9nxVeqaFL6BB414vlWLK8+Y9xYLICh+65AffvjB9g1phW0daTcqDdotZtDfeustazEAlxUQd0T53Kh8i6ZLPwq+ZQSCRic9k3Qdqbd8R9LXss4hdNT1LHHFVsTyCG6RcBvF9/riiy+2Rf3++++tyX3qg6umPN8KdpvRj9PXQXCDlNcsoY/gG8cCHe50IJXUTfhpVl1akU+zxipi0YTvNc9HnpGcU3cJl2vur1wjXvqb754TD9INrmHSAukGi1duuhLHF8Y1N1+J6/66ebvhcizpyrnvlzi8dz4FBOm7RCnf/aGwPHmH7m23cCwrhixWnHTSSe1W3KQ8jK9838X/+7//K9RXJwnqgSLQQAS0vTYQXE06iEAd7Y51qf79+3vzwGJFXteB3gQ0sBACjGfY3ONz++FLCGsi4vLTd13DWoMA6w9Vx6XM0dgoEhIsjtW5/hrKpzeF1/HcwIvNPSFSzNChQw2b13q61IVlT8dJ61cvAp9//rlNkA2kzZBvvvnGZoP1Wp+oKxAfKhqmCAQQwMc9u69RVqr0XASY7Oy5557eCkJ82Xrrrb3XNLBzEUDhxV9ZgXDDX53CQKGsSwf8pPNXVOjbWtG/Valr0TqWid+I51umHO49ZZ+xm4bv2Ge9wxevncJoswsssID9a6dypcty+eWXWwV9Ojzv+ZdffmlQNnWiYHFHiGJFyz948GBz1FFHFb3NG78IqcKbwK+BEFxmmWWW0GVvOCZeIVUgIVdN3htrCER5DPmKPxVFoFMRYHdnqB/YdtttrVuzTq1bby43c2tcUaWFb92ZZ56ZDtZzRaClCGh7bSn8vTZzbXc969HjAiQvqaJn1bxn1YZx6ZFHHumtFONSrIlmCXM0NmTh/sMnzdzo5Mu/J4bV8dx6Ii5l6qRYlkFN7+lpCCixoqc9Ua1PQxHAlD2KEWV0NxTmtk4cxZaKIqAIKAKKgCJQFAGxClT0Polf1uKD3N/KXwiLZaUqbmXzrXrfO++8Yx555BFz3333mfPOO88mh5snSEAqioAiUB8CPusb9aWuKbUCAVU6tQJ1zbMsAtpeyyKn91VBQNtdFfRad++TTz4ZzXyNNdYwWKlgxzuWRnqSda1oxXvQxSJrxvPPP3/Q5YfP5XAPgqntqlLkubVd4dusQIplmz0QLU7DEFBiRcOg1YR7KgL33HOPwUUOg10VRUARUAQUAUVAEVAE8iCw7LLLmltvvTVPVG+cZpm782ZeMfDKK680YkavaFJ1uGArmmcd8R944AEzYMCAJCmsdpxyyinJuR4oAoqAIqAIKAKKgCKgCCgCikDvQeDdd98NVhardijaVXoPAv369bMuJt9///0ulYaMP9dcc3UJ0xNFQBFQBBSB9kJAiRXt9Ty0NB2CAKZJMevcyUqODoFai6kIKAKKgCKgCPQIBKq6HOpkEJZeeumOLP7AgQPNhx9+aOabb77C5Z988snNMsssY91EzTnnnAazsGVcNBXOWG9QBBQBRUARUAQUAUVAEVAEFIG2QyBkZWu66aZTUkXbPa3GFwjXZ7gUwZIJVmiw8ojLyT59+jQ+c81BEVAEFAFFoBICSqyoBJ/e3FsRYMCDWedddtmlt0Kg9VYEFAFFQBFQBBQBRaBHI7DzzjuXrt8KK6xg+FNRBBQBRUARUAQUAUVAEVAEFAFF4LPPPvOC8Kc//ckbroE9H4GxxhrLLLbYYj2/olpDRUARUAR6GAKj97D6aHUUgaYhAKP0oYcealp+mpEioAgoAoqAIqAIKAKKgCKgCCgCioAioAgoAoqAIqAIKAKKQM9A4He/+13PqIjWQhFQBBQBRUAR6CUIKLGilzxorWZjEMAlyCeffNKYxDVVRUARUAQUAUVAEVAEFAFFQBFQBBQBRUARUAQUAUVAEVAEFAFFQBFQBBQBRUARUAQUgZYjoK5AWv4ItACdjsDpp59uDjjgADP66K3nKeGi5PHHHzcffPCB+cc//mE++ugj+/eb3/zG4Nv9D3/4g/2beeaZzZ///OfcZf7000/N3//+d++jIq1JJpnEey0d+M4775j33nsvHWzPF1lkETPaaKN5r6UDn3vuOfPNN9+kg80MM8xg69ftQkYA5vhGjhxpY/3yyy/Wr13oFvJ+7LHHulwec8wxrf/1vOXvcvN/T8j3lVdeMU899ZQl6/D8+MPn3mSTTWbrhY92ntsYY4zhS6Jw2Jdffmn+9re/2WeLr0fO//Wvf9l0yJe/CSec0OLKc55gggkK56E3KAKKgCKgCCgCioAioAjUj8Dbb79tXnzxRcM4/eOPPzajRo0ymBOeZpppzJRTTmnH/rPOOqtp9C5IxvbPP/+8ef311w3jScbVn3/+uWH+MfHEE9u/SSed1I5hKc8444yTCcZbb71lPvzwQxuP8TVziJBgQZB8XPn9739vfVS7YbHjn3/+2Y6H//rXv5p3333XjonBk7kV42HSn2iiicxUU01lx/zMOdph7herU5VrP/74o/X3/eabb9r5CO2LeQkyxRRTJHNK/IDnnVNKmm65Qr7mifPoo4+6Ue0xeY033njdwn0B3333nXn55ZcNczfaEu2SZ/rvf//b0D6Yv/I722yzmXnnndce+9JpRhjt76WXXrLzMt5nmQfS/pi/S1lnnHFGs+CCC9r5Wd5yMcdMz13lXuaWv/3tb+3pDz/8YO6//37bp/D+gRfv8JJLLmkGDBggtwR/5fnW2WaCmaUu8EzpC+mH2PTie9bMaWeaaSb7rGnDWSL1ceM1sr2SD/NwnlV6LYc+aPLJJ0/eu/nmm89MN910btGaftzoPpN1iREjRnSrF+sgCyywQJf+l3UhcGNdg+fP+8O7A0a4V6Df5pvIuz722GN3S7NMwPfff2+efvpp88Ybb9hvMPnKN4t3lm8ef+S/0EILmXHHHTdXNq1od+mC0WeA5RNPPGGxZE1R1qV4d2iL9MXzzz9/betSlIF2z1qYfG/Il3cZPFkPA0/yZt0w/c1P1yF93qx+MJ0v/Sp1yiMPP/ywbS/puHPNNVe3dTgwYszlE7df9133hTH2+fbbb7tdGn/88c3cc8/dLTwvntxIX0H6vC+8J/KN47nyjk499dT2HWU8Udd4tRHfVL5t8o5Tr9i49MEHH+w2pqDNUse0MObkLy1gMfvss6eDc503Si/gZs6YhXzSIn2uG05bZUwHfqKj4Ls2/fTT2zZP/8y4Gp1F3dKo51aknOA0fPhw89prr9l3gL6OcQv1pk8DsyWWWML2c0XSjcWlTfHegT1zMvpSGdfRFvnjHZxnnnnstzHP3KwdsIzVWa8pAq1AYLQTTjjhl1jGvGQqikBvQACl9qGHHuqtKkrlELGAG/r27WtWW201772+QAbCu+66q++SXbwYNGiQ91ookLLde++9hsF4XmEgs9JKK9n8WCiMCekffPDB3igbbrihWXPNNb3X0oEnn3yynaClwzk/5phj7IDad80NY5Dcr18/Nyg5ZtK60047Jed5D1hwO/bYY210JgllZI899ugy6aCcTIy33HJLb3LLLLOM2XTTTe01JhnXXnutnURm5c/i1+qrr26fGwvNEl9+SZC8XZFz4vDHgOiGG26wv8Rz73Xvc4+Jw3vwyCOPuMGVjj9ZeubS9086zE/0KZ2g3qgIKAKKgCKgCCgCikAKgWaNVc4//3ybM8p6xndC1pVzLko44/J77rnHvPrqq6nSdj9FMbreeutZ382S1t57720JEOnYKJ122223JG8pA/HkWH4ZF0LmZjzJQnkRWXbZZW2ZIOxKeun7r7zySnPrrbcmwaF4SQTPwTnnnBNVwpMmynfyue222+wipycZbxC4rrPOOmbllVeuVbHkzSxH4CGHHJKQxN3oLJqedNJJblD0GGUmyvW77rrLu2DuuxlyAjgstdRSBiVMSL7++muz9dZbhy7nCl9jjTXMRhttFI1LPrTL22+/PRovfZH2379/f69iKx23rnMU6czfwVuIK3nSRqm51lpr2blZVvzY3HnFFVe0pAn6kqFDh3rLgJJun332CWbTyDYTzPS/F1AS0FcUWQPhVhQZm2yyiSVJhfJoVnslf8hpd999t13PCZUnHQ7JhrUc1j/q2nSRzsN33qw+M7Y2t8suu1iCEWW5+uqrzR133OErarcwlFjbb7+9mXbaabtdyxvAOt6wYcPs80IxlleWX355w/oPxMeYNKrdsS5F/+YTyrb55pvbS7g75p1C+ZklrCfyHeT+Mt9o0mcsASnqzjvvtCS4rDzlOu2e/qtPnz4SFP1tdD8Yypw+vujabjot3vP0s0Nxf9ZZZ6Wj2nPWtOkfisiee+5p3n///W63oPg+/PDDu4XnwZOb7rvvPnPNNdfkGk8wrtpqq63Moosu2i2/vAGN/KZeccUV5pZbbslbFG+8c889t9u49Oabb7bvnO8GvstZa/XufY3WC7h50S4gYKWF7+uvekYbTD9+ySWXJOvO6bjp87XXXtvwx8bFuqRRz+3666+3a/i+cspz++qrr8xll11meF/zCKRJdB0QycoI/Snr9egWiowpyWu55ZYz66+/fkK29eXfKCx9eWmYIhBCAKIQIsTwULy6wmVTd4jMWF9vVVeJNR1FoA0RYEFhjjnmMHw8fXL55Zcb4mRNlHz3VgljgnTppZfaiV3RdGBNMhFlILfjjjtapmIoDQbUIRFLD6HrEs7gm10kIWFQxm6CLIkxg1kQa5X89NNPhbNm4HPTTTfZv7w3M1mgvbGTiEFXkYUUFh8YZIV2LWWVgYF6TxEWjVUUAUVAEVAEFAFFoLMRQFHRW0TGjQ888EDuKqP4YVEPxSOKkzw7tbMSZ7EO0gI7r8oIC+0s/EE+ZudpoyRrbP7CCy+Ys88+2+7gKloGcGU8zmLpdttt1/Ld40XL74vP7kMWw4soC0kH5TZtDIXD4MGDKyktfeVyw5j7xuTZZ581p512WuE6kCZzUcoPeWODDTbosiM+lmfZa5AZjj/++FwKp3QebArgj7Kuu+661lJNOk6ec94Rdk4eddRRpTBrZZtBmY7CpoygNAZ7LB/QD6EgboRktVfyjCnVYmWi/6WtQ7KDENeMBeZ26TPBlV3vJ554Ym6FHViiON53332t8oh3p8g6CvfHlNlcjwnPiT/6FjYllSUixPKQa3nancSVX8YXrHVed911EpT5y3rihRdeaK12oBAvqgxlbQrXyljGKCrcwx+kPkhSVSxIVe0Hi5a9aPwyz7NoHnXGB08sulxwwQW5Fcrkz9iDPo1NZ4xXi/Zp7fBNzcIxa1yavj/vsydeM/QC6fL5zln3RyAL0j8UEUixzzzzjCXAYcmkXaToc6PcWOcYMmRIIYIDdcdSEwR4n3WTGB6Q/s4444zohuDY/bJRtyq5KZYH18pgmZWmXlcEWonA6K3MXPNWBDoJAXaFYKosJAwCMfXWLGF3yBFHHFGKVOGWkQEs1hpuvPHGoOUCcXXh3ifHLOrI4EnCfL8QAWILdUzU80hsd15ZU2l58m1EHCauECvKCKbUcEPDJDiPMLmB1V6WVJEnD42jCCgCioAioAgoAoqAIlA/AixEsVOInbJlBLchzFV8pp6LpAepgl1qZUkVkhdzAnZ01WkJTdLO88v85eijjy5FqnDTR1F32GGHBV0dunHb+Riyy5FHHhmdq2WVHyUbSkuUIq0Q8j3uuOMq1YFyo+hGGZB3jlWmrpCjDjrooFKkCjc/yoq1EhSUZYS1C6xGxubooXRb2Wauuuqq0qQKtz6Y6EfxUbVfdNPMe4wiDGIX1gGqCJtccEsLQaaRgknxdukzseqANVWscJYRdtCz9pVX+P5edNFFQQsBedMhHhubsCJU5p0rkk/RuLxTRUgVbvq444KUV6TPZMcp384ypAo3bwhW9Puyo9S9lve4Sj+YN4/eFI+1YRS8eXfpp7HBGhrEtyLtqV2+qem6NOO8mXqBvPUpQ6qQtNlIWcf4SNJrxS+E4/32268QqULKybeBcR2u7PIKpAowq7oRkryZKxa1Apa3nBpPEeiJCKjFip74VLVODUEAcgE7kjCT5hMW1pik4Rak0cLknw9nUfNOsXIxyeNDGjKvislRGJQ+wXwlfsFi4jMT5sZnhxELDFlM95CFDEyk1bELzy1TI48Z9IBbFWGXEBNZfN9mCYzxqgOtrDw68frCCy/cicXWMisCioAioAgoAr0aARZee5OwiwsT3VWEHb7saCsrKLNQrGE9rS5h8R1XErPOOmtdSWamA0lbXABmRs4RgfkTZBOwmXDCCXPc0V5Rquz899UEBRuWH/AL3yxhTiWmp+vIk517k0wyibUIUUd6bhpVFA5uOnL8xhtvGNxt4pay6K7tsoqvVrYZ8i67MUEwc39RzqPops020oqAmycKQ55ZaG3FjZvnmDWh/fff3yoji5iNz5M2cdqtz2Rdo6pAIsCn/aSTTpqZFCTAOsccEHogFkAOKfrOZha2RATW12JWYfMkCVkRshXm5LOEsQRkIJSPdQh5QxA78MADS+FZth+so+w9MY06LMOybsmYF5cvWdJO39SsstZ9vRV6gaw68D0qaqkinSbjavpocVGUvt7u57h3pA5VhO8OBKNxxhknmgz9KSQ1yM11CRs4mZu10iJ4XXXRdBSBRiOgFisajbCm36MQwC/jZpttFqwTPnqzCATBmwtcwOxlHlIFfurwr5dFepCs2fUSYkbGrEHErEhI2vhOzBIWhrIEMoFP5p13Xl9w24bFSBU8t7yCGWLxMRW6hzaZxyII/vBY2MYyS9YALpSXhisCioAioAgoAoqAIqAI1IcA1iaKWHaImU9mV/8XX3xRqnAoNLPGnIxhGUfOPffcuV1CMJZtlqDQvPjiizOzwzUAZnghljM+zhIWNPER32mCqeI87hR4pig4cJ3AfDhLWJRtphUAiEcx4XkuvvjiZuONNzYDBw406623XuaCMZYE6lyopnxYFcircKDdMY/PMy9EsVh2t3kMN9+1VrYZdubmaa9/+MMfrJtWXLWiHMgS1iliLkuz7i96nd2geUgVM888s3WXRD+UVQ+UOHnbVpHy0mdirSFL2qHP5F3J875IXbAClSU8q7ykCvpJXOjmKQNWn4pYzcgqZ5XrMVJFnrpI3igTR40aJafBXwieWaQK8uX9XXTRRW1fnVUOFPG4WlFpbwSKuF2ir8+yxtQTvqlVnlgr9AJVylvk+fM+x/qmKuVo9L0ha0pZ/ZhbLvpINr9mCW748vSnfJsYS/CdyiO4+FNRBBSBbATGzI6iMRQBRcBFYPnllzdYVwgpqllIgjE93njjubfVdkzeWb6VWTjCb+RUU02V5ItJNibwTOBCH3oiw4z0lZ/FHSb0vo82LPdll102ySt9wIA4D7EC0gQLCCGBTBJa4GLiVVZY/JVFGhYPKC++xXzC7it2BBHPlao7XGD3L7300mayySazu2VgnmIFhUVaFstiggnFFVdcMRglNmmHQMG9LJaOO+64Ng3qRnvBfQs7gt59991g2npBEVAEFAFFQBFQBBQBRaAxCDAey6MwXWyxxZJxJNbfMF3OOJKdfMwdqgpkjNtvvz2YDPOEtdde2yreXb/1jI9xQ8cCXWgMz7wEYrdrtWLDDTe0vujJkDQgCWMRwidY21t11VW7XfLtBMacfYzIzTgf9499+vTpkh5zg9tuu81ce+21XcLdEwjqzL8aNQd086rjmLaFm8CY4L9+hRVWsPMTNx4EcfAI7fTlWaO03GKLLZLbxh9//G4WU9ixHXIr47Ou4ptvYYkl5uqQXensekyTxtdZZx3zyiuvWLPHvvktBWdhf911103qUOUAvFkniAlKB0gflHnsscdOooIni+dgHhLIJaxTVLGawnx0nnnmsXnzvMCWualIs9uM5Cu/bGKJCW2VNuuWmfjUAwVFzLw1aaN0EGlUe4WcFrO4gOJl/fXXt22AMogwP6cfxEJqyAollhBwF4oyui5p9z6Td4Z+l2/g7373O1vtr776yloGhbQX6l+ICGGCe6eddlp7X/of7QayQExYu+Lbx7fD7Z9ef/11+87GLE3xPaHNofASaVS7k/Tz/K600krW8gTWYKkTeDKeoA/KGk/wjq255prBbFhDDX03uImxBN//+eef37hjCdzagiXfhdBYAgIQeKbf/2BhAhey+sHAbd5giK7pb1m/fv28cXlvsZCcFrddpa91wvkqq6xix6d//OMfbXtiPIXrAtY5Y+vafJe5HlrnbPY3lbEmbVOEtevYuHS11VaTqMmvb1yaXCx40Cq9QMFi2nkBfQpkZerPc2NdH91ElvKe793uu+9eNMsu8Vv93Njkyndmvvnms+NQ6k/7Z95D3xCzbAGhfYMNNug2fpUKMp5g7hES+lPGlKz1u/0p4wnGCuhAQv2pb27WaixD9dRwRaCVCKjFilair3l3JAIMbNnpEmIbMgBsxG4BwOIjjC/OmOy66652QO6SKojPIIZdRpiJirmOoPxMmnzCBMcnIZKJxI1NaCUOv1XScRdj3TTzHPNMwUf+YpMXiZP+jd2TVYZtttnGupCRySvxmVTPNNNMZocddrC7q2JpxHZRsBDORNgnLDDusssuZplllvEuArPIsOOOO9pBsO9+DVMEFAFFQBFQBBQBRUARaBwCEJNjBFfGcnvttZcdKzKOZHyKsIDGYh5EYcZyVSXkio902f2ECW7cq7kLd1xjfIyyYMiQISa2Uy2trCkyNk/HlTE6+aclRlZGmbL33nt3I1WQBjijiIcIEJNmWC6M5V/k2vDhw4MKWtJhTrnpppt6lVTMMwcNGtSFOJHOG3caH330UZdgeTbub5cIzokbR459862YFUAWk5lnpUkVkg0EGt6fkOTZGBC6Nx2OMjFG6kG5itln2qFLqiAd3p1NNtnEHHXUUcE1COKxCF9GWNdgYwVEGIgVWKpkHsjcf+qpp06SbEWbSTL/9QDiQEhQSGJZ1KdUxa0L11EKhIR3N+3mSNqd+xu6340jx772Ku5XfemwieXQQw+15BCXVEFc0uK54PIjtpaDRZ70BhBfXnnD2rnPpN3iHhfFrZAqqNcEE0xg+3H6a/rtmLCRJCSxZ8U9KE7Jn0066Wc9wwwz2HWW0GYdydNH3JD24/5K/PSvG0eO02VJ3xM7Z+2pf//+RpTgxAVPlKIoOAcMGBC7PUpeylrLhJyCW620EpAM6RPZPEYfyJgjJHmIqKF78/aDoftD4fJc5DdvPIlf5XmG8mpW+M4772wgkmDpSurB95jxKWvqbFiLCQSlkDT7m0r55ZnIb6hscj39G4pfNDzrXSK9RuoF8pYXQgXlYK0eLBB+UfhDiGbcgYWpkOSxjB26V8Jb+dzoq/gOMQ+ScSj1Z77GGjz9mUuskzK7vzEdScjaOPeTLrof8vbNzSAj4hYxNjfDyqErrcTSLYceKwLthIASK9rpaWhZOgYBJr1bb711sLwwtbEiULfw4QwxCsmLQQvkiZjwIWcQu8giiwSjDRs2zDshn2OOObz3UCYY/SEJue9Ix2f3xTfffJMOTs5DuzMwk8qErxMF1jOTx5AweMEaCLtvQoJJVlivPoktFrC4xKQ5JuTPrhkVRUARUAQUAUVAEVAEFIHmIpCl2N1tt926KD59pUMZR7wqElvchriRVgKm82KcHps7hcax6XSqno8YMcKbBIu8WDVg3BsTdievvvrqwSiffPJJ8Fq7XUBJHhJIE1lzSu6FBBDDI7ZbO5R30fCYe8w8dUDBE5pnMfdEgVGHxHZpo3Tab7/9Mt+jaaaZxuy0007B4hRxGeQmss8++3SxdOlec49b2WZwAxJ61rRDlK5ZgiI8psSIrWdkpZ3nOju1Y+1g8ODBmc8Bi0T0paF6sC6Td1NLnjKH1nHaoc+EZIKCKiSse2FxJqaIT5O/JC12EccsnNBn9O3bN/ObgfLMtdwj6csvZKtmff8kz9Av5C2UcCHh+4j1AHZfh4QNPaxN+YT+NGQdCOUqa5lZFp8mmmii6A52nhnWLcpI3n6wTNq98R7afWydE0xw5+yz7CB44eojJLG+tNXf1FCZ6wpvtV4gTz3oS0LWWeR+SLoxshbfs2a6lZNy1fFLnwZxN7Qhlzwggu65557R7GKE0ti3ng2UWXMzLOow3g9Ju3ybQuXTcEWgHRBQYkU7PAUtQ0ciADEhNoHHtGqWH+KiFY+ZOcW0VJ7FI/JkUhQb5DCA8ZEYYlYhYguuMZZlGoPYjrjQYii7BDpR2G0CizePEC82KAst5KbZqZIXjNm8uMFijblokTT1VxFQBBQBRUARUAQUAUWgHgR+/PHHqNltlBsxpZJbCsZxKB/LCso8n7CjfeKJJ/Zd6hYWc9sXUsR0S6RiQGgszTg7i1QhWYcs+HE9NB6Xe9vllzlqyLrGbLPNZt0Q5C0rO8JDO94wNdxowUx9SNKWH0LxmEeHJG3FIBQvFo7C3je3lnu23HLLxCWjhIV+MXUf2iCB0rLo+gN5YyUxS1rdZn744YfgXDhv34aifcEFFwxWtdHEiueffz6YN+a60xZHQ5GpR8wSQp2EJnEVmi5Lq/tMyIIhcolbVvr1jTfe2A3qchz69qStKLk30d8V2XjCJplYWWPWR918G3kMAcTnUsuXJ4rw0LeU+CFlXGzjGco92dHty9MNY5Mb1mlCEiIDheITnrcfjKWh1/6HAMSjvP1yjJwJ8chngaedv6n/Q6FxR63WC2TVjP4Oa2F8q7IEK1mxteZQf5KVbiU1KzUAAEAASURBVKuvQ5R0LSmFykMcvv8hCVmfJn5obsY4B0tdeQRLQSGJEZtC92i4ItDbEPCvkPQ2FLS+ikBJBGBXQhqAiJAWWO6QKzApm3ehLp2Ge85iQmxxKjZhdNORY9jeMPhD5vIYrGHyzxUYjwx6fAtDhPkYySxG4Z8rLewK8/kXZSLE4CotX3/9ddClRWyhNp1OO53jBzevgD0T3pB/a18bJG2wOe2002w2TErkL2++Eg/LFr7nLtf1VxFQBBQBRUARUAQUAUWgPgR842dJHQsQMXPwEs/9RWnCjnN2TRcVfPyiSErPadLnsXQh+077q3sBnzU1xvnNkCOOOCJZpHfL7h5nlSNm7a1Tdtbh2zokKESK4IEybKmllvL6eX7nnXesOxB2tzdKJpxwwmDS999/v4GIEFp8lhshk1x++eVyWvtvbMchO3ZxSVJEll56aRNSrLAQzjw/r8Q2TrhptLrNoCQ477zz3CIlx0Xaq+vaJEngvweNfn9jCvS8SkgpM30pyiufexn6+TzWFCSt2K/bZ7rximBed58JsYH3Jq/E2njI1VbMWgUWR2PEgnS5wIq1OrD0CTvv11xzTd+lpoXl3exDgRh/rLDCCt4+n+tYl0kLln9CFgawGhR7Rum0OMeMfcj9Mu9ZkfZBekXz5x6VMAJF+jN2zfMNDpE9aU/p73w7f1PDqNRzpR30Alk14flnjbvcNFj/D601Y6mK710nCa4Ri4x7GXdfe+213iqOGjXKG04g3/mieqB0YszNsOrkm3PGrImn09FzRaC3IqDEit765LXetSCAshvzt6FJEqSLe+65x048qmYIUxGyhk/4aMcmrL57CGN3TohYEbIOERr0hOK/8sor3uxJB3zSizR//etfrT/f9E0xM1exHQDpdNrlfNJJJ7W+BouUB5N2IfFNYCVuaOHDx/6We9K/WWYZ0/H1XBFQBBQBRUARUAQUAUWgPAIhhQ8poiwea6yxCiXOzmN2McXM+ccSZDyZHlOmz2P3cy3P7q2sNKpelzLLb9H0skzrFk2vFfFjO3pDrh9j5WROefPNN3ujMIctssDsTSQSGPPP/dxzz5njjjvOunnB5HKrJDQfpjwx0/uh8qKE8rn3QZHBtSKS99m0Q5sp+866eLTSfWiIWMEzC1l9ccuePqY/9xEr2HCBJRcUlnVIVdzr7jNRWuXZCS11R3FEP+FzJfPFF19ItC6/9B0h8W0CCsWVcBT3kDF863m4I2EzUl3PS/LM+ws2ea2lSJoxgpIP0/fee89bd9LjeRYV2hQbiHzu0iD0FZW8/WDRdHtjfLDMa01N8GEtO0Ss4N1IEyva+ZsqdWrUb7voBWL1y2sZWdJgbTwkoQ2EofjtEJ7XkriUlfkZlnh8rpKoP8S00Dev6veZMrTD3Eyw0F9FoNMQUGJFpz0xLW/bIYDfYhiGd9xxh7dsMKlZoCpDfHATjCnOYyYt3TTSx/hpZRLvG6yEmJHU1ydMYGA0phXwPsIFg212nbAonCZWMLFkQMHAwpUQsYJBS8jdhXt/ux0XnWxQ/pg5rzK7D32Y/PTTT3bSy7MkTSb/7N6JmW70paNhioAioAgoAoqAIqAIKALlEYi5OCi7u5LFzrLEiiI1YUcd40d3LMl5zBR+kfSbERcCMr7aGRPLeJg69IQdXDGXB2WUUrF5SGwOW8dzxNpDSGFJ+hD5d911V2t1ETeexGdeHlqkrqNM6TRC82rilSGyUPaYS5p0/qFzFPp5cei0NoMigveWP95Z3l3+2MTRCom9I8y/X3311cLFon8KCes7zVbUN6vPjK2JhPBg/clHrPDFp82EhA09aSVvKK4bznuGFYWQBVr6yWY/LylfmXXKGKGN9ywtPrKFxOFdLdP+Q+9U3ucs+RfpB+Ue/Q0jUIakUvSdbtdvahiV+q7ExlTN1AvEalS0j4wRK2L5tOu1MvWB3OYjVlBHvvVFrCSFcJG5mYyH5DdGJAylpeGKgCLwHwSUWKEtQRGoAQHM4zJJhxTgk6FDh5pDDz20EgEgNhnBfF4Zgd3I5ND3IWVCyQc87ZuW+KHFK3ZMpBeHfGnLQlA6rtQBtjILX668/PLL7mlyHPMJlkRqw4MyrNA02aRKtfCTC1kFk2uwnmlfMR/CRaxbVCmX3qsIKAKKgCKgCCgCioAiYKLjsqK7SwVPzL3WJYwN2YWKQgQitey69RG268qzEemw0MgchvkHuyA/+eQTOy6OKdcaUY5mphlTkh900EG1FiU2h60jI6w0rLXWWubKK6+MJsecR0xNM5dFmYbbS9xczjDDDIXMVkcz8lwM4c3croylAk8WpYKKKMBCdSDjVrYZ3AjxXOmDmNtSTiFDlQKlQTfF3oORI0fWjiHKt5i1yyrVbHWfWWYdhR3BeSWmuKxiKRVz9jFiRdnvet56heIVVYKSzsQTTxxKzhsea/+YwA+ZwfcmlhHIt/vHH3/M3acX6QczstbLvyLQ6PcTkEPfo1Z/U5vRAGLvUjP1AqG6MqYpakUBl3I9ScqM62JktSLYMDfD4iHzGcZFuIdjnb/T5mZF6qxxFYFWIqDEilair3n3GAQYCOy0005m33339dYJf1U33nijWXfddb3X8wTGBlBlPtySZ+xePr5p9jBseyxN+ExZsqjhkiVgi/sY40KGwCSrzywjAwCXWMHEKGQaLmRBQ+rXrr9FzTdTjzL3uPVnkeDee++1JhPdyYiSJlyU9FgRUAQUAUVAEVAEFIHWIxAjvKYtxOUtbdn73PTffvttc+edd1pidqeSDxj7Pvnkk2bYsGHWooFbv55+zO7gZi6wxuawdWG92mqr2bki1inyCO322WeftX8SH5ccmKRnV3leKw5yb+w3hnedpPlYGULX8tYzVodQ2lXCs9oMmz9wt/rYY495XWFUybtR9zbznaMOWRgWrWc79ZmNtlYaI1bE1s6yMI1ZpKj7eWWVxb1eZo2p6D0xTN2y1HXM+5a3f83bD9ZVtp6eTtG2URSP2Pco7zMvmmc7xY/1FVX6p9i9Pr1ACJM6LCuE0u6U8DLvQHpDa9G6onO67bbb7Li2U+dmReus8RWBdkBAiRXt8BS0DD0CARjoG220UXC3zHXXXWcgFMw000yl6hubjFfxWxm7lwXdNLGCwmNG2EesgPywzjrrJPULWZlwMcAnb9qNCtY/mLwL0/Wtt95K0nQPIGW00l+uW5Z2P2bhuM6dAO1eXy2fItBOCGDiVxRkLKo1ekGwnequZemKAAuLfN/YzSPfuK4x9EwRUAQUgf8gIN8NHx5lF+BQIEAID5nQ9uUlYSgzsQrwwAMPSFBH/kL6Pvvss01ontKRlSpQaHb4N1OascBLu8bdx0UXXVS6fbKTnD92L/fr188SLOrAKebSJ6bIqCPvutJopzbz0ksvmTPPPDNoMruuOtedTmwtp+68SI/+ui75+OOPzTnnnBPc6FJXPu2STuxZxdbOssofuzeWZ1a6nXC92cSKMmOcTsBRy2hMT/imVnmOsb4i1sdk5Rm7N6QXyEpTrzceAfq6Sy65xNx///2Nz0xzUAQUgW4IKLGiGyQaoAiUR4DdMux+ETOj6ZRwCTJkyJB0cK7zGOsRiw5lJXZvKM+QlQiIFSgQRWn44osvdisW1i5cU19zzjlnN2IFg0XcU4g5xJDPRdJSyUbgpptuMnfffXd2RI1RGoHTTjvNPPHEE9H7UYJMMMEE9g9y0RprrJF7J0U04YyLmLRO+/nDRC5WdhiIY0L5ggsuyEilZ12m37vhhhvsLlXM5LEgz05F/FJCHKtjR6+L2IknnpiY+MU0n+ym2Hvvva15PuIeeOCBpYl3bl51HbMbYscdd7TJQQC4+OKL60q6x6ez7bbbJos+xxxzjJliiilsnT/88EMz44wz2uOzzjrLKm56PBhaQUVAESiNQGgcToIuAbl0BgVuREl30kknWdOyBW5ru6goCA8++OCmWmxoNxBkntZu5apaHuaXAwcOtGM5LEWG5uNZ+eDS5rjjjjOrrrqq6du3b2USZOw9js3Ds8rZzOvt0mZYZ+HZdKJ06q54+kxcvcSUeZ34PGJlZm4ckirvLOtkIYn1E6F7Oik8hmkn1UPL2noEYu9Klfez9TXLV4JG1T+GXSzPfKXWWI1AgLXcY489tteQHhuBoaapCFRFIDxirJqy3q8I9EIEmDCjUGHHjE/YIXXZZZfZhRrf9VjYRBNNFLwcY+0Gb/rvhdgkObSLBisW7OZh4SktmAfG9yQLvix+pCVNhph11lnTUew5JA0hVuB31Ceu2xHfdQ0zdudVEVKFKP7xQ8ofCmZ+H3roIYUzgsCtt95qhg8fHonR/dL2229v3QOxWIVv57rl22+/NSeffLJBqc+imCsoza+44ookqDcRKx5++GGzww47WJ/wCQC/HvAMEd4BTJzPM8889rzqP9dv8iGHHJKQKkj3rrvuSsohJIaq+dV1PxO166+/PklOiRUJFJkH4CbfZQgzIhAsGCOcccYZZvfddzfLLrtsQrqQOPqrCCgCioAgEDMbzjc+trtM0kj//vDDD6WsVWAJACJiXmHewveUOjCWpKz83X777XmTqD0edT/ssMNyKwgxZ8xcSMbG1INjfm+++ebay9esBBnXx2TJJZeMXQ5e++yzz7qMcSSiEArlvNG/zDX5e+ONNwxWELGyCGG/qGBSmXa8yiqrFL21S/wY3jGT3l0SafFJrA4UrRlt5r333itEquD9nXDCCbu9v7SL1157remIYqksJnVjWIdVz97aZ9JuQhKzJBW6R8Jj98bylPs7+TfW/mebbbZum0Dy1jX03VF3BHkR7Lx4se9Rp3xTq6DeTnqBKvXQe6sjcN555xUiVbC5S+Y0Mi/jl/GuiiKgCJRDQIkV5XDTuxSBIAJMYtktg4lZn9x7772lFCmxyVaVAeSoUaN8xbRhsQVd/M/6FkdZqIBYwa5sn+lXJk6usLsIqxVp6xb4yF1hhRUsQSPkLzdEynDT783H7IoQZXEIBxY7l1hiCUuUYaAFOQhSDL4LEY75YwDme96hdDU8HwK4CIKAhLI/9o7nS+1/sTC3udhiixl87an8DwH6mRVXXPF/Af89on2LIpzfxRdf3E4wllpqqW5xiwTwDkKgQbAast122xW5XeP2QAQGDx5szTXSznbbbbcuBKceWF2tkiKgCFRAIDYOhxjNYlhRKTNngEj92GOPRbNiLLnIIovYOQ7jGXF1lN6ljYL7+eefj6bVqIu4efj888+DyaOIwfog8xKIcIwNQtLJxAqeDWN+FFJpwXLXoEGD0sEdec58lL91113XMC5+/fXXrRULCEJ5rVlceumldjwdUwrmAQf3lWywSIsvLB2nHc7boc1kvXNgvOaaa9pnzgYQ10KmiyGWMCG1N1tCG1Yox2abbWbXPZpdpqz8HnnkEW8/Iff11D4z9r77+k3BI+s39v2J5ZmVbidcj9Wvf//+5k9/+lMnVKMjysjaXVGJkX6KptWM+J3+Ta2CUWzNsMwYX8pSVi8g9+tvcxHAEipryDFhLZM1YeY0EHJkbpa+h7nZc889lw7Wc0VAEciBgBIrcoCkURSBogiw4+CZZ56xf7578YFVVGKTEXyNLr300kWTNOx2C+3YYPIf+vCSEdYifIp2FqsgRIwYMaJbeUhTrFC4F9lVlCZWoGzGHBluDHwEjZlnnrl2c/1umXrCMe0iNoHfYostrNsDIU/EJmHsWFHJhwAuPrbaaqtukVGy44KDBT3MUItAfhgwYIDBZUtdgi9kJVV0RRPsWVwXmXLKKQ3uGJhw0NexyI4lCxYREUxAE0a8sgKLXJRRhx9+eLc+a/75508UY+yAVen5CGDxaY899rB9AEoC3nsUASqKgCKgCKQRiCn2Gb+Lm6H0fbFzLMIVlQceeCB4C2P7fffdN3dZmHu0SmI7siB+Q3bL8y3uCWNivkU+BaHPGmGrnled+TKPZlMAfwhWuXgXnnzySfPggw9Gs8LVH3PbKgLePhIFc1wsMfjmx1Xya8S9rWwzEGNiCoTVV1/dbLjhhnaDQFbdcWvUComt5Xz66aetKFJmnr21z4yRYFijYs0ktk4WAja93uXGi+XpxuvU41j7R6GrxIr6nmzMIrEvF9aNit7jS6eZYT3hm1oWr9i71Aq9QNl66H3VEGDDbkj4nmA19Y9//GMoSpdw1klVFAFFoBwCSqwoh5vepQhEEWCihWIVcoGPFBC9OXCRnUUhwcwpStui/k9ffvnlUJKZCzwhaxGyYOubOLILyifsDPMJiuHQAl9dZvp9+faUsA8++CBYFXbkzT333MHr6QsxBnM6bm8/n3322a2J/xgO66+/vmF3BgQshIFxpyysxurVztfuv//+LqagUWi7/RhkrWuvvdZAdhCT0bhu2muvvUpVC+XRAQccYO+FnMGCb1rOPffcdJCe9wIEsGqFj3CsVrBrEoVAeld3L4BBq6gIKAIZCMR2pTHe/stf/pKRQvfLIStw3WP+LwQrdCGBkFiE4BEa14fSryuceZJ829Npsut65513zkWq4N52VYKm6xU7Z7enz2rDO++8YxjzTzzxxLHbO/4a1gyYS/IHkZZvso/4QEXrICqDt8yR0+DxThYlVrAIfvrpp6eTsueQQOaaay7vtSqBrWwz7MwMCXXdaKONciu62bTRCsFHPcoOnwITgk/fvn1bUaxgnr25z2RNLWTVh7W9t956y0w33XRB7HwXsAgQ2tBE/Nj33pdep4VlrWXq2l6xJxpb9w19y0I5pF3GhuK1U3hP+KaWxTPrXWq2XqBsPfS+agjggj0kuKbPS6ogjVbNzULl13BFoJMQGL2TCqtlVQQ6CQGYpCw21iUMHkNMbiZ4TMiLCorGkMw333yhSzacBam0Ww8usFiAgthnSipEoEDp6GPpQ84YOXKktxwor1XiCMQWfossuGE5xLf4Gs9dr8YQmHbaac0RRxzRJYqQLLoE6kltCOB2RWTzzTfvQqqQcPohFmdFfAQxuZb1C0lD3ItgHYYFVRVFAAQYH0g7w4JNbMeBIqYIdDICtG+V8gjgri0kkLeLLp5DkGA3W1GJERIgJeYV5gc+pWLe+6vEixGEsWIQc7uSztdnlS8dp93PsRYYkqeffjp0KRjOQj5E//RfmfYWzMRzAct8WJTw/cWs9rlJQWqIuT/Jm46bZvo4Nq9mDAB+RYT6snPe9xdTuBXJIx23lW0mRoZg40YR6wFlyGVpLMqehzaZ0JejrC8qtM30O8d5HWSg2DpCb+gzF1544eDjGDZsWPBa6ELM4gr9Q8h1TSi9TguHgMl6pk/AhvWmosKYwtf+Y223aB7tGj9m0awoUcK3btuu9ZZy9YRvqtSl6G+76QWKll/j14MA/Z9PIIvPMsssvkvesFbOzbwF0kBFoMMQUIsVHfbAtLidhQCTzmWWWcbECAxFarT44oubyy+/3HvLRRddZM2b5p2UsdDFYkxIFlpoodClJJwFFt/um5DZSB8Rg8RYDGGXeBonFj58C7AMFvCZ2wpppQnjovXFzG1Ixhwzf/dPOxEFcSg9DS+OQPodYyEblwAnnXSSwSQjgoufRRddNJo4u+x41rxHm266qbn44otN2k+mkDiYhK600kre9PA9jWsCyoH/8xlmmMH6S6ecuDfK2lEP0xkLD/QJ9C+UCQIPf/SDYn45nTlxxQ3K8ssvb1h0xB0HvtD5Q4EBKYuys6uwiKUVNy/uxWwkdcNiS0joX0TKLPJw788//2yOP/54ScbgHsYnZ555pt0ZCrbbbbedVbhLvNNOO836BGdXwrbbbmtdyOB+CUxYRIJoh8UN/DKnFxdQIJG2CHFiLk1YgBHrGUVIgSzokg/1RUL3Yjb9xhtvtIQ7ys6OLchxPEsWLkNtkvRlRybvAW3x7LPPtu2Fa3w3sA5FGnx3ZGFoyy23tLtt77zzTks6xB0Li2yyOxWLMVk7rMuWWTDP+l1rrbUSzE844YTKZsaz8tPrikAZBCBGnHzyyXY3/0wzzVQoCbl3lVVWMfypFEeAxVMsB4RIAXw7t95661wJY7r8yiuvzBU3HSlkOr8oYTA0P0jnV/Q8VD43nVicIvUgnVtvvdVNuiOPY7uDr7rqKjv+85HeQ5W9++67TcjVJa7QyszbGINlzVdQSNNH+YQxtc9amC8uhOeQlB0LuumFNhcQh/Ez5IoVV1zRvSV4zJgrRshk/N4IaWWbib2/WW3ExQJrjo8//rgb1OW4CEGjy42/nuRpr4xjQ8/u0ksvNfvtt18hkgguB0PrObyPVUg2MZdHvaHPZG7hc3vLc+cZLrfccsFNT+m2wXrWNddckw5OzrPm+klEz0Gedue5rSVBWNlyNzpIIdgkxhrEOuusI0GZv1jt4dviWytkjbKsxcnMjNskAnPukDz00EPW/WkewijzYzaDdJq0+zc19s2qA+t20wvUUad2SKPRz63OOobKOvbYYxfKhr63ERIqXyPy0jQVgVYikF+z1spSat6KQAcj0K9fP6tkLLqrzFdlJuMhYgWTCibX22yzTaYClF0frtItnRcEiJiJMYk/xxxzyGGXX5+vWna0jT/++F3iuSco2NLEipCVBCZLKCJZJG6ExBYLYqZIG1GWKmlONNFEwdtRoucx84uishMnW8GKt9EFBr0ou9M7QSEaXHHFFbakEAxCizpEYDENVwIiKIyPPPJIOU1+JQzllk+JfcMNNxj6KlfY7SSLf7guQPnrW3Bk4e2MM84w++yzj3u7PUaxxgIKZcR3OX7Yxx133C7xXnnllaTMEB/uu+8+u1DiRgIjlOQQRIYMGWK23357b1nce9LH6623nuEvJvQpri95Fs3KCDuZZKc2ysgQqYx+WOItu+yyllQi+XFNdpzR16afG5hAGDj//PPNJptsYoYOHZpYxWCx5ZxzzjGyw4+2tueee0rS3X6vvvrq5BlQ5zzWlr744gtLUBEyA4lKu3UzgESBxY60RRbKjyIGYSENxUj6uwN5QtoubfuUU05J7uE+sKONssvvnnvusXUmHCxpI7QZV4hPXWlHKI6WWmop93JyXKXMSSIZByyIsNsI0trw4cMN1lFii0QZyellRaAhCIjCsii5gndN7pVvmJIryj0ixrx8F31Cv0EfCCkxJnzb6PMY+5WRSSed1FqjS98LiZP5zWSTTZa+1OUcRTDfh9iO3S43eE5ixHH51nluS4JiZtZxjZhHOQXpNeYyIsmsAw4Yi0Fk9Vk8RMnFnHKnnXbKpZhFMRMiVfBdj5EWXDJrGjYIRVltK5Y2Y7G1117b5FlkZiwakiLmlENpUAZIyr45MvewQQLySR4CGwQpGR+m8yONGKbp+EXOW9lmYnNa3t8lllgisyq4uZExZShy1tpCDNs87RVCNGnwjqUFYjrfS4jgeeSpp54Kkipoa1VIFeTf2/tMCEr0X5999pn3cUD8Zl6bRUBDucSczvfMJeHQ5gO5XrXdSTqt/l1ggQW8xArKxXoT86A8faDE95EquLbIIovw06Ml9n7S1m655ZZM90KMe/j2dKK0wze16ri0Cu7tpheoUpdm39vK51ZnXSHfM65JC/0im6ayxs/MzdgU18q5Wbrseq4IdCIC6gqkE5+alrmjEGAihIKnDmFhMzbx4qPIQnZ6t7qbNwsxBxxwQHCSSFx8s+aRaaaZJvfiTWyXC3mx0JBXirixyJumGw/SRmg3MwOVMqY63fSbdYySOiQMorJ8qbH4RzyVxiAA/i6pQpTvLsGBZ+DGSZcEJbEIO/fHG288OfX+pkkNEsnNk7C0eUmsBBx44IESvcsv/UmaVAFhpE+fPl3iQcxAaR+zpAL5gt0nIulyEL733ntb6wQSp65fFheoC2QWkbLEClehLy4fJM0yvy6pApIFCkoXG95TrFKIsHvP3cWctWhy4YUXyq3dCDbJBecAUgVWOFxSBQSatGUOdgVCmnNJFXzHUOa45b/++uvtty1mupWdXkLEcIpi+vfv757aY3apus/AzYsIkBlYuPaZSq2zzN0K5gRA4IMsIgIxREURaCcEhPQlZWJ8mQ6Ta+6vS6pww/W4HAJZ42d2GmG5ImRRjXErfbxLGixakpD5btI59dRTo991yJcooNw+uWj+xOfbERK+RbGxBfelvwNuWpBDwCimVEVpevDBBwddFLrphY6POeYYs8suu3T7O/roo0O3NDQ8NsZBaXvUUUdF55QUDitU+++/f7CcjF9iFs9C8y0SxMJYlrBAHnJHQ9unfYpVrVBa7HyOWVOJlTGUpi8c620xgYQM7qF2SBtH+RizmJLX6kWsHLFrrWozsc0AzJWyFAOQFnh/aRNVJNYW8rRX3oWVV145WATG8/zF2izXIGCceOKJwXSy2lrwRudCO/SZTnGafshmghjJBYUWbSo2T2e+RL/vzpfSFeGdjSn6iF+13aXzbNU51hZjLs7oA7HMGBMIjqxLhMYUrL2GXO7E0u20a5DNQm6iqQvfCUh4oV3jWO8Bb3eO3mkYZPVzjf6mxsaljI2yxqVV8G43vUCVujT73lY+tzrrGiNOMD6ItT/mZljHveOOOyoVqadgWQkEvbnXIzBmr0dAAVAEmoAAzGt2zLArvKpg4pzFgRDrnQUZ/jB1j6JWWPTs5mJXbMhcpJQLs4d5JyNMOImLubksydqJy+SdhbGQlQo3fVFAu2F1H7M7KWSdgp3hKLFDC3l1l6VselmMfxZM2dnN7gEmZ+xsYbLKjkZ898Z2b5Utk973HwRQ4u+8885d4JB2jZlMBqmyAxOFNbsG08JE+YILLkiCN954Y2sBg2fIZNl9/oRlCUQIFn/Y5QFBY+TIkdbSgCwGQYzArKZrVpLBOIvWIosttpi1GgDpCmEBc/DgwcluCNLi/YFAEZMBAwZYc7gQNFCCs+CN1QORs846K+rOQ+Jl/UKSor+kzWP5wV0cY1eq1CMrnfR1V0meZxdd+n7fOX0k7jRkFw6TpV133TXBlmvgJIuAmL+WnXkQ6lg4SbsMIR8Wgt13Xe73lYEwnikECnchBsUefYkr6TZOm2YHrMRjYRhloJB6aO+HHXZYssvdTcs9hliChQ7aNO3PR1wR10VYpqCvBjv6c5R7tGMRdtjusccecmp3LLvvZV1lTjJIHbAgJO8wu86z3ovU7XqqCDQUAb4hkLjE4gSZZVmu8JEqSEOtVZR/VIxHGRcwhg8J/QfX2aVMfMZzP/30kyUCQ6jwWZsKpeULZ3wSmj+8++67th/FvRFjfbE8hMUhXPphbcP9tvrSzxMWM3vNd4mxBd+TGAmEHX6Mb32C1Ty+lczX2KnMblDGWRDwGCfwfQ3NvXzppcP45sl4Kn2tCLk8fW+Vc76nMSsKzDcHDRpkXVQw9oCwjQIQTMS3fQhPKRdtNyaTTz558DJkF6wdkneMnIHbvND8kbEKyk+eK9Zf3HeB54m1A8aUMYW7b+wULHTkAn3q6quvbncSh6KxGD7ddNPZTQ68yxCi2THPO8SYKVZOxsyMwxsprWoz1I01jVD9Gd/xrPnWoISm3UCYoX+CdJG2ilkWozraK+RfLM6FNjjQ19CfUxc2k9Cn0n8wjqUdYIklZLGEeqFsdeeAZevKfa3sM6uUu657IT3Qx4X6F54hFgHBCXceQgCinTK/uuuuu6JF4dnmcVdUR7uLFqSJF7Gu68690lmj7GPcyUYv+RbL2gZkFq6F+gHSYp6ZRVRJ59mp57Q53451qQ/zc6xS0T7pQ1nfYY2I9Y8sAouk0c6/rf6mZo1LacuMS2MK8Cr4tpNeoEo9mn1vq59bXfVlzsX8xCf0C6xpYRWWTU7ybWI8ybeJzUrNmJs1+h3w1V3DFIFmI6DEimYjrvn1WgRY0GFBLTYRzgMOCnB2IrvKTN99sJRjO1p897Bgsfnmm/suBcP4oGcRK2COx0y1SuLsygtNXCUOC6axRVOJV/U3tjOAhQ0UgAgTXRY7mCDG7qlanjL3syCXRVZhwZsFeZX6EMBiDDtU0kI4bYdF3GOPPbZLXwARikEvgkKEhWyx3IC1AR+xgmcnCmQWYZk0lxUUyEy+mXSLzDLLLJZs4FrJoQ9zF8m33XZbiW7D6XNcX8f0KSx2snAkO6uwCoFLjtAuCxTl3COCUpxFJzAVxTMLpCyIx0yjyv2xX6wgsOCeFky2brrppungXOc8Y3dXt4tprgQCkZgASRshCotG4ISCQ3btQKQQYgQ7glhgFwsc1NWnHChi9YQ2zIKwS6ogb7dNSPEvvvhi6wZLzmmvrt9vlCR8F/l+CPnk3HPPtQQat55yP7+0U3CQCXHaUoobF2wg6IjQPx966KF2MQkLGQhpuYt7jSiz5O/7nWqqqZJgdlyiBMiyOpPcoAeKQBMQEEJEHnKFkioa90DY9c/ieGz3Edfo0xohKLYvvfTSYNIoOeg/GykoxJlLoBDwCd8l/hgXQIpg/LHffvt1GZOgqIkRAZijueQ7Xz5lw4Qs67sfhX+rhEV/dlbGFFUoB7MUhL7yo0CT77XvOmFZczoIM/wRD8ImY7P0eJcxCOPP0CIx7r0YdyOMyVC6oxCN1dlG/vUf715WGSVunt91113XLoSHlOqkQTuE7FFUsFwWI6AUTS8UvxVthrkFSm7GsiHh3Y6936H7ioRntYU87RUT9tttt13QEiDloW2y25y/IkL/R9p1iRALQuk1ss8M5dnMcN4n5roQ2WNStu0xv88zl62j3cXK38xrrE/Rh8TGFG+88UbUbXGovKwtMLfsLQKxIquP4FsDKa+nSiu/qYxLWYMLre/7xqVY+HLXyqo8l3bTC1SpSzPvbfVzq6uurPOxMSwkjCMgKDdSegqWjcRI0+75CIze86uoNVQE2gMBBlCuErJKqVjgjJmRLJs2rEZ3N3qedGSXfSzu/PPPn2uhJ8uqBXn4FIOxvMtey7vjh8kKJoRRprajsIOwqrAo6lOcVk23p94PM5eF2/QfFiHYVceCV3oChnUEVzbYYIPkFGsCL730UnIuB5dffrkcWkIUA9uywi5kHwEAcoXr0sP1M0sdXEUBZKPQRJHdPBAkRFyLDhImvyi/fZJeKPnyyy990QqFpZ+D3IwyAHJLmd2pWPpwJbbLyI0XO8ZlRIhsgH9fEYgv7EQRYZFdBMsImP1zBSUFZAYRrJ6EBBIPz8D1xw5ZItQ3YJ1CBDcyLqlCwvmlT2dRRCS2+APZKEtJQzrsYGHRLi28I5B6ROi7XWlEmd3008csLroSUhi6cfRYEWg2ApArhGAheafdgvhIFbyH6fvkfv0thgCEK1+fViyV/8TGfVLMN7cvTRQ/PutAvrixMAgE7HgvK4yhsoTvNmNziNpp9yiMaVyyaFZaoeuxb2Xontg8Ic9cKpRu1XBIBrgnyaPcK5IX7VVIk7H7qLtYOYnF43vNGNQlrkp8UX7KeewX8gVtIw+pgnFxeuwZSzvPNZTq4A3xp05hbjH77LPXmWQwrVa1GdyQ5GkrwYL/90IeCwGhNOpor6QN+bksgTtUNsKxEhgirsfuC11rZZ8ZKlOzw9lt7lqzqyt/+si81k/rand1lb1qOhDW8lrIzZsX5BPaf28iqGNFyp3r58UqHQ9yQB19azrdZpy3+ptadVxaFaN20gtUrUsz72/1c6ujrlg0q2Mcwdwsjx4mVOaegGWobhquCORBQIkVeVDSOIpATQiwO9XdQVslWT6iWK6oQ1D8odgtY4o2y78f5cOMZR5hJ1rWwl6VBdk8ZZA4U089tTXXKued+stEqeqAiwlbUcJNp+LV7HJjqeLFF180tDdXUEK7Cuv0Di1MbMuue+5ziRhuOnmP07v/3Pumn3765BSLBSKugh3yBS5lQoIy3FUK+RbGuRfyhY/gwTUWD1xJkwTca3mPcRPBLsynn37aXHHFFV0wZydNGeXJp59+mmSPhYU6zJHGFk0gJpCPiGsSEJPTIhAjMAnvCpY/8lo9wZQgpotFwA3XUT7BP7hr8hxT44SF/lzlS6htkA8LvHkE60dYfvGJa44TYolIo8os6ft+3bJwfdSoUb5oGqYItByBGLkiRKpohCKi5UC0sACMf6sStPnW5yUOp6uKtYey95IWcw3KH+qb0/n5znGf5I5JfHFiYZDrUECHxhmxe+UaO0QZuxUVl/To3ouCtdVjbMZwEBezdkW75Y4dY9kqL6mKMRLmrKsK7eKQQw6pmkxyP8ppLKw14tmQNhbGmKPVIeC3+OKL15FU7jRa0WZ4FrgkrCJgVYXIVFd7pQ5sktl9992rVKfLvZDY8yrqu9wYOaHP3H777VvSZ0aK1fRLfDvpX+oiRPHc8/aRVLbOdtd08DwZQoZjjOgS6z3RcgfxXLBiWJQ0mjuDNo64/PLLWzdXZYvI2itkP5S0nSqt/KZWHZfWgXm76AXqqEuz0miH51ZHXRlHsM5WVpib7bDDDi2dm5Utu96nCLQLAkqsaJcnoeXoNQiwMFmFEegCBTuQSV6VHdEoxlhMS++cdfPJOs4yYZt3Bw2TLKxbxMTdPR+LV8c1rD1UWcCtowx1pMEzRoFcVMGLch/XC1UWoOsofyemgaI7/QeODHwhV7GDHxcKV111VbCNuSQs3IHgL13kxhtvlEPDxCBNzEgu5jwQv3u+6O5EG+WzCKajRfIs5LkLyLhD8UlMcU7/4IpbFje8yDE7V1mMhlS2xhprWL+trtsVzKpjlaGIuMpxt85F0kjHzdp95uKPaxARFqHZnSxCe3MFMokI5I2Y1RNxKSLx0yQNCec3beIaf7eQZkJ/rgIWn+4hyYtnDC+XvPf9998nWTWqzEkGnoOxxhqrCynGbTue6BqkCLQUgRC5AusVrmCpwn2n3Wt6XA0BvpGYJM9juSedE7u03XFF+nqec74TZSyhMV9BSV11JynjAEjlVZRbjGkoS4xQGsKib9++BotWsW9l6N733nvPe6lZlvi8mTuBzAOPOOKIUrhIMiismZcWtQgAGZL5cVWh78GVS1WrJFipOOiggyq1s6y6sDuYuQBWGMoKc9RjjjnGMMZqhbSizTC+O/roowtbZQBv5rR1YFVXe+WZ8f7zDGPj1qxnyzzwlFNOMZSrEdKqPrMRdamSJv3LUUcdlXvDkC8v5jE87zL9fp3tzle2ZofxHYVYUcWCD3M6rGkxDk2T1Ztdn1blB464tRRXoEXKwZgSS6HuBo0i97dT3FZ9UxmXDhw4sKHjhTw4t4teIE9Z2yFOuzy3OrBgnd+1yJo3TcYOuESuY27WDu9A3nprPEWgbgTGrDtBTU8R6FQEiiqdy9aTwS8fHnYVlDEzn86XSd7xxx9vUEahAHz88cfTUbqdMwmB3bjUUkvVMpCGKHLzzTd3y4cAFgqwapFXMHf/8MMPe6OzYOcqeb2RagykTTDYoDz4ji76vNKK4BqL1i2prB1VTMZZgBs2bJjddS671Lsl9GsASnYmZ0IAQoHtunHw3aNh/0OAHRP4T6wqrrUBXG48+uijiUWFyy67LEm+qkUSEkLBW1Tc3f5paxK+tFzy1ttvv+2LUkt/5E04ZyDvLO/8HXfckZibvvrqqwstxLruUrBSVIe42PnSc69jzcSVTTbZxPZfhEGkOOmkk+z7jCsV6iZS1OoJi4v0E76F3NDzlbxiv7i+CUmedsa9MaJQKO1GlTmUn4SzW1lc6qSfncTRX0WgXRCQHZa33367t0hKqvDCUmvgtL9ad0Pp+/zzzxvcaoUsIUimWJNiwc3dyckC9BdffCFRkt8swgbWJrBGAKH63nvvDY7XJUFIi5ARKLNIVh4SL/TLvOLEE0+0846Y66jQ/YQzZoZEif9rLDe5FpZ890GK5Rvpzmcgd+RxJyHpvfPOO3LY5TevVb8uN3lO6pgf4eIBUhRuNx588EE7Fsoz90E5QxvLS6T3FN9A2sGkNW7LQlj57kuHsdkAJdOIESNsHbBIlqcO3IdpehTvzVIyMc/cYostrLuR4cOHW3JvnjZFObEeg3K2mXPNNNact6LN0AewKYR1D+a1sfbCmgdkMFwPYDIeqULMsgn8+q+u9kp6zBUgi2D9if6Idy+PYD0HxfQUU0yRJ3qlOGBG38D71Kw+s+61udC3x/02ZoHENwB3E7gUAgfaX57+hW8IfQtj/ipSpd01s68IYe2rO/0Zfdmzzz5rxxVY8swS2iN4MialD+o0oV/K027y1otny3yfdVTGha71Sl8ajAFZPwL7LKKoO+7xpVVXWKxfzrsO2apvKt8k1lcYk5YZl9Ie6pBm6wXqGHdKvWNr2bG2IfeX+a363Or+RoXqQPsIuVvmHuZmWJaFVIxF2awxBDoV+gt3w1KRPttXzqpY+tLUMEWgUxAY7VdW//+2n3pK7Vsw90TTIEVAEWgTBFCYix9adr+iqEFpiqKJQTR/LB7FPs5tUpXMYtSxYz2dCWn60v3555+t8osdZ/x98803diLCIg2DPfpKsBUhfkh8eUie8su9ciy/vjC5Jr/ESect58ThD8sH1IH2wQIe5ac+MP0xA8wgOX2PnLMAWJd8svTMpZOadNjfS9/LjSyGICFXBvZigX8s2LEoitRFrCAtTFZjrQLZfPPNzWmnnWZef/31LrtleN/TiwooWphciXz99ddyaH+zrruRsXhw3XXX2aAzzzwzcS2DYgcXQghuPs466yx7HPrHYjmm5hAWUB566CF7fO211ya7aFkgSbs9sZH++8+tJwr4qpY63LTd4/32289OkAljoR8FUl5h1xhtAMEKhmsVIp0GyilxfcHiHAscIph9f/PNN+0pzys24YGEI22aZ+Kai+fdRXEjaZ1//vl2NymuTgYNGmTTh7F+yy23SNb2F8sXrsUeFjVYLIAVL2lhQQjCT3piiZLKNRkPmTDvgh7fpiFDhtgyvPHGGwnBi/xdaxxdCvvrCTuezjnnHBvMAvWOO+6YjmLP3bJhRQZf64gbznnZMnMvfamQ10jXfRe57gpuUFDuIbwjRQkublp6rAg0CwGIFWlyRbNJFUIkpv9qpDRrrELfjNBXstAti91yzjUJl2uEQcxirA+pjz/6UMh2KNsY07Hg5va/cm/oV/Jxf91juY8wrP7wPYCkwR8KaUiX5M9cgzGymzf3pMVNL31Nzonji4dLsA8//NC8++671lISigrqyzgWZRnfodh8R9KEaPjWW2/ZOnA/6XA/Ck8wzKqDlDP0y9ibRcy0sFh63nnneeuWjtuKc54l1pykbfFLmXmuPF++dcwvq+KTrhvtGcUlz5V2BX6MM9hVB4nDHZuk702fMwaijeKmjTkPLu2+/fZbO25m/sMfY8l22O1MWRnngDPlZZ723XffWSIQ7REFFyQldyycrm+rz1vRZugDGCfTVnietB/6IP7ATN7zRmFTZ3uljMzJZS2HtsAcjjrQBujX6WeZEzS6XjG8Gt1nxvJup2u8n/LO8r6CC+tu9FeQwVkb4htSdUewr851tztfHq0Io170f/LdoV+kX5FvTqPwbEVdG5UnGDKm4Zc/xkrgR//Bt46+pDdIK76p7riUbxN9hIxL6bexlBobl9b5XHqTXqAqbu303KrWhTbHejHvPuMi+kzqx7oX/UB63a5qfun7exKW6brpeXsgQNtGYoSsOkvKuBzhvfLJmL5ADVMEFIHORQDlE39FFp06t7bNKzmLhkxE+EMpzCJfpwp1gVUqSmnqIn/UqZPr1qnPJFRuCAtCrIBwwC5NVwEO0aVVC6zurhtRtIfqQTgL5CLN2F0lefHLxBorFJQTUhFmwGO4uZYRWNwpIu7ivFgiKHK/Ly4T8xixwsU/vdOS9x3z71jiQK6//npLrBCyDGF5rJ5AHMLlyNChQxO/wJBbIEFgztoVlwFPOLvcUAa0s7SqzK4LErfttDNWWjZFIG25otmkCn0C/0EAxRoLZvQdHIuirW5FdwhvFOwQ7CTfULxGhaPAYjzLXxXh+8pOz0YJCiKf4I6kVdj5ypMOY/Efckld1rfS6YfOUYbzB8G0qvAu4NqQv3YXysr4uNlj5DpxaUWbaTVmdbZXngVKeMbM/LWrNLrPbNd6p8uFgqqOb1A63Tzndbe7PHk2I47Uqxl59dQ8FMP/PNlWfFPrGpfW0TZVL5AfxXZ6bvlL7Y/JdwmrFK2SnoRlqzDUfDsLgdE7q7haWkVAEVAEFAFFoPcggLUEUfjCOmeHrmticOONN24ZGFIuCoBJcnYBxkQsVBCnqhIklo/vGsxpLAHsvffe5tRTT7WmW33xJOzll1+WQ0ukSk5yHLjK8aKkjFDyL7zwQuiS3a3rEiswvZ4W19/5rbfeanf23X333Um0PH5ZIVUgmLPFeooIxAqxuCBhLLgymRfBdHBMsOqAz+Err7zSPPnkk7GoDbvWqjKzK1cEBamKItApCECu4E9JFZ3yxLScrULAJdC5ZcBqlYoioAgoAoqAIqAIKAKKgCKgCCgCioAioAh0FgJKrOis56WlVQQUAUVAEehFCLCT0VVin3322YniGWIDxAufNGO3KrtURSB9nH766XLa7Rc/yI899lgSLrudk4AGH8DcXmGFFZJccLkQEkx8XXbZZcnlou5iXOU4bj4wX1pVIC9gdcMnuB4RoU34fJxDZHHN5UMwEaF9xax3SDz3F9/WrmWMLbfcspuvWExdimAtI+RLFgs522+/vTnkkEMM6YgbELm3mb/NLnN6F7PbdppZb81LESiLAH05FmlUFAFFIIyAS6BzY7VyR5lbDj1WBBQBRUARUAQUAUVAEVAEFAFFQBFQBBSB/AgosSI/VhpTEVAEFAFFQBFoOgKutQHcOIjg3iFkQhr/4q689tpr7mktx7jLGDx4cJLWoYceam677bbkXA5GjBjRRfGGQh6/582W1VdfPcnyzjvvNGeddVZyLge43HCJLFhdyGPNQe7n13WRwvlLL73ETyXB5QZkhjS5AusTLrFi4MCBwXz69++fXHPbUd++fZPwvAf4ZnXzhUBy1FFH/T975wFvRXH24aEJqBgFKSIqgmBXEMWCDUXsmth7N5bEGLuxEXusMTHGqMHPih17xd7BEntiR4qKgFiwIcjHs2ZO9u6dmd095d5zzv2/v9+5Z8/s1Gf37s688847DZLHtwfBowaTr3Z/unjEESNGGDxWWDn00EPtYZN/N3Wd4548MIphr3qJCIiACIhAfRH4+OOPGzUIL1BNtTdso8IVIAIiIAIiIAIiIAIiIAIiIAIiIAIiUDSBtkWnVEIREAEREAEREIGKE2Bv62HDhpmHH364QVlsbeGTpAcCDBkGDx4c7YV+3nnn+ZLlDj/yyCPNyJEjzdSpU6O01IntSdguokOHDubll19uMAFPpKuvvtqwL3tTC4Yot99+u3n00Uejoqn7448/brbbbjuDIcrrr79uLrroIoP3DSsYX/Ts2dP+zPRN23bccUdzyy23RPHHjh1ryuHuG08OL7zwQlRf9l9+4oknIpa2UngQOeSQQ+zPRt8YiGAoEm8fk/l5PXLYjLfZZpuoLtZI4/zzzzcYr6y++upRFParP/jgg80//vGP6Pd1111nYMF1YN9ojApgFF/Ji1eNoUOH2iKa/Lup68zWPla23XZbe6hvERABERCBOiLw0UcfNWrNaqut1ihMASIgAiIgAiIgAiIgAiIgAiIgAiIgAtVPQIYV1X+NVEMREAEREIEWToDJ6LhhBYYLSy21lJdK27ZtG0x6M5mOQcG4ceNMOQ0rMOC48847o8lyvBYgN9xwQ/RxVQ4jDOreHNKmTZvICIQtQWxd77rrLsPHJXhg+OUvf+k6lRqGe3xrWPHMM8+Ygw46KDVNlghcQ2sYEo+PUQVGI+3atYsHNzjGGAPvFGwnYwUvFqVsG8O99NBDDxWMNQ444IBoyxfrMYXtPbj3MKpA4H7SSSfZ4ht8Dxo0KLpvSqlPgwyL/NGUdX7yyScLtdxss80KxzoQAREQARGoHwIuw4qVV165fhqoloiACIiACIiACIiACIiACIiACIhACyKgrUBa0MVWU0VABERABCpPAE8N5ZbkpGt8WwdfWZdeeqnBq0BcmOT+/PPP40ElH7PK/7nnnjN4gMAjgkv22GOPyHvFLrvs4jqdOSyef/v27TOnsxG7desWGZckt62w5/nGO8irr75qfve738WDcx1vvPHGhfi33XZbwfCgEPjfg6RnkeR5+xvjhQMPPND+LHzD4+ijj46MLZZccslCuO8g6eUk+TueLgvfHj16mAsuuKCQDMOJuOEG9cPrBwww/nAJW8P8+c9/Ng8++KD3/iGdNdZw5ZEnLP7/ibFJUspR5yx1xTU8/zcIZRbrOSRZf/0WAREQARGoHgI//PCD+f777xtUiPcQnpskIiACIiACIiACIiACIiACIiACIiACtUeg1YUXXjg3VO2BAweGTuucCIiACDQbgblzg4+voupFnlnyTYvz008/ect3lWHzs98ktsf22xVmz9lv4iTLtr+JYz/JvJLhyTT293777UfSssjUof2LzqfrY+8UnZaEdtV/rUxmTpkyxfTp06fQZn4zGZtF5syZY4iPcr979+7GNZmcJZ+scT799FPz9ttvR8YEiy++uOnbt29V7iM+e/ZsM2HCBPPee++Zb7/91vTr1y+qa3ziPWubXfF+/etfm+uvvz46dcUVV0TeIlzxfGErrbSS+fDDD6PTTz31lMFtOHV+4403zMSJEw2GFNQ5z/W8++67jTVuwXPIfffd5yu+IuFwfv/998348ePNIossErWBrVbwsFKtUqk6z+t/m5NPPjlq9jHHHGP++Mc/VisC1UsEqpKA3UqHLYQqKU3VV7nyyiujZuC1p1WrVtGHAPubYxvOt/1tv+05fic9/8R/u9LaPPhGknF8YTbcxud3UuJlJ8/xO5TWxidOlng2ftbvSuTpKhuD1m+++aZwii3D6I9JREAEREAEREAEREAEREAEREAEREAE0gnMmDEjitSpU6f0yGWIgT4YQY/tkurVZLtqqzAREAEREAERaIEE7LYSNB3PBVmNKojPFhhMXjeV4MWAT7ULk/kYq8QNVspZ56OOOqpgWMGEGdtwlCrUecCAAdGnmLyuueaaQrJyGkkVMk05wAgE9+e15AK9EnXGUM1OooLs0EMPTSGn0yIgAiIgArVKoHPnzoaPRAREQAREQAREQAREQAREQAREQAREoPYJtK79JqgFIiACIiACIlC/BCZNmmTOP//8QgP33nvvwrEOqpfAsssua7bffvuogmz58OabbzZrZR9//PGChwoMc7bccstmrU9LLvyJJ54oeCNhyxm2qJGIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAhUNwF5rKju66PaiYAIiIAItEACF198sZk6dWrkOvq2226LjsGw3nrrGW3RVTs3xPHHH2+4fshpp51mbrrppiarPFvAHH300aZLly7R1hs33HBDoewjjzzSdOzYsfBbB01HAG8VI0aMKBSIYYVEBERABERABERABERABERABERABERABERABERABESg+gnIsKL6r5FqKAIiIAIi0MIIjBs3zowePbpBq/EycMkllzQI04/qJrDCCiuYk08+2Zx++unmnnvuMc8++6xZZ511mqTSbAEzatQoM3PmzAblDR482GgyvwGSJv1xxx13mJdeeikq89JLLzWLLbZYk5avwkRABERABERABERABERABERABERABERABERABERABIojoK1AiuOmVCIgAiIgAiJQMQK9evVqlDeeD/r27dsoXAHVTeCoo44yAwYMiCp54oknmrlz5zZZhXv37t2grMUXX9zceOON8lbRgErT/Zg1a5Y55ZRTogKHDx9u9txzz6YrXCWJgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiUREAeK0rCp8QiIAIiIAIiUH4CBx98sFl++eXNxIkTzaBBg8yZH2RWAABAAElEQVS6665r8FghqT0C7dq1MyNHjoy8R1B7PEh06tQptSG33367+eGHH6J4ffr0SY3vioBHhLFjx0Zlso3M6quvbtq2VdfPxaopwiZNmmS22267yLBlr732Mq1atWqKYlWGCIiACIiACIiACIiACIiACIiACIiACIiACIiACIhAGQhIu14GiMpCBERABERABMpJYKmlljJMvErqg8Byyy1nTjvttFyN6devX674rsirrbaa4SOpDgIYyOS9D6qj5qqFCIiACIiACIiACIiACIiACIiACIiACIiACIiACIiADCt0D4iACIhAmQh8/PHH5uWXX45c/Sfd/Q8bNsx06NChTCUpGxEQAREQAREQAREQAREQAREQARHITuCnn34yDz74oBkzZoz59NNPTefOnSPPeL/61a9M+/bts2ekmGUnMHnyZPPSSy85tw3cdNNNm0SXUGv3RzUwK/uNUIUZfvLJJ+b66683b731lvn+++/Nsssua3bbbTfjWwiALuzxxx83X331VaPWsIDEbpOZPKnrmSRSX7+nTp1qnn32WWej8NLq2g7XGbnEQN1nJQJUchEQAREQgYiADCt0I4iACIhAmQjgcn/06NHO3IYMGdIkyhBn4QoUAREQAREQAREQAREQAREQARFo0QRuvvlmc9dddxUYfP7559FvJk6POOKIQrgOmp4AuoRbb73VWfD666/fJLqEWrs/qoGZ84LVUSDPiBNPPDEyqLDNevvtt82IESPMmWeeaZZeemkbXPieM2eOueKKKwq/4webbLKJ17BC1zNOqv6OMay46aabnA3r0aNHkxlW6D5zXgIFioAIiIAI5CTQOmd8RRcBERABERABERABERABERABERABERABERABEagRAt98800Do4p4tV944QXz0UcfxYN03MII6P5oYRc8Y3MfeuihBkYV8WR33HFH/KeORUAEREAEREAERKDFEJDHihZzqdVQERABEXATmDVrlpkxY0bB7SiuG/m0atXKdOnSxZ1IoSIgAiIgAiIgAiIgAiLQAgh8/fXXZubMmY1aytYJbKUgEYFKEyjHPci2lSHBPTpu+iUtk4Duj5Z53dNaPX78eG8UGWN50eiECIhAjRD44YcfDJ55ktK6dWvTvXv3ZLB+i4AIiECBgAwrCih0IAIiIAItkwCD5UsuucTZ+F122cWsttpqznMKFAEREAEREAEREAEREIF6J/Dggw96t/u78MILDS6sJSJQSQLluAc7duwYrGLa+WBinax5AmnXP+18zQNQA5wEFlhgAWc4gaFz3kQ6IQIiIAJVRODdd981Z511lrNGhxxyiFlvvfWc5xQoAiIgAjKs0D0gAiIgAiLgJcDqqHqW559/vp6bp7aJgAiIgAiIgAiIgAhUkAB9ZRlWVBCwsk4lkPUe7NmzZ+RhxbUyk0L69u2bWpYi1C8B3R/1e21Ladkqq6xinnvuOWcWAwYMcIYrUAREQATqgcCXX35ZD81QG0RABCpEoHWF8lW2IiACIiACIiACIiACIiACIiACIiACIiACIiACzUwAt9aHH3646dChQ6OaEL7QQgs1CldAyyGg+6PlXOs8LV1//fXN2muv3ShJ//79zTbbbNMoXAEiIAIiIAIiIAIi0BIIyGNFS7jKaqMIiIAIiEADAhtttFGD3/ohAiIgAiIgAiIgAiIgAiIgAvVMoF+/fuaCCy4wL730kvn+++9NmzZtzMCBA+V1pZ4veo626f7IAauFRG3VqpU57LDDzAYbbGDYQhYDnK5du5o11lgjOm4hGNRMERABERABERABEWhAQIYVDXDohwiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAjUH4FFFlnEDBs2rP4aphaVhYDuj7JgrLtM2BKEj0QEREAEREAEREAERMAYbQWiu0AEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEPARkWOEBo2AREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAER0FYgugdEIAOBH374wbzwwgvmww8/NNOmTTNTpkwxn332WZSyS5cu0R6DnTt3NiuuuKJZbbXVTPv27TPkmi3KV199ZZ5//nnz8ccfR2V++umnhk+HDh1Mz549Tbdu3aJP//79zYABA4ra5/CNN94wlJOUJZdc0vTq1asQDIdnnnnGEB8Gn3zyiZlvvvlMnz59zNJLL22Izx6thIXkgw8+MO+9956ZMGFCtE8jvxdaaKFCW9ivEY7t2rULZVM49+WXX5q33nqr8NsesGfs6quv3ogJcbmWEydOjMrnG5eXSyyxRFSHpZZayqy99tplvY62Tnm/Yfzyyy+bqVOnRh+4z5gxI7rn2NuS+497gHbShixCe+39S/xJkyZ5k7344ovmF7/4hZk7d643jk6IgAiIgAiIgAiIgAgUT4C+de/evaP+cPG5/JySPht93f/85z9m+vTphT77wgsvHPXX6e/Sv2fcEu+z089/9dVXDfupJ4U0iy++eDK47L/p41IH6k/d+f31119H5VB/+rr0fVdYYYVozMH4oRLyyiuvmG+//baQ9UcffVQ4Th489dRTUR89Hs7YqEePHvGgqC/93HPPNQizP1ZeeWXTqVOn6OePP/5oHn30UfP6669H45TPP/88Gvexv/3ee+9tk3i/f/rpJ/POO++Yf/3rX9FYh3ESLBnrwQt+cOQeGDRokOnbt2+jsZI383knuL+ytIM8qAv1YDzBWIZxNGMQxi6MHe29uOyyy0bjjVC5aecoizEl147vZLsXXXTRqN2Uy7iJcWu5pBK6gkrcg7T3zTffjNgk254c98fPM2Z3jRf5n+R/MS6zZs2K/ocZb5KOMT/3MP8PPEO6d+9ull9++ej/t3Xryqzz4p777rvv4tWKjjt27BiV2+iEIyB0n3Pf8skitJ1ncVJ49nIfFiv8P/PsgS//W+iKvv/++4gxrLme66+/fsQ7TxnF3B9p+XMf2GcAdUWXBReeR9QVPRr3xpprrtlA95SWb97zlWKWtR48l2i7S9B/ZdV9+XR36Gx4r2eR2bNnm3Hjxjmj8l6I6zPhRplJQddGvSv1f5wsr6l+0+fgHZfUv9r71epf4cT7JK/keZ7yznzyyScNfRCO0Q0i6Cv58B7nu1+/fnmr4YzPM4S+B/0w/lf5P6X/QDj/p7xHee5THvraxRZbzJlPuQL//e9/F/S26G9hZ58XvEto+7rrrtvgfi1X2Xnysf1u+q52roB3pn0mU1d0t9R3rbXWivp0efIvJu67777bqG9q81lnnXXsYaZv+qXMh7iEOQnGL1mF58lrr70WfbjH6OcThnBvcX1hxdwGWw/x3i63cC/Z/yXy5r7yyRNPPBHVKX6efjT91jxCGys9r5OnPoorAiJQHgKtLrzwwuBsGZOkEhFoqQQY+DzyyCPRh05RVtlwww3NdtttF3U8s6ZJxkMh9vDDD5unn346ecr7m87+ZpttZlC8ZZ1kJ7MzzjjDaZjAQHfeMyIq76GHHjI33nhj1Dn0VmDeCQbFhx12mFNZhYLr2muvNc8++2woi+gchiO777672Xjjjb1x6cAib7/9tjnttNOc8Q4//HAzePDg6Byd3KuuuirqxDkjzwu0eVL+lltuGe0/axWd8TQ2Xjzs9ttvN6NHj44HFY4vuuiiwjUhbTK9/W3P0SkfM2ZMsK6FzP97wOBm6NChkYI0fg5FI2LzvvPOO6N7y8axZdvfrm8bh85vuWTq0P5FZ9X1sXeKTquEIiACIiACIiACIpCFQFP1VVAiMpGxww47RBN/1riBCQt7zLf9UPdkOP29l156Keo/MiFgxcazv+03Ze6zzz4G42zioLQ//vjj7ekG3zvuuKPZYostCmXak/H62LD4d9qEi60bk4OjRo2KDALi6e2xjWd/22+UrowX4obg9lzaty9P0p144omRMj8tD995DCsYX8WF67PHHnvEgwrHm266aWQ0gSL8kksuaWAAbSNhfPGHP/zB/mz0zeT+PffcY+69997U8Vo8MWMexq2bb765YaIsTbK0gzwYQ99yyy0FhXkoX+pwwAEHmLzKfvKkPhii3HrrrZnKsvVgcox7h4nBYqWSuoJK3IO08+yzz44mzpJthgfjVZfccccd5uabb3adiu5Xq3dgUv6KK65w3r/JxOgZtt12WzNkyBDTtm1513v52kgdrrnmmkzlMdHiex4yMfa73/0u2STn7/vuu89cd911znPnnntug2cXegTuY5fwXIDzzJkzzfXXX2+Y7MkiTP7y3GFiL4v42IXuD1e+duIeHRJ6razCRDXPw/XWW6/R+8aVRzUwc9XLFYYO5qabbnKdMn/84x+jd7HzZCyQ5x3PSpdukufoyJEjM3HDyOOkk06K5fy/w/3337+BDo730ogRI/4XIXaErg2DmKRw/ffaa69kcPR7k002Mfvuu6/zXJbr6UxYhkAmwrlf0cFmlWWWWSbSv8Igy/uTfLM8T+mPXX311VGfLktd+D/nvsC4phjBgAJdbx7dM+XwHOc9SvlZBB1nsm9k08XvJfS2tB8DwzThvt9qq60M95VLb+tKX677jH4Xk+X0vSZPnuwqyhlGf2v48OGZn8vOTFICL7vsMu97gv52HsHY6KCDDnIm4T2+8847O8/FA+kv8e5inJJHmFvZZZddymJ4bsu94YYbzN13321/FvX9z3/+08w///ypaZtyXie1MoogAnVAAGMsJOvzvtQm24UW77//vjOr8o5gnEUoUARqkwDKIAYmxcjjjz8edbAYMDAozCMMQhh806nPK1hBovS46667IuOGUg2jGLjxwRgh6wCDDiVKCBS1dBatsKLi//7v/5yDQBsn/s1gEf4YTRx44IGZLfjjeXA8Z86cKIiOE4OFrEL5t912W6ScRrHVFKv0qBurfGi3zyI4VH88W/DZaKONIgVpmjI7lJfOiYAIiIAIiIAIiIAINB0BFLQoO5mcZKJ7gQUWyFw4/dYrr7zSaSjtywRj2fPOOy9a7bfrrrv6olU0nDZjdM3YqRixq95Q7GKUUi19X8ZzeYTxCsYwTGq6JszS8oLD5ZdfHq0uTYubPE953HdM1B566KFFrcC1edIOxjKM+bJO/JKWOvztb3+LVrUzfs6qLGPF4V/+8pfgakNbt+Q3njP+/Oc/R6tumTDIWqbNp7l0Bbb8tO+892De+LZ8dAX2+ZNnUo5JFiZ+0BEceeSRmSYobJlp3xghseraJePHjzdMhqaJy8uETcNkH+3O8rxhxbVLmAxkpW8e4X4/55xzMhmu2HyZxOKdctxxx+VeYWvz4DvP/YHS+4ILLog8x8TzyHLMSuJ//OMfkS4NHZA12smS1hWnOZkl6xPyJsHkG0aOaYLBj+8dQTjnWRWfJhhL+CRLPWxaVrLXg6A/zaMrtG3GKJR3FwuieI7lfY/YfOw3zxWeGfTNfNfZxo1/2//zQw45JLex4P333x/1w+L5ZT3mOc7/OgaKGOSw0K9UCRmeuPKGEwZp6M9PPvnkJtPb0of405/+5PVC46qrDYM5n9/85jeRcaENr8dvFuixANFnNJjWZju3UqzxbVr+xZ638wy+9Lwzq2Vex1dHhYuACJROoHXpWSgHEagvArwAUUwWa1RhadDBu/TSSyPFkg1L+8ajw5lnnlmUUUU8b8qmM06n1HoaiJ/Pc4yhRlajini+GGOguEAYzMMiz+AgSjjvDwoaLEpLkccee6yogRJlYqyChT6DpkrLF198ESlLijGqiNcNRR+8XS5Q4/F0LAIiIAIiIAIiIAIiUF0EcMHMxHTWPjx9VSaXWQlYjNDXRvmXtbxiynClwagChXyxRhXxPFkJzPitqdsQr0Mpx0xOsXq9mLES2x6g3GfFaSmCcfzpp5/u3PIha75MCjEGyWNUEc+blZ/cE1muIxM6p556alFGFfEyMUqHX9ZxU3PqCuL1rpZjrhUrN/MYVcTrznMLz5OMg8slK620kjer0IRyPBHGSj7h/zS0PZBNBxv0IC5xbVfqimfD+P9msUd8O097Lu2b+vK/4jPySEuf5zw6Ezzr4BGhFMF45aijjirpeVRtzPBkhEGNS0KGPPH4adcwaz/AVx4T48V4gIrXsZaOeZ5jlFiMUUW8nSwGY1I/7i0sfj7rMf83vIeL6QuQBmNB3zPHVQc8qGDcWqqgv8ToK+t71FceBio+70i+NDacvjDXwLeq2MYrxzfvERYT0g8pRfBEhGevLH2eUsppzrT8bxVrVGHrzb2NAVMWz9c2TXN+V+O8TnPyUNkiUM8EZFhRz1dXbSuKAC/sYgwJfIXROcQCOk3ohDKBT6e8XEKn1OduMEsZDNyz1N2XF0pa3OagYCtFHnjggWh/3mLyYHCCsqcUoSOHe8ZiFBlZy/3mm2+iQRSrNMoh7INJRx0Fp0QEREAEREAEREAERKB2CGCcHJrYsy1hxRT9vYkTJ9qgor7ZT5x9vJtSGB9knQTKUi8MqUsZt2Qpo1JxMEQoZpyBch9j+nIJYx7cdBc7yc2WHGPHji2pOqzcHjduXDAPDFGoJxMp5RDGXxgnZZHm0hVkqVtzxMGgv9TJDlbZs7gkbQVo1vYtueSS3gnsLLoWJlsxuAlJlslLJln5n3IJ2xjlEQzHfHllzYd3BQZtlRL0LqecckrZ/i9pL0ZP1u1z3npXGzM8nAwYMMDZDN6FWSZXfZ5YbKZp54lHORhwuoStZUPbZLnS1GoYHHjul8O4Ewa8w9lepdj7lTwwjChVWOCWRQeIxwSMUsslvEfZTirLfewqk3c/RsWlCM8MjCvKuX1xsj70u9Dbl/o8tvmW4s3B5lGt3/xvlbrlRrxt9L+yvMPjaZr6uBrndZqagcoTgZZEQIYVLelqq62pBHBFmabIsZmw/yOfLIKVZppyFEvhLAo1rNxxX4nCIIugYEyzbM+STzyOz9I+HodjBoi4xPOtoMqaD3kV2+lnX1OfUH6eOmAoUinBACZtEEZdV1hhhWgfy+WWWy617lhrN7WSvFJ8lK8IiIAIiIAIiIAItCQC9OHZViEkKC3zrJAMualGyd5Uwrgoyz7LrJxlIgrX5Fn67BiVsxd0SxAmL9iDPE1YgbzssstGHNkPPU0wVsCovdySx0U44+LQBDDjG9/40tYb1+Tbb799tC/4brvtFm15Y8+5vrkn08brzakrcNW5GsJCY/Qs/7O2DXhMefDBB+3Pkr6ZwMYjhEu4xmkTf1m8LWSZwA55vGRMn0d8iy/yMOZ/ptjV4Gl15f+VSa8s0rlz5+iZzneaUGcmv9OumSufamS26qqruqoaTdLyPxAS+gN48ggJ59O255gyZYp3UphtdFqK4GUnSz+E/sfaa68dvUPT7lkm2zFsKLfk+T/nPsLIMSSsqM/iqaJbt26Ge4JPWtspj+eiz2gnVB/OhfqgtD8Pg2uuuSatuKLO8z+YZdEg3DBSWmuttTJtPYVxhe95VVRFqyARBoppnmCY0xg2bFi0jThbyWyzzTYmrZ96/fXXV0Hr/FWopXkdfyt0RgREICuBtlkjKp4I1DuBadOmpVrI4r6P/XsZEFlLbgZ5dF7pNIRWNjBxTofUpovzJF2apfS6664bdTTirvmwRGYwwJYfoY4YqxNwLzv//PPHi811TEcWpdSQIUNMx44do8EYE/fUPdQJTq4kwhjFMkTpwXnyYWDDajmfYMHMHpmLLbaYL0qmcJR6lD948ODCHoh41aAddGgpwyfEwd3uwIEDfVGKCse7RMh9avfu3c2vfvWrqFy7lyv3HYNmrj/u43xKZO675Zdf3nTt2rVQt6233tpstdVWBQUFVr++AcIWW2xh1l9//UxW74UCdCACIiACIiACIiACIlASARTfrP6nH+aS6dOnpxoe038fPnx4NCnAXvX0I+k/MnF47733NtvKr5BHPepMv3fDDTc0CyywQDR2suMnVgqiMA9NfOJ5kPSlCK6443LbbbdF44R4mD3GxX7fvn3tz7J8o2hmvDHffPNFDBinMh6IC2OSEAdWxP/yl780GGPHhQlQrn3INTNGPSi4Sxk7UibjiKFDh5qePXtG15GymdTDcCM09mUylfObbrppvOqFY8ZsPmG8fthhhzXiRXwMLa644gqvp5TRo0cbnyeBptYVNPc96OObFm71JYw/27dvH403WTyAUQpGGKFVvixiYCIqywReWj24jq7xNeXjvj2kU2BsniZMIHI/00af+FbWLr744iW1kcko/j8HDRoUlY9OiP8rFtPAMMQYvc1OO+0UrLevPaFwnidpbvGp8+abb25+8YtfFLKCIdeJyTJfvdEDYTBQig6mWpiFDGowxInr+gqQ/nuQdYsD8uH/zyflNPjxlVHt4TyTQt4R6IfsuOOOUf+LfogVdHAsHkP/xn3pErbFwIvPOuus4zqdOQy96ZZbbln4P6ds6k0/iLon9azxjEeNGhX1odq2dU/53HPPPfHojY7pN/K/mux38B7EOMv1bLWZkLfPM4uNk+UbvS3XIK63xcsv+k/e1aFFicSphN6WvkfoOUe76XdhjBMXrhVe1UJ937///e/m7LPPNr5rFs+vFo5ZsBq6R/fcc0+z2WabNZof4f1Ef+Gyyy5zNpPnFx6jVlxxRef5LIG77LKL2XnnnQtReefjHcklxEV3nhSrl4+H18K8Try+OhYBESidgDxWlM5QOdQJAQwjfIM5mrjJJptEWzXQWbLKPcI5ZgB09NFHm4MPPpggp2D44LIwZyDMvn4hOeKII8yhhx7aaKDFy5zVOCheNthgA28WKKdKdcGFW0eUfBhVIAw26MzQIcLgIoswoD3hhBMaGAjQYWaQ/Nvf/jZ1JVGp7oJhxYqHjTfeuGBUQb1RGmK4givdjTbaKNgUBinlFK4/bip9wh6x7KfKqps2bdo0iNauXbvIewUuB2Hrk6TXDu5Z7p34x5c2GdcXT+EiIAIiIAIiIAIiIALlJRDa4oPtBkNC3/C0006LFPNMVNrxC/1HJtvZv3733XcPZVGRc4xLcP3vEsYXuFhmMiE+mWHj9uvXL2qTb9Uv8UKG2jaftO94H5ljy86XLhmf38UI7ccYfr/99ovGR4y1evfuHY0DllhiiQZZusaVNgJjtuOOO66RUQXnmQjebrvtom0ObXzXd6njrsMPP9zssccehklky4+yuS9//etfR2NnV7k2zDeJiEE895BLGFeyfWNyMsjGJZz7njq5hIkyJnpd0tS6guQ9ZRm66kZYMn6x96Av/yzhTECwRQv6EmtwQL15/my77bbRODzN42epOgtbz9CkCxOTIUnzXGLThiaoieP7H2Ilc7ECP+5xJm0tY641hiLoMZiYw7glJFnbF8ojfo5FRhhr+YTnGpNW3B9xowri0wZ0M+hoQvdGyBDMV64NryZmLHbxrcj2GeLYdvjuJ3vefqfF8xkEwCl5fWye9faNcYBP98vzir4ThgXJfgjPM54t6N9C+lcMQDGEKFbwUIz+Nf5/bp+la665prnggguCxgu0LbQdBsYfPkHvvM8++zjfo4suumikl+Z/2Sfcf75FX740yXCMxv7617820ttyPTA2vvDCC4P8ya/celsW4IU8NGE4dswxxzQyqqAu9E14B2KIy/PQJTxHn3nmGdepmgzz9fNpzL777hv9f7n6NbzP+N866KCDvO0u1SM35Sb7TL7CkvHs72T8WpnXSdZbv0VABEojUNyIv7QylVoEqo4A+2CF9gblxU7n0vXijzeGTh4dJp+4OrB0CkKWnBhVYBAQEl7uKKhwUecTLGSL7dzTqe89T6nnEyw4GXiEhAEkRhXJwYlNA1s6TyErfp8SzeYR+oYhq5dY+eUTOKLIDA2S6FDzKZeg2PFtAcLA+ze/+U3qarGFF144GuD46oS1cJpLSF9ahYuACIiACIiACIiACDQPAVYhuwQFHivyfILR9+9///sGhsSuuBtuuKHZa6+9XKcqFhbysnDAAQeYpAFBsiKMGQ488MBkcOE3yulixzyFTJrp4A9/+EMjQ3pfVXyr6hlzobROG7eyohIvdj4JTcr40thwxlNM/oSEyWXXKkCbxrfFTWiVKitb01Z7skggvlLRlme/J02aZA8L382pKyhUosoPMNJiYikkbEXEgoHQggAMo8rx/4uHnpABja+eGO74Jp6TaXz/g8RjfO+7V0NGH8ky4r9xL3/sscd6J+aIi/EQk3shcemkQvHTzj3//PPBKExSh645ibk32ELWN+nIIiUfz1Dh1cjM53kjbXsZVuBnkbR4vvu2HF4GstSvueNgPPfEE094q3H88cenvod5z9AP8Rkxod9NM7zyVYB3OP/D1nDKFQ+daqgfRBpf/xFvaL7/JYwyWXCWJry7fW0nLZ4tihWMKui/pult0X/7PLpRNn1BH4Ni6hZ6zsEMY5O0fhfGweikfVIOw2Bf3k0dHtKZc43TBJ287x0eGkek5Vup87Uwr1OptitfEWjJBGRY0ZKvvtpeIBAafDC4Q1GQ1kmymeGuDItUl7isx0OdJzocaUYVthzqx6ogn9C5z6okiOfBiqakC9n4eXucVk9c8vq42DzwyID7T58Ua1jBNUTBmPT44CoHjnjg8A3qSVPsvoGu8l588UVXcBRGnUMDinhCjCtCluP/+c9/4tF1LAIiIAIiIAIiIAIiUOUE8FjhmmRkksm3sp4m7brrrgUvc2lNXG+99YKGzWnp8573TXzT98ZDWxZh0tS3ZQPpQ0brWfJvjjjsL43SPatYL4LJ+C7Xysk49neId7GGFRjbMzmTRUKGHSjOXfc+Rg4+wRtLFmF7Tp+4xpvNqSvw1bOawjHSYduXLIKnSMa4PuF/d/z48b7TucJ9kze+iWUyT/MaEK9AyPODz+MK6Zdddtl4NpmPmfDN4lGAOGx96hMmHMsl/I/itt0n6MZC21vE03Xp0iXoRSm09W08n/hxNTLzPX949vgW3LAFQtbJROIR3yX8f/m2MijW4MdVTjWHhXR5/N9kvV9ZlIUxqE9Y3FSM4A0DQ6M0oR+ErtYnPuMJFlz5dJ1Z3920HUNGn5RiWIFhZla9LfpvX1uoG1szlEt8zznKx4tzVsGwyqc7551Si/1XV9t9zyDiZu2r+RaOuvpprjo0ZVi1z+s0JQuVJQItiUDbltRYtVUEfARC3ioYDC644IK+pI3C6WTiztC19yudW5Sg1vqYTm2obJSieYTONXvHsg+wS3jZ5x3IZ90bMOS6kbrgzi6L9A54xvC560vLlwFSFiWEzQcLcPZ2w4WfS1jl4dvz1xXfF8ZqQ9/+hKzWy3utGNzgptYlDCrYVkQiAiIgAiIgAiIgAiJQXQT69u1rfBNxuFROGieHVrYymRhaSehqOf1e3Ms3hbAq1vaxk4bryd+h+rAC2jexGTI6CeXZnOeWX375XMWfeeaZTsODPAx79uzpLTNkwOBNNO9E1okZ8mDyCG+FrsUHnGdlLcbjcUn+L8TPjR07NvKCwZg4JIzF87gJD43XK6krCLWhms7h9SbPfccYl+eUz+sOhixpuoUs7WcC+6677moUFZ0M95ZLP+C6F7nnMBxJjrOZ6GcSzHVP+rYboU5WF9SoYoEAFp/4tpBwJcPAybd9xvTp011JigoLeZJgwjGrwY0tnHaOHDnS/mzwjTeZNE848QTVyiz0rMfLgWvS1Wfwg8fXyy67LN7s6JjV0y7DOV8/g0R5DPsaFVhDASHPA3neXzQZ3SX9LZfRCxPxLNjK82zE8wFbkWQVniejR492Rvd5DGA7D9//WJ66hryLFdt/YEFj2vs73lj09LyDr7322nhw4Zh3TJpn5ULkwAHPHp9BElswZTGEiWc/dOhQ4/McxPsv5EE5nk81Hyf7bvG6Pvroo0FP3zYuhkMh4yEbr7m/a2Fep7kZqXwRqFcCMqyo1yurduUiELJkdQ1s0jIfPny4UxlAJzE+kGa1gM9YgIFzSNnlqwNKCp9hxZtvvulL5g3POoCnXSg4XXupMajOmk+og+6tZMoJn6VrKBkDUav0TcZjYMvqjDwDj2Qe/A5d/2LuO1YAMVB3KYTKuTLF1RaFiYAIiIAIiIAIiIAIFEeA7d98Ex6s+kpO3Lm2K7Al+1Zp2/Oub1ZoMu7wbb/gSlNKmO1D2+9i8sqryC6mjKZMk3WsFK9TKfzIx7dFY7yMPMe0YbHFFsuTJLrvXGMXMsGoKKmcZ1W7T1jFePLJJ5vDDz88MuovlY8tp7l0Bbb8av7mmuc15KI9jM99hhXFutBPcgot7OB5y3Y0SXnllVeSQdEENROYScMKIuIV0rVy26d3KXa7hby6ATzaMEHrWtmLMQgLPFgQVKqErhULdOK6ryxl8Uzif9i12jmvR4VqZQYTn0EZHmZd9XbdT1xfPE5dffXVjXSKxHcZVvgMNPhfyLqKPMt1rOY4PsMKrkmyr5WlHfz/uwwr+D+bOXNmrkn3vP03jCR88sUXX/hOlazHJOM8iw+9FUmcyLqoL56M/xefYQV9i3LobX19FOrh+j+L1891HNr+Gk919SBsS+WTm266yWB8g9eycvdDfWVWMjyk16ePVA3zOpVsv/IWgZZMQIYVLfnqq+0RAZ9hAyfZ0yvUWfUhZPVDlg4WKyV84hqg++LGw5daaqloQOByIZZ3dQIDizwDbp9rX6zfsyq2GGhiiBG6LvH2ph2j6Ekq5NLScJ6BKkpmn+Ka/VdL7QSGrj/KDqtgj7vBtcfJb9umWbNm2cMG33mvfYPE+iECIiACIiACIiACIlAxAnlW6FGJkMI8r8cz2ygU+k1lWGHLzPI9Z86caFyAEpYPYwT64Y888kiW5DURByV7njFX3kYxbmCMADf4WZb8LqcUYxySd6zNOJGJFN9qTyaSR4wYYbp16xat+sRjH6uKi500DI1JK60rKOe1qVReeTwIxOsQmiQPjZHjeaQdo1fAkMFlLMEEdtKwgm0YXIsR2HYIHYtLR8G2Ikm9DR5zXBOt1DfU7lB7ML7LK+gyXIYV5MPzgPaUKr78ybdYI5KQR4c89a1WZpaNa7IWTxMucW1HxHOQ9wack8YCxN97770bZeXbHja0tVajTGo4IOTNir6Gz9NMqMk+/Rtp0MnmMQLN462C/PP2HUmTV9BL8h60fS/bf3Ddk3nzjsdHb1tMe+hD0PfweZSgvixAK0V8W/SQZ7H3ja8+of69L001hvN8cnnxtnXFmxQf+hB4F8JzX97+oM2rub9DfZZk/yBrXcs5r5O1TMUTARHIT0CGFfmZKUWdEQi9BItVTGZFFOo04f2hGMGAgU6pS4FAZ5iO/3zzzZcp63IMtikoyx55mSpURKSQNXBadqxy8RlWYH1eScOKO+64w/Apl3Dt6fRXUmlbrroqHxEQAREQAREQARFoSQTyrup1GVDDC6VksQrkYsce5bpOGAEz6cNKW1bs8du2M6uBdrnq0tT5FGOQ4Koj7oiZ0GXCDpZTp06NjHAYBzSFuLZWSCuXlfV5he0FfIYVNi+2e7jllluiD2H9+/ePPPvxzSfrOK45dQW2LdX8DctihHvF51GhnAsCfIYVeSa1reETE0BPPPFEg+bizWS//fZrEOYzqkC3Uqx3zmJW0mNcVGkJ6bMwaGpOqVZmMPFt0cq9E986mLjTpk1zThpbY4hVV121kWEFzz+e/3HjEvLFoMglxRr8uPKq5rDQ/Yo3D4zyyim8PzDAyyp571l0ey6Dr6zlxePhJYb7gz4Ynmi476wxZjxepY5LuQeXW2455/8IdcXzVbH9YtvW0H3DtmzllHK+/8pZr7x58fzH01No60LyZAs3Pgj3P8815mFYnMn7shb6/6H7o9ixVTnndSK4+iMCIlARAjKsqAhWZVpLBELKkmKUQ3naHnoB5+1Ux8sNpUVBWauWoPE2Zj0OsUjLI5QWjiH3Zml5cz5072VJnzcOg4pK39N566T4IiACIiACIiACIiAC2Qkwee5bdRnqu6aVkGdVZVpeWc+zCvC+++6LtgRgIqilSimGz3ijGDdunHnsscfMa6+91qwIi/UKkbfSKN133nlngzvprMKEUXxSEYU/KwnZ0z5k2BQar2lc9fNESNZrkIyHV0mXxwPG2dzX5ZhQ8S2yYOIwOYGN94mksNDCurznnkkaVlD/KVOmNNAL+Fa9Y5hRbJuK+d/Kupgm2eY8v0MruZvjnRKve7Uyo44+Dyicw2tp/L71eZlgMhnxGWlgPLTBBhtEcfjj2rKXcPoNeSb/SVOrYo01m6r+IX2vqw4+D8CuuOUIY9HdmDFjzHPPPef1slOOcrLkUcr7NNT3LYfeNvScy9K2PHGasqw89Som7qGHHmqOO+64gpF0Wh5cq6effjr6EJfryvYw9NOK2XIsrbxynQ/9n4fuzbTyQ2lh1ZLmddJY6bwINBeB0jfVa66aq1wRKBOBUOfaDqLLVFSjbEJlZ11F0yjTeQGhtEyutyQp5RqG0rr2/czLNXT98+aVJb5PCZ8lreKIgAiIgAiIgAiIgAg0P4FQfy7Ud02reTGeA9LyDJ1/8MEHzWGHHWbuv/9+05KNKkKM0s4xoctqyb/85S/NblSRVtdyn992223NvvvuW3S2rKIcOXKkOeSQQ8w999xjcHfuktB4rZT/N1dZtRhWCoPQpEG5tqlhwthXzvjx4wvIMeTA+0RSBg4cWAjyrahObt/gmwjHMKPexGUYY9sYMliycVrqNwY2vq2Dk4Y5LoMfDC/sO7tLly5Owwg8D8QFjwwu8dXDFbfWw0LP80q0LbRNSCXKy5Mn99WRRx5prr/++mY3qqDeIR12WrtC7yE8DZcqoYnzUvNOpm/qezRZfjl/YyxzxhlnGAwUixFYPPDAA+akk04yZ599ttebdDF5lzNN6JqVcl+H0ra0eZ1yXi/lJQLlJCDDinLSVF41SSBkFTx79uyKtilkRV9K2aG0oTIr2thmypztL4qVEMdybG9SjjyKbZvSiYAIiIAIiIAIiIAI1B6B0CrkUrZ8aMoJADwNXHfddbUHv4pqjFEFbstdWxpUUTUrWpVNNtnEnHvuudGKxmIL4n9m1KhR5qyzzjIuw/nm1BUU26amTIcHnWIl9MwJcc9TXtYJ7E8++cS5qjbuDYBJoqWXXrpR8XFPMRjouLZkJdHyyy/fKG2tB4SMJzBWkfgJsIWHS+IGEDB03U9scROXQYMGxX9Gxy+++GLk+cWeiOdrw/iuR4OfePvix6V4h4rnU+vHGJHxzgsZRjV1Gyulty2H/lt62+LvBrwqnHLKKWb//fePtv8qNieMYY899tjIu0qxeVQqXegeC80ppNUnlDZUZlq+Oi8CIlA+AtoKpHwslVONEsAFpU8qbQW4yCKL+Io2pVjWhiwmfSs2vBWp8RMhFmlNC13/cnAMubtD8cLqg6QkFRSu37iPi99bNg77L0pEQAREQAREQAREQARql0DIsCLUd01rcSlp0/KOn8eVPh4Csgr9ZVzKsyKR1Vt8OMbTRUsVJrNPP/1050SwiwljAMYucOPDfuP2+6677nIlqZmwXr16md/+9rdmp512Mv/617/MCy+8UJSxCQYql156qTnqqKMabNfQnLqCWrgIpegsQtushCbs83Jh4vjRRx9tlAzPEltttVUU7jJQ4v+mb9++DdKtttpq5sMPP2wQxsQ3BhVM2k6aNKnBOfuDfdbj43MbXuvfoTbhdSS04rbW215q/ePbfcTzit9PkydPdj7n4wY/pOUeTz7LMRpj+w+2HUEflPRgYcv01cOer6fvkP6Ndsa3TsnTbgwUOnfu3ChJqVsHN8qwDAE8o84///zMOfEc5D2Y7D988MEHhi2VyiWV0ttS71KF51zyuW/zLPae+e6776IsrOcZm1/ytw2v5W8MJTfeeGOz4YYbGgwkeMY9//zzzmdbWjsvvvjiaAuMfv36pUVtsvOh92ApfaTQ/0Q55iOaDJAKEoE6JiDDijq+uGpaNgKhznWlLXhDippS3I1Nnz7d2/jm3uvSW7EKnZg6dWrROYeufzk4hu69XXfdteDS0RpG0BB77PsmTtKVrf1NGpuOeBIREAEREAEREAEREIHaI4Dxrau/z6prVv0Vs7quKbbjoG6jR48OAmeSZ/jw4YYJ827dukVtYdV5UhhH3XDDDcngFvH7mWeeCa40ZSKECWMm2xZbbLFoQsQHJjkZ54tX7eHcK5tuumn0YbscJn1wqc/kuWvFt6s9rOJ96aWXGrjoD43XQmNFV/71GDZt2rSimsWY1PUMIzOuZTnF5ykCYwprEOHaboFtQJIr3FdZZRVz2223NageE9gfffRR5M0iuY2DjZj0MGDDa/3bNZls24Q+S4YVlkbjbybjMLjB+CEpEydOjAwifAY/GEvEpX///vGfhWPSExcDDZdHqz59+kSGi4UEdX4QmozcZ599or5HnSNoZICTbC/PX7ba4t7o0aOH8Rm58azDa1a5pJQ+aOg9FLrmWese0tsfdNBBWbOp2XilGAfEG83YhHchn7333jvaBhDjHLzp8A7+9NNP49G9x5dffrk577zzvOeb+kTo/tC8TlNfDZUnAk1LQIYVTctbpVUhgVBHC+WKHWxXouohRQ0di6FDh+YuFstXn+UwbXUpJnMXUkMJuIYobvK2m+v+6quveltaDiVB6N5D0cSesBIREAEREAEREAEREAERiBNgDOGblBw/fnyjVdbxtL7jrJPPvvRZwikjNBl9+OGHmzXWWCNLVobJ85Yq9957r7fpGKawbzpeKdKklG0c0vJuzvNMBDGZzmebbbaJxvPvv/9+ZDTx0EMPOScYbX2feuqpBoYVofFapXUFtk7V/M3/9Lrrrpu7ihgiuCZ6ySg0SZG7oHkJuIZMEmJsExfK//jjj03Pnj1NfDsPG8e1VQP5YLiUrDveANgmpKVttxC6Vhg1SZ9h7yb3NxOMLsMKJq0xiGB1d1LWXHPNRrot3MLjTYVnUlxIv/nmm3v1gxgPtSQJ6V9Dk/P1wggvQU8//bS3OVtvvbXZeeedGxmUuRKEtnJyxU8LK0Vv6/o/seWVY0FcyCMBW4iVQzds69sU33ioy8Mlq8FDnrqjn8ejC58hQ4ZESfHQQJ/i2Wefdb6Tbf4YitGHSBqY2fNN/R16rmhep6mvhsoTgaYlIMOKpuWt0qqQAFaTWNq7lHwMmFFOMoDOIwyE7rzzTmcS9hazHbOQhT+uTItZcfbvf//bWS6BrPxqaULnDCVK0o1nGgfSJBUmNg3KFJ/lto2T5dveB664KHdYESMRAREQAREQAREQAREQgTgBvBAkJwnteZR4efu9rEZjEqzSgjLUJ2zlkNWogjxKWd3oq0MthDM+9HFkjIJxShajCtraEiaSaCdeB3AbzQdPHv/4xz8aTUASD0lOjDenruDnGlX3XyZADj74YIOr7zwSmghzbYeZJ29XXCaQXc9MFqRgpOUa9ye3WyBfu+IWN+ZxoT3cWy4DDeJVk9vyeL1LPe7atas3C7y/4P49r/zf//2f03AQQ6ktt9wyb3ZVHd+1hQcVfueddyK3+TBMCmlcgpFG0rCCSUoM6JLPNZvedY/bc/X4jQEKhlYuF/vjxo0zu+22Wz02u9AmvJr5BN3jLrvs0shoxxe/FM/Arjy5Jmy3kVf3jtGk6/lNGfSJuOalSuidxGK8ddZZp9Qiyp4+tLCQvl8ew4rQfVPOivO/uf7660cf5kNCXinsNkflLL/YvDSvUyw5pROB2ieQb/RT++1VC0TASWCttdYy9913n/Mc+3Hm7dw9+OCDjQY1NvPDDjvMHkZuLn3u/+gc0rlfe+21C/GzHLj2D7XpBg0aZA9b1Pfdd99tfv/73+dqM6uZfDJ48GDfqVzhuNZDGeEalDz33HPRwCavkopVN8n88NjBapHQipJcFVdkERABERABERABERCBZiPAZAjbQbjkgQceiLzehVbaJ9P5xkHJeKX+DhlD5BmnzJ492zuBWWodqz19yBiCFct5lOWssq8lwaPgCy+84KwyxkaMq9OE/dYPOeQQw5jcNRnD5E7SY2Vz6QrS2lIt59E/sH1PVmGlM/oSn1RicQHPzOQWHpTPhLNrkpWxs2+yBE8WLsMKxuGuvJjwnm+++XzNrenw0LViUn/KlCnRiuSsjcRobMyYMc7oeASpN/EZ3GCgwySzS3zGEL5wjId8i6/yGmG66lNrYejyHn744UbVpn/CorrevXs3OhcKmDFjRpQuGQfdW7Xds0k9YbzOcAlNxsfjcuwzIkvGy/P7nnvuMb/73e/yJAm+S/DuUg7xGTORN3rbYgwr+J909UHwOlaORXyhMQD3etZ7E12yr9/lY4vRg88YAwPq5BZbrnwwhtxhhx3Mrbfe6jpt+L+rFmH7HM3rVMvVUD1EoGkJyLCiaXmrtColQIfLp1BEUYClfdaOBy94Vm64ZJlllmnUScJ15qhRo1zRzdVXXx259MvasWKFWtJKPZ5xuTqW8Txr4ZiOIGx8g81kGxh8+q4hccvpMpFOuMu7CZ1s7knc12YVtoH585//7FTo0HZWE+WVenURnJeD4ouACIiACIiACIhAtRDwTcbY+tG33HPPPe3P4DeTgSGD4mDinCddSmSbRZ5Vhbiydk1g2rzK/Y1i2SdN3VcOlZeHIZPbTGLUkmDw8Je//MVZZRZCnHHGGc5zyUDcdqMId7ngT8bld3PqCmx9quketHWy3zfeeKPB+CQ0kWPj8s3zxuUt1MYJTdbbOHm/fRPIeJpwTTaGDL1WXHFFZ/Es5nCJa0sRV7xaDOOac718k6zXXXedOeqoozI3LbRIKO29l7mQKoqIwQ2GNxihxIX3m4sFOknf/xmLdlyeeJ988kmnhyfu8byLeOJ1rNVjnucuwwraw/164okn5jIwGDlypFcHe+2110ZebqqFVWj7jjz3Av3GpHFZvI15DDTi6chz2LBhBuOCLIKn6JDeFmPTcggeK/r37x95kknmh1cZjFR974VkfH7jPen00093nTJ77LGH2WKLLZzn8gSGtqe4//77o35NlvxY7OnzeONLj7eJm266yXn6+OOPz+yZOWTkFOoTOQsuMjD0PxPPUvM6cRo6FoGWQ6B1y2mqWioCfgIYPPhWJJDq4osvzmQRiaLLp+whH1cHMWTswICKjjpKpDRBIYBbU59QdqiNvnT1Eo7BwcSJE1Obg/XuX//612C8PJ3mYEbzToaUNijFcW2XVVDmsF+eS0LlhFbQhJRernIUJgIiIAIiIAIiIAIiUFkCTKCHDH1RNNOPTFM8sm/y+eefX9nKxnIPuVPOuhUJqwOvuOKKWK6VP8SdtE9CHiR8aUoJD3mgYwUk3jzShD3Bzz77bOdkW1ra5jzPxA+TGy5hooLVxlmE8ZLPqAKDi+RqyubUFdj2VNM9aOtkvzGY4jny7bff2iDvN27TfYtKSATr0HaZ3oxTTnDvuLYaYqz71ltvNUodWqG86KKLGiaxk/LEE08kg6Lf5dQdOAto5sCQh1UmHbMa7rFAiAk/n3Bv1KNgWOES1/2UNlHs8qzqyofy6tngx8XThrGljO95yrPAt+DOpo9/s4DLt7Btgw02qCqjCuoderb6vJrE28sx787TTjstGdzgd1rfs0HkxA90sZMmTUqENv6J/vuSSy5pfCIWknVhXSyJ9zDkleLSSy81X375pTdt/AS6/csvvzwe1OA4pLdtEDHlR0j3z1ZDGD+kCfMRbM2UV0LP6kceeSRzdiGDjtA2VJkL+G/E0EJWl+GlK3/N67ioKEwE6p+ADCvq/xqrhRkIYFG7+eabe2OidDz11FODHTwG5XQC6aT4ZOjQoY1O0SEIDZBYkYWxhm/CnAxxE3jyyScHV37kcc/ZqJJ1EIDC549//GPUgfR19BlMECdkTECHOuu+xVmwLbHEEsF9sM8666xoS5hQXiixsIZ3rWogHQNH34Cd86FON0rurFa65CURAREQAREQAREQARGoPIG0vj1bgmCgjWv1pGAM/tRTT5kzzzwzOMZIpiv1d0gRiqLZVdd4mUx4/O1vf4sHNclx9+7dveUwcdiUwlYWPsFA/Kqrrgoa1EyfPj0a74QU1r78qyE8NFFy0UUXpS6GYFLj3nvv9TalV69ejc41p67AVqaa7kFbp/g3Hh95nvgMVubMmWMef/xxc84558STNTrecMMNG4WVKyCPJ4w07wiuCWxXPfEuwLYi9SwYrPi8KNBunklsw+Iz+kI3M3bs2KCRH5PU5dTBVNP1cC2+8tUv9PwjTcggKJlnvRv8JNtrf2M4F9L9Xn/99YZPaHEb5+iPsHjLJxtttJHvVLOFh4xbMcBB9xwSDE/Ql1bSYxh5n3LKKUG9LTpK9N/0eXyC3rZjx46+07nDmTj3GeSgP8bTyUcffRTMlz4uRim+9yQ629C7Pph54iQGRCFh8SjebHyC4QXbaRdzrUOGFRgjZfGWxlYiPqMw6sz2b+WS0NgEDj/88ENqUZrXSUWkCCJQlwTa1mWr1CgRKIIAnWtWQLHaxSV02o499ljDIHrIkCGGFyedciwYcUF21113uZIVwjbZZBNvJ2n//fePVkr43OPS+eCz1VZbRV4v7MCVslGK+qykbeG45sw6+Ldp6vHbrqbBpRiuuljxxTXEuphrj1GMz+jC8thll13sYdm+uf4nnHCCNz8Uzaz0YHBG3XHrxkozDH7wwoErw5DhDfcrXil8bQvtxTxz5kxzww03mC233DJogOGtvE6IgAiIgAiIgAiIgAiUnQCTdfQNfYa1FMikP+ME3OCjhGRiC6MK+ryhvmPZK/vfDJdddtlg1scdd1w03llvvfUMq8LxzEFflPoyKctq9+YQvBj4hDEae0DjurmpJv5Q8DMR6RLuB4zuf/WrX0XXnfEORtJTpkyJxpMYFfjGnK78qi2Mcc3o0aOd1WK8zmTLL3/5S8M9FF+FyL3PuImtNkMLIXyrUptTV0Bjq+0edF0A7jvcfDPRjhED/BmDMkEyZsyY4OIF8mObgw0raFiRNilt28TkVsijI/GYwE7T/xCPBTTFusUnfS0Iz72DDjrInHfeed7qYljBPbD11ltH1xl9Bu8gnkuE+3RwNsPtt9/eHtbdN+9y9HtZJjBDE5aASZtMtfBYWFPOiUmbb618b7vttpH+D32aS3hPomflvc6zDF4YU/AsY3L8sccei96zrrSELbnkkibNOMuXtpLhaffa3//+96jfSLu5P9g2i0VcvDsxugj1N8tZb/ooPE94J6C35XnRpk2bgt42i2HobrvtVs4qRXXYd999Dd4pXIJxxR/+8Ifo/cd7rGfPngY9K+HcM8wZpHlDYRuUcgnPlNA2TTDG4zXGFbwbqS/6YryFUFff9k5Z6se7H2M4n2EEXqswLuE+Q78dF56DzzzzTLRwMB4eP8Zj1FJLLRUPKuk4tG0K9cGgmy1a0oxeNK9T0mVQYhGoSQIyrKjJy6ZKV4IAE+yHHnqoOfroo4PZs8cYnzxCpwYFj09wyXbggQdGW4744hCOZWcW6854HpRNB1DyPwK4ieWTV+ich7w75M3PxmfQsvPOO3v3oSMe9b3yyittkszfrLoKWeSTEcoePGf4tkphz8A33ngjUo7tt99+mctWRBEQAREQAREQAREQgcoR2GyzzaJxCcYHIWFrubTt5VAYMslVSaG/ycRPyOW0a7zT3BOTodVs8GKinw/jLlY04sp5zz33rBjKTTfd1GtYQaFMcF944YUVK785M2bcRPsffPBBZzWYxGDMxAdjBAxLvvjii+DKVpsRk04sSHBJc+oKqE+13YMuRjbMLgqxv7N+77PPPo22YcmaNks8nnGM5blHQhLy9GjTZZ00zeNBwOZdi99sTRWaSKNNTFDhCSCv7LjjjpGhXd50tRKf99vqq6+eP3BmwAAAQABJREFUOmnNQikml0PC+wcPGK7tbeLpQh5z4/Hq9RjDKXS/eEbwCffrjTfeGH18cVzhXAPyrkZhSyTen7fccou3ehht+gw3vYkqdIK+DJ+8svvuu1dEb4vBJmxCCxuLff9hjBHa4i8vA+JjfJ1mIMGzIu15UUzZGMP5DCvID0MdPvy/0K/jOfjxxx9nMvzdddddy9pXoGyMeHz3GkbqfKgrfUr6+ieddJLh/ykumteJ09CxCLQMAq1bRjPVShHIRgArzXJ3gnn54hYstJ8dtWNvyrQJ8GytaBjr8MMPjyxlG4a2nF8Ylbj2QM1LgAFqmsvlvHnG4+PRpFz76dl8UcAddthhmVzg+ZSINi++s7hAi8fXsQiIgAiIgAiIgAiIQOUIMM6gr4+irxRhwpEVx00hO+20U8nFMK6qxLjJVzFWbWbpKzMRg9cEjJIrKXj+KMfEGMrpWhQU9hhBpAnXAu8UfGeRgw8+OKisb05dQbXdg5Zn2qIUGy/tGw8rWY0V0vIKnWcCO02yGEMwMZvFAKMlbbeAMVmaR4U09snzTAyGFigl49fq7yz3XJb7jfZneTfk2RanVpmm1Zt7tRIGkHjtwWNFtQpeEcqxWIyFYeWUAw44IOiZKWtZ6G0xHqmU4JWgHPrleP3w8kT7meAvp2CMRd6lSjF54HUOVmmC5wwMGvBalMWbGl7FsrzH08pNnndt256MQ/3wckO/8rvvvkuejn5rXseJRYEiULcEZFhRt5dWDSuWAK7GRowY4d0/LU++WDLiDozVWVmEjj2eK8ohdPbOP//8zO4Ay1FmNeaBEuqII44oqWoYPKA0SlqklpRpIrFdBYVbwnIIbud+97vfBfc7jZdDB7CaB4DxuupYBERABERABERABETgZwL0+emnsuKrGMGoAkPcptrGgsmMUsc7tLdUY5K8rCoxAZO3DjY+yvff/OY3mYwLbJrkN8pptpmsRVlwwQWj1YJZjCuytA8DpdNPPz3aOiUtfnPrCtLq19TnccddqlEWE3R4JWgKSZvAZsIx67M0bXUxK2DRB7UU4R3CVjx4riiHkA/eMss92ViOupU7DyaD0yRLHPLIsuVN1i1D0upU6+cx0DzqqKPK1oxjjjnG9O/fv2z5VSIj9IRscV2KMGGe9X7MWg562yOPPDJrdGc8DABoWyX1thj2nnHGGZkMmJyVTATCkf4c+uBKCM/QUgxp6LPvvffeRVVt4403NniiKpfQ/2IhbCXeCRjx9enTpyxV1bxOWTAqExGoCQKVeXLXRNNVSRHwE2AV0LnnnltSZ3H99dePDBvyrrzAUvLUU08tyQqWFVV09lhVIzGG7TAwMinGMh+LblYCpu2zWg7OdBAxrKBjXawShv3sWPGDchAr4axCRx6lFopKiQiIgAiIgAiIgAiIQO0QwMiAyYFtttkms3E4k8l4LLDjjiwrxcpFhHESxhzUIY8wGXT22Web3ok9mfPkUWxclOn00atFOnbsGE1irrnmmrmrxPaGeGeohHI6d2WKTMCe2Ny7W265ZZE5/JyMcfOf/vSnTEYVtqDm0hVU2z1oeTABzipttl7JKxhZlWthQZay0yaU83iQTJvAzuphIEu9ayVOu3btIkMbJtPyPt9tG9GDYDyHwU6lJhttWdXyzWR3aFIPA8qs/18s6grpkpgoZRJb8jMB/ufR/ZayyIhJ2b/+9a9l38qhUteItvLey9tmJugxfmDCvBJCfc4777yi9PBsjddUeluMyOCA96xihf9n+sEnnHBCRXXN9JXoNxdjCMN9jbEQz/ViBa/PtLEUQ1ieZ7wP0ryKFVtH0vGu+fWvfx18dubJX/M6eWgprgjULoGGGwLVbjtUcxEoOwEmpdk3a+LEidF+h759XOMFM3hEUThkyJCSXFlijHHBBRdEe5098sgj5vnnn48X4zymbCyuN9xww9Q9WJMZoJirpNCZyyMoh3GxVU5h5clxxx1n2PPu6quvNjNmzAhmj0EFPFnFl1WKVR4k82dwhyLmlVdeMY8//ngmd8IMxtnzj3oXWw8McbjnH3744eiTrJd+i4AIiIAIiIAIiIAIlJ9AyLA1qycJ+vO4P0bhTX/33XffNVOnTo32LGY7N4xvMTbmQ58PV7rxyZdPPvnE27Bi+5beDOedwEUxE9SMsdiHmW00fIICGiMQViNaY4C84wtf3nnCGeOxGnXUqFFVsQc514+JhBdffDEarzJ2CAkT4GzFwgS9FfIIsbfxKvUdvweTZYT+L4jL/wZ7qaP8Z/zCHthZtv3gfsZjBzzyLoKwdWwuXUGp92Al/pdhwgIGFjLcd9995o477gi69KYObO/As6qpJ3i5Z/gfxpW3S/IsxEC/wETj559/7soqk+eAeEKe0U0h8Pet6C7X/cFkGv9fY8eONQ899FDk5j2tbVwX9Bl40sz63qsGZmntynoeDyi4w3dJlu09bDrekbzfH330URvU4DuvwU8xk6rFGsQ01fVsAGTeD/pFGBrQb4IbfZIswnuEyfWsXm7Is9xt9OlO07x6YcTAYjz0zY899piZMGGCt8n2mY3xgl1wFnp3+zLKkoYJeLbSfvbZZ821116b2j+hTnyyGh6V6xpwj3Pt0Rk/88wz5v7778+kw8ZICiNonnVt2rTxoSprOLpijBueeuopM2bMGO9zxhbKs3ivvfYqGHt9/fXX9lSj77T7jAQYIZ5zzjlR+bwT0vqqthDqgfEwRgrlejfZvF3f/E9cdNFF5s4774w+rjh5wpp6XidP3RRXBESgPARaXXjhhXNDWaW5twul1TkRqCcCKCSnTJlipk+fHg2eGUDPmTMnUkzRmWBQjbtH3yC1FBYzZ86MlESUSfkYBTDA6dKlS1QuZdNBq0TZpdS70mnnzv358fX222+b0047zVncb3/722hwnjxJ5/Djjz82kyZNitii1OnatWvk5QGWaUoeW3YyX/v7p59+soeNvkmbTG9/228S2eMvvviicN25B8j7xx9/jIw+UOpR73hHM1m2/U1+9hPP34bZ8vieNWtWQRmPUp77n8HDLbfc0qg9xQZMHVq8m8Suj7mVYcXWRelEQAREQAREQAREIEmgqfoqV155ZVQ0fS0mRazxgP3NSRtuz8W/7TnikSYu/KbfyDjBnounJS6/USTefffd8aSF49///vdm1VVXLdTLnoiXa8Pi37a8eFj82NaDvur48ePNtGnTzJdffhlt8/HNN99EK9xQsqdNsMfzzHpsy84aPxnv22+/NZMnT46M8JnMZ1zIhAN9cuqcZyIsmXexv2EHR8YOKOzxQsI4lUkjJh3Srkex5VZTOgyEGN8x1uPDfcREFhM6fODQe57Hk1Kvf7LNzaEraKp7EEOJm2++Odnk6PfFF18c6STiJxlLorPg/4MP9yPGPIxZ+TAJaSfn4ul0XL8EeLZzT9gP/5sYA6LHwkiOZ1Qeb5v1S0otqwYCPFt5r6N748N7hHcG71OeXzzHuG/L/R5pzrbz7kQ/yvOadyU6Z4xw+fD8bq620q/hPcJ7necI/UEWv3EN0NtmNcKqNFvee/F7hmcdfS76YtSTvgefYgyVyl13WHK9ucbc39SJ+5oPbCvNlP7Se++9F91rGPYy30EfGh089x7/W3379jUYhDSXMG6CEQtt+abOXEveW9SPbUnyzr9oXqe5rqbKrScCdpF0Uz0f6A8g77//vhOjPFY4sShQBBoTQCGDBSOfphY6j3xC7gGbuk61Xh4PYVbJ8YkLHWI+1SR03Pggtm6+73LVm04iHWsGAZRljTPKlb/yEQEREAEREAEREAERKJ7Am2++WVjJh8LbKr2Z1MfYOy5pitzvvvvOPP300/EkDY4x5q6koHxmnOMa69h2VbL8YvJG8cxqtGI9HhRTZloaxgsYwLRksZMDTc2gOXQF1XgPwp3/WSbJ+bT0+7Gp78NqLc/eD9VaP9VLBOIEeLb2nmeAx6elSHO9O9P4Wl1oMVtZpOVdzvO89zBKyOPxuJzl58kLQzY+zSX0l1ZcccXmKj5TuYybyj3/o3mdTOgVSQRqioAMK2rqcqmyIiACIiACIiACIiACIiACIiACLZkAnsUuu+wyJwI8JowYMSJaWemM4Ai86aabgtvkscpOIgIiIAIiIAIiIAIiIAIiIAIiIAIiIAItnUBDP6EtnYbaLwIiIAIiIAIiIAIiIAIiIAIiIAJVTAA3+r6V4Gz/wB7Bvr3a483CvSVGFSFvFVtssYXc9seh6VgEREAEREAEREAEREAEREAEREAERKDFEpDHihZ76dVwERABERABERABERABERABERCBWiSw9tprm1dffdVZ9SlTppjzzjvPrLTSSmbQoEHRXsW4oGVvYPYmZe/nCRMmmHvuucdgiBGSjTbaKHRa50RABERABERABERABERABERABERABESgxRCQYUWLudRqqAiIgAiIgAiIgAiIgAjUD4Fx735lnv/Pl+bNCd+YidO+N19+M9v8NLd+2qeW+Am0bmXMLxZoa5ZYtINZcckFzFrL/cIM7reQP0EdnmG/6cGDB5tx48Z5W/fGG2+YN99803s+7cQOO+xgOnfunBZN50VABERABERABERABERABERABERABESgRRCQYUWLuMxqpAiIgAiIgAiIgAiIgAjUB4HRz001Nz89xXz0WXilfX20Vq1wEcCAZsbM2fM+M81r42eaG56cYpbq1sHstG53s93aXV1J6jIMw4dPPvnETJw4seztGzp0qGEbEIkIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiMDPBGRYoTtBBERABERABERABERABESg6gn8Z9K35s93Togm0qnskl07mKGrLGIG9e1k+nTvaBZZsK1pjSsDSd0T+GmeZQWGFR9M+c689P7X5rHXZkSGNueN/sg8+PJ0c8S2S5rles1f9xw6dOhgDj/8cDNq1Cjz8ssvl629w4cPNzvttFPZ8lNGIiACIiACIiACIiACIiACIiACIiACIlAPBGRYUQ9XUW0QAREQAREQAREQAREQgTom8PCrn5sR138QbfWBQcX+m/Q0wwdqi4I6vuTBpmFA02WhdtFnjXlbgBy82eLmoX99bkaO+TgyvNn/r2+ZU3fvY4atWv/3SPv27c2+++5rVl11VXPvvfeazz77LMgudLJXr15mn332MUsvvbRp1UpGSiFWOicCIiACIiACIiACIiACIiACIiACItDyCMiwouVdc7VYBOqOQOvWrQ0r9lzStq0ecy4uChMBERABERCBWiGAUcXJ130QVXfbNbuaY7dbUp4pauXiNWE9MbQZtuoi5tzRE8ydY6cW7pmWYFyBEcTqq69uVlttNfP666+bV1991bz11lvm66+/Tr0CnTp1MoMHDzYDBgwwyy67rGnTpk1qGkUQARFoOQQw3vKNtWWA1XLuA7VUBERABERABERABERABETgZwKacdSdIAIiUPME+vXrZ0aOHFnz7VADREAEREAEREAEGhJg+w88VSB7b7xY5JmgYQz9EoH/EcCTxfE7LGUWnrctzNWPfBLdO726dGgR24JAAWPjgQMHRp+5c+eaKVOmmK+++srMnDnTfPPNN2a++eYzP/74o8GYYqGFFoo+3bt3j9L9j6KOREAEROB/BDbffHPDRyICIiACIiACIiACIiACIiACImCMDCt0F4iACIiACIiACIiACIiACFQlgT/fOSHa/gNPFWz3IBGBLAS4V76YOTvyXME9dNlvlsuSrK7isJK8R48epmfPnoV22dXlye9CBB2IgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAh4CbT2ntEJERABERABERABERABERABEWgmAqOfm2peGz/TLNm1Q7T9RzNVQ8XWKAG2jOHe4R7iXpKIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIQCkEZFhRCj2lFQEREAEREAEREAEREAERqAiBm5+eEuW7/yY9521V0KoiZSjT+iXAPcO9g9h7qX5bq5aJgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAhUmoAMKypNWPmLgAiIgAiIgAiIgAiIgAjkIjDu3a/MR599H3kcGD6wc660iiwClgD3Dl4ruJe4pyQiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiUCyBtsUmVDoREAEREAEREAEREIHKEpg+fbp55ZVXzOTJk82cOXMqW5hyF4EyEGjTpo1ZfPHFzYABA0yXLl2KzvH5/3wZpR26yiKpebw3dbYZ9cJ35l8TfzQ/zJ6bGl8Rap9A+7atzMAl2pnd1uholukaHtJyD139yCeGe2pwv4Vqv/FqgQiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIQLMQCGuhmqVKKlQEmofAa6+9Zj788MNGhS+wwAJm2LBhjcIVIAKWwDfffGOefPJJM3v2bBtk5s79eWJn4MCB0QRT4YQOREAERCAjAYwq7r33XhlUZOSlaNVBAAOgCRMmRMZAW265ZdHGFW9O+CZq0KC+nYINw6jimNFfyaAiSKn+TmJA8/yHsyJjmvO2WyhoXME9hGGFvafqj4ZaJAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIi0BQEZFjRFJRVRk0QuP32283bb7/dqK7dunWTYUUjKgqIE2ACadSoUfGgwjH3Dyt3JSIgAiKQlwCeKuSlIi81xa8WAty73MMbb7xxUVWaOO37KF2f7h2D6fFUIS8VQUR1fZJrzz1wyhZ+Axx7D9l7qq6BqHEiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIVI9C6YjkrYxEQAREQAREQAREQgaIJsP2HRARqmUAp9/CX3/zsBWqRBcN24Gz/IWnZBNLuAXsP2XuqZdNS60VABERABERABERABERABERABERABERABIolENZUFpur0omACIhADRBgu45PP/20QU0J47Pooouadu3aNTinHyIgAiLQlATkraIpaausShAo5R7+6ecdtUzr1q2CVZO3iiCeFnEy7R6w95C9p1oEFDVSBERABERABERABERABERABERABERABESg7ARkWFF2pMpQBESgVgjMmjXLHH300Q2qi1EFssEGG5gDDzywwTn9EAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAERaHkEtBVIy7vmarEIiEAGAl9++WWGWIoiAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiJQ7wRkWFHvV1jtEwEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAERKJqADCuKRqeEIiACIiACIiACIiACIiACIiACIiACIiACIiACIiACIiACIiACIiACIiACIiAC9U5AhhX1foXVPhEQAREQAREQAREQAREQAREQAREQAREQAREQAREQAREQAREQAREQAREQAREQgaIJyLCiaHRKKAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiUO8EZFhR71dY7RMBERABERABERABERABERABERABERABERABERABERABERABERABERABERABESiaQNuiUyqhCIhAKoHJkyebF154wXz22WfR59NPPzWff/656dy5s+natavp3r179D1w4EDTp0+f1PzyRvjqq6/M888/bz7++ONC+dShQ4cOpmfPnqZbt27Rp3///mbAgAGmdev8tlZvvPGGoZykLLnkkqZXr14NgmfMmGHefPNNM2nSJDN+/PjoM2vWLLPYYouZHj16RJ/VV1/dLL300g3SlesH7N9+++1CdpTtk1deecU899xzDU63a9fODBo0yLRq1apBeJ4flPniiy+a119/3UybNs1MnTrVwMXeD1yTNddc0yyzzDJ5sjXca1xnZO7cuYW0Cy20UIO8iPfkk09GcT/55BPzww8/RGXvu+++Ef9CQh2IgAiIgAiIgAiIgAg0CYFzzz3XLLzwwtGHPvSqq65qOnXqVLayZ86cGfU/p0yZEvU/GZtwzJiAPjj90EUXXTTqM66yyipFjQno43/99dcN6szYYoklljCLL754Ifyll14yY8eONRMmTIj6r9SBscBpp52WqY9Nf9eOr2gDYxv60nZcQ1vIb6211jJdunQplFvKAf3lf//734bxAf1nxhTTp08333//fTSugx3juxVWWMGsttpq0XEp5SmtCIiACIiACIiACIiACIiACIiACIhAdRKQYUV1XhfVqoYJzJkzJ1Jcjhkzxrz11lvOlqCMi0/y33bbbZExwfDhwyMlYPv27Z3psga+88475uGHHzZPP/20MwlKwA8++CD62AhMwG+22WZmgw02MIsssogNTv2+4447nO1ESXvhhRdG6X/66Sfz6KOPmlGjRkUKyGSmH374oeGD3H777WbllVc2W2+9tVlppZWSUUv6jQL3b3/7W+Y8LrnkkkZxjznmmEjZ3ehESgAM7rnnHnPvvfc6GWBgwQejiEceecT07t3bbL/99pGCNiXr6PRrr71m7rzzzug4blhBwFlnnRUp52+++Wbz1FNPRXHif1Cuc0+EhPsVJfh+++0XiqZzIiACIiACIiACIiACOQkwSc8H492XX37Z0L9efvnlzbBhw0oyvn7//fej8QB9OJfQ/7PGzvY8YwLKXXfddSNDDxue9n333XdHxgfJeIwJzjvvvMj44dJLL20UhzrYcUAyrf1N3xZj7gceeCAybrDh8W9ryG7DGHdgrMz4arnllrPBub6/+eabaGxy3333edPZcR0RMGi/8soro/77XnvtZTCSkYiACIiACIiACIiACIiACIiACIiACNQPARlW1M+1VEuqgMAXX3xh/vKXvzTwipC1WigUL7vssmhy/Nhjjy3Ke8Ds2bPNddddZx566KGsxRbi4XWCife77rrLHHbYYQYvGqUIhgQIq7owUMCQI6vgzYHPFltsYXbfffdMq9ey5l1qPAxn8sp3331nUCS/+uqrmZOi5L7gggui9g8dOjRzOldEroXPqMIVPxmGh42bbropGazfIiACIiACIiACIiACFSKAhwQ+G2+8sdl0003NfPPNl7kk+qu33nqrefzxx3P3oxkTjB492mBMcPDBBxs8WJQi9EPx+IDBNf3bvELayy+/PDLwzZsWgxI+m2++udltt91yeeLAwAWD7DTjY1edMK4//vjjzTbbbGN22mmnXOW68lOYCIiACIiACIiACIiACIiACIiACIhAdRDI7/e/OuqtWohA1RHAcAAFWnyriWIqiTvbE044wbsay5fnl19+ac4888yijCrieaI8ZFUZK+WSng/i8bIck9c555yTy6gini8KXYxNijFmiOfTnMcokzGQyGNUEa/v9ddfb+6///54UO5jFMouTxVpGVF37gOMMiQiIAIiIAIiIAIiIAJNTwBPZkzwh7awi9cKw4iLLrooMqqIh+c9ph9PPnhcK3VMQH+2GKMKjNYZ3/g8bmRtE33p888/33z77beZkmBUTPxijCriBWCwftVVV5XML56njkVABERABERABERABERABERABERABJqPgAwrmo+9Sq4jAigKTzrpJIMisxyCEo+9lv/1r39lyg6PCCNGjCjZqCNeGJPppXgpwHsGrnBxy1uKPPnkk+aaa64pJYtmTYsi99133y2pDmwVM2nSpKLzwDVzMYIS/JlnnikmqdKIgAiIgAiIgAiIgAiUiQDb2TFBj9FrSBhDYBDw3nvvhaLlOof3CvqixQpjgcceeyx3crbhOOWUUwzbmZRDMHLGeDyNIX1uu51hOcple8Zi++LlKF95iIAIiIAIiIAIiIAIiIAIiIAIiIAIlI+ADCvKx1I5tVACrB5jq4ss0rlzZ9O/f3/TrVu3LNHNxRdfnMlY49prr81kwNChQwezzDLLZN7vl1VWuCAuRthv+Omnn/YmZf/mrDJmzJiyKVWzllmueL7VeVyLPPLPf/4zVRGcJ79kXPb0jstLL71UtJeNeD46FgEREAEREAEREAERCBNo3759OMK8s2wv8cADDwTjYQAxderUYBxO0g/t06eP6dWrV2pcIuBFrlSvfJkKikUaNWqUYTwREtqx0kormXXWWcessMIKUbtC8d955x3DuCIkt99+e+i0YQyz7rrrml133dX8+te/NjvssENUdijRjTfemGlMF8pD50RABERABERABERABERABERABERABJqfQNvmr4JqIAK1TeCWW24xkydPDjZiu+22M8OHD48UcTYiK8pYvXXnnXd6FW3EGTlypDniiCNsskbf7P/L/skhQfnHHr9x5SmrtZg8Z6uHDz/80JscoxG8Z8w///zeOFlPrL322marrbaKDDvatGkTGQp8/PHHkZL40UcfDWaD94vTTz+9pD2KV111VYMRihWMYvbff3/7s8E3+0kfffTRDcL4kTRAaBQhEIDyd9tttzVDhgwxnTp1imLOmDHDsArxhhtuMFOmTPGmZvUc28307dvXGyfLiSWWWMJwHXr27GlQ4rNvNUrrpZZaqpCcOrE6USICIiACIiACIiACIlB5AqeddpqZOXOmwVMbH588+OCDZr311mswprBxX3/9dfPss8/an87vtdZay2y66aZm8cUXj87Tr2VMgDeHe++913z00UfOdARefvnl5owzzih5TDBw4MDIEAIDBcYXbM9BHeJ9bNryxBNPeOvSo0cPs9NOO5nVV1/dMKawQt9+3LhxBq9rPk+CeMIbMGCAIY+kTJs2zTz33HPJ4MLv9ddf3+y7775RH7oQOO+Asd5//vOfaMsWnzEIBh3bb799PJmORUAEREAEREAEREAEREAEREAEREAEaoyADCtq7IKputVFAKMAlJA+QWF48sknF5SX8XhMsm+++ebRJPs555zjNW544YUXzGuvvWaY6E8KSkiUnCHBKGONNdZoFKV169ZR+KBBg8wVV1zhVV6iHMR97c4779wojzwBJ554ollxxRUbJKEOGHsccMABZuONN44MJzAmcQnGH+x3PHjwYNfpTGEobONK2/hxMgPqxqdcwvXGnTGKbPaptntVL7LIIobPsssuGymBn3rqKW+RGMKUYliBIn7HHXcs5G/r0Lt37wZ1YlUiBhcSERABERABERABERCBpiGw4IILRgbI9M3//ve/e/tiGFRjMB0XxgQYE4TkoIMOMquttlqjKPR3CcfY4Oqrr/ZuA4fhLVvclWIccMghh0RGFbYSrr44bWFs4hPGRIcddpjTwGO++eaLvEkw5mBLFJ/nOAyIDz300EZFhLbeW3PNNc3BBx/cKI0NWG655cyxxx5rjj/+eBvU4BtjkVLYNchMP0RABERABERABERABERABERABERABJqFQPlmDZul+ipUBJqXwPPPP++tABPpp556qtOoIp4I4wuMDkLbg/hWn7FNh281FmX4jCri5aNMxY0tXgx8gmcNOwnvixMKh0PSqCIZf+mllzas1gsJhhW1KkcddVTwXsB7BCvg4OCTsWPH+k6lhqMwx6jCpcCOJ8agAgMOiQiIgAiIgAiIgAiIQNMTwKvYnnvu6S3Y1R9+7733zNdff+1Ng1EFniJCwphgn332MRgQ+AQvEsWOCfbYY48GRhW+Mtiuw+f1gfHS73//e6dRRTw/jJbpe/uE7QrxbpGUzz77LBlU+O0yVC+c/O/BkksuGRnOJ8P5TbswGpGIgAiIgAiIgAiIgAiIgAiIgAiIgAjULgEZVtTutVPNm5kASsWQq14msbt3756plrjB3Xvvvb1xKcflQSDkqpbVblkUgBTKZDvKTp9gvIEysBj51a9+Zfr165cpKd4rQp4xUCTPmTMnU17VFInVbf3790+tEtch7lEimYDr8N133yWDU38vvPDCZq+99srkgePNN9/05sdKSokIiIAIiIAIiMDPBBbq0MoM6TOfWarz/7YiEBsRKAcBvB/gQcIlX375peETl5BRLFvhpRlV2Lzoi7LFhk8w3sCII69gwM0WJFmErTx8gjE4xshZpHPnzpGhiC/uG2+80egU27H4BG8YWYQxmE9Cxi++NAoXAREQAREQAREQAREQAREQAREQARGoHgLaCqR6roVqUmME2JrCt6oJLxSbbLJJrhah8GQ7iLffftuZ7pVXXmmwguzHH38M7qO86667OvPxBbKyC/e0t912mzMKRhzUL4/gtSPpqjgt/WabbRa5GXZ54mCbEPissMIKadlUzXkYhFb+JSuKIh2vFdxfLkEh27FjR9cpb9gyyyxj2rVrl2mFYUgxn1Uh7q2IToiACFQdAQwA2ZYKwXDtlltuMb4tmWzlMcRr27ZtZOh100032eAm/WZVNfLtt9+am2++OTp2/WnTpo3BwM8ahmEUiSt73/vblUe9hO2www4RB/oPaVsG1EubK9GONZaazxyy/vxm0QXamLYxe4q58wr7+vu55q1PfjRnPfC1mV2hhelD+s5nTti0U9S0q5+fd/+/nN/gshJcbJ4d27UyW67Uwdz6r+qql61fLX3Tf6T/75IpU6YYDGcR/qddXixsOp6BeYR8t912W3PnnXc6k+FBLavRtM0ga98djw4+w/UllljCLL/88jbLTN/rrLOOueqqq5xx8TyY3BrFMnUlePTRRyNjF95/IaGto0aNCkXROREQAREQAREQAREQAREQAREQAREQgRolII8VNXrhVO3mJxBarcWqrDSlm6sFa621lis4Ckt6jJg8ebJ38qtHjx4GN8J5JbTCKuTJwFfO+uuvn3lVmc2DVWiDBw+2Pxt9f/DBB43CqjkAhS6ulfMIboR94jI48cW14UsttZQ9TP1+6623vHHyKrO9GemECIhA1RDgXcUKZT4cZzGgwliB+BhsNZfYOofqQD0xGOzUqVOhjRgJtkSjCq4TrOAGF0lxBI7YaEFz6ladTI+FGhpVkFureR88WKy19Hzmmr0XMV075Xv3Z60RhgvzLmP0mb89pVaPbL1yB3PT/p3NbmvkMwCtnhZUV0369u0bbRO33377GT77779/9GFbj7hhA0YWLs92tAbjOcYFecXnLYN82Iowr/Tu3TtTktD4JjRO8mW+wAILmJVWWsl5esKECY3CQ1szYuRy/vnnG3hLREAEREAEREAEREAEREAEREAEREAEWiaB8HKLlslErRaBTAR8e/+SGJe7xYhP8UdeM2bMaJBl0gVw/GTIMCEeL3nMBDzeNlyT99OnT09GT/2dXAWWmuC/EVZeeWXz8MMPO6PXmgvdkILW2cB5gV27dvWd8hrTeBPMOxEy1Iin8ynlicMqQSYnJSIgAvVNANfprLYNGVnVAgFrVMGkmpUnnnjC1Jpxnq27vpufwLardjCbLP+/LQg++/on8+JHs8wnX/1kOs0zcFimW1szsBfGK8YsPH9rM3L3eZ7Arvjc/DgHXxYtQ/Zcc/7Ii0elvHW0DIr/ayWGufSJMYhCrEGZ/W1juvrt9lzIQMLGcX3T7/ONCUJjIFdehC2++OK+Uw3Cv/jiiwa/4z/wZvHuu+/GgzIdz5o1yxnPZWSH5zi8zfk8N7322mvmiCOOiLb4W3fddQ3xMWbPa0TtrJACRUAEREAEREAEREAEREAEREAEREAEqp6ADCuq/hKpgtVKIGTYkHUiO9m2kJeJpBIzpHgstnwUtX369HG6HUbBiGIy6/7CtI2VdsVIaFVb0sCkmPybMs0vfvGL3MUtuuiiudOEEnTp0iV0unAuZLSSVSFeyEwHIiACNUtgjTXWiLYj+u672nTl7zKqwIX7Rx99VLPXRBVvfgLDlv2fUcU1Y781N77Y+P8DjxVX7bWI6TDPqwTbhAxbrr25/83vm7/yqkFdEwgZVvTq1auotjMmoD+OIUFS8o4JMNgLeReK5x8aX7FdoW/LwngeWY9px+zZsxt4GcRz0y9/+Utz4403BrPBk6D1JoghBgaJbJnYv3//aPxTjOfCYIE6KQIiIAIiIAIiIAIiIAIiIAIiIAIiUBUEKuOjtiqapkqIQGUJJA0d4qXFV8jGw9OOUWKyOswl06ZNaxAcMqzw5dEgA8+PUNqQ4taV3fzzz+8KTg0LeUbIW4fUwiocoRjFah7jlXJWP2RYseCCC5azKOUlAiJQxQRYeZtlS5A8TeB9kFxlnSd91rhJo4q5c+eaMWPG5DaqKPb9RT2ZQKQeWaXUsrJOWGatj+K5CfTu8rM9+nc/znUaVZDqq+/nmj8/OrOQwfCYh4tCoOOg7bwRGV4uKiXkTRnFCtualJK+2HKVLhuBUN+4lP5bqD8e6jMma52nLxwa3yTzLcdvF7utttrKrLLKKpmzx0Dj5ZdfNjfccIM59dRTzV577WX+9re/mRdffNHgZUMiAiIgAiIgAiIgAiIgAiIgAiIgAiJQPwTksaJ+rqVa0sQEQoYV7dv/b1Vj3mqhxHQp+ZLlueLYsoo17CB9KC1K1KzeFDDQKHYSjZVfPsmjyPXloXA3gZkz/zcZlIzRsaP2S08y0W8RqDcCeARaZJFFombxXeqWIGxvxeQUxmL2ffDjjz8a3K8/9thjhuNyStKoggmthx56yHzyySeZill77bXN0ksvbeLvcCbMWJX80ksvOfPo0aOHGTZsWHTukUceMUOGDClsm8TK67Fjx5rJk/+/vfOAt6Mo+/CQXklCGjWEkkAoQiBAQDD0KgJBmvQOgiAKiH7SBVEQ8RMFRaRI9aP33qUX6WBCIAFDIISW3r99Jrwnc/fu7un3nnPu//397t09s1OfmZ367sx//fO9997bfxn9+uuvO9p0ju1i0dO2kCcswrGvoBMDjAz5+nvUqFE+HFPgmD9/vu87sDNHVv8gzU+ZZxOI9F6jfFpkh90o2JkCJYokeeq9Of7ZgkipZ/a8ZDu4695pCffLHXq6oQM7uK6Rn8j8aA328xkL3KVPTnfPjEs+vsBbLOAfu2UcOLKb6921nWv/TdxRCnl94lx37r3T3Jw8R5RwrMdOa3XxabXgONbkmXFz3f8+Ns3NmLM4bdjd5VtdXLcoTQiMbjp8KX9/9A1fusnRsSmS6hHI6r+Vo7iVNSYgzEJ3RCsm5Vk7VhTjT6F2k47Bo07muI+rrrrKPfbYY4V61cTe008/7fijjdhvv/1cqccjNvFUP0RABERABERABERABERABERABERABFqdQBnfLrV63BUBEWhVAuHCSzwifCFbqqQtNMWVDbK+UGVb21Ily21WmPHw0s4zjttL+p31dZctziW5k1l5BLK+KGTRTiICItDYBFgoe+edd3KJ5EiQUhblWJTaY489HO5pK8N6m3aEo4X22Wcff80FVuZNklLFvffeW5BSBYuHe+21l1t99dWbKFUQJdpelEN23333xKOwUDojTfyhYBF+4c1RUGG7aXaHDBni7aKAaEoVFhaKGSNHjkylMXz4cLfLLru43r17N9kVg/SjDDN69Gg3bNiwVPd6UBoBunUff7WoHUR14PzRvdyyvZJ3JcHu3pd/7n7w9y/cKbd9nRjg+oM6umsP6ePWWb5jTqkCiyhA9O/Rzp0aKVz8fLueiW7zGaIEcu4uS7qfbNXD9e2+WKkCdyhwbLhiJ3f9oX3capFCR5J0bL+Eu2zf3m6fEV2bKFVgl2ffGdLJXX1gn5wSBebLLNmuyW/MULLgz5RGMJNUh0C1+m9ZY4KsMMtJZbX8LTZOtF1HHHGEO/nkk/3xHsW6N/uTJk1yF1xwgbv22mtdOeND809XERABERABERABERABERABERABERCB1iWQPKPWunFS6CJQFwTsq96kyM6YMSNz54ckN2aW9qVp/KuwrPCzvlyzcNKuaeFjP+uYkLh/fHnLYrx9TRt/nvV7+vTpqY+z0p3qSA8KIhAuCMYdZOVJ3K5+i4AI1C+BZ555xq244ooOJQAW/bfddlt32223FZUgFAxs+3kWkt59912/awPKAGuuuaZXVqBt2GqrrfxiU7mKWyzEoVBgX1cT5l133eWmTJlSULy32WabnAIJC4mvvfaa4/itAQMGOHbdwH/av80339zvgJHmqS0I0v5xj0LJBx980My61bW0t2PHjvV2V1lllVz8V1ttNffCCy/4NjR0THzWXXfdnBE7ccCWcIYOHeqWWWYZf49ixoQJE5zq7Ryqitzc/fosd/im3b1fK/Rp7/62X2/3ZbS7xOsT57lH3p3tXhg/xy0oQK+2U6SccNqOPb2SAp5N+nqBu+mVmW7KtAVuw8Ed3fZrdnEob2y2aif3yodd3H1vzfJhFvrvkI27uXUjhQ0EJQ/cP/f+XLdMr3Zul3W6uqUjJQiUHc787pJeASTu7ynb9nDL9V6kNIL7eyP3r0yY60ZEChmjIqUKdqNAYeJX34uUN276yju/+d+z3HufzXcHbBQpGkXpmxdtUHHVszP8s0lfabeKOONK/0aJK03KGRNk7RJXzJggLW5J5llpYRel/v37JznLNKNNYJeg+FgKR3HF9bhH1Ln8jRs3zr3yyivu2Wefze1CFLeb9fvuu+/2ym877rhjljU9EwEREAEREAEREAEREAEREAEREAERqHECUqyo8QxS9GqXAFtxpwnb2NoCT5qdJHO2o2VBJknik4EsUKVJOecTZy1E2WJQWrhxc/xiIahYYTv6NJFiRRqZ8s2z8relt2YuPzXyQQREoFQC999/v9t11129c+pclCHefPPNgryjzmdHCoTdh1DKsPqDxX6Owdhtt90ci2coV3znO9/xx4IU5HmCJZQKQqUKrGBGfZbVnplXKJFYu8JOSzfccENOoYEjPEg3u29wnAnpoi3O8vf555/PsQp3q7Dw7Prhhx+6hx56yH66l19+2XFUCIt8KLQQLxbyQkGxw+TFF1/0LO03dtlZY/311/dGW265pbvzzjvtsa4VIHDrq7N82Tr029284gNe9u7WzitAoASBTgVHXvwrOsLjuudnuOnBURlh8Mdv2T2nVPHmx/PcSbcsUk7AznMfzIkUIWa7i/bo5cM4crNu7qF3ZnlFhdCPtHuOKNk1Up5AiM+P/vmVG/fZ4l3Mbn9tlvvd7r3csKUjZaHI7r4bdnPXRnE16RDtmDFy5U7+J+6PvfFL9/6URTt1kK5bX23vLt1nUf+THS86d1jCH3fy3uR5jr+91kexwrl50ZEhN0fKIpKWIZCl5JClMJ0vdvFjCEP7pjwXmlXiPkuxYv/993eDBg2qRDDeD9qKQmXllVd2/LF7EW3ae++9549tYpenfMc3WRjXXHONPy4qK41mV1cREAEREAEREAEREAEREAEREAEREIHaJBBNn0lEQARKIWALMUlu33777STjvGZjxoxJtRMPL2tS7o033kj1J+vBzJkz/dezSXaYtC1mAhI/So1HuBV9PC5Zk8dxu/pdHIGsSXLKtLYwLo6nbItAvRJAuS1sx0aMGJHb0SFfmth5wYTdGEypwsyoR0KFAlPCsOfFXlFeSFJkHDVqlN91I59/a6+9ds7KU089lVOqMEOULV566SX76ZVMcj9iNyhGhgooaUd74ezxxx9v4houKHKYxNNE/Wxm7IqFgkpc2GkDBU2kX79+8cf6XQECt/x7pvvF7V+7DyJlA3ZzCIUl2gE927nd1unibjh0KbfneosUHEI73G9iiguR+9PubH5UyJhP50U7Vcz1zlBcGL7CIkWHuD9Jv3deu4s/ToRnT46Z00SpwuyfeffiMLdZvbMZ++uay3bMKY28HO1SYUoVZmnC5/Pdk2PnuK9nLfSKFP2iY0skrU8gq2/MrjalCPUZygNJguJasWOCJH+SzLLGN1lKbUl+VcuMOK633npeGe6MM85wV1xxhTvppJMc7U4+ee655/JZ0XMREAEREAEREAEREAEREAEREAEREIEaJqAdK2o4cxS12iaQtWjBVrFscV6svPrqq6lO4lvfZu2YQfilHMMRLqTFI7L88svHjfL+5otavpotVvhyN03iCiZp9mRePAG+HmcnlKQdT1ismzhxYvGeyoUIiEBdEmC7c3ZN6Natm99BYbvttnO33npr3rRwHIUJC/1JwhfUKPJx3EjWrg5JbtPMUGLg+I+dd97ZH63Brg9suX7zzTenOfHmoUIZ7Xp8dygshXHMWsAsdMt94pqkdBHWvcQ/lPjuTyzqJUmoAEfaCo1Tkl8ySybw6kdz3Q9v+DJaWHZu01U6uS2GdnZrLNPR7wBhLtpH2XdQdCRHx0gxItwRAjcoSyDRpg7u+ynKF92jozZMhg5oHx0zYr+yryv1Wzy069V1Cbf/Rt0SHaAUQlywE8rwFRYdIYLZg9FOGUny6/unJhnLrAoEqCfZRcckVGZgt59hw4b5R1m72KGEVcqYIEsho1yFOEtP0jWrn8/4Zvjw4UnOWtWsc+fOPl7EbaeddnIXXHCB+/TTTxPj9P777yeay1AEREAEREAEREAEREAEREAEREAERKA+CCyefauP+CqWIlAzBNhyO01QDJg8eXJR5wDzZdiTTz6Z5mWziUQWWdgOl63V44JfbEe+8cYbxx9l/n7kkUdSn9v24qkWEh78+9//9ufLDx48OOFpstFHH33kz7dPfur8efdpz2RePgHOkX7ssccSPaJMSURABNoOgQceeCB3JAgLd2uttVbenYhQljCZOjV9AZZdF8xumkKX+ZPvipLCLbfc4vCTdmzbbbf1TlCCoB185plnUr1gQcwkq103O6EihpnZNb47h5nHr7arRNw8VLYIF1CxFyp8oOyyzjrrxJ03+00/QYoVzbBUzADlBHZv4A/p0XkJryix+7pdc7tG7L5ulyaKFSv1XTz04tiNfUYsfl/SIhYqS6TZMfNle0XncHwj6yzf0fGXJSh5oGBhu29wRIgJu3JIWpcAymnhLjgWG+qHLbbYwn76+gFlh3DXG3vImACFBHYeKkaeeOKJVOvVVG5AOY+6K0kx4V//+pc74IADvPJcauQSHjC2YFwWF8ZRoaI8uzWlHesxdOjQ3LFRcX/C3yiiH3nkke7ss88OjXP3Wccd5izpRgREQAREQAREQAREQAREQAREQAREoGYJLJ49q9koKmIiUJsEWLBhERrlgSS57rrr3PHHH5/0KNGMs9DTzkFmgnGllVZq5m7TTTd1hJMkV111ld+mNlw0SrJnZhzbkbVTxEYbbWRWi7peeeWV7vTTTy94y+C09BDo0ksv7QYOHFhU+KVa5ivBtihZihV8wS4RARFoOwRYAHrrrbfcGmus4RONgt24ceMyAfBldLESVyIoxv2CBQvcTTfd5Fg8RFhYZPt6O5Jk9dVXd+PHj0/dcScMu5C4h8oP8XimKUzE7RHnYiVsy9mVohA/wrQVG57sNyWw2aqd3NrLRbtSdG7nfvPg1JwiQmhr2uyF7spnZrg7X5vlLtu3t+vScQn/t1Lf9rkjNXrHdoiYy7YVeWTOvPx2zAvCNCnEb+x2ar+Em/1NGOFOGcWEa2HqWjkCvONZSmEoBYSy4YYbpu4qdOONNzoUxzp16hQ6Sb2n3k8b3+Bogw02SHVbiQeMb1CWiwv1/B133OFGjx4df5T6G4W7c845J3GMRZ/35JNPzrlFmeMPf/hD7nd4s8suu7i99torNEq9z1IonzdvXqo7PRABERABERABERABERABERABERABEah9AlKsqP08UgxrmMAmm2ySOvHIGboPP/xwQUeC8EVa1hbrbPebJCg7pCkioKRx+eWXu6OOOspv457k3sz4iuvSSy+1n82uLKplHT3SzEFgwJdfKHkceOCBeZUrmETNmsgtdgeOIBqJt+H27nELH3/8cdyoTfxmop6zowv98rpNQFEiRaANE6AtY5EoPBIkCwcLX7YTBdc0JTWzg19ZO1tkhcUzFqlMqcLssvvTsssum4sHR3OxsDhnzqKdBcyeuactQFnh6quvDh/V1H34lTPt6tNPP11T8Wv0yBw4spuz3SCefb+ze2zM7NQkT5m+wL04Ya4/JgRLo6KjQt6PFC6Qdz9ZvKg68cv57rBrv/Tmlfr36dT5buklo60wIvmfO6a6NybOLcrrj79a4Fbut8jJikt1cJO+bv7OdIuOKVkzOvrk/Snz3GfTilcSKipCbdjyPffc49hpIUnoq4XKVthBSSBtLEEde+211/q+OMe+Zclnn33m/v73v6daQVkt67iOVIdFPEBxI0mxAi843mnttdd2Q4YMKchHFO/SFNfj44oshYhHH33U7bbbbgUpp7zzzjupcaNtSpMpU6b4XaHIA3bSIJ2ljr/SwpC5CIiACIiACIiACIiACIiACIiACDQ6AeajWd9iztg+hGMepUuXLn7tK5yXLoXFopm3UlzKjQiIgOPr3azz1lFsuP322/3CTxIuFnJYHDnvvPOSHufMNttss9x9eNO/f3+/K0VoFt4/9dRT/surrEUrzvo99dRT3eeffx46bXJv26o3MSziB9vJX3LJJamL9dOnT/cLWkx+Zkl8AjTLbiHPOMOeXTCShEnYDz74IOlRQ5vxhfPmm2/e0GlU4kRABIojQB1uwrEd1J1pEiplrbrqqonW+GraOrB8lV3pL3hpW++7775c2B06dHA77LBD7nd4w9fMCHUfu0MlCYuI3/ve9/wRI7Z7R5K9apqF2+KzVX6afPvb33bf/e53HQqZWceWpLmXeTKBj75YvBPLLut0SbYUmPbvsfgdmRIoH0yfs9DN/0YXYcCS7V3HaLeIJNlhzS7uf/fs5X65Q0+3/qDs4zxC9+M/XxzPUUOSdyfgCJLzR/dy5+26pDtmVPfQufsgUpYwGbFicrjfH97Vnfndnu7qA/u4/TfqZtZ1rRABFMCoc9OOZSOYJIVrjgtiIT5NUJL761//mnk8ELv7nHvuuS5U5Ir7h6JatWWFFVZwae0HYZ9xxhmZu3lgh7HFZZdd5u6//35+NhMmU9jlIxQmWTjyI0kYF/zxj3/Mu1sQbcrdd9+d5IU3S6u/X3zxRfejH/3I/eUvf/HKI1yPPfZYf4xLqmd6IAIiIAIiIAIiIAIiIAIiIAIiIAIikCPAnDBzqKx5st7JGJ0divnjHjOehfOsOcdF3GjHiiJgyaoIxAmwMHT00Ue73/zmN/FHud98JXvvvff6RRm+hMINi0hsV87Cz4QJE3J2k24OOeQQhwJFmhx66KF+q/b4F7tm/4UXXnD8sdDCgpApgrBLBV/1Zh3/gR8jR45sNvFofhdzRcmDv+22286tvPLKji/mWFAj/Q899FCzL47jfrMoxrnFlRbOpJ40aVKit3/605/c4YcfnjrJmuioAQxR5Hn11VfbpGJJA2SfkiACFScQPxIkKwA6p7R1CF9Qs6V8/IgN6hg7piJrAc97UuK/L7/80i9IDR8+3PvAV7/rrbdeszaPtphdepAtttjC72zhfwT/aLdMEYSjQEhTSwtfMNNmotRCOw7juPIfx5/YoiD9Bh3fVLlcuv7FmW7DwYsUFVYb2MH9drcl/Y4QScdtoHgxNLKDcIjH0+Oa7vrw32inikFLtXcoOPx0qx7uvAemerv2r3/Pdu7YSOFhiUjnYtWo+/fE2PTdMcyNXR+PdtLYee1Fih/br9HFXfvCTPfljKa7SpyyXc9ox4lF8VuhT3v3p8enm3Mf1303XKQssd2wLu6vT81w8TRuv0bnnP173piVu+dmwTenlnRoF0VeUhQBdqJhYM/OCCgFpAkL8yh2J8k+++zjxowZk9qnZlc4/lCYZueJnj17+rqY+oVjR+j7ZQk7SYwYMSLLSsWeHXHEEU2O6Yh7fPHFFzt29SAtjCtQ+oPbxIkT3Ycffuifpe1UgV9bbrlls10/MKcdIC+S5KWXXvJKHexcQftm7Rh2GYe9/fbbXjEiK9ykvKMdvPDCC5OC9MocF110UW78lmhJhiIgAiIgAiIgAiIgAiIgAiIgAiLQxgmwMwXzAUk7FsfRMA8ybdo0x9pgfEfQuIgd1U0AAEAASURBVN2k31KsSKIiMxEogsA666zjtt56a68ckOaMCbZrrrkm7XGqOech5/syjC9pWfznK6osueuuuxx/xQiLNwcffHAxTvLaTftyLMsh8dh9992zrJT8LO3LMTzkOJCzzjrL+409FgdPOukkl+Wm5IjUkEMW7vbee++8O6nUUJQVFREQgSoTCI8EyQqKxX6UGljkYqcI6hK+vGaxix0UOELLtkJHUYDFvGoJC4goINi29bTXdLBRLDR5/vnn/ZbyHAfCcSd77rmnX9jEDl9N48aUKnCD/dYQNK5RhLRFTRb/Xn/9dcdRYigqDhs2rMnX6rRfhQwkWiMt9RgmR3i8FB3vYbtHrLVsR/fPw/q4cZ/Nd29PmusmR7tSDOnfwaF0sVzvxUctvPDBHMfRIKGce/9Ud8k+vR2qB9+JdpXo2WVJ97+PTnNfzFjothnW2e27QVevVIGb6bMXuifGNFXMCP2K37/18Tz3ZvSH4kT7SHHjygN6R35Pj/yYHSlzdHC7Rkofm6y8eCeLGyKFkVDenzLfvfrRXLfO8h1dhygZ/ziojzvn3qnu9ehIERQ+Tot20OjdLfI4kolfzW+WtkVKGEt4tydu3SM6LmS+u/+tWW5alA5JNgF2uUPCxfokF/SH03YNQknsBz/4QeZRHvjJjhjhTkRJ4cTNUMLYf//948ZV+007se+++/ojTNICGTduXOZRhmnuqNtRjkgSFP8YL6F0lyRjx451559/vn/EBEz37t29gnaWMoX5s/322yfujIRCRpqgsPHuu+86lFokIiACIiACIiACIiACIiACIiACIiACyQTYRbmYuVDG27hJ28E4OZRFpotmxrJs6JkIiEBeAkz82VeieS0XaIEjKo488si8E6x4xxEZaducFxhcorXjjz/ef82W+DCPIRUSX5tVQuDAglc1hG3TCxEWqfiSkGujSdIkPmc7t+QEeqMxVXpEoBEJFKoY9/DDD+eO9+DYD74oPuigg9z3v//9nFKFHdcRKjlUgxk7Q6HAYcLuEygimBCPxx9/PGeHRTJ2eEKpEKXJcMcolEuyviQ3P6t1RZFiypQpOe/Z9p/+B8orKIDYYivnCLITlKSyBE6982t366uLd2jo3GEJN2zpDm70ul3dkZt2d1uu1rmJUsWDb892Z9zddDcKYjQhOq7jtsCf4St0dFcc0MfddtRS/mgOU1zgyJCf3fZ10Yn4VaQIMSM6cgTpFB01goLDHUf3dRfv1cttvfri3SZeHD/X3fn64vRYQL+OFD9mzl3kfskuS7jfRLtz3HNMX3dVFMdVIuURZF504siJtzSPG2kzgcehm3Rroshhz3QtjcB+++2Xd7zBjgj5lLJLCf2HP/xhix8vRH1daYUCxiennHJK6riCepTdCAsRlC/Y3aIQpQqUMNKUObKOYyQe+Z4XElfZEQEREAEREAEREAEREAEREAEREIFGJcAxH+xCUazghp0uihUpVhRLTPZFIIEA28X88pe/9IswCY+LNmK78l/96le5r2wL8YBFcHauqISg1HHBBRf4L2DL8W/zzTd3o0aNKscL94tf/MLZVu5leZTieNCgQW7nnXdOedq2jVmo43xnFholIiACjUkgVDpAySBL2InizTffzLLin7HIdMMNN6QqotHZRUnjk08+yetXPgv54oz2McdQmbAzBbs9hMIuFjfddJPfaSM0t3sUFdh1I+kIkJBfeG9uk65pcQ7dh/ehH3fccYd78cUXc4og4TPuOV7rlltuySm2hM/Twg3t6D6bwGVPTXe/fXCamzx1gZu3WF8n54hX6PPo6A2O1/j9I9Ny5vEb/Pn57V+7qbOS37lxn81zx/3zy2hHjHlxp7njNniA8kVcvpq5wO19+efuX+/NcUmvNLtK/PPlme60u5orRuDX11Gc9r78C79DR1Lsxk6e5w6/9otmR4zg9tz7pjbbxWLoAG2QCJtyZY899sjtWJPPL5TYUMKohDAmOOecc9xqq61WCe+K8gMlh+OOO65iu9axA97Pf/5zv6NSVkQ4WuTMM8/MslLUM8Yap556aqqyer6vY/I9LyoysiwCIiACIiACIiACIiACIiACIiACDUagkA8e0pJcyjHVmulKoylzESiSAFueH3LIIW6llVZy//jHP1LPN87nLZOhu+66a+7L03z2w+csFi2//PLukksu8dvShs8KvR85cqQ77LDDUr/kKtQfs4eyBxOU119/fVFMllpqKffjH//YrbrqquZV1a58QcZiIVsK15uw20Q1F8tWXHFFd8IJJ7gbb7wx9czpemOm+IqACCwmwC48V1xxxWKDPHcchVHIcRhz58517BaB9O3b1w0cONC3AexQMXVq86/48wTb7HExcX7vvfccf1nCThS33nqr3yWKXSr4w4z4Zu1SMX78+IL55Ysz273zl0/YuYI/jijhaCqUO9nJgj+OrEoTlF0k5RN47D+zHX/IwOh4jBErdvJHd3AMR5IiRFqIHLmxV6QAwc4X31quY7TbRTv34Rfz3ZhP53nlhjR3j7w72/GXJSh9nBMpOSAr9Gnv1o78nztvoftP5PeEKIwkhYvQP5Qv2KEDWTXapWLNZTu4T75e4F7/71w3/ZvdMEL7ds+z/a/8wnPp16NdpGSx0E36Or1Mmjtd0wlwbAXHe6DgUIywIxv1w9VXX+13XCvGrdndcMMN3QEHHFCxMYH5W8yVfu7o0aP90UzUoaVMlnTp0sWPrdg9qdCzU4cMGeIuvPBCf5QjxzCVKowx2AUpPFIq7teaa67pUPpIShvmraHUEo+jfouACIiACIiACIiACIiACIiACIhArRLgo7hSpZQdK6RYUSptuWs4AlkTXsUkFuUGJjP5opTzi9kiNp+wPSzb3XL2fLlHXjAR+Lvf/c5/Wct27M8++2y+4B0Tjhwlwg4T4bbneR0WYIGvzbbZZhvH5CyLOmy5niW2Ve5GG23UZLv2LDflPmOSlS/TnnzyST8BXWxFXOgkbbnxxD1nXCcJ2+1XS5jUPfTQQ0uemK9WvOSvCIhAfRCwRf96iC2Kahz7xF+tC21VPSoE1jrXYuL3SbRzxd1vND9Ooxg/ZkcKDy+MnxP9FeOqcLsoa/BXqrBDBX/FCFz4k5ROgKN+2MGOa3h8UTE+oth8+umnu7Fjx7onnnjCvfTSS3mdMyag377pppsWPSao1FgqKZKMIzjmBCUHjjp64403kqw1MaP/uuWWW7odd9yxpN3XUGY58cQTvfI14xfGduyClE9wR3w5kqWQcRU7w/3kJz/xihyhcgXx/+lPf1r22DBffPVcBERABERABERABERABERABERABOqZwJw5c0qOfimKFUtEX2Ik7fKai0Q1t+DPBaIbEWhgAragxHk9dkYuX5TyBS9/7MzAFq98kVUNmTZtml8gImziwtY2bIVuYRM+E4DsuFGKcGRJ0vbopOmiiy5q5iVpnzRpkps4caJj+3UqvX79+vmJR9wQl0JZVGOnBuLHgtpHH33k/9iyHuUQFBdQamCSG2b5wk7bxh0guI27t992NXvhNbyP2wt/x8O239ixv9Av7rFjfnCNu7Hf7MpSKZm8xdCSver/aH6FpZI9l0MRqBEC+XY4qJFoKhoikEng4IMPznye9nDjk170j545f0SaFW++45+mZD7Xw7ZB4J5j+mYmtNDyFPekpfoqBx54oN+1oFevXn73OVO0pg9q/WKu/DYJzbm336Ed7Npvdt+xsQDjAY53on/bp08f37flyu5CNiYw//DD7u2KGcLvuNmiJ4v+W9ihWXif5dbsJYVB3NlRiHSQJvqp8+bN8+MI0sCYwhiaP/FrIWGHbgjj/fff9+e2ogDB7ksouKEYgRIEf+wwQvilCH6xuxJjRhQy2LWvJZW3S4mz3IiACIiACIiACIiACIiACIiACIhAtQnYcR1pHx0nrU8WE6c11lijiXXWBJG0HZBLW0ltEoR+iIAIZBEwBYqhQ0tfRM7yP9+zHj16OP74aq0WhK/u2JWCvw022KAWotQkDkwAMyHKH1/GSURABERABERABERABESgmgRGjRrlvacfWuyCf6HxQgGAMcHgwYNzTiwsu+Ye1PhN7969HX8tKeTNKqus4v+qES47fqy11lrV8Fp+ioAIiIAIiIAIiIAIiIAIiIAIiIAIVIjA4k9eKuShvBEBERABERABERABERABERABERABERABERABERABERABERABERABERABERABERCBRiEgxYpGyUmlQwREQAQKJFBvXyUWmCxZEwEREAEREAEREIE2RUB9ujaV3UqsCIiACIiACIiACIiACIiACIiACIhAKxOQYkUrZ4CCFwEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAERqF0CUqyo3bxRzERABNo4AX2F2MYLgJIvAiIgAiIgAiIgAq1AQH3QVoCuIEVABERABERABERABERABERABERABGqegBQraj6LFEEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREIHWIiDFitYir3BFQAREQAREQAREQAREQAREQAREQAREQAREQAREQAREQAREQAREQAREQAREQARqnoAUK2o+ixRBERABEWh9AtoSuvXzQDEQAREQAREQARFoXALqazVu3iplIiACIiACIiACIiACIiACIiACIiACjUGgQ2MkQ6kQARFoLQLdu3d3Xbp0aRZ8jx49mpnJQAREQAREQAREQAREQAREQAREQAREQAREQAREQAREQAREQAREQAREQATqjYAUK+otxxRfEagxAieccEKNxUjRiRPgC8iFCxfGjfVbBERABERABERABESggQho14sGykwlRQREQAREQAREQAREQAREQAREQAREoOYI6CiQmssSRUgEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAERKBWCEixolZyQvEQAREQAREQAREQAREQAREQAREQAREQAREQAREQAREQAREQAREQAREQAREQARGoOQJSrKi5LFGEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEREAEaoWAFCtqJScUDxEQgYYioDOuGyo7lRgREAEREAEREAEREIEiCKgvXAQsWRUBERABERABERABERABERABERABEagLAlKsqItsUiRFQAREoGUJaDK8ZXkrNBEQAREQAREQAREICagvFtLQvQiIgAiIgAiIgAiIgAiIgAiIgAiIgAi0PgEpVrR+HigGIiACIuA0ea5CIAIiIAIiIAIiIAIiUKsE1Fet1ZxRvERABERABERABERABERABERABERABFqKgBQrWoq0whEBEWgoAppcbqjsVGJEoCYJtG/fvibjpUiJQKEEyinD7ZZYFMqCBQszg+vc4RuLmbb0sJEJ5CsDVoasTDUyi3pKm/rS9ZRbiqsIiIAIiIAIiIAIiIAIiIAIiIAIiAAEpFihciACIiACIqAdM1QGRKAGCSy33HI1GCtFSQQKJ1BOGe7VvYMP6Itp8zIDHL5Cx8znetj4BPKVAStDVqbqlYgUEeo15xRvERABERABERABERABERABERABERCBRiEgxYpGyUmlQwREQAS+IaCJdxUFEWgMAuuuu64r54v/xqCgVNQrAcouZbhUWaFfF+903CczM734wQZdXb4dCzI90MO6JkDeUwayxMqQlaksu432TH3CRstRpUcEREAEREAEREAEREAEREAEREAERKA1CUixojXpK2wREAERKJKAJsiLBCbrIlDHBPr27et22mknN2jQIClY1HE+trWoo1BBmaXsUoZLlTUHdfdOX3pvaqYXq/bv4M4fvaQbuVInKVhkkmqshyhUkOfkPWUgS6wMWZnKstsWn6lv2RZzXWkWAREQAREQAREQAREQAREQAREQAREohUD2LFQpPsqNCIiACIiACIiACIhARQiwML3VVltVxC95IgL1RGDk6r3c9U984h597Qt31PbZx+KwsH7ajj3rKXmKawsSoAwhlCmJCIiACIiACIiACIiACIiACIiACIiACIiACJRKQDtWlEpO7kRABERABERABERABERABKpCYMMhS7oVB3RxEybPcg+88nlVwpCnjU+AskMZoixRpiQiIAIiIAIiIAIiIAIiIAIiIAIiIAIiIAKNQ6BDh9L3kCjFrRQrGqfsKCUiIAJtlIC2cG6jGa9ki4AIiECDE9hz04E+hZc/ONEtWLCwwVOr5FWaAGWGsoNYWap0GPXmn/qM9ZZjiq8IiIAIiIAIiIAIiIAIiIAIiIAIiEAWgS5dumQ9znxWilspVmQi1UMREAERaEwCpUysl+KmMekpVSIgAiIgAi1BYPTG/d23BvfwOw789pYJLRGkwmggApQZdqugDFGWallK6WOV4qaWGShuIiACIiACIiACIiACIiACIiACIiACIlAsgVKUIyyMUtxKscLo6SoCIiACIiACIiACIiACIlBTBE7YZZBrt4Rztz832V16339rKm6KTO0SoKxQZig7lCGJCIiACIiACIiACIiACIiACIiACIiACIhA4xHo3bu3K+Xjk3bt2jncFitSrCiWmOyLgAiIQBshUEpj1EbQKJkiIAIiIAItRGD15bu5M/dd2Yd21cMfu/NuGq9jQVqIfT0Gw/EflBHKCkLZoQzVm6gPVm85pviKgAiIgAiIgAiIgAiIgAiIgAiIgAi0BoFOnTq5/v2L36kUN7gtVjoU60D2RUAEREAEREAEREAEREAERKClCGy9zlI+qNOvHed3IXhl3FR36DbLum2HLzJvqXgonNom8MArn7vLH5zoj/9gpwqUKqzs1HbMFTsREAEREAEREAEREAEREAEREAEREAEREIFSCfTr189NnTrVzZw5syAvOAKkb9++BdmNW5JiRZyIfouACIhAAxLgy8eFCxc2YMqUJBEQAREQgbZAgAXy5ft2cb+/fYJ77YNp7vTrxvlF9C2+1cetv0pPt/LArq5Pjw6uHSvqkoYnwM4UX0yb58Z9MtO99N5U9+hrX3iFChL+rcE9/PEf9bhTRTkZp10uyqEntyIgAiIgAiIgAiIgAiIgAiIgAiIgAvVMYPDgwW7y5Mnus88+y0wGShil7HBhnkqxwkjoKgIiIAIRgbasgNCW067CLwIiIAIiUPsEWCj/yzGru1uemez++dQnbvyns/yRD3bsQ+2nQDGsJoEVB3Rxe2460I3euPjtH6sZr0r43ZaVJtpy2itRduSHCIiACIiACIiACIiACIiACIiACLQFAswfDBgwwPXs2dN99dVXbtasWW727Nk+6Z07d3bsUtGrVy/XtWvXsnBIsaIsfHIsAiIgAsUTKEaBoRi7xcdELkRABERABESg/giwcM7f82O+ds++85V7c8J09+Fns9xX0+e5aCMDSRsgwMYkvbp3cCv06+LWHNTdjVy9l9twyJJtIOXVT2IxigzF2K1+zBWCCIiACIiACIiACIiACIiACIiACIhAWyeA4kS5yhNZDKVYkUVHz0RABESgTglIIaNOM07RFgEREAERKJgAC+laTC8Ylyy2MQJSemhjGa7kioAIiIAIiIAIiIAIiIAIiIAIiIAIVJ1Au6qHoABEQAREQARqkoAm3GsyWxQpERABERABERABEcgkoD5cJh49FAEREAEREAEREAEREAEREAEREAEREIGqEJBiRVWwylMREAERqH0CmpSv/TxSDEVABERABERABEQgTkB9uDgR/RYBERABERABERABERABERABERABERCB6hOQYkX1GSsEERABEahbApq4r9usU8RFQAREQAREQATqkID6XnWYaYqyCIiACIiACIiACIiACIiACIiACIhAmyAgxYo2kc1KpAiIQD0QKGcivRy39cBGcRQBERABERABERABESidQDl9xXLclh5juRQBERABERABERABERABERABERABERCB2iIgxYrayg/FRgREQASqRoBJ8XwT4/meVy1y8lgEREAEREAEREAERKAZgXx9s0L6d808lYEIiIAIiIAIiIAIiIAIiIAIiIAIiIAIiEDRBKRYUTQyORABERCBtkUg34R+26Kh1IqACIiACIiACIhAdQioz1UdrvJVBERABERABERABERABERABERABERABCpBQIoVlaAoP0RABFqFQGtPPrd2+K0CXYGKgAiIgAiIgAiIgAiIQBkEWrsP3drhl4FOTkVABERABERABERABERABERABERABFqRgBQrWhG+ghYBEWhsApq0bez8VepEQAREQAREQAREQASaE1AfuDkTmYiACIiACIiACIiACIiACIiACIiACNQ/ASlW1H8eKgUiIAJ1SKAlJpwLCaMQO3WIV1EWAREQAREQAREQgYYkUEjfrRA75cJpiTDKjaPci4AIiIAIiIAIiIAIiIAIiIAIiIAIiEAlCUixopI05ZcIiIAIVIGAJq6rAFVeioAIiIAIiIAIiIAINCGgPmcTHPohAiIgAiIgAiIgAiIgAiIgAiIgAiIgAk0ISLGiCQ79EAEREAER0KS6yoAIiIAIiIAIiIAItD4B9claPw8UAxEQAREQAREQAREQAREQAREQAREQAREwAlKsMBK6ioAIiEAdEdBEex1llqIqAiIgAiIgAiIgAjVGQH3JGssQRUcEREAEREAEREAEREAEREAEREAERKDmCUixouazSBEUARFoSwRqcZKbONVivNpSuVBaRUAEREAEREAEGptArfa31Ads7HKn1ImACIiACIiACIiACIiACIiACIiACBROQIoVhbOSTREQgRokUI3J3mr42RLoSo13krsks5ZIg8IQAREQAREQAREQARFwiUqtpfbPSnXX2vlQjXhXw8/W5qTwRUAEREAEREAEREAEREAEREAEREAEWoaAFCtahrNCEQEREIGKEcg3IRw+D+/zRSC0G97nc6fnIiACIiACIiACIiAClSUQ9sXC+3yhhHbD+yR3+Z4nuZGZCIiACIiACIiACIiACIiACIiACIiACLRVAlKsaKs5r3SLgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAiIgAjkJSDFiryIZEEEREAE0gnk+9Iv3/N0n/M/KdXvlnaXPyWyIQIiIAIiIAIiIAJtl0BL981KDa+QHMrnd77nhYQhOyIgAiIgAiIgAiIgAiIgAiIgAiIgAiLQGgQ6tEagClMEREAEKkmACdqFCxdW0sua86vQNBZqL57AUt3F/Wmp35O3GNpSQSkcERABERABERABEWh1AvTVSpFC3RVqr5Q41IqbtpDGWmGteIiACIiACIiACIiACIiACIiACIhAIxLQjhWNmKtKkwiIQF0QaKnJ3VLDKdVdXcBXJEVABERABERABESgRgmU2gcr1V2xGFoqnGLjJfsiIAIiIAIiIAIiIAIiIAIiIAIiIAIiUE0CUqyoJl35LQIiIAIlEKjmZLX5bdcSoicnIiACIiACIiACIiACrUzA+nJ2rUZ0qul3NeIrP0VABERABERABERABERABERABERABESgmgSkWFFNuvJbBERABERABERABERABERABERABERABERABERABERABERABERABERABERABESgrglIsaKus0+RFwERMAKV/qKu0v5ZPCt9TYpnklmlw5V/IiACIiACIiACIiACtU0gqU+YZFaLqah0PCvtXy0yU5xEQAREQAREQAREQAREQAREQAREQASqS0CKFdXlK99FQAREoGIEypkQLsSt2bErEQ/vK5YQeSQCIiACIiACIiACbZjAkUce6fhLkrDvZfd2TbJvZoXYMbvxazlu437ptwiIgAiIgAiIgAiIgAiIgAiIgAiIgAg0KgEpVjRqzipdIiACLUYg32R0vuctFtFYQLUar1g09VMEREAEREAEREAEGoZAmkJFMQms1T5cvnjle14MA9kVAREQAREQAREQAREQAREQAREQAREQgZYm0KGlA1R4IiACIiACiwkwwbxw4cLFBt/cpZk3s1hhg6RwNQleYcjyTgREQAREQAREoE0SMKWK/fbbz2222WbNGCT1uZLMmjmsgkFauGnmVYiCvBQBERABERABERABERABERABERABERCBmiKgHStqKjsUGREQAREonkDSBHdoZvft2jWv8u1Z8aHKhQiIgAiIgAiIgAiIQKEE8ilVFOpPUt/N+njhs/De/E4ys2e6ioAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIZBNovsqWbV9PRUAEREAEGpxA0qS7Tdg3eNKVPBEQAREQAREQARGoOIFClCqS+lpJfbKKR04eioAIiIAIiIAIiIAIiIAIiIAIiIAIiIAIFERAihUFYZIlERABESiPQKUmxivlTyGpacmwComP7IiACIiACIiACIhAvREoRKkinqaW7INVKqxK+RNnod8iIAIiIAIiIAIiIAIiIAIiIAIiIAIiUCsEpFhRKzmheIiACLQpAmmTz2nm+eAkuSvEDDtZ9uxZmr188dJzERABERABERABEWirBApVqgj7WWHfK84ttGfPzL795lqoWegm7T7Jr7Qw0vww84ULF7rJkyfbT11FQAREQAREQARqkIDa6xrMFEVJBBqcwIIFC9ycOXOapXL69OluxowZzcxlIAIiIAKtSaBDawausEWgFgjMnj275Gh07NjR2ba9d955p7v77ru9X7/+9a9dnz59SvZXDmuDABPJDCgLkWLsxv1Lc2vmdo27028REAEREAEREAEREIHaJJClVGHP/vKXv9RU5OlzInaNRy7NPG4v6TeTpWeccYZ7//333dChQ92pp55alXCSwq4VM8adxx9/vI/OqFGj3D777FMrUVM8RKCmCLTWu3LBBRe4sWPHugEDBrizzjqrppjUWmSYJ/n000/dhAkT3CeffOIGDhzoBg0a5NmV01bUWjorEZ958+a5+fPne686d+5cCS+r6gdxPe2003Lt9emnn57aXlc1IiV6/s4777iLLrrIuz7ssMPciBEjSvRJzlqTwFNPPeWuueYaH4Wf/exnbqWVVmrN6CjsKhGgLWE95eWXX3b/+c9/fCgbbbRRrr/89NNPu4svvtibn3jiiW699darUkzkrQiIgAgUR0CKFcXxku0GI/D555+7Y489tuRUMTFGg4+gQfn111/7ewZOEhGoRQJpkxyYF6pEUovpUpxEQAREQAREQAREoNYI7Lfffm6zzTZrEi1TqmhiWMCPrD5cAc5b3QqTpShVINyPHz/eDR482P9uK//oa9t4cerUqW0l2UqnCBRNoLXelS+//NK/ox06aKo0LdNYdL/uuuvco48+6mbNmtXMWpcuXdxOO+3kdtttt9xHSM0stTEDFHZee+01n+rLL7/cde3ataYJvPvuu03a6w8++KCuFrVRzLK2NqmM1jR8RS5HgLyzfJw7d27OXDeNReCqq65yDzzwQJNEhfn94IMP5p498sgjUqzI0dCNCIhAaxPQaKG1c0Dh1zUBvrySiEChBCqlvFCMP0l22WUlXnbNnl1JU3hfaBplTwREQAREQAREQAREwLkspYqkZyEz+mAmdm9XM+dqO+eFZkn2wufhfTF2Q3fx+0L8WXHFFXPOWHhbdtllc78rdfPQQw/ldhA87rjjWnQhiL41X9JxXX311d1RRx1VqWRV1J9LL73U8TUvcuGFFyaWoYoGKM9yBCifd911l//NBxr6+jaHRjd1QoBFzt///veOhfc0YTH05ptvdmPGjHHHHHOM69mzZ5rVNmMettXhfa0CCJUeaa+XW265Wo2q4lVhAijA/uEPf/C+fve733Vbb711hUOQdyKwmADKjKFSxTbbbOOGDx/u+vXrl7P0rW99K9fmrLnmmjnzat7US5++mgzagt+q79pCLlc3jVKsqC5f+V7jBLp37+723XffxFjee++9jh0tELZpTRoAhQOORE9kKAItSIBJbdt1IrxvwSgUFVT/Rxdt81aUI1kWAREQAREQAREQgRolYLtRJClOZD2rRnJCZYfwvhphFeJnt27d3J///Ge/WwWKB506dSrEWVF2pk2b5remx1HSGc1FeVaC5UmTJnlX4YRwCd5U1clnn32WY1TVgOR5MwJh+SznONJmHstABFqAAAtNZ599tvvvf//rQ2PBfY899vAKQn379nXULexGdOONN/rn7NDAcVconLV1CY//qEbbV2m+tNco4ZGf1WqvKx1n+VcZArRNHPGD0GZJRKCaBDhKymSHHXZw+++/v/3MXXfddVe3xhpr+DWZIUOG5MyrfVMPffpqM2h0/1XfNXoOVz99UqyoPmOFUMMEGOCwTWGSvPLKKznFCuwkKVYkuZNZ/RNoDaWEtDDTzOOUC7Vn7pLsh2Z2b1fccc8xN9oa1SjqKgIiIAIiIAIiIAKLCGQpTmQ9Y1t1+lgmdm9XzMP7uD37ne+a5EeSmzR7aeZJfqSZLbnkkkWddV6JMNPiInMREAEREIHCCaAoYUoVAwYMcL/85S+bfFXcv39/N2zYMLfhhhu6//mf//HHhLz88svuiy++cH369Ck8oAa0iRKKSb20a8W215Y+XUVABESgUAKmvID9tddeO9EZdeZqq62W+EyGIiACItCaBKRY0Zr0FXabIMCuFxMnTnTLLLOMQ5O/UEFz7pNPPnFsjdWjRw/HQLVS2yjiN4NitmlkG97evXsXFC12Q5gyZYr/GoFJYNLDoDpN6QT7dqYhmvnt27f34ZAmNFNJ18orr+yID19A4E+ozR+PFHawi3Ts2DFxgd+4ffXVV95/vhjL4sbZbSgLhGETDltCTZ8+3bFtcZJ7tLc/+ugjHw8Yck4mHb5idoywdMMl6cuFML0oMxg/0k98eU7c+UPS2JEOtM5nzpzpevXq5fMNfoWKpYvrmOirhWGRtrBEBERABERABERABERgEYEsxYmsZ7ieGPXJ6WMh9EvpS9Lvs74h/b2PP/7Y96kZD9BvN/veUfAvNMedjSVwx1/4PK3/jnf0c+nzT5061Q0cOLCZ2yBIH9+k/j5bxtPfZ4fAVVZZxTuxvm/Y7+ZBfMxgSrz0YUk77ujTk4akeJu/4S4V9Hv5Q+gjh/1obxj9M7Ys/OE345qQkdnLuuKHhW/26Jtb2PG0mp3win3OsEcYexTaT4cbX4mTzyyCMSYxdt6z4B95hH0bN/CIOBpPFv6KTTt+kHbGlfjFdvFZ48p4PluexMeG+BsK407GMpRJ3gvGoMWMq0O/4vfEqdDxreUpnMKF0tBPKw+Y2RjPygdXE/wy/yiflg9pY1PKB+8lx4ckjU153yZPnuzHryxiU5bTxobEweJkcTQzxsC4oyzF3ZM28oEyl+99SfKf95NFFPKbOFK3WD1nXPJdQ764tTKU5I7wKDsIY/VKC+WGuR7ysRDmSXlLnHh/yTvquKy5lTD+lFvLCzgsvfTSuXIRMir1vQ7Dsvvx48fbrdtiiy2aKFXkHkQ3zHvxhfENN9zgjV944QW37bbbhlaa3BfLsYnj4EdYv6TNFVH/kQ9IGhsru2l1dyn1kdXp8XrDykRWfHxko39Wh1cyXuZ30jWNQ8g5fAfpL1BGllpqKV8erU4zv/GPsk5dtcIKK/h5KXsWXtP8L7Q/EPpVyH2t1Z1hnGFRaPuEuzR2sKcNIU94P5mHjYu9G9Yu8Rx39pu+hZXjuFvL21LmrolzWJfR9tBvrKQQv3L7KYUwLCXOxZa/MAzYFdoHDN3ZPWWLPjZzxJSLpP4j6aZNSat3zK+w7KXVv2aXq/lr4wfMCN/KW+hHWptmdovtkxFWmlhYXE14NyysLA64oS2HKzyoC2nTs/opFkbS1eLCs7C9YsxCX4q40BcjnDSxNiaMN/5SH1SiTxnGMWwPkuJjec6zpD4ZzOqhvktKm8zaLgEpVrTdvFfKq0zgwQcf9Gf80kk0YcKLQeiee+6ZOnHFgOGmm25y999/vznLXTfaaCO39957+0mInGERN5yFefXVV3ulgdAZjfRuu+3md++gwU0SdvBgW8dwqy7s0YgzcE46e4/O68knn+y9I94oUVx11VW5Lx2YAOBs35///Oe+Y4DFv/3tb46tB5OEQbmd97f77rs7/kzg9n//939NzmezZ8aNTk1cLrnkEvfcc895Y+J22WWXuaeeesp3hDD88Y9/3OTLuocffrhZvmIPvw888EDH+W+FyimnnOK/4IDDeeed18wZzP/0pz/5uHzve99zu+yySzM7//jHP9zTTz/tzS+66CLPjg4JQif5tttuc6+++qr/beb82GqrrRxnJoaDI5tMDe1hF3Mze/iRR9xKUT7GJwWwJxEBERABERABERCBtkiA7c5RoNhss82aJT/rGQs0r0ZfAZucfvrpfrKRrbcPPvhgvzD173//2x77KwvXbJWLnVCsH8fE9jXXXOPeeOON8LG///a3v+3HIWl9bfqOt9xyi+Mr41Do97EN7w9+8INmi2kokP/iF7/w1hnjsPBL+IwDEPq5F1xwgb8/6aST/EIkY4KzzjrLm/EPu/SLEcYMm266qU/7v/71L29m/+hvE4cNNtjAjPwVbh9++GETs/PPPz/3Gzf0e01YDGXMEWfL81GjRnm+aYzMD7vSX//d735nP/2V7dMPPfTQnNl1112Xuw9vmBylfPAleChDhw51hx12mFt++eVD49w9k6HXXnute/zxx3NmdgNbxiThdskseJmCj9njevjhh+d+kh+rrrpq7ne+G8oI+Rx+bYgbxrsbb7yxP24zPklf6NjQwmb8wfGcd9xxh1+MM3OupJPjOss5b7uY8S0TwieccEIuHj/72c/cOuusE0bJ3998883u1ltv9fc77rij41ggymd8DJ1WPhmbPvvss9494/a//vWvfmxqARGHsPyj6M8Y/aWXXjIruSvhc1RDXEECC0cffbRfqGXseswxxzjCjb8PvDf4Qd3Cu0h+swhkQr3AezV69Ggzyl1D/4nz3Xff7ec4chaiG9zbGNfqr/B50n04H4Bb6os0Oe2003LcGeNXarGOsk8+o4QSly233NLXsbwHcQnzlveXOR/mFkKmuDnooIP83EravMyLL77oqFPi797666/vDjjgAF+fXH755T74M888s0ldEI9TMb/DBbB8ik0oUtgXxiz8JEmpHJP8wowFmeOOO84/Jnw4xuX666/3dQrmtFtrrbVW3Io7/vjjfZ7Qlp1zzjm55+XUR/YOxtsVysEDDzzgw0iLDw9ps4499lhvj/bhjDPO8Pf8KydeOU8Sbn7605/m2utf/epXORvxepxdSq688som7wPlnzZn+PDhvk9z1113+Xcm50l0wzwi7SR2Qon7T7+KfGOOLhT6AxzrHNaH4fN897Vad1q8i2mfzE2c3Xrrref7OvRJQqE/R/uPcpsJilD33HOP/fTX22+/3fGHrLvuurm5XW8Q/St37po2h3eAeIfCrje07+VKJfopxTAsJr6llj/CKLYPGMYLhUPeJ/qPYZ2OHersI444witZmJtwrp7+apJiJ3bJS+vX5GubsW/1LPcm5557rt36tQk7tv2ZZ57x8+I8ZKxAv6WcPlkukISbUvr01MH0cajn4u05deF2223n5/LT2vSEaHijR6K597///e/+nrYcBQ3q2rFjxzZxwvtM2z9o0KAm5vwI+x3V6FOGfTL6gt///vebxcEM6Dfb+tgVV1zRpG9aD/WdpUNXEQgJJK+ghjZ0LwIiUDSBJ5980tFQWKNhHtDI0jE17X0ztyuakL///e8TlSqwgwLAr3/9a//1mLkp9IqiB41x0gQAHSo6V3Rk7KuO0F8m++gkxSeEsMMgj8beBoShOzoYJnQcUaKId5p5zuSpSXxCx8y52iQT9+EAyrglxQG7hXKjUx8fsOEegQvnTCblK8/JaxgxGZ0l4aSRTcYxKcIOG3F56623vBFuTDkibuf111/3RnzdFg7UmaiFd5o7JnFQyiCPwjjF/bffZof823nnnd190SRn+FWg2dNVBERABERABERABNoiASYc0yT+jL732DFj/AIPi0GI9bW45wsjJs+YaIoLihN//OMf3Ztvvhl/5N577z2/iJukVIFlFkdZkOGLqrgQj9/85jfNlCqwR3yZoGbrdxS104R+IkrQSf39NDeYh2MGxktnn312Yp+c/jaKxPH08cVUocICw4knnthsEdncM9mMYjhf1hYiYdwLsW92ZsyY4RVO4koVPCeOLGQlxYHxGPFPUqrA7bhx43wZYPG1GCkmHZRNlGXiC7uER/7xgQDjIvvCz+IRhpE1NjT7LDzHF/PtGelk0ZMyX4oUO75lYTRUTmGhnon9UFDuMaUKFv1sgjlpfB26C+9DRqQ9bWyKG95ZykmSUgXPWSRj/Br6iXkopIF3NmkMzuL9nXfe6eupP//5z80WDKgXyKOs8S/jdCb2sRcX3P/zn//MdB93Y+NnzMOPIeL2eHds7oKFsUopVVAnU/aT5lSIAwshv/3tb5uVDZ6F+UA54S++CIM93i+4JAnlljF+0rtHOTj11FOb1O9hmEn+FWMWKl499thjuZ0fkvxAaYZFOv6SvqYth2NSeJix44eFlVSvYid8V2weBXMT21GB3/Ft6cupj/iSF7Gr/xH94wMgk+eff95um13DeKMgGUo58Qr9KfQ+LFN8LY9iYfx9oFzTBrz99tvu4osvbqZUQVjMI2Innleh//jDHGZSPUh/gLnTeH+gkHTUet1ZbPtkaQ7ZkTe0D3GlCuwyz4jCG3OGJqFbM8u62hxs0geBuMs3Bzsm6gNTVyb1F3kXWNAnDaVKJfopxTIsNK7llL9y+oDkN+8TeUb7Gxf69yhUhWOPcK6ecUCa2MeKPEcxplwJ+/Vh2bT7cvpkWXEz/7PsxJ+h3Ep/Kak9x4wPQFFqKEfIG8ZgcaUK/OR9Zi0nfJ8trDA91ehTxvtkFm78Srm19THaPVM2xF491Hfx9Oi3CBiBDnajqwiIQOUIMLhBM5EdBtAopzFjcouvbRAmKBjgmxY/ZtjhywJbTEdDni+m+BqHzia7EjD4ozFiMM25lfGvgPAnSZi4QyHAJNQMf+edd/xEB4Nzwiae4QCPCaJwN4UddtjBa/YzKMQtmpl0yui48jVCXOPcwrTBEJrODFLZ4s0mkBkc2mQLHbJNNtnEnOWuhGGdNTQxTRszzm3w4MFu880391/LGTcGWzbw4kuANG4oZjAJwJcmbFnMbg7kA0JaLQ2mXY8dFCJ4ZnyZICF8G9TnEpBwAwcmJRA6SHxlYh0fKzP+YfSPbRUJi23aTOjo8wUaEnZomCBjwt2ewZzyxpclDHqfeOIJP1FLx5gJCDSKQyFfCN/yx+KEHcxQ1jgg+hIO4Rm8KKds50V5YRIPpQuesTOGfb3Jb/KELwTNT3ZwoSygFEJ6mCRmkI3glngjdBKZwER4p8I44xd/hMnAHaEs8jUnQqccxSJbgGCik69TuBIW+WcTb8SFnVAK2a7N0oDCj5VNygx5QflkEpV8i09U8owdYkLBjk2Qmx9skQlvmFKGbXKa9yNULAr9Sbqno/roo4/mHuE/gx3SyrtA2sMvQvnChy9PTEgnXwsy+EUo2zxnu2e+UsB9ODEFP/vCEm167DBJZXHgy0KbqKJDnbVltMWBK3EMFwkob3Bg20KEifXwOV/okUYT6gAUyEyod/iKlrLH4JY6lsUqhHfY3ikmhExpKzQ3f7iSRzapzHtsA1DKJAMpmxSgzmBSkveYOpe8sTBHjBjh4hNlYRhJ95RrazMoz2ir8+UJ5ZrBV1iu0SAPyzXvqeUpfpMP1N8wYaKE98X85jlfv4Z5RXlkEGlKYSh3kTbePdJLftgkG9uN7rXXXk22HUUB0QbntElJW5ISLl9qEhb5zJfQoaAgZpNplAfKFe8N8SdPKJe23S/u4u8eWyDaVzjmL+8G5Ze2gDwinuZHse9enDFpgDH5z1fhVv9b2Fypm+DIu0F9ae0Oz8hD0mdSbvlikcTShp+UH/ol1Au0SeGkioUJA/jAmDJm9SrP+eI1bF9JY7gwwLtPOSGv+cKdutfeDdpulPbCLzni/Ki7yGPKKGWZMo9f4XtAOeN5XJiQNpZ8fRt+yR23y2/aDVt4pm4mLUj4ZSzbftMXKqeOxE8YoNgZCjwor4RBOwC3fML7bgt6cKENhQV1MGXJ6mD8ib9zlc6rQss6+UBZZ4HV8of40Y7EyzplycoL7whu7V2iLrXJJNoF63fgV1zgyR9C3U9Zpl+DH8g222yTa1eo82wxjvchPnnM+0w84c0XXLQ5vFMsutEXI5yRI0f6uNLfol9GncK7wzPed+pWi4+PwDf/bLGY94Y00eaSxvvuuy9Xt8KE99bqdvyhLbLFXsoA/SzaOeo7yjJpxZ+HHnrIf+lpYVJOGF9Y35HdMKgPKXvU5bxDtIf0x1HyZqE0VOg1f6w/QRvK+0pZSEqf2U+68u4j9MFpT+n3UUZo463dYDGFeFAPIHz5Rp1Iuqxu5WtlygoCfxMmP21CmXENeU4+wxz3hEE7St8HP/IJecTiBf0+diZAeH/56g8J6zVv8M0/W0SjXmXsBSvaHfsSnclY+r5MpIZCvtvkLV/tUd7JJ/KdvgzxRqjj6XMTPmWUOCK0q9Y/sC/gMKeMFSKUB+sXYZ96Ec68j+QTfQPSQRtMeU87AsDe+aSxIf4yXrE6jXE1/lDe6VvSb2YBG0G5gsWZMI/9g4x/9BFKGd/yzrNLI+WEMsL41b6opN2wsQpB//CHP8zt8McOiORPWD7ZkcaOyEmLu41NeZdhTBvLmAuhb8SipJUF6gneWd4J2nDaRvKBMQp5ErZf3oNv/lEfIcw70A+lXaNs2nuIWxPaWPKAd4133d41OOy0005NJsrNjfUlyUPSQb1AfUNdBA+E3R94Z0hDPqF/RlxtzMh7a+956JavKE2y2gSzU8iVfjPMTWxcwNgIjpRp3i2UflBWYYHK6mdzY1eY0UbTJyH+MKWdtvEg80b4H/ZpeL9QLDNhzMH4gXaIMBmTwtvmnMxepa5h34lwePcYbzEuTKvnksKuJMe4/7wDtJOU/fjcCeNRW9jBHWUk/lW8vQ88p6yalFsfmUJFfPtz2lrKD/UJ5Yc+QVKZoW43Cefqyo2X+Vnq1d5hlMjgxbwjfSWb/0BJEiGNjGOov0grZdQW/Knn03Z9tXoo3h8g76w/QN+F/kC4+0JWemq97iy1fYqn2fKGr+XpkzEXyNxUqKxIf8IUBqnDaQOoU21ukzrIdia2/jDhMPYpZ+6aMhDu9EX+U65pBwif8k75KLUuq1Q/pViG8TxI+l1u+SulD2jxYO7E5md4X+kX8N4wTuSdYscFhA/w6JvRf6dMhHP1tL9xYexDXYTQZlk/JW4v/M16Bu7oS1i/lV1UbMwbzjuF7sL7UvtkoR/x+2L79NR3Vk7pn9BXZXwHO+apaNfpp9GfY1yftAt1PA5JvxkbILT79JUYc/KOwI88JQzeKcYhzJkkSTX6lGGfjPaVOsbyMIxDOE/7ne98J/eoHuq7XGR1IwIJBKRYkQBFRiJQLgEaFybBbHER/xgwY05HCGHwGypW0CDaQJqJLToaNmGJWyYWmTRikooBH5NJaRNVPoDgHxMXJiw2M6lhwmQeHVgm22iM6VDZYI0JorDDS6c77EjR6SANtmUXi/k2gWf+h1cGXAyo4kJnDn9IF+HT2YwPOsM0sJBvUig3OjX4T8eGCdQkYSIKzWiutmiOPe5t8pPfP/nJT9zgaNEDYaKS/GJh4MpIuYSJWibfQ8beYsK/MP/pFNFJMmGRwya3zYz4M1lgEmqrhgvhlDE6xwhb8bItGB070sGgFGUF8gz/6VwRbrgAjTuzzz3C7/Dqf0T/2CKWgRplBaEjzcIqE4u4YQLI/OJqC/Dw4ggZJmjMLZOKxIPjTxA6WcSNeNMJZdIIM1jRCbcOI/7yRyfOhMEZZgj2bfGPAWW4JS7hMUHIgB73LPZhl4GESVgWzIwr/rMoY0oVmFG+jaXx5v2yzjZ2EIsb9/hh7z6/8YPJdRPcw8k60ww06awWOnkQhoWfKHVYHPmNPwyUKQsIiy8wMSHPbAGe8g6/8P0kbuS5TXCTVuoKJn9ZaOIv/FKPifdwktDCyXcN00HeU5+E29DCjEkrm3hi8ixcJGARF8EtCynhgA9/cG/b5lJurQxQ/xob3kEzD+PLBIAJE2QWVwaYthAIU+oee0YesFjEgip1HoMN6gRYFiIscNlkNZNVLETyXiGkhTqBo4CY4LVybcoicf/JE/I1nDAxdhYG7x7voQmT6aZUwcIAW0Fb2shf2gcmNmHGIgjlI20giTtza/4nXUM71JGmVIFd0h8uTKwU1XXksU0EmH+hH+E9zykXYb1MW0DZQDkGYZI27sY/KOAffvFuW73Fewf3ULGDyXFTysFL8pH3yBYuWOinPjCpZPmizgzbVvKfid1wEEz+wdWEOpmFImuLqMvs3ab+Q4nUhAG0KcphRvlnQod6jXJEvUM7H9oxt1xhBT+ucaGsWznlXYRbXGgHEPhTLvLlI2m3tITvhZmF/pdTR+JPPC4sxPNXrIT1EMqHlDmE+pp3g/qR95D2kwkYm8SudF6FZZ20wYzJMeojEyaE4mWdvDHlD8p6OCkTlnXqFvq/xo2yxHvLRDET+vQjKRPxutTsWxy4wgVzyp8J7ihDmNufPQuv9H9oHxDs2aIS7wPvBWYs5m2//fbeDs9hQ31JP4d+Gm0rfSDe86SwyKNDDjnEv4s8J160MSxU0LbwxySWxRdFPSsH1Pfh0YNM8tHmoPRBenm3WVCyeNMWWR1He0Vf157xzjCxjvKq1Qlsy5vW1+VdpY9HnEsVxlB8ec3YCYEbYxCUBej7099m4p9tZRFrs8J8p760OsviwmS+1Qf0MU0JFz9o3yk78LVFSvrQxgE7ScI7BiPrz2KH/hJm+YR+AcobFj/STRx+9KMf+TRSt+GvxQGlGKvvLJ9swY6wbKGeSWoY0XbzLuG/xYe4mWDf/DazfFdTiCBvUKgLxy/kA+8F8UfoU2eNV9PGhvTh2GnBBMX4sP2jvaTvQxtPOlkE4OvbQgSe5YxvUaRAEYt3jw8MGGvBlvrV2kPqYN43EyufVi9jThtqeWL24lfsMzZN6vOTZlOQ4d1AkcfKEX1zxvNwY3xP35x4hvVqGBbvN3WNCXGnXgrHLxzjwyKGCeUPBQnqXISyZnWi2QmvvM/GAXPKDe+nKaOgLMWxnNZPCt3G72k/bOxEnZQULnUUQjkN4x33q9Df8XLDES8oRZjAnH4UzCkbLCyz4BLaMbtcyVuYhH1rKzOWNt6fsN9BO0d5R8hzWxDlN2WJ8KnjbVEb80oKyjGEaTswUZeiXAFjyhsMSAP5bGUxHn6lOcb9p2/J+AOhjaWuMAnHDZjR5tGOhuMHxlcmpAepRH3EOIn+QJwLv8k3q8sYr9LPCYV6n/EUQv+JfEAqES/vUZn/OKKEOUUT+hu0o9bWEl/KutVjgwcP9n0ZdoaiTSZtYTtn/tiV8sSxPjbODfsDtEfWH7DjxMxd2rWW6874+1Hu/CvtFQoTJrQ71Jf08RDmsaweoU3lDyUvE+qppHaq0DnYtLnrULmDvhfti70b5C/vBMeTWZtq8Sn0Wsl+SjEMC4lfOeWv1D6gxSvkAnPaeYS6jj/eJZRJqBtp0+l38d4yzuI9pW1hDjl+HEhYt5J3hQhlEQnzuJB+UdzvUvpkcT/C38X06ZkzpN9iQn/N2g3MqMutL8ZvFFVpo5LeKZ7nExSdTGkbu7zLKNCzdkSeMXah/eNjlSSpVp8y3idL6muGZQ8GSL3Ud0ksZSYCRqCd3egqAiJQOQI0ZKFShfkcdjKK9TKKAAAFXklEQVRs4tOeWUPDb7Z3NaUKe84kv50ZiVnYATE7aVf7IprnSZMVxJXJKxY47OxG7BJHJgYQFkVCpQpvGP1j4GS7B9ARY4CXJDTiTLSmCZ0Ek6TJgPAYEFP8wH4luaGxSzzjQic/ZGgd0NAenQmUShgkpE00h/a5Z2LTOl6mcGB2bNKUCWIWmoiDfU1pdmywym8mprDDgokxYZKASR8bpJg7FjiYKDah01yKMOixRWablCWswdFg2TjaYoXFgYVLBsZMhNNBxxy3XPlj0czeHdyGz+mA8RthUcjc2DXkYX7zLJwgYaKfyR9zw5V3Kzx32xYWzA7xS/uzL5qJEwsoNpGEW3NDhzec1AmfYSesC3jH8MPc2pVJNftagLB4/+1ZvivhmbBIA9+4GyZHTRiwhc9tIofnvOssMobPuacc2GQgZZAFo7gd8z+e/ri9tN9hOlAw4t2I2w0VB6i7wucMOphEYLKfPAmfcU/ZM4UTJqrtOeXF+LCYz8KdPeOKWBkjTgw+MWegYAo9+M3iCWUtdMtEky264Q/lKXyedR/mC+WaQWBon3oqLNfUzeHzkCdfIjBADp9zb+83cWNi3p7zhbe9b7RVpCGeNn6zmGILOLyzLDaaH2H4ZpZ0NXtcw+fhu8eXONQ54XPumQwI2624H9gxYSDPYlbcD8xNgYfBc/x51m+LO2HAmAnB0D71dihMlobPuQ8H3kz+2vNKlK8wfrRh5rdd7Z0mjjCwBTh7Th5jZsLkqD1DmQeFIYQ0sIBiz+xKmaXsmlCm7RnXMH7Uryw+hM/tnjyyPhMT0vF8puxaX4Z3mUVIc1vI1eLHNcl++C6WWkdaGNQVTE4nhZPPjAUuE/p6cftM7lD/UQ/ybtvzSudVWNbJC/4GR/2CUJLKevg+8H6bWxTzbMKO/gt1KXG351ypv+hfmJDfmFsa4/ZDt7gJf9u9uQmfm/+06bQj9gy7dk8ZY0EBhWXqJjPnavGhrkGoE8O6zBsG/1AYM7/NmLo9rNeoF0wo6ybxvirpog5i8o3+Kl94mt/035lcNztHHXVU7pn5x5W+I+UI5Y4w3NAOdXH4XvMMf4sVyqktooRu2W3F+pj0i9OUX0M34b0pBGIWZ4QZYZJ3jIkYGxkjnlVDkvrp9LPos5jQ9zChHuQIRuKHEn+oVGF2wkXkYsaL5j7fFWUUwiceoVKFuaO9sPYjPr4xO1zJx7SxYai0zKJPqFRhfqAobG1kWA/b87RrueNbyggKJSbsAEKdY+dg04/n3a2EoPxki5Ghfyx8mdIlHHkv4u8ZC2S8yyb0w9KEnSjiQj1tQprCcoU54YXKkPSR0oTdO/AjLpTzcEHWPgyI24v/pg61xWXGvfF6gD6vpZf+TdJ7Evcz32/6+lbHku6wzTG39EWYxzFh8TFNUHwLlSrMHm2cSTivQhqt702eh4owZp/6inbe2Jh5Ja+0P7yTjI9MaENQBqFtYbH86KOP9gtIjCnjUmmOcf+tfcXcxmdmx+aYNo/mnSz+NlYzO1ZnkcdWbipRH9Fnpu4wPy08ruE7EIZldsJjQMIvfUO7la4nLex8V/puYfyxT1rD+oN+Ybwe412x8TVuwrLO71B4pyrVH6j1urPc9inkRj0RKlXYM+aVbIzPuxuOH8xOvqvNN2KvlLlrm+ukrqI9jbdf9M/Y6alUqWQ/pZIMyy1/5fQBaUNsPJxUD8GadoX+HX9hv4s60yRpR8vwI0SUOFtSWrJPFk9XmG768za3H9obHI2B6aOZhPW2mRVypQ91UKSIHRfmU0xRimdZ/f5q9SnDPhk71cWF9Qbm2BHWxGz8VS/1XTw9+i0CIYH/BzDhm6+e8Ic2AAAAAElFTkSuQmCC"
    }
   },
   "cell_type": "markdown",
   "id": "7a54ee20-96b5-4c07-b99c-e182d73de528",
   "metadata": {},
   "source": [
    "![Screenshot 2024-10-16 at 14.02.27.png](attachment:a52ecb72-4827-47b6-984b-56d0ed64b8c1.png)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6038eddc-68ff-4ac3-8eb2-54e45decf51e",
   "metadata": {},
   "source": [
    "# Now that we have prepared the data, lets create another function that completes the process of scoring a transctip which will enable us to loop through them all and get scores."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b7370c13-f33b-42f1-a294-f7c8f5fc750d",
   "metadata": {},
   "source": [
    "The servers we have do not have enough memory for some transcripts that are extremply long. So we've implemented an easy fix to prevent the notebooks from crashing, if the transcripts are more than X words, then only save the X first words. We've used 80.000 here which has worked well before, but you are free to test if you can increase it. "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "id": "84505c39-963e-4cf7-a3ab-19c405fcff4f",
   "metadata": {},
   "outputs": [],
   "source": [
    "def score_transcript(text):\n",
    "    # Fix to prevent notebook from crashing\n",
    "    if len(text) > 20_000:\n",
    "        text = text[:20_000] # Only save the X first words. \n",
    "    \n",
    "    \n",
    "    # Running the function we created earlier that remove stopwords, spaces and so on... \n",
    "    words = process_text(text)\n",
    "\n",
    "        \n",
    "    # This is the same as above as well. \n",
    "    # We the save the amount of words for later. This will show us how many % of the words are e.g. positive. \n",
    "    number_of_words=len(words)\n",
    "    \n",
    "    counts=Counter(words)\n",
    "\n",
    "    keys=set(counts.keys())\n",
    "\n",
    "    # Calculate the positive score by finding the intersection between the keys in 'counts'\n",
    "    # and the 'LM_positive_set', summing the counts for those words, and dividing by the total number of words.\n",
    "    # 'keys & LM_positive_set' gives the set of words that are both in 'counts' and in the 'LM_positive_set'.\n",
    "    pos = round(\n",
    "        (sum([counts[k] for k in (keys & LM_positive_set)]) / number_of_words),\n",
    "        4\n",
    "    )\n",
    "\n",
    "    # Similarly, calculate the negative score by finding the intersection between the keys and 'LM_negative_set'.\n",
    "    neg = round(\n",
    "        (sum([counts[k] for k in (keys & LM_negative_set)]) / number_of_words),\n",
    "        4\n",
    "    )\n",
    "\n",
    "    # Finally, calculate the uncertainty score using the same method.\n",
    "    unc = round(\n",
    "        (sum([counts[k] for k in (keys & LM_uncertainty_set)]) / number_of_words),\n",
    "        4\n",
    "    )\n",
    "    \n",
    "    # This could also be done with the simpler loop that checks what list each word is in, this is a slightly optimized version to reduce the time we have to spend on each calculation\n",
    "\n",
    "    return(pos, neg, unc)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "id": "e50b27c2-2394-43ac-8c7b-4e1a323c84d1",
   "metadata": {},
   "outputs": [],
   "source": [
    "# If you want to run a test and not run through all (which will take time) do this,\n",
    "# and it will only run on 4 instead of all transctips \n",
    "# transcripts_texts = transcripts_texts[:4]"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "02b81297-fd72-4e64-83ca-177c5a5986e1",
   "metadata": {},
   "source": [
    "Now we are also printing how much of the compute resources we are using to get an indication if we are using too much, which would indicate that we need to kill other kernals and reduce the maximum text length in the score_transcript function."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "id": "1fe1f5bb-741e-49ed-ae26-809a25aaa328",
   "metadata": {
    "scrolled": true,
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "scores: (0.0392, 0.0109, 0.0169) Memory Usage: 78.7% and CPU Usage: 18.3%\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/9t/x3x7t9jx2sl_j1zfhq6vmmxh0000gn/T/ipykernel_79255/2288903398.py:17: FutureWarning: The behavior of DataFrame concatenation with empty or all-NA entries is deprecated. In a future version, this will no longer exclude empty or all-NA columns when determining the result dtypes. To retain the old behavior, exclude the relevant entries before the concat operation.\n",
      "  sentiment_scores = pd.concat([sentiment_scores, pd.DataFrame([np.array(scores)], columns=['pos', 'neg', 'unc'])]).reset_index(drop=True)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "scores: (0.0502, 0.0081, 0.0092) Memory Usage: 78.6% and CPU Usage: 19.0%\n",
      "scores: (0.0507, 0.0139, 0.0145) Memory Usage: 78.7% and CPU Usage: 22.7%\n",
      "scores: (0.03, 0.049, 0.0249) Memory Usage: 79.7% and CPU Usage: 33.3%\n",
      "scores: (0.0315, 0.0448, 0.0124) Memory Usage: 79.3% and CPU Usage: 17.1%\n",
      "scores: (0.0512, 0.0085, 0.0268) Memory Usage: 79.0% and CPU Usage: 19.5%\n",
      "scores: (0.0328, 0.053, 0.0088) Memory Usage: 78.6% and CPU Usage: 19.1%\n",
      "scores: (0.0426, 0.0226, 0.0146) Memory Usage: 78.6% and CPU Usage: 19.0%\n",
      "scores: (0.0302, 0.0497, 0.0098) Memory Usage: 78.7% and CPU Usage: 19.8%\n",
      "scores: (0.0331, 0.0523, 0.0177) Memory Usage: 78.5% and CPU Usage: 22.3%\n",
      "scores: (0.0363, 0.0168, 0.0209) Memory Usage: 78.6% and CPU Usage: 18.2%\n",
      "scores: (0.0459, 0.0147, 0.0159) Memory Usage: 78.5% and CPU Usage: 17.7%\n",
      "scores: (0.0419, 0.01, 0.0133) Memory Usage: 78.6% and CPU Usage: 17.7%\n",
      "scores: (0.0476, 0.0133, 0.0231) Memory Usage: 78.6% and CPU Usage: 21.0%\n",
      "scores: (0.0378, 0.0192, 0.0135) Memory Usage: 78.8% and CPU Usage: 17.1%\n",
      "scores: (0.057, 0.0088, 0.0113) Memory Usage: 78.5% and CPU Usage: 17.7%\n",
      "scores: (0.0261, 0.008, 0.0094) Memory Usage: 78.8% and CPU Usage: 18.1%\n",
      "scores: (0.0483, 0.0074, 0.0108) Memory Usage: 78.6% and CPU Usage: 19.2%\n",
      "scores: (0.0218, 0.0211, 0.0178) Memory Usage: 78.6% and CPU Usage: 26.6%\n",
      "scores: (0.0517, 0.0115, 0.0121) Memory Usage: 79.4% and CPU Usage: 20.7%\n",
      "scores: (0.0575, 0.0135, 0.0112) Memory Usage: 79.1% and CPU Usage: 22.5%\n",
      "scores: (0.0504, 0.0095, 0.0095) Memory Usage: 79.2% and CPU Usage: 16.0%\n",
      "scores: (0.0436, 0.0142, 0.0102) Memory Usage: 78.6% and CPU Usage: 25.6%\n",
      "scores: (0.0397, 0.0109, 0.0092) Memory Usage: 79.0% and CPU Usage: 23.8%\n",
      "scores: (0.0373, 0.0189, 0.0106) Memory Usage: 78.8% and CPU Usage: 18.6%\n",
      "scores: (0.0388, 0.0139, 0.01) Memory Usage: 78.6% and CPU Usage: 15.2%\n",
      "scores: (0.0416, 0.0086, 0.0063) Memory Usage: 78.4% and CPU Usage: 41.7%\n",
      "scores: (0.0516, 0.0146, 0.0118) Memory Usage: 79.5% and CPU Usage: 23.6%\n",
      "scores: (0.0516, 0.0133, 0.0094) Memory Usage: 79.2% and CPU Usage: 24.6%\n",
      "scores: (0.0404, 0.0107, 0.0123) Memory Usage: 79.1% and CPU Usage: 23.5%\n",
      "scores: (0.0465, 0.01, 0.0188) Memory Usage: 78.9% and CPU Usage: 21.4%\n",
      "scores: (0.0562, 0.0108, 0.0096) Memory Usage: 78.7% and CPU Usage: 22.7%\n",
      "scores: (0.0526, 0.0157, 0.0112) Memory Usage: 78.6% and CPU Usage: 20.4%\n",
      "scores: (0.0564, 0.0088, 0.0231) Memory Usage: 78.7% and CPU Usage: 27.1%\n",
      "scores: (0.059, 0.0174, 0.0162) Memory Usage: 79.1% and CPU Usage: 16.8%\n",
      "scores: (0.0481, 0.0097, 0.0092) Memory Usage: 78.7% and CPU Usage: 18.8%\n",
      "scores: (0.0393, 0.0177, 0.0097) Memory Usage: 78.8% and CPU Usage: 13.6%\n",
      "scores: (0.0418, 0.0112, 0.0091) Memory Usage: 78.8% and CPU Usage: 18.2%\n",
      "scores: (0.0397, 0.0209, 0.0132) Memory Usage: 78.8% and CPU Usage: 25.6%\n",
      "scores: (0.034, 0.0314, 0.0133) Memory Usage: 78.5% and CPU Usage: 19.5%\n",
      "scores: (0.0454, 0.0199, 0.015) Memory Usage: 78.5% and CPU Usage: 12.9%\n",
      "scores: (0.0456, 0.0231, 0.0152) Memory Usage: 78.5% and CPU Usage: 19.4%\n",
      "scores: (0.0535, 0.0144, 0.0103) Memory Usage: 78.6% and CPU Usage: 19.9%\n",
      "scores: (0.0318, 0.0178, 0.0135) Memory Usage: 78.6% and CPU Usage: 26.0%\n",
      "scores: (0.043, 0.0175, 0.0148) Memory Usage: 78.6% and CPU Usage: 16.8%\n",
      "scores: (0.0374, 0.024, 0.0107) Memory Usage: 78.5% and CPU Usage: 20.8%\n",
      "scores: (0.0351, 0.0284, 0.019) Memory Usage: 78.5% and CPU Usage: 30.0%\n",
      "scores: (0.0209, 0.0285, 0.0167) Memory Usage: 76.8% and CPU Usage: 24.4%\n"
     ]
    }
   ],
   "source": [
    "import numpy as np\n",
    "import psutil # Now we monitor how much of the compute we use as well\n",
    "\n",
    "# Let's create a dataframe to save all scores.\n",
    "sentiment_scores = pd.DataFrame(columns=['pos', 'neg', 'unc'])\n",
    "\n",
    "# Loop through all texts \n",
    "for texts in transcripts_texts:\n",
    "    # Calls our scoring function and gets 3 scores back\n",
    "    scores = score_transcript(texts)\n",
    "    \n",
    "    # it is nice to add some prints to know the loop is working and we are progressing\n",
    "    print(f\"scores: {scores} Memory Usage: {psutil.virtual_memory().percent}% and CPU Usage: {psutil.cpu_percent(interval=1)}%\")\n",
    "    \n",
    "    # This creates a new dataframe with one line of 3 scores \n",
    "    # and adds it to the bottom of our dataframe that stores all scores\n",
    "    sentiment_scores = pd.concat([sentiment_scores, pd.DataFrame([np.array(scores)], columns=['pos', 'neg', 'unc'])]).reset_index(drop=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "id": "005e7890-e794-4641-a962-2519037861d5",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>pos</th>\n",
       "      <th>neg</th>\n",
       "      <th>unc</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.0392</td>\n",
       "      <td>0.0109</td>\n",
       "      <td>0.0169</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>0.0502</td>\n",
       "      <td>0.0081</td>\n",
       "      <td>0.0092</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>0.0507</td>\n",
       "      <td>0.0139</td>\n",
       "      <td>0.0145</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>0.0300</td>\n",
       "      <td>0.0490</td>\n",
       "      <td>0.0249</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>0.0315</td>\n",
       "      <td>0.0448</td>\n",
       "      <td>0.0124</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>0.0512</td>\n",
       "      <td>0.0085</td>\n",
       "      <td>0.0268</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>0.0328</td>\n",
       "      <td>0.0530</td>\n",
       "      <td>0.0088</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>0.0426</td>\n",
       "      <td>0.0226</td>\n",
       "      <td>0.0146</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>0.0302</td>\n",
       "      <td>0.0497</td>\n",
       "      <td>0.0098</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>0.0331</td>\n",
       "      <td>0.0523</td>\n",
       "      <td>0.0177</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>0.0363</td>\n",
       "      <td>0.0168</td>\n",
       "      <td>0.0209</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>0.0459</td>\n",
       "      <td>0.0147</td>\n",
       "      <td>0.0159</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>0.0419</td>\n",
       "      <td>0.0100</td>\n",
       "      <td>0.0133</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>0.0476</td>\n",
       "      <td>0.0133</td>\n",
       "      <td>0.0231</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>0.0378</td>\n",
       "      <td>0.0192</td>\n",
       "      <td>0.0135</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>0.0570</td>\n",
       "      <td>0.0088</td>\n",
       "      <td>0.0113</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>0.0261</td>\n",
       "      <td>0.0080</td>\n",
       "      <td>0.0094</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>0.0483</td>\n",
       "      <td>0.0074</td>\n",
       "      <td>0.0108</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>0.0218</td>\n",
       "      <td>0.0211</td>\n",
       "      <td>0.0178</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>0.0517</td>\n",
       "      <td>0.0115</td>\n",
       "      <td>0.0121</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>0.0575</td>\n",
       "      <td>0.0135</td>\n",
       "      <td>0.0112</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>0.0504</td>\n",
       "      <td>0.0095</td>\n",
       "      <td>0.0095</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>0.0436</td>\n",
       "      <td>0.0142</td>\n",
       "      <td>0.0102</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>0.0397</td>\n",
       "      <td>0.0109</td>\n",
       "      <td>0.0092</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>0.0373</td>\n",
       "      <td>0.0189</td>\n",
       "      <td>0.0106</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>0.0388</td>\n",
       "      <td>0.0139</td>\n",
       "      <td>0.0100</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>0.0416</td>\n",
       "      <td>0.0086</td>\n",
       "      <td>0.0063</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>0.0516</td>\n",
       "      <td>0.0146</td>\n",
       "      <td>0.0118</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>0.0516</td>\n",
       "      <td>0.0133</td>\n",
       "      <td>0.0094</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>0.0404</td>\n",
       "      <td>0.0107</td>\n",
       "      <td>0.0123</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>0.0465</td>\n",
       "      <td>0.0100</td>\n",
       "      <td>0.0188</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>0.0562</td>\n",
       "      <td>0.0108</td>\n",
       "      <td>0.0096</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>0.0526</td>\n",
       "      <td>0.0157</td>\n",
       "      <td>0.0112</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>0.0564</td>\n",
       "      <td>0.0088</td>\n",
       "      <td>0.0231</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>0.0590</td>\n",
       "      <td>0.0174</td>\n",
       "      <td>0.0162</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>0.0481</td>\n",
       "      <td>0.0097</td>\n",
       "      <td>0.0092</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>0.0393</td>\n",
       "      <td>0.0177</td>\n",
       "      <td>0.0097</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>0.0418</td>\n",
       "      <td>0.0112</td>\n",
       "      <td>0.0091</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>0.0397</td>\n",
       "      <td>0.0209</td>\n",
       "      <td>0.0132</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>0.0340</td>\n",
       "      <td>0.0314</td>\n",
       "      <td>0.0133</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>0.0454</td>\n",
       "      <td>0.0199</td>\n",
       "      <td>0.0150</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>0.0456</td>\n",
       "      <td>0.0231</td>\n",
       "      <td>0.0152</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>0.0535</td>\n",
       "      <td>0.0144</td>\n",
       "      <td>0.0103</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>0.0318</td>\n",
       "      <td>0.0178</td>\n",
       "      <td>0.0135</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>0.0430</td>\n",
       "      <td>0.0175</td>\n",
       "      <td>0.0148</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>0.0374</td>\n",
       "      <td>0.0240</td>\n",
       "      <td>0.0107</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>0.0351</td>\n",
       "      <td>0.0284</td>\n",
       "      <td>0.0190</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>0.0209</td>\n",
       "      <td>0.0285</td>\n",
       "      <td>0.0167</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       pos     neg     unc\n",
       "0   0.0392  0.0109  0.0169\n",
       "1   0.0502  0.0081  0.0092\n",
       "2   0.0507  0.0139  0.0145\n",
       "3   0.0300  0.0490  0.0249\n",
       "4   0.0315  0.0448  0.0124\n",
       "5   0.0512  0.0085  0.0268\n",
       "6   0.0328  0.0530  0.0088\n",
       "7   0.0426  0.0226  0.0146\n",
       "8   0.0302  0.0497  0.0098\n",
       "9   0.0331  0.0523  0.0177\n",
       "10  0.0363  0.0168  0.0209\n",
       "11  0.0459  0.0147  0.0159\n",
       "12  0.0419  0.0100  0.0133\n",
       "13  0.0476  0.0133  0.0231\n",
       "14  0.0378  0.0192  0.0135\n",
       "15  0.0570  0.0088  0.0113\n",
       "16  0.0261  0.0080  0.0094\n",
       "17  0.0483  0.0074  0.0108\n",
       "18  0.0218  0.0211  0.0178\n",
       "19  0.0517  0.0115  0.0121\n",
       "20  0.0575  0.0135  0.0112\n",
       "21  0.0504  0.0095  0.0095\n",
       "22  0.0436  0.0142  0.0102\n",
       "23  0.0397  0.0109  0.0092\n",
       "24  0.0373  0.0189  0.0106\n",
       "25  0.0388  0.0139  0.0100\n",
       "26  0.0416  0.0086  0.0063\n",
       "27  0.0516  0.0146  0.0118\n",
       "28  0.0516  0.0133  0.0094\n",
       "29  0.0404  0.0107  0.0123\n",
       "30  0.0465  0.0100  0.0188\n",
       "31  0.0562  0.0108  0.0096\n",
       "32  0.0526  0.0157  0.0112\n",
       "33  0.0564  0.0088  0.0231\n",
       "34  0.0590  0.0174  0.0162\n",
       "35  0.0481  0.0097  0.0092\n",
       "36  0.0393  0.0177  0.0097\n",
       "37  0.0418  0.0112  0.0091\n",
       "38  0.0397  0.0209  0.0132\n",
       "39  0.0340  0.0314  0.0133\n",
       "40  0.0454  0.0199  0.0150\n",
       "41  0.0456  0.0231  0.0152\n",
       "42  0.0535  0.0144  0.0103\n",
       "43  0.0318  0.0178  0.0135\n",
       "44  0.0430  0.0175  0.0148\n",
       "45  0.0374  0.0240  0.0107\n",
       "46  0.0351  0.0284  0.0190\n",
       "47  0.0209  0.0285  0.0167"
      ]
     },
     "execution_count": 59,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sentiment_scores"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "16e9048f-ee40-44e7-8963-5559c89da839",
   "metadata": {},
   "source": [
    "# Lets now add the dates in."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "id": "ad95b087-5511-436e-9a3c-0d5c528299f8",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>pos</th>\n",
       "      <th>neg</th>\n",
       "      <th>unc</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2013-03-13 23:56:19</th>\n",
       "      <td>0.0209</td>\n",
       "      <td>0.0285</td>\n",
       "      <td>0.0167</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-04-26 16:01:16</th>\n",
       "      <td>0.0351</td>\n",
       "      <td>0.0284</td>\n",
       "      <td>0.0190</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-05-15 03:26:07</th>\n",
       "      <td>0.0374</td>\n",
       "      <td>0.0240</td>\n",
       "      <td>0.0107</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-06-13 23:59:05</th>\n",
       "      <td>0.0430</td>\n",
       "      <td>0.0175</td>\n",
       "      <td>0.0148</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-07-26 17:10:06</th>\n",
       "      <td>0.0318</td>\n",
       "      <td>0.0178</td>\n",
       "      <td>0.0135</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-09-10 22:25:10</th>\n",
       "      <td>0.0535</td>\n",
       "      <td>0.0144</td>\n",
       "      <td>0.0103</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013-10-25 16:30:05</th>\n",
       "      <td>0.0456</td>\n",
       "      <td>0.0231</td>\n",
       "      <td>0.0152</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2014-01-31 16:51:14</th>\n",
       "      <td>0.0454</td>\n",
       "      <td>0.0199</td>\n",
       "      <td>0.0150</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2014-03-05 18:57:07</th>\n",
       "      <td>0.0340</td>\n",
       "      <td>0.0314</td>\n",
       "      <td>0.0133</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2014-04-25 18:44:09</th>\n",
       "      <td>0.0397</td>\n",
       "      <td>0.0209</td>\n",
       "      <td>0.0132</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2014-07-25 15:58:12</th>\n",
       "      <td>0.0418</td>\n",
       "      <td>0.0112</td>\n",
       "      <td>0.0091</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2014-10-31 19:29:15</th>\n",
       "      <td>0.0393</td>\n",
       "      <td>0.0177</td>\n",
       "      <td>0.0097</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2015-01-30 20:44:14</th>\n",
       "      <td>0.0481</td>\n",
       "      <td>0.0097</td>\n",
       "      <td>0.0092</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2015-03-05 21:41:17</th>\n",
       "      <td>0.0590</td>\n",
       "      <td>0.0174</td>\n",
       "      <td>0.0162</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2015-03-13 06:15:11</th>\n",
       "      <td>0.0564</td>\n",
       "      <td>0.0088</td>\n",
       "      <td>0.0231</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2015-04-23 21:30:10</th>\n",
       "      <td>0.0526</td>\n",
       "      <td>0.0157</td>\n",
       "      <td>0.0112</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2015-07-24 18:17:10</th>\n",
       "      <td>0.0562</td>\n",
       "      <td>0.0108</td>\n",
       "      <td>0.0096</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2015-10-30 23:38:12</th>\n",
       "      <td>0.0465</td>\n",
       "      <td>0.0100</td>\n",
       "      <td>0.0188</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2016-01-29 18:50:13</th>\n",
       "      <td>0.0404</td>\n",
       "      <td>0.0107</td>\n",
       "      <td>0.0123</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2016-04-29 05:36:22</th>\n",
       "      <td>0.0516</td>\n",
       "      <td>0.0133</td>\n",
       "      <td>0.0094</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2016-07-29 20:04:23</th>\n",
       "      <td>0.0516</td>\n",
       "      <td>0.0146</td>\n",
       "      <td>0.0118</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2016-10-28 18:47:11</th>\n",
       "      <td>0.0416</td>\n",
       "      <td>0.0086</td>\n",
       "      <td>0.0063</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2017-01-27 19:31:15</th>\n",
       "      <td>0.0388</td>\n",
       "      <td>0.0139</td>\n",
       "      <td>0.0100</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2017-04-27 19:34:39</th>\n",
       "      <td>0.0373</td>\n",
       "      <td>0.0189</td>\n",
       "      <td>0.0106</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2017-07-28 22:38:23</th>\n",
       "      <td>0.0397</td>\n",
       "      <td>0.0109</td>\n",
       "      <td>0.0092</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2017-10-27 18:12:06</th>\n",
       "      <td>0.0436</td>\n",
       "      <td>0.0142</td>\n",
       "      <td>0.0102</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2018-01-26 21:18:06</th>\n",
       "      <td>0.0504</td>\n",
       "      <td>0.0095</td>\n",
       "      <td>0.0095</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2018-04-26 18:04:21</th>\n",
       "      <td>0.0575</td>\n",
       "      <td>0.0135</td>\n",
       "      <td>0.0112</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2018-07-27 21:46:59</th>\n",
       "      <td>0.0517</td>\n",
       "      <td>0.0115</td>\n",
       "      <td>0.0121</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2018-09-12 19:19:10</th>\n",
       "      <td>0.0218</td>\n",
       "      <td>0.0211</td>\n",
       "      <td>0.0178</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2018-11-02 16:23:27</th>\n",
       "      <td>0.0483</td>\n",
       "      <td>0.0074</td>\n",
       "      <td>0.0108</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2018-11-27 20:25:24</th>\n",
       "      <td>0.0261</td>\n",
       "      <td>0.0080</td>\n",
       "      <td>0.0094</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-01-09 21:27:30</th>\n",
       "      <td>0.0570</td>\n",
       "      <td>0.0088</td>\n",
       "      <td>0.0113</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-01-25 18:52:18</th>\n",
       "      <td>0.0378</td>\n",
       "      <td>0.0192</td>\n",
       "      <td>0.0135</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-03-12 16:14:08</th>\n",
       "      <td>0.0476</td>\n",
       "      <td>0.0133</td>\n",
       "      <td>0.0231</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-03-13 19:19:09</th>\n",
       "      <td>0.0419</td>\n",
       "      <td>0.0100</td>\n",
       "      <td>0.0133</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-04-25 22:11:10</th>\n",
       "      <td>0.0459</td>\n",
       "      <td>0.0147</td>\n",
       "      <td>0.0159</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-06-12 21:21:57</th>\n",
       "      <td>0.0363</td>\n",
       "      <td>0.0168</td>\n",
       "      <td>0.0209</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-06-25 19:29:10</th>\n",
       "      <td>0.0331</td>\n",
       "      <td>0.0523</td>\n",
       "      <td>0.0177</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-07-26 17:56:58</th>\n",
       "      <td>0.0302</td>\n",
       "      <td>0.0497</td>\n",
       "      <td>0.0098</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-09-10 20:22:25</th>\n",
       "      <td>0.0426</td>\n",
       "      <td>0.0226</td>\n",
       "      <td>0.0146</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-11-01 19:45:10</th>\n",
       "      <td>0.0328</td>\n",
       "      <td>0.0530</td>\n",
       "      <td>0.0088</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-01-15 19:22:17</th>\n",
       "      <td>0.0512</td>\n",
       "      <td>0.0085</td>\n",
       "      <td>0.0268</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-02-07 18:36:46</th>\n",
       "      <td>0.0315</td>\n",
       "      <td>0.0448</td>\n",
       "      <td>0.0124</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-05-01 19:27:53</th>\n",
       "      <td>0.0300</td>\n",
       "      <td>0.0490</td>\n",
       "      <td>0.0249</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-07-31 19:59:11</th>\n",
       "      <td>0.0507</td>\n",
       "      <td>0.0139</td>\n",
       "      <td>0.0145</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-10-30 20:18:17</th>\n",
       "      <td>0.0502</td>\n",
       "      <td>0.0081</td>\n",
       "      <td>0.0092</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2021-02-04 00:59:09</th>\n",
       "      <td>0.0392</td>\n",
       "      <td>0.0109</td>\n",
       "      <td>0.0169</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                        pos     neg     unc\n",
       "2013-03-13 23:56:19  0.0209  0.0285  0.0167\n",
       "2013-04-26 16:01:16  0.0351  0.0284  0.0190\n",
       "2013-05-15 03:26:07  0.0374  0.0240  0.0107\n",
       "2013-06-13 23:59:05  0.0430  0.0175  0.0148\n",
       "2013-07-26 17:10:06  0.0318  0.0178  0.0135\n",
       "2013-09-10 22:25:10  0.0535  0.0144  0.0103\n",
       "2013-10-25 16:30:05  0.0456  0.0231  0.0152\n",
       "2014-01-31 16:51:14  0.0454  0.0199  0.0150\n",
       "2014-03-05 18:57:07  0.0340  0.0314  0.0133\n",
       "2014-04-25 18:44:09  0.0397  0.0209  0.0132\n",
       "2014-07-25 15:58:12  0.0418  0.0112  0.0091\n",
       "2014-10-31 19:29:15  0.0393  0.0177  0.0097\n",
       "2015-01-30 20:44:14  0.0481  0.0097  0.0092\n",
       "2015-03-05 21:41:17  0.0590  0.0174  0.0162\n",
       "2015-03-13 06:15:11  0.0564  0.0088  0.0231\n",
       "2015-04-23 21:30:10  0.0526  0.0157  0.0112\n",
       "2015-07-24 18:17:10  0.0562  0.0108  0.0096\n",
       "2015-10-30 23:38:12  0.0465  0.0100  0.0188\n",
       "2016-01-29 18:50:13  0.0404  0.0107  0.0123\n",
       "2016-04-29 05:36:22  0.0516  0.0133  0.0094\n",
       "2016-07-29 20:04:23  0.0516  0.0146  0.0118\n",
       "2016-10-28 18:47:11  0.0416  0.0086  0.0063\n",
       "2017-01-27 19:31:15  0.0388  0.0139  0.0100\n",
       "2017-04-27 19:34:39  0.0373  0.0189  0.0106\n",
       "2017-07-28 22:38:23  0.0397  0.0109  0.0092\n",
       "2017-10-27 18:12:06  0.0436  0.0142  0.0102\n",
       "2018-01-26 21:18:06  0.0504  0.0095  0.0095\n",
       "2018-04-26 18:04:21  0.0575  0.0135  0.0112\n",
       "2018-07-27 21:46:59  0.0517  0.0115  0.0121\n",
       "2018-09-12 19:19:10  0.0218  0.0211  0.0178\n",
       "2018-11-02 16:23:27  0.0483  0.0074  0.0108\n",
       "2018-11-27 20:25:24  0.0261  0.0080  0.0094\n",
       "2019-01-09 21:27:30  0.0570  0.0088  0.0113\n",
       "2019-01-25 18:52:18  0.0378  0.0192  0.0135\n",
       "2019-03-12 16:14:08  0.0476  0.0133  0.0231\n",
       "2019-03-13 19:19:09  0.0419  0.0100  0.0133\n",
       "2019-04-25 22:11:10  0.0459  0.0147  0.0159\n",
       "2019-06-12 21:21:57  0.0363  0.0168  0.0209\n",
       "2019-06-25 19:29:10  0.0331  0.0523  0.0177\n",
       "2019-07-26 17:56:58  0.0302  0.0497  0.0098\n",
       "2019-09-10 20:22:25  0.0426  0.0226  0.0146\n",
       "2019-11-01 19:45:10  0.0328  0.0530  0.0088\n",
       "2020-01-15 19:22:17  0.0512  0.0085  0.0268\n",
       "2020-02-07 18:36:46  0.0315  0.0448  0.0124\n",
       "2020-05-01 19:27:53  0.0300  0.0490  0.0249\n",
       "2020-07-31 19:59:11  0.0507  0.0139  0.0145\n",
       "2020-10-30 20:18:17  0.0502  0.0081  0.0092\n",
       "2021-02-04 00:59:09  0.0392  0.0109  0.0169"
      ]
     },
     "execution_count": 60,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sentiment_scores.index = pd.to_datetime(times)\n",
    "\n",
    "# Lets also reverse the order so that old is first. Makes it easier to merge. \n",
    "# https://stackoverflow.com/a/3940137\n",
    "sentiment_scores = sentiment_scores[::-1]\n",
    "\n",
    "sentiment_scores"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "id": "51c43a61-e903-416f-adb1-6f9d20fdabc8",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<Axes: >"
      ]
     },
     "execution_count": 31,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1008x504 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "sentiment_scores.plot(figsize=(14,7))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "c792301f-8558-43c4-833b-afc985bd5060",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>pos</th>\n",
       "      <th>neg</th>\n",
       "      <th>unc</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>pos</th>\n",
       "      <td>1.000000</td>\n",
       "      <td>-0.378070</td>\n",
       "      <td>-0.417022</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>neg</th>\n",
       "      <td>-0.378070</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.609713</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>unc</th>\n",
       "      <td>-0.417022</td>\n",
       "      <td>0.609713</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "          pos       neg       unc\n",
       "pos  1.000000 -0.378070 -0.417022\n",
       "neg -0.378070  1.000000  0.609713\n",
       "unc -0.417022  0.609713  1.000000"
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import seaborn as sns\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "# Generate the correlation matrix\n",
    "correlation_matrix = sentiment_scores.corr()\n",
    "correlation_matrix"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "id": "f925b2e7-d42e-43f0-93c8-f19bfb31287c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 360x288 with 2 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Set up the matplotlib figure\n",
    "plt.figure(figsize=(5, 4))\n",
    "\n",
    "# Create a heatmap using seaborn\n",
    "sns.heatmap(correlation_matrix, annot=True, cmap=\"coolwarm\", linewidths=0.5, fmt=\".2f\")\n",
    "\n",
    "# Add a title\n",
    "plt.title('Correlation Heatmap of Sentiment Scores', fontsize=16, fontweight='bold')\n",
    "\n",
    "# Show the plot\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6ee8fae3-cafc-4af1-b0d0-25556bd1cb45",
   "metadata": {},
   "source": [
    "# Lets quickly get some market data and plot the returns and share price in the same plot. "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "id": "94143902-aa13-473e-9af7-471bb1b08d28",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[*********************100%%**********************]  1 of 1 completed\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Adj Close</th>\n",
       "      <th>returns</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Date</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2006-01-20</th>\n",
       "      <td>2.294861</td>\n",
       "      <td>-0.088972</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2006-01-23</th>\n",
       "      <td>2.342515</td>\n",
       "      <td>0.047654</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2006-01-24</th>\n",
       "      <td>2.293353</td>\n",
       "      <td>-0.049162</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2006-01-25</th>\n",
       "      <td>2.237860</td>\n",
       "      <td>-0.055493</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2006-01-26</th>\n",
       "      <td>2.181460</td>\n",
       "      <td>-0.056399</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2024-10-10</th>\n",
       "      <td>229.039993</td>\n",
       "      <td>-0.500000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2024-10-11</th>\n",
       "      <td>227.550003</td>\n",
       "      <td>-1.489990</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2024-10-14</th>\n",
       "      <td>231.300003</td>\n",
       "      <td>3.750000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2024-10-15</th>\n",
       "      <td>233.850006</td>\n",
       "      <td>2.550003</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2024-10-16</th>\n",
       "      <td>231.779999</td>\n",
       "      <td>-2.070007</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>4717 rows √ó 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "             Adj Close   returns\n",
       "Date                            \n",
       "2006-01-20    2.294861 -0.088972\n",
       "2006-01-23    2.342515  0.047654\n",
       "2006-01-24    2.293353 -0.049162\n",
       "2006-01-25    2.237860 -0.055493\n",
       "2006-01-26    2.181460 -0.056399\n",
       "...                ...       ...\n",
       "2024-10-10  229.039993 -0.500000\n",
       "2024-10-11  227.550003 -1.489990\n",
       "2024-10-14  231.300003  3.750000\n",
       "2024-10-15  233.850006  2.550003\n",
       "2024-10-16  231.779999 -2.070007\n",
       "\n",
       "[4717 rows x 2 columns]"
      ]
     },
     "execution_count": 34,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import yfinance as yf\n",
    "import pandas as pd\n",
    "\n",
    "# Assuming sentiment_scores is already defined and has a valid index\n",
    "date_start = sentiment_scores.index[0] \n",
    "\n",
    "# Download market data using yfinance\n",
    "market_data = yf.download('AAPL', start=date_start)\n",
    "\n",
    "# Calculate returns\n",
    "market_data['returns'] = market_data['Adj Close'] - market_data['Adj Close'].shift(1)\n",
    "\n",
    "# Keep only 'Adj Close' and 'returns', and drop NaN values\n",
    "market_data = market_data[['Adj Close', 'returns']].dropna()\n",
    "\n",
    "# Ensure the index is in datetime format\n",
    "market_data.index = pd.to_datetime(market_data.index)\n",
    "\n",
    "market_data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "1e905ffa-6ade-4b7d-b2ab-229cd5e4fcfe",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>pos</th>\n",
       "      <th>neg</th>\n",
       "      <th>unc</th>\n",
       "      <th>Adj Close</th>\n",
       "      <th>returns</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2006-04-20 11:01:29</th>\n",
       "      <td>0.0298</td>\n",
       "      <td>0.0118</td>\n",
       "      <td>0.0073</td>\n",
       "      <td>2.039709</td>\n",
       "      <td>0.059717</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2006-07-20 00:49:46</th>\n",
       "      <td>0.0310</td>\n",
       "      <td>0.0161</td>\n",
       "      <td>0.0103</td>\n",
       "      <td>1.824669</td>\n",
       "      <td>0.193022</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2006-10-19 04:57:25</th>\n",
       "      <td>0.0387</td>\n",
       "      <td>0.0199</td>\n",
       "      <td>0.0114</td>\n",
       "      <td>2.382324</td>\n",
       "      <td>0.134511</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2007-01-18 03:24:19</th>\n",
       "      <td>0.0364</td>\n",
       "      <td>0.0194</td>\n",
       "      <td>0.0073</td>\n",
       "      <td>2.686336</td>\n",
       "      <td>-0.177340</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2007-04-26 02:50:27</th>\n",
       "      <td>0.0347</td>\n",
       "      <td>0.0202</td>\n",
       "      <td>0.0127</td>\n",
       "      <td>2.980997</td>\n",
       "      <td>0.105258</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-01-29 02:36:45</th>\n",
       "      <td>0.0263</td>\n",
       "      <td>0.0204</td>\n",
       "      <td>0.0092</td>\n",
       "      <td>78.696976</td>\n",
       "      <td>1.613548</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-05-01 01:52:14</th>\n",
       "      <td>0.0309</td>\n",
       "      <td>0.0340</td>\n",
       "      <td>0.0108</td>\n",
       "      <td>70.305626</td>\n",
       "      <td>-1.150375</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-07-31 03:36:08</th>\n",
       "      <td>0.0418</td>\n",
       "      <td>0.0109</td>\n",
       "      <td>0.0071</td>\n",
       "      <td>103.655144</td>\n",
       "      <td>9.823151</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2020-10-30 03:41:57</th>\n",
       "      <td>0.0454</td>\n",
       "      <td>0.0168</td>\n",
       "      <td>0.0067</td>\n",
       "      <td>106.382889</td>\n",
       "      <td>-6.312973</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2021-01-28 01:49:07</th>\n",
       "      <td>0.0385</td>\n",
       "      <td>0.0165</td>\n",
       "      <td>0.0110</td>\n",
       "      <td>134.201630</td>\n",
       "      <td>-4.865295</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>62 rows √ó 5 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                        pos     neg     unc   Adj Close   returns\n",
       "2006-04-20 11:01:29  0.0298  0.0118  0.0073    2.039709  0.059717\n",
       "2006-07-20 00:49:46  0.0310  0.0161  0.0103    1.824669  0.193022\n",
       "2006-10-19 04:57:25  0.0387  0.0199  0.0114    2.382324  0.134511\n",
       "2007-01-18 03:24:19  0.0364  0.0194  0.0073    2.686336 -0.177340\n",
       "2007-04-26 02:50:27  0.0347  0.0202  0.0127    2.980997  0.105258\n",
       "...                     ...     ...     ...         ...       ...\n",
       "2020-01-29 02:36:45  0.0263  0.0204  0.0092   78.696976  1.613548\n",
       "2020-05-01 01:52:14  0.0309  0.0340  0.0108   70.305626 -1.150375\n",
       "2020-07-31 03:36:08  0.0418  0.0109  0.0071  103.655144  9.823151\n",
       "2020-10-30 03:41:57  0.0454  0.0168  0.0067  106.382889 -6.312973\n",
       "2021-01-28 01:49:07  0.0385  0.0165  0.0110  134.201630 -4.865295\n",
       "\n",
       "[62 rows x 5 columns]"
      ]
     },
     "execution_count": 35,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Let's merge the data to put it into the same time intervals.\n",
    "plot_data = pd.merge_asof(sentiment_scores, market_data, left_index=True, right_index=True).dropna()\n",
    "plot_data"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a0416046-91a7-4f9b-aa54-c5f0a20ac03f",
   "metadata": {},
   "source": [
    "### Analyzing the Relationship Between Net Sentiment (pos - neg) and Stock Prices\n",
    "\n",
    "In this plot, we're trying to understand if the **net sentiment** (positive sentiment minus negative sentiment) correlates with changes in the stock price over time. A positive value for net sentiment indicates that overall sentiment is more positive than negative, whereas a negative value suggests that negative sentiment outweighs the positive.\n",
    "\n",
    "#### What are we looking for?\n",
    "- **Do peaks in net sentiment align with increases in stock price?** \n",
    "    - If yes, this could indicate that when sentiment is more positive, investors are more optimistic, leading to higher stock prices.\n",
    "- **Does a drop in net sentiment correspond with a fall in stock price?**\n",
    "    - This would suggest that negative sentiment correlates with declining stock performance.\n",
    "\n",
    "By plotting the stock price alongside net sentiment, we can visually examine whether these patterns are present. However, visual inspection alone may not reveal the full extent of the relationship, so we also include a **rolling correlation** to quantify how the sentiment and returns relate over time.\n",
    "\n",
    "---\n",
    "\n",
    "### Why Include Rolling Correlations?\n",
    "\n",
    "A **rolling correlation** allows us to observe how the relationship between **net sentiment** and **stock returns** changes over time. By applying a rolling window, we can smooth out short-term fluctuations and focus on medium- to long-term trends. This is especially useful when dealing with sentiment data, as its influence on the stock market might not be immediate, but rather manifests over time.\n",
    "\n",
    "In our case, the data is **quarterly** (i.e., updated every 3 months), so using a **window size that matches this timeframe** is critical. Instead of a 30-day window (which makes sense for daily data), we adjust the rolling window to **4 periods**. This represents a moving window of one year (4 quarters) of data, allowing us to capture yearly sentiment trends and their impact on stock returns.\n",
    "\n",
    "#### What are we looking for in the rolling correlation?\n",
    "- **Positive Correlation**: A positive correlation indicates that higher net sentiment (more optimism) is associated with higher stock returns.\n",
    "- **Negative Correlation**: A negative correlation suggests that higher sentiment may be associated with lower returns, or that negative sentiment correlates with higher returns.\n",
    "\n",
    "By plotting the rolling correlation alongside the sentiment and stock price, we can better understand if sentiment serves as a reliable **predictive indicator** of stock performance.\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "id": "2074228a-f815-4bf8-9673-53996f7f9d62",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1080x864 with 3 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "\n",
    "# Step 1: Create the net sentiment score (pos - neg)\n",
    "plot_data['net_sentiment'] = plot_data['pos'] - plot_data['neg']\n",
    "\n",
    "# Step 2: Calculate rolling correlation between net_sentiment and returns\n",
    "# Since we have quarterly data, we use a rolling window of 4 periods (4 quarters = 1 year)\n",
    "window_size = 4  # 4 quarters (1 year) rolling window for quarterly data\n",
    "rolling_corr_net_sent = plot_data['returns'].rolling(window_size).corr(plot_data['net_sentiment'])\n",
    "\n",
    "# Step 3: Create a figure with two subplots\n",
    "fig, (ax1, ax2) = plt.subplots(2, 1, figsize=(15, 12), sharex=True, gridspec_kw={'height_ratios': [3, 1]})\n",
    "\n",
    "# Plotting Net Sentiment and Adjusted Close Price in the first subplot\n",
    "ax1.plot(plot_data.index, plot_data['net_sentiment'], color='green', label='Net Sentiment (pos - neg)', linewidth=2)\n",
    "ax1.set_ylabel('Net Sentiment', color='green', fontsize=14)\n",
    "\n",
    "# Creating a second y-axis on the first subplot for Adjusted Close Price\n",
    "ax1_twin = ax1.twinx()\n",
    "ax1_twin.plot(plot_data.index, plot_data['Adj Close'], color='black', label='Adjusted Close Price', linewidth=2)\n",
    "ax1_twin.set_ylabel('Adjusted Close Price', color='black', fontsize=14)\n",
    "\n",
    "# Title for the first subplot\n",
    "ax1.set_title('Net Sentiment and Adjusted Close Price Over Time', fontsize=16)\n",
    "\n",
    "# Adding a legend\n",
    "ax1.legend(loc='upper left', bbox_to_anchor=(0.1, 0.9), fontsize=12)\n",
    "\n",
    "# Step 4: Plot the rolling correlation in the second subplot\n",
    "ax2.plot(plot_data.index, rolling_corr_net_sent, label='Rolling Correlation (Net Sentiment and Returns)', color='blue', linewidth=2)\n",
    "ax2.set_xlabel('Date', fontsize=14)\n",
    "ax2.set_ylabel('Rolling Correlation', fontsize=14)\n",
    "ax2.set_title('Rolling Correlation of Net Sentiment with Stock Returns', fontsize=16)\n",
    "\n",
    "# Add a horizontal line at 0 correlation for reference\n",
    "ax2.axhline(0, color='grey', linewidth=1, linestyle='--')\n",
    "\n",
    "# Adjust the layout to avoid overlap\n",
    "plt.tight_layout()\n",
    "\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "id": "82406759-7aa6-49e0-9ae0-c506f24115bc",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>net_sentiment</th>\n",
       "      <th>returns</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>count</th>\n",
       "      <td>62.000000</td>\n",
       "      <td>62.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>mean</th>\n",
       "      <td>0.023568</td>\n",
       "      <td>0.117235</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>std</th>\n",
       "      <td>0.010538</td>\n",
       "      <td>1.942848</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>min</th>\n",
       "      <td>-0.003100</td>\n",
       "      <td>-6.312973</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25%</th>\n",
       "      <td>0.016250</td>\n",
       "      <td>-0.371179</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50%</th>\n",
       "      <td>0.022650</td>\n",
       "      <td>0.111287</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75%</th>\n",
       "      <td>0.031700</td>\n",
       "      <td>0.744166</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>max</th>\n",
       "      <td>0.047600</td>\n",
       "      <td>9.823151</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       net_sentiment    returns\n",
       "count      62.000000  62.000000\n",
       "mean        0.023568   0.117235\n",
       "std         0.010538   1.942848\n",
       "min        -0.003100  -6.312973\n",
       "25%         0.016250  -0.371179\n",
       "50%         0.022650   0.111287\n",
       "75%         0.031700   0.744166\n",
       "max         0.047600   9.823151"
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "plot_data[['net_sentiment', \"returns\"]].describe()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ae7187cb-8485-4aa3-99b8-e50380321e8e",
   "metadata": {},
   "source": [
    "# Tip for scoring all your transcripts\n",
    "# Why Loading All Pickle Files at Once is a Bad Idea\n",
    "\n",
    "When working in environments with limited resources, such as Jupyter notebooks or small servers, loading all pickle files containing large amounts of JSON data at once can be inefficient and risky. Here's why:\n",
    "\n",
    "## 1. Memory Overload\n",
    "Loading all pickle files at once stores each file's data in memory. If the files are large (e.g., company transcripts), this quickly consumes available RAM. When the memory fills up:\n",
    "- The system may start **swapping** (using disk space as virtual memory), which is much slower than RAM and drastically reduces performance.\n",
    "- Eventually, the memory demand might exceed the available resources, leading to **server crashes**.\n",
    "\n",
    "## 2. CPU Inefficiency\n",
    "When you load all the data at once, the CPU has to deserialize and process everything before any actual computation (like sentiment scoring) starts. This puts unnecessary pressure on the CPU, leading to inefficiencies. A better approach is to process each file as you load it, which spreads the workload over time.\n",
    "\n",
    "## 3. Scalability Issues\n",
    "As the number of files or the size of the data increases, loading everything at once becomes unsustainable. Handling one file at a time ensures that the solution can scale to larger datasets.\n",
    "\n",
    "## 4. Wasted Time and Resources\n",
    "If your goal is to score transcripts one at a time, there is no need to load all files upfront. **Loading, processing, and discarding** files one by one saves both memory and computational resources, making the process more efficient.\n",
    "\n",
    "---\n",
    "\n",
    "# Bad Approach: Loading All Files at Once\n",
    "\n",
    "```python\n",
    "# Load all pickle files at once (Bad approach)\n",
    "# Step 1: Load all data into a list\n",
    "all_data = []\n",
    "\n",
    "for filename in os.listdir(directory):\n",
    "    if filename.endswith('.p'):\n",
    "        with open(os.path.join(directory, filename), 'rb') as f:\n",
    "            data = pickle.load(f)  # Load data into memory\n",
    "            all_data.append(data)   # Store the entire data object in the list\n",
    "# NOW WE HAVE A HUGE AMOUNT OF DATA (THE WHOLE COURSE MATERIAL) IN all_data... THIS WILL CRASH\n",
    "            \n",
    "            \n",
    "# Step 2: Loop over the loaded data and process transcripts\n",
    "sentiment_scores = pd.DataFrame(columns=['pos', 'neg', 'unc'])\n",
    "\n",
    "for data in all_data:  # Loop over the loaded data\n",
    "    for transcript in data['transcripts']:  # Process each transcript\n",
    "        score = score_transcript(transcript)  # Perform scoring\n",
    "        sentiment_scores = pd.concat([sentiment_scores, pd.DataFrame([score], columns=['pos', 'neg', 'unc'])]).reset_index(drop=True)\n",
    "\n",
    "```\n",
    "                    \n",
    "Problems:\n",
    "* Loads all pickle files into memory, consuming a lot of RAM. Too much RAM which causes a kernel crash\n",
    "* Causes memory pressure and potentially server crashes if the dataset size exceeds available memory.\n",
    "* Inefficient, as processing only begins after all files are loaded.\n",
    "\n",
    "# Good Approach: Load, Process, and Move to the Next File\n",
    "```python\n",
    "# Load, process, and move to the next file (Good approach)\n",
    "for filename in os.listdir(directory):\n",
    "    if filename.endswith('.p'):\n",
    "        with open(os.path.join(directory, filename), 'rb') as f:\n",
    "            data = pickle.load(f)  # Load one file at a time\n",
    "            for transcript in data['transcripts']:\n",
    "                score = score_transcript(transcript)  # Perform some scoring\n",
    "                sentiment_scores = pd.concat([sentiment_scores, pd.DataFrame([np.array(scores)], columns=['pos', 'neg', 'unc'])]).reset_index(drop=True)\n",
    "```\n",
    "Benefits:\n",
    "* Memory-efficient: Only one file is loaded into memory at a time, reducing memory usage.\n",
    "* Scalable: This approach can handle larger datasets without overwhelming the system.\n",
    "* Faster overall process: Processing starts immediately as files are loaded, improving performance.\n",
    "\n",
    "# Conclusion\n",
    "By loading, processing, and discarding files one by one, you make your application far more efficient. This method avoids overloading the server‚Äôs memory and keeps your CPU usage in check, allowing for smooth and continuous processing without crashes. This approach is particularly well-suited for resource-limited environments like Jupyter notebooks, especially when dealing with large datasets such as company transcripts stored in pickle files."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "0a2d6b25-eb84-47e8-86a6-f09d72bd7382",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "islp",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
